data_1ddm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ddm _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.855 0.36 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.677 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 5.8 m-20 -85.21 -18.95 32.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -44.0 97.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.6 mt-10 -97.62 -5.95 34.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 72' ' ' ASP . . . -63.92 -55.98 18.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 123' ' ' VAL . 1.2 t -61.54 -36.27 72.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.707 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.411 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 22.9 mtp180 -62.0 -28.6 69.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.373 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.6 m -85.66 -92.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.798 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -175.94 34.14 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.454 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -174.41 97.22 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.036 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 10.5 t -122.88 6.01 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.591 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.618 ' HB2' HG21 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -113.15 -153.38 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.076 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.423 ' CD1' ' HE2' ' A' ' 181' ' ' LYS . 6.8 m-85 -154.56 -169.39 3.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.684 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.63 137.61 15.32 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.763 0.315 . . . . 0.0 111.012 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -132.53 179.54 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 0.0 111.675 -179.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.0 66.56 1.56 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.814 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -58.3 101.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -69.84 -37.91 76.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.151 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.98 -132.08 4.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.467 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.724 ' HB3' ' HD2' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -148.23 136.94 21.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.099 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -130.77 167.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.833 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -96.39 143.53 27.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.126 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.55 -171.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -149.46 62.98 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.164 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 1.3 mt-10 -168.95 -68.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.097 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.0 p 52.44 38.92 26.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -146.91 25.96 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.069 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -159.24 161.65 32.21 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -15.88 35.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -80.22 -18.03 50.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.945 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 t -61.49 -27.29 41.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.531 ' HB3' ' HG ' ' A' ' 161' ' ' SER . 67.3 m -81.12 -26.1 36.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.932 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -15.96 63.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -99.81 -42.9 6.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.512 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.7 -39.7 81.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.974 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 tp -56.51 -32.36 64.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.804 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 5.8 tptp -75.87 -38.9 57.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' HA ' ' A' ' 105' ' ' ALA . 16.4 t -58.18 -44.43 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.683 HD21 ' HG3' ' A' ' 114' ' ' ARG . 1.1 mt -72.67 -15.93 61.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 110' ' ' ARG . 3.8 ttt-85 -84.84 -12.39 53.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.249 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 1.5 mm100 -72.49 -64.81 0.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.658 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -177.73 -169.14 0.2 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.425 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 112' ' ' SER . 0.5 OUTLIER 69.87 -71.95 0.12 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.21 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.683 ' HG3' HD21 ' A' ' 109' ' ' LEU . 8.3 mmm180 -75.67 100.3 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.728 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.449 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -80.31 135.04 54.34 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.126 -179.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.758 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 16.4 Cg_exo -68.2 156.74 64.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.819 2.346 . . . . 0.0 112.104 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.44 140.57 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -92.29 98.04 11.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -125.77 -162.33 11.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.682 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.31 102.14 6.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.699 0.285 . . . . 0.0 110.598 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.662 HD21 HD23 ' A' ' 187' ' ' LEU . 40.8 tp -69.2 128.52 36.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.708 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' HB2' ' HG2' ' A' ' 129' ' ' ARG . 34.4 m170 -121.73 87.95 2.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.773 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.618 HG21 ' HB2' ' A' ' 82' ' ' SER . 35.8 t -62.8 94.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.148 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.798 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -98.39 144.86 27.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.287 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -60.61 -7.93 8.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.94 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.94 34.54 5.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.727 0.298 . . . . 0.0 110.997 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.651 ' HA2' HG13 ' A' ' 144' ' ' ILE . . . 109.14 143.51 10.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.774 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.41 HD21 HD11 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -73.78 164.03 27.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.955 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.525 ' HG2' ' HB2' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -158.04 114.78 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.534 179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.1 t -99.39 103.21 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.517 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.516 HG13 ' HD2' ' A' ' 136' ' ' LYS . 2.5 t -93.79 109.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.376 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.68 139.61 9.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.093 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -98.63 12.98 33.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.864 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -138.57 0.73 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.2 m -148.89 -26.46 0.3 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.438 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.516 ' HD2' HG13 ' A' ' 131' ' ' VAL . 18.3 mmtm 49.64 35.33 8.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.667 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.31 -5.15 54.71 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.63 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.403 ' HG ' ' N ' ' A' ' 139' ' ' ILE . 7.3 tp 66.26 149.52 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 110.898 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.403 ' N ' ' HG ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -138.49 -35.91 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.526 -179.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.84 95.74 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 111.351 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.66 25.79 8.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.597 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -76.65 -164.82 0.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.256 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 9.2 m -141.11 158.39 43.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.921 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.651 HG13 ' HA2' ' A' ' 127' ' ' GLY . 30.4 mt -73.13 -41.69 58.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.844 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HG2' HG23 ' A' ' 143' ' ' THR . 18.4 pt-20 -78.33 -7.14 56.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.568 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.611 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -87.9 -40.58 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.814 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.442 ' H ' HG21 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -74.86 152.91 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.803 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -65.29 0.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.722 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.641 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 26.5 p90 -174.33 141.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.83 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.4 m -67.25 166.25 14.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.452 ' HB3' ' HG ' ' A' ' 102' ' ' CYS . . . -170.09 124.54 0.66 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.34 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.1 -158.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.676 2.251 . . . . 0.0 112.405 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.726 179.561 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.796 0.331 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -147.82 124.0 1.82 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.691 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 4.7 m-85 -126.34 165.25 19.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.632 0.253 . . . . 0.0 110.562 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.72 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -163.6 158.83 21.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 -179.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.547 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -131.46 148.85 52.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.252 178.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.58 150.54 9.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.411 . . . . 0.0 111.62 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -146.37 100.02 3.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.45 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.626 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 7.3 ptt180 -72.44 -153.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -178.23 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.093 0.473 . . . . 0.0 111.6 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.0 -3.87 60.63 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.3 t -171.97 -9.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.936 0.398 . . . . 0.0 110.366 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.666 HG21 ' HG3' ' A' ' 173' ' ' MET . 2.0 m -133.86 -6.88 2.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.101 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 59.09 16.91 5.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.168 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.27 179.69 2.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.781 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.626 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -85.07 113.53 21.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.666 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.9 OUTLIER -131.49 116.45 17.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.622 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 27.3 t -108.75 129.27 55.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.222 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.724 ' HD2' ' HB3' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -96.95 142.22 29.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 179.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.72 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -124.09 157.13 18.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.331 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 22.7 p90 -161.05 172.5 16.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.676 0.274 . . . . 0.0 110.422 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.2 mp -138.53 148.9 44.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.83 121.6 25.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.069 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.74 8.48 9.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 83' ' ' PHE . 17.7 mmmt -102.12 -29.14 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.944 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 56.98 81.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.966 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.4 t -159.89 -33.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.29 37.46 80.49 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.411 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -151.47 -32.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.313 . . . . 0.0 111.136 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.646 ' HB2' HD12 ' A' ' 187' ' ' LEU . 5.7 mmt180 -74.01 -11.9 60.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.065 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.662 HD23 HD21 ' A' ' 121' ' ' LEU . 5.5 mp -135.29 -43.93 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 t -57.22 -75.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.509 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -28.59 57.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.252 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.84 84.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.918 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.74 -36.36 73.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.69 -11.34 35.56 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.32 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . 0.44 ' O ' HG22 ' A' ' 197' ' ' VAL . 56.5 m -107.78 -16.11 14.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 0.0 110.566 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.08 -51.55 66.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.213 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.544 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.9 p90 -62.0 -38.02 87.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.428 ' O ' HD12 ' A' ' 199' ' ' LEU . . . -58.75 -26.61 64.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 197' ' ' VAL . 47.0 t -97.44 -22.21 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.754 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 15.8 t -65.61 -29.92 70.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.975 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 5.1 p -168.71 145.14 3.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.779 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.65 HD22 ' HB3' ' B' ' 7' ' ' PHE . 2.5 p-10 -60.16 154.95 18.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.024 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 13.9 mmm -129.06 -15.42 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.264 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 9.5 t -84.82 20.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.65 ' HB3' HD22 ' B' ' 4' ' ' ASN . 40.1 p90 -63.49 159.8 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -91.75 0.76 57.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.783 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 59.26 81.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.132 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -74.36 150.95 87.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.86 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.571 2.181 . . . . 0.0 112.394 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.665 0.269 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -26.62 40.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -47.1 87.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.762 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -83.05 -15.95 48.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.881 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' THR . . . -53.62 -52.45 59.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.28 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.716 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.4 t -61.08 -43.62 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.565 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -55.21 -35.21 64.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.337 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 m -77.09 -92.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.531 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 179.54 35.72 0.0 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.393 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 122' ' ' HIS . 1.1 t -173.03 100.81 0.13 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.009 0.433 . . . . 0.0 111.887 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.837 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.0 t -124.29 -149.45 0.42 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.413 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.572 ' HB2' HG21 ' A' ' 123' ' ' VAL . 0.4 OUTLIER 53.74 -153.33 0.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.768 0.318 . . . . 0.0 111.805 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -158.99 -168.34 2.34 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.749 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.7 OUTLIER -52.32 143.15 15.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.532 -179.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -136.91 -171.87 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.987 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.778 ' HD2' ' HB2' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -142.23 89.94 2.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 91.5 t80 -58.31 107.68 0.52 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.01 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.501 HD13 ' HB3' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -70.06 -60.66 2.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.61 -134.11 3.14 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.469 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.533 ' HB2' ' HE3' ' A' ' 173' ' ' MET . 0.9 OUTLIER -152.41 131.28 12.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 110.898 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.42 164.74 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.783 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -100.87 136.32 40.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.967 0.413 . . . . 0.0 111.012 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.3 m -140.25 140.37 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.96 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.5 ' HA ' ' HE3' ' A' ' 172' ' ' TRP . 50.0 m-85 -102.14 64.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -147.89 -81.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.075 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.03 46.61 22.43 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.92 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.87 70.75 1.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.775 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 101' ' ' VAL . . . 144.25 179.27 20.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.247 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.49 -7.42 24.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -83.62 9.49 11.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 98' ' ' GLY . 3.2 t -80.13 -19.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.021 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.0 p -83.05 -36.88 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.961 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -66.17 -4.96 8.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.105 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.424 ' O ' HG21 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -119.59 -53.65 2.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.082 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.97 -53.34 59.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.212 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -55.54 -36.36 66.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.695 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -38.24 90.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.75 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 112' ' ' SER . 48.7 t -62.6 -45.24 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.727 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.501 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.2 mt -61.74 -37.61 84.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.586 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -28.94 64.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.93 2.54 53.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.257 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.579 ' HB3' ' HG2' ' A' ' 114' ' ' ARG . 0.1 OUTLIER -109.7 -163.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.916 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.508 ' H ' ' HG2' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -96.56 15.95 20.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.579 ' HG2' ' HB3' ' A' ' 112' ' ' SER . 1.5 mmt180 -67.14 101.74 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.01 126.79 90.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.095 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.778 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 88.1 Cg_endo -78.66 153.97 26.74 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.545 2.163 . . . . 0.0 112.314 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -129.49 121.51 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.206 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -77.96 109.41 11.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.563 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -139.33 -152.74 5.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.6 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 0.9 OUTLIER -128.92 126.27 39.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.834 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.8 tp -102.25 116.25 32.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.62 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 0.0 OUTLIER -107.09 93.12 4.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.837 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 45.2 t -60.82 95.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -94.6 129.7 41.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.198 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.06 5.22 1.37 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.217 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 124' ' ' SER . 7.7 p-10 -134.86 27.81 3.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.886 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 126.21 107.07 1.53 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.376 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.0 mt -61.34 150.7 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.949 0.405 . . . . 0.0 111.296 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.448 ' C ' HG23 ' A' ' 130' ' ' VAL . 5.7 ttm-85 -142.66 151.61 41.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.528 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.641 HG22 ' HB ' ' A' ' 140' ' ' VAL . 50.8 t -141.04 110.79 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.804 0.335 . . . . 0.0 111.368 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.8 t -104.16 126.4 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.835 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.435 ' OD2' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -54.07 151.94 6.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.563 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -104.91 8.52 34.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.028 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.74 -4.2 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.226 0.536 . . . . 0.0 110.347 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 135' ' ' THR . 26.2 m -141.83 -21.36 0.72 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.898 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 19.5 mmtp 52.09 36.96 20.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.218 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.01 -112.3 1.67 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.377 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 tp -169.78 119.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.698 0.285 . . . . 0.0 110.647 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.73 -49.77 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.319 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.641 ' HB ' HG22 ' A' ' 130' ' ' VAL . 8.2 t -114.22 105.42 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 111.311 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -118.53 34.3 5.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -73.29 -166.63 0.34 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.138 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.662 HG21 ' HG2' ' A' ' 145' ' ' GLU . 27.1 m -144.42 155.03 43.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.887 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.2 mt -64.08 -53.73 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.955 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.662 ' HG2' HG21 ' A' ' 143' ' ' THR . 0.3 OUTLIER -69.11 -9.19 51.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.853 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 36.9 tttm -85.81 -51.29 6.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.046 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.561 HG11 ' HD2' ' A' ' 162' ' ' TYR . 4.4 m -69.28 145.35 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.073 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.82 -63.86 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -166.15 142.9 5.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.699 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.423 ' H ' ' H ' ' B' ' 4' ' ' ASN . 1.2 m -71.78 165.12 24.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.3 101.2 0.48 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.41 -90.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.425 2.083 . . . . 0.0 112.366 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.812 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.44 156.75 15.43 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.346 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.64 157.21 43.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.757 0.313 . . . . 0.0 110.952 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.77 138.03 17.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.125 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.561 ' HD2' HG11 ' A' ' 147' ' ' VAL . 12.8 p90 -114.76 144.44 43.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.736 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -109.99 157.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.991 0.424 . . . . 0.0 111.589 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 14.5 t -161.24 136.05 7.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.571 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -88.73 -151.22 0.2 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.267 -179.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.436 ' HB2' ' HA ' ' A' ' 170' ' ' ARG . 6.5 p-10 -65.7 -149.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.435 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.436 ' O ' HG21 ' A' ' 168' ' ' THR . . . 83.35 -8.41 64.59 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.436 HG21 ' O ' ' A' ' 167' ' ' GLY . 0.6 OUTLIER -163.03 -42.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.081 0.467 . . . . 0.0 110.171 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.591 HG23 ' HG3' ' A' ' 171' ' ' ARG . 16.6 m -96.32 -11.4 25.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.946 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.436 ' HA ' ' HB2' ' A' ' 166' ' ' ASP . 1.1 mtp180 63.44 20.06 12.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.934 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.591 ' HG3' HG23 ' A' ' 169' ' ' THR . 1.6 ptp85 -174.31 173.47 3.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.678 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.7 OUTLIER -85.9 105.02 16.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.533 ' HE3' ' HB2' ' A' ' 90' ' ' CYS . 8.9 mtp -121.41 139.55 53.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.653 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 25.2 t -118.27 141.81 48.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.933 0.396 . . . . 0.0 110.984 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -111.14 151.31 28.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.548 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -128.22 156.2 20.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.64 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -170.78 132.93 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.12 173.62 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.834 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -97.98 133.62 42.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.09 -24.06 61.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.776 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -82.08 -28.0 32.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.913 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.05 84.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.998 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 t -169.24 -38.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.55 26.6 62.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.402 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -132.49 -23.7 2.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 111.203 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.408 ' HB2' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -86.9 -17.99 31.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.455 HD11 ' N ' ' A' ' 187' ' ' LEU . 5.9 mp -124.87 -49.2 1.74 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.249 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.8 -46.55 87.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.241 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.89 1.26 13.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.316 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.15 -46.74 4.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.109 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.688 ' HA ' HG13 ' A' ' 123' ' ' VAL . 8.5 p -71.41 -20.72 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.4 -14.04 66.13 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.722 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.9 m -103.84 1.06 31.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.988 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.716 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -78.51 -42.31 29.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.987 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.518 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.0 m-85 -60.57 -37.77 82.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.626 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.46 ' O ' HD13 ' A' ' 199' ' ' LEU . . . -54.59 -34.6 62.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.439 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.6 -10.67 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.173 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.6 t -84.3 -16.31 43.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.191 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.333 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.816 0.341 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.83 144.11 14.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.963 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.491 HD22 ' HG ' ' B' ' 6' ' ' SER . 22.7 t-20 -62.89 105.18 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.037 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -9.08 53.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.491 ' HG ' HD22 ' B' ' 4' ' ' ASN . 1.2 p -81.05 11.74 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.226 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -56.87 142.47 41.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.33 10.17 13.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 32.4 t0 56.04 78.15 0.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.144 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 26.2 m-85 -61.79 139.0 95.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.028 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 47.0 Cg_exo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.656 2.237 . . . . 0.0 112.386 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.842 0.353 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -86.3 -28.34 23.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -66.89 -47.91 70.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.594 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.663 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -69.72 -26.8 64.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.5 80.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.687 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.739 HG12 ' HA ' ' A' ' 194' ' ' ALA . 42.1 t -59.33 -36.83 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.3 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.663 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 2.2 mtm-85 -65.36 -37.09 85.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.117 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.66 -5.97 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.435 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 70.58 46.89 0.51 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.414 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.814 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -172.57 87.04 0.07 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.47 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.826 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.7 t -119.7 -149.19 0.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.302 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.612 ' HG ' HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER 57.64 -154.85 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.375 . . . . 0.0 111.573 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 5.5 m-85 -158.32 -170.77 3.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.503 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.14 154.35 3.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.79 0.329 . . . . 0.0 111.005 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.28 -170.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.073 0.464 . . . . 0.0 111.592 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 5.1 mmtp -141.54 80.15 1.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.467 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 48.4 t80 -56.83 108.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.276 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.465 HD21 HD12 ' A' ' 178' ' ' LEU . 7.9 mt -70.53 -51.37 29.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.661 ' HA3' ' HD3' ' A' ' 114' ' ' ARG . . . 152.71 -131.48 3.37 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.615 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 114' ' ' ARG . 1.4 p -153.3 134.15 13.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.819 0.342 . . . . 0.0 110.854 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.414 HG11 ' HG ' ' A' ' 109' ' ' LEU . 7.0 m -128.02 146.2 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -71.33 132.94 45.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.168 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 174' ' ' CYS . 10.7 m -117.26 -178.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.046 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -139.34 59.61 1.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.037 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HB3' HG21 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -171.54 -63.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.821 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m 60.23 31.32 20.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.399 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 ptt180 -165.39 88.12 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.95 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.19 158.73 9.16 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.753 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -37.77 54.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 110.86 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 2.2 pt20 -67.36 -22.55 65.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 95' ' ' GLU . 41.2 t -60.92 -33.13 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.08 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.49 ' HB3' ' HG ' ' A' ' 161' ' ' SER . 83.5 m -80.07 -39.33 29.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.997 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.643 ' HG2' ' HA ' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -64.26 -28.63 69.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.047 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 68.0 mt-10 -81.31 -50.87 9.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.78 75.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.321 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.8 tp -57.87 -38.9 76.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -73.21 -37.99 66.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 t -58.66 -38.49 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.425 HD22 ' HG3' ' A' ' 114' ' ' ARG . 1.9 mt -72.76 -33.58 66.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -80.91 -3.32 51.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.759 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -117.32 -13.52 10.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.9 p -93.62 -166.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.38 27.4 6.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.046 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.661 ' HD3' ' HA3' ' A' ' 89' ' ' GLY . 0.1 OUTLIER -72.79 113.55 9.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.75 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 131.11 91.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 90.8 Cg_endo -85.05 145.59 9.9 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.742 2.295 . . . . 0.0 112.187 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 1.8 t -108.43 155.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -116.49 103.25 10.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.971 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.42 -164.73 12.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.622 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -112.15 131.41 55.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 111.143 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.612 HD23 ' HG ' ' A' ' 82' ' ' SER . 22.0 tp -98.14 120.8 39.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.171 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.814 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 74.7 m-70 -109.16 98.46 7.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.09 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.826 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 16.9 t -67.11 100.3 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.246 0.546 . . . . 0.0 110.503 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -98.9 131.43 44.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.268 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.86 20.94 1.01 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.616 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 124' ' ' SER . 9.3 t70 -150.32 14.69 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.782 0.325 . . . . 0.0 110.759 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.778 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 139.4 107.87 0.76 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.684 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.77 ' HG ' HD13 ' A' ' 144' ' ' ILE . 12.8 mt -50.59 150.1 2.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.842 0.353 . . . . 0.0 111.131 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -145.32 113.43 6.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 140' ' ' VAL . 2.8 t -111.46 115.17 49.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 111.657 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 2.1 t -97.33 156.92 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.647 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.526 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 0.3 OUTLIER -95.69 165.08 12.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.417 179.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.45 -5.82 18.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 135' ' ' THR . 0.0 OUTLIER -107.69 -36.95 6.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.939 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.451 ' N ' ' HG3' ' A' ' 134' ' ' GLU . 8.8 t -118.99 -12.5 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 30.5 mmtt 59.25 23.02 11.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.777 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 131' ' ' VAL . . . -87.91 -161.77 37.26 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.131 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 tp -116.17 124.32 50.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.0 -25.62 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.365 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.502 ' HB ' HG22 ' A' ' 130' ' ' VAL . 48.4 t -132.45 94.67 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.863 0.363 . . . . 0.0 111.131 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -96.77 72.0 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.756 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.14 -175.78 3.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.852 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 20.2 m -136.47 151.83 49.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.77 HD13 ' HG ' ' A' ' 128' ' ' LEU . 9.5 mm -61.33 -40.54 86.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.041 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.86 -6.13 59.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.606 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.852 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 2.6 tttp -87.69 -42.95 12.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.907 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 143' ' ' THR . 0.7 OUTLIER -64.89 128.58 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.2 t -62.87 -35.37 79.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.143 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.518 ' HB2' HD11 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -147.78 150.77 34.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.344 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.5 m -129.04 80.52 1.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.299 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -109.72 128.69 24.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.61 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.713 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 69.8 Cg_endo -75.45 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.535 2.156 . . . . 0.0 112.329 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.643 ' HA ' ' HG2' ' A' ' 103' ' ' GLU . 13.8 p-10 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.51 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 183' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 120.799 0.333 . . . . 0.0 110.838 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -107.36 143.03 15.86 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.568 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -123.97 168.18 13.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.653 0.264 . . . . 0.0 110.892 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.49 ' HG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -162.02 166.12 26.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.494 . . . . 0.0 111.288 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.419 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -152.55 141.09 20.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.29 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.518 HD11 ' HB2' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -106.72 147.71 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.976 0.417 . . . . 0.0 111.558 -178.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.14 106.5 4.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.641 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -84.89 132.6 34.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.1 p30 44.64 -161.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.869 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.32 -9.6 60.86 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.477 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.6 t -176.06 -19.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 110.425 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.458 HG21 ' HG3' ' A' ' 171' ' ' ARG . 7.6 m -111.08 -15.45 13.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.762 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 58.91 26.48 14.99 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.901 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.458 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -177.88 177.87 1.03 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.023 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.41 132.65 45.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.019 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.1 132.75 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.665 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.498 ' HB2' HG12 ' A' ' 93' ' ' VAL . 20.3 t -116.13 160.19 20.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.307 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -124.92 138.18 54.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.537 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -123.37 147.26 16.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.661 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 6.5 p90 -162.78 143.2 9.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 0.0 110.745 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.465 HD12 HD21 ' A' ' 88' ' ' LEU . 1.2 mt -111.76 154.92 24.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.137 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.402 ' HB1' HD21 ' A' ' 187' ' ' LEU . . . -83.71 129.51 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.15 6.27 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.57 -26.53 12.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 55.38 83.07 0.09 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.431 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -169.66 -37.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.076 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.2 28.5 73.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.435 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.88 -16.42 5.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 110.954 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 -9.77 16.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.586 HD23 HD23 ' A' ' 121' ' ' LEU . 4.1 mp -125.55 -46.3 1.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.194 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -61.8 2.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.989 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.76 -8.27 34.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.141 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.14 -41.7 13.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.236 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' A' ' 123' ' ' VAL . 7.0 p -77.44 -29.2 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.046 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.87 -3.83 52.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.231 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 92.2 m -115.27 1.53 13.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 110.683 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.739 ' HA ' HG12 ' A' ' 76' ' ' VAL . . . -77.69 -44.26 28.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.07 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.451 ' HD2' HD23 ' A' ' 199' ' ' LEU . 4.2 p90 -64.96 -25.22 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.938 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -61.14 -19.05 61.07 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.21 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.99 -27.29 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.001 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.9 t -74.76 -30.84 61.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.765 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' A' ' 196' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.405 ' HB2' ' H ' ' B' ' 3' ' ' SER . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.754 0.312 . . . . 0.0 110.795 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.405 ' H ' ' HB2' ' B' ' 2' ' ' PHE . 51.4 p -168.61 161.38 11.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.561 HD22 ' HB3' ' B' ' 7' ' ' PHE . 0.6 OUTLIER -78.12 159.91 28.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.999 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' MET . . . . . 0.428 ' HE1' ' HE2' ' A' ' 195' ' ' PHE . 10.2 mtm -130.33 -10.94 4.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.995 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -83.59 8.26 14.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.959 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.561 ' HB3' HD22 ' B' ' 4' ' ' ASN . 52.5 p90 -63.4 151.69 40.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -98.56 12.92 33.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.862 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t70 56.03 75.99 0.31 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -71.01 143.71 89.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.934 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo . . . . . 0 C--O 1.249 1.068 0 C-N-CA 122.638 2.225 . . . . 0.0 112.25 -179.757 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.91 0.386 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.46 -27.29 25.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.862 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -87.26 -23.77 24.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.55 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.727 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.0 OUTLIER -90.45 -15.14 31.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 81' ' ' CYS . . . -60.93 -49.44 77.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.943 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.797 HG13 ' HA ' ' A' ' 194' ' ' ALA . 2.0 t -60.52 -41.0 86.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.255 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.727 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 9.8 mtt180 -56.07 -33.91 65.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.452 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 m -80.7 -92.02 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.7 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -178.71 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.453 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -172.44 98.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.788 0.328 . . . . 0.0 111.099 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.512 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 15.7 t -129.0 61.06 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.641 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.436 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -161.01 -156.54 0.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.098 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.541 ' HB2' HD12 ' A' ' 187' ' ' LEU . 1.9 m-85 -156.12 -170.55 3.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.179 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 1.4 m -51.13 141.76 13.75 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.99 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.9 m -135.86 -175.55 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.42 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -133.99 73.92 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.703 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 78.2 t80 -61.37 108.04 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HB2' HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -80.22 -36.54 34.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.12 -127.16 3.02 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.606 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.2 p -164.64 130.11 2.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.07 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m -114.21 146.81 18.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -72.43 129.9 39.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.109 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.67 176.79 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.924 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -141.3 59.73 1.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 2.3 mt-10 -162.08 -63.17 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.093 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.17 34.44 17.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -146.12 141.76 27.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.979 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.79 -139.48 14.48 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.571 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.25 -33.31 0.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 0.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -18.87 65.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.228 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -37.24 48.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.767 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.468 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 85.8 m -69.22 -28.69 66.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.67 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -22.27 61.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.905 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.31 -52.59 5.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.96 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.53 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.31 -49.16 78.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.136 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.1 tp -53.39 -30.81 41.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.975 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -37.03 67.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.8 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.0 t -60.82 -48.09 90.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.755 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 105' ' ' ALA . 1.4 mp -70.49 -17.18 62.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.698 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 110' ' ' ARG . 2.0 ttm-85 -87.46 -9.67 53.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.569 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -80.56 -63.86 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.744 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -171.91 -175.67 1.55 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.294 179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 112' ' ' SER . 7.1 mpt_? 70.08 -71.55 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.97 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.421 ' H ' ' HG2' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -66.82 110.56 3.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.932 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.57 142.65 24.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.443 ' HB3' HD21 ' A' ' 88' ' ' LEU . 97.8 Cg_endo -79.42 148.67 21.04 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.575 2.184 . . . . 0.0 112.348 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.23 117.45 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -65.17 97.98 0.29 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.989 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -127.44 -161.48 10.83 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.195 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.449 HD21 ' HA ' ' A' ' 120' ' ' LEU . 0.3 OUTLIER -129.27 117.68 21.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.334 . . . . 0.0 110.643 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.5 tp -89.87 130.71 36.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.728 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.419 ' CE1' HD13 ' A' ' 120' ' ' LEU . 30.9 m-70 -118.22 93.19 4.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.915 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 79.4 t -66.15 94.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.616 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -99.46 135.69 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.346 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -58.06 -9.56 5.85 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.104 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -114.88 32.73 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.29 134.97 6.64 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 mt -66.98 171.1 5.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.907 0.384 . . . . 0.0 111.233 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.538 ' HD3' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -167.24 110.67 0.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.665 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.7 t -106.32 114.8 46.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.92 0.39 . . . . 0.0 111.384 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.72 120.35 57.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.874 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 37.6 m-20 -52.22 152.97 3.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.55 2.52 28.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.939 0.4 . . . . 0.0 111.165 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.42 -24.73 6.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.572 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.01 -10.52 5.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.686 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 27.4 mmtm 54.03 26.27 6.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.817 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -90.67 135.76 13.03 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.443 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.538 HD12 ' HD3' ' A' ' 129' ' ' ARG . 5.1 tp -67.65 108.17 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.663 0.268 . . . . 0.0 110.619 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 3.0 pt -99.36 -25.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.435 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 129' ' ' ARG . 74.8 t -136.68 106.19 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.214 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.22 27.93 8.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.327 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -70.24 -173.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.23 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.589 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 2.8 m -131.46 164.7 25.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.709 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 16.0 mt -77.61 -33.45 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.62 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -85.87 -10.87 54.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.45 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 7.1 tttm -83.53 -37.83 22.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.762 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.415 ' H ' HG21 ' A' ' 147' ' ' VAL . 3.5 m -77.67 138.35 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -60.5 -68.58 0.29 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.516 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 148' ' ' SER . 0.1 OUTLIER -141.22 136.44 31.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.054 178.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.517 ' O ' ' HB3' ' B' ' 2' ' ' PHE . 60.6 m -98.35 93.26 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.549 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -105.11 153.17 39.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.464 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.883 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 82.8 Cg_endo -86.6 -118.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.783 2.322 . . . . 0.0 112.149 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.596 0.236 . . . . 0.0 111.042 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 120.857 0.361 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -149.9 119.04 0.99 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.429 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.724 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -111.3 -179.42 3.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.01 0.433 . . . . 0.0 111.034 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.468 ' OG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -166.44 169.85 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.498 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -150.6 145.54 25.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -117.03 157.12 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.063 0.459 . . . . 0.0 111.567 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.7 -174.97 5.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.677 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.9 OUTLIER -127.65 -149.37 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.799 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER -63.57 -163.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.903 0.382 . . . . 0.0 111.384 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.91 -16.29 60.46 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.7 t -163.96 -5.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 110.068 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.504 HG21 ' HG3' ' A' ' 173' ' ' MET . 6.9 m -132.17 -12.37 3.21 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.592 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 34.3 mtt85 60.8 19.39 9.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.059 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.587 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -171.89 172.79 4.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.935 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -81.76 115.33 20.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.625 179.453 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.587 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 3.2 mtp -131.31 145.91 52.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.522 ' HB2' HG22 ' A' ' 163' ' ' ILE . 16.4 t -119.11 142.95 47.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -112.25 156.63 22.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.628 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -137.93 146.77 18.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.537 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -164.72 161.06 20.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 0.0 110.959 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.44 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 2.0 mp -127.92 168.6 15.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.88 125.32 45.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.071 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.42 -13.94 45.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.692 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' A' ' 83' ' ' PHE . 5.9 mmtm -80.73 -28.65 36.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 56.33 37.13 28.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.992 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.43 -44.33 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.987 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.24 31.05 43.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.534 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -127.88 -30.12 2.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 110.978 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -8.94 53.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.742 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 83' ' ' PHE . 4.9 mp -127.32 -55.99 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.278 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -63.38 1.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.421 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -59.95 -19.18 50.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.258 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -79.77 -44.57 20.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.238 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.8 -32.58 57.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.722 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.95 -7.57 30.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.425 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 59.5 m -109.75 -17.4 13.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.778 0.323 . . . . 0.0 110.97 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.797 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -55.7 -44.83 77.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.128 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.457 ' HD2' ' HB3' ' B' ' 6' ' ' SER . 2.4 p90 -74.9 -29.7 61.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.53 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -60.18 -17.13 38.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 89.8 t -106.82 -27.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.088 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.2 t -75.38 -4.39 39.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.53 HD11 ' HA ' ' A' ' 196' ' ' ALA . 5.1 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.883 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.692 0.282 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' B' ' 2' ' ' PHE . 91.0 p 177.39 140.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.881 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -73.1 178.46 4.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.55 -17.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.005 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.457 ' HB3' ' HD2' ' A' ' 195' ' ' PHE . 51.9 p -80.15 3.31 20.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -70.91 164.23 25.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -107.63 -1.31 21.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t70 58.86 95.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.225 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -58.08 146.55 68.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.86 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo . . . . . 0 C--O 1.248 1.011 0 C-N-CA 122.493 2.128 . . . . 0.0 112.285 -179.846 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.425 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -82.09 -38.46 24.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.107 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -63.04 -20.3 65.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.644 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 8.9 tt0 -104.53 -12.94 16.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.635 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 80' ' ' THR . . . -54.77 -48.75 72.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.241 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 81' ' ' CYS . 1.2 t -62.03 -35.51 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.388 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -65.9 -29.96 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -90.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -176.58 34.7 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.519 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -176.8 102.82 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.894 0.378 . . . . 0.0 111.251 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.587 ' HG ' ' HB1' ' A' ' 190' ' ' ALA . 23.0 t -141.34 65.28 1.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.586 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -163.27 -160.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.35 . . . . 0.0 111.158 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -156.05 -171.17 3.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.898 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.27 148.69 2.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.878 0.371 . . . . 0.0 111.305 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.7 -167.08 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.24 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.84 75.84 1.5 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.765 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.445 ' O ' HG23 ' A' ' 117' ' ' VAL . 83.0 t80 -63.71 91.82 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.016 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.528 ' HB2' HD23 ' A' ' 109' ' ' LEU . 0.7 OUTLIER -61.46 -43.24 99.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.522 ' HA3' ' HD3' ' A' ' 114' ' ' ARG . . . 150.58 -126.75 2.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.332 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.92 132.34 8.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 0.0 111.107 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.491 HG13 ' HG ' ' A' ' 109' ' ' LEU . 4.2 m -126.02 149.91 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.993 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.51 137.22 54.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.41 ' H ' HG21 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -119.9 -169.68 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.898 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -122.77 80.4 1.74 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 63.8 109.22 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.804 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.417 ' HA ' HG21 ' A' ' 163' ' ' ILE . 1.5 p -45.9 -30.16 1.64 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.576 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.32 126.67 19.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.096 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.3 -125.35 2.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.574 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -170.18 -50.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.718 0.294 . . . . 0.0 110.638 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -78.84 11.51 2.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.188 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.502 HG13 HG12 ' A' ' 163' ' ' ILE . 9.6 t -62.61 -16.27 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.936 0.398 . . . . 0.0 110.599 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 67.2 m -102.31 -35.49 8.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.875 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.87 -19.72 62.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' O ' HG21 ' A' ' 108' ' ' VAL . 76.3 mt-10 -104.49 -48.28 3.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.145 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 101' ' ' VAL . . . -56.84 -37.03 70.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.279 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.586 ' HB2' ' HG ' ' A' ' 161' ' ' SER . 14.8 tp -58.48 -35.93 72.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.66 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -34.97 61.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 104' ' ' GLU . 21.2 t -58.7 -33.14 48.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.668 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -80.01 -25.12 40.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.529 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.1 -14.47 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.711 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -105.99 -3.86 21.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.949 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.66 -173.53 2.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.03 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.5 10.94 16.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.002 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.579 ' HG3' HD22 ' A' ' 109' ' ' LEU . 5.6 mmp_? -62.98 105.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -83.03 134.79 45.74 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.088 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.86 142.49 28.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.525 2.15 . . . . 0.0 112.182 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 87' ' ' TYR . 2.3 t -107.5 122.35 61.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -69.17 112.93 6.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -151.53 145.9 14.16 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.576 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.07 110.14 17.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 0.0 111.004 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.445 ' O ' ' HB3' ' A' ' 82' ' ' SER . 27.3 tp -80.65 137.68 36.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.586 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -124.08 85.83 2.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.704 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.586 ' H ' ' HB2' ' A' ' 82' ' ' SER . 74.7 t -62.39 98.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.108 0.48 . . . . 0.0 111.002 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -98.53 142.34 30.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.205 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.59 16.84 2.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.672 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 124' ' ' SER . 35.7 t0 -146.97 27.99 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.879 0.371 . . . . 0.0 110.433 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.34 113.07 1.77 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -75.79 141.49 42.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.948 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -142.23 131.55 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 140' ' ' VAL . 9.1 t -106.88 112.44 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.73 109.92 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.736 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 2.8 m-20 -51.29 147.38 5.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.983 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -97.41 11.45 36.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.927 0.394 . . . . 0.0 110.651 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.05 -30.64 6.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.869 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.675 HG21 ' H ' ' A' ' 137' ' ' GLY . 14.8 t -132.71 -8.69 3.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.005 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 13.3 mmtp 58.34 22.65 9.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.831 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.675 ' H ' HG21 ' A' ' 135' ' ' THR . . . -75.47 -133.49 0.38 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.577 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.784 HD22 ' HB3' ' A' ' 141' ' ' ASP . 2.8 tp -151.12 112.85 4.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 0.0 110.66 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.26 -45.38 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.198 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 130' ' ' VAL . 36.5 t -119.63 97.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.249 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.784 ' HB3' HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -105.86 59.38 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.691 179.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.17 -169.62 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.044 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.746 HG23 ' HG2' ' A' ' 145' ' ' GLU . 62.1 m -136.31 156.88 48.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.554 ' N ' HG22 ' A' ' 143' ' ' THR . 0.3 OUTLIER -57.22 -42.27 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.695 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.746 ' HG2' HG23 ' A' ' 143' ' ' THR . 7.5 pt-20 -81.39 -14.22 57.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.428 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.536 ' HB3' ' H ' ' A' ' 143' ' ' THR . 0.7 OUTLIER -76.29 -39.55 53.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.587 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.616 HG11 ' HD2' ' A' ' 162' ' ' TYR . 1.1 m -80.02 150.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -62.44 1.73 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.624 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.788 ' HB2' ' HB3' ' B' ' 3' ' ' SER . 22.1 p90 -173.22 135.8 0.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.73 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.31 136.17 36.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.294 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.4 102.52 4.03 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.641 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 12.4 Cg_endo -54.76 -83.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.626 2.217 . . . . 0.0 112.408 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.955 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.882 0.372 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -145.2 136.92 6.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.293 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.62 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -122.6 -175.29 3.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.586 ' HG ' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -164.95 173.72 11.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.411 . . . . 0.0 111.05 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.616 ' HD2' HG11 ' A' ' 147' ' ' VAL . 10.0 p90 -158.24 147.18 19.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.514 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.762 HG22 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -116.39 158.61 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 0.0 111.51 -178.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.5 p -157.52 -176.54 6.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.483 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -130.6 135.63 48.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.3 p30 44.19 -158.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.811 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.05 -12.36 62.21 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.1 t 179.76 -17.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.096 0.474 . . . . 0.0 110.176 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.547 HG23 ' HG3' ' A' ' 171' ' ' ARG . 87.6 m -112.77 -14.18 13.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.499 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 58.37 26.46 14.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.357 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.547 ' HG3' HG23 ' A' ' 169' ' ' THR . 0.0 OUTLIER -174.53 -171.44 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 111.561 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.44 135.54 57.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.477 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.17 145.54 4.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.658 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.762 ' HB2' HG22 ' A' ' 163' ' ' ILE . 44.7 t -128.0 145.35 51.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.163 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -115.14 137.25 52.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.593 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.515 ' HA3' HD12 ' A' ' 109' ' ' LEU . . . -110.74 152.91 17.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.673 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -167.51 132.89 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.87 0.367 . . . . 0.0 111.047 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.581 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 3.9 mp -106.42 156.8 18.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.11 120.66 25.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.9 t -70.47 -11.87 61.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.958 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.81 -26.19 24.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 54.8 71.82 0.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.4 t -155.17 -30.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 64.91 36.91 93.65 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.401 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -139.52 -30.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.737 0.304 . . . . 0.0 111.021 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -90.58 -2.53 57.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.886 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 186' ' ' ARG . 5.5 mp -135.96 -58.22 0.76 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.27 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.05 -57.67 8.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.342 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -59.84 -20.54 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.074 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.587 ' HB1' ' HG ' ' A' ' 81' ' ' CYS . . . -78.12 -45.45 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.073 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 187' ' ' LEU . 98.6 t -63.82 -30.71 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.91 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.475 ' HA2' ' HE1' ' A' ' 195' ' ' PHE . . . -64.09 -7.38 23.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.427 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -119.24 -5.12 10.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 0.0 110.743 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -74.5 -52.53 11.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.333 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.475 ' HE1' ' HA2' ' A' ' 192' ' ' GLY . 40.1 p90 -65.94 -31.14 71.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.945 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -58.22 -24.22 58.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.791 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.75 -18.97 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.962 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 3.7 t -74.89 -27.07 60.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.957 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.444 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.801 0.334 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.788 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER 62.87 118.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.184 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.552 ' ND2' ' HA ' ' A' ' 149' ' ' PHE . 21.0 p30 -57.5 157.59 6.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.07 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 3.1 mtp -125.0 0.21 7.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.018 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 32.6 p -92.01 25.08 2.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.443 ' HD2' ' H ' ' B' ' 9' ' ' ASP . 39.4 p90 -72.14 162.0 30.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -114.74 11.7 16.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.489 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . 0.443 ' H ' ' HD2' ' B' ' 7' ' ' PHE . 35.3 t70 57.45 78.27 0.24 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.211 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -63.08 146.4 95.85 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.725 2.283 . . . . 0.0 112.384 -179.512 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.906 0.384 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.63 -28.13 45.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.272 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.41 -29.16 69.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.308 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.696 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.6 tm-20 -82.52 -23.2 34.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.688 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.18 -49.97 72.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.885 HG11 ' HA ' ' A' ' 194' ' ' ALA . 55.2 t -63.51 -42.17 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.487 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.696 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -55.31 -37.12 66.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.272 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.7 m -71.74 -90.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.218 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.624 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 176.91 38.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.422 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.652 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 1.5 t -174.23 102.34 0.1 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.986 0.422 . . . . 0.0 112.045 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 9.6 t -142.17 56.81 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.994 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.643 ' HG ' HD22 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -151.75 -151.34 0.38 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.168 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -155.41 -172.89 4.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.023 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.92 146.64 13.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.494 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 121' ' ' LEU . 10.5 m -146.56 -176.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.19 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 1.1 mptt -143.0 81.54 1.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.875 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -61.32 100.08 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.684 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 1.0 OUTLIER -64.85 -48.33 74.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.61 -131.42 3.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.595 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.651 ' HB2' ' HE1' ' A' ' 173' ' ' MET . 0.8 OUTLIER -144.96 133.56 22.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.71 0.29 . . . . 0.0 110.991 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.621 HG12 ' HG ' ' A' ' 109' ' ' LEU . 4.4 m -124.79 157.69 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -83.55 142.96 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -179.01 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.898 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.64 59.66 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.173 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 2.7 tt0 -170.22 -61.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.072 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.5 p 48.71 54.25 10.97 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.965 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 1.7 ptm180 -163.38 114.47 1.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.993 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.77 -137.03 12.5 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.807 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -147.58 -19.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.867 0.365 . . . . 0.0 110.761 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -79.26 4.72 14.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.071 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.38 -15.52 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.767 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.618 ' HB3' ' HG ' ' A' ' 161' ' ' SER . 89.4 m -88.43 -34.37 17.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.813 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.14 -22.51 66.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -93.66 -46.37 7.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.78 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.68 64.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.973 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.61 -39.9 76.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.702 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -24.49 65.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.738 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.547 HG12 HG11 ' A' ' 91' ' ' VAL . 59.0 t -75.13 -45.89 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.621 ' HG ' HG12 ' A' ' 91' ' ' VAL . 1.3 mt -60.07 -35.7 75.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.957 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -72.09 -39.24 69.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.712 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -77.09 -11.95 59.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.26 -174.98 2.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 113' ' ' ARG . 1.4 mtp85 -87.67 14.37 8.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.47 ' HG3' HD23 ' A' ' 109' ' ' LEU . 3.1 mmp_? -61.34 103.26 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 115' ' ' ARG . 4.7 ptp85 -76.2 123.31 87.95 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.133 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 73.5 Cg_endo -75.66 172.82 15.57 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.488 2.125 . . . . 0.0 112.211 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.4 t -130.47 140.23 49.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.21 72.87 8.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 132' ' ' ASP . . . -123.95 149.24 16.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.708 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.14 126.79 31.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 110.94 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.631 HD23 HD22 ' A' ' 187' ' ' LEU . 51.8 tp -89.52 136.82 32.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.499 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.652 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 89.8 m-70 -126.72 94.76 4.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.1 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 191' ' ' VAL . 54.3 t -60.8 97.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.016 0.436 . . . . 0.0 110.725 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 11.9 p -103.53 137.0 42.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.269 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -78.56 39.92 1.98 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.692 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -162.07 13.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.397 . . . . 0.0 110.729 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.746 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 134.57 97.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.468 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.5 ' HG ' HG13 ' A' ' 144' ' ' ILE . 2.4 mt -53.68 138.58 34.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.068 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.641 ' HG2' HD13 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -137.31 142.22 41.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.472 HG23 HD13 ' A' ' 121' ' ' LEU . 8.7 t -114.93 102.33 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.035 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.517 HG13 ' HD2' ' A' ' 136' ' ' LYS . 2.6 t -92.85 114.99 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.401 ' HA ' ' CA ' ' A' ' 119' ' ' GLY . 4.6 t0 -50.5 144.72 7.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.077 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.21 5.15 51.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.165 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 -32.74 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.692 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.49 -19.53 13.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.737 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.517 ' HD2' HG13 ' A' ' 131' ' ' VAL . 5.5 mmtm 50.02 39.63 19.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.919 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.41 -124.07 5.23 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.492 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.641 HD13 ' HG2' ' A' ' 129' ' ' ARG . 10.3 tp -154.76 113.81 3.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 110.726 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 5.5 mt -96.23 -54.01 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.4 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.9 t -112.5 111.81 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.904 0.383 . . . . 0.0 111.313 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.32 25.32 10.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.608 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -68.43 -170.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.169 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.746 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 5.6 m -146.03 154.29 41.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.931 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.5 HG13 ' HG ' ' A' ' 128' ' ' LEU . 13.6 mt -70.11 -43.51 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.706 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.473 ' HG2' HG22 ' A' ' 143' ' ' THR . 0.1 OUTLIER -78.24 -1.05 31.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.683 179.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' B' ' 10' ' ' PHE . 0.1 OUTLIER -96.89 -43.08 7.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 143' ' ' THR . 0.6 OUTLIER -66.02 145.06 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 110.993 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -55.39 -64.8 0.73 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.628 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 148' ' ' SER . 0.0 OUTLIER -144.51 -178.01 5.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.869 179.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.452 ' HB3' ' HA ' ' B' ' 3' ' ' SER . 2.2 t -123.18 155.58 36.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.419 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' A' ' 99' ' ' MET . . . -176.12 126.06 0.34 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.77 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 96.4 Cg_endo -85.09 -90.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.76 2.307 . . . . 0.0 112.308 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 5.9 p-10 . . . . . 0 C--O 1.232 0.166 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.568 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.858 0.361 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 153' ' ' ASP . . . -105.19 143.82 15.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.355 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.607 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -119.22 169.68 9.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.323 . . . . 0.0 110.87 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.656 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -164.41 176.84 8.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -147.43 145.52 29.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.403 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -106.85 152.49 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.468 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.13 127.54 12.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.685 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -99.95 113.49 26.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.469 ' HA ' ' N ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER 50.45 -153.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.311 179.25 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.94 -37.31 2.51 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.385 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 166' ' ' ASP . 0.7 OUTLIER -153.26 5.47 0.34 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.75 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.1 OUTLIER -128.72 -17.79 3.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.731 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.469 ' N ' ' HA ' ' A' ' 166' ' ' ASP . 0.1 OUTLIER 58.6 25.35 13.09 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.095 -178.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.448 ' H ' ' HA ' ' A' ' 166' ' ' ASP . 0.0 OUTLIER 172.19 176.4 0.09 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.552 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.08 124.33 26.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.5 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.75 ' HB2' HG21 ' A' ' 169' ' ' THR . 24.6 mtp -153.63 125.45 7.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.203 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 6.7 t -106.84 141.05 38.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.353 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 8.5 m170 -103.54 129.87 50.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.001 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.656 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -112.57 154.33 16.94 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.35 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -158.73 136.22 10.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.731 0.3 . . . . 0.0 110.536 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.8 mt -97.07 139.85 32.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.299 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.34 115.69 17.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.779 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 3.0 t -58.91 -23.69 61.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -28.52 31.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.045 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 55.08 82.93 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.8 t -161.33 -37.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.925 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.51 18.61 78.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.578 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -134.81 -0.37 2.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 0.0 110.816 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -98.54 -25.38 14.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.903 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.643 HD22 ' HG ' ' A' ' 82' ' ' SER . 4.2 mp -124.39 -51.04 1.75 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.806 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.0 t -58.26 -49.38 77.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.673 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 1.4 t-80 -69.67 -1.92 10.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.547 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -103.97 -40.75 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.167 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.661 ' HA ' HG13 ' A' ' 123' ' ' VAL . 4.8 p -67.92 -15.29 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.08 97.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.565 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 66.1 m -84.35 -11.58 56.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.988 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.885 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -60.06 -28.46 67.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.274 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.461 ' C ' HD11 ' A' ' 199' ' ' LEU . 3.0 m-85 -80.89 -37.73 29.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -55.91 -21.84 22.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.264 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.437 ' H ' HG23 ' A' ' 197' ' ' VAL . 0.8 OUTLIER -75.3 -42.1 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.803 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . 0.425 ' HB3' ' HG ' ' B' ' 6' ' ' SER . 85.4 m -78.76 -15.12 58.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.483 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.461 HD11 ' C ' ' A' ' 195' ' ' PHE . 8.3 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.817 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 3.4 p90 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.634 0.254 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 150' ' ' CYS . 2.7 p -145.34 171.34 14.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.937 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -81.18 161.1 24.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.974 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 16.3 mtp -134.34 -7.49 2.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.026 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.425 ' HG ' ' HB3' ' A' ' 198' ' ' CYS . 20.6 t -93.12 27.13 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -62.72 158.25 19.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.75 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -85.05 7.3 21.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.857 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 17.7 t70 53.67 68.73 0.8 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.136 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.4 ' HE2' ' HA ' ' A' ' 146' ' ' LYS . 60.7 m-85 -67.86 140.69 94.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 C--O 1.248 1.004 0 C-N-CA 122.534 2.156 . . . . 0.0 112.336 -179.802 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.838 0.351 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.69 -32.58 6.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -60.36 -41.47 93.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.873 0.368 . . . . 0.0 110.777 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.832 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.6 mt-10 -92.88 -5.08 51.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.762 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -66.08 -46.42 77.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.045 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.448 HG23 HG11 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -64.79 -36.58 77.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.394 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.832 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -59.31 -39.27 82.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.359 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -91.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.555 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -178.36 36.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.488 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.514 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -176.0 101.71 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.668 0.27 . . . . 0.0 111.253 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.494 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 16.6 t -128.22 0.06 5.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.791 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.662 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -97.78 -163.38 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.6 0.238 . . . . 0.0 111.042 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.633 ' HB3' ' HD2' ' A' ' 181' ' ' LYS . 8.5 m-85 -154.88 -169.14 3.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.354 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.834 ' HB2' ' HE2' ' A' ' 181' ' ' LYS . 0.3 OUTLIER -41.07 142.31 0.52 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.072 -178.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.456 HG21 ' N ' ' A' ' 121' ' ' LEU . 4.1 m -142.26 -165.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.03 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.27 71.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.605 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.52 ' HB3' HG22 ' A' ' 117' ' ' VAL . 89.9 t80 -59.81 99.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -73.62 -40.24 63.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.58 -132.44 3.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.321 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.454 ' HB3' ' CG ' ' A' ' 175' ' ' HIS . 1.2 p -161.69 142.73 11.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.83 0.347 . . . . 0.0 110.927 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.434 HG12 ' HE ' ' A' ' 114' ' ' ARG . 12.2 m -127.17 153.38 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.067 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.77 142.5 42.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.988 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.94 -178.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.078 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -143.32 59.51 1.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -176.74 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 172' ' ' TRP . 1.0 OUTLIER 62.92 18.52 10.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.61 -178.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -119.61 51.92 1.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.29 169.07 37.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.497 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -85.12 -27.39 26.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.937 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.46 -19.02 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.035 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.605 ' HB ' HD12 ' A' ' 163' ' ' ILE . 60.5 t -57.94 -34.61 49.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.745 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 65.2 m -82.91 -33.49 26.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -65.63 -20.64 66.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.986 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.68 -46.44 4.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.048 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.62 -47.03 77.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.33 -32.87 68.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.768 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 1.2 tttm -72.47 -39.77 67.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.1 t -57.88 -40.95 78.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.472 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.8 mt -65.44 -27.88 68.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.913 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -28.2 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.79 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 14.4 mt-30 -84.69 -23.13 29.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -106.4 169.32 8.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.26 69.47 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.472 ' HG3' HD23 ' A' ' 109' ' ' LEU . 16.1 mmt-85 -72.26 -154.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.924 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' H ' ' HB3' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -111.26 85.97 6.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.548 -178.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 91.6 Cg_endo -79.82 128.4 7.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.701 2.267 . . . . 0.0 112.187 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -113.43 164.68 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -112.1 72.52 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -131.39 -167.81 12.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.445 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.48 141.27 45.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 111.184 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.526 HD13 HG22 ' A' ' 130' ' ' VAL . 64.3 tp -76.32 147.92 37.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.347 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.493 ' HD1' ' HB ' ' A' ' 80' ' ' THR . 30.4 m-70 -127.28 77.45 1.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.724 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.662 ' H ' ' HB2' ' A' ' 82' ' ' SER . 53.3 t -53.17 98.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 121.108 0.48 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.464 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -106.65 131.78 53.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.146 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.04 -15.08 9.15 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.824 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -112.5 35.72 3.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 113.2 126.19 4.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.448 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.66 139.16 37.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.718 0.294 . . . . 0.0 110.99 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.556 ' HB2' HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.23 141.95 39.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.024 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.526 HG22 HD13 ' A' ' 121' ' ' LEU . 20.2 t -109.2 114.28 46.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.008 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.469 HG13 ' HD3' ' A' ' 136' ' ' LYS . 2.4 t -104.7 121.31 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.577 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 2.6 t0 -60.94 165.81 3.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.886 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.81 2.15 25.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.55 -45.38 2.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.68 -24.57 19.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.64 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.469 ' HD3' HG13 ' A' ' 131' ' ' VAL . 0.2 OUTLIER 50.78 40.58 24.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.795 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.8 -114.92 3.89 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.504 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 129' ' ' ARG . 10.0 tp -168.57 120.27 0.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.771 0.319 . . . . 0.0 110.665 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.85 -54.43 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.277 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 129' ' ' ARG . 80.4 t -103.1 101.78 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.173 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -97.03 21.4 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.61 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -68.54 -177.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.103 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.527 HG23 ' N ' ' A' ' 144' ' ' ILE . 28.4 m -140.75 157.53 45.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.593 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.527 ' N ' HG23 ' A' ' 143' ' ' THR . 21.4 mt -59.86 -45.97 94.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.188 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -76.88 -1.47 28.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.507 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 5.3 tttt -99.58 -38.17 8.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.921 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 162' ' ' TYR . 1.9 m -75.07 130.44 36.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.043 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.425 ' HB3' ' HD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -65.7 -50.12 66.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.032 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.668 ' HB2' HD11 ' A' ' 163' ' ' ILE . 61.9 m-85 -131.55 -173.05 3.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 0.0 111.363 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 161' ' ' SER . 8.9 t -161.89 34.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.043 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 99' ' ' MET . . . -64.23 148.85 95.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.108 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.899 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 61.4 Cg_endo -88.79 -142.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.053 2.502 . . . . 0.0 112.305 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 23.5 t0 . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.709 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.538 ' HG2' ' HA ' ' A' ' 182' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.87 0.367 . . . . 0.0 110.93 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.72 128.73 3.87 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.537 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.659 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -121.46 168.5 11.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.688 0.28 . . . . 0.0 110.702 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 150' ' ' CYS . 1.1 m -157.87 172.28 18.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -145.41 145.21 31.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.593 178.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.747 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.1 OUTLIER -111.62 169.54 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.289 -179.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.424 ' H ' HG21 ' A' ' 163' ' ' ILE . 40.9 t -169.98 136.6 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.624 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.75 115.32 30.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 111.148 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.494 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 50.09 -159.72 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.401 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.42 -16.0 42.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.775 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.1 t -170.28 -4.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.063 0.459 . . . . 0.0 110.044 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -133.19 -12.65 2.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.977 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.494 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 5.6 mmt180 58.96 23.37 11.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.5 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -174.3 171.77 3.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.221 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.426 ' HB3' ' OG ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -74.98 119.98 19.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.936 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.5 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 0.1 OUTLIER -142.44 146.23 34.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.641 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.747 ' HB2' HG23 ' A' ' 163' ' ' ILE . 16.9 t -131.54 124.71 30.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.95 0.405 . . . . 0.0 111.293 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.529 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 9.2 m-70 -91.41 136.58 33.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.228 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -114.35 154.06 17.21 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.221 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 21.3 p90 -161.89 143.42 11.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.666 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.87 138.07 50.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.022 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.41 113.87 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.072 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 3.6 t -64.53 -32.47 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.957 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.834 ' HE2' ' HB2' ' A' ' 84' ' ' SER . 0.1 OUTLIER -65.47 -27.07 68.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.027 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.538 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 65.4 m-20 55.95 90.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.199 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 t -168.23 -43.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.777 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.39 30.51 56.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 32.3 tt0 -136.27 -42.39 0.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.701 0.286 . . . . 0.0 110.986 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.54 ' HB2' ' HD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -75.17 -5.95 47.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.9 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 83' ' ' PHE . 5.7 mp -131.29 -49.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.995 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -60.94 2.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 0.3 OUTLIER -62.37 -13.1 25.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.396 -179.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -88.19 -44.4 10.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.153 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.631 ' HA ' HG12 ' A' ' 123' ' ' VAL . 1.7 p -69.95 -24.38 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.86 -10.22 83.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.458 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.8 m -110.0 14.4 23.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.392 . . . . 0.0 110.557 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.59 -43.4 11.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.172 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.561 ' HB3' ' HB2' ' B' ' 4' ' ' ASN . 5.1 p90 -61.34 -33.35 73.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.733 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.63 -27.41 64.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.886 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.458 HG23 HH21 ' A' ' 77' ' ' ARG . 3.7 t -105.94 -5.53 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.756 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 2.0 t -88.97 -5.4 57.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.923 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.021 179.766 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.899 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.406 0.146 . . . . 0.0 110.882 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.489 ' H ' ' HB3' ' B' ' 2' ' ' PHE . 0.0 OUTLIER 64.51 131.74 0.02 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.976 0.417 . . . . 0.0 111.369 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 7.6 p30 -109.95 -165.6 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.742 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' MET . . . . . 0.402 ' HG2' ' CE2' ' B' ' 7' ' ' PHE . 0.0 OUTLIER -125.94 -137.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.6 p 56.55 18.17 3.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.562 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.413 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 32.1 p90 -85.69 151.88 23.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.687 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -82.78 9.02 10.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . 0.413 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 8.1 t0 54.46 70.33 0.63 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.777 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 31.0 m-85 -60.0 139.2 90.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.958 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 32.1 Cg_exo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.705 2.27 . . . . 0.0 112.229 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.831 0.348 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.56 -16.39 10.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.151 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -104.91 -13.93 15.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.3 -14.56 14.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.79 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HB2' ' SG ' ' A' ' 81' ' ' CYS . . . -66.95 -50.79 61.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.017 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.433 HG21 ' SG ' ' A' ' 81' ' ' CYS . 1.8 t -59.83 -44.88 95.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.799 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -57.97 -39.17 77.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.536 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.1 m -69.2 -93.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.526 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.59 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -177.9 30.98 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.382 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.673 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -171.73 100.13 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.903 0.382 . . . . 0.0 111.789 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.592 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 4.1 t -121.7 -147.48 0.39 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.126 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.539 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 52.83 -157.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 111.635 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.482 ' HB3' ' HD2' ' A' ' 181' ' ' LYS . 2.8 m-85 -159.14 -166.21 1.78 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.492 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 0.2 OUTLIER -46.77 151.1 0.63 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.726 0.298 . . . . 0.0 111.309 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.403 ' HB ' ' H ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -145.7 -169.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.102 0.477 . . . . 0.0 111.706 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -152.4 71.91 0.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.266 178.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.517 ' HB3' HG21 ' A' ' 117' ' ' VAL . 22.4 t80 -56.06 111.22 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.192 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.484 HD23 HD13 ' A' ' 178' ' ' LEU . 4.3 mt -70.53 -80.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.887 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.07 -127.5 1.02 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.561 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 8.3 p -155.84 137.75 14.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.703 0.287 . . . . 0.0 111.04 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.33 157.87 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -75.84 147.08 39.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.211 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 174' ' ' CYS . 2.9 m -137.49 -176.05 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.574 ' HA ' ' HE3' ' A' ' 172' ' ' TRP . 1.7 t80 -146.03 64.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.256 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.03 -68.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.442 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.431 ' HG ' ' HB3' ' A' ' 172' ' ' TRP . 0.3 OUTLIER 58.54 19.62 6.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.822 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.38 125.4 12.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.33 -112.67 1.31 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.546 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.36 -34.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 111.05 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -76.65 -9.74 58.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.299 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.6 -22.85 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 24.0 m -87.24 -33.99 19.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 153' ' ' ASP . 2.9 mt-10 -64.03 -15.66 59.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.026 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -97.32 -48.73 5.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.039 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.14 -34.22 71.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.133 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.509 HD23 ' HA3' ' A' ' 159' ' ' GLY . 6.8 tp -64.71 -29.84 70.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -45.99 30.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.835 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 t -59.28 -37.73 70.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.173 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.535 HD21 ' HG3' ' A' ' 114' ' ' ARG . 8.5 mt -70.51 -26.75 63.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -9.68 59.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -114.93 1.78 14.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.034 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -118.19 -18.33 9.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.283 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.5 69.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.874 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.535 ' HG3' HD21 ' A' ' 109' ' ' LEU . 18.7 mmt180 -84.77 43.43 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.49 90.94 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.421 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 70.2 Cg_endo -74.03 163.17 37.43 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.605 2.204 . . . . 0.0 112.075 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 87' ' ' TYR . 2.3 t -124.44 160.94 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.818 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.469 ' HB2' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -130.75 79.5 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -135.16 -174.17 13.33 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.752 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -101.97 122.97 45.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.749 0.309 . . . . 0.0 110.968 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.748 HD11 HG23 ' A' ' 130' ' ' VAL . 28.9 tp -86.6 124.11 32.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.377 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.673 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 67.6 m-70 -112.72 90.48 3.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.972 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.813 HG12 ' HA ' ' A' ' 191' ' ' VAL . 44.1 t -66.3 94.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.052 0.453 . . . . 0.0 110.851 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.59 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -91.8 141.06 29.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.938 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.31 34.39 1.54 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.671 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.456 ' N ' HD13 ' A' ' 144' ' ' ILE . 16.5 t70 -166.43 18.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.858 0.361 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.463 ' H ' HD13 ' A' ' 144' ' ' ILE . . . 140.96 106.64 0.64 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.473 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.05 136.1 51.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 111.106 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.82 137.59 41.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.748 HG23 HD11 ' A' ' 121' ' ' LEU . 3.8 t -119.47 118.47 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.147 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.7 t -106.74 117.22 52.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.83 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.403 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 3.1 m-20 -51.4 145.03 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.964 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.87 15.47 25.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.533 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.64 -5.76 2.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.592 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.72 -13.62 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.435 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 50.66 42.55 27.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.6 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.28 -117.73 4.37 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 141' ' ' ASP . 6.7 tp -171.54 128.12 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.683 0.278 . . . . 0.0 110.726 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.541 HG13 ' HB ' ' A' ' 130' ' ' VAL . 1.3 pt -114.69 -39.82 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.321 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.0 t -122.84 105.2 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.196 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.4 ' HB2' HD23 ' A' ' 138' ' ' LEU . 19.8 t70 -111.81 28.62 8.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -70.8 -177.0 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.113 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.714 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 21.7 m -128.41 156.79 42.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.559 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.463 HD13 ' H ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -67.71 -48.54 75.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.813 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.701 ' HG3' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER -72.24 -17.28 61.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.714 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 15.8 tttt -74.0 -53.67 9.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.837 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.11 144.19 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.104 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.8 t -46.56 -58.15 4.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.95 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.741 ' HA ' ' HB3' ' B' ' 4' ' ' ASN . 40.1 p90 -173.1 151.83 2.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.983 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 56.2 m -91.58 113.26 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.91 98.56 47.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.074 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 50.1 Cg_exo -54.42 -90.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.454 2.102 . . . . 0.0 112.236 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.456 ' HA ' ' HG3' ' A' ' 103' ' ' GLU . 10.7 p-10 . . . . . 0 C--N 1.332 -0.16 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.475 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.737 ' HG2' ' H ' ' A' ' 183' ' ' SER . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.928 0.394 . . . . 0.0 111.082 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.509 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . -144.63 127.57 2.97 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.591 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.541 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -117.08 166.68 11.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.332 . . . . 0.0 110.646 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 16.4 m -157.96 161.12 38.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.989 0.423 . . . . 0.0 111.288 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.8 145.76 44.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.191 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.509 HG23 ' HB2' ' A' ' 174' ' ' CYS . 1.3 mt -112.94 159.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.01 0.433 . . . . 0.0 111.586 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.426 ' N ' HG21 ' A' ' 163' ' ' ILE . 29.6 p -147.67 153.35 39.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.346 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.29 119.97 36.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 111.406 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.717 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 54.26 -160.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.34 179.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.04 -18.19 52.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.428 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 8.9 t -168.4 -0.49 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.046 0.45 . . . . 0.0 109.943 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.426 HG22 ' HG3' ' A' ' 173' ' ' MET . 3.9 m -135.35 -20.36 1.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.04 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.717 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 31.6 mtt-85 58.34 42.82 20.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.957 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -179.82 -139.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.797 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.574 ' HE3' ' HA ' ' A' ' 94' ' ' PHE . 9.7 m0 -111.18 136.31 50.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.903 0.382 . . . . 0.0 111.377 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.426 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -157.89 130.61 7.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.239 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.509 ' HB2' HG23 ' A' ' 163' ' ' ILE . 34.7 t -117.25 136.72 52.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.426 . . . . 0.0 111.531 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.464 ' O ' ' HB3' ' A' ' 161' ' ' SER . 10.0 m170 -106.73 151.23 25.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.292 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -129.54 155.16 20.73 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.02 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -159.35 144.16 15.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.738 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.484 HD13 HD23 ' A' ' 88' ' ' LEU . 1.7 mt -108.91 176.6 5.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.075 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 187' ' ' LEU . . . -111.16 128.4 55.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.8 OUTLIER -62.72 -31.76 72.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.916 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.482 ' HD2' ' HB3' ' A' ' 83' ' ' PHE . 4.0 mttm -90.98 -19.91 22.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 184' ' ' GLY . 61.3 m-20 57.39 -157.42 0.29 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.837 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.737 ' H ' ' HG2' ' A' ' 158' ' ' ARG . 8.7 t 72.63 -20.88 0.25 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.635 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 182' ' ' ASP . . . 54.16 40.12 66.08 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.91 -10.59 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.79 0.328 . . . . 0.0 110.884 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.464 ' HD3' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -115.64 4.77 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.922 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' A' ' 179' ' ' ALA . 5.0 mp -142.62 -51.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.308 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.0 t -56.87 -62.22 1.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.549 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.72 -3.82 7.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.608 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -92.4 -47.31 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.248 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.813 ' HA ' HG12 ' A' ' 123' ' ' VAL . 8.2 p -71.07 -20.05 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.267 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.54 -4.55 52.74 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.718 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.33 -6.75 14.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.359 . . . . 0.0 110.794 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.28 -59.69 3.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.987 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.413 ' HB3' HG21 ' A' ' 144' ' ' ILE . 25.5 p90 -65.62 -26.9 68.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.776 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.484 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -66.12 -18.92 65.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 86.7 t -105.58 -26.19 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.97 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 19.1 t -76.64 -10.21 59.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.676 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.484 HD11 ' HA ' ' A' ' 196' ' ' ALA . 4.6 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.057 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.418 ' HB2' ' H ' ' B' ' 3' ' ' SER . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.418 ' H ' ' HB2' ' B' ' 2' ' ' PHE . 0.0 OUTLIER -163.7 150.29 11.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.02 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.741 ' HB3' ' HA ' ' A' ' 149' ' ' PHE . 3.5 t30 -67.65 146.95 53.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.684 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 14.1 mtp -126.05 -4.19 6.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.081 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -92.83 24.6 3.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.43 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 37.7 p90 -80.62 156.2 26.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.165 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -90.37 9.92 27.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . 0.43 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 31.0 t0 58.87 71.53 0.58 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.049 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -62.08 141.84 95.67 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.015 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.617 2.212 . . . . 0.0 112.312 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.742 0.306 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -45.24 48.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.726 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -65.77 -21.24 66.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.684 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.588 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.5 tt0 -106.58 -2.48 21.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.733 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.83 -50.98 64.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.98 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 194' ' ' ALA . 2.8 t -55.09 -37.5 43.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.3 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.588 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 4.8 mtm180 -66.23 -35.91 81.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.184 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 m -81.11 1.47 31.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.601 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 124' ' ' SER . . . 66.77 43.7 2.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.516 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.587 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -172.36 84.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.99 0.424 . . . . 0.0 111.326 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.771 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.8 t -111.48 -151.43 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.352 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.781 ' HG ' HD22 ' A' ' 187' ' ' LEU . 0.4 OUTLIER 55.62 -160.04 0.19 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.866 0.365 . . . . 0.0 111.379 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.817 ' HB2' HD12 ' A' ' 187' ' ' LEU . 22.0 m-85 -157.37 -167.77 2.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.236 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.9 m -49.01 148.64 2.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.82 0.343 . . . . 0.0 111.038 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.41 HG13 HD23 ' A' ' 121' ' ' LEU . 2.7 m -144.52 -173.82 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.043 0.449 . . . . 0.0 111.537 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -137.1 68.85 1.41 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.762 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CD2' HG21 ' A' ' 139' ' ' ILE . 36.7 t80 -56.67 110.2 0.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.805 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 0.3 OUTLIER -83.56 -52.71 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.33 -179.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 162.78 -137.56 4.88 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.756 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.541 ' HB3' ' ND1' ' A' ' 175' ' ' HIS . 0.8 OUTLIER -151.35 128.25 11.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.686 0.279 . . . . 0.0 111.087 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.455 HG13 HD21 ' A' ' 109' ' ' LEU . 28.7 m -119.99 162.52 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.03 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -81.45 143.04 32.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.953 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -145.44 127.67 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -92.79 61.01 3.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.94 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.64 -77.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.27 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.539 ' HA ' HG23 ' A' ' 163' ' ' ILE . 0.3 OUTLIER 54.59 32.4 16.95 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.696 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -134.34 132.06 39.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.693 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.38 -164.69 38.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.438 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.573 ' HE3' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -113.83 -11.19 12.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.003 179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.573 ' NE2' ' HE3' ' A' ' 99' ' ' MET . 6.9 mm-40 -77.9 15.08 0.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.393 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.486 HG11 HG12 ' A' ' 163' ' ' ILE . 4.7 t -82.94 -17.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.413 ' CB ' ' HB2' ' A' ' 161' ' ' SER . 16.9 p -87.74 -34.3 18.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.123 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -66.23 -0.21 2.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.961 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -120.34 -59.64 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.372 . . . . 0.0 111.367 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.446 ' HA ' HG23 ' A' ' 108' ' ' VAL . . . -55.5 -38.46 69.21 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.464 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.95 -36.53 62.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -76.66 -37.51 56.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.023 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 105' ' ' ALA . 21.3 t -57.15 -44.59 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.455 HD21 HG13 ' A' ' 91' ' ' VAL . 1.2 mt -72.19 -17.44 61.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.813 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.09 -11.37 58.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.665 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -80.4 -62.48 1.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.821 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.12 -163.96 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.271 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 72.26 -65.81 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.564 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.402 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 31.0 mmt180 -94.56 109.17 21.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.842 0.353 . . . . 0.0 111.001 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -82.1 142.48 47.86 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.982 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 73.3 Cg_endo -77.33 160.05 32.65 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.589 2.193 . . . . 0.0 112.565 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 87' ' ' TYR . 1.4 t -128.15 152.22 35.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.056 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -96.84 100.09 11.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.751 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -144.51 -169.7 13.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.781 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -117.78 128.75 55.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.655 0.264 . . . . 0.0 110.623 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.627 HD22 ' HG ' ' A' ' 82' ' ' SER . 61.3 tp -92.78 122.44 35.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.177 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.587 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 8.0 m-70 -112.88 89.18 3.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.019 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.802 HG13 ' HA ' ' A' ' 191' ' ' VAL . 54.3 t -67.27 90.86 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.056 0.455 . . . . 0.0 110.527 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.462 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 11.8 p -82.92 156.54 23.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.452 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.47 -7.1 38.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.362 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 143' ' ' THR . 0.5 OUTLIER -124.16 34.61 5.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 110.839 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.659 ' HA2' HG13 ' A' ' 144' ' ' ILE . . . 122.52 -162.45 16.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.574 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 mt -122.96 166.86 14.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -159.84 103.87 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.554 HG23 HG13 ' A' ' 140' ' ' VAL . 4.4 t -90.32 98.57 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.21 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.569 HG13 ' HA ' ' A' ' 136' ' ' LYS . 0.7 OUTLIER -92.38 114.57 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.913 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.72 146.99 9.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.61 19.28 11.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -131.15 -19.75 2.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.749 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.624 HG23 ' H ' ' A' ' 137' ' ' GLY . 12.2 t -134.87 -21.65 1.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.88 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.569 ' HA ' HG13 ' A' ' 131' ' ' VAL . 9.3 mmtt 56.65 23.95 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.817 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.624 ' H ' HG23 ' A' ' 135' ' ' THR . . . -77.43 -105.43 0.16 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.443 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.3 tp -165.95 102.34 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 110.699 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.454 HG21 ' CD2' ' A' ' 87' ' ' TYR . 3.2 mt -80.16 -30.06 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.213 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.554 HG13 HG23 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -156.56 148.38 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.267 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -129.29 48.57 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.819 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.478 ' HG3' ' HE2' ' A' ' 162' ' ' TYR . 1.5 mm-40 -79.09 -175.58 4.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.052 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 2.6 m -149.0 164.85 33.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.659 HG13 ' HA2' ' A' ' 127' ' ' GLY . 69.2 mt -82.83 -37.93 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -12.2 60.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.626 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -86.43 -48.63 8.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 143' ' ' THR . 11.7 m -64.97 141.45 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.12 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 t -49.87 -65.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.808 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -159.64 123.33 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.805 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 77.0 m -59.87 163.16 4.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.42 125.12 0.74 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.075 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 72.3 Cg_endo -76.1 -94.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.557 2.171 . . . . 0.0 112.438 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 C--O 1.232 0.139 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.434 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.486 HH11 ' HB3' ' A' ' 182' ' ' ASP . 8.8 mtm180 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.803 0.335 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.415 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -122.81 140.37 13.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.419 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -119.49 168.08 11.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 110.833 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 175' ' ' HIS . 13.5 m -154.02 160.52 42.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.859 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.478 ' HE2' ' HG3' ' A' ' 142' ' ' GLN . 4.7 p90 -134.1 151.59 51.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.799 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.539 HG23 ' HA ' ' A' ' 96' ' ' SER . 0.7 OUTLIER -115.77 157.16 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.046 0.451 . . . . 0.0 111.734 -178.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.418 ' H ' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -158.98 135.94 9.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.287 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -118.22 119.99 36.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.895 0.378 . . . . 0.0 111.675 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.86 -164.12 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.713 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.19 -17.61 12.22 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.847 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.6 t -174.05 -0.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.031 0.443 . . . . 0.0 109.932 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.0 -15.73 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.868 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.44 21.31 9.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 177.91 176.48 0.43 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.438 ' HB3' ' HG ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -80.1 121.32 25.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 9.4 mtp -143.02 138.67 30.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.568 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.415 ' HB2' HG21 ' A' ' 163' ' ' ILE . 5.6 t -123.02 136.68 54.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.151 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.542 ' O ' ' HB3' ' A' ' 161' ' ' SER . 5.6 m-70 -102.44 157.71 16.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.555 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -133.07 145.26 17.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.865 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 17.8 p90 -153.95 136.44 15.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.768 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.415 HD23 ' HA3' ' A' ' 159' ' ' GLY . 5.7 mt -101.82 166.26 10.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.938 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.16 115.83 29.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -10.75 56.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -84.79 -24.09 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.486 ' HB3' HH11 ' A' ' 158' ' ' ARG . 47.1 m-20 56.98 82.97 0.11 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.6 t -167.02 -58.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.102 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.37 29.11 11.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.299 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -133.88 -54.71 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.408 ' HB2' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -59.93 -15.74 24.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.271 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.817 HD12 ' HB2' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -115.16 -53.89 2.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -49.89 75.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.404 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -73.99 9.0 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.206 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.48 ' HB3' ' HG ' ' A' ' 81' ' ' CYS . . . -103.53 -55.75 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.81 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.802 ' HA ' HG13 ' A' ' 123' ' ' VAL . 13.2 p -64.03 -25.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.434 ' N ' HG11 ' A' ' 191' ' ' VAL . . . -63.69 -19.42 62.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.335 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 91.8 m -103.09 10.22 38.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.828 0.347 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.608 ' HA ' HG12 ' A' ' 76' ' ' VAL . . . -90.56 -34.0 15.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.217 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 1.6 m-85 -62.03 -45.35 93.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.002 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.43 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -58.2 -16.03 12.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.597 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.21 -27.99 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.185 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -27.32 60.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.249 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.751 0.31 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -168.16 153.91 7.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.722 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -65.39 146.83 54.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.79 -12.26 13.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.403 ' N ' HD21 ' A' ' 199' ' ' LEU . 83.5 p -91.34 25.6 2.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.84 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -61.57 145.24 52.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.071 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.89 0.24 56.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t0 56.6 78.41 0.22 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -82.44 150.98 64.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.998 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.585 2.19 . . . . 0.0 112.333 179.933 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.844 0.354 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.17 -28.32 65.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.652 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.31 -16.03 61.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.672 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.614 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 5.7 mt-10 -105.31 -16.07 14.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.663 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.507 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -54.81 -45.64 74.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.061 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 194' ' ' ALA . 2.1 t -64.52 -45.38 95.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.465 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.614 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -54.19 -31.89 54.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.274 178.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -78.93 -91.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.399 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 178.45 34.97 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.373 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.433 ' HG1' ' HB3' ' A' ' 122' ' ' HIS . 1.4 t -174.35 101.21 0.1 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.929 0.395 . . . . 0.0 111.913 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.771 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 2.8 t -122.49 -149.09 0.42 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.461 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.55 -155.68 0.24 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.847 0.356 . . . . 0.0 111.81 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -159.39 -169.35 2.58 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.502 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.12 147.04 5.71 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.831 0.348 . . . . 0.0 110.962 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.555 HG11 HD23 ' A' ' 121' ' ' LEU . 4.6 m -140.77 -174.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.453 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.09 70.6 1.3 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.596 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 41.1 t80 -52.01 99.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.741 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.657 HD23 HD11 ' A' ' 178' ' ' LEU . 0.7 OUTLIER -71.41 -6.32 39.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.272 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.36 -164.48 12.14 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.619 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 10.1 p -125.72 144.51 50.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.683 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.04 161.89 40.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.021 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.03 155.36 20.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.724 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.9 165.87 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.973 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -134.97 59.76 1.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.006 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -155.81 -71.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 54.13 41.09 32.16 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -148.65 108.73 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.999 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.01 -144.32 16.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.765 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.45 -29.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.84 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -73.87 1.65 10.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.13 -28.12 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.031 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.857 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 1.7 m -90.79 -17.55 26.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -7.49 34.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.46 -41.34 2.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.019 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.08 82.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.541 ' HB2' ' HG ' ' A' ' 161' ' ' SER . 6.4 tp -57.68 -39.27 76.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -70.39 -38.78 74.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.8 t -56.44 -34.61 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.639 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.782 HD22 ' HG3' ' A' ' 114' ' ' ARG . 2.5 mt -72.21 -28.16 63.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.669 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -12.76 59.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.55 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.84 -18.42 15.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.198 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.7 m -118.7 171.82 7.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.083 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -114.33 66.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.782 ' HG3' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -63.35 -92.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.2 -179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -150.01 75.72 8.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.337 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 67.2 Cg_endo -73.97 108.72 2.72 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.637 2.225 . . . . 0.0 112.219 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.476 HG12 ' OD1' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -119.26 125.98 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.017 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.61 106.49 18.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.908 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -148.45 -171.99 17.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.822 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.02 138.89 36.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.04 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.555 HD23 HG11 ' A' ' 85' ' ' VAL . 28.0 tp -108.81 125.42 51.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.181 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 0.1 OUTLIER -117.76 95.61 5.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.292 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.771 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 74.9 t -67.1 94.22 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.977 0.418 . . . . 0.0 110.557 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.13 143.0 26.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.627 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -80.1 37.65 2.17 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.648 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.553 ' N ' HD13 ' A' ' 144' ' ' ILE . 9.5 t0 -168.89 20.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.729 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 135.39 101.05 0.65 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.221 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 mt -60.89 132.82 55.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -122.13 146.72 46.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.654 179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.635 HG22 ' HB ' ' A' ' 140' ' ' VAL . 16.2 t -133.52 98.02 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.26 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.408 ' H ' ' HE1' ' A' ' 122' ' ' HIS . 2.3 t -98.07 124.81 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.889 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.517 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 8.5 t70 -53.67 160.39 1.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.478 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.6 OUTLIER -99.49 -1.51 38.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.387 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.03 -43.67 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.937 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.47 -23.2 21.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.43 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp 50.62 26.55 2.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.19 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.73 -109.05 0.73 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.418 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 141' ' ' ASP . 13.8 tp -160.04 116.72 2.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.93 0.395 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.5 mm -96.54 -56.39 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.156 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 130' ' ' VAL . 17.3 t -127.68 116.42 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.233 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.467 ' HB3' HD22 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -111.78 39.99 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.581 179.106 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -77.19 -168.44 1.11 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.47 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.592 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 5.1 m -146.05 158.34 43.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.826 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.553 HD13 ' N ' ' A' ' 126' ' ' ASP . 4.5 mt -67.65 -35.63 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.041 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -80.62 -11.02 59.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.683 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -90.59 -40.58 11.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 143' ' ' THR . 1.0 OUTLIER -64.86 125.77 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.99 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.6 -73.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.112 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.46 124.49 12.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.29 159.99 22.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.402 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . . . -170.51 108.53 0.43 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.035 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.38 9.95 2.95 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.487 2.125 . . . . 0.0 112.459 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.53 0.193 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.386 -179.41 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.689 ' HG2' ' N ' ' A' ' 183' ' ' SER . 1.3 mpt_? . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.919 0.39 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -105.52 144.68 15.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.729 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 1.7 m-85 -131.34 150.97 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.857 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 0.9 OUTLIER -154.39 151.82 29.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.463 -178.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.546 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -127.05 163.0 24.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.282 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.631 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.8 OUTLIER -122.24 161.49 23.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.975 0.417 . . . . 0.0 111.362 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.429 ' H ' HG21 ' A' ' 163' ' ' ILE . 2.1 t -155.93 118.93 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.621 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -89.93 119.01 29.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.448 ' HA ' ' N ' ' A' ' 170' ' ' ARG . 0.5 OUTLIER 50.35 -152.14 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.221 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.67 -29.8 2.92 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.775 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 166' ' ' ASP . 0.7 OUTLIER -156.56 -1.15 0.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.031 0.444 . . . . 0.0 109.952 179.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.682 HG23 ' HG3' ' A' ' 171' ' ' ARG . 1.6 m -128.98 -20.96 3.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.448 ' N ' ' HA ' ' A' ' 166' ' ' ASP . 5.7 mtt-85 66.41 24.14 10.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.316 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.682 ' HG3' HG23 ' A' ' 169' ' ' THR . 0.0 OUTLIER 178.14 -176.86 0.21 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.051 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.17 132.28 48.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.194 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.481 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -163.21 124.45 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.561 179.201 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.631 ' HB2' HG23 ' A' ' 163' ' ' ILE . 1.9 t -115.84 140.94 48.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.96 0.41 . . . . 0.0 111.251 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.546 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -108.28 145.44 34.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -129.61 152.9 19.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.121 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 42.5 p90 -156.43 154.31 30.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.719 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.657 HD11 HD23 ' A' ' 88' ' ' LEU . 9.1 mt -112.59 158.12 20.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.821 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.441 ' HB3' HD12 ' A' ' 187' ' ' LEU . . . -88.38 118.43 28.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.854 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.14 -4.29 16.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.023 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -101.57 -29.64 11.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 58.0 92.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.689 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 28.9 t -167.08 -36.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.009 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.78 19.05 76.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -136.75 -20.87 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.551 ' HB2' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -79.09 -25.6 43.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.037 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.551 HD13 ' HB2' ' A' ' 186' ' ' ARG . 6.7 mp -120.89 -43.33 2.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.4 t -58.4 -52.49 65.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -75.57 7.63 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.227 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.441 ' HB1' ' HG ' ' A' ' 81' ' ' CYS . . . -97.79 -56.82 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.091 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.531 ' HA ' HG13 ' A' ' 123' ' ' VAL . 7.6 p -65.76 -22.07 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.204 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.64 -18.95 62.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.508 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.07 -3.3 23.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 110.712 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.642 ' HA ' HG12 ' A' ' 76' ' ' VAL . . . -64.52 -46.26 83.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.152 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.7 p90 -70.07 -39.1 75.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.991 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.579 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -57.98 -20.03 35.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.514 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.5 t -105.48 -24.84 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.7 t -73.29 -3.11 24.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.771 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' ' 196' ' ' ALA . 5.0 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.102 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.734 0.302 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.5 p -173.81 141.94 0.86 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.643 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -60.62 161.46 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.149 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 9.8 ttp -124.17 -2.15 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.959 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p -93.95 17.32 12.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.991 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -65.37 146.02 55.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.974 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -88.45 -1.57 58.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.954 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t0 55.03 77.13 0.22 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -60.03 141.91 89.63 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.583 2.189 . . . . 0.0 112.267 -179.876 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.89 0.376 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.54 -39.32 53.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.98 -39.69 79.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.694 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -74.56 -15.56 60.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.78 -47.84 79.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.3 t -58.8 -40.89 81.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -65.63 -31.88 73.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.396 178.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.66 -0.93 40.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.514 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 69.0 39.94 1.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.594 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.759 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -171.37 88.02 0.1 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.074 0.464 . . . . 0.0 111.439 178.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.894 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.9 t -117.75 -145.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.078 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.443 ' HB2' HG22 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.55 -156.67 0.19 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.925 0.393 . . . . 0.0 111.483 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -161.81 -167.94 1.82 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.539 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.4 m -50.78 150.26 2.98 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.977 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.47 -171.77 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.021 0.439 . . . . 0.0 111.839 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.02 80.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.289 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.457 ' HB3' HG22 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -53.91 166.44 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.296 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 18.4 mt -126.42 -46.97 1.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.628 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.14 -127.0 2.3 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.434 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.8 p -152.6 134.21 14.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.988 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.492 HG22 HD11 ' A' ' 109' ' ' LEU . 6.1 m -135.19 159.84 40.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 2.9 pt-20 -88.72 138.99 30.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.397 . . . . 0.0 110.986 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 m -129.33 127.07 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.94 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.89 65.77 4.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.967 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.577 ' HG3' ' HG3' ' A' ' 97' ' ' ARG . 1.4 tp10 -163.31 -65.57 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.282 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.4 22.89 11.37 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.637 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -151.84 117.04 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.901 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.41 158.65 11.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.454 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.74 -4.89 54.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.805 0.336 . . . . 0.0 111.031 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.75 -20.7 30.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 5.7 t -61.29 -32.68 53.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.844 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.411 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 58.5 m -85.6 -27.09 25.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.983 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.27 -15.44 63.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.017 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -110.11 -45.63 3.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.653 ' HA ' HG22 ' A' ' 108' ' ' VAL . . . -58.85 -31.79 68.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.35 -42.11 90.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.667 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -73.75 -32.53 63.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.788 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 105' ' ' ALA . 52.1 t -55.99 -42.51 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.572 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -68.65 -35.38 77.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.549 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -69.1 -22.85 63.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.501 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -94.81 -14.38 24.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.769 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m -94.21 179.35 5.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.091 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 12.38 19.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.42 ' CG ' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -57.68 110.87 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.927 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 136.22 94.36 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.279 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -84.83 153.25 11.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.816 2.344 . . . . 0.0 112.565 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -128.54 97.55 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.774 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.73 129.68 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.39 -163.01 20.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.291 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.02 118.34 36.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.814 0.34 . . . . 0.0 111.077 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.3 127.16 35.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.456 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.759 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 35.5 m-70 -112.86 95.99 5.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.014 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.894 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 40.0 t -65.46 95.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.043 0.449 . . . . 0.0 110.441 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -94.42 126.7 39.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.222 179.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -63.17 -1.29 3.94 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.831 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 124' ' ' SER . 6.4 t70 -131.56 32.79 4.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 110.817 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.69 102.28 1.15 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.452 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mt -68.64 125.63 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 111.319 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.1 143.34 49.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.435 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.494 HG21 ' HB ' ' A' ' 140' ' ' VAL . 18.4 t -122.67 115.1 44.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.904 0.383 . . . . 0.0 111.483 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.8 t -94.68 147.67 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.35 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.453 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 38.7 m-20 -83.42 161.3 21.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.789 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -112.54 5.25 17.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.625 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.12 -3.06 5.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.968 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.38 -14.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.523 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 23.1 mmtt 53.98 29.71 10.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.085 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.447 ' H ' ' HB2' ' A' ' 132' ' ' ASP . . . -99.33 148.4 18.69 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.394 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.2 tp -76.36 120.88 22.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 9.5 pt -108.5 -16.01 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.228 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.571 HG11 ' HG2' ' A' ' 142' ' ' GLN . 84.4 t -129.88 94.75 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 111.148 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.62 17.21 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.715 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.571 ' HG2' HG11 ' A' ' 140' ' ' VAL . 7.6 mm100 -72.46 -173.84 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.793 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 24.4 m -142.56 160.58 40.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.619 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 45.0 mt -59.36 -56.28 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.089 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.26 -18.95 64.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.779 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.793 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 1.8 tttp -71.2 -61.38 1.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.973 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.6 m -61.25 140.04 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.093 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -43.89 -67.86 0.24 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.081 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.637 ' HZ ' ' HA ' ' A' ' 97' ' ' ARG . 0.3 OUTLIER -169.76 142.52 2.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.167 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.42 165.06 19.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.587 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -166.37 124.64 1.07 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.352 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.439 ' HB2' ' H ' ' A' ' 153' ' ' ASP . 90.8 Cg_endo -82.86 -136.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.693 2.262 . . . . 0.0 112.104 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.821 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.954 0.407 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -148.35 114.75 0.7 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.468 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.4 m-85 -107.92 171.49 7.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.772 0.32 . . . . 0.0 111.203 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.639 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -165.11 154.48 12.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.46 160.38 34.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.52 151.96 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 110.29 6.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -83.36 97.96 9.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.98 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 51.94 -160.01 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.973 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 72.24 -3.3 23.64 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.768 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 8.9 t -172.19 -8.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 0.0 110.061 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.661 HG22 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -129.41 -16.14 3.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.835 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 58.45 29.84 18.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.773 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -178.71 -167.41 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.712 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.77 99.5 10.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 0.0 110.78 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.661 ' HB2' HG22 ' A' ' 169' ' ' THR . 3.8 mtp -138.81 147.05 42.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.977 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.29 148.48 52.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.118 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -107.11 145.77 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.684 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.639 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -121.33 157.05 16.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.714 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 15.4 p90 -165.85 175.71 8.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.682 0.277 . . . . 0.0 110.504 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.489 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 1.2 mp -139.89 -172.85 3.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.967 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -115.82 130.67 56.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.021 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 7.3 t -67.35 -27.84 67.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.426 ' HB2' ' HD3' ' A' ' 186' ' ' ARG . 4.2 mttm -83.47 -42.23 17.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.162 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 57.86 89.94 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.016 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.8 t -156.97 -26.31 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.988 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.497 ' H ' ' CZ ' ' A' ' 186' ' ' ARG . . . 84.61 5.74 86.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.607 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -131.54 12.65 4.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.852 0.358 . . . . 0.0 111.061 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.674 HH11 ' HB2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -115.18 -10.17 12.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 -179.272 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.674 ' HB2' HH11 ' A' ' 186' ' ' ARG . 1.5 mp -148.42 -45.95 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.354 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.0 t -51.17 -63.53 1.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.626 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 5.06 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.638 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.49 -53.14 3.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.225 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.07 -18.32 21.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.07 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.415 ' HA2' ' HE2' ' A' ' 195' ' ' PHE . . . -73.74 1.74 44.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.257 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.7 m -118.09 -5.57 10.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.697 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.06 -52.56 47.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.205 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.424 ' HD1' HD12 ' A' ' 199' ' ' LEU . 46.2 p90 -65.4 -24.24 67.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.764 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.775 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -66.81 -8.72 30.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.286 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.97 -12.95 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.114 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.96 3.71 22.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.691 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.775 HD11 ' HA ' ' A' ' 196' ' ' ALA . 4.9 mt . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.054 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.96 0.41 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -165.41 136.22 3.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.8 111.03 1.02 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.025 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.6 6.93 45.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.163 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 73.9 p -96.32 18.54 13.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -67.34 150.23 49.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.04 11.71 33.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 14.5 t70 56.85 80.68 0.15 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.15 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.8 152.14 84.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.486 2.124 . . . . 0.0 112.231 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.962 0.41 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -36.07 68.24 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.46 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.74 -22.79 66.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.361 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.637 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 3.6 mt-10 -96.02 -14.32 23.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.648 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -58.33 -50.78 72.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.807 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 t -63.77 -39.86 86.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.367 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.637 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -58.22 -35.39 71.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.454 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.9 m -78.41 -90.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.556 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.574 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 179.28 32.69 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.525 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.771 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -170.26 99.66 0.27 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.92 0.391 . . . . 0.0 111.938 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.731 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.1 t -119.94 -151.53 0.48 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.104 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.536 ' HG ' HD21 ' A' ' 187' ' ' LEU . 0.2 OUTLIER 55.26 -155.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.837 0.351 . . . . 0.0 111.46 179.264 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.563 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 1.9 m-85 -164.32 -167.64 1.35 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.63 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.4 150.44 3.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.069 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' A' ' 121' ' ' LEU . 2.1 m -147.71 -178.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 111.871 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 3.7 mmtt -130.63 85.99 2.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.657 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 29.1 t80 -58.56 94.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 3.9 mt -67.1 -17.47 64.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.055 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 114' ' ' ARG . . . 117.59 -131.03 9.13 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.572 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.534 ' N ' HD22 ' A' ' 109' ' ' LEU . 7.1 p -156.61 141.6 17.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.686 0.279 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.795 HG12 ' HG ' ' A' ' 109' ' ' LEU . 3.9 m -131.84 161.85 40.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.205 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -83.32 131.25 35.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.371 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 174' ' ' CYS . 16.3 m -141.65 131.87 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.94 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -103.04 73.4 1.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.941 0.401 . . . . 0.0 111.105 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -164.78 -71.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.059 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.749 ' HB3' HG23 ' A' ' 163' ' ' ILE . 5.8 p 45.15 33.5 1.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -121.86 -40.61 2.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.484 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.52 158.28 15.43 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.901 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.619 ' HB2' ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -75.82 -17.89 59.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.866 0.365 . . . . 0.0 110.904 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -72.36 -24.68 61.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 t -59.94 -30.18 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.522 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 96.5 m -79.72 -28.25 40.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.766 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.71 -14.63 61.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.135 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -108.72 -44.32 4.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.22 -31.87 69.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.086 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.78 -38.55 91.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -40.87 84.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.1 t -63.25 -44.51 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.795 ' HG ' HG12 ' A' ' 91' ' ' VAL . 3.0 mt -61.31 -34.95 76.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.269 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 110' ' ' ARG . 11.1 ttt-85 -74.05 -31.48 62.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.738 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -86.63 -14.45 42.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.308 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.12 -6.78 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.311 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 36.68 71.56 0.13 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.652 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.683 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -82.72 68.12 9.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.931 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 58.43 82.87 0.23 Allowed Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.361 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 92.7 Cg_endo -80.52 135.05 10.26 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.623 2.215 . . . . 0.0 112.23 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -129.85 158.94 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.191 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.6 ttp-105 -119.68 98.5 6.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -131.69 169.78 21.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.615 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.34 104.2 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.693 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.432 HD12 HG22 ' A' ' 130' ' ' VAL . 15.9 tp -74.92 129.11 37.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.425 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.771 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 52.2 m170 -115.05 94.6 4.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.731 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 71.4 t -69.31 90.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.927 0.394 . . . . 0.0 110.506 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.574 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -90.17 140.79 29.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.195 179.179 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.49 1.95 4.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.774 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -130.64 32.45 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 119.66 122.98 3.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.536 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.42 HD22 HG12 ' A' ' 144' ' ' ILE . 2.6 mt -76.05 141.93 41.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.739 0.304 . . . . 0.0 111.041 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -145.47 122.56 11.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.69 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.712 HG11 HD13 ' A' ' 139' ' ' ILE . 2.2 t -102.16 118.51 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.337 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 137' ' ' GLY . 1.7 t -106.2 116.62 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.768 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.55 151.43 2.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.028 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.48 -6.83 54.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.364 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.72 -50.3 2.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.966 0.412 . . . . 0.0 110.695 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.0 m -82.95 -21.75 33.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.636 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp 51.69 28.19 4.64 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.211 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -87.41 -116.2 1.12 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.435 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tp -171.97 113.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.693 0.282 . . . . 0.0 110.543 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.712 HD13 HG11 ' A' ' 130' ' ' VAL . 2.9 pt -94.49 -41.49 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.497 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.506 ' HB ' HG23 ' A' ' 130' ' ' VAL . 39.8 t -122.85 103.78 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.177 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -113.19 48.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.798 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.502 ' HG2' HG13 ' A' ' 140' ' ' VAL . 46.4 mm-40 -98.11 -166.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.804 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.525 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 12.1 m -133.96 158.4 43.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.532 HD12 ' SG ' ' A' ' 198' ' ' CYS . 2.0 mt -65.05 -44.56 95.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.664 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.05 -20.02 56.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.56 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 12.9 tttp -69.82 -45.34 68.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.709 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 144' ' ' ILE . 5.9 m -74.83 150.98 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.747 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.8 -53.89 49.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.446 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 40.3 p90 -174.62 -174.21 0.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.1 t -110.95 157.92 19.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.726 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.619 ' HB2' ' HB2' ' A' ' 99' ' ' MET . . . -169.0 115.6 0.55 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.797 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 84.4 Cg_endo -79.96 -119.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 111.996 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.47 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 8.1 p-10 . . . . . 0 C--N 1.332 -0.165 0 CA-C-O 120.742 0.306 . . . . 0.0 110.72 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 121.023 0.439 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.98 133.64 10.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.466 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.797 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 1.7 m-85 -126.92 163.65 23.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.3 . . . . 0.0 110.665 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -164.6 144.57 7.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.009 0.433 . . . . 0.0 111.255 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -126.44 139.59 53.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.481 178.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.749 HG23 ' HB3' ' A' ' 96' ' ' SER . 0.4 OUTLIER -101.04 139.99 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.242 -179.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 10.7 t -149.02 129.62 14.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.716 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.2 OUTLIER -92.87 122.62 35.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.711 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 50.38 -158.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.432 179.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.48 -29.51 8.29 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.457 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.4 t -164.63 6.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.57 . . . . 0.0 109.532 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.523 HG22 ' HG3' ' A' ' 173' ' ' MET . 24.7 m -136.88 -18.1 1.39 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.65 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.711 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 7.3 mtt180 57.72 32.48 21.94 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.407 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.41 150.11 12.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.711 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -75.02 79.11 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.405 178.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.523 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.2 OUTLIER -110.57 166.78 10.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.078 -179.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.597 ' HB2' HG21 ' A' ' 163' ' ' ILE . 53.2 t -123.6 127.59 48.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 10.8 m170 -90.75 124.99 35.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.559 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -108.2 156.28 15.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.612 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -170.66 152.68 3.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.714 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.5 165.9 14.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.67 ' HB1' HD12 ' A' ' 187' ' ' LEU . . . -87.52 126.24 34.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.971 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 4.5 t -61.99 -21.07 64.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.815 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.563 ' HE3' ' HB3' ' A' ' 83' ' ' PHE . 2.8 mmtp -84.39 -23.02 30.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.672 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 55.08 83.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.1 t -159.74 -64.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 108.44 41.51 1.48 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.385 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.35 -33.48 0.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.752 0.31 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.624 ' HB2' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -72.48 -11.51 60.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.706 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.67 HD12 ' HB1' ' A' ' 179' ' ' ALA . 5.2 mp -137.07 -36.89 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.114 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.2 t -57.94 -55.6 32.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.256 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.25 0.43 16.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.054 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -89.17 -54.81 3.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 123' ' ' VAL . 10.9 p -75.41 -30.48 22.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.68 -9.49 45.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.252 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 57.5 m -110.53 -10.28 14.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 110.707 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.61 -43.35 94.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.244 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 2.0 p90 -61.74 -32.58 72.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.725 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.421 ' O ' HD11 ' A' ' 199' ' ' LEU . . . -61.86 -33.66 74.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.21 5.62 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.641 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . 0.532 ' SG ' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -93.62 -43.92 8.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.823 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.421 HD11 ' O ' ' A' ' 196' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.866 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.658 0.266 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.9 p -168.81 148.36 4.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.942 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -64.36 156.93 27.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.811 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 20.5 mtm -126.63 -18.18 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -76.52 0.1 21.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.083 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -63.12 148.91 46.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.972 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -97.22 4.61 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.926 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 29.2 t0 56.98 77.3 0.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -70.03 151.61 96.05 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.763 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.487 2.125 . . . . 0.0 112.262 179.696 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.838 0.352 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.39 -32.6 26.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.562 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -71.78 -36.22 70.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.243 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.735 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -69.36 -19.45 63.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.265 178.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.69 -52.15 65.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.945 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.712 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.3 t -58.9 -37.99 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.54 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.735 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 11.5 mtp180 -56.89 -40.34 76.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.61 -91.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.477 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 179.34 38.51 0.0 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.343 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.415 ' HB ' ' ND1' ' A' ' 122' ' ' HIS . 1.7 t -173.2 95.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.991 0.424 . . . . 0.0 111.466 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.584 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 11.6 t -122.68 10.29 9.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.433 ' HB2' HG21 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -114.2 -162.84 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.218 -179.44 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.431 ' CG ' ' HE2' ' A' ' 181' ' ' LYS . 60.3 m-85 -150.07 -168.6 3.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.72 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 1.0 OUTLIER -47.53 151.52 0.79 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.87 0.367 . . . . 0.0 111.366 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 121' ' ' LEU . 2.2 m -145.42 -170.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.125 0.488 . . . . 0.0 111.679 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.93 73.09 1.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.311 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 83.6 t80 -55.45 98.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.143 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.429 HD21 HD11 ' A' ' 178' ' ' LEU . 4.3 mt -61.36 -50.03 74.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.492 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.499 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 153.04 -128.13 2.38 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.241 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.596 ' HB2' ' HE1' ' A' ' 173' ' ' MET . 1.6 p -161.79 126.15 3.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 0.0 110.866 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.624 HG12 ' HG ' ' A' ' 109' ' ' LEU . 14.3 m -110.18 165.8 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.036 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.77 116.02 28.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.142 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 174' ' ' CYS . 12.3 m -108.99 -165.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.865 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.95 65.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 1.2 mm-40 -166.32 -66.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.81 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.749 ' HA ' HG22 ' A' ' 163' ' ' ILE . 2.1 m 59.92 33.23 21.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 15.7 ptt180 -169.57 80.57 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.59 146.62 4.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.246 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.458 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -72.29 -29.89 64.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.775 0.322 . . . . 0.0 111.206 -179.421 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 99' ' ' MET . 0.5 OUTLIER -77.39 -21.19 53.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.926 -179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 t -60.73 -35.02 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 161' ' ' SER . 55.5 m -73.26 -49.98 24.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.951 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -56.33 -29.68 61.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.295 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.57 -51.72 11.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.94 -31.63 68.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.048 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.68 -43.33 93.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.845 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -62.86 -43.27 99.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.8 t -62.62 -39.81 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.047 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.624 ' HG ' HG12 ' A' ' 91' ' ' VAL . 8.1 mt -65.83 -36.15 82.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.827 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -76.13 -14.35 60.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.298 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -95.87 -16.53 21.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.786 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.84 -177.08 3.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.516 ' H ' ' HE ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -116.85 71.77 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.814 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.499 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 22.7 mmt180 -85.19 22.52 1.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.071 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 54.29 88.15 0.13 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.817 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 17.2 Cg_exo -66.57 137.29 45.78 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.82 2.347 . . . . 0.0 111.77 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.76 113.39 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.01 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -75.28 107.42 7.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.697 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -142.67 -167.3 11.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.834 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.404 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -118.4 122.87 43.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.658 0.266 . . . . 0.0 110.715 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.663 HD12 HD21 ' A' ' 128' ' ' LEU . 32.4 tp -89.5 133.76 34.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.777 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.415 ' ND1' ' HB ' ' A' ' 80' ' ' THR . 14.2 m170 -123.03 94.75 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.186 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 53.2 t -62.28 96.15 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.061 0.457 . . . . 0.0 110.338 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.445 ' O ' HD12 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -99.7 130.6 45.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.487 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -64.25 -0.24 4.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.961 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -126.17 29.01 5.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.855 0.36 . . . . 0.0 110.807 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 117.19 113.49 2.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.259 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.663 HD21 HD12 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -57.04 146.33 27.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 -179.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -138.41 120.35 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.667 HG13 HD11 ' A' ' 139' ' ' ILE . 2.2 t -110.29 108.28 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 111.271 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.99 117.69 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.058 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 76.9 m-20 -53.71 156.75 2.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.75 1.39 29.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -116.62 -31.33 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.523 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.25 -6.53 9.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.727 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 4.4 mmtm 50.91 25.59 2.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.11 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.11 167.27 30.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.357 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 141' ' ' ASP . 8.7 tp -99.48 116.32 31.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.61 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.667 HD11 HG13 ' A' ' 130' ' ' VAL . 1.2 pt -94.42 -50.23 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.374 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.596 ' HB ' HG21 ' A' ' 130' ' ' VAL . 48.7 t -110.37 95.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.916 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.437 ' HB2' HD21 ' A' ' 138' ' ' LEU . 31.3 t0 -105.09 67.49 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.656 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -114.8 -171.91 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.152 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.629 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 88.6 m -131.16 151.88 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.552 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.445 HD12 ' O ' ' A' ' 124' ' ' SER . 3.4 mt -61.28 -31.89 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -90.65 -6.62 54.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.516 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.629 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 5.7 tptm -90.08 -37.75 14.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.028 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.486 ' H ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -58.42 134.32 23.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.806 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.6 t -70.61 -21.15 62.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CB ' HD12 ' A' ' 163' ' ' ILE . 0.2 OUTLIER -170.05 151.96 4.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.125 0.488 . . . . 0.0 111.514 -179.285 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.32 137.22 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.916 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -168.55 119.81 0.66 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.66 0.267 . . . . 0.0 111.687 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.43 -94.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.342 2.028 . . . . 0.0 111.625 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.459 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 120.757 0.313 . . . . 0.0 111.476 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.54 129.73 6.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.56 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.58 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 0.5 OUTLIER -127.13 155.42 43.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 110.682 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.556 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -160.84 159.98 30.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 111.273 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.97 143.1 33.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.323 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -104.23 148.7 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.948 0.404 . . . . 0.0 111.183 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.8 p -135.37 148.65 49.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.74 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.28 101.37 9.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.01 -152.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.075 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.73 -15.03 22.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.508 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.404 ' H ' ' H ' ' A' ' 169' ' ' THR . 15.1 t -171.25 -0.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 110.008 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.404 ' H ' ' H ' ' A' ' 168' ' ' THR . 3.3 m -127.63 -18.74 4.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.083 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 60.07 30.66 20.11 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.755 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -179.43 -168.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.882 179.53 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -98.78 112.39 24.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.025 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.755 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 25.3 mtp -139.6 149.84 44.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.567 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.499 ' HB2' HG23 ' A' ' 163' ' ' ILE . 20.4 t -117.69 147.37 42.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.154 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -114.78 137.2 52.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.445 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.556 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -128.84 156.55 21.17 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.994 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -166.93 155.85 10.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 111.076 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.429 HD11 HD21 ' A' ' 88' ' ' LEU . 1.4 mt -111.93 178.17 4.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.612 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.58 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -113.57 125.66 54.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 0.0 110.959 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.3 OUTLIER -71.13 -5.07 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.787 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.431 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 13.1 mmmt -91.01 -37.54 13.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 58.14 85.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.99 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.2 t -163.86 -39.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.83 17.94 79.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.494 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -132.57 1.11 3.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.868 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -108.8 -33.6 6.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp -114.99 -43.21 3.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.125 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.5 t -58.72 -66.39 0.5 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.451 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.6 -16.22 55.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.157 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.72 -56.28 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 123' ' ' VAL . 2.7 p -65.22 -19.72 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.018 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -77.47 -0.14 71.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.334 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 58.0 m -120.29 0.37 10.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.712 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -76.31 -40.94 50.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.104 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 7.1 p90 -67.72 -31.18 70.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.814 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.39 69.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.373 . . . . 0.0 110.969 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 4.9 t -99.29 0.48 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.889 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -92.6 -38.31 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.222 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.73 0.3 . . . . 0.0 110.904 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.94 162.25 23.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.003 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -65.81 167.09 9.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 3.6 mtp -134.92 -22.45 1.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 60.3 p -81.2 14.91 2.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -62.55 153.9 30.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.934 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -91.33 -0.27 57.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 t0 56.36 78.59 0.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.197 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.674 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 25.5 m-85 -66.45 -51.61 41.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.134 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.674 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 31.8 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.213 1.942 . . . . 0.0 112.255 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.929 0.395 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.48 -33.34 48.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -65.26 -22.02 66.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.575 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.729 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.5 mt-10 -100.61 -13.68 18.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.802 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB1' ' HB2' ' A' ' 81' ' ' CYS . . . -59.5 -46.89 87.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.763 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 194' ' ' ALA . 7.1 t -61.49 -42.64 94.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.349 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.729 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 7.5 mtp180 -54.45 -34.8 62.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.143 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.457 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 1.4 m -78.12 -90.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.251 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 176.28 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.683 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 122' ' ' HIS . 0.7 OUTLIER -173.7 98.0 0.11 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.866 0.365 . . . . 0.0 111.777 -179.599 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.575 ' HG ' ' HB1' ' A' ' 190' ' ' ALA . 10.3 t -139.26 63.48 1.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.393 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.656 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -159.44 -155.15 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.802 0.334 . . . . 0.0 111.297 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -154.62 -172.82 4.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.596 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 t -51.1 152.34 2.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.801 0.334 . . . . 0.0 111.168 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 121' ' ' LEU . 1.3 m -137.74 -167.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.286 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -148.18 65.3 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.823 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 55.0 t80 -62.6 117.02 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.439 ' O ' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -116.45 62.6 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.408 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 62.77 -168.7 17.73 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.396 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -138.47 146.37 41.97 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.593 HG11 ' HG ' ' A' ' 109' ' ' LEU . 4.6 m -115.24 163.86 12.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.369 . . . . 0.0 111.188 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.63 145.88 29.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.027 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -139.02 178.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.648 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -145.77 65.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 0.0 111.16 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -169.08 -72.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 p 67.48 0.76 2.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.2 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.46 ' HE ' HH22 ' A' ' 165' ' ' ARG . 0.0 OUTLIER -154.8 114.48 3.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.789 179.308 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 140.07 121.21 1.81 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.159 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.487 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 60.48 -88.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.617 0.246 . . . . 0.0 110.551 -178.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.725 ' HG2' ' HB3' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -154.15 -28.25 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.034 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.538 ' HB ' HD12 ' A' ' 163' ' ' ILE . 1.1 t 49.38 23.46 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.371 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 62.6 m -118.64 -24.22 6.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.013 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -9.31 58.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.018 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -104.52 -53.76 2.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.24 -51.12 71.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.222 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.403 HD23 ' CG ' ' A' ' 153' ' ' ASP . 33.1 tp -57.77 -32.09 67.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -67.36 -43.01 82.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 t -59.21 -49.92 81.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.593 ' HG ' HG11 ' A' ' 91' ' ' VAL . 1.3 mt -65.85 -25.03 67.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.591 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -77.64 -25.59 49.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.626 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 23.1 mt-30 -91.36 -19.88 22.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.201 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 m -113.6 179.36 3.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 0.0 111.253 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.66 72.38 0.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.675 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.534 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 3.8 mmt180 -82.66 40.44 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.232 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 59.0 77.9 0.37 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.567 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 87.9 Cg_endo -81.09 121.8 4.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.667 2.245 . . . . 0.0 112.256 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.02 140.74 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 118' ' ' ARG . 12.3 ttp180 -99.39 103.6 15.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.622 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -135.58 172.68 22.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.8 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -92.44 127.26 37.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.795 0.331 . . . . 0.0 111.0 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.51 HD11 HD23 ' A' ' 128' ' ' LEU . 39.6 tp -97.06 129.62 44.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.56 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.454 ' CE1' HD11 ' A' ' 120' ' ' LEU . 89.6 m-70 -116.71 93.02 4.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.852 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 82' ' ' SER . 41.9 t -58.35 103.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.982 0.42 . . . . 0.0 110.849 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -100.76 134.65 43.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.192 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.61 8.57 4.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.015 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 124' ' ' SER . 8.2 t0 -137.35 28.19 2.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 110.615 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.733 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 124.63 113.22 1.99 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.315 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.603 HD22 HG21 ' A' ' 123' ' ' VAL . 1.3 mt -58.0 144.25 40.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 111.233 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.452 ' HE ' HD11 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -136.5 124.62 23.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.817 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.726 HG11 HD11 ' A' ' 139' ' ' ILE . 2.9 t -110.93 112.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.311 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.9 t -104.9 114.22 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.795 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.44 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 1.4 m-20 -48.86 147.57 2.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.895 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.622 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -103.23 9.04 38.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.616 -179.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.63 -1.19 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.403 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.2 m -151.52 -11.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.546 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 22.9 mmtp 54.77 25.74 6.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.895 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.65 -166.84 35.83 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.549 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.452 HD11 ' HE ' ' A' ' 129' ' ' ARG . 8.6 tp -119.18 116.92 27.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.913 0.387 . . . . 0.0 110.634 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.726 HD11 HG11 ' A' ' 130' ' ' VAL . 6.3 mt -98.02 -57.29 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.263 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.718 ' HB ' HG21 ' A' ' 130' ' ' VAL . 61.3 t -124.51 116.63 48.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.45 36.48 4.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.583 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.443 ' HG2' HG13 ' A' ' 140' ' ' VAL . 73.1 mm-40 -81.75 -165.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.111 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.733 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 19.3 m -129.42 153.94 47.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.428 ' HB ' ' SG ' ' A' ' 198' ' ' CYS . 3.5 mt -65.89 -44.9 92.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.0 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.669 ' HG3' HG21 ' A' ' 143' ' ' THR . 1.5 pt-20 -78.64 -0.21 29.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.506 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -95.73 -44.84 7.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.667 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -62.29 148.22 10.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.93 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.8 t -83.11 -37.03 24.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.201 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -137.95 -172.68 3.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.908 0.385 . . . . 0.0 111.395 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.8 t -168.35 25.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.456 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.725 ' HB3' ' HG2' ' A' ' 100' ' ' GLN . . . -51.12 138.94 25.23 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.159 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.927 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 72.2 Cg_endo -95.56 12.86 1.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.35 2.7 . . . . 0.0 112.385 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.174 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.866 0.365 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.633 ' HA3' HD21 ' A' ' 178' ' ' LEU . . . -133.59 128.89 5.16 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.41 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 188' ' ' SER . 0.1 OUTLIER -104.46 168.43 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.3 . . . . 0.0 110.805 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.45 150.94 14.65 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.005 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.502 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -132.17 145.61 51.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.636 179.015 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.538 HD12 ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -107.44 144.5 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.188 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.9 130.51 9.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 3.3 mtt-85 -74.91 -144.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.507 ' H ' ' HB3' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.17 -166.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.909 0.385 . . . . 0.0 111.136 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.61 -11.45 68.39 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.397 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.3 t -166.55 -8.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 109.926 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.458 HG22 ' HG3' ' A' ' 171' ' ' ARG . 18.5 m -129.7 -9.79 4.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.645 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 61.19 17.4 8.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.131 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.458 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.9 OUTLIER -176.44 174.31 1.95 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.94 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -77.53 109.58 11.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.995 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.08 159.64 41.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.638 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.41 ' HB2' HG22 ' A' ' 163' ' ' ILE . 31.1 t -129.39 139.36 51.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.859 0.361 . . . . 0.0 111.236 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.502 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -103.53 143.58 32.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.665 179.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -126.55 149.86 17.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.859 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -166.5 139.41 3.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.755 0.312 . . . . 0.0 110.715 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.633 HD21 ' HA3' ' A' ' 159' ' ' GLY . 1.5 mt -100.11 -177.81 3.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.943 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -110.48 129.99 55.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.052 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.5 1.28 17.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.172 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -99.85 -23.69 14.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.756 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 55.97 79.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.155 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.5 t -165.9 -59.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.941 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.78 32.2 6.03 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.553 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -141.81 -32.39 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.731 0.3 . . . . 0.0 110.953 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.401 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 4.9 mmm180 -73.57 -6.06 44.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.836 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.489 HD23 HD23 ' A' ' 121' ' ' LEU . 5.6 mp -139.24 -50.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.444 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 3.6 t -62.18 -60.87 2.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.336 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 0.1 OUTLIER -52.64 -37.2 58.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.575 ' HB1' ' HG ' ' A' ' 81' ' ' CYS . . . -65.82 -41.78 91.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 187' ' ' LEU . 24.7 t -62.25 -32.3 54.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.76 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -59.3 -20.62 51.29 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.529 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 2.6 m -95.18 -15.42 23.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.729 0.3 . . . . 0.0 111.097 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.63 ' HA ' HG12 ' A' ' 76' ' ' VAL . . . -63.07 -30.87 71.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.18 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.467 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 1.3 m-85 -72.86 -40.11 65.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.804 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -54.98 -21.05 10.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.586 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.5 t -105.56 -12.88 9.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . 0.429 ' HB3' ' OG ' ' B' ' 6' ' ' SER . 0.0 OUTLIER -79.36 -27.06 41.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.02 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.839 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.927 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.634 0.254 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.455 ' H ' ' HB3' ' B' ' 2' ' ' PHE . 0.0 OUTLIER 63.84 158.25 0.08 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.449 179.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.427 ' HB3' ' CD1' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -87.82 -173.15 4.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.207 -179.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 68.9 mtp -125.98 -30.31 2.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.823 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 198' ' ' CYS . 89.6 p -88.09 36.91 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.452 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.572 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 3.1 p90 -63.94 -3.34 2.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.849 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 55.69 8.89 0.36 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.665 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . 0.572 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 21.5 t70 48.9 76.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.401 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -58.92 135.65 87.32 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.472 2.115 . . . . 0.0 112.24 179.924 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.893 0.378 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -83.51 -19.95 34.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.986 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.52 -29.99 71.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.617 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -100.57 -17.26 17.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.978 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.07 -52.66 64.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.537 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.732 HG11 ' HA ' ' A' ' 194' ' ' ALA . 0.9 OUTLIER -66.36 -35.32 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.729 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.617 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 3.1 mtp180 -55.34 -24.03 27.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.109 0.48 . . . . 0.0 109.808 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.488 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -98.03 -97.11 0.21 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.659 179.032 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.503 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -176.47 48.36 0.01 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.565 0.221 . . . . 0.0 111.457 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.627 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 1.4 t -176.04 86.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.919 0.39 . . . . 0.0 111.112 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.66 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 6.7 t -121.22 4.16 10.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.97 -156.97 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.161 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -154.84 -171.63 3.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.558 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 0.9 OUTLIER -53.01 150.71 5.33 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.048 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.81 -168.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.528 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -143.24 81.28 1.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.925 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -62.28 93.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.668 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.427 HD23 HD12 ' A' ' 178' ' ' LEU . 1.1 mp -58.21 -41.01 83.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.16 -130.44 3.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.357 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -164.28 141.21 6.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 111.046 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.89 172.7 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.473 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 4.1 pt-20 -95.15 142.43 27.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.889 0.376 . . . . 0.0 111.053 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.71 163.65 36.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -121.24 65.34 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.058 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -175.77 -70.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.036 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.439 ' HB3' HG21 ' A' ' 163' ' ' ILE . 0.7 OUTLIER 58.72 25.89 13.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.863 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.88 61.8 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.64 160.78 24.37 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.722 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.495 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -77.18 -30.8 55.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.782 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.548 ' H ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER -69.01 -23.04 64.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.028 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.5 t -58.56 -33.37 48.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 110.537 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.847 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 58.5 m -80.54 -37.01 32.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.615 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.3 -34.7 78.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.93 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -76.96 -52.84 8.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.908 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.92 66.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.962 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.575 ' HB2' ' HG ' ' A' ' 161' ' ' SER . 3.0 tp -66.08 -36.68 83.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.951 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.8 tptp -70.22 -46.21 64.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.481 ' HA ' ' NE2' ' A' ' 111' ' ' GLN . 11.0 t -60.75 -38.06 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.503 HD21 ' HG3' ' A' ' 114' ' ' ARG . 18.7 mt -61.55 -31.97 72.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.075 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 110' ' ' ARG . 1.2 tpp85 -78.08 -32.88 50.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.481 ' NE2' ' HA ' ' A' ' 108' ' ' VAL . 4.3 mt-30 -81.89 -15.36 54.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.793 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.415 ' HG ' HH12 ' A' ' 113' ' ' ARG . 2.7 m -105.13 179.42 4.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.82 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.557 ' H ' HH11 ' A' ' 113' ' ' ARG . 0.0 OUTLIER -115.88 65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.503 ' HG3' HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.26 20.32 3.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 55.34 95.04 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.993 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.5 127.27 6.43 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.79 2.326 . . . . 0.0 112.087 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.33 143.79 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.225 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -102.69 97.83 7.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.65 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -131.64 163.06 23.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.911 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.472 ' HB3' ' HE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -87.18 124.22 33.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.735 0.302 . . . . 0.0 110.977 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.77 HD11 HD23 ' A' ' 128' ' ' LEU . 29.4 tp -96.85 135.34 38.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.763 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.627 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 1.9 m-70 -125.43 105.39 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.094 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.66 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 11.4 t -70.46 104.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 0.0 110.838 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -104.81 143.37 33.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.408 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.31 28.96 1.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.848 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 124' ' ' SER . 3.0 t70 -153.51 21.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.594 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 124.73 131.72 3.71 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.523 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.77 HD23 HD11 ' A' ' 121' ' ' LEU . 1.7 mp -67.16 168.77 9.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 14.5 ttm180 -168.75 115.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.903 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.72 HG22 ' HB ' ' A' ' 140' ' ' VAL . 3.9 t -107.97 109.21 27.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.07 0.462 . . . . 0.0 111.421 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.57 115.38 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.941 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -50.9 144.58 8.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.24 17.19 21.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.988 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -127.67 -8.69 5.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.606 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.09 -8.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.843 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp 58.1 25.78 12.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.551 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.18 -138.5 0.25 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.444 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.738 HD23 ' HB2' ' A' ' 141' ' ' ASP . 15.7 tp -159.09 116.06 2.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.663 0.268 . . . . 0.0 110.438 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.616 HG13 ' HB ' ' A' ' 130' ' ' VAL . 3.6 pt -106.73 -28.48 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.562 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.72 ' HB ' HG22 ' A' ' 130' ' ' VAL . 43.1 t -137.35 116.65 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.167 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.738 ' HB2' HD23 ' A' ' 138' ' ' LEU . 17.8 t0 -130.04 29.91 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.345 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -76.55 -167.51 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.206 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.562 HG23 ' HG3' ' A' ' 145' ' ' GLU . 1.8 m -123.66 171.0 9.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.658 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.3 mt -88.03 -28.16 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.701 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.562 ' HG3' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -89.77 -8.98 50.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.86 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -92.96 -39.63 11.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.77 126.1 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.013 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.39 -49.9 73.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.414 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.501 ' HB2' HG13 ' A' ' 163' ' ' ILE . 12.3 m-85 -130.44 -171.94 2.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.095 0.474 . . . . 0.0 111.526 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.3 t -162.35 35.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.31 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 102' ' ' CYS . . . -68.41 143.58 95.64 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.498 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.883 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 71.6 Cg_endo -87.68 -89.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.722 2.281 . . . . 0.0 112.111 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 110.755 179.616 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 120.782 0.325 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.687 ' HA3' HD21 ' A' ' 178' ' ' LEU . . . -127.9 129.33 6.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.671 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.91 168.87 8.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.604 0.24 . . . . 0.0 110.448 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.847 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 24.4 m -158.76 155.65 28.35 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.012 0.434 . . . . 0.0 111.375 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -132.29 160.05 37.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.077 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.501 HG13 ' HB2' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -117.14 153.63 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.401 . . . . 0.0 111.638 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 6.4 t -159.49 118.12 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.447 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.644 HH21 ' HB3' ' B' ' 10' ' ' PHE . 15.2 ptt85 -74.01 -152.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.29 -178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -179.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.199 0.523 . . . . 0.0 111.69 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.93 -8.37 29.5 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.402 ' H ' ' H ' ' A' ' 169' ' ' THR . 15.2 t -170.08 -5.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.244 -0.478 . . . . 0.0 109.934 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.619 HG22 ' HG3' ' A' ' 171' ' ' ARG . 22.4 m -133.43 -12.6 2.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.054 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 170' ' ' ARG . 43.3 mtt180 62.29 22.58 13.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.799 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.619 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -175.71 -179.07 1.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.56 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.9 OUTLIER -81.49 124.0 29.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.9 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.436 ' SD ' HG23 ' A' ' 169' ' ' THR . 0.2 OUTLIER -142.5 126.33 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 34.8 t -104.11 136.32 43.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.485 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 1.3 m80 -105.82 145.69 30.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.359 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.05 154.73 21.49 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.185 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -161.66 144.67 12.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.715 0.293 . . . . 0.0 110.739 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.687 HD21 ' HA3' ' A' ' 159' ' ' GLY . 1.1 mt -105.29 162.52 13.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.131 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.502 ' HB3' HD11 ' A' ' 187' ' ' LEU . . . -89.13 122.5 32.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 84' ' ' SER . 0.5 OUTLIER -71.83 -11.23 60.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.935 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -89.34 -17.21 29.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.715 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 53.84 80.63 0.11 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.02 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.42 -43.08 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.091 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.94 31.61 55.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.306 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -146.08 -34.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.701 0.286 . . . . 0.0 110.793 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 186' ' ' ARG . 0.7 OUTLIER -59.51 -28.25 66.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.793 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 179' ' ' ALA . 4.8 mp -117.04 -39.13 3.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.879 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.13 -63.06 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.32 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -16.05 61.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.373 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.0 -53.61 8.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.025 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.46 -18.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.08 -1.54 59.99 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.334 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.3 m -120.54 -4.7 9.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.32 . . . . 0.0 110.781 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.732 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -74.82 -45.61 42.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.248 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.618 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 38.9 p90 -68.3 -36.18 78.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.072 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -56.65 -31.69 64.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.022 0.439 . . . . 0.0 110.69 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.46 -19.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.812 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . 0.618 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -73.37 -6.02 43.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.548 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.005 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.883 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.573 0.225 . . . . 0.0 111.17 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.42 ' H ' ' HB3' ' B' ' 2' ' ' PHE . 7.9 t 62.96 157.14 0.06 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.137 0.494 . . . . 0.0 111.246 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -92.51 176.53 6.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.829 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mtp -123.32 -7.31 8.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.7 p -83.62 6.87 19.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -62.56 145.57 54.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -106.85 10.11 30.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 t70 54.42 70.54 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.983 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.644 ' HB3' HH21 ' A' ' 165' ' ' ARG . 44.8 m-85 -61.3 134.92 93.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.967 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.598 2.199 . . . . 0.0 112.445 -179.725 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.763 0.316 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -91.13 -25.53 19.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.966 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.63 -34.3 77.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.708 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.4 mt-10 -92.38 -9.38 41.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.558 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -60.16 -50.59 73.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.667 HG11 HG23 ' A' ' 197' ' ' VAL . 5.2 t -56.51 -40.61 69.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.955 0.407 . . . . 0.0 110.432 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.708 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 5.3 mtm180 -65.03 -32.03 73.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.332 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.2 m -81.12 3.46 23.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.61 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 65.01 41.92 4.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.42 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -176.17 85.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 13.1 t -116.35 21.4 13.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.371 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.65 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -117.06 -160.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.33 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -158.66 -169.5 2.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.537 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 2.3 t -48.94 142.09 6.93 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.893 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.3 m -138.0 -171.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.062 0.458 . . . . 0.0 111.761 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -141.65 60.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.416 179.193 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.435 ' O ' HG23 ' A' ' 117' ' ' VAL . 71.4 t80 -53.26 114.84 1.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.03 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -82.66 -56.08 4.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.022 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.0 -124.64 1.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.592 ' HB2' ' HE1' ' A' ' 173' ' ' MET . 1.2 p -164.76 142.19 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.936 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.51 163.41 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.998 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -91.56 130.14 37.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.7 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 172' ' ' TRP . 0.9 OUTLIER -131.54 128.98 61.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.195 -179.402 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -91.26 68.7 5.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 98' ' ' GLY . 0.7 OUTLIER -162.18 -65.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.137 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.652 ' HA ' HG21 ' A' ' 101' ' ' VAL . 50.4 p 52.78 22.66 2.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.991 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 96' ' ' SER . 10.1 mtp180 -149.36 -56.19 0.19 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.912 0.386 . . . . 0.0 111.601 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.48 ' H ' ' HG2' ' A' ' 95' ' ' GLU . . . -61.6 135.96 47.17 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.692 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.639 ' HE1' ' HB2' ' A' ' 103' ' ' GLU . 3.1 tpt 53.32 23.28 3.17 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.527 0.331 . . . . 0.0 111.789 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.429 ' HB3' ' CB ' ' A' ' 151' ' ' ALA . 11.3 mp0 61.03 5.15 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.408 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.652 HG21 ' HA ' ' A' ' 96' ' ' SER . 2.3 t 53.43 30.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.856 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.6 p -118.18 -47.43 2.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.219 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.639 ' HB2' ' HE1' ' A' ' 99' ' ' MET . 0.1 OUTLIER -69.18 -3.38 13.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.586 -178.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -118.22 -57.57 2.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.58 -53.21 57.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.214 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.501 HD12 ' HG ' ' A' ' 178' ' ' LEU . 4.1 tp -50.34 -34.49 24.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -67.15 -38.52 85.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.803 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 36.7 t -63.57 -46.8 93.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.318 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.42 HD21 ' HG3' ' A' ' 114' ' ' ARG . 3.5 mp -72.46 -18.79 61.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.109 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -94.84 -11.13 29.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.541 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -71.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.581 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.8 t -175.89 88.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.381 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -165.17 -62.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.42 ' HG3' HD21 ' A' ' 109' ' ' LEU . 3.8 mmp_? -101.24 110.35 22.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.381 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -62.44 134.06 94.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.119 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HB2' ' HE2' ' A' ' 86' ' ' LYS . 73.3 Cg_endo -78.28 161.1 29.13 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.654 2.236 . . . . 0.0 112.603 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -130.36 153.75 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.79 179.265 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.48 97.57 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -141.46 166.9 26.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.5 113.92 25.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.331 . . . . 0.0 110.878 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.522 HD22 ' HG ' ' A' ' 82' ' ' SER . 25.4 tp -83.8 138.48 33.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.758 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -123.17 84.18 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.65 ' H ' ' HB2' ' A' ' 82' ' ' SER . 48.4 t -58.75 102.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.852 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.508 ' O ' HD12 ' A' ' 144' ' ' ILE . 3.7 p -105.18 144.33 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.548 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.7 19.8 1.93 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.888 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.454 ' H ' ' HG ' ' A' ' 124' ' ' SER . 0.8 OUTLIER -139.0 22.64 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.665 179.393 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.18 118.5 2.59 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.395 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 mt -54.1 144.7 18.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 111.171 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 16.4 ttm180 -147.58 112.21 5.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 140' ' ' VAL . 1.9 t -100.39 133.32 43.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.093 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.451 HG13 ' CD ' ' A' ' 136' ' ' LYS . 1.5 t -121.97 109.05 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -53.03 157.49 1.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.218 -179.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -3.64 53.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -116.19 -54.69 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.386 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.6 m -80.74 -31.84 35.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.459 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.451 ' CD ' HG13 ' A' ' 131' ' ' VAL . 4.2 mmtm 52.39 29.95 7.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.9 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.19 -108.7 1.51 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.45 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 141' ' ' ASP . 3.6 tp -160.59 113.76 2.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.678 0.275 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.55 -49.07 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.36 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.482 ' HB ' HG23 ' A' ' 130' ' ' VAL . 93.4 t -122.45 102.52 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.827 ' HB3' HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -108.42 25.95 11.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.408 178.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -76.23 -156.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.166 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.858 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 59.9 m -135.46 161.75 34.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.966 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.624 ' H ' HG21 ' A' ' 143' ' ' THR . 2.5 mt -77.24 -33.42 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.718 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -86.09 -24.3 26.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.389 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.858 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -60.03 -41.04 91.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.772 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.6 m -73.16 144.92 12.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.8 t -49.56 -55.28 14.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.763 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' B' ' 3' ' ' SER . 30.8 p90 -168.97 126.93 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.72 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 116.67 13.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . . . -131.11 104.07 15.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.036 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.523 ' HB3' ' HD1' ' A' ' 160' ' ' PHE . 32.7 Cg_exo -62.3 -88.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.674 2.249 . . . . 0.0 112.248 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.46 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 8.6 p-10 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.66 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.434 ' HB2' ' NH1' ' A' ' 158' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.8 0.333 . . . . 0.0 110.982 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -106.31 147.46 16.24 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.351 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.523 ' HD1' ' HB3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -124.48 169.16 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 0.0 110.845 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.493 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 3.3 m -168.58 151.0 5.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.082 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.65 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -134.95 148.04 49.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.531 178.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.495 HG12 ' HB ' ' A' ' 101' ' ' VAL . 0.2 OUTLIER -103.89 151.38 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.209 -179.056 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.91 106.95 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.85 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 15.7 ptm180 -68.29 -156.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.196 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.08 -162.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.462 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.93 -10.16 53.7 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.45 -19.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.949 0.404 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -130.25 -2.41 4.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.721 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.5 9.64 3.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -172.44 -176.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.658 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -78.52 122.08 25.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 110.942 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.592 ' HE1' ' HB2' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -147.74 110.06 4.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.738 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 28.2 p -98.11 159.89 14.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.231 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.65 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 4.6 m-70 -122.96 142.2 51.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.228 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.493 ' HA2' ' OG ' ' A' ' 161' ' ' SER . . . -111.8 150.12 18.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.856 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -170.29 133.35 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.872 0.368 . . . . 0.0 110.756 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.501 ' HG ' HD12 ' A' ' 106' ' ' LEU . 4.7 mp -110.16 171.07 7.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.244 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.44 128.47 41.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.5 OUTLIER -78.37 -0.34 28.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.576 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.98 -21.08 18.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 55.51 83.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.97 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.2 t -168.99 -42.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.19 42.63 42.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.441 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.02 -34.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.743 0.306 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.497 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.3 OUTLIER -75.84 -16.65 60.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.504 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.5 mp -126.93 -44.17 1.65 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.019 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 t -59.98 -69.19 0.23 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -21.0 58.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.02 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.9 -52.61 19.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.5 t -61.16 -31.46 50.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.27 -17.43 46.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.283 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 96.1 m -104.12 -11.37 17.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.719 0.295 . . . . 0.0 110.845 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.99 -33.63 67.32 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 0.0 OUTLIER -77.51 -34.99 53.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.279 178.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.588 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -55.87 -26.03 45.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.874 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.667 HG23 HG11 ' A' ' 76' ' ' VAL . 21.8 t -100.49 -19.46 5.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.686 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -72.56 -12.08 60.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.604 178.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.588 HD12 ' HA ' ' A' ' 196' ' ' ALA . 1.5 mt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.879 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.466 ' HB2' ' H ' ' B' ' 3' ' ' SER . 1.2 p90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.495 0.188 . . . . 0.0 110.547 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 1.4 p -163.91 162.99 23.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.855 0.359 . . . . 0.0 111.192 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' B' ' 7' ' ' PHE . 41.5 p-10 -76.44 175.4 9.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.063 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 36.6 mtp -128.33 -24.14 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.2 t -90.0 23.64 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.452 ' HB3' ' ND2' ' B' ' 4' ' ' ASN . 43.5 p90 -65.08 149.87 49.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -83.82 0.48 47.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 t0 57.41 94.67 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.026 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.599 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 11.1 m-85 -90.4 -51.32 0.33 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.504 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 35.8 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.113 1.875 . . . . 0.0 112.272 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.794 0.33 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.47 -26.08 32.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.81 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -29.52 70.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.703 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.65 -17.35 17.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.791 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.63 -51.57 59.46 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.295 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.29 -43.97 87.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.727 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -55.17 -39.06 69.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.655 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -91.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.638 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 179.84 36.4 0.0 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.24 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.442 ' HB ' ' HD1' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -173.77 101.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 111.556 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.5 t -134.54 55.46 1.89 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.844 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.59 -163.05 1.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.822 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CG ' ' HE3' ' A' ' 181' ' ' LYS . 10.5 m-85 -156.96 -171.33 3.61 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.819 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -49.56 145.96 4.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.919 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.0 m -143.89 173.53 5.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.971 0.415 . . . . 0.0 111.83 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -122.38 61.19 0.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.327 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 177' ' ' PHE . 1.0 OUTLIER -54.06 96.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.94 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -62.86 -31.36 72.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.78 -131.76 5.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.519 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -158.9 130.27 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.64 136.21 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.977 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 112.56 5.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.069 0.461 . . . . 0.0 110.659 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' ' 174' ' ' CYS . 17.0 m -103.58 173.64 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -122.2 64.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -149.53 -90.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 p 63.3 9.62 4.15 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.454 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.423 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -166.52 47.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.988 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -125.21 -129.68 3.39 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.27 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.499 ' HE3' ' CD ' ' A' ' 100' ' ' GLN . 9.4 ttt -75.38 -73.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.578 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.566 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . 4.9 mt-30 -146.57 -24.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.824 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.0 t 73.18 -30.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.291 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.566 ' SG ' ' HB3' ' A' ' 100' ' ' GLN . 3.7 p -63.17 -27.61 69.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.53 -18.26 38.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.79 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.02 -44.63 2.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.727 0.299 . . . . 0.0 111.457 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.31 75.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.597 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 tp -54.23 -33.73 59.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.181 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 11.5 tptm -74.93 -45.54 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.229 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.1 t -56.54 -30.1 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.396 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.739 HD22 ' HG3' ' A' ' 114' ' ' ARG . 1.5 mt -87.66 -23.54 24.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.008 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.568 ' HG2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -82.46 -9.95 59.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.473 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -75.21 -62.85 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.723 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 2.0 t -177.33 -168.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.544 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 112' ' ' SER . 1.3 mpt_? 70.61 -69.19 0.18 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.297 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.739 ' HG3' HD22 ' A' ' 109' ' ' LEU . 8.3 mmt180 -84.28 91.8 7.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 115' ' ' ARG . 6.5 ptp180 -69.08 141.7 92.15 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 72.3 Cg_endo -77.73 133.16 12.51 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.589 2.193 . . . . 0.0 112.69 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.0 143.59 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.969 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -101.72 108.19 19.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -150.68 178.98 27.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.44 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.67 118.01 35.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.74 0.305 . . . . 0.0 111.033 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.528 HD11 HG23 ' A' ' 130' ' ' VAL . 24.4 tp -92.89 138.46 31.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.642 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.5 ' H ' HD12 ' A' ' 121' ' ' LEU . 11.3 m170 -123.62 103.67 8.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.02 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -71.66 102.45 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.4 . . . . 0.0 110.513 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.16 117.95 35.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.72 -16.17 3.69 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.713 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -111.59 34.63 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.687 0.279 . . . . 0.0 110.975 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.739 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 114.75 111.31 2.87 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.412 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.17 162.55 5.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.961 0.41 . . . . 0.0 111.299 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.56 119.85 5.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.513 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.528 HG23 HD11 ' A' ' 121' ' ' LEU . 1.9 t -107.15 127.94 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.605 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.52 156.29 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.506 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.99 148.26 23.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.766 0.317 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.456 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.7 OUTLIER -99.09 19.79 14.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -138.94 -9.32 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.965 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.594 HG21 ' H ' ' A' ' 137' ' ' GLY . 13.6 t -154.16 -10.39 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.876 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 13.8 mmtm 60.16 27.26 16.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.594 ' H ' HG21 ' A' ' 135' ' ' THR . . . -73.62 -159.68 5.92 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.408 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 141' ' ' ASP . 11.5 tp -121.97 118.73 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.689 0.28 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 8.7 mt -96.84 -55.26 6.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.012 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.502 ' HB ' HG22 ' A' ' 130' ' ' VAL . 95.6 t -139.2 118.07 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.596 ' HB2' HD23 ' A' ' 138' ' ' LEU . 4.4 t0 -122.06 74.06 1.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -119.47 -165.01 1.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.187 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.739 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 1.6 m -115.52 177.31 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.908 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.684 HD12 ' HB1' ' A' ' 194' ' ' ALA . 8.1 mt -96.18 -42.3 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.835 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -81.3 -10.21 59.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.664 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.764 ' HE2' HG21 ' A' ' 168' ' ' THR . 1.7 ttpm? -77.03 -43.35 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.811 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.492 HG11 ' CD2' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -70.29 154.2 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.948 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.62 -68.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.921 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.662 ' HB3' ' HB2' ' B' ' 3' ' ' SER . 0.0 OUTLIER -155.19 129.15 8.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.999 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -85.58 104.76 15.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.826 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.467 ' HB1' ' HG2' ' A' ' 100' ' ' GLN . . . -118.2 133.18 23.48 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.261 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.53 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 56.3 Cg_endo -70.69 -87.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.407 2.072 . . . . 0.0 112.156 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.78 0.324 . . . . 0.0 110.91 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.685 0.279 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.55 134.64 8.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.578 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.53 ' HA ' ' O ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -131.3 142.82 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.644 0.259 . . . . 0.0 110.772 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.2 m -153.51 131.2 11.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.069 0.462 . . . . 0.0 111.402 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.492 ' CD2' HG11 ' A' ' 147' ' ' VAL . 38.1 p90 -109.13 164.99 11.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.519 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.84 163.2 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.448 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.75 110.87 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.678 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.724 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 2.5 ptp180 -72.37 -163.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.132 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -175.05 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.71 -2.04 88.4 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.488 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.764 HG21 ' HE2' ' A' ' 146' ' ' LYS . 8.8 t -167.75 -12.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.392 . . . . 0.0 110.471 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.619 HG22 ' HG3' ' A' ' 173' ' ' MET . 0.7 OUTLIER -136.14 1.12 2.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.928 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 64.79 1.52 1.43 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.465 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 171' ' ' ARG . 5.1 ptp180 -175.47 -179.68 1.31 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.032 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.724 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -86.0 94.18 9.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.064 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.619 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.9 OUTLIER -107.23 129.93 54.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . 0.73 ' HB2' HG22 ' A' ' 93' ' ' VAL . 17.9 t -114.14 110.95 20.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.102 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . 3.1 m80 -85.26 126.44 33.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -112.95 154.19 17.08 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.526 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.504 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . 30.6 p90 -166.21 175.93 7.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.827 0.346 . . . . 0.0 111.064 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.1 mp -137.89 175.16 9.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.932 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.429 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -105.06 119.53 39.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.5 OUTLIER -71.11 -13.67 62.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.695 ' HB2' ' HD2' ' A' ' 186' ' ' ARG . 1.5 mmmp? -83.05 -30.95 27.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.954 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 57.09 92.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.331 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.511 ' HB3' ' HD3' ' A' ' 186' ' ' ARG . 1.5 t -169.22 -38.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.46 ' H ' ' CZ ' ' A' ' 186' ' ' ARG . . . 76.65 47.53 9.95 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.635 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -155.96 -36.33 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.828 0.347 . . . . 0.0 110.908 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.695 ' HD2' ' HB2' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -66.09 -29.99 70.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.69 -42.19 2.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.371 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 t -57.66 -75.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.443 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -58.85 -24.78 62.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.2 -56.75 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.076 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 191' ' ' VAL . 61.7 t -59.63 -34.06 53.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -60.45 -15.35 38.76 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.619 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 73.4 m -102.34 -12.77 17.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.64 0.257 . . . . 0.0 111.093 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.684 ' HB1' HD12 ' A' ' 144' ' ' ILE . . . -58.14 -29.18 65.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.414 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.453 ' CG ' ' HA ' ' B' ' 4' ' ' ASN . 0.1 OUTLIER -81.49 -27.23 34.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.788 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.529 ' HA ' HD13 ' A' ' 199' ' ' LEU . . . -62.03 -12.88 21.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.03 -31.64 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -1.89 19.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.819 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 196' ' ' ALA . 3.4 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.964 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.464 ' CE1' ' HD3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.696 0.284 . . . . 0.0 110.517 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' A' ' 149' ' ' PHE . 4.8 p 62.51 154.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.477 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.453 ' HA ' ' CG ' ' A' ' 195' ' ' PHE . 0.6 OUTLIER -70.47 153.69 42.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.13 -21.11 12.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.805 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t -95.41 20.78 8.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.42 ' HB3' ' OD1' ' B' ' 4' ' ' ASN . 26.3 p90 -61.5 149.07 39.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.976 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -103.49 -4.56 23.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.911 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 54.64 83.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.933 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -56.58 145.34 60.8 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo . . . . . 0 C--O 1.25 1.088 0 C-N-CA 122.55 2.167 . . . . 0.0 112.387 -179.676 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.809 0.338 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.08 -43.73 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -80.3 -46.4 16.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.887 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 77' ' ' ARG . 12.9 tt0 -65.5 -23.1 66.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.006 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.8 -52.8 62.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.132 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.784 HG13 ' HA ' ' A' ' 194' ' ' ALA . 3.1 t -62.79 -43.01 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.624 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.467 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 37.2 mtp180 -54.22 -34.93 61.79 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.329 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 11.6 m -78.05 -90.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.369 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 78' ' ' SER . . . 177.05 36.22 0.0 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.232 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.41 101.2 0.26 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.868 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 2.9 t -127.94 -147.35 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.285 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.52 ' HG ' HD22 ' A' ' 121' ' ' LEU . 0.3 OUTLIER 53.47 -163.06 0.1 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 111.607 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.562 ' HB3' ' HD3' ' A' ' 181' ' ' LYS . 2.1 m-85 -158.28 -169.09 2.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.333 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 3.5 m -42.58 144.26 0.56 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.762 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.445 HG11 HD21 ' A' ' 187' ' ' LEU . 34.9 m -139.5 -170.55 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.591 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.69 74.81 1.19 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.701 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 42.8 t80 -58.56 97.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.09 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -64.18 -33.63 76.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.81 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.54 -152.05 24.15 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.5 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.494 ' HB2' ' HE3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -136.41 129.98 32.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.312 . . . . 0.0 110.797 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.68 152.86 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -84.81 144.66 28.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.44 -172.23 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.997 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -150.0 59.81 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.064 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -170.06 -77.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.98 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.413 ' HA ' HG23 ' A' ' 163' ' ' ILE . 49.6 m 61.01 24.83 14.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.988 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 3.5 ptt-85 -135.78 37.61 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.774 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -160.15 161.24 32.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.486 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.628 ' HG2' ' HB3' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -83.92 -37.25 22.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 111.065 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -70.4 -9.77 57.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.168 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.84 -36.88 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.85 0.357 . . . . 0.0 110.925 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 3.5 m -79.17 -24.62 43.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.468 ' HA ' ' OD2' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -71.62 -7.74 49.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.972 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -111.77 -49.89 2.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.963 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.551 ' HA ' HG23 ' A' ' 108' ' ' VAL . . . -57.2 -41.83 80.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 tp -58.24 -36.96 73.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.604 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -67.39 -38.07 84.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.607 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 105' ' ' ALA . 3.6 t -60.7 -33.33 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.557 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 114' ' ' ARG . 2.5 mt -77.39 -26.94 52.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.661 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.97 -21.02 44.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.614 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -98.48 1.23 46.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.974 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.95 172.05 13.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.954 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.74 74.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.717 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.436 ' HG3' HD21 ' A' ' 109' ' ' LEU . 4.2 mmp_? -86.87 36.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.177 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 115' ' ' ARG . 0.1 OUTLIER 56.16 87.13 0.15 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.65 178.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 3.5 Cg_exo -76.2 116.39 4.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.969 2.446 . . . . 0.0 111.886 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.49 HG12 ' OD1' ' A' ' 132' ' ' ASP . 0.1 OUTLIER -85.43 145.42 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.966 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -104.26 102.6 12.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.327 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.714 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -158.78 -137.64 2.3 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.176 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.496 ' O ' HG13 ' A' ' 130' ' ' VAL . 3.0 pp -155.2 169.56 23.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 111.101 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.52 HD22 ' HG ' ' A' ' 82' ' ' SER . 54.4 tp -112.07 140.25 46.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.136 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.578 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 4.7 m-70 -121.5 85.65 2.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.112 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.868 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 69.0 t -60.4 93.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.159 0.504 . . . . 0.0 111.228 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.565 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -87.05 142.04 28.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.857 177.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.87 23.47 1.7 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.415 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 124' ' ' SER . 21.6 t0 -155.55 27.61 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.529 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.25 112.24 1.73 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.282 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.46 159.35 8.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.83 0.348 . . . . 0.0 111.026 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -154.5 116.74 4.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.713 HG23 HG21 ' A' ' 140' ' ' VAL . 13.6 t -101.24 106.09 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.086 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.22 129.35 53.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.977 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.714 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -64.4 175.78 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.01 -4.66 13.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -117.04 -45.13 2.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.381 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.6 m -92.22 -24.04 19.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.451 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 54.09 32.89 16.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.627 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -102.87 -178.56 26.72 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.466 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' A' ' 141' ' ' ASP . 4.5 tp -87.11 135.9 33.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.808 0.337 . . . . 0.0 110.792 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 130' ' ' VAL . 40.8 mt -116.88 -51.77 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.034 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.713 HG21 HG23 ' A' ' 130' ' ' VAL . 92.7 t -117.75 103.72 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.863 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.519 ' HB2' HD22 ' A' ' 138' ' ' LEU . 16.3 t0 -96.36 32.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.43 ' HG2' HG11 ' A' ' 140' ' ' VAL . 20.2 mm100 -77.5 -173.06 2.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 82.8 m -150.09 148.91 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.776 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.565 HD11 ' O ' ' A' ' 124' ' ' SER . 1.0 OUTLIER -63.22 -39.87 86.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.628 179.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -84.46 13.92 5.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.681 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.628 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 10.0 tttp -115.43 -48.49 2.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.978 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.8 m -69.58 146.48 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.101 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.6 t -53.54 -63.09 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.414 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.73 146.23 2.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.776 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.37 165.59 22.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.96 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.628 ' HB3' ' HG2' ' A' ' 99' ' ' MET . . . -167.16 100.82 0.63 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.222 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.25 30.94 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.037 2.491 . . . . 0.0 112.433 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.468 ' OD2' ' HA ' ' A' ' 103' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.104 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.736 0.303 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.38 130.31 9.35 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.488 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.574 ' HZ ' ' HA2' ' A' ' 184' ' ' GLY . 3.3 m-85 -128.93 152.56 48.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.338 . . . . 0.0 111.012 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.526 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -161.74 148.51 14.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.09 162.47 24.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.843 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -120.47 151.43 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.076 0.465 . . . . 0.0 111.418 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 10.0 t -150.95 148.03 27.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.332 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -158.66 0.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.24 -176.85 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.207 0.527 . . . . 0.0 111.658 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.72 -12.07 35.34 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.62 -22.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.134 -0.533 . . . . 0.0 109.984 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.565 HG21 ' HG3' ' A' ' 171' ' ' ARG . 33.3 m -113.2 -12.77 13.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.832 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 65.12 17.2 10.95 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.284 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.565 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.9 OUTLIER -173.0 -170.03 0.61 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.051 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.68 112.86 24.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.3 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.494 ' HE3' ' HB2' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -123.59 173.53 8.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.461 179.018 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 19.5 t -155.01 129.59 9.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.752 0.31 . . . . 0.0 111.292 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.43 155.17 17.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.504 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.526 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -137.48 155.46 23.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.786 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.42 ' HE2' HD22 ' A' ' 187' ' ' LEU . 11.9 p90 -166.62 176.07 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.361 . . . . 0.0 110.811 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.2 mp -146.23 152.05 38.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.795 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.33 113.28 7.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 4.0 t -57.37 -41.52 80.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -73.36 -21.29 60.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.557 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 62.27 103.68 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.997 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.8 t -163.77 -43.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.574 ' HA2' ' HZ ' ' A' ' 160' ' ' PHE . . . 76.39 17.34 80.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.317 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.73 -25.67 2.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 0.0 111.018 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -80.8 -17.7 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.991 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.445 HD21 HG11 ' A' ' 85' ' ' VAL . 9.5 mp -119.59 -46.6 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.229 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 t -61.86 -56.77 15.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.517 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.92 -5.46 21.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.621 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -96.78 -48.42 5.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.698 0.285 . . . . 0.0 111.544 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.577 ' HA ' HG11 ' A' ' 123' ' ' VAL . 1.7 p -70.7 -22.11 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.211 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.88 67.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.395 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 77.4 m -119.72 4.39 11.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.773 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.784 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -78.11 -51.77 9.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.169 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.541 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 51.0 p90 -63.72 -26.2 68.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.804 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -62.45 -23.14 66.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.11 11.85 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.6 -13.05 10.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.979 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.804 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.141 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.449 ' HB2' ' H ' ' B' ' 3' ' ' SER . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.67 0.271 . . . . 0.0 110.892 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.449 ' H ' ' HB2' ' B' ' 2' ' ' PHE . 0.2 OUTLIER -167.63 150.13 5.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.843 179.677 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' B' ' 7' ' ' PHE . 0.1 OUTLIER -60.19 146.78 42.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.739 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 12.0 mtm -116.45 -15.63 10.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.127 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 9.1 p -84.74 20.79 1.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.205 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.467 ' HB3' ' OD1' ' B' ' 4' ' ' ASN . 44.0 p90 -64.05 149.8 46.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -90.62 11.94 20.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 39.0 t0 56.0 85.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.804 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.598 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 2.7 m-85 -92.85 -52.24 0.27 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.392 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 26.5 Cg_exo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.117 1.878 . . . . 0.0 112.212 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.883 0.373 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.727 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -98.56 -18.07 18.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.768 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -62.63 -38.91 92.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.568 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.744 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -92.27 -7.5 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.429 179.259 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.727 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . . . -65.85 -49.12 69.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.84 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.546 HG13 HG23 ' A' ' 197' ' ' VAL . 1.2 t -61.06 -36.31 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.047 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.744 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -66.53 -34.36 77.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.276 178.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.32 6.26 14.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.756 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 66.32 42.43 3.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.589 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.445 ' HB ' ' ND1' ' A' ' 122' ' ' HIS . 1.5 t -177.19 86.95 0.02 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.241 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 75' ' ' ALA . 11.5 t -116.69 4.84 13.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.473 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.639 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.4 OUTLIER -103.78 -167.93 1.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.721 0.295 . . . . 0.0 111.251 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -152.74 -171.07 3.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -39.0 141.99 0.25 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.823 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.516 HG11 ' HD2' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -149.41 -165.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.323 -179.409 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.406 ' H ' ' HB ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -152.19 70.61 0.93 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -61.58 119.88 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.82 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.435 ' HB2' HD21 ' A' ' 109' ' ' LEU . 1.2 mp -79.03 -75.39 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.259 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.85 -117.57 0.45 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.349 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.596 ' N ' HD22 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -159.14 128.45 5.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.713 0.292 . . . . 0.0 110.768 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.12 158.03 28.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.331 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.1 152.64 30.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.583 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 172' ' ' TRP . 1.9 m -141.55 150.09 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.303 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.453 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 1.7 t80 -118.48 59.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.389 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 94' ' ' PHE . 4.7 mt-10 -154.07 -68.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.692 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.62 14.99 1.92 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.211 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -141.13 116.54 10.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.008 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.8 -170.98 15.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.561 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -116.06 -26.28 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 110.738 -179.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -69.28 -11.71 61.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.321 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.641 ' HB ' HD13 ' A' ' 163' ' ' ILE . 14.1 t -59.6 -27.5 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 110.988 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.601 ' HB3' ' HG ' ' A' ' 161' ' ' SER . 73.2 m -79.32 -39.32 33.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.151 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.36 -14.69 63.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.285 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.421 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.8 mt-10 -103.98 -47.77 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.039 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 101' ' ' VAL . . . -60.27 -34.95 74.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.16 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.406 HD22 ' HA3' ' A' ' 159' ' ' GLY . 3.2 tp -57.37 -44.4 84.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.72 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.542 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -69.08 -34.34 74.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.606 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.2 t -61.68 -31.0 49.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.333 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 90' ' ' CYS . 1.2 mt -80.29 -30.32 38.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.852 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -80.41 -21.2 42.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.501 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -19.2 20.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.901 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.6 m -100.32 10.97 40.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.057 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER 32.01 78.79 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.301 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.473 ' HG3' HD23 ' A' ' 109' ' ' LEU . 14.4 mmm180 -95.07 22.2 6.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.909 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 56.59 104.94 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.861 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.59 149.16 30.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.514 2.143 . . . . 0.0 111.951 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.88 136.34 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.085 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.13 82.61 8.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.063 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -151.76 -179.6 27.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.132 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.17 158.22 24.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 0.0 111.236 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.49 ' HB2' HG21 ' A' ' 85' ' ' VAL . 67.7 tp -96.09 146.7 24.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.222 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.445 ' ND1' ' HB ' ' A' ' 80' ' ' THR . 1.7 m170 -123.68 76.85 1.46 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.821 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.639 ' H ' ' HB2' ' A' ' 82' ' ' SER . 40.7 t -53.0 104.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.956 0.408 . . . . 0.0 110.582 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 2.0 t -110.48 126.39 54.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.469 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -55.6 -14.29 6.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.607 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -108.29 31.09 5.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 0.0 110.831 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 114.87 125.5 4.03 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.6 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.5 163.82 8.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.86 0.362 . . . . 0.0 110.947 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.76 133.9 1.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.78 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.411 HG23 ' HB ' ' A' ' 140' ' ' VAL . 2.8 t -110.12 125.91 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.85 0.357 . . . . 0.0 111.261 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.31 132.23 64.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.619 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.567 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -61.87 -173.89 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 0.0 111.018 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.74 -15.47 5.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.774 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.54 -22.04 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.546 HG23 ' H ' ' A' ' 137' ' ' GLY . 9.4 t -133.19 -18.79 2.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.331 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.32 33.5 23.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.737 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.546 ' H ' HG23 ' A' ' 135' ' ' THR . . . -84.11 145.68 22.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.439 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 141' ' ' ASP . 24.0 tp -75.1 128.86 36.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.787 0.327 . . . . 0.0 110.924 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.5 mt -111.1 -50.37 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.49 HG13 ' HH ' ' A' ' 162' ' ' TYR . 53.8 t -104.25 114.99 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.971 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.411 ' HB2' HD21 ' A' ' 138' ' ' LEU . 26.4 t0 -117.27 57.44 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.716 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.58 -176.2 2.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.133 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.501 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 2.4 m -121.16 168.63 11.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.667 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.438 ' H ' HG22 ' A' ' 143' ' ' THR . 5.8 mt -84.33 -33.09 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 110.873 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -83.67 -13.16 54.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.615 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -87.05 -42.35 13.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.981 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 147' ' ' VAL . 0.6 OUTLIER -61.73 126.7 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.923 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.85 -37.72 63.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.878 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -151.97 166.37 31.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.084 0.469 . . . . 0.0 111.626 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.75 63.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.797 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.46 ' HB1' ' SG ' ' A' ' 102' ' ' CYS . . . -90.06 136.93 28.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.984 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 72.7 Cg_endo -80.16 -91.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.704 2.269 . . . . 0.0 111.603 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.421 ' H ' ' HG2' ' A' ' 152' ' ' PRO . 1.1 p30 . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.677 0.275 . . . . 0.0 110.655 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 158' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.406 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -127.63 123.3 4.46 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.541 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -115.39 161.94 17.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.645 0.259 . . . . 0.0 110.54 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.601 ' HG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -158.92 -177.87 6.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.013 0.435 . . . . 0.0 111.448 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.49 ' HH ' HG13 ' A' ' 140' ' ' VAL . 10.4 p90 -156.38 158.06 36.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.085 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.641 HD13 ' HB ' ' A' ' 101' ' ' VAL . 0.6 OUTLIER -123.71 165.04 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.069 0.461 . . . . 0.0 112.027 -177.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 5.7 p -165.57 135.6 3.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.394 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -160.43 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 111.263 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -175.17 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.442 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.25 -7.32 69.16 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.1 t -168.95 -11.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.216 -0.492 . . . . 0.0 110.002 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.08 -7.88 5.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.739 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 64.15 9.72 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.574 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -176.12 -173.72 0.58 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.968 0.413 . . . . 0.0 111.317 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.485 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -88.93 108.07 19.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.593 179.373 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 24.9 mtp -128.36 133.51 48.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.759 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 43.5 t -113.58 132.43 55.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' A' ' 161' ' ' SER . 35.1 m170 -98.8 158.72 15.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.624 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -139.81 149.41 20.78 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.005 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.516 ' HD2' HG11 ' A' ' 85' ' ' VAL . 10.3 p90 -157.08 135.98 11.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.78 0.324 . . . . 0.0 110.815 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.68 160.19 14.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.52 118.02 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -6.56 45.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.592 ' HB3' ' HZ2' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -89.51 -26.76 20.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.765 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.16 75.87 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.027 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -165.65 -32.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.786 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 63.82 37.09 94.17 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.514 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -133.29 -31.25 1.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 111.011 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -88.16 -5.72 58.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.82 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.07 -58.0 1.22 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.29 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -62.51 1.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.344 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.98 -19.64 32.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.29 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.05 -45.65 33.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.03 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.4 -29.05 45.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.962 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.53 -17.69 48.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.366 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 68.6 m -110.58 -8.73 14.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.761 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.527 ' HA ' HG21 ' A' ' 76' ' ' VAL . . . -61.98 -40.1 94.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.187 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.519 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 3.5 p90 -70.42 -29.59 66.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.763 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.08 -22.7 51.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.066 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 76' ' ' VAL . 49.4 t -101.43 -21.95 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.528 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . 0.47 ' HB3' ' HG ' ' B' ' 6' ' ' SER . 1.8 t -64.16 -28.23 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.467 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.516 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.724 0.297 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.76 166.43 33.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.148 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.511 HD21 ' HB3' ' B' ' 7' ' ' PHE . 1.1 p-10 -70.12 128.14 35.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.994 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 1.2 mtm -95.97 -19.76 19.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.47 ' HG ' ' HB3' ' A' ' 198' ' ' CYS . 16.0 p -75.04 7.38 3.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.511 ' HB3' HD21 ' B' ' 4' ' ' ASN . 38.7 p90 -57.19 146.92 26.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -99.44 11.36 39.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.716 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 13.4 t70 54.42 72.74 0.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.953 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 65.8 m-85 -65.84 139.98 97.07 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 28.1 Cg_exo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.678 2.252 . . . . 0.0 112.31 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.849 0.357 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -86.54 -29.31 22.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -69.17 -38.41 78.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.688 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.54 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.5 tt0 -84.98 -10.61 56.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.641 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -59.87 -54.92 40.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.009 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.494 HG13 ' HA ' ' A' ' 194' ' ' ALA . 14.6 t -58.17 -40.32 76.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.54 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 5.8 mtp180 -58.51 -38.29 77.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.456 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 m -75.13 -91.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.414 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.676 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 179.65 35.29 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.53 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.616 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -173.16 99.78 0.12 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.895 0.379 . . . . 0.0 111.739 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 4.1 t -120.73 -150.02 0.44 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.23 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.618 ' HG ' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.77 -157.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 111.539 179.202 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.578 ' HB3' ' HE2' ' A' ' 181' ' ' LYS . 6.1 m-85 -159.0 -167.03 1.99 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.416 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.7 m -51.59 153.61 2.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.706 0.289 . . . . 0.0 110.995 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -144.33 -173.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.415 -179.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -142.3 63.95 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.69 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.424 ' O ' HG21 ' A' ' 117' ' ' VAL . 31.8 m-85 -57.81 103.12 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 0.3 OUTLIER -67.69 -33.61 75.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.479 -178.382 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.73 -167.44 28.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.602 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.504 ' HB2' ' HE3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -114.89 128.44 56.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.074 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.461 HG13 HD22 ' A' ' 109' ' ' LEU . 15.5 m -119.76 144.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.028 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.49 141.96 42.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.06 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.94 154.98 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -120.97 61.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.812 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 22.3 mt-10 -152.42 -76.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.254 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m 62.67 29.76 16.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -151.4 107.3 3.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.659 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.57 146.3 7.56 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.316 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.409 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -78.03 -23.39 48.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.748 0.309 . . . . 0.0 110.953 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.409 ' N ' ' HG3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -70.31 -20.74 62.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.104 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.8 t -59.73 -39.24 79.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 151' ' ' ALA . 57.6 m -70.77 -36.89 73.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -9.2 18.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.219 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.472 ' O ' HG21 ' A' ' 108' ' ' VAL . 23.5 mt-10 -99.93 -55.53 2.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.011 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.55 -31.79 66.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.238 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.449 HD22 ' HA3' ' A' ' 159' ' ' GLY . 6.8 tp -59.18 -46.56 88.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -67.01 -32.24 73.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 104' ' ' GLU . 47.3 t -58.39 -49.94 80.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.986 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 91' ' ' VAL . 1.3 mt -64.68 -22.31 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.678 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 110' ' ' ARG . 7.0 tpt180 -82.45 -28.14 31.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.709 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -97.67 -2.2 41.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.919 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.1 -177.65 3.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.049 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.79 16.29 5.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.093 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -67.46 99.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.929 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -73.47 135.71 78.61 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 74.2 Cg_endo -77.12 161.74 32.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.585 2.19 . . . . 0.0 112.552 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -124.25 108.73 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.738 179.339 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 96.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.998 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -139.0 161.9 25.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.533 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.28 129.86 35.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.664 ' HB2' HG21 ' A' ' 85' ' ' VAL . 28.0 tp -101.48 123.42 45.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.616 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 12.1 m-70 -112.81 89.3 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.911 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.618 HG23 ' HG ' ' A' ' 82' ' ' SER . 69.1 t -68.82 89.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.399 . . . . 0.0 110.937 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.676 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 1.2 p -84.32 150.74 25.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.234 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.32 34.4 2.44 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.385 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.99 19.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.809 0.338 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.655 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 134.04 112.59 1.31 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.546 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -65.42 154.05 39.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 111.184 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.52 124.79 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.8 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.702 HG21 ' HB ' ' A' ' 140' ' ' VAL . 2.8 t -112.45 113.75 45.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.441 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.6 117.25 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.581 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.448 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 2.6 t0 -51.96 158.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -108.89 0.95 20.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.061 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.69 -20.46 8.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.191 0.52 . . . . 0.0 110.01 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.1 m -123.4 -24.84 4.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.067 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 54.81 27.34 8.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.793 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.22 -109.6 1.19 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.364 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 141' ' ' ASP . 27.3 tp -160.02 131.2 5.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.778 0.323 . . . . 0.0 111.1 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.8 mt -113.47 -48.92 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.041 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.702 ' HB ' HG21 ' A' ' 130' ' ' VAL . 71.5 t -136.93 112.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.063 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.598 ' HB2' HD23 ' A' ' 138' ' ' LEU . 3.2 t0 -118.14 65.57 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.798 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -112.61 -171.8 1.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.904 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 38.1 m -125.21 158.72 33.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.484 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -66.31 -48.08 82.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.916 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -75.09 -21.95 58.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.612 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.904 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 2.8 ttmm -63.07 -52.34 63.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.694 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 m -67.95 143.09 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -44.92 -67.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.107 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.499 ' HA ' ' ND2' ' B' ' 4' ' ' ASN . 0.1 OUTLIER -165.08 124.93 1.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.961 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.0 t -63.85 159.37 19.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.765 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.536 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . . . -157.25 136.06 7.88 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.421 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HB2' ' H ' ' A' ' 153' ' ' ASP . 89.5 Cg_endo -80.2 -142.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.643 2.228 . . . . 0.0 111.993 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.475 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.77 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.606 ' HG2' ' HA ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.769 0.319 . . . . 0.0 110.965 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 153' ' ' ASP . . . -119.45 112.06 2.19 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.652 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 1.5 m-85 -119.55 151.57 38.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.689 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -159.81 170.26 21.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.858 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.566 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -147.51 164.46 33.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.158 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.5 132.6 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.058 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.4 p -111.01 153.64 25.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -119.1 94.01 4.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.008 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.624 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 49.08 29.17 2.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.481 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -65.35 -13.82 58.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.551 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.0 t 175.75 15.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.539 HG23 ' HG3' ' A' ' 171' ' ' ARG . 24.6 m -124.78 -11.52 7.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.887 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.624 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 0.0 OUTLIER 60.49 31.15 20.23 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.719 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.539 ' HG3' HG23 ' A' ' 169' ' ' THR . 0.2 OUTLIER -176.35 -168.43 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.589 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.99 126.17 39.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.362 . . . . 0.0 111.196 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.504 ' HE3' ' HB2' ' A' ' 90' ' ' CYS . 1.4 mtp -142.24 161.38 38.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.635 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 33.9 t -140.69 116.07 10.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.077 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.566 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 11.9 m-70 -92.15 134.5 34.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.71 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.689 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -118.0 143.34 17.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.532 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 41.4 p90 -149.96 154.16 37.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 0.0 111.223 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.419 HD13 HH11 ' A' ' 110' ' ' ARG . 1.0 OUTLIER -126.89 135.49 51.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.643 179.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.431 ' HB1' HD12 ' A' ' 187' ' ' LEU . . . -59.74 117.49 5.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -16.12 63.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.741 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 83' ' ' PHE . 3.4 mmtt -88.41 -26.91 21.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.781 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.606 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 4.3 m-20 57.59 87.64 0.06 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.2 t -162.5 -30.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.996 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.94 20.35 76.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.399 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -137.66 2.09 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.689 0.28 . . . . 0.0 111.02 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.516 ' HB2' HD13 ' A' ' 187' ' ' LEU . 7.8 mmt85 -106.25 -14.88 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 186' ' ' ARG . 4.4 mp -134.55 -39.94 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -59.27 -60.26 4.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -18.21 64.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.31 -41.55 63.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 67.7 t -73.62 -29.53 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.68 -7.64 29.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.248 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 68.3 m -108.47 -19.77 13.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.697 0.284 . . . . 0.0 110.751 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -58.91 -60.8 3.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.159 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -64.69 -32.71 74.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.664 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.682 ' HA ' HD13 ' A' ' 199' ' ' LEU . . . -57.44 -16.81 10.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.236 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 56.4 t -105.34 -29.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.055 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -9.56 58.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.718 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.682 HD13 ' HA ' ' A' ' 196' ' ' ALA . 4.3 mt . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.915 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.036 0 CA-C-O 120.641 0.258 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 93.0 p 51.4 95.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.177 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 149' ' ' PHE . 3.9 p30 -52.38 146.26 9.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.396 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 23.2 ttm -113.03 3.86 16.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.914 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.8 p -94.02 19.35 9.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -62.88 152.24 36.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.01 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -85.05 11.55 9.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.739 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.5 t0 57.46 80.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.615 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 24.0 m-85 -90.38 -50.8 0.34 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.248 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 45.0 Cg_exo . . . . . 0 C--O 1.25 1.085 0 C-N-CA 122.197 1.932 . . . . 0.0 112.278 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 120.677 0.275 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.51 -54.52 44.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.94 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.6 m0 -71.92 -24.07 61.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -11.08 60.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.295 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.96 -22.22 9.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.948 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.677 ' HA ' ' HB2' ' A' ' 75' ' ' ALA . 5.8 m-20 -85.21 -18.95 32.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -44.0 97.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.6 mt-10 -97.62 -5.95 34.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 72' ' ' ASP . . . -63.92 -55.98 18.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 123' ' ' VAL . 1.2 t -61.54 -36.27 72.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.707 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.411 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 22.9 mtp180 -62.0 -28.6 69.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.373 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.6 m -85.66 -92.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.798 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -175.94 34.14 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.454 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -174.41 97.22 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.036 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 10.5 t -122.88 6.01 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.591 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.618 ' HB2' HG21 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -113.15 -153.38 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.076 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.423 ' CD1' ' HE2' ' A' ' 181' ' ' LYS . 6.8 m-85 -154.56 -169.39 3.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.684 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.63 137.61 15.32 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.763 0.315 . . . . 0.0 111.012 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -132.53 179.54 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 0.0 111.675 -179.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.0 66.56 1.56 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.814 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -58.3 101.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -69.84 -37.91 76.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.151 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.98 -132.08 4.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.467 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.724 ' HB3' ' HD2' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -148.23 136.94 21.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.099 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -130.77 167.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.833 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -96.39 143.53 27.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.126 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.55 -171.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -149.46 62.98 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.164 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 1.3 mt-10 -168.95 -68.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.097 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.0 p 52.44 38.92 26.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -146.91 25.96 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.069 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -159.24 161.65 32.21 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -15.88 35.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -80.22 -18.03 50.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.945 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 t -61.49 -27.29 41.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.531 ' HB3' ' HG ' ' A' ' 161' ' ' SER . 67.3 m -81.12 -26.1 36.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.932 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -15.96 63.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -99.81 -42.9 6.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.512 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.7 -39.7 81.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.974 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 tp -56.51 -32.36 64.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.804 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 5.8 tptp -75.87 -38.9 57.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' HA ' ' A' ' 105' ' ' ALA . 16.4 t -58.18 -44.43 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.683 HD21 ' HG3' ' A' ' 114' ' ' ARG . 1.1 mt -72.67 -15.93 61.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 110' ' ' ARG . 3.8 ttt-85 -84.84 -12.39 53.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.249 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 1.5 mm100 -72.49 -64.81 0.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.658 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -177.73 -169.14 0.2 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.425 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 112' ' ' SER . 0.5 OUTLIER 69.87 -71.95 0.12 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.21 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.683 ' HG3' HD21 ' A' ' 109' ' ' LEU . 8.3 mmm180 -75.67 100.3 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.728 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.449 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -80.31 135.04 54.34 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.126 -179.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.758 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 16.4 Cg_exo -68.2 156.74 64.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.819 2.346 . . . . 0.0 112.104 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.44 140.57 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -92.29 98.04 11.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -125.77 -162.33 11.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.682 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.31 102.14 6.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.699 0.285 . . . . 0.0 110.598 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.662 HD21 HD23 ' A' ' 187' ' ' LEU . 40.8 tp -69.2 128.52 36.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.708 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' HB2' ' HG2' ' A' ' 129' ' ' ARG . 34.4 m170 -121.73 87.95 2.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.773 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.618 HG21 ' HB2' ' A' ' 82' ' ' SER . 35.8 t -62.8 94.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.148 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.798 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -98.39 144.86 27.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.287 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -60.61 -7.93 8.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.94 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.94 34.54 5.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.727 0.298 . . . . 0.0 110.997 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.651 ' HA2' HG13 ' A' ' 144' ' ' ILE . . . 109.14 143.51 10.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.774 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.41 HD21 HD11 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -73.78 164.03 27.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.955 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.525 ' HG2' ' HB2' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -158.04 114.78 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.534 179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.1 t -99.39 103.21 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.517 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.516 HG13 ' HD2' ' A' ' 136' ' ' LYS . 2.5 t -93.79 109.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.376 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.68 139.61 9.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.093 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -98.63 12.98 33.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.864 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -138.57 0.73 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.2 m -148.89 -26.46 0.3 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.438 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.516 ' HD2' HG13 ' A' ' 131' ' ' VAL . 18.3 mmtm 49.64 35.33 8.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.667 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.31 -5.15 54.71 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.63 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.403 ' HG ' ' N ' ' A' ' 139' ' ' ILE . 7.3 tp 66.26 149.52 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 110.898 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.403 ' N ' ' HG ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -138.49 -35.91 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.526 -179.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.84 95.74 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 111.351 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.66 25.79 8.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.597 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -76.65 -164.82 0.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.256 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 9.2 m -141.11 158.39 43.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.921 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.651 HG13 ' HA2' ' A' ' 127' ' ' GLY . 30.4 mt -73.13 -41.69 58.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.844 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HG2' HG23 ' A' ' 143' ' ' THR . 18.4 pt-20 -78.33 -7.14 56.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.568 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.611 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -87.9 -40.58 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.814 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.442 ' H ' HG21 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -74.86 152.91 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.803 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -65.29 0.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.722 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.641 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 26.5 p90 -174.33 141.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.83 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.4 m -67.25 166.25 14.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.452 ' HB3' ' HG ' ' A' ' 102' ' ' CYS . . . -170.09 124.54 0.66 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.34 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.513 ' HG3' ' H1 ' ' B' ' 1' ' ' GLY . 86.9 Cg_endo -82.1 -158.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.676 2.251 . . . . 0.0 112.405 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -130.89 -179.42 5.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.726 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 154' ' ' ARG . 1.7 mmm180 -130.58 21.25 5.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.902 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.37 -57.74 2.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.42 ' HD2' ' H ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -154.46 14.54 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 57.62 21.39 7.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.277 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.42 ' H ' ' HD2' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -110.41 16.95 21.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.686 179.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -147.82 124.0 1.82 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.691 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 4.7 m-85 -126.34 165.25 19.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.632 0.253 . . . . 0.0 110.562 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.72 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -163.6 158.83 21.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 -179.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.547 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -131.46 148.85 52.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.252 178.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.58 150.54 9.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.411 . . . . 0.0 111.62 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -146.37 100.02 3.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.45 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.626 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 7.3 ptt180 -72.44 -153.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -178.23 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.093 0.473 . . . . 0.0 111.6 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.0 -3.87 60.63 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.3 t -171.97 -9.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.936 0.398 . . . . 0.0 110.366 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.666 HG21 ' HG3' ' A' ' 173' ' ' MET . 2.0 m -133.86 -6.88 2.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.101 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 59.09 16.91 5.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.168 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.27 179.69 2.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.781 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.626 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -85.07 113.53 21.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.666 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.9 OUTLIER -131.49 116.45 17.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.622 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 27.3 t -108.75 129.27 55.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.222 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.724 ' HD2' ' HB3' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -96.95 142.22 29.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 179.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.72 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -124.09 157.13 18.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.331 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 22.7 p90 -161.05 172.5 16.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.676 0.274 . . . . 0.0 110.422 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.2 mp -138.53 148.9 44.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.83 121.6 25.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.069 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.74 8.48 9.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 83' ' ' PHE . 17.7 mmmt -102.12 -29.14 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.944 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 56.98 81.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.966 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.4 t -159.89 -33.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.29 37.46 80.49 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.411 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -151.47 -32.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.313 . . . . 0.0 111.136 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.646 ' HB2' HD12 ' A' ' 187' ' ' LEU . 5.7 mmt180 -74.01 -11.9 60.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.065 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.662 HD23 HD21 ' A' ' 121' ' ' LEU . 5.5 mp -135.29 -43.93 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 t -57.22 -75.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.509 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -28.59 57.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.252 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.84 84.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.918 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.74 -36.36 73.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.69 -11.34 35.56 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.32 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.44 ' O ' HG22 ' A' ' 197' ' ' VAL . 56.5 m -107.78 -16.11 14.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 0.0 110.566 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.08 -51.55 66.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.213 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.544 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.9 p90 -62.0 -38.02 87.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.428 ' O ' HD12 ' A' ' 199' ' ' LEU . . . -58.75 -26.61 64.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 197' ' ' VAL . 47.0 t -97.44 -22.21 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.754 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 15.8 t -65.61 -29.92 70.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.975 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER -105.8 29.46 6.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 197' ' ' VAL . 4.6 mm-40 -68.08 -29.3 68.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.865 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.513 ' H1 ' ' HG3' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.113 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.8 178.02 7.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 5.1 p -168.71 145.14 3.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.779 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.65 HD22 ' HB3' ' B' ' 7' ' ' PHE . 2.5 p-10 -60.16 154.95 18.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.024 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 13.9 mmm -129.06 -15.42 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.264 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 9.5 t -84.82 20.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.65 ' HB3' HD22 ' B' ' 4' ' ' ASN . 40.1 p90 -63.49 159.8 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -91.75 0.76 57.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.783 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 59.26 81.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.132 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -74.36 150.95 87.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.86 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.571 2.181 . . . . 0.0 112.394 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.825 0.345 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -79.17 -39.15 34.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -73.71 -30.84 63.08 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -67.77 -9.54 44.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.631 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.05 -19.68 11.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.042 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -26.62 40.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -47.1 87.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.762 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -83.05 -15.95 48.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.881 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' THR . . . -53.62 -52.45 59.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.28 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.716 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.4 t -61.08 -43.62 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.565 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -55.21 -35.21 64.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.337 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 m -77.09 -92.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.531 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 179.54 35.72 0.0 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.393 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 122' ' ' HIS . 1.1 t -173.03 100.81 0.13 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.009 0.433 . . . . 0.0 111.887 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.837 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.0 t -124.29 -149.45 0.42 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.413 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.572 ' HB2' HG21 ' A' ' 123' ' ' VAL . 0.4 OUTLIER 53.74 -153.33 0.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.768 0.318 . . . . 0.0 111.805 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -158.99 -168.34 2.34 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.749 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.7 OUTLIER -52.32 143.15 15.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.532 -179.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -136.91 -171.87 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.987 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.778 ' HD2' ' HB2' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -142.23 89.94 2.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 91.5 t80 -58.31 107.68 0.52 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.01 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.501 HD13 ' HB3' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -70.06 -60.66 2.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.61 -134.11 3.14 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.469 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.533 ' HB2' ' HE3' ' A' ' 173' ' ' MET . 0.9 OUTLIER -152.41 131.28 12.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 110.898 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.42 164.74 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.783 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -100.87 136.32 40.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.967 0.413 . . . . 0.0 111.012 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.3 m -140.25 140.37 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.96 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.5 ' HA ' ' HE3' ' A' ' 172' ' ' TRP . 50.0 m-85 -102.14 64.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -147.89 -81.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.075 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.03 46.61 22.43 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.92 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.87 70.75 1.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.775 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 101' ' ' VAL . . . 144.25 179.27 20.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.247 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.49 -7.42 24.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -83.62 9.49 11.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 98' ' ' GLY . 3.2 t -80.13 -19.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.021 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.0 p -83.05 -36.88 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.961 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -66.17 -4.96 8.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.105 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.424 ' O ' HG21 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -119.59 -53.65 2.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.082 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.97 -53.34 59.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.212 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -55.54 -36.36 66.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.695 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -38.24 90.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.75 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 112' ' ' SER . 48.7 t -62.6 -45.24 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.727 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.501 ' HB3' HD13 ' A' ' 88' ' ' LEU . 1.2 mt -61.74 -37.61 84.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.586 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -28.94 64.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.93 2.54 53.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.257 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.579 ' HB3' ' HG2' ' A' ' 114' ' ' ARG . 0.1 OUTLIER -109.7 -163.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.916 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.508 ' H ' ' HG2' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -96.56 15.95 20.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.579 ' HG2' ' HB3' ' A' ' 112' ' ' SER . 1.5 mmt180 -67.14 101.74 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.01 126.79 90.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.095 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.778 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 88.1 Cg_endo -78.66 153.97 26.74 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.545 2.163 . . . . 0.0 112.314 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -129.49 121.51 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.206 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -77.96 109.41 11.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.563 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -139.33 -152.74 5.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.6 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 0.9 OUTLIER -128.92 126.27 39.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.834 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.8 tp -102.25 116.25 32.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.62 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 0.0 OUTLIER -107.09 93.12 4.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.837 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 45.2 t -60.82 95.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -94.6 129.7 41.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.198 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.06 5.22 1.37 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.217 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 124' ' ' SER . 7.7 p-10 -134.86 27.81 3.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.886 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 126.21 107.07 1.53 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.376 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.0 mt -61.34 150.7 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.949 0.405 . . . . 0.0 111.296 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.448 ' C ' HG23 ' A' ' 130' ' ' VAL . 5.7 ttm-85 -142.66 151.61 41.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.528 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.641 HG22 ' HB ' ' A' ' 140' ' ' VAL . 50.8 t -141.04 110.79 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.804 0.335 . . . . 0.0 111.368 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.8 t -104.16 126.4 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.835 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.435 ' OD2' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -54.07 151.94 6.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.563 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -104.91 8.52 34.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.028 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.74 -4.2 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.226 0.536 . . . . 0.0 110.347 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 135' ' ' THR . 26.2 m -141.83 -21.36 0.72 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.898 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 19.5 mmtp 52.09 36.96 20.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.218 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.01 -112.3 1.67 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.377 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 tp -169.78 119.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.698 0.285 . . . . 0.0 110.647 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.73 -49.77 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.319 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.641 ' HB ' HG22 ' A' ' 130' ' ' VAL . 8.2 t -114.22 105.42 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 111.311 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -118.53 34.3 5.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -73.29 -166.63 0.34 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.138 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.662 HG21 ' HG2' ' A' ' 145' ' ' GLU . 27.1 m -144.42 155.03 43.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.887 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.2 mt -64.08 -53.73 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.955 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.662 ' HG2' HG21 ' A' ' 143' ' ' THR . 0.3 OUTLIER -69.11 -9.19 51.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.853 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 36.9 tttm -85.81 -51.29 6.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.046 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.561 HG11 ' HD2' ' A' ' 162' ' ' TYR . 4.4 m -69.28 145.35 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.073 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.82 -63.86 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -166.15 142.9 5.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.699 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.423 ' H ' ' H ' ' B' ' 4' ' ' ASN . 1.2 m -71.78 165.12 24.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.3 101.2 0.48 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.41 -90.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.425 2.083 . . . . 0.0 112.366 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -173.49 -164.03 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.812 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 154' ' ' ARG . 10.1 mmm180 -80.73 -83.64 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.67 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -176.0 48.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.12 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -169.27 -17.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.244 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -82.81 -33.24 27.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.225 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 58.99 15.16 3.78 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.958 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.44 156.75 15.43 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.346 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.64 157.21 43.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.757 0.313 . . . . 0.0 110.952 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.77 138.03 17.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.125 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.561 ' HD2' HG11 ' A' ' 147' ' ' VAL . 12.8 p90 -114.76 144.44 43.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.736 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -109.99 157.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.991 0.424 . . . . 0.0 111.589 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 14.5 t -161.24 136.05 7.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.571 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -88.73 -151.22 0.2 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.267 -179.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.436 ' HB2' ' HA ' ' A' ' 170' ' ' ARG . 6.5 p-10 -65.7 -149.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.435 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.436 ' O ' HG21 ' A' ' 168' ' ' THR . . . 83.35 -8.41 64.59 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.436 HG21 ' O ' ' A' ' 167' ' ' GLY . 0.6 OUTLIER -163.03 -42.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.081 0.467 . . . . 0.0 110.171 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.591 HG23 ' HG3' ' A' ' 171' ' ' ARG . 16.6 m -96.32 -11.4 25.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.946 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.436 ' HA ' ' HB2' ' A' ' 166' ' ' ASP . 1.1 mtp180 63.44 20.06 12.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.934 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.591 ' HG3' HG23 ' A' ' 169' ' ' THR . 1.6 ptp85 -174.31 173.47 3.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.678 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.7 OUTLIER -85.9 105.02 16.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.533 ' HE3' ' HB2' ' A' ' 90' ' ' CYS . 8.9 mtp -121.41 139.55 53.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.653 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 25.2 t -118.27 141.81 48.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.933 0.396 . . . . 0.0 110.984 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -111.14 151.31 28.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.548 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -128.22 156.2 20.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.64 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -170.78 132.93 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.12 173.62 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.834 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -97.98 133.62 42.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.09 -24.06 61.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.776 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -82.08 -28.0 32.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.913 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.05 84.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.998 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 t -169.24 -38.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.55 26.6 62.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.402 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -132.49 -23.7 2.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 111.203 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.408 ' HB2' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -86.9 -17.99 31.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.455 HD11 ' N ' ' A' ' 187' ' ' LEU . 5.9 mp -124.87 -49.2 1.74 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.249 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.8 -46.55 87.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.241 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.89 1.26 13.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.316 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.15 -46.74 4.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.109 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.688 ' HA ' HG13 ' A' ' 123' ' ' VAL . 8.5 p -71.41 -20.72 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.4 -14.04 66.13 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.722 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.9 m -103.84 1.06 31.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.988 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.716 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -78.51 -42.31 29.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.987 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.518 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.0 m-85 -60.57 -37.77 82.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.626 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.46 ' O ' HD13 ' A' ' 199' ' ' LEU . . . -54.59 -34.6 62.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.439 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.6 -10.67 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.173 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.6 t -84.3 -16.31 43.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.191 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER -123.62 44.8 2.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.333 . . . . 0.0 111.241 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.46 -29.88 70.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.641 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.715 179.257 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.125 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.31 176.45 5.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.816 0.341 . . . . 0.0 110.685 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.83 144.11 14.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.963 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.491 HD22 ' HG ' ' B' ' 6' ' ' SER . 22.7 t-20 -62.89 105.18 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.037 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -9.08 53.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.491 ' HG ' HD22 ' B' ' 4' ' ' ASN . 1.2 p -81.05 11.74 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.226 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -56.87 142.47 41.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.33 10.17 13.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 32.4 t0 56.04 78.15 0.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.144 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 26.2 m-85 -61.79 139.0 95.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.028 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 47.0 Cg_exo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.656 2.237 . . . . 0.0 112.386 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.7 t60 . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 120.845 0.355 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.89 -69.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -65.83 -27.69 68.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -10.42 54.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.492 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.76 -23.36 12.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.876 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -86.3 -28.34 23.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -66.89 -47.91 70.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.594 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.663 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -69.72 -26.8 64.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.5 80.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.687 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.739 HG12 ' HA ' ' A' ' 194' ' ' ALA . 42.1 t -59.33 -36.83 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.3 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.663 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 2.2 mtm-85 -65.36 -37.09 85.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.117 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.66 -5.97 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.435 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 70.58 46.89 0.51 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.414 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.814 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -172.57 87.04 0.07 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.47 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.826 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.7 t -119.7 -149.19 0.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.302 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.612 ' HG ' HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER 57.64 -154.85 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.375 . . . . 0.0 111.573 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 5.5 m-85 -158.32 -170.77 3.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.503 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.14 154.35 3.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.79 0.329 . . . . 0.0 111.005 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.28 -170.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.073 0.464 . . . . 0.0 111.592 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 5.1 mmtp -141.54 80.15 1.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.467 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 48.4 t80 -56.83 108.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.276 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.465 HD21 HD12 ' A' ' 178' ' ' LEU . 7.9 mt -70.53 -51.37 29.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.661 ' HA3' ' HD3' ' A' ' 114' ' ' ARG . . . 152.71 -131.48 3.37 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.615 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 114' ' ' ARG . 1.4 p -153.3 134.15 13.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.819 0.342 . . . . 0.0 110.854 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.414 HG11 ' HG ' ' A' ' 109' ' ' LEU . 7.0 m -128.02 146.2 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -71.33 132.94 45.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.168 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 174' ' ' CYS . 10.7 m -117.26 -178.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.046 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -139.34 59.61 1.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.037 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HB3' HG21 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -171.54 -63.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.821 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m 60.23 31.32 20.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.399 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 ptt180 -165.39 88.12 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.95 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.19 158.73 9.16 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.753 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -37.77 54.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 110.86 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 2.2 pt20 -67.36 -22.55 65.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 95' ' ' GLU . 41.2 t -60.92 -33.13 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.08 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.49 ' HB3' ' HG ' ' A' ' 161' ' ' SER . 83.5 m -80.07 -39.33 29.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.997 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.643 ' HG2' ' HA ' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -64.26 -28.63 69.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.047 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 68.0 mt-10 -81.31 -50.87 9.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.78 75.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.321 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.8 tp -57.87 -38.9 76.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -73.21 -37.99 66.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 t -58.66 -38.49 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.425 HD22 ' HG3' ' A' ' 114' ' ' ARG . 1.9 mt -72.76 -33.58 66.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -80.91 -3.32 51.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.759 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -117.32 -13.52 10.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.9 p -93.62 -166.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.38 27.4 6.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.046 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.661 ' HD3' ' HA3' ' A' ' 89' ' ' GLY . 0.1 OUTLIER -72.79 113.55 9.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.75 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 131.11 91.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 90.8 Cg_endo -85.05 145.59 9.9 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.742 2.295 . . . . 0.0 112.187 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 1.8 t -108.43 155.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -116.49 103.25 10.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.971 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.42 -164.73 12.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.622 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -112.15 131.41 55.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 111.143 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.612 HD23 ' HG ' ' A' ' 82' ' ' SER . 22.0 tp -98.14 120.8 39.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.171 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.814 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 74.7 m-70 -109.16 98.46 7.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.09 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.826 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 16.9 t -67.11 100.3 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.246 0.546 . . . . 0.0 110.503 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -98.9 131.43 44.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.268 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.86 20.94 1.01 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.616 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 124' ' ' SER . 9.3 t70 -150.32 14.69 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.782 0.325 . . . . 0.0 110.759 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.778 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 139.4 107.87 0.76 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.684 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.77 ' HG ' HD13 ' A' ' 144' ' ' ILE . 12.8 mt -50.59 150.1 2.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.842 0.353 . . . . 0.0 111.131 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -145.32 113.43 6.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 140' ' ' VAL . 2.8 t -111.46 115.17 49.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 111.657 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 2.1 t -97.33 156.92 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.647 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.526 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 0.3 OUTLIER -95.69 165.08 12.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.417 179.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.45 -5.82 18.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 135' ' ' THR . 0.0 OUTLIER -107.69 -36.95 6.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.939 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.451 ' N ' ' HG3' ' A' ' 134' ' ' GLU . 8.8 t -118.99 -12.5 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 30.5 mmtt 59.25 23.02 11.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.777 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 131' ' ' VAL . . . -87.91 -161.77 37.26 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.131 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 tp -116.17 124.32 50.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.0 -25.62 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.365 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.502 ' HB ' HG22 ' A' ' 130' ' ' VAL . 48.4 t -132.45 94.67 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.863 0.363 . . . . 0.0 111.131 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -96.77 72.0 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.756 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.14 -175.78 3.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.852 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 20.2 m -136.47 151.83 49.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.77 HD13 ' HG ' ' A' ' 128' ' ' LEU . 9.5 mm -61.33 -40.54 86.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.041 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.86 -6.13 59.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.606 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.852 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 2.6 tttp -87.69 -42.95 12.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.907 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 143' ' ' THR . 0.7 OUTLIER -64.89 128.58 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.2 t -62.87 -35.37 79.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.143 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.518 ' HB2' HD11 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -147.78 150.77 34.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.344 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.5 m -129.04 80.52 1.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.299 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -109.72 128.69 24.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.61 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.713 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 69.8 Cg_endo -75.45 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.535 2.156 . . . . 0.0 112.329 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.643 ' HA ' ' HG2' ' A' ' 103' ' ' GLU . 13.8 p-10 -154.64 -176.81 6.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.51 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.429 ' HG2' ' HG3' ' A' ' 103' ' ' GLU . 0.2 OUTLIER -130.03 -3.37 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.305 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -100.6 -85.94 0.4 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.599 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 170.39 20.37 0.0 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.114 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -74.43 5.36 4.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.376 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 183' ' ' SER . 0.1 OUTLIER 54.22 27.06 7.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.799 0.333 . . . . 0.0 110.838 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -107.36 143.03 15.86 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.568 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -123.97 168.18 13.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.653 0.264 . . . . 0.0 110.892 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.49 ' HG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -162.02 166.12 26.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.494 . . . . 0.0 111.288 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.419 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -152.55 141.09 20.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.29 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.518 HD11 ' HB2' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -106.72 147.71 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.976 0.417 . . . . 0.0 111.558 -178.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.14 106.5 4.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.641 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -84.89 132.6 34.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.1 p30 44.64 -161.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.869 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.32 -9.6 60.86 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.477 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.6 t -176.06 -19.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 110.425 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.458 HG21 ' HG3' ' A' ' 171' ' ' ARG . 7.6 m -111.08 -15.45 13.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.762 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 58.91 26.48 14.99 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.901 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.458 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -177.88 177.87 1.03 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.023 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.41 132.65 45.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.019 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.1 132.75 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.665 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.498 ' HB2' HG12 ' A' ' 93' ' ' VAL . 20.3 t -116.13 160.19 20.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.307 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -124.92 138.18 54.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.537 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -123.37 147.26 16.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.661 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 6.5 p90 -162.78 143.2 9.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 0.0 110.745 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.465 HD12 HD21 ' A' ' 88' ' ' LEU . 1.2 mt -111.76 154.92 24.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.137 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.402 ' HB1' HD21 ' A' ' 187' ' ' LEU . . . -83.71 129.51 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.15 6.27 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.57 -26.53 12.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 55.38 83.07 0.09 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.431 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -169.66 -37.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.076 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.2 28.5 73.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.435 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.88 -16.42 5.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 110.954 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 -9.77 16.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.586 HD23 HD23 ' A' ' 121' ' ' LEU . 4.1 mp -125.55 -46.3 1.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.194 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -61.8 2.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.989 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.76 -8.27 34.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.141 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.14 -41.7 13.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.236 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' A' ' 123' ' ' VAL . 7.0 p -77.44 -29.2 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.046 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.87 -3.83 52.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.231 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 92.2 m -115.27 1.53 13.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 110.683 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.739 ' HA ' HG12 ' A' ' 76' ' ' VAL . . . -77.69 -44.26 28.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.07 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.451 ' HD2' HD23 ' A' ' 199' ' ' LEU . 4.2 p90 -64.96 -25.22 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.938 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -61.14 -19.05 61.07 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.21 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.99 -27.29 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.001 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.9 t -74.76 -30.84 61.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.765 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' A' ' 196' ' ' ALA . 0.5 OUTLIER -117.99 39.57 3.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -61.16 -50.09 74.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.976 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.716 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.491 ' HA3' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.405 ' HB2' ' H ' ' B' ' 3' ' ' SER . 0.2 OUTLIER -149.44 -164.54 2.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.312 . . . . 0.0 110.795 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.405 ' H ' ' HB2' ' B' ' 2' ' ' PHE . 51.4 p -168.61 161.38 11.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.561 HD22 ' HB3' ' B' ' 7' ' ' PHE . 0.6 OUTLIER -78.12 159.91 28.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.999 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.428 ' HE1' ' HE2' ' A' ' 195' ' ' PHE . 10.2 mtm -130.33 -10.94 4.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.995 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -83.59 8.26 14.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.959 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.561 ' HB3' HD22 ' B' ' 4' ' ' ASN . 52.5 p90 -63.4 151.69 40.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -98.56 12.92 33.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.862 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t70 56.03 75.99 0.31 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -71.01 143.71 89.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.934 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo . . . . . 0 C--O 1.249 1.068 0 C-N-CA 122.638 2.225 . . . . 0.0 112.25 -179.757 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.836 0.351 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -152.41 -67.62 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.585 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -22.71 60.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.377 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -68.23 -23.56 64.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.055 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.65 -18.69 20.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.645 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.46 -27.29 25.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.862 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -87.26 -23.77 24.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.55 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.727 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.0 OUTLIER -90.45 -15.14 31.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 81' ' ' CYS . . . -60.93 -49.44 77.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.943 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.797 HG13 ' HA ' ' A' ' 194' ' ' ALA . 2.0 t -60.52 -41.0 86.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.255 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.727 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 9.8 mtt180 -56.07 -33.91 65.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.452 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 m -80.7 -92.02 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.7 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -178.71 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.453 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -172.44 98.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.788 0.328 . . . . 0.0 111.099 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.512 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 15.7 t -129.0 61.06 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.641 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.436 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -161.01 -156.54 0.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.098 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.541 ' HB2' HD12 ' A' ' 187' ' ' LEU . 1.9 m-85 -156.12 -170.55 3.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.179 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 1.4 m -51.13 141.76 13.75 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.99 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.9 m -135.86 -175.55 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.42 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -133.99 73.92 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.703 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 78.2 t80 -61.37 108.04 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HB2' HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -80.22 -36.54 34.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.12 -127.16 3.02 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.606 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.2 p -164.64 130.11 2.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.07 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m -114.21 146.81 18.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -72.43 129.9 39.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.109 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.67 176.79 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.924 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -141.3 59.73 1.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 2.3 mt-10 -162.08 -63.17 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.093 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.17 34.44 17.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -146.12 141.76 27.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.979 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.79 -139.48 14.48 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.571 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.25 -33.31 0.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 0.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -18.87 65.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.228 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -37.24 48.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.767 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.468 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 85.8 m -69.22 -28.69 66.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.67 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -22.27 61.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.905 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.31 -52.59 5.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.96 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.53 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.31 -49.16 78.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.136 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.1 tp -53.39 -30.81 41.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.975 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -37.03 67.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.8 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.0 t -60.82 -48.09 90.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.755 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 105' ' ' ALA . 1.4 mp -70.49 -17.18 62.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.698 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 110' ' ' ARG . 2.0 ttm-85 -87.46 -9.67 53.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.569 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -80.56 -63.86 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.744 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -171.91 -175.67 1.55 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.294 179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 112' ' ' SER . 7.1 mpt_? 70.08 -71.55 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.97 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.421 ' H ' ' HG2' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -66.82 110.56 3.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.932 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.57 142.65 24.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.443 ' HB3' HD21 ' A' ' 88' ' ' LEU . 97.8 Cg_endo -79.42 148.67 21.04 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.575 2.184 . . . . 0.0 112.348 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.23 117.45 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -65.17 97.98 0.29 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.989 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -127.44 -161.48 10.83 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.195 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.449 HD21 ' HA ' ' A' ' 120' ' ' LEU . 0.3 OUTLIER -129.27 117.68 21.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.334 . . . . 0.0 110.643 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.5 tp -89.87 130.71 36.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.728 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.419 ' CE1' HD13 ' A' ' 120' ' ' LEU . 30.9 m-70 -118.22 93.19 4.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.915 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 79.4 t -66.15 94.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.616 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -99.46 135.69 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.346 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -58.06 -9.56 5.85 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.104 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -114.88 32.73 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.29 134.97 6.64 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 mt -66.98 171.1 5.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.907 0.384 . . . . 0.0 111.233 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.538 ' HD3' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -167.24 110.67 0.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.665 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.7 t -106.32 114.8 46.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.92 0.39 . . . . 0.0 111.384 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.72 120.35 57.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.874 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 37.6 m-20 -52.22 152.97 3.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.55 2.52 28.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.939 0.4 . . . . 0.0 111.165 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.42 -24.73 6.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.572 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.01 -10.52 5.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.686 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 27.4 mmtm 54.03 26.27 6.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.817 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -90.67 135.76 13.03 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.443 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.538 HD12 ' HD3' ' A' ' 129' ' ' ARG . 5.1 tp -67.65 108.17 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.663 0.268 . . . . 0.0 110.619 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 3.0 pt -99.36 -25.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.435 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 129' ' ' ARG . 74.8 t -136.68 106.19 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.214 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.22 27.93 8.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.327 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -70.24 -173.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.23 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.589 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 2.8 m -131.46 164.7 25.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.709 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 16.0 mt -77.61 -33.45 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.62 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -85.87 -10.87 54.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.45 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 7.1 tttm -83.53 -37.83 22.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.762 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.415 ' H ' HG21 ' A' ' 147' ' ' VAL . 3.5 m -77.67 138.35 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -60.5 -68.58 0.29 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.516 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 148' ' ' SER . 0.1 OUTLIER -141.22 136.44 31.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.054 178.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.517 ' O ' ' HB3' ' B' ' 2' ' ' PHE . 60.6 m -98.35 93.26 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.549 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -105.11 153.17 39.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.464 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.883 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 82.8 Cg_endo -86.6 -118.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.783 2.322 . . . . 0.0 112.149 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -148.68 -3.99 0.45 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.596 0.236 . . . . 0.0 111.042 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 45.42 23.54 0.13 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.995 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -103.8 -55.93 2.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.389 . . . . 0.0 110.657 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.535 ' HB2' ' HG3' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -142.07 2.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.402 178.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 60.61 30.75 19.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.081 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.535 ' HG3' ' HB2' ' A' ' 156' ' ' HIS . 6.6 mtm180 -116.83 7.39 13.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.806 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -149.9 119.04 0.99 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.429 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.724 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -111.3 -179.42 3.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.01 0.433 . . . . 0.0 111.034 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.468 ' OG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -166.44 169.85 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.498 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -150.6 145.54 25.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -117.03 157.12 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.063 0.459 . . . . 0.0 111.567 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.7 -174.97 5.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.677 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.9 OUTLIER -127.65 -149.37 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.799 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER -63.57 -163.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.903 0.382 . . . . 0.0 111.384 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.91 -16.29 60.46 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.7 t -163.96 -5.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 110.068 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.504 HG21 ' HG3' ' A' ' 173' ' ' MET . 6.9 m -132.17 -12.37 3.21 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.592 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 34.3 mtt85 60.8 19.39 9.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.059 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.587 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -171.89 172.79 4.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.935 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -81.76 115.33 20.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.625 179.453 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.587 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 3.2 mtp -131.31 145.91 52.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.522 ' HB2' HG22 ' A' ' 163' ' ' ILE . 16.4 t -119.11 142.95 47.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -112.25 156.63 22.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.628 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -137.93 146.77 18.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.537 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -164.72 161.06 20.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 0.0 110.959 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.44 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 2.0 mp -127.92 168.6 15.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.88 125.32 45.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.071 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.42 -13.94 45.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.692 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' A' ' 83' ' ' PHE . 5.9 mmtm -80.73 -28.65 36.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 56.33 37.13 28.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.992 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.43 -44.33 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.987 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.24 31.05 43.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.534 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -127.88 -30.12 2.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 110.978 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -8.94 53.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.742 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 83' ' ' PHE . 4.9 mp -127.32 -55.99 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.278 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -63.38 1.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.421 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -59.95 -19.18 50.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.258 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -79.77 -44.57 20.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.238 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.8 -32.58 57.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.722 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.95 -7.57 30.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.425 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 59.5 m -109.75 -17.4 13.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.778 0.323 . . . . 0.0 110.97 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.797 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -55.7 -44.83 77.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.128 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.457 ' HD2' ' HB3' ' B' ' 6' ' ' SER . 2.4 p90 -74.9 -29.7 61.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.53 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -60.18 -17.13 38.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 89.8 t -106.82 -27.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.088 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.2 t -75.38 -4.39 39.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.53 HD11 ' HA ' ' A' ' 196' ' ' ALA . 5.1 mt -73.62 -10.19 59.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.16 -46.84 87.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.965 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.883 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER -125.19 150.94 46.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.692 0.282 . . . . 0.0 110.966 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' B' ' 2' ' ' PHE . 91.0 p 177.39 140.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.881 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -73.1 178.46 4.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.55 -17.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.005 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.457 ' HB3' ' HD2' ' A' ' 195' ' ' PHE . 51.9 p -80.15 3.31 20.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -70.91 164.23 25.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -107.63 -1.31 21.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t70 58.86 95.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.225 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -58.08 146.55 68.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.86 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo . . . . . 0 C--O 1.248 1.011 0 C-N-CA 122.493 2.128 . . . . 0.0 112.285 -179.846 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.797 0.332 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.33 -35.53 9.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.897 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.764 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -64.02 -26.77 68.72 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.501 179.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -63.92 -18.23 64.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.275 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.81 -7.7 10.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.616 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.764 ' HB2' ' HA ' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -82.09 -38.46 24.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.107 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -63.04 -20.3 65.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.644 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 8.9 tt0 -104.53 -12.94 16.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.635 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 80' ' ' THR . . . -54.77 -48.75 72.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.241 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 81' ' ' CYS . 1.2 t -62.03 -35.51 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.388 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -65.9 -29.96 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -90.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -176.58 34.7 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.519 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -176.8 102.82 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.894 0.378 . . . . 0.0 111.251 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.587 ' HG ' ' HB1' ' A' ' 190' ' ' ALA . 23.0 t -141.34 65.28 1.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.586 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -163.27 -160.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.35 . . . . 0.0 111.158 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -156.05 -171.17 3.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.898 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.27 148.69 2.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.878 0.371 . . . . 0.0 111.305 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.7 -167.08 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.24 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.84 75.84 1.5 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.765 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.445 ' O ' HG23 ' A' ' 117' ' ' VAL . 83.0 t80 -63.71 91.82 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.016 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.528 ' HB2' HD23 ' A' ' 109' ' ' LEU . 0.7 OUTLIER -61.46 -43.24 99.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.522 ' HA3' ' HD3' ' A' ' 114' ' ' ARG . . . 150.58 -126.75 2.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.332 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.92 132.34 8.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 0.0 111.107 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.491 HG13 ' HG ' ' A' ' 109' ' ' LEU . 4.2 m -126.02 149.91 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.993 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.51 137.22 54.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.41 ' H ' HG21 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -119.9 -169.68 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.898 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -122.77 80.4 1.74 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 63.8 109.22 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.804 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.417 ' HA ' HG21 ' A' ' 163' ' ' ILE . 1.5 p -45.9 -30.16 1.64 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.576 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.32 126.67 19.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.096 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.3 -125.35 2.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.574 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -170.18 -50.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.718 0.294 . . . . 0.0 110.638 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -78.84 11.51 2.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.188 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.502 HG13 HG12 ' A' ' 163' ' ' ILE . 9.6 t -62.61 -16.27 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.936 0.398 . . . . 0.0 110.599 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 67.2 m -102.31 -35.49 8.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.875 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.87 -19.72 62.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.443 ' O ' HG21 ' A' ' 108' ' ' VAL . 76.3 mt-10 -104.49 -48.28 3.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.145 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 101' ' ' VAL . . . -56.84 -37.03 70.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.279 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.586 ' HB2' ' HG ' ' A' ' 161' ' ' SER . 14.8 tp -58.48 -35.93 72.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.66 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -34.97 61.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 104' ' ' GLU . 21.2 t -58.7 -33.14 48.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.668 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -80.01 -25.12 40.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.529 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.1 -14.47 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.711 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -105.99 -3.86 21.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.949 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.66 -173.53 2.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.03 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.5 10.94 16.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.002 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.579 ' HG3' HD22 ' A' ' 109' ' ' LEU . 5.6 mmp_? -62.98 105.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -83.03 134.79 45.74 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.088 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.86 142.49 28.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.525 2.15 . . . . 0.0 112.182 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 87' ' ' TYR . 2.3 t -107.5 122.35 61.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -69.17 112.93 6.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -151.53 145.9 14.16 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.576 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.07 110.14 17.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 0.0 111.004 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.445 ' O ' ' HB3' ' A' ' 82' ' ' SER . 27.3 tp -80.65 137.68 36.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.586 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -124.08 85.83 2.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.704 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.586 ' H ' ' HB2' ' A' ' 82' ' ' SER . 74.7 t -62.39 98.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.108 0.48 . . . . 0.0 111.002 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -98.53 142.34 30.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.205 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.59 16.84 2.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.672 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 124' ' ' SER . 35.7 t0 -146.97 27.99 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.879 0.371 . . . . 0.0 110.433 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.34 113.07 1.77 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -75.79 141.49 42.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.948 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -142.23 131.55 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 140' ' ' VAL . 9.1 t -106.88 112.44 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.73 109.92 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.736 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 2.8 m-20 -51.29 147.38 5.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.983 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -97.41 11.45 36.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.927 0.394 . . . . 0.0 110.651 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.05 -30.64 6.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.869 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.675 HG21 ' H ' ' A' ' 137' ' ' GLY . 14.8 t -132.71 -8.69 3.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.005 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 13.3 mmtp 58.34 22.65 9.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.831 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.675 ' H ' HG21 ' A' ' 135' ' ' THR . . . -75.47 -133.49 0.38 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.577 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.784 HD22 ' HB3' ' A' ' 141' ' ' ASP . 2.8 tp -151.12 112.85 4.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 0.0 110.66 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.26 -45.38 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.198 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 130' ' ' VAL . 36.5 t -119.63 97.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.249 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.784 ' HB3' HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -105.86 59.38 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.691 179.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.17 -169.62 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.044 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.746 HG23 ' HG2' ' A' ' 145' ' ' GLU . 62.1 m -136.31 156.88 48.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.554 ' N ' HG22 ' A' ' 143' ' ' THR . 0.3 OUTLIER -57.22 -42.27 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.695 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.746 ' HG2' HG23 ' A' ' 143' ' ' THR . 7.5 pt-20 -81.39 -14.22 57.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.428 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.536 ' HB3' ' H ' ' A' ' 143' ' ' THR . 0.7 OUTLIER -76.29 -39.55 53.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.587 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.616 HG11 ' HD2' ' A' ' 162' ' ' TYR . 1.1 m -80.02 150.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -62.44 1.73 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.624 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.788 ' HB2' ' HB3' ' B' ' 3' ' ' SER . 22.1 p90 -173.22 135.8 0.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.73 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.31 136.17 36.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.294 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.4 102.52 4.03 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.641 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 12.4 Cg_endo -54.76 -83.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.626 2.217 . . . . 0.0 112.408 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -165.99 169.33 14.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.955 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.422 ' H ' ' HG3' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -57.0 -45.43 83.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.976 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.6 -63.77 1.37 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.802 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.487 ' NE2' ' HA3' ' A' ' 184' ' ' GLY . 0.5 OUTLIER -178.15 -73.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.831 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 58.43 14.49 2.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.087 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 49.19 32.26 4.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -145.2 136.92 6.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.293 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.62 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -122.6 -175.29 3.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.586 ' HG ' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -164.95 173.72 11.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.411 . . . . 0.0 111.05 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.616 ' HD2' HG11 ' A' ' 147' ' ' VAL . 10.0 p90 -158.24 147.18 19.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.514 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.762 HG22 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -116.39 158.61 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 0.0 111.51 -178.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.5 p -157.52 -176.54 6.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.483 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -130.6 135.63 48.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.3 p30 44.19 -158.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.811 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.05 -12.36 62.21 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.1 t 179.76 -17.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.096 0.474 . . . . 0.0 110.176 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.547 HG23 ' HG3' ' A' ' 171' ' ' ARG . 87.6 m -112.77 -14.18 13.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.499 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 58.37 26.46 14.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.357 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.547 ' HG3' HG23 ' A' ' 169' ' ' THR . 0.0 OUTLIER -174.53 -171.44 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 111.561 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.44 135.54 57.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.477 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.17 145.54 4.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.658 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.762 ' HB2' HG22 ' A' ' 163' ' ' ILE . 44.7 t -128.0 145.35 51.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.163 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -115.14 137.25 52.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.593 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.515 ' HA3' HD12 ' A' ' 109' ' ' LEU . . . -110.74 152.91 17.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.673 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -167.51 132.89 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.87 0.367 . . . . 0.0 111.047 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.581 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 3.9 mp -106.42 156.8 18.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.11 120.66 25.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.9 t -70.47 -11.87 61.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.958 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.81 -26.19 24.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 54.8 71.82 0.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.4 t -155.17 -30.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.487 ' HA3' ' NE2' ' A' ' 156' ' ' HIS . . . 64.91 36.91 93.65 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.401 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -139.52 -30.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.737 0.304 . . . . 0.0 111.021 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -90.58 -2.53 57.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.886 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 186' ' ' ARG . 5.5 mp -135.96 -58.22 0.76 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.27 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.05 -57.67 8.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.342 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -59.84 -20.54 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.074 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.587 ' HB1' ' HG ' ' A' ' 81' ' ' CYS . . . -78.12 -45.45 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.073 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 187' ' ' LEU . 98.6 t -63.82 -30.71 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.91 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.475 ' HA2' ' HE1' ' A' ' 195' ' ' PHE . . . -64.09 -7.38 23.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.427 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -119.24 -5.12 10.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 0.0 110.743 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -74.5 -52.53 11.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.333 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.475 ' HE1' ' HA2' ' A' ' 192' ' ' GLY . 40.1 p90 -65.94 -31.14 71.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.945 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -58.22 -24.22 58.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.791 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.75 -18.97 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.962 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 3.7 t -74.89 -27.07 60.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.957 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.444 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.4 OUTLIER -112.56 24.43 12.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -39.97 95.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.755 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.905 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.449 ' HA2' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.357 -0.297 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -119.15 -47.38 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.801 0.334 . . . . 0.0 110.759 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.788 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER 62.87 118.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.184 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.552 ' ND2' ' HA ' ' A' ' 149' ' ' PHE . 21.0 p30 -57.5 157.59 6.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.07 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 3.1 mtp -125.0 0.21 7.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.018 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 32.6 p -92.01 25.08 2.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.443 ' HD2' ' H ' ' B' ' 9' ' ' ASP . 39.4 p90 -72.14 162.0 30.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -114.74 11.7 16.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.489 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . 0.443 ' H ' ' HD2' ' B' ' 7' ' ' PHE . 35.3 t70 57.45 78.27 0.24 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.211 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -63.08 146.4 95.85 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.725 2.283 . . . . 0.0 112.384 -179.512 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.746 0.308 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.22 -48.5 81.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.589 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.38 -22.36 61.15 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.546 178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -25.68 65.02 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.396 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.35 -23.13 17.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.646 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.63 -28.13 45.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.272 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.41 -29.16 69.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.308 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.696 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.6 tm-20 -82.52 -23.2 34.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.688 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.18 -49.97 72.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.885 HG11 ' HA ' ' A' ' 194' ' ' ALA . 55.2 t -63.51 -42.17 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.487 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.696 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -55.31 -37.12 66.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.272 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.7 m -71.74 -90.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.218 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.624 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 176.91 38.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.422 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.652 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 1.5 t -174.23 102.34 0.1 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.986 0.422 . . . . 0.0 112.045 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 9.6 t -142.17 56.81 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.994 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.643 ' HG ' HD22 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -151.75 -151.34 0.38 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.168 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -155.41 -172.89 4.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.023 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.92 146.64 13.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.494 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 121' ' ' LEU . 10.5 m -146.56 -176.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.19 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 1.1 mptt -143.0 81.54 1.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.875 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -61.32 100.08 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.684 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 1.0 OUTLIER -64.85 -48.33 74.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.61 -131.42 3.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.595 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.651 ' HB2' ' HE1' ' A' ' 173' ' ' MET . 0.8 OUTLIER -144.96 133.56 22.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.71 0.29 . . . . 0.0 110.991 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.621 HG12 ' HG ' ' A' ' 109' ' ' LEU . 4.4 m -124.79 157.69 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -83.55 142.96 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -179.01 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.898 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.64 59.66 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.173 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 2.7 tt0 -170.22 -61.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.072 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.5 p 48.71 54.25 10.97 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.965 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 1.7 ptm180 -163.38 114.47 1.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.993 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.77 -137.03 12.5 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.807 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -147.58 -19.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.867 0.365 . . . . 0.0 110.761 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -79.26 4.72 14.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.071 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.38 -15.52 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.767 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.618 ' HB3' ' HG ' ' A' ' 161' ' ' SER . 89.4 m -88.43 -34.37 17.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.813 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.14 -22.51 66.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -93.66 -46.37 7.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.78 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.68 64.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.973 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.61 -39.9 76.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.702 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -24.49 65.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.738 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.547 HG12 HG11 ' A' ' 91' ' ' VAL . 59.0 t -75.13 -45.89 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.621 ' HG ' HG12 ' A' ' 91' ' ' VAL . 1.3 mt -60.07 -35.7 75.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.957 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -72.09 -39.24 69.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.712 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -77.09 -11.95 59.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.26 -174.98 2.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 113' ' ' ARG . 1.4 mtp85 -87.67 14.37 8.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.47 ' HG3' HD23 ' A' ' 109' ' ' LEU . 3.1 mmp_? -61.34 103.26 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 115' ' ' ARG . 4.7 ptp85 -76.2 123.31 87.95 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.133 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 73.5 Cg_endo -75.66 172.82 15.57 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.488 2.125 . . . . 0.0 112.211 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.4 t -130.47 140.23 49.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.21 72.87 8.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 132' ' ' ASP . . . -123.95 149.24 16.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.708 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.14 126.79 31.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 110.94 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.631 HD23 HD22 ' A' ' 187' ' ' LEU . 51.8 tp -89.52 136.82 32.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.499 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.652 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 89.8 m-70 -126.72 94.76 4.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.1 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 191' ' ' VAL . 54.3 t -60.8 97.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.016 0.436 . . . . 0.0 110.725 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 11.9 p -103.53 137.0 42.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.269 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -78.56 39.92 1.98 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.692 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -162.07 13.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.397 . . . . 0.0 110.729 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.746 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 134.57 97.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.468 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.5 ' HG ' HG13 ' A' ' 144' ' ' ILE . 2.4 mt -53.68 138.58 34.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.068 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.641 ' HG2' HD13 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -137.31 142.22 41.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.472 HG23 HD13 ' A' ' 121' ' ' LEU . 8.7 t -114.93 102.33 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.035 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.517 HG13 ' HD2' ' A' ' 136' ' ' LYS . 2.6 t -92.85 114.99 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.401 ' HA ' ' CA ' ' A' ' 119' ' ' GLY . 4.6 t0 -50.5 144.72 7.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.077 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.21 5.15 51.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.165 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 -32.74 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.692 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.49 -19.53 13.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.737 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.517 ' HD2' HG13 ' A' ' 131' ' ' VAL . 5.5 mmtm 50.02 39.63 19.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.919 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.41 -124.07 5.23 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.492 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.641 HD13 ' HG2' ' A' ' 129' ' ' ARG . 10.3 tp -154.76 113.81 3.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 110.726 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 5.5 mt -96.23 -54.01 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.4 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.9 t -112.5 111.81 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.904 0.383 . . . . 0.0 111.313 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.32 25.32 10.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.608 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -68.43 -170.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.169 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.746 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 5.6 m -146.03 154.29 41.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.931 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.5 HG13 ' HG ' ' A' ' 128' ' ' LEU . 13.6 mt -70.11 -43.51 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.706 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.473 ' HG2' HG22 ' A' ' 143' ' ' THR . 0.1 OUTLIER -78.24 -1.05 31.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.683 179.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' B' ' 10' ' ' PHE . 0.1 OUTLIER -96.89 -43.08 7.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 143' ' ' THR . 0.6 OUTLIER -66.02 145.06 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 110.993 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -55.39 -64.8 0.73 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.628 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 148' ' ' SER . 0.0 OUTLIER -144.51 -178.01 5.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.869 179.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.452 ' HB3' ' HA ' ' B' ' 3' ' ' SER . 2.2 t -123.18 155.58 36.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.419 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' A' ' 99' ' ' MET . . . -176.12 126.06 0.34 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.77 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 96.4 Cg_endo -85.09 -90.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.76 2.307 . . . . 0.0 112.308 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 5.9 p-10 -174.17 -173.75 0.83 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.568 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.6 mtm-85 -74.66 -85.76 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.636 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.65 47.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.775 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.89 -33.19 0.38 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.178 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -98.0 -26.31 14.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.308 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 59.03 18.25 6.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 110.972 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 153' ' ' ASP . . . -105.19 143.82 15.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.355 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.607 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -119.22 169.68 9.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.323 . . . . 0.0 110.87 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.656 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -164.41 176.84 8.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -147.43 145.52 29.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.403 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -106.85 152.49 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.468 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.13 127.54 12.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.685 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -99.95 113.49 26.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.469 ' HA ' ' N ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER 50.45 -153.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.311 179.25 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.94 -37.31 2.51 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.385 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 166' ' ' ASP . 0.7 OUTLIER -153.26 5.47 0.34 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.75 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.1 OUTLIER -128.72 -17.79 3.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.731 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.469 ' N ' ' HA ' ' A' ' 166' ' ' ASP . 0.1 OUTLIER 58.6 25.35 13.09 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.095 -178.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.448 ' H ' ' HA ' ' A' ' 166' ' ' ASP . 0.0 OUTLIER 172.19 176.4 0.09 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.552 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.08 124.33 26.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.5 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.75 ' HB2' HG21 ' A' ' 169' ' ' THR . 24.6 mtp -153.63 125.45 7.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.203 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 6.7 t -106.84 141.05 38.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.353 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 8.5 m170 -103.54 129.87 50.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.001 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.656 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -112.57 154.33 16.94 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.35 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -158.73 136.22 10.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.731 0.3 . . . . 0.0 110.536 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.8 mt -97.07 139.85 32.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.299 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.34 115.69 17.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.779 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 3.0 t -58.91 -23.69 61.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -28.52 31.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.045 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 55.08 82.93 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.8 t -161.33 -37.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.925 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.51 18.61 78.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.578 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -134.81 -0.37 2.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 0.0 110.816 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -98.54 -25.38 14.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.903 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.643 HD22 ' HG ' ' A' ' 82' ' ' SER . 4.2 mp -124.39 -51.04 1.75 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.806 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.0 t -58.26 -49.38 77.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.673 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 1.4 t-80 -69.67 -1.92 10.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.547 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -103.97 -40.75 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.167 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.661 ' HA ' HG13 ' A' ' 123' ' ' VAL . 4.8 p -67.92 -15.29 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.08 97.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.565 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 66.1 m -84.35 -11.58 56.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.988 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.885 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -60.06 -28.46 67.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.274 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.461 ' C ' HD11 ' A' ' 199' ' ' LEU . 3.0 m-85 -80.89 -37.73 29.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -55.91 -21.84 22.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.264 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.437 ' H ' HG23 ' A' ' 197' ' ' VAL . 0.8 OUTLIER -75.3 -42.1 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.803 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . 0.425 ' HB3' ' HG ' ' B' ' 6' ' ' SER . 85.4 m -78.76 -15.12 58.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.483 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.461 HD11 ' C ' ' A' ' 195' ' ' PHE . 8.3 mt -87.19 -26.18 23.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.817 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.62 -18.63 65.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.7 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 201' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.992 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.056 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -163.31 161.12 24.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.634 0.254 . . . . 0.0 111.106 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 150' ' ' CYS . 2.7 p -145.34 171.34 14.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.937 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -81.18 161.1 24.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.974 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 16.3 mtp -134.34 -7.49 2.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.026 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.425 ' HG ' ' HB3' ' A' ' 198' ' ' CYS . 20.6 t -93.12 27.13 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -62.72 158.25 19.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.75 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -85.05 7.3 21.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.857 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 17.7 t70 53.67 68.73 0.8 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.136 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.4 ' HE2' ' HA ' ' A' ' 146' ' ' LYS . 60.7 m-85 -67.86 140.69 94.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 C--O 1.248 1.004 0 C-N-CA 122.534 2.156 . . . . 0.0 112.336 -179.802 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.825 0.345 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.64 -52.77 7.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.974 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -62.84 -25.14 68.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.897 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -27.2 60.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.678 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -108.23 11.25 27.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.884 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.69 -32.58 6.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -60.36 -41.47 93.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.873 0.368 . . . . 0.0 110.777 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.832 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.6 mt-10 -92.88 -5.08 51.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.762 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -66.08 -46.42 77.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.045 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.448 HG23 HG11 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -64.79 -36.58 77.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.394 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.832 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -59.31 -39.27 82.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.359 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -91.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.555 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -178.36 36.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.488 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.514 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -176.0 101.71 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.668 0.27 . . . . 0.0 111.253 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.494 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 16.6 t -128.22 0.06 5.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.791 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.662 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -97.78 -163.38 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.6 0.238 . . . . 0.0 111.042 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.633 ' HB3' ' HD2' ' A' ' 181' ' ' LYS . 8.5 m-85 -154.88 -169.14 3.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.354 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.834 ' HB2' ' HE2' ' A' ' 181' ' ' LYS . 0.3 OUTLIER -41.07 142.31 0.52 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.072 -178.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.456 HG21 ' N ' ' A' ' 121' ' ' LEU . 4.1 m -142.26 -165.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.03 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.27 71.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.605 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.52 ' HB3' HG22 ' A' ' 117' ' ' VAL . 89.9 t80 -59.81 99.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -73.62 -40.24 63.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.58 -132.44 3.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.321 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.454 ' HB3' ' CG ' ' A' ' 175' ' ' HIS . 1.2 p -161.69 142.73 11.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.83 0.347 . . . . 0.0 110.927 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.434 HG12 ' HE ' ' A' ' 114' ' ' ARG . 12.2 m -127.17 153.38 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.067 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.77 142.5 42.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.988 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.94 -178.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.078 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -143.32 59.51 1.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -176.74 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 172' ' ' TRP . 1.0 OUTLIER 62.92 18.52 10.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.61 -178.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -119.61 51.92 1.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.29 169.07 37.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.497 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -85.12 -27.39 26.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.937 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.46 -19.02 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.035 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.605 ' HB ' HD12 ' A' ' 163' ' ' ILE . 60.5 t -57.94 -34.61 49.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.745 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 65.2 m -82.91 -33.49 26.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -65.63 -20.64 66.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.986 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.68 -46.44 4.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.048 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.62 -47.03 77.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.33 -32.87 68.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.768 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 1.2 tttm -72.47 -39.77 67.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.1 t -57.88 -40.95 78.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.472 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.8 mt -65.44 -27.88 68.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.913 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -28.2 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.79 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 14.4 mt-30 -84.69 -23.13 29.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -106.4 169.32 8.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.26 69.47 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.472 ' HG3' HD23 ' A' ' 109' ' ' LEU . 16.1 mmt-85 -72.26 -154.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.924 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' H ' ' HB3' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -111.26 85.97 6.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.548 -178.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 91.6 Cg_endo -79.82 128.4 7.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.701 2.267 . . . . 0.0 112.187 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -113.43 164.68 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -112.1 72.52 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -131.39 -167.81 12.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.445 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.48 141.27 45.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 111.184 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.526 HD13 HG22 ' A' ' 130' ' ' VAL . 64.3 tp -76.32 147.92 37.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.347 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.493 ' HD1' ' HB ' ' A' ' 80' ' ' THR . 30.4 m-70 -127.28 77.45 1.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.724 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.662 ' H ' ' HB2' ' A' ' 82' ' ' SER . 53.3 t -53.17 98.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 121.108 0.48 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.464 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -106.65 131.78 53.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.146 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.04 -15.08 9.15 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.824 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -112.5 35.72 3.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 113.2 126.19 4.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.448 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.66 139.16 37.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.718 0.294 . . . . 0.0 110.99 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.556 ' HB2' HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.23 141.95 39.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.024 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.526 HG22 HD13 ' A' ' 121' ' ' LEU . 20.2 t -109.2 114.28 46.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.008 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.469 HG13 ' HD3' ' A' ' 136' ' ' LYS . 2.4 t -104.7 121.31 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.577 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 2.6 t0 -60.94 165.81 3.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.886 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.81 2.15 25.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.55 -45.38 2.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.68 -24.57 19.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.64 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.469 ' HD3' HG13 ' A' ' 131' ' ' VAL . 0.2 OUTLIER 50.78 40.58 24.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.795 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.8 -114.92 3.89 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.504 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 129' ' ' ARG . 10.0 tp -168.57 120.27 0.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.771 0.319 . . . . 0.0 110.665 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.85 -54.43 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.277 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 129' ' ' ARG . 80.4 t -103.1 101.78 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.173 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -97.03 21.4 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.61 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -68.54 -177.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.103 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.527 HG23 ' N ' ' A' ' 144' ' ' ILE . 28.4 m -140.75 157.53 45.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.593 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.527 ' N ' HG23 ' A' ' 143' ' ' THR . 21.4 mt -59.86 -45.97 94.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.188 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -76.88 -1.47 28.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.507 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 5.3 tttt -99.58 -38.17 8.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.921 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 162' ' ' TYR . 1.9 m -75.07 130.44 36.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.043 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.425 ' HB3' ' HD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -65.7 -50.12 66.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.032 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.668 ' HB2' HD11 ' A' ' 163' ' ' ILE . 61.9 m-85 -131.55 -173.05 3.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 0.0 111.363 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 161' ' ' SER . 8.9 t -161.89 34.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.043 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 99' ' ' MET . . . -64.23 148.85 95.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.108 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.899 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 61.4 Cg_endo -88.79 -142.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.053 2.502 . . . . 0.0 112.305 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 157' ' ' GLU . 23.5 t0 -135.79 77.66 1.68 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.709 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 62.44 10.81 4.21 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.121 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.44 36.63 13.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.35 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.66 -0.22 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.162 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 153' ' ' ASP . 1.9 mt-10 -112.31 0.89 15.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.079 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.538 ' HG2' ' HA ' ' A' ' 182' ' ' ASP . 1.0 OUTLIER 53.15 43.94 30.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.93 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.72 128.73 3.87 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.537 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.659 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -121.46 168.5 11.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.688 0.28 . . . . 0.0 110.702 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 150' ' ' CYS . 1.1 m -157.87 172.28 18.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -145.41 145.21 31.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.593 178.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.747 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.1 OUTLIER -111.62 169.54 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.289 -179.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.424 ' H ' HG21 ' A' ' 163' ' ' ILE . 40.9 t -169.98 136.6 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.624 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.75 115.32 30.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 111.148 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.494 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 50.09 -159.72 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.401 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.42 -16.0 42.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.775 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.1 t -170.28 -4.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.063 0.459 . . . . 0.0 110.044 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -133.19 -12.65 2.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.977 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.494 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 5.6 mmt180 58.96 23.37 11.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.5 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -174.3 171.77 3.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.221 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.426 ' HB3' ' OG ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -74.98 119.98 19.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.936 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.5 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 0.1 OUTLIER -142.44 146.23 34.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.641 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.747 ' HB2' HG23 ' A' ' 163' ' ' ILE . 16.9 t -131.54 124.71 30.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.95 0.405 . . . . 0.0 111.293 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.529 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 9.2 m-70 -91.41 136.58 33.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.228 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -114.35 154.06 17.21 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.221 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 21.3 p90 -161.89 143.42 11.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.666 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.87 138.07 50.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.022 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.41 113.87 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.072 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 3.6 t -64.53 -32.47 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.957 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.834 ' HE2' ' HB2' ' A' ' 84' ' ' SER . 0.1 OUTLIER -65.47 -27.07 68.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.027 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.538 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 65.4 m-20 55.95 90.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.199 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 t -168.23 -43.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.777 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.39 30.51 56.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 32.3 tt0 -136.27 -42.39 0.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.701 0.286 . . . . 0.0 110.986 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.54 ' HB2' ' HD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -75.17 -5.95 47.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.9 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 83' ' ' PHE . 5.7 mp -131.29 -49.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.995 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -60.94 2.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 0.3 OUTLIER -62.37 -13.1 25.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.396 -179.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -88.19 -44.4 10.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.153 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.631 ' HA ' HG12 ' A' ' 123' ' ' VAL . 1.7 p -69.95 -24.38 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.86 -10.22 83.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.458 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.8 m -110.0 14.4 23.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.392 . . . . 0.0 110.557 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.59 -43.4 11.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.172 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.561 ' HB3' ' HB2' ' B' ' 4' ' ' ASN . 5.1 p90 -61.34 -33.35 73.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.733 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.63 -27.41 64.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.886 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.458 HG23 HH21 ' A' ' 77' ' ' ARG . 3.7 t -105.94 -5.53 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.756 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 2.0 t -88.97 -5.4 57.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.923 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.67 -12.4 59.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.021 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -61.73 -32.71 72.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.947 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 201' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.905 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.899 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -145.78 -104.61 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.406 0.146 . . . . 0.0 110.882 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.489 ' H ' ' HB3' ' B' ' 2' ' ' PHE . 0.0 OUTLIER 64.51 131.74 0.02 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.976 0.417 . . . . 0.0 111.369 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 7.6 p30 -109.95 -165.6 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.742 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.402 ' HG2' ' CE2' ' B' ' 7' ' ' PHE . 0.0 OUTLIER -125.94 -137.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.6 p 56.55 18.17 3.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.562 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.413 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 32.1 p90 -85.69 151.88 23.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.687 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -82.78 9.02 10.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . 0.413 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 8.1 t0 54.46 70.33 0.63 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.777 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 31.0 m-85 -60.0 139.2 90.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.958 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 32.1 Cg_exo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.705 2.27 . . . . 0.0 112.229 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.6 t60 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.821 0.343 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -39.59 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.811 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -30.01 70.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.553 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -67.01 -11.13 56.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.568 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.44 6.97 6.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.946 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.56 -16.39 10.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.151 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -104.91 -13.93 15.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.3 -14.56 14.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.79 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HB2' ' SG ' ' A' ' 81' ' ' CYS . . . -66.95 -50.79 61.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.017 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.433 HG21 ' SG ' ' A' ' 81' ' ' CYS . 1.8 t -59.83 -44.88 95.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.799 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -57.97 -39.17 77.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.536 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.1 m -69.2 -93.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.526 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.59 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -177.9 30.98 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.382 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.673 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -171.73 100.13 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.903 0.382 . . . . 0.0 111.789 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.592 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 4.1 t -121.7 -147.48 0.39 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.126 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.539 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 52.83 -157.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 111.635 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.482 ' HB3' ' HD2' ' A' ' 181' ' ' LYS . 2.8 m-85 -159.14 -166.21 1.78 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.492 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 0.2 OUTLIER -46.77 151.1 0.63 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.726 0.298 . . . . 0.0 111.309 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.403 ' HB ' ' H ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER -145.7 -169.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.102 0.477 . . . . 0.0 111.706 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -152.4 71.91 0.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.266 178.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.517 ' HB3' HG21 ' A' ' 117' ' ' VAL . 22.4 t80 -56.06 111.22 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.192 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.484 HD23 HD13 ' A' ' 178' ' ' LEU . 4.3 mt -70.53 -80.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.887 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.07 -127.5 1.02 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.561 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 8.3 p -155.84 137.75 14.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.703 0.287 . . . . 0.0 111.04 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.33 157.87 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -75.84 147.08 39.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.211 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 174' ' ' CYS . 2.9 m -137.49 -176.05 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.574 ' HA ' ' HE3' ' A' ' 172' ' ' TRP . 1.7 t80 -146.03 64.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.256 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.03 -68.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.442 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.431 ' HG ' ' HB3' ' A' ' 172' ' ' TRP . 0.3 OUTLIER 58.54 19.62 6.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.822 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.38 125.4 12.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.33 -112.67 1.31 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.546 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.36 -34.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 111.05 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -76.65 -9.74 58.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.299 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.6 -22.85 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 24.0 m -87.24 -33.99 19.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 153' ' ' ASP . 2.9 mt-10 -64.03 -15.66 59.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.026 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -97.32 -48.73 5.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.039 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.14 -34.22 71.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.133 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.509 HD23 ' HA3' ' A' ' 159' ' ' GLY . 6.8 tp -64.71 -29.84 70.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -45.99 30.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.835 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 t -59.28 -37.73 70.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.173 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.535 HD21 ' HG3' ' A' ' 114' ' ' ARG . 8.5 mt -70.51 -26.75 63.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -9.68 59.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -114.93 1.78 14.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.034 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -118.19 -18.33 9.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.283 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.5 69.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.874 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.535 ' HG3' HD21 ' A' ' 109' ' ' LEU . 18.7 mmt180 -84.77 43.43 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.49 90.94 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.421 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 70.2 Cg_endo -74.03 163.17 37.43 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.605 2.204 . . . . 0.0 112.075 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 87' ' ' TYR . 2.3 t -124.44 160.94 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.818 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.469 ' HB2' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -130.75 79.5 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -135.16 -174.17 13.33 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.752 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -101.97 122.97 45.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.749 0.309 . . . . 0.0 110.968 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.748 HD11 HG23 ' A' ' 130' ' ' VAL . 28.9 tp -86.6 124.11 32.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.377 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.673 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 67.6 m-70 -112.72 90.48 3.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.972 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.813 HG12 ' HA ' ' A' ' 191' ' ' VAL . 44.1 t -66.3 94.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.052 0.453 . . . . 0.0 110.851 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.59 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -91.8 141.06 29.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.938 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.31 34.39 1.54 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.671 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.456 ' N ' HD13 ' A' ' 144' ' ' ILE . 16.5 t70 -166.43 18.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.858 0.361 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.463 ' H ' HD13 ' A' ' 144' ' ' ILE . . . 140.96 106.64 0.64 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.473 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.05 136.1 51.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 111.106 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.82 137.59 41.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.748 HG23 HD11 ' A' ' 121' ' ' LEU . 3.8 t -119.47 118.47 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.147 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.7 t -106.74 117.22 52.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.83 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.403 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 3.1 m-20 -51.4 145.03 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.964 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.87 15.47 25.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.533 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.64 -5.76 2.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.592 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.72 -13.62 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.435 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 50.66 42.55 27.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.6 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.28 -117.73 4.37 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 141' ' ' ASP . 6.7 tp -171.54 128.12 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.683 0.278 . . . . 0.0 110.726 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.541 HG13 ' HB ' ' A' ' 130' ' ' VAL . 1.3 pt -114.69 -39.82 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.321 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.0 t -122.84 105.2 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.196 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.4 ' HB2' HD23 ' A' ' 138' ' ' LEU . 19.8 t70 -111.81 28.62 8.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -70.8 -177.0 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.113 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.714 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 21.7 m -128.41 156.79 42.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.559 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.463 HD13 ' H ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -67.71 -48.54 75.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.813 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.701 ' HG3' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER -72.24 -17.28 61.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.714 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 15.8 tttt -74.0 -53.67 9.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.837 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.11 144.19 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.104 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.8 t -46.56 -58.15 4.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.95 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.741 ' HA ' ' HB3' ' B' ' 4' ' ' ASN . 40.1 p90 -173.1 151.83 2.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.983 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 56.2 m -91.58 113.26 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.91 98.56 47.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.074 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 50.1 Cg_exo -54.42 -90.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.454 2.102 . . . . 0.0 112.236 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.456 ' HA ' ' HG3' ' A' ' 103' ' ' GLU . 10.7 p-10 -178.88 -149.52 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.475 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.12 13.81 2.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.756 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.77 47.32 18.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.983 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.05 -38.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.885 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -75.25 -9.91 58.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.737 ' HG2' ' H ' ' A' ' 183' ' ' SER . 0.9 OUTLIER 56.15 47.83 18.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.082 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.509 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . -144.63 127.57 2.97 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.591 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.541 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -117.08 166.68 11.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.332 . . . . 0.0 110.646 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 16.4 m -157.96 161.12 38.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.989 0.423 . . . . 0.0 111.288 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.8 145.76 44.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.191 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.509 HG23 ' HB2' ' A' ' 174' ' ' CYS . 1.3 mt -112.94 159.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.01 0.433 . . . . 0.0 111.586 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.426 ' N ' HG21 ' A' ' 163' ' ' ILE . 29.6 p -147.67 153.35 39.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.346 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.29 119.97 36.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 111.406 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.717 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 54.26 -160.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.34 179.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.04 -18.19 52.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.428 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 8.9 t -168.4 -0.49 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.046 0.45 . . . . 0.0 109.943 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.426 HG22 ' HG3' ' A' ' 173' ' ' MET . 3.9 m -135.35 -20.36 1.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.04 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.717 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 31.6 mtt-85 58.34 42.82 20.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.957 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -179.82 -139.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.797 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.574 ' HE3' ' HA ' ' A' ' 94' ' ' PHE . 9.7 m0 -111.18 136.31 50.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.903 0.382 . . . . 0.0 111.377 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.426 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -157.89 130.61 7.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.239 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.509 ' HB2' HG23 ' A' ' 163' ' ' ILE . 34.7 t -117.25 136.72 52.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.426 . . . . 0.0 111.531 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.464 ' O ' ' HB3' ' A' ' 161' ' ' SER . 10.0 m170 -106.73 151.23 25.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.292 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -129.54 155.16 20.73 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.02 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -159.35 144.16 15.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.738 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.484 HD13 HD23 ' A' ' 88' ' ' LEU . 1.7 mt -108.91 176.6 5.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.075 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 187' ' ' LEU . . . -111.16 128.4 55.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.8 OUTLIER -62.72 -31.76 72.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.916 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.482 ' HD2' ' HB3' ' A' ' 83' ' ' PHE . 4.0 mttm -90.98 -19.91 22.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 184' ' ' GLY . 61.3 m-20 57.39 -157.42 0.29 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.837 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.737 ' H ' ' HG2' ' A' ' 158' ' ' ARG . 8.7 t 72.63 -20.88 0.25 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.635 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 182' ' ' ASP . . . 54.16 40.12 66.08 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.91 -10.59 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.79 0.328 . . . . 0.0 110.884 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.464 ' HD3' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -115.64 4.77 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.922 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' A' ' 179' ' ' ALA . 5.0 mp -142.62 -51.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.308 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.0 t -56.87 -62.22 1.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.549 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.72 -3.82 7.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.608 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -92.4 -47.31 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.248 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.813 ' HA ' HG12 ' A' ' 123' ' ' VAL . 8.2 p -71.07 -20.05 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.267 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.54 -4.55 52.74 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.718 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.33 -6.75 14.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.359 . . . . 0.0 110.794 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.28 -59.69 3.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.987 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.413 ' HB3' HG21 ' A' ' 144' ' ' ILE . 25.5 p90 -65.62 -26.9 68.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.776 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.484 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -66.12 -18.92 65.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 86.7 t -105.58 -26.19 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.97 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 19.1 t -76.64 -10.21 59.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.676 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.484 HD11 ' HA ' ' A' ' 196' ' ' ALA . 4.6 mt -63.08 -42.5 99.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.057 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 201' ' ' ARG . 0.0 OUTLIER -58.83 -29.63 67.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . 0.536 ' N ' ' HG3' ' A' ' 200' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.163 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.421 ' N ' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.487 2.095 0 N-CA-C 112.598 -0.201 . . . . 0.0 112.598 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.418 ' HB2' ' H ' ' B' ' 3' ' ' SER . 0.6 OUTLIER -160.08 -164.94 1.37 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.418 ' H ' ' HB2' ' B' ' 2' ' ' PHE . 0.0 OUTLIER -163.7 150.29 11.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.02 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.741 ' HB3' ' HA ' ' A' ' 149' ' ' PHE . 3.5 t30 -67.65 146.95 53.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.684 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 14.1 mtp -126.05 -4.19 6.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.081 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -92.83 24.6 3.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.43 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 37.7 p90 -80.62 156.2 26.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.165 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -90.37 9.92 27.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . 0.43 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 31.0 t0 58.87 71.53 0.58 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.049 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -62.08 141.84 95.67 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.015 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.617 2.212 . . . . 0.0 112.312 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.839 0.352 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -95.93 -34.74 11.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.094 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -18.24 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.937 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -70.66 -20.96 62.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.425 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.5 -25.59 13.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.773 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -45.24 48.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.726 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -65.77 -21.24 66.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.684 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.588 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.5 tt0 -106.58 -2.48 21.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.733 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.83 -50.98 64.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.98 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 194' ' ' ALA . 2.8 t -55.09 -37.5 43.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.3 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.588 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 4.8 mtm180 -66.23 -35.91 81.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.184 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 m -81.11 1.47 31.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.601 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 124' ' ' SER . . . 66.77 43.7 2.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.516 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.587 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -172.36 84.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.99 0.424 . . . . 0.0 111.326 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.771 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.8 t -111.48 -151.43 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.352 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.781 ' HG ' HD22 ' A' ' 187' ' ' LEU . 0.4 OUTLIER 55.62 -160.04 0.19 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.866 0.365 . . . . 0.0 111.379 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.817 ' HB2' HD12 ' A' ' 187' ' ' LEU . 22.0 m-85 -157.37 -167.77 2.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.236 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.9 m -49.01 148.64 2.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.82 0.343 . . . . 0.0 111.038 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.41 HG13 HD23 ' A' ' 121' ' ' LEU . 2.7 m -144.52 -173.82 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.043 0.449 . . . . 0.0 111.537 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -137.1 68.85 1.41 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.762 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CD2' HG21 ' A' ' 139' ' ' ILE . 36.7 t80 -56.67 110.2 0.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.805 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 0.3 OUTLIER -83.56 -52.71 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.33 -179.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 162.78 -137.56 4.88 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.756 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.541 ' HB3' ' ND1' ' A' ' 175' ' ' HIS . 0.8 OUTLIER -151.35 128.25 11.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.686 0.279 . . . . 0.0 111.087 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.455 HG13 HD21 ' A' ' 109' ' ' LEU . 28.7 m -119.99 162.52 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.03 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -81.45 143.04 32.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.953 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -145.44 127.67 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -92.79 61.01 3.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.94 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.64 -77.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.27 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.539 ' HA ' HG23 ' A' ' 163' ' ' ILE . 0.3 OUTLIER 54.59 32.4 16.95 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.696 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -134.34 132.06 39.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.693 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.38 -164.69 38.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.438 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.573 ' HE3' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -113.83 -11.19 12.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.003 179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.573 ' NE2' ' HE3' ' A' ' 99' ' ' MET . 6.9 mm-40 -77.9 15.08 0.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.393 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.486 HG11 HG12 ' A' ' 163' ' ' ILE . 4.7 t -82.94 -17.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.413 ' CB ' ' HB2' ' A' ' 161' ' ' SER . 16.9 p -87.74 -34.3 18.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.123 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.795 ' HG2' ' HD2' ' A' ' 154' ' ' ARG . 26.0 mt-10 -66.23 -0.21 2.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.961 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -120.34 -59.64 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.372 . . . . 0.0 111.367 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.446 ' HA ' HG23 ' A' ' 108' ' ' VAL . . . -55.5 -38.46 69.21 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.464 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.95 -36.53 62.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -76.66 -37.51 56.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.023 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 105' ' ' ALA . 21.3 t -57.15 -44.59 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.455 HD21 HG13 ' A' ' 91' ' ' VAL . 1.2 mt -72.19 -17.44 61.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.813 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.09 -11.37 58.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.665 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -80.4 -62.48 1.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.821 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.12 -163.96 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.271 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 72.26 -65.81 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.564 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.402 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 31.0 mmt180 -94.56 109.17 21.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.842 0.353 . . . . 0.0 111.001 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -82.1 142.48 47.86 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.982 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 73.3 Cg_endo -77.33 160.05 32.65 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.589 2.193 . . . . 0.0 112.565 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 87' ' ' TYR . 1.4 t -128.15 152.22 35.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.056 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -96.84 100.09 11.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.751 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -144.51 -169.7 13.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.781 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -117.78 128.75 55.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.655 0.264 . . . . 0.0 110.623 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.627 HD22 ' HG ' ' A' ' 82' ' ' SER . 61.3 tp -92.78 122.44 35.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.177 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.587 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 8.0 m-70 -112.88 89.18 3.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.019 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.802 HG13 ' HA ' ' A' ' 191' ' ' VAL . 54.3 t -67.27 90.86 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.056 0.455 . . . . 0.0 110.527 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.462 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 11.8 p -82.92 156.54 23.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.452 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.47 -7.1 38.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.362 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 143' ' ' THR . 0.5 OUTLIER -124.16 34.61 5.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 110.839 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.659 ' HA2' HG13 ' A' ' 144' ' ' ILE . . . 122.52 -162.45 16.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.574 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 mt -122.96 166.86 14.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -159.84 103.87 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.554 HG23 HG13 ' A' ' 140' ' ' VAL . 4.4 t -90.32 98.57 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.21 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.569 HG13 ' HA ' ' A' ' 136' ' ' LYS . 0.7 OUTLIER -92.38 114.57 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.913 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.72 146.99 9.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.61 19.28 11.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -131.15 -19.75 2.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.749 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.624 HG23 ' H ' ' A' ' 137' ' ' GLY . 12.2 t -134.87 -21.65 1.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.88 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.569 ' HA ' HG13 ' A' ' 131' ' ' VAL . 9.3 mmtt 56.65 23.95 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.817 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.624 ' H ' HG23 ' A' ' 135' ' ' THR . . . -77.43 -105.43 0.16 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.443 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.3 tp -165.95 102.34 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 110.699 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.454 HG21 ' CD2' ' A' ' 87' ' ' TYR . 3.2 mt -80.16 -30.06 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.213 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.554 HG13 HG23 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -156.56 148.38 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.267 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -129.29 48.57 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.819 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.478 ' HG3' ' HE2' ' A' ' 162' ' ' TYR . 1.5 mm-40 -79.09 -175.58 4.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.052 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 2.6 m -149.0 164.85 33.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.659 HG13 ' HA2' ' A' ' 127' ' ' GLY . 69.2 mt -82.83 -37.93 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -12.2 60.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.626 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -86.43 -48.63 8.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 143' ' ' THR . 11.7 m -64.97 141.45 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.12 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 t -49.87 -65.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.808 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -159.64 123.33 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.805 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 77.0 m -59.87 163.16 4.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.42 125.12 0.74 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.075 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 72.3 Cg_endo -76.1 -94.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.557 2.171 . . . . 0.0 112.438 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -175.64 -158.8 0.07 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.434 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.795 ' HD2' ' HG2' ' A' ' 103' ' ' GLU . 1.0 OUTLIER -67.3 -89.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.463 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.41 40.61 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.029 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.6 -17.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.264 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.98 -27.85 49.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.223 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.486 HH11 ' HB3' ' A' ' 182' ' ' ASP . 8.8 mtm180 58.9 19.26 6.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.759 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.415 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -122.81 140.37 13.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.419 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -119.49 168.08 11.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 110.833 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 175' ' ' HIS . 13.5 m -154.02 160.52 42.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.859 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.478 ' HE2' ' HG3' ' A' ' 142' ' ' GLN . 4.7 p90 -134.1 151.59 51.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.799 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.539 HG23 ' HA ' ' A' ' 96' ' ' SER . 0.7 OUTLIER -115.77 157.16 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.046 0.451 . . . . 0.0 111.734 -178.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.418 ' H ' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -158.98 135.94 9.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.287 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -118.22 119.99 36.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.895 0.378 . . . . 0.0 111.675 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.86 -164.12 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.713 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.19 -17.61 12.22 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.847 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.6 t -174.05 -0.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.031 0.443 . . . . 0.0 109.932 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.0 -15.73 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.868 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.44 21.31 9.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 177.91 176.48 0.43 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.438 ' HB3' ' HG ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -80.1 121.32 25.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 9.4 mtp -143.02 138.67 30.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.568 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.415 ' HB2' HG21 ' A' ' 163' ' ' ILE . 5.6 t -123.02 136.68 54.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.151 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.542 ' O ' ' HB3' ' A' ' 161' ' ' SER . 5.6 m-70 -102.44 157.71 16.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.555 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -133.07 145.26 17.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.865 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 17.8 p90 -153.95 136.44 15.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.768 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.415 HD23 ' HA3' ' A' ' 159' ' ' GLY . 5.7 mt -101.82 166.26 10.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.938 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.16 115.83 29.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -10.75 56.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -84.79 -24.09 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.486 ' HB3' HH11 ' A' ' 158' ' ' ARG . 47.1 m-20 56.98 82.97 0.11 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.6 t -167.02 -58.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.102 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.37 29.11 11.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.299 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -133.88 -54.71 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.408 ' HB2' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -59.93 -15.74 24.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.271 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.817 HD12 ' HB2' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -115.16 -53.89 2.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -49.89 75.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.404 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -73.99 9.0 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.206 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.48 ' HB3' ' HG ' ' A' ' 81' ' ' CYS . . . -103.53 -55.75 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.81 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.802 ' HA ' HG13 ' A' ' 123' ' ' VAL . 13.2 p -64.03 -25.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.434 ' N ' HG11 ' A' ' 191' ' ' VAL . . . -63.69 -19.42 62.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.335 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 91.8 m -103.09 10.22 38.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.828 0.347 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.608 ' HA ' HG12 ' A' ' 76' ' ' VAL . . . -90.56 -34.0 15.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.217 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 1.6 m-85 -62.03 -45.35 93.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.002 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.43 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -58.2 -16.03 12.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.597 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.21 -27.99 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.185 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -27.32 60.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.7 OUTLIER -111.13 16.82 20.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.249 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.36 -66.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.858 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -138.03 -174.75 3.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.751 0.31 . . . . 0.0 110.993 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -168.16 153.91 7.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.722 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -65.39 146.83 54.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.79 -12.26 13.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.403 ' N ' HD21 ' A' ' 199' ' ' LEU . 83.5 p -91.34 25.6 2.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.84 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -61.57 145.24 52.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.071 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.89 0.24 56.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t0 56.6 78.41 0.22 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -82.44 150.98 64.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.998 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.585 2.19 . . . . 0.0 112.333 179.933 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.077 0 CA-C-O 120.801 0.334 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -164.24 -45.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.043 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -27.85 36.63 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -69.48 -11.08 60.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.515 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.4 -27.22 8.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.957 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.17 -28.32 65.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.652 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.31 -16.03 61.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.672 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.614 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 5.7 mt-10 -105.31 -16.07 14.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.663 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.507 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -54.81 -45.64 74.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.061 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 194' ' ' ALA . 2.1 t -64.52 -45.38 95.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.465 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.614 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -54.19 -31.89 54.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.274 178.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -78.93 -91.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.399 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 178.45 34.97 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.373 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.433 ' HG1' ' HB3' ' A' ' 122' ' ' HIS . 1.4 t -174.35 101.21 0.1 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.929 0.395 . . . . 0.0 111.913 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.771 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 2.8 t -122.49 -149.09 0.42 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.461 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.55 -155.68 0.24 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.847 0.356 . . . . 0.0 111.81 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -159.39 -169.35 2.58 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.502 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.12 147.04 5.71 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.831 0.348 . . . . 0.0 110.962 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.555 HG11 HD23 ' A' ' 121' ' ' LEU . 4.6 m -140.77 -174.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.453 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.09 70.6 1.3 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.596 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 41.1 t80 -52.01 99.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.741 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.657 HD23 HD11 ' A' ' 178' ' ' LEU . 0.7 OUTLIER -71.41 -6.32 39.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.272 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.36 -164.48 12.14 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.619 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 10.1 p -125.72 144.51 50.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.683 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.04 161.89 40.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.021 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.03 155.36 20.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.724 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.9 165.87 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.973 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -134.97 59.76 1.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.006 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -155.81 -71.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 54.13 41.09 32.16 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -148.65 108.73 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.999 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.01 -144.32 16.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.765 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.45 -29.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.84 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -73.87 1.65 10.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.13 -28.12 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.031 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.857 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 1.7 m -90.79 -17.55 26.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -7.49 34.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.46 -41.34 2.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.019 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.08 82.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.541 ' HB2' ' HG ' ' A' ' 161' ' ' SER . 6.4 tp -57.68 -39.27 76.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -70.39 -38.78 74.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.8 t -56.44 -34.61 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.639 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.782 HD22 ' HG3' ' A' ' 114' ' ' ARG . 2.5 mt -72.21 -28.16 63.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.669 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -12.76 59.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.55 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.84 -18.42 15.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.198 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.7 m -118.7 171.82 7.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.083 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -114.33 66.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.782 ' HG3' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -63.35 -92.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.2 -179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -150.01 75.72 8.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.337 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 67.2 Cg_endo -73.97 108.72 2.72 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.637 2.225 . . . . 0.0 112.219 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.476 HG12 ' OD1' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -119.26 125.98 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.017 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.61 106.49 18.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.908 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -148.45 -171.99 17.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.822 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.02 138.89 36.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.04 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.555 HD23 HG11 ' A' ' 85' ' ' VAL . 28.0 tp -108.81 125.42 51.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.181 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 0.1 OUTLIER -117.76 95.61 5.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.292 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.771 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 74.9 t -67.1 94.22 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.977 0.418 . . . . 0.0 110.557 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.13 143.0 26.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.627 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -80.1 37.65 2.17 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.648 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.553 ' N ' HD13 ' A' ' 144' ' ' ILE . 9.5 t0 -168.89 20.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.729 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 135.39 101.05 0.65 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.221 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 mt -60.89 132.82 55.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -122.13 146.72 46.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.654 179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.635 HG22 ' HB ' ' A' ' 140' ' ' VAL . 16.2 t -133.52 98.02 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.26 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.408 ' H ' ' HE1' ' A' ' 122' ' ' HIS . 2.3 t -98.07 124.81 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.889 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.517 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 8.5 t70 -53.67 160.39 1.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.478 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.6 OUTLIER -99.49 -1.51 38.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.387 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.03 -43.67 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.937 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.47 -23.2 21.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.43 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp 50.62 26.55 2.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.19 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.73 -109.05 0.73 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.418 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 141' ' ' ASP . 13.8 tp -160.04 116.72 2.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.93 0.395 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.5 mm -96.54 -56.39 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.156 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 130' ' ' VAL . 17.3 t -127.68 116.42 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.233 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.467 ' HB3' HD22 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -111.78 39.99 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.581 179.106 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -77.19 -168.44 1.11 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.47 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.592 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 5.1 m -146.05 158.34 43.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.826 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.553 HD13 ' N ' ' A' ' 126' ' ' ASP . 4.5 mt -67.65 -35.63 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.041 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -80.62 -11.02 59.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.683 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -90.59 -40.58 11.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 143' ' ' THR . 1.0 OUTLIER -64.86 125.77 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.99 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.6 -73.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.112 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.46 124.49 12.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.29 159.99 22.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.402 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . . . -170.51 108.53 0.43 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.035 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.651 ' HD2' ' HA3' ' B' ' 1' ' ' GLY . 88.1 Cg_endo -78.38 9.95 2.95 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.487 2.125 . . . . 0.0 112.459 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.64 -149.69 0.43 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.386 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.5 -101.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.423 0.154 . . . . 0.0 110.711 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.407 ' C ' HD21 ' A' ' 155' ' ' ASN . 0.1 OUTLIER 49.72 -98.54 0.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.962 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 175.71 1.94 0.0 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.058 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -82.78 2.03 36.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.36 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.689 ' HG2' ' N ' ' A' ' 183' ' ' SER . 1.3 mpt_? 55.84 38.09 29.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.919 0.39 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -105.52 144.68 15.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.729 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 1.7 m-85 -131.34 150.97 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.857 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 0.9 OUTLIER -154.39 151.82 29.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.463 -178.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.546 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -127.05 163.0 24.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.282 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.631 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.8 OUTLIER -122.24 161.49 23.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.975 0.417 . . . . 0.0 111.362 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.429 ' H ' HG21 ' A' ' 163' ' ' ILE . 2.1 t -155.93 118.93 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.621 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -89.93 119.01 29.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.448 ' HA ' ' N ' ' A' ' 170' ' ' ARG . 0.5 OUTLIER 50.35 -152.14 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.221 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.67 -29.8 2.92 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.775 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 166' ' ' ASP . 0.7 OUTLIER -156.56 -1.15 0.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.031 0.444 . . . . 0.0 109.952 179.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.682 HG23 ' HG3' ' A' ' 171' ' ' ARG . 1.6 m -128.98 -20.96 3.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.448 ' N ' ' HA ' ' A' ' 166' ' ' ASP . 5.7 mtt-85 66.41 24.14 10.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.316 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.682 ' HG3' HG23 ' A' ' 169' ' ' THR . 0.0 OUTLIER 178.14 -176.86 0.21 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.051 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.17 132.28 48.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.194 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.481 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -163.21 124.45 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.561 179.201 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.631 ' HB2' HG23 ' A' ' 163' ' ' ILE . 1.9 t -115.84 140.94 48.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.96 0.41 . . . . 0.0 111.251 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.546 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -108.28 145.44 34.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -129.61 152.9 19.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.121 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 42.5 p90 -156.43 154.31 30.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.719 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.657 HD11 HD23 ' A' ' 88' ' ' LEU . 9.1 mt -112.59 158.12 20.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.821 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.441 ' HB3' HD12 ' A' ' 187' ' ' LEU . . . -88.38 118.43 28.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.854 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.14 -4.29 16.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.023 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -101.57 -29.64 11.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 58.0 92.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.689 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 28.9 t -167.08 -36.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.009 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.78 19.05 76.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -136.75 -20.87 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.551 ' HB2' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -79.09 -25.6 43.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.037 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.551 HD13 ' HB2' ' A' ' 186' ' ' ARG . 6.7 mp -120.89 -43.33 2.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.4 t -58.4 -52.49 65.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -75.57 7.63 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.227 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.441 ' HB1' ' HG ' ' A' ' 81' ' ' CYS . . . -97.79 -56.82 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.091 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.531 ' HA ' HG13 ' A' ' 123' ' ' VAL . 7.6 p -65.76 -22.07 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.204 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.64 -18.95 62.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.508 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.1 m -105.07 -3.3 23.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 110.712 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.642 ' HA ' HG12 ' A' ' 76' ' ' VAL . . . -64.52 -46.26 83.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.152 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.7 p90 -70.07 -39.1 75.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.991 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.579 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -57.98 -20.03 35.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.514 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.5 t -105.48 -24.84 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.7 t -73.29 -3.11 24.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.771 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' ' 196' ' ' ALA . 5.0 mt -89.06 1.05 56.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.102 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.37 -3.59 43.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.041 -179.526 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.651 ' HA3' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.62 -164.58 0.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.734 0.302 . . . . 0.0 110.785 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.5 p -173.81 141.94 0.86 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.643 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -60.62 161.46 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.149 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 9.8 ttp -124.17 -2.15 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.959 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p -93.95 17.32 12.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.991 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -65.37 146.02 55.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.974 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -88.45 -1.57 58.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.954 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t0 55.03 77.13 0.22 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -60.03 141.91 89.63 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.583 2.189 . . . . 0.0 112.267 -179.876 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.8 t60 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.798 0.332 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -98.68 -47.84 5.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -26.45 68.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.61 -8.49 34.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.678 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.24 -24.75 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.013 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.54 -39.32 53.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.98 -39.69 79.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.694 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -74.56 -15.56 60.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.78 -47.84 79.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.3 t -58.8 -40.89 81.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -65.63 -31.88 73.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.396 178.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.66 -0.93 40.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.514 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 69.0 39.94 1.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.594 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.759 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -171.37 88.02 0.1 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.074 0.464 . . . . 0.0 111.439 178.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.894 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.9 t -117.75 -145.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.078 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.443 ' HB2' HG22 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.55 -156.67 0.19 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.925 0.393 . . . . 0.0 111.483 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -161.81 -167.94 1.82 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.539 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.4 m -50.78 150.26 2.98 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.977 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.47 -171.77 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.021 0.439 . . . . 0.0 111.839 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.02 80.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.289 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.457 ' HB3' HG22 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -53.91 166.44 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.296 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 18.4 mt -126.42 -46.97 1.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.628 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.14 -127.0 2.3 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.434 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.8 p -152.6 134.21 14.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.988 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.492 HG22 HD11 ' A' ' 109' ' ' LEU . 6.1 m -135.19 159.84 40.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 2.9 pt-20 -88.72 138.99 30.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.397 . . . . 0.0 110.986 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 m -129.33 127.07 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.94 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.89 65.77 4.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.967 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.577 ' HG3' ' HG3' ' A' ' 97' ' ' ARG . 1.4 tp10 -163.31 -65.57 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.282 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.4 22.89 11.37 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.637 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -151.84 117.04 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.901 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.41 158.65 11.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.454 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.74 -4.89 54.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.805 0.336 . . . . 0.0 111.031 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.75 -20.7 30.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 5.7 t -61.29 -32.68 53.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.844 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.411 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 58.5 m -85.6 -27.09 25.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.983 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.27 -15.44 63.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.017 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -110.11 -45.63 3.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.653 ' HA ' HG22 ' A' ' 108' ' ' VAL . . . -58.85 -31.79 68.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.35 -42.11 90.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.667 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -73.75 -32.53 63.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.788 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 105' ' ' ALA . 52.1 t -55.99 -42.51 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.572 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -68.65 -35.38 77.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.549 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -69.1 -22.85 63.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.501 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -94.81 -14.38 24.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.769 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m -94.21 179.35 5.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.091 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 12.38 19.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.42 ' CG ' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -57.68 110.87 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.927 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 136.22 94.36 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.279 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -84.83 153.25 11.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.816 2.344 . . . . 0.0 112.565 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -128.54 97.55 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.774 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.73 129.68 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.39 -163.01 20.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.291 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.02 118.34 36.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.814 0.34 . . . . 0.0 111.077 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.3 127.16 35.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.456 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.759 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 35.5 m-70 -112.86 95.99 5.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.014 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.894 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 40.0 t -65.46 95.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.043 0.449 . . . . 0.0 110.441 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -94.42 126.7 39.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.222 179.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -63.17 -1.29 3.94 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.831 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 124' ' ' SER . 6.4 t70 -131.56 32.79 4.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 110.817 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.69 102.28 1.15 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.452 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mt -68.64 125.63 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 111.319 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.1 143.34 49.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.435 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.494 HG21 ' HB ' ' A' ' 140' ' ' VAL . 18.4 t -122.67 115.1 44.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.904 0.383 . . . . 0.0 111.483 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.8 t -94.68 147.67 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.35 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.453 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 38.7 m-20 -83.42 161.3 21.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.789 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -112.54 5.25 17.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.625 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.12 -3.06 5.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.968 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.38 -14.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.523 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 23.1 mmtt 53.98 29.71 10.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.085 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.447 ' H ' ' HB2' ' A' ' 132' ' ' ASP . . . -99.33 148.4 18.69 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.394 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.2 tp -76.36 120.88 22.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 9.5 pt -108.5 -16.01 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.228 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.571 HG11 ' HG2' ' A' ' 142' ' ' GLN . 84.4 t -129.88 94.75 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 111.148 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.62 17.21 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.715 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.571 ' HG2' HG11 ' A' ' 140' ' ' VAL . 7.6 mm100 -72.46 -173.84 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.793 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 24.4 m -142.56 160.58 40.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.619 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 45.0 mt -59.36 -56.28 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.089 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.26 -18.95 64.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.779 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.793 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 1.8 tttp -71.2 -61.38 1.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.973 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.6 m -61.25 140.04 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.093 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -43.89 -67.86 0.24 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.081 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.637 ' HZ ' ' HA ' ' A' ' 97' ' ' ARG . 0.3 OUTLIER -169.76 142.52 2.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.167 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.42 165.06 19.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.587 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -166.37 124.64 1.07 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.352 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HG3' ' HA3' ' B' ' 1' ' ' GLY . 90.8 Cg_endo -82.86 -136.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.693 2.262 . . . . 0.0 112.104 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -130.3 -163.4 1.31 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.821 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 -19.18 1.76 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.115 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' A' ' 156' ' ' HIS . 3.4 t30 -90.67 -59.6 2.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.48 ' HB2' ' ND2' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -151.62 129.74 11.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.54 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -72.44 74.6 1.03 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.399 . . . . 0.0 111.06 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.21 -4.77 3.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -148.35 114.75 0.7 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.468 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.4 m-85 -107.92 171.49 7.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.772 0.32 . . . . 0.0 111.203 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.639 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -165.11 154.48 12.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.46 160.38 34.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.52 151.96 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 110.29 6.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -83.36 97.96 9.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.98 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 51.94 -160.01 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.973 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 72.24 -3.3 23.64 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.768 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 8.9 t -172.19 -8.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 0.0 110.061 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.661 HG22 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -129.41 -16.14 3.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.835 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 58.45 29.84 18.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.773 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -178.71 -167.41 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.712 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.77 99.5 10.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 0.0 110.78 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.661 ' HB2' HG22 ' A' ' 169' ' ' THR . 3.8 mtp -138.81 147.05 42.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.977 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.29 148.48 52.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.118 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -107.11 145.77 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.684 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.639 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -121.33 157.05 16.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.714 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 15.4 p90 -165.85 175.71 8.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.682 0.277 . . . . 0.0 110.504 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.489 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 1.2 mp -139.89 -172.85 3.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.967 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -115.82 130.67 56.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.021 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 7.3 t -67.35 -27.84 67.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.426 ' HB2' ' HD3' ' A' ' 186' ' ' ARG . 4.2 mttm -83.47 -42.23 17.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.162 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 57.86 89.94 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.016 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.8 t -156.97 -26.31 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.988 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.497 ' H ' ' CZ ' ' A' ' 186' ' ' ARG . . . 84.61 5.74 86.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.607 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -131.54 12.65 4.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.852 0.358 . . . . 0.0 111.061 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.674 HH11 ' HB2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -115.18 -10.17 12.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 -179.272 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.674 ' HB2' HH11 ' A' ' 186' ' ' ARG . 1.5 mp -148.42 -45.95 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.354 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.0 t -51.17 -63.53 1.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.626 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 5.06 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.638 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.49 -53.14 3.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.225 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.07 -18.32 21.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.07 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.415 ' HA2' ' HE2' ' A' ' 195' ' ' PHE . . . -73.74 1.74 44.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.257 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.7 m -118.09 -5.57 10.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.697 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.06 -52.56 47.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.205 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.424 ' HD1' HD12 ' A' ' 199' ' ' LEU . 46.2 p90 -65.4 -24.24 67.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.764 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.775 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -66.81 -8.72 30.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.286 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.97 -12.95 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.114 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.96 3.71 22.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.691 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.775 HD11 ' HA ' ' A' ' 196' ' ' ALA . 4.9 mt -88.13 -48.89 7.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.054 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -61.43 -19.34 61.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.948 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 201' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.094 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.477 ' HA3' ' HG3' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.81 166.29 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.96 0.41 . . . . 0.0 111.143 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -165.41 136.22 3.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.8 111.03 1.02 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.025 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.6 6.93 45.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.163 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 73.9 p -96.32 18.54 13.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -67.34 150.23 49.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.04 11.71 33.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 14.5 t70 56.85 80.68 0.15 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.15 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.8 152.14 84.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.486 2.124 . . . . 0.0 112.231 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.1 t60 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.817 0.341 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.74 -36.49 16.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.707 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 1.7 m0 -66.27 -27.2 67.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.602 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.99 -22.37 66.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.136 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.22 -18.32 13.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.574 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.707 ' HB2' ' HA ' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -72.52 -36.07 68.24 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.46 179.289 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.74 -22.79 66.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.361 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.637 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 3.6 mt-10 -96.02 -14.32 23.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.648 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -58.33 -50.78 72.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.807 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 t -63.77 -39.86 86.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.367 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.637 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -58.22 -35.39 71.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.454 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.9 m -78.41 -90.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.556 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.574 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 179.28 32.69 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.525 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.771 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -170.26 99.66 0.27 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.92 0.391 . . . . 0.0 111.938 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.731 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.1 t -119.94 -151.53 0.48 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.104 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.536 ' HG ' HD21 ' A' ' 187' ' ' LEU . 0.2 OUTLIER 55.26 -155.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.837 0.351 . . . . 0.0 111.46 179.264 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.563 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 1.9 m-85 -164.32 -167.64 1.35 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.63 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.4 150.44 3.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.069 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' A' ' 121' ' ' LEU . 2.1 m -147.71 -178.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 111.871 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 3.7 mmtt -130.63 85.99 2.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.657 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 29.1 t80 -58.56 94.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 3.9 mt -67.1 -17.47 64.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.055 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 114' ' ' ARG . . . 117.59 -131.03 9.13 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.572 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.534 ' N ' HD22 ' A' ' 109' ' ' LEU . 7.1 p -156.61 141.6 17.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.686 0.279 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.795 HG12 ' HG ' ' A' ' 109' ' ' LEU . 3.9 m -131.84 161.85 40.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.205 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -83.32 131.25 35.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.371 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 174' ' ' CYS . 16.3 m -141.65 131.87 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.94 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -103.04 73.4 1.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.941 0.401 . . . . 0.0 111.105 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -164.78 -71.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.059 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.749 ' HB3' HG23 ' A' ' 163' ' ' ILE . 5.8 p 45.15 33.5 1.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -121.86 -40.61 2.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.484 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.52 158.28 15.43 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.901 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.619 ' HB2' ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -75.82 -17.89 59.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.866 0.365 . . . . 0.0 110.904 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -72.36 -24.68 61.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.7 t -59.94 -30.18 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.522 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 96.5 m -79.72 -28.25 40.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.766 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.71 -14.63 61.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.135 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -108.72 -44.32 4.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.22 -31.87 69.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.086 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.78 -38.55 91.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -40.87 84.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.1 t -63.25 -44.51 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.795 ' HG ' HG12 ' A' ' 91' ' ' VAL . 3.0 mt -61.31 -34.95 76.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.269 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 110' ' ' ARG . 11.1 ttt-85 -74.05 -31.48 62.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.738 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -86.63 -14.45 42.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.308 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.12 -6.78 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.311 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 36.68 71.56 0.13 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.652 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.683 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -82.72 68.12 9.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.931 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 58.43 82.87 0.23 Allowed Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.361 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 92.7 Cg_endo -80.52 135.05 10.26 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.623 2.215 . . . . 0.0 112.23 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -129.85 158.94 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.191 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.6 ttp-105 -119.68 98.5 6.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -131.69 169.78 21.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.615 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.34 104.2 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.693 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.432 HD12 HG22 ' A' ' 130' ' ' VAL . 15.9 tp -74.92 129.11 37.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.425 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.771 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 52.2 m170 -115.05 94.6 4.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.731 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 71.4 t -69.31 90.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.927 0.394 . . . . 0.0 110.506 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.574 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -90.17 140.79 29.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.195 179.179 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.49 1.95 4.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.774 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -130.64 32.45 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 119.66 122.98 3.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.536 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.42 HD22 HG12 ' A' ' 144' ' ' ILE . 2.6 mt -76.05 141.93 41.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.739 0.304 . . . . 0.0 111.041 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -145.47 122.56 11.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.69 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.712 HG11 HD13 ' A' ' 139' ' ' ILE . 2.2 t -102.16 118.51 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.337 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 137' ' ' GLY . 1.7 t -106.2 116.62 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.768 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.55 151.43 2.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.028 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.48 -6.83 54.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.364 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.72 -50.3 2.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.966 0.412 . . . . 0.0 110.695 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.0 m -82.95 -21.75 33.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.636 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp 51.69 28.19 4.64 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.211 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -87.41 -116.2 1.12 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.435 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tp -171.97 113.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.693 0.282 . . . . 0.0 110.543 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.712 HD13 HG11 ' A' ' 130' ' ' VAL . 2.9 pt -94.49 -41.49 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.497 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.506 ' HB ' HG23 ' A' ' 130' ' ' VAL . 39.8 t -122.85 103.78 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.177 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -113.19 48.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.798 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.502 ' HG2' HG13 ' A' ' 140' ' ' VAL . 46.4 mm-40 -98.11 -166.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.804 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.525 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 12.1 m -133.96 158.4 43.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.532 HD12 ' SG ' ' A' ' 198' ' ' CYS . 2.0 mt -65.05 -44.56 95.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.664 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.05 -20.02 56.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.56 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 12.9 tttp -69.82 -45.34 68.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.709 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 144' ' ' ILE . 5.9 m -74.83 150.98 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.747 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.8 -53.89 49.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.446 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 40.3 p90 -174.62 -174.21 0.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.1 t -110.95 157.92 19.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.726 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.619 ' HB2' ' HB2' ' A' ' 99' ' ' MET . . . -169.0 115.6 0.55 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.797 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 84.4 Cg_endo -79.96 -119.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 111.996 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.47 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 8.1 p-10 -160.28 178.81 9.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.742 0.306 . . . . 0.0 110.72 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -120.28 -2.06 10.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.109 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -64.18 -66.43 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.649 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.78 2.97 3.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.434 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 60.18 15.87 5.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.091 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -104.04 1.35 30.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.535 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.98 133.64 10.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.466 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.797 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 1.7 m-85 -126.92 163.65 23.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.3 . . . . 0.0 110.665 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -164.6 144.57 7.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.009 0.433 . . . . 0.0 111.255 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -126.44 139.59 53.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.481 178.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.749 HG23 ' HB3' ' A' ' 96' ' ' SER . 0.4 OUTLIER -101.04 139.99 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.242 -179.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 10.7 t -149.02 129.62 14.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.716 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.2 OUTLIER -92.87 122.62 35.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.711 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 50.38 -158.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.432 179.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.48 -29.51 8.29 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.457 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.4 t -164.63 6.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.57 . . . . 0.0 109.532 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.523 HG22 ' HG3' ' A' ' 173' ' ' MET . 24.7 m -136.88 -18.1 1.39 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.65 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.711 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 7.3 mtt180 57.72 32.48 21.94 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.407 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.41 150.11 12.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.711 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -75.02 79.11 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.405 178.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.523 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.2 OUTLIER -110.57 166.78 10.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.078 -179.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.597 ' HB2' HG21 ' A' ' 163' ' ' ILE . 53.2 t -123.6 127.59 48.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 10.8 m170 -90.75 124.99 35.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.559 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -108.2 156.28 15.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.612 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -170.66 152.68 3.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.714 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.5 165.9 14.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.67 ' HB1' HD12 ' A' ' 187' ' ' LEU . . . -87.52 126.24 34.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.971 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 4.5 t -61.99 -21.07 64.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.815 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.563 ' HE3' ' HB3' ' A' ' 83' ' ' PHE . 2.8 mmtp -84.39 -23.02 30.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.672 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 55.08 83.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.1 t -159.74 -64.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 108.44 41.51 1.48 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.385 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.35 -33.48 0.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.752 0.31 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.624 ' HB2' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -72.48 -11.51 60.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.706 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.67 HD12 ' HB1' ' A' ' 179' ' ' ALA . 5.2 mp -137.07 -36.89 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.114 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.2 t -57.94 -55.6 32.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.256 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.25 0.43 16.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.054 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -89.17 -54.81 3.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 123' ' ' VAL . 10.9 p -75.41 -30.48 22.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.68 -9.49 45.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.252 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 57.5 m -110.53 -10.28 14.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 110.707 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.61 -43.35 94.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.244 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 2.0 p90 -61.74 -32.58 72.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.725 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.421 ' O ' HD11 ' A' ' 199' ' ' LEU . . . -61.86 -33.66 74.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.21 5.62 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.641 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . 0.532 ' SG ' HD12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -93.62 -43.92 8.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.823 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.421 HD11 ' O ' ' A' ' 196' ' ' ALA . 0.0 OUTLIER -74.55 -3.02 28.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.866 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 201' ' ' ARG . 0.0 OUTLIER -59.64 -28.95 67.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.643 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . 0.44 ' N ' ' HG3' ' A' ' 200' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.702 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.42 174.81 10.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.0 110.978 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.9 p -168.81 148.36 4.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.942 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -64.36 156.93 27.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.811 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 20.5 mtm -126.63 -18.18 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -76.52 0.1 21.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.083 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -63.12 148.91 46.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.972 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -97.22 4.61 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.926 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 29.2 t0 56.98 77.3 0.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -70.03 151.61 96.05 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.763 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.487 2.125 . . . . 0.0 112.262 179.696 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.676 0.274 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -72.11 -59.17 2.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.478 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.63 -16.49 56.96 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.432 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -68.99 -32.76 72.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.96 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.2 -19.2 23.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.631 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.39 -32.6 26.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.562 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -71.78 -36.22 70.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.243 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.735 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -69.36 -19.45 63.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.265 178.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.69 -52.15 65.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.945 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.712 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.3 t -58.9 -37.99 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.54 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.735 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 11.5 mtp180 -56.89 -40.34 76.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.61 -91.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.477 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 179.34 38.51 0.0 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.343 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.415 ' HB ' ' ND1' ' A' ' 122' ' ' HIS . 1.7 t -173.2 95.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.991 0.424 . . . . 0.0 111.466 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.584 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 11.6 t -122.68 10.29 9.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.433 ' HB2' HG21 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -114.2 -162.84 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.218 -179.44 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.431 ' CG ' ' HE2' ' A' ' 181' ' ' LYS . 60.3 m-85 -150.07 -168.6 3.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.72 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 1.0 OUTLIER -47.53 151.52 0.79 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.87 0.367 . . . . 0.0 111.366 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 121' ' ' LEU . 2.2 m -145.42 -170.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.125 0.488 . . . . 0.0 111.679 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.93 73.09 1.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.311 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 83.6 t80 -55.45 98.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.143 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.429 HD21 HD11 ' A' ' 178' ' ' LEU . 4.3 mt -61.36 -50.03 74.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.492 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.499 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 153.04 -128.13 2.38 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.241 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.596 ' HB2' ' HE1' ' A' ' 173' ' ' MET . 1.6 p -161.79 126.15 3.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 0.0 110.866 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.624 HG12 ' HG ' ' A' ' 109' ' ' LEU . 14.3 m -110.18 165.8 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.036 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.77 116.02 28.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.142 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 174' ' ' CYS . 12.3 m -108.99 -165.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.865 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.95 65.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 1.2 mm-40 -166.32 -66.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.81 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.749 ' HA ' HG22 ' A' ' 163' ' ' ILE . 2.1 m 59.92 33.23 21.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 15.7 ptt180 -169.57 80.57 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.59 146.62 4.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.246 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.458 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -72.29 -29.89 64.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.775 0.322 . . . . 0.0 111.206 -179.421 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 99' ' ' MET . 0.5 OUTLIER -77.39 -21.19 53.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.926 -179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 t -60.73 -35.02 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 161' ' ' SER . 55.5 m -73.26 -49.98 24.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.951 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.483 ' HG3' ' HG2' ' A' ' 154' ' ' ARG . 2.9 tm-20 -56.33 -29.68 61.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.295 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.57 -51.72 11.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.94 -31.63 68.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.048 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.68 -43.33 93.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.845 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -62.86 -43.27 99.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.8 t -62.62 -39.81 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.047 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.624 ' HG ' HG12 ' A' ' 91' ' ' VAL . 8.1 mt -65.83 -36.15 82.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.827 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -76.13 -14.35 60.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.298 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -95.87 -16.53 21.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.786 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.84 -177.08 3.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.516 ' H ' ' HE ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -116.85 71.77 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.814 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.499 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 22.7 mmt180 -85.19 22.52 1.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.071 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 54.29 88.15 0.13 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.817 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 17.2 Cg_exo -66.57 137.29 45.78 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.82 2.347 . . . . 0.0 111.77 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.76 113.39 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.01 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -75.28 107.42 7.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.697 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -142.67 -167.3 11.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.834 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.404 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -118.4 122.87 43.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.658 0.266 . . . . 0.0 110.715 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.663 HD12 HD21 ' A' ' 128' ' ' LEU . 32.4 tp -89.5 133.76 34.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.777 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.415 ' ND1' ' HB ' ' A' ' 80' ' ' THR . 14.2 m170 -123.03 94.75 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.186 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 53.2 t -62.28 96.15 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.061 0.457 . . . . 0.0 110.338 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.445 ' O ' HD12 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -99.7 130.6 45.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.487 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -64.25 -0.24 4.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.961 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -126.17 29.01 5.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.855 0.36 . . . . 0.0 110.807 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 117.19 113.49 2.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.259 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.663 HD21 HD12 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -57.04 146.33 27.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 -179.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -138.41 120.35 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.667 HG13 HD11 ' A' ' 139' ' ' ILE . 2.2 t -110.29 108.28 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 111.271 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.99 117.69 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.058 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 76.9 m-20 -53.71 156.75 2.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.75 1.39 29.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -116.62 -31.33 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.523 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.25 -6.53 9.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.727 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 4.4 mmtm 50.91 25.59 2.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.11 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.11 167.27 30.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.357 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 141' ' ' ASP . 8.7 tp -99.48 116.32 31.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.61 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.667 HD11 HG13 ' A' ' 130' ' ' VAL . 1.2 pt -94.42 -50.23 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.374 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.596 ' HB ' HG21 ' A' ' 130' ' ' VAL . 48.7 t -110.37 95.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.916 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.437 ' HB2' HD21 ' A' ' 138' ' ' LEU . 31.3 t0 -105.09 67.49 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.656 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -114.8 -171.91 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.152 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.629 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 88.6 m -131.16 151.88 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.552 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.445 HD12 ' O ' ' A' ' 124' ' ' SER . 3.4 mt -61.28 -31.89 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -90.65 -6.62 54.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.516 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.629 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 5.7 tptm -90.08 -37.75 14.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.028 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.486 ' H ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -58.42 134.32 23.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.806 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.6 t -70.61 -21.15 62.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CB ' HD12 ' A' ' 163' ' ' ILE . 0.2 OUTLIER -170.05 151.96 4.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.125 0.488 . . . . 0.0 111.514 -179.285 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.32 137.22 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.916 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -168.55 119.81 0.66 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.66 0.267 . . . . 0.0 111.687 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.43 -94.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.342 2.028 . . . . 0.0 111.625 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.79 -163.13 1.28 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.459 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.483 ' HG2' ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -124.95 14.43 8.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.802 0.334 . . . . 0.0 111.266 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 9.1 t30 -164.81 -74.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 155' ' ' ASN . 5.8 t60 176.06 36.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.96 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.512 ' C ' ' HG2' ' A' ' 158' ' ' ARG . 14.1 mm-40 -85.97 28.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.296 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.512 ' HG2' ' C ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER 37.95 39.52 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.476 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.54 129.73 6.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.56 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.58 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 0.5 OUTLIER -127.13 155.42 43.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 110.682 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.556 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -160.84 159.98 30.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 111.273 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.97 143.1 33.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.323 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -104.23 148.7 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.948 0.404 . . . . 0.0 111.183 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.8 p -135.37 148.65 49.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.74 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.28 101.37 9.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.01 -152.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.075 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.73 -15.03 22.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.508 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.404 ' H ' ' H ' ' A' ' 169' ' ' THR . 15.1 t -171.25 -0.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 110.008 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.404 ' H ' ' H ' ' A' ' 168' ' ' THR . 3.3 m -127.63 -18.74 4.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.083 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 60.07 30.66 20.11 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.755 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -179.43 -168.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.882 179.53 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -98.78 112.39 24.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.025 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.755 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 25.3 mtp -139.6 149.84 44.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.567 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.499 ' HB2' HG23 ' A' ' 163' ' ' ILE . 20.4 t -117.69 147.37 42.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.154 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -114.78 137.2 52.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.445 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.556 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -128.84 156.55 21.17 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.994 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -166.93 155.85 10.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 111.076 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.429 HD11 HD21 ' A' ' 88' ' ' LEU . 1.4 mt -111.93 178.17 4.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.612 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.58 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -113.57 125.66 54.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 0.0 110.959 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.3 OUTLIER -71.13 -5.07 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.787 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.431 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 13.1 mmmt -91.01 -37.54 13.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 58.14 85.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.99 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.2 t -163.86 -39.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.83 17.94 79.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.494 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -132.57 1.11 3.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.868 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -108.8 -33.6 6.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp -114.99 -43.21 3.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.125 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.5 t -58.72 -66.39 0.5 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.451 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.6 -16.22 55.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.157 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.72 -56.28 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 123' ' ' VAL . 2.7 p -65.22 -19.72 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.018 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -77.47 -0.14 71.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.334 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 58.0 m -120.29 0.37 10.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.712 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -76.31 -40.94 50.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.104 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 7.1 p90 -67.72 -31.18 70.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.814 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.39 69.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.373 . . . . 0.0 110.969 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.429 ' HA ' ' HG2' ' A' ' 200' ' ' GLU . 4.9 t -99.29 0.48 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.889 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -92.6 -38.31 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.222 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.2 OUTLIER -87.91 16.98 5.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.73 0.3 . . . . 0.0 110.904 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.429 ' HG2' ' HA ' ' A' ' 197' ' ' VAL . 70.9 mm-40 -63.31 -35.26 79.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.376 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.466 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.604 -0.198 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -161.63 154.44 20.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.94 162.25 23.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.003 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -65.81 167.09 9.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 3.6 mtp -134.92 -22.45 1.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 60.3 p -81.2 14.91 2.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -62.55 153.9 30.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.934 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -91.33 -0.27 57.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 t0 56.36 78.59 0.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.197 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.674 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 25.5 m-85 -66.45 -51.61 41.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.134 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.674 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 31.8 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.213 1.942 . . . . 0.0 112.255 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.803 0.335 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -99.69 -46.83 5.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.869 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -67.23 -21.0 65.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.785 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.25 -18.78 63.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.511 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -106.62 -21.62 13.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.86 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.48 -33.34 48.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -65.26 -22.02 66.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.575 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.729 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.5 mt-10 -100.61 -13.68 18.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.802 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB1' ' HB2' ' A' ' 81' ' ' CYS . . . -59.5 -46.89 87.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.763 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 194' ' ' ALA . 7.1 t -61.49 -42.64 94.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.349 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.729 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 7.5 mtp180 -54.45 -34.8 62.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.143 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.457 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 1.4 m -78.12 -90.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.251 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 176.28 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.683 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 122' ' ' HIS . 0.7 OUTLIER -173.7 98.0 0.11 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.866 0.365 . . . . 0.0 111.777 -179.599 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.575 ' HG ' ' HB1' ' A' ' 190' ' ' ALA . 10.3 t -139.26 63.48 1.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.393 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.656 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -159.44 -155.15 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.802 0.334 . . . . 0.0 111.297 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -154.62 -172.82 4.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.596 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 t -51.1 152.34 2.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.801 0.334 . . . . 0.0 111.168 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 121' ' ' LEU . 1.3 m -137.74 -167.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.286 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -148.18 65.3 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.823 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 55.0 t80 -62.6 117.02 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.439 ' O ' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -116.45 62.6 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.408 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 62.77 -168.7 17.73 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.396 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -138.47 146.37 41.97 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.593 HG11 ' HG ' ' A' ' 109' ' ' LEU . 4.6 m -115.24 163.86 12.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.369 . . . . 0.0 111.188 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.63 145.88 29.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.027 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -139.02 178.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.648 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -145.77 65.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 0.0 111.16 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -169.08 -72.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 p 67.48 0.76 2.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.2 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.46 ' HE ' HH22 ' A' ' 165' ' ' ARG . 0.0 OUTLIER -154.8 114.48 3.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.789 179.308 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 140.07 121.21 1.81 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.159 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.487 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 60.48 -88.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.617 0.246 . . . . 0.0 110.551 -178.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.725 ' HG2' ' HB3' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -154.15 -28.25 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.034 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.538 ' HB ' HD12 ' A' ' 163' ' ' ILE . 1.1 t 49.38 23.46 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.371 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 62.6 m -118.64 -24.22 6.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.013 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -9.31 58.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.018 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -104.52 -53.76 2.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.24 -51.12 71.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.222 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.403 HD23 ' CG ' ' A' ' 153' ' ' ASP . 33.1 tp -57.77 -32.09 67.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -67.36 -43.01 82.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.4 t -59.21 -49.92 81.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.593 ' HG ' HG11 ' A' ' 91' ' ' VAL . 1.3 mt -65.85 -25.03 67.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.591 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -77.64 -25.59 49.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.626 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 23.1 mt-30 -91.36 -19.88 22.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.201 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 m -113.6 179.36 3.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 0.0 111.253 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.66 72.38 0.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.675 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.534 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 3.8 mmt180 -82.66 40.44 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.232 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 59.0 77.9 0.37 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.567 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 87.9 Cg_endo -81.09 121.8 4.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.667 2.245 . . . . 0.0 112.256 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.02 140.74 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 118' ' ' ARG . 12.3 ttp180 -99.39 103.6 15.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.622 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -135.58 172.68 22.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.8 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -92.44 127.26 37.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.795 0.331 . . . . 0.0 111.0 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.51 HD11 HD23 ' A' ' 128' ' ' LEU . 39.6 tp -97.06 129.62 44.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.56 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.454 ' CE1' HD11 ' A' ' 120' ' ' LEU . 89.6 m-70 -116.71 93.02 4.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.852 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 82' ' ' SER . 41.9 t -58.35 103.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.982 0.42 . . . . 0.0 110.849 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -100.76 134.65 43.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.192 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.61 8.57 4.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.015 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 124' ' ' SER . 8.2 t0 -137.35 28.19 2.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 110.615 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.733 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 124.63 113.22 1.99 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.315 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.603 HD22 HG21 ' A' ' 123' ' ' VAL . 1.3 mt -58.0 144.25 40.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 111.233 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.452 ' HE ' HD11 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -136.5 124.62 23.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.817 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.726 HG11 HD11 ' A' ' 139' ' ' ILE . 2.9 t -110.93 112.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.311 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.9 t -104.9 114.22 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.795 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.44 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 1.4 m-20 -48.86 147.57 2.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.895 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.622 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -103.23 9.04 38.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.616 -179.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.63 -1.19 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.403 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.2 m -151.52 -11.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.546 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 22.9 mmtp 54.77 25.74 6.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.895 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.65 -166.84 35.83 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.549 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.452 HD11 ' HE ' ' A' ' 129' ' ' ARG . 8.6 tp -119.18 116.92 27.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.913 0.387 . . . . 0.0 110.634 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.726 HD11 HG11 ' A' ' 130' ' ' VAL . 6.3 mt -98.02 -57.29 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.263 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.718 ' HB ' HG21 ' A' ' 130' ' ' VAL . 61.3 t -124.51 116.63 48.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.45 36.48 4.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.583 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.443 ' HG2' HG13 ' A' ' 140' ' ' VAL . 73.1 mm-40 -81.75 -165.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.111 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.733 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 19.3 m -129.42 153.94 47.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.428 ' HB ' ' SG ' ' A' ' 198' ' ' CYS . 3.5 mt -65.89 -44.9 92.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.0 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.669 ' HG3' HG21 ' A' ' 143' ' ' THR . 1.5 pt-20 -78.64 -0.21 29.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.506 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -95.73 -44.84 7.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.667 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -62.29 148.22 10.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.93 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.8 t -83.11 -37.03 24.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.201 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -137.95 -172.68 3.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.908 0.385 . . . . 0.0 111.395 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.8 t -168.35 25.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.456 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.725 ' HB3' ' HG2' ' A' ' 100' ' ' GLN . . . -51.12 138.94 25.23 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.159 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.927 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 72.2 Cg_endo -95.56 12.86 1.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.35 2.7 . . . . 0.0 112.385 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER 61.94 65.29 0.92 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.174 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 61.03 8.21 1.84 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.764 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.64 30.52 4.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.948 0.404 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.25 -23.12 4.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.747 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.2 -2.29 58.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.724 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 56.76 24.2 8.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.898 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.633 ' HA3' HD21 ' A' ' 178' ' ' LEU . . . -133.59 128.89 5.16 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.41 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 188' ' ' SER . 0.1 OUTLIER -104.46 168.43 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.3 . . . . 0.0 110.805 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.45 150.94 14.65 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.005 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.502 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -132.17 145.61 51.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.636 179.015 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.538 HD12 ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -107.44 144.5 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.188 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.9 130.51 9.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 3.3 mtt-85 -74.91 -144.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.507 ' H ' ' HB3' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.17 -166.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.909 0.385 . . . . 0.0 111.136 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.61 -11.45 68.39 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.397 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.3 t -166.55 -8.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 109.926 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.458 HG22 ' HG3' ' A' ' 171' ' ' ARG . 18.5 m -129.7 -9.79 4.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.645 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 61.19 17.4 8.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.131 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.458 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.9 OUTLIER -176.44 174.31 1.95 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.94 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -77.53 109.58 11.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.995 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.08 159.64 41.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.638 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.41 ' HB2' HG22 ' A' ' 163' ' ' ILE . 31.1 t -129.39 139.36 51.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.859 0.361 . . . . 0.0 111.236 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.502 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -103.53 143.58 32.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.665 179.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -126.55 149.86 17.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.859 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -166.5 139.41 3.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.755 0.312 . . . . 0.0 110.715 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.633 HD21 ' HA3' ' A' ' 159' ' ' GLY . 1.5 mt -100.11 -177.81 3.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.943 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -110.48 129.99 55.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.052 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.5 1.28 17.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.172 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -99.85 -23.69 14.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.756 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 55.97 79.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.155 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.5 t -165.9 -59.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.941 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.78 32.2 6.03 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.553 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -141.81 -32.39 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.731 0.3 . . . . 0.0 110.953 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.401 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 4.9 mmm180 -73.57 -6.06 44.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.836 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.489 HD23 HD23 ' A' ' 121' ' ' LEU . 5.6 mp -139.24 -50.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.444 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 3.6 t -62.18 -60.87 2.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.336 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 0.1 OUTLIER -52.64 -37.2 58.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.575 ' HB1' ' HG ' ' A' ' 81' ' ' CYS . . . -65.82 -41.78 91.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 187' ' ' LEU . 24.7 t -62.25 -32.3 54.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.76 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -59.3 -20.62 51.29 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.529 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 2.6 m -95.18 -15.42 23.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.729 0.3 . . . . 0.0 111.097 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.63 ' HA ' HG12 ' A' ' 76' ' ' VAL . . . -63.07 -30.87 71.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.18 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.467 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 1.3 m-85 -72.86 -40.11 65.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.804 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -54.98 -21.05 10.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.586 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.5 t -105.56 -12.88 9.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . 0.429 ' HB3' ' OG ' ' B' ' 6' ' ' SER . 0.0 OUTLIER -79.36 -27.06 41.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.02 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -101.42 35.79 2.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.839 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.08 -39.99 76.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.653 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 33.6 ttp85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.79 179.426 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.927 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -139.99 -91.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.634 0.254 . . . . 0.0 110.835 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.455 ' H ' ' HB3' ' B' ' 2' ' ' PHE . 0.0 OUTLIER 63.84 158.25 0.08 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.449 179.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.427 ' HB3' ' CD1' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -87.82 -173.15 4.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.207 -179.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 68.9 mtp -125.98 -30.31 2.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.823 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 198' ' ' CYS . 89.6 p -88.09 36.91 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.452 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.572 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 3.1 p90 -63.94 -3.34 2.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.849 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 55.69 8.89 0.36 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.665 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . 0.572 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 21.5 t70 48.9 76.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.401 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -58.92 135.65 87.32 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.472 2.115 . . . . 0.0 112.24 179.924 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.608 0.242 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 76.25 -56.8 0.57 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.542 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -68.29 -11.0 58.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.701 0.286 . . . . 0.0 110.855 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -77.87 -4.69 47.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.043 0.449 . . . . 0.0 110.094 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.93 -31.55 4.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.108 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -83.51 -19.95 34.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.986 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.52 -29.99 71.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.617 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -100.57 -17.26 17.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.978 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.07 -52.66 64.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.537 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.732 HG11 ' HA ' ' A' ' 194' ' ' ALA . 0.9 OUTLIER -66.36 -35.32 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.729 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.617 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 3.1 mtp180 -55.34 -24.03 27.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.109 0.48 . . . . 0.0 109.808 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.488 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -98.03 -97.11 0.21 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.659 179.032 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.503 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -176.47 48.36 0.01 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.565 0.221 . . . . 0.0 111.457 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.627 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 1.4 t -176.04 86.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.919 0.39 . . . . 0.0 111.112 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.66 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 6.7 t -121.22 4.16 10.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.97 -156.97 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.161 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -154.84 -171.63 3.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.558 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 0.9 OUTLIER -53.01 150.71 5.33 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.048 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.81 -168.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.528 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -143.24 81.28 1.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.925 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -62.28 93.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.668 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.427 HD23 HD12 ' A' ' 178' ' ' LEU . 1.1 mp -58.21 -41.01 83.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.16 -130.44 3.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.357 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -164.28 141.21 6.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 111.046 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.89 172.7 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.473 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 4.1 pt-20 -95.15 142.43 27.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.889 0.376 . . . . 0.0 111.053 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.71 163.65 36.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -121.24 65.34 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.058 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -175.77 -70.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.036 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.439 ' HB3' HG21 ' A' ' 163' ' ' ILE . 0.7 OUTLIER 58.72 25.89 13.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.863 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.88 61.8 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.64 160.78 24.37 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.722 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.495 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -77.18 -30.8 55.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.782 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.548 ' H ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER -69.01 -23.04 64.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.028 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.5 t -58.56 -33.37 48.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 110.537 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.847 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 58.5 m -80.54 -37.01 32.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.615 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.3 -34.7 78.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.93 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -76.96 -52.84 8.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.908 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.92 66.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.962 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.575 ' HB2' ' HG ' ' A' ' 161' ' ' SER . 3.0 tp -66.08 -36.68 83.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.951 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.8 tptp -70.22 -46.21 64.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.481 ' HA ' ' NE2' ' A' ' 111' ' ' GLN . 11.0 t -60.75 -38.06 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.503 HD21 ' HG3' ' A' ' 114' ' ' ARG . 18.7 mt -61.55 -31.97 72.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.075 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 110' ' ' ARG . 1.2 tpp85 -78.08 -32.88 50.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.481 ' NE2' ' HA ' ' A' ' 108' ' ' VAL . 4.3 mt-30 -81.89 -15.36 54.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.793 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.415 ' HG ' HH12 ' A' ' 113' ' ' ARG . 2.7 m -105.13 179.42 4.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.82 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.557 ' H ' HH11 ' A' ' 113' ' ' ARG . 0.0 OUTLIER -115.88 65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.503 ' HG3' HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.26 20.32 3.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 55.34 95.04 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.993 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.5 127.27 6.43 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.79 2.326 . . . . 0.0 112.087 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.33 143.79 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.225 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -102.69 97.83 7.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.65 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -131.64 163.06 23.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.911 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.472 ' HB3' ' HE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -87.18 124.22 33.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.735 0.302 . . . . 0.0 110.977 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.77 HD11 HD23 ' A' ' 128' ' ' LEU . 29.4 tp -96.85 135.34 38.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.763 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.627 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 1.9 m-70 -125.43 105.39 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.094 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.66 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 11.4 t -70.46 104.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 0.0 110.838 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -104.81 143.37 33.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.408 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.31 28.96 1.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.848 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 124' ' ' SER . 3.0 t70 -153.51 21.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.594 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 124.73 131.72 3.71 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.523 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.77 HD23 HD11 ' A' ' 121' ' ' LEU . 1.7 mp -67.16 168.77 9.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 14.5 ttm180 -168.75 115.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.903 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.72 HG22 ' HB ' ' A' ' 140' ' ' VAL . 3.9 t -107.97 109.21 27.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.07 0.462 . . . . 0.0 111.421 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.57 115.38 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.941 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -50.9 144.58 8.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.24 17.19 21.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.988 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -127.67 -8.69 5.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.606 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.09 -8.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.843 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp 58.1 25.78 12.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.551 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.18 -138.5 0.25 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.444 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.738 HD23 ' HB2' ' A' ' 141' ' ' ASP . 15.7 tp -159.09 116.06 2.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.663 0.268 . . . . 0.0 110.438 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.616 HG13 ' HB ' ' A' ' 130' ' ' VAL . 3.6 pt -106.73 -28.48 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.562 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.72 ' HB ' HG22 ' A' ' 130' ' ' VAL . 43.1 t -137.35 116.65 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.167 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.738 ' HB2' HD23 ' A' ' 138' ' ' LEU . 17.8 t0 -130.04 29.91 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.345 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -76.55 -167.51 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.206 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.562 HG23 ' HG3' ' A' ' 145' ' ' GLU . 1.8 m -123.66 171.0 9.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.658 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.3 mt -88.03 -28.16 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.701 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.562 ' HG3' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -89.77 -8.98 50.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.86 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -92.96 -39.63 11.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.77 126.1 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.013 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.39 -49.9 73.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.414 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.501 ' HB2' HG13 ' A' ' 163' ' ' ILE . 12.3 m-85 -130.44 -171.94 2.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.095 0.474 . . . . 0.0 111.526 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.3 t -162.35 35.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.31 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 102' ' ' CYS . . . -68.41 143.58 95.64 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.498 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.883 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 71.6 Cg_endo -87.68 -89.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.722 2.281 . . . . 0.0 112.111 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -167.72 -163.93 0.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 110.755 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.96 28.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.015 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.39 45.89 19.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -164.89 -27.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.912 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -75.58 -18.04 59.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 56.53 18.94 3.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.071 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.687 ' HA3' HD21 ' A' ' 178' ' ' LEU . . . -127.9 129.33 6.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.671 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.91 168.87 8.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.604 0.24 . . . . 0.0 110.448 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.847 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 24.4 m -158.76 155.65 28.35 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.012 0.434 . . . . 0.0 111.375 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -132.29 160.05 37.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.077 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.501 HG13 ' HB2' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -117.14 153.63 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.401 . . . . 0.0 111.638 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 6.4 t -159.49 118.12 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.447 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.644 HH21 ' HB3' ' B' ' 10' ' ' PHE . 15.2 ptt85 -74.01 -152.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.29 -178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -179.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.199 0.523 . . . . 0.0 111.69 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.93 -8.37 29.5 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.402 ' H ' ' H ' ' A' ' 169' ' ' THR . 15.2 t -170.08 -5.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.244 -0.478 . . . . 0.0 109.934 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.619 HG22 ' HG3' ' A' ' 171' ' ' ARG . 22.4 m -133.43 -12.6 2.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.054 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 170' ' ' ARG . 43.3 mtt180 62.29 22.58 13.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.799 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.619 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -175.71 -179.07 1.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.56 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.9 OUTLIER -81.49 124.0 29.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.9 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.436 ' SD ' HG23 ' A' ' 169' ' ' THR . 0.2 OUTLIER -142.5 126.33 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 34.8 t -104.11 136.32 43.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.485 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 1.3 m80 -105.82 145.69 30.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.359 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.05 154.73 21.49 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.185 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -161.66 144.67 12.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.715 0.293 . . . . 0.0 110.739 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.687 HD21 ' HA3' ' A' ' 159' ' ' GLY . 1.1 mt -105.29 162.52 13.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.131 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.502 ' HB3' HD11 ' A' ' 187' ' ' LEU . . . -89.13 122.5 32.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 84' ' ' SER . 0.5 OUTLIER -71.83 -11.23 60.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.935 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -89.34 -17.21 29.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.715 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 53.84 80.63 0.11 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.02 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.42 -43.08 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.091 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.94 31.61 55.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.306 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -146.08 -34.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.701 0.286 . . . . 0.0 110.793 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 186' ' ' ARG . 0.7 OUTLIER -59.51 -28.25 66.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.793 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 179' ' ' ALA . 4.8 mp -117.04 -39.13 3.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.879 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.13 -63.06 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.32 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -16.05 61.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.373 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.0 -53.61 8.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.025 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.46 -18.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.08 -1.54 59.99 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.334 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.3 m -120.54 -4.7 9.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.32 . . . . 0.0 110.781 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.732 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -74.82 -45.61 42.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.248 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.618 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 38.9 p90 -68.3 -36.18 78.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.072 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -56.65 -31.69 64.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.022 0.439 . . . . 0.0 110.69 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.46 -19.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.812 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . 0.618 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -73.37 -6.02 43.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.548 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.6 mt -88.74 14.02 11.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.005 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -92.11 -34.96 14.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.196 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.271 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.883 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -145.7 -98.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.573 0.225 . . . . 0.0 111.17 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.42 ' H ' ' HB3' ' B' ' 2' ' ' PHE . 7.9 t 62.96 157.14 0.06 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.137 0.494 . . . . 0.0 111.246 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -92.51 176.53 6.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.829 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mtp -123.32 -7.31 8.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.7 p -83.62 6.87 19.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -62.56 145.57 54.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -106.85 10.11 30.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 t70 54.42 70.54 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.983 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.644 ' HB3' HH21 ' A' ' 165' ' ' ARG . 44.8 m-85 -61.3 134.92 93.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.967 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.598 2.199 . . . . 0.0 112.445 -179.725 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.0 t60 . . . . . 0 N--CA 1.461 0.085 0 CA-C-O 120.862 0.363 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.498 ' H ' HE21 ' A' ' 68' ' ' GLN . 0.1 OUTLIER -63.9 -48.28 77.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -25.18 68.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.929 0.395 . . . . 0.0 110.757 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -70.12 -7.78 44.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -125.96 -8.89 6.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.969 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -91.13 -25.53 19.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.966 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.63 -34.3 77.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.708 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.4 mt-10 -92.38 -9.38 41.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.558 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -60.16 -50.59 73.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.667 HG11 HG23 ' A' ' 197' ' ' VAL . 5.2 t -56.51 -40.61 69.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.955 0.407 . . . . 0.0 110.432 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.708 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 5.3 mtm180 -65.03 -32.03 73.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.332 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.2 m -81.12 3.46 23.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.61 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 65.01 41.92 4.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.42 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -176.17 85.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 13.1 t -116.35 21.4 13.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.371 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.65 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -117.06 -160.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.33 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -158.66 -169.5 2.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.537 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 2.3 t -48.94 142.09 6.93 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.893 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.3 m -138.0 -171.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.062 0.458 . . . . 0.0 111.761 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -141.65 60.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.416 179.193 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.435 ' O ' HG23 ' A' ' 117' ' ' VAL . 71.4 t80 -53.26 114.84 1.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.03 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -82.66 -56.08 4.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.022 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.0 -124.64 1.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.592 ' HB2' ' HE1' ' A' ' 173' ' ' MET . 1.2 p -164.76 142.19 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.936 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.51 163.41 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.998 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -91.56 130.14 37.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.7 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 172' ' ' TRP . 0.9 OUTLIER -131.54 128.98 61.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.195 -179.402 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -91.26 68.7 5.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 98' ' ' GLY . 0.7 OUTLIER -162.18 -65.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.137 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.652 ' HA ' HG21 ' A' ' 101' ' ' VAL . 50.4 p 52.78 22.66 2.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.991 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 96' ' ' SER . 10.1 mtp180 -149.36 -56.19 0.19 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.912 0.386 . . . . 0.0 111.601 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.48 ' H ' ' HG2' ' A' ' 95' ' ' GLU . . . -61.6 135.96 47.17 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.692 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.639 ' HE1' ' HB2' ' A' ' 103' ' ' GLU . 3.1 tpt 53.32 23.28 3.17 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.527 0.331 . . . . 0.0 111.789 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.429 ' HB3' ' CB ' ' A' ' 151' ' ' ALA . 11.3 mp0 61.03 5.15 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.408 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.652 HG21 ' HA ' ' A' ' 96' ' ' SER . 2.3 t 53.43 30.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.856 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.6 p -118.18 -47.43 2.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.219 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.639 ' HB2' ' HE1' ' A' ' 99' ' ' MET . 0.1 OUTLIER -69.18 -3.38 13.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.586 -178.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -118.22 -57.57 2.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.58 -53.21 57.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.214 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.501 HD12 ' HG ' ' A' ' 178' ' ' LEU . 4.1 tp -50.34 -34.49 24.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -67.15 -38.52 85.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.803 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 36.7 t -63.57 -46.8 93.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.318 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.42 HD21 ' HG3' ' A' ' 114' ' ' ARG . 3.5 mp -72.46 -18.79 61.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.109 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -94.84 -11.13 29.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.541 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -71.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.581 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.8 t -175.89 88.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.381 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -165.17 -62.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.42 ' HG3' HD21 ' A' ' 109' ' ' LEU . 3.8 mmp_? -101.24 110.35 22.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.381 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -62.44 134.06 94.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.119 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HB2' ' HE2' ' A' ' 86' ' ' LYS . 73.3 Cg_endo -78.28 161.1 29.13 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.654 2.236 . . . . 0.0 112.603 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -130.36 153.75 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.79 179.265 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.48 97.57 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -141.46 166.9 26.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.5 113.92 25.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.331 . . . . 0.0 110.878 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.522 HD22 ' HG ' ' A' ' 82' ' ' SER . 25.4 tp -83.8 138.48 33.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.758 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -123.17 84.18 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.65 ' H ' ' HB2' ' A' ' 82' ' ' SER . 48.4 t -58.75 102.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.852 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.508 ' O ' HD12 ' A' ' 144' ' ' ILE . 3.7 p -105.18 144.33 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.548 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.7 19.8 1.93 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.888 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.454 ' H ' ' HG ' ' A' ' 124' ' ' SER . 0.8 OUTLIER -139.0 22.64 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.665 179.393 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.18 118.5 2.59 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.395 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 mt -54.1 144.7 18.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 111.171 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 16.4 ttm180 -147.58 112.21 5.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 140' ' ' VAL . 1.9 t -100.39 133.32 43.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.093 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.451 HG13 ' CD ' ' A' ' 136' ' ' LYS . 1.5 t -121.97 109.05 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -53.03 157.49 1.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.218 -179.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -3.64 53.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -116.19 -54.69 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.386 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.6 m -80.74 -31.84 35.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.459 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.451 ' CD ' HG13 ' A' ' 131' ' ' VAL . 4.2 mmtm 52.39 29.95 7.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.9 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.19 -108.7 1.51 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.45 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 141' ' ' ASP . 3.6 tp -160.59 113.76 2.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.678 0.275 . . . . 0.0 110.727 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.55 -49.07 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.36 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.482 ' HB ' HG23 ' A' ' 130' ' ' VAL . 93.4 t -122.45 102.52 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.827 ' HB3' HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -108.42 25.95 11.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.408 178.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -76.23 -156.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.166 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.858 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 59.9 m -135.46 161.75 34.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.966 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.624 ' H ' HG21 ' A' ' 143' ' ' THR . 2.5 mt -77.24 -33.42 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.718 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -86.09 -24.3 26.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.389 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.858 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -60.03 -41.04 91.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.772 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.6 m -73.16 144.92 12.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.8 t -49.56 -55.28 14.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.763 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' B' ' 3' ' ' SER . 30.8 p90 -168.97 126.93 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.72 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 116.67 13.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . . . -131.11 104.07 15.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.036 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.523 ' HB3' ' HD1' ' A' ' 160' ' ' PHE . 32.7 Cg_exo -62.3 -88.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.674 2.249 . . . . 0.0 112.248 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.46 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 8.6 p-10 -166.48 177.95 6.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.66 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.413 ' HG3' ' H2 ' ' B' ' 1' ' ' GLY . 7.4 mtp180 -145.6 33.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.072 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.0 -87.24 0.63 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.9 t60 178.36 3.94 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -68.52 -8.31 40.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.334 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.434 ' HB2' ' NH1' ' A' ' 158' ' ' ARG . 0.9 OUTLIER 56.47 23.23 7.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.982 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -106.31 147.46 16.24 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.351 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.523 ' HD1' ' HB3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -124.48 169.16 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 0.0 110.845 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.493 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 3.3 m -168.58 151.0 5.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.082 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.65 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -134.95 148.04 49.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.531 178.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.495 HG12 ' HB ' ' A' ' 101' ' ' VAL . 0.2 OUTLIER -103.89 151.38 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.209 -179.056 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.91 106.95 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.85 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 15.7 ptm180 -68.29 -156.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.196 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.08 -162.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.462 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.93 -10.16 53.7 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.45 -19.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.949 0.404 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -130.25 -2.41 4.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.721 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.5 9.64 3.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -172.44 -176.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.658 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -78.52 122.08 25.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 110.942 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.592 ' HE1' ' HB2' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -147.74 110.06 4.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.738 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 28.2 p -98.11 159.89 14.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.231 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.65 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 4.6 m-70 -122.96 142.2 51.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.228 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.493 ' HA2' ' OG ' ' A' ' 161' ' ' SER . . . -111.8 150.12 18.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.856 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -170.29 133.35 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.872 0.368 . . . . 0.0 110.756 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.501 ' HG ' HD12 ' A' ' 106' ' ' LEU . 4.7 mp -110.16 171.07 7.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.244 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.44 128.47 41.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.5 OUTLIER -78.37 -0.34 28.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.576 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.98 -21.08 18.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 55.51 83.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.97 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.2 t -168.99 -42.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.19 42.63 42.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.441 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.02 -34.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.743 0.306 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.497 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.3 OUTLIER -75.84 -16.65 60.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.504 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.5 mp -126.93 -44.17 1.65 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.019 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 t -59.98 -69.19 0.23 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -21.0 58.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.02 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.9 -52.61 19.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.5 t -61.16 -31.46 50.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.27 -17.43 46.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.283 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 96.1 m -104.12 -11.37 17.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.719 0.295 . . . . 0.0 110.845 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.99 -33.63 67.32 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 0.0 OUTLIER -77.51 -34.99 53.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.279 178.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.588 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -55.87 -26.03 45.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.874 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.667 HG23 HG11 ' A' ' 76' ' ' VAL . 21.8 t -100.49 -19.46 5.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.686 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -72.56 -12.08 60.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.604 178.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.588 HD12 ' HA ' ' A' ' 196' ' ' ALA . 1.5 mt -81.2 10.64 5.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.879 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -56.36 -20.94 21.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.413 ' H2 ' ' HG3' ' A' ' 154' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.377 -0.289 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.466 ' HB2' ' H ' ' B' ' 3' ' ' SER . 1.2 p90 -88.12 -148.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.495 0.188 . . . . 0.0 110.547 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 1.4 p -163.91 162.99 23.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.855 0.359 . . . . 0.0 111.192 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' B' ' 7' ' ' PHE . 41.5 p-10 -76.44 175.4 9.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.063 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 36.6 mtp -128.33 -24.14 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.2 t -90.0 23.64 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.452 ' HB3' ' ND2' ' B' ' 4' ' ' ASN . 43.5 p90 -65.08 149.87 49.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -83.82 0.48 47.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 t0 57.41 94.67 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.026 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.599 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 11.1 m-85 -90.4 -51.32 0.33 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.504 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 35.8 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.113 1.875 . . . . 0.0 112.272 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -108.55 -35.51 6.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.295 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -63.57 -23.07 67.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.048 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -70.82 -25.09 62.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.934 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.63 -23.83 16.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.959 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.47 -26.08 32.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.81 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -29.52 70.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.703 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.65 -17.35 17.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.791 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.63 -51.57 59.46 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.295 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.29 -43.97 87.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.727 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -55.17 -39.06 69.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.655 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -91.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.638 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 179.84 36.4 0.0 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.24 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.442 ' HB ' ' HD1' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -173.77 101.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 111.556 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.5 t -134.54 55.46 1.89 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.844 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.59 -163.05 1.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.822 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CG ' ' HE3' ' A' ' 181' ' ' LYS . 10.5 m-85 -156.96 -171.33 3.61 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.819 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -49.56 145.96 4.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.919 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.0 m -143.89 173.53 5.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.971 0.415 . . . . 0.0 111.83 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -122.38 61.19 0.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.327 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 177' ' ' PHE . 1.0 OUTLIER -54.06 96.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.94 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -62.86 -31.36 72.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.78 -131.76 5.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.519 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -158.9 130.27 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.64 136.21 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.977 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 112.56 5.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.069 0.461 . . . . 0.0 110.659 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' ' 174' ' ' CYS . 17.0 m -103.58 173.64 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -122.2 64.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -149.53 -90.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 p 63.3 9.62 4.15 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.454 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.423 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -166.52 47.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.988 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -125.21 -129.68 3.39 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.27 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.499 ' HE3' ' CD ' ' A' ' 100' ' ' GLN . 9.4 ttt -75.38 -73.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.578 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.566 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . 4.9 mt-30 -146.57 -24.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.824 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.0 t 73.18 -30.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.291 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.566 ' SG ' ' HB3' ' A' ' 100' ' ' GLN . 3.7 p -63.17 -27.61 69.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.7 ' HG3' ' HB3' ' A' ' 154' ' ' ARG . 2.0 tt0 -59.53 -18.26 38.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.79 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -120.02 -44.63 2.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.727 0.299 . . . . 0.0 111.457 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.31 75.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.597 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 tp -54.23 -33.73 59.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.181 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 11.5 tptm -74.93 -45.54 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.229 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.1 t -56.54 -30.1 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.396 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.739 HD22 ' HG3' ' A' ' 114' ' ' ARG . 1.5 mt -87.66 -23.54 24.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.008 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.568 ' HG2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -82.46 -9.95 59.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.473 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -75.21 -62.85 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.723 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 2.0 t -177.33 -168.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.544 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 112' ' ' SER . 1.3 mpt_? 70.61 -69.19 0.18 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.297 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.739 ' HG3' HD22 ' A' ' 109' ' ' LEU . 8.3 mmt180 -84.28 91.8 7.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 115' ' ' ARG . 6.5 ptp180 -69.08 141.7 92.15 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 72.3 Cg_endo -77.73 133.16 12.51 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.589 2.193 . . . . 0.0 112.69 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.0 143.59 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.969 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -101.72 108.19 19.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -150.68 178.98 27.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.44 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.67 118.01 35.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.74 0.305 . . . . 0.0 111.033 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.528 HD11 HG23 ' A' ' 130' ' ' VAL . 24.4 tp -92.89 138.46 31.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.642 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.5 ' H ' HD12 ' A' ' 121' ' ' LEU . 11.3 m170 -123.62 103.67 8.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.02 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -71.66 102.45 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.4 . . . . 0.0 110.513 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.16 117.95 35.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.72 -16.17 3.69 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.713 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -111.59 34.63 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.687 0.279 . . . . 0.0 110.975 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.739 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 114.75 111.31 2.87 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.412 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.17 162.55 5.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.961 0.41 . . . . 0.0 111.299 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.56 119.85 5.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.513 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.528 HG23 HD11 ' A' ' 121' ' ' LEU . 1.9 t -107.15 127.94 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.605 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.52 156.29 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.506 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.99 148.26 23.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.766 0.317 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.456 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.7 OUTLIER -99.09 19.79 14.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -138.94 -9.32 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.965 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.594 HG21 ' H ' ' A' ' 137' ' ' GLY . 13.6 t -154.16 -10.39 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.876 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 13.8 mmtm 60.16 27.26 16.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.594 ' H ' HG21 ' A' ' 135' ' ' THR . . . -73.62 -159.68 5.92 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.408 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 141' ' ' ASP . 11.5 tp -121.97 118.73 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.689 0.28 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 8.7 mt -96.84 -55.26 6.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.012 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.502 ' HB ' HG22 ' A' ' 130' ' ' VAL . 95.6 t -139.2 118.07 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.596 ' HB2' HD23 ' A' ' 138' ' ' LEU . 4.4 t0 -122.06 74.06 1.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -119.47 -165.01 1.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.187 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.739 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 1.6 m -115.52 177.31 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.908 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.684 HD12 ' HB1' ' A' ' 194' ' ' ALA . 8.1 mt -96.18 -42.3 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.835 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -81.3 -10.21 59.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.664 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.764 ' HE2' HG21 ' A' ' 168' ' ' THR . 1.7 ttpm? -77.03 -43.35 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.811 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.492 HG11 ' CD2' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -70.29 154.2 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.948 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.62 -68.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.921 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.662 ' HB3' ' HB2' ' B' ' 3' ' ' SER . 0.0 OUTLIER -155.19 129.15 8.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.999 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -85.58 104.76 15.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.826 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.467 ' HB1' ' HG2' ' A' ' 100' ' ' GLN . . . -118.2 133.18 23.48 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.261 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.791 ' HD2' ' HA3' ' B' ' 1' ' ' GLY . 56.3 Cg_endo -70.69 -87.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.407 2.072 . . . . 0.0 112.156 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -145.69 -166.23 2.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.78 0.324 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.7 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -70.69 -13.91 62.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -166.4 -63.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.68 55.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.966 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -86.3 30.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.968 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? 56.17 19.39 3.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.963 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.55 134.64 8.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.578 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.53 ' HA ' ' O ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -131.3 142.82 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.644 0.259 . . . . 0.0 110.772 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.2 m -153.51 131.2 11.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.069 0.462 . . . . 0.0 111.402 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.492 ' CD2' HG11 ' A' ' 147' ' ' VAL . 38.1 p90 -109.13 164.99 11.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.519 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.84 163.2 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.448 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.75 110.87 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.678 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.724 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 2.5 ptp180 -72.37 -163.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.132 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -175.05 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.71 -2.04 88.4 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.488 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.764 HG21 ' HE2' ' A' ' 146' ' ' LYS . 8.8 t -167.75 -12.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.392 . . . . 0.0 110.471 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.619 HG22 ' HG3' ' A' ' 173' ' ' MET . 0.7 OUTLIER -136.14 1.12 2.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.928 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 64.79 1.52 1.43 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.465 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 171' ' ' ARG . 5.1 ptp180 -175.47 -179.68 1.31 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.032 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.724 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -86.0 94.18 9.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.064 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.619 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.9 OUTLIER -107.23 129.93 54.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.73 ' HB2' HG22 ' A' ' 93' ' ' VAL . 17.9 t -114.14 110.95 20.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.102 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . 3.1 m80 -85.26 126.44 33.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -112.95 154.19 17.08 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.526 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.504 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . 30.6 p90 -166.21 175.93 7.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.827 0.346 . . . . 0.0 111.064 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.1 mp -137.89 175.16 9.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.932 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.429 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -105.06 119.53 39.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.5 OUTLIER -71.11 -13.67 62.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.695 ' HB2' ' HD2' ' A' ' 186' ' ' ARG . 1.5 mmmp? -83.05 -30.95 27.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.954 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 57.09 92.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.331 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.511 ' HB3' ' HD3' ' A' ' 186' ' ' ARG . 1.5 t -169.22 -38.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.46 ' H ' ' CZ ' ' A' ' 186' ' ' ARG . . . 76.65 47.53 9.95 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.635 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -155.96 -36.33 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.828 0.347 . . . . 0.0 110.908 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.695 ' HD2' ' HB2' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -66.09 -29.99 70.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.69 -42.19 2.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.371 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 t -57.66 -75.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.443 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -58.85 -24.78 62.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.2 -56.75 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.076 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 191' ' ' VAL . 61.7 t -59.63 -34.06 53.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -60.45 -15.35 38.76 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.619 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 73.4 m -102.34 -12.77 17.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.64 0.257 . . . . 0.0 111.093 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.684 ' HB1' HD12 ' A' ' 144' ' ' ILE . . . -58.14 -29.18 65.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.414 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.453 ' CG ' ' HA ' ' B' ' 4' ' ' ASN . 0.1 OUTLIER -81.49 -27.23 34.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.788 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.529 ' HA ' HD13 ' A' ' 199' ' ' LEU . . . -62.03 -12.88 21.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.03 -31.64 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -1.89 19.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.819 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 196' ' ' ALA . 3.4 mt -75.44 -8.67 57.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.964 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.06 -25.39 66.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.038 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.751 179.791 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.791 ' HA3' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.464 ' CE1' ' HD3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -108.21 -49.15 3.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.696 0.284 . . . . 0.0 110.517 179.06 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' A' ' 149' ' ' PHE . 4.8 p 62.51 154.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.477 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.453 ' HA ' ' CG ' ' A' ' 195' ' ' PHE . 0.6 OUTLIER -70.47 153.69 42.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.13 -21.11 12.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.805 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t -95.41 20.78 8.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.42 ' HB3' ' OD1' ' B' ' 4' ' ' ASN . 26.3 p90 -61.5 149.07 39.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.976 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -103.49 -4.56 23.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.911 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 54.64 83.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.933 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -56.58 145.34 60.8 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo . . . . . 0 C--O 1.25 1.088 0 C-N-CA 122.55 2.167 . . . . 0.0 112.387 -179.676 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.943 0.401 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.86 -38.37 19.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.001 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -26.42 61.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.035 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -74.06 -2.84 26.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.78 -11.41 6.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.08 -43.73 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -80.3 -46.4 16.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.887 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 77' ' ' ARG . 12.9 tt0 -65.5 -23.1 66.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.006 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.8 -52.8 62.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.132 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.784 HG13 ' HA ' ' A' ' 194' ' ' ALA . 3.1 t -62.79 -43.01 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.624 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.467 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 37.2 mtp180 -54.22 -34.93 61.79 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.329 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 11.6 m -78.05 -90.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.369 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 78' ' ' SER . . . 177.05 36.22 0.0 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.232 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.41 101.2 0.26 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.868 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 2.9 t -127.94 -147.35 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.285 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.52 ' HG ' HD22 ' A' ' 121' ' ' LEU . 0.3 OUTLIER 53.47 -163.06 0.1 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 111.607 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.562 ' HB3' ' HD3' ' A' ' 181' ' ' LYS . 2.1 m-85 -158.28 -169.09 2.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.333 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 3.5 m -42.58 144.26 0.56 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.762 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.445 HG11 HD21 ' A' ' 187' ' ' LEU . 34.9 m -139.5 -170.55 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.591 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.69 74.81 1.19 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.701 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 42.8 t80 -58.56 97.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.09 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -64.18 -33.63 76.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.81 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.54 -152.05 24.15 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.5 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.494 ' HB2' ' HE3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -136.41 129.98 32.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.312 . . . . 0.0 110.797 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.68 152.86 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -84.81 144.66 28.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.44 -172.23 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.997 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -150.0 59.81 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.064 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -170.06 -77.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.98 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.413 ' HA ' HG23 ' A' ' 163' ' ' ILE . 49.6 m 61.01 24.83 14.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.988 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 3.5 ptt-85 -135.78 37.61 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.774 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -160.15 161.24 32.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.486 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.628 ' HG2' ' HB3' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -83.92 -37.25 22.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 111.065 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -70.4 -9.77 57.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.168 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.84 -36.88 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.85 0.357 . . . . 0.0 110.925 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 3.5 m -79.17 -24.62 43.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.468 ' HA ' ' OD2' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -71.62 -7.74 49.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.972 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -111.77 -49.89 2.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.963 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.551 ' HA ' HG23 ' A' ' 108' ' ' VAL . . . -57.2 -41.83 80.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 tp -58.24 -36.96 73.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.604 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -67.39 -38.07 84.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.607 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 105' ' ' ALA . 3.6 t -60.7 -33.33 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.557 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 114' ' ' ARG . 2.5 mt -77.39 -26.94 52.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.661 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.97 -21.02 44.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.614 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -98.48 1.23 46.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.974 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.95 172.05 13.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.954 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.74 74.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.717 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.436 ' HG3' HD21 ' A' ' 109' ' ' LEU . 4.2 mmp_? -86.87 36.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.177 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 115' ' ' ARG . 0.1 OUTLIER 56.16 87.13 0.15 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.65 178.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 3.5 Cg_exo -76.2 116.39 4.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.969 2.446 . . . . 0.0 111.886 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.49 HG12 ' OD1' ' A' ' 132' ' ' ASP . 0.1 OUTLIER -85.43 145.42 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.966 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -104.26 102.6 12.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.327 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.714 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -158.78 -137.64 2.3 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.176 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.496 ' O ' HG13 ' A' ' 130' ' ' VAL . 3.0 pp -155.2 169.56 23.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 111.101 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.52 HD22 ' HG ' ' A' ' 82' ' ' SER . 54.4 tp -112.07 140.25 46.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.136 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.578 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 4.7 m-70 -121.5 85.65 2.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.112 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.868 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 69.0 t -60.4 93.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.159 0.504 . . . . 0.0 111.228 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.565 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -87.05 142.04 28.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.857 177.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.87 23.47 1.7 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.415 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 124' ' ' SER . 21.6 t0 -155.55 27.61 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.529 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.25 112.24 1.73 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.282 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.46 159.35 8.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.83 0.348 . . . . 0.0 111.026 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -154.5 116.74 4.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.713 HG23 HG21 ' A' ' 140' ' ' VAL . 13.6 t -101.24 106.09 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.086 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.22 129.35 53.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.977 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.714 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -64.4 175.78 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.01 -4.66 13.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -117.04 -45.13 2.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.381 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.6 m -92.22 -24.04 19.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.451 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 54.09 32.89 16.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.627 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -102.87 -178.56 26.72 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.466 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' A' ' 141' ' ' ASP . 4.5 tp -87.11 135.9 33.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.808 0.337 . . . . 0.0 110.792 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 130' ' ' VAL . 40.8 mt -116.88 -51.77 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.034 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.713 HG21 HG23 ' A' ' 130' ' ' VAL . 92.7 t -117.75 103.72 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.863 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.519 ' HB2' HD22 ' A' ' 138' ' ' LEU . 16.3 t0 -96.36 32.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.43 ' HG2' HG11 ' A' ' 140' ' ' VAL . 20.2 mm100 -77.5 -173.06 2.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 82.8 m -150.09 148.91 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.776 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.565 HD11 ' O ' ' A' ' 124' ' ' SER . 1.0 OUTLIER -63.22 -39.87 86.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.628 179.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -84.46 13.92 5.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.681 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.628 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 10.0 tttp -115.43 -48.49 2.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.978 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.8 m -69.58 146.48 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.101 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.6 t -53.54 -63.09 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.414 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.73 146.23 2.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.776 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.37 165.59 22.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.96 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.628 ' HB3' ' HG2' ' A' ' 99' ' ' MET . . . -167.16 100.82 0.63 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.222 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.842 ' HD2' ' HA3' ' B' ' 1' ' ' GLY . 5.8 Cg_exo -76.25 30.94 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.037 2.491 . . . . 0.0 112.433 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.468 ' OD2' ' HA ' ' A' ' 103' ' ' GLU . 1.0 OUTLIER 60.4 -93.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.104 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -131.79 -4.45 3.63 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.016 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.23 44.08 22.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -139.27 -24.43 0.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.803 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -105.84 11.29 32.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.986 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 57.67 27.29 14.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.162 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.38 130.31 9.35 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.488 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.574 ' HZ ' ' HA2' ' A' ' 184' ' ' GLY . 3.3 m-85 -128.93 152.56 48.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.338 . . . . 0.0 111.012 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.526 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -161.74 148.51 14.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.09 162.47 24.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.843 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -120.47 151.43 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.076 0.465 . . . . 0.0 111.418 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 10.0 t -150.95 148.03 27.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.332 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -158.66 0.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.24 -176.85 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.207 0.527 . . . . 0.0 111.658 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.72 -12.07 35.34 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.62 -22.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.134 -0.533 . . . . 0.0 109.984 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.565 HG21 ' HG3' ' A' ' 171' ' ' ARG . 33.3 m -113.2 -12.77 13.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.832 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 65.12 17.2 10.95 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.284 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.565 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.9 OUTLIER -173.0 -170.03 0.61 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.051 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.68 112.86 24.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.3 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.494 ' HE3' ' HB2' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -123.59 173.53 8.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.461 179.018 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 19.5 t -155.01 129.59 9.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.752 0.31 . . . . 0.0 111.292 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.43 155.17 17.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.504 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.526 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -137.48 155.46 23.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.786 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.42 ' HE2' HD22 ' A' ' 187' ' ' LEU . 11.9 p90 -166.62 176.07 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.361 . . . . 0.0 110.811 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.2 mp -146.23 152.05 38.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.795 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.33 113.28 7.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 4.0 t -57.37 -41.52 80.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -73.36 -21.29 60.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.557 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 62.27 103.68 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.997 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.8 t -163.77 -43.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.574 ' HA2' ' HZ ' ' A' ' 160' ' ' PHE . . . 76.39 17.34 80.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.317 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.73 -25.67 2.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 0.0 111.018 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -80.8 -17.7 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.991 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.445 HD21 HG11 ' A' ' 85' ' ' VAL . 9.5 mp -119.59 -46.6 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.229 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 t -61.86 -56.77 15.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.517 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.92 -5.46 21.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.621 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -96.78 -48.42 5.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.698 0.285 . . . . 0.0 111.544 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.577 ' HA ' HG11 ' A' ' 123' ' ' VAL . 1.7 p -70.7 -22.11 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.211 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.88 67.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.395 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 77.4 m -119.72 4.39 11.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.773 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.784 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -78.11 -51.77 9.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.169 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.541 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 51.0 p90 -63.72 -26.2 68.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.804 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -62.45 -23.14 66.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.11 11.85 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.6 -13.05 10.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.979 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.804 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.4 OUTLIER -119.55 -0.45 10.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.141 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -103.5 -47.54 4.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.239 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.058 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.842 ' HA3' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.449 ' HB2' ' H ' ' B' ' 3' ' ' SER . 0.4 OUTLIER -123.7 -156.36 0.7 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.67 0.271 . . . . 0.0 110.892 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.449 ' H ' ' HB2' ' B' ' 2' ' ' PHE . 0.2 OUTLIER -167.63 150.13 5.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.843 179.677 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' B' ' 7' ' ' PHE . 0.1 OUTLIER -60.19 146.78 42.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.739 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 12.0 mtm -116.45 -15.63 10.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.127 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 9.1 p -84.74 20.79 1.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.205 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.467 ' HB3' ' OD1' ' B' ' 4' ' ' ASN . 44.0 p90 -64.05 149.8 46.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -90.62 11.94 20.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 39.0 t0 56.0 85.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.804 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.598 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 2.7 m-85 -92.85 -52.24 0.27 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.392 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 26.5 Cg_exo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.117 1.878 . . . . 0.0 112.212 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.816 0.341 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.87 -34.06 17.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.67 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -31.31 72.46 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.732 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -67.38 -17.36 64.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.59 -15.75 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.841 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.727 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -98.56 -18.07 18.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.768 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -62.63 -38.91 92.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.568 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.744 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -92.27 -7.5 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.429 179.259 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.727 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . . . -65.85 -49.12 69.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.84 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.546 HG13 HG23 ' A' ' 197' ' ' VAL . 1.2 t -61.06 -36.31 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.047 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.744 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -66.53 -34.36 77.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.276 178.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.32 6.26 14.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.756 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 66.32 42.43 3.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.589 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.445 ' HB ' ' ND1' ' A' ' 122' ' ' HIS . 1.5 t -177.19 86.95 0.02 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.241 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 75' ' ' ALA . 11.5 t -116.69 4.84 13.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.473 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.639 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.4 OUTLIER -103.78 -167.93 1.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.721 0.295 . . . . 0.0 111.251 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -152.74 -171.07 3.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -39.0 141.99 0.25 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.823 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.516 HG11 ' HD2' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -149.41 -165.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.323 -179.409 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.406 ' H ' ' HB ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -152.19 70.61 0.93 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -61.58 119.88 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.82 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.435 ' HB2' HD21 ' A' ' 109' ' ' LEU . 1.2 mp -79.03 -75.39 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.259 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.85 -117.57 0.45 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.349 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.596 ' N ' HD22 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -159.14 128.45 5.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.713 0.292 . . . . 0.0 110.768 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.12 158.03 28.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.331 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.1 152.64 30.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.583 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 172' ' ' TRP . 1.9 m -141.55 150.09 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.303 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.453 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 1.7 t80 -118.48 59.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.389 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 94' ' ' PHE . 4.7 mt-10 -154.07 -68.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.692 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.62 14.99 1.92 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.211 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -141.13 116.54 10.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.008 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.8 -170.98 15.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.561 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -116.06 -26.28 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 110.738 -179.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -69.28 -11.71 61.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.321 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.641 ' HB ' HD13 ' A' ' 163' ' ' ILE . 14.1 t -59.6 -27.5 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 110.988 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.601 ' HB3' ' HG ' ' A' ' 161' ' ' SER . 73.2 m -79.32 -39.32 33.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.151 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.36 -14.69 63.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.285 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.421 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.8 mt-10 -103.98 -47.77 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.039 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 101' ' ' VAL . . . -60.27 -34.95 74.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.16 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.406 HD22 ' HA3' ' A' ' 159' ' ' GLY . 3.2 tp -57.37 -44.4 84.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.72 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.542 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -69.08 -34.34 74.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.606 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.2 t -61.68 -31.0 49.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.333 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 90' ' ' CYS . 1.2 mt -80.29 -30.32 38.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.852 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -80.41 -21.2 42.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.501 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -19.2 20.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.901 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.6 m -100.32 10.97 40.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.057 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER 32.01 78.79 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.301 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.473 ' HG3' HD23 ' A' ' 109' ' ' LEU . 14.4 mmm180 -95.07 22.2 6.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.909 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 56.59 104.94 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.861 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.59 149.16 30.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.514 2.143 . . . . 0.0 111.951 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.88 136.34 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.085 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.13 82.61 8.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.063 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -151.76 -179.6 27.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.132 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.17 158.22 24.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 0.0 111.236 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.49 ' HB2' HG21 ' A' ' 85' ' ' VAL . 67.7 tp -96.09 146.7 24.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.222 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.445 ' ND1' ' HB ' ' A' ' 80' ' ' THR . 1.7 m170 -123.68 76.85 1.46 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.821 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.639 ' H ' ' HB2' ' A' ' 82' ' ' SER . 40.7 t -53.0 104.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.956 0.408 . . . . 0.0 110.582 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 2.0 t -110.48 126.39 54.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.469 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -55.6 -14.29 6.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.607 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -108.29 31.09 5.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 0.0 110.831 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 114.87 125.5 4.03 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.6 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.5 163.82 8.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.86 0.362 . . . . 0.0 110.947 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.76 133.9 1.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.78 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.411 HG23 ' HB ' ' A' ' 140' ' ' VAL . 2.8 t -110.12 125.91 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.85 0.357 . . . . 0.0 111.261 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.31 132.23 64.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.619 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.567 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -61.87 -173.89 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 0.0 111.018 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.74 -15.47 5.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.774 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.54 -22.04 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.546 HG23 ' H ' ' A' ' 137' ' ' GLY . 9.4 t -133.19 -18.79 2.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.331 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.32 33.5 23.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.737 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.546 ' H ' HG23 ' A' ' 135' ' ' THR . . . -84.11 145.68 22.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.439 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 141' ' ' ASP . 24.0 tp -75.1 128.86 36.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.787 0.327 . . . . 0.0 110.924 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.5 mt -111.1 -50.37 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.49 HG13 ' HH ' ' A' ' 162' ' ' TYR . 53.8 t -104.25 114.99 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.971 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.411 ' HB2' HD21 ' A' ' 138' ' ' LEU . 26.4 t0 -117.27 57.44 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.716 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.58 -176.2 2.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.133 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.501 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 2.4 m -121.16 168.63 11.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.667 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.438 ' H ' HG22 ' A' ' 143' ' ' THR . 5.8 mt -84.33 -33.09 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 110.873 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -83.67 -13.16 54.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.615 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -87.05 -42.35 13.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.981 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 147' ' ' VAL . 0.6 OUTLIER -61.73 126.7 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.923 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.85 -37.72 63.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.878 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -151.97 166.37 31.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.084 0.469 . . . . 0.0 111.626 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.75 63.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.797 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.46 ' HB1' ' SG ' ' A' ' 102' ' ' CYS . . . -90.06 136.93 28.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.984 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 72.7 Cg_endo -80.16 -91.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.704 2.269 . . . . 0.0 111.603 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.421 ' H ' ' HG2' ' A' ' 152' ' ' PRO . 1.1 p30 -136.23 -166.75 1.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.677 0.275 . . . . 0.0 110.655 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -116.81 9.22 13.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.029 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -168.14 -65.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.851 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.33 39.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.716 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.89 0.36 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.006 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 158' ' ' ARG . 0.0 OUTLIER 58.16 21.7 8.3 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.755 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.406 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -127.63 123.3 4.46 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.541 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -115.39 161.94 17.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.645 0.259 . . . . 0.0 110.54 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.601 ' HG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -158.92 -177.87 6.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.013 0.435 . . . . 0.0 111.448 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.49 ' HH ' HG13 ' A' ' 140' ' ' VAL . 10.4 p90 -156.38 158.06 36.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.085 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.641 HD13 ' HB ' ' A' ' 101' ' ' VAL . 0.6 OUTLIER -123.71 165.04 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.069 0.461 . . . . 0.0 112.027 -177.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 5.7 p -165.57 135.6 3.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.394 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -160.43 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 111.263 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -175.17 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.442 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.25 -7.32 69.16 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.1 t -168.95 -11.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.216 -0.492 . . . . 0.0 110.002 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.08 -7.88 5.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.739 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 64.15 9.72 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.574 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -176.12 -173.72 0.58 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.968 0.413 . . . . 0.0 111.317 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.485 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -88.93 108.07 19.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.593 179.373 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 24.9 mtp -128.36 133.51 48.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.759 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 43.5 t -113.58 132.43 55.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' A' ' 161' ' ' SER . 35.1 m170 -98.8 158.72 15.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.624 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -139.81 149.41 20.78 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.005 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.516 ' HD2' HG11 ' A' ' 85' ' ' VAL . 10.3 p90 -157.08 135.98 11.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.78 0.324 . . . . 0.0 110.815 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.68 160.19 14.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.52 118.02 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -6.56 45.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.592 ' HB3' ' HZ2' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -89.51 -26.76 20.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.765 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.16 75.87 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.027 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -165.65 -32.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.786 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 63.82 37.09 94.17 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.514 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -133.29 -31.25 1.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 111.011 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -88.16 -5.72 58.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.82 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.07 -58.0 1.22 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.29 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -62.51 1.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.344 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.98 -19.64 32.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.29 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.05 -45.65 33.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.03 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.4 -29.05 45.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.962 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.53 -17.69 48.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.366 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 68.6 m -110.58 -8.73 14.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.761 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.527 ' HA ' HG21 ' A' ' 76' ' ' VAL . . . -61.98 -40.1 94.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.187 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.519 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 3.5 p90 -70.42 -29.59 66.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.763 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.08 -22.7 51.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.066 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 76' ' ' VAL . 49.4 t -101.43 -21.95 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.528 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . 0.47 ' HB3' ' HG ' ' B' ' 6' ' ' SER . 1.8 t -64.16 -28.23 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.467 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.3 OUTLIER -103.34 47.77 0.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.516 178.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.0 -34.0 71.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.039 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.709 179.715 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.81 174.58 14.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.724 0.297 . . . . 0.0 110.77 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.76 166.43 33.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.148 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.511 HD21 ' HB3' ' B' ' 7' ' ' PHE . 1.1 p-10 -70.12 128.14 35.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.994 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 1.2 mtm -95.97 -19.76 19.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.47 ' HG ' ' HB3' ' A' ' 198' ' ' CYS . 16.0 p -75.04 7.38 3.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.511 ' HB3' HD21 ' B' ' 4' ' ' ASN . 38.7 p90 -57.19 146.92 26.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -99.44 11.36 39.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.716 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 13.4 t70 54.42 72.74 0.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.953 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 65.8 m-85 -65.84 139.98 97.07 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 28.1 Cg_exo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.678 2.252 . . . . 0.0 112.31 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.78 0.324 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -115.07 -41.98 3.26 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.13 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -27.54 68.74 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.031 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -70.15 -22.2 63.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.16 -17.98 15.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -86.54 -29.31 22.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -69.17 -38.41 78.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.688 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.54 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.5 tt0 -84.98 -10.61 56.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.641 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 72' ' ' ASP . . . -59.87 -54.92 40.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.009 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.494 HG13 ' HA ' ' A' ' 194' ' ' ALA . 14.6 t -58.17 -40.32 76.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.54 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 5.8 mtp180 -58.51 -38.29 77.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.456 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 m -75.13 -91.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.414 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.676 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 179.65 35.29 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.53 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.616 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -173.16 99.78 0.12 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.895 0.379 . . . . 0.0 111.739 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 4.1 t -120.73 -150.02 0.44 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.23 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.618 ' HG ' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.77 -157.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 111.539 179.202 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.578 ' HB3' ' HE2' ' A' ' 181' ' ' LYS . 6.1 m-85 -159.0 -167.03 1.99 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.416 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.7 m -51.59 153.61 2.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.706 0.289 . . . . 0.0 110.995 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -144.33 -173.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.415 -179.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -142.3 63.95 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.69 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.424 ' O ' HG21 ' A' ' 117' ' ' VAL . 31.8 m-85 -57.81 103.12 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 0.3 OUTLIER -67.69 -33.61 75.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.479 -178.382 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.73 -167.44 28.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.602 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.504 ' HB2' ' HE3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -114.89 128.44 56.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.074 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.461 HG13 HD22 ' A' ' 109' ' ' LEU . 15.5 m -119.76 144.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.028 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.49 141.96 42.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.06 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.94 154.98 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -120.97 61.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.812 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 22.3 mt-10 -152.42 -76.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.254 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m 62.67 29.76 16.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -151.4 107.3 3.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.659 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.57 146.3 7.56 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.316 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.409 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -78.03 -23.39 48.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.748 0.309 . . . . 0.0 110.953 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.409 ' N ' ' HG3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -70.31 -20.74 62.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.104 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.8 t -59.73 -39.24 79.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 151' ' ' ALA . 57.6 m -70.77 -36.89 73.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -9.2 18.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.219 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.472 ' O ' HG21 ' A' ' 108' ' ' VAL . 23.5 mt-10 -99.93 -55.53 2.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.011 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.55 -31.79 66.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.238 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.449 HD22 ' HA3' ' A' ' 159' ' ' GLY . 6.8 tp -59.18 -46.56 88.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -67.01 -32.24 73.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 104' ' ' GLU . 47.3 t -58.39 -49.94 80.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.986 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 91' ' ' VAL . 1.3 mt -64.68 -22.31 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.678 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 110' ' ' ARG . 7.0 tpt180 -82.45 -28.14 31.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.709 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -97.67 -2.2 41.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.919 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.1 -177.65 3.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.049 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.79 16.29 5.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.093 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -67.46 99.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.929 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -73.47 135.71 78.61 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 74.2 Cg_endo -77.12 161.74 32.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.585 2.19 . . . . 0.0 112.552 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -124.25 108.73 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.738 179.339 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 96.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.998 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -139.0 161.9 25.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.533 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.28 129.86 35.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.664 ' HB2' HG21 ' A' ' 85' ' ' VAL . 28.0 tp -101.48 123.42 45.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.616 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 12.1 m-70 -112.81 89.3 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.911 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.618 HG23 ' HG ' ' A' ' 82' ' ' SER . 69.1 t -68.82 89.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.399 . . . . 0.0 110.937 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.676 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 1.2 p -84.32 150.74 25.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.234 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.32 34.4 2.44 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.385 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.99 19.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.809 0.338 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.655 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 134.04 112.59 1.31 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.546 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -65.42 154.05 39.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 111.184 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.52 124.79 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.8 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.702 HG21 ' HB ' ' A' ' 140' ' ' VAL . 2.8 t -112.45 113.75 45.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.441 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.6 117.25 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.581 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.448 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 2.6 t0 -51.96 158.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -108.89 0.95 20.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.061 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.69 -20.46 8.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.191 0.52 . . . . 0.0 110.01 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.1 m -123.4 -24.84 4.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.067 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 54.81 27.34 8.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.793 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.22 -109.6 1.19 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.364 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 141' ' ' ASP . 27.3 tp -160.02 131.2 5.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.778 0.323 . . . . 0.0 111.1 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.8 mt -113.47 -48.92 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.041 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.702 ' HB ' HG21 ' A' ' 130' ' ' VAL . 71.5 t -136.93 112.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.063 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.598 ' HB2' HD23 ' A' ' 138' ' ' LEU . 3.2 t0 -118.14 65.57 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.798 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -112.61 -171.8 1.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.904 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 38.1 m -125.21 158.72 33.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.484 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -66.31 -48.08 82.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.916 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -75.09 -21.95 58.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.612 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.904 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 2.8 ttmm -63.07 -52.34 63.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.694 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 m -67.95 143.09 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -44.92 -67.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.107 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.499 ' HA ' ' ND2' ' B' ' 4' ' ' ASN . 0.1 OUTLIER -165.08 124.93 1.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.961 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.0 t -63.85 159.37 19.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.765 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.536 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . . . -157.25 136.06 7.88 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.421 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HB2' ' H ' ' A' ' 153' ' ' ASP . 89.5 Cg_endo -80.2 -142.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.643 2.228 . . . . 0.0 111.993 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.475 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 0.8 OUTLIER -111.81 -153.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.77 179.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.464 ' H ' ' HB2' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -73.6 -36.17 65.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.048 -179.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.432 HD21 ' CG ' ' A' ' 156' ' ' HIS . 0.4 OUTLIER -157.32 -58.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.251 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.467 ' C ' ' H ' ' A' ' 158' ' ' ARG . 0.6 OUTLIER -166.38 37.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.14 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -72.87 10.68 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.706 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.606 ' HG2' ' HA ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER 57.81 25.77 12.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.965 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 153' ' ' ASP . . . -119.45 112.06 2.19 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.652 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 1.5 m-85 -119.55 151.57 38.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.689 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -159.81 170.26 21.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.858 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.566 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -147.51 164.46 33.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.158 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.5 132.6 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.058 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.4 p -111.01 153.64 25.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -119.1 94.01 4.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.008 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.624 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 49.08 29.17 2.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.481 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -65.35 -13.82 58.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.551 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.0 t 175.75 15.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.539 HG23 ' HG3' ' A' ' 171' ' ' ARG . 24.6 m -124.78 -11.52 7.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.887 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.624 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 0.0 OUTLIER 60.49 31.15 20.23 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.719 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.539 ' HG3' HG23 ' A' ' 169' ' ' THR . 0.2 OUTLIER -176.35 -168.43 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.589 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.99 126.17 39.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.362 . . . . 0.0 111.196 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.504 ' HE3' ' HB2' ' A' ' 90' ' ' CYS . 1.4 mtp -142.24 161.38 38.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.635 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 33.9 t -140.69 116.07 10.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.077 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.566 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 11.9 m-70 -92.15 134.5 34.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.71 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.689 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -118.0 143.34 17.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.532 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 41.4 p90 -149.96 154.16 37.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 0.0 111.223 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.419 HD13 HH11 ' A' ' 110' ' ' ARG . 1.0 OUTLIER -126.89 135.49 51.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.643 179.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.431 ' HB1' HD12 ' A' ' 187' ' ' LEU . . . -59.74 117.49 5.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -16.12 63.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.741 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 83' ' ' PHE . 3.4 mmtt -88.41 -26.91 21.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.781 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.606 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 4.3 m-20 57.59 87.64 0.06 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.2 t -162.5 -30.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.996 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.94 20.35 76.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.399 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -137.66 2.09 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.689 0.28 . . . . 0.0 111.02 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.516 ' HB2' HD13 ' A' ' 187' ' ' LEU . 7.8 mmt85 -106.25 -14.88 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 186' ' ' ARG . 4.4 mp -134.55 -39.94 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -59.27 -60.26 4.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -18.21 64.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.31 -41.55 63.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 67.7 t -73.62 -29.53 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.68 -7.64 29.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.248 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 68.3 m -108.47 -19.77 13.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.697 0.284 . . . . 0.0 110.751 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 76' ' ' VAL . . . -58.91 -60.8 3.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.159 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -64.69 -32.71 74.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.664 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.682 ' HA ' HD13 ' A' ' 199' ' ' LEU . . . -57.44 -16.81 10.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.236 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 56.4 t -105.34 -29.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.055 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -9.56 58.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.718 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.682 HD13 ' HA ' ' A' ' 196' ' ' ALA . 4.3 mt -81.93 77.67 8.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.915 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -74.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.601 -0.2 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.27 -66.73 0.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.641 0.258 . . . . 0.0 110.996 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 93.0 p 51.4 95.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.177 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 149' ' ' PHE . 3.9 p30 -52.38 146.26 9.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.396 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 23.2 ttm -113.03 3.86 16.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.914 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.8 p -94.02 19.35 9.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -62.88 152.24 36.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.01 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -85.05 11.55 9.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.739 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 22.5 t0 57.46 80.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.615 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 24.0 m-85 -90.38 -50.8 0.34 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.248 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 45.0 Cg_exo . . . . . 0 C--O 1.25 1.085 0 C-N-CA 122.197 1.932 . . . . 0.0 112.278 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.855 0.36 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -85.21 -18.95 32.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -44.0 97.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.6 mt-10 -97.62 -5.95 34.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -63.92 -55.98 18.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.501 HG23 ' CB ' ' A' ' 81' ' ' CYS . 1.2 t -61.54 -36.27 72.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.707 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.404 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 22.9 mtp180 -62.0 -28.6 69.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.373 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.6 m -85.66 -92.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.819 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -175.94 34.14 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.454 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.543 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.8 t -174.41 97.22 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.036 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.645 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 10.5 t -122.88 6.01 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.591 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.726 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -113.15 -153.38 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.076 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.434 ' CG ' ' HE2' ' A' ' 181' ' ' LYS . 6.8 m-85 -154.56 -169.39 3.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.684 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.63 137.61 15.32 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.763 0.315 . . . . 0.0 111.012 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.53 179.54 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 0.0 111.675 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -133.0 66.56 1.56 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.814 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -58.3 101.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.73 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -69.84 -37.91 76.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.151 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.98 -132.08 4.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.467 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 136.94 21.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.099 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -130.77 167.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.833 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 5.6 pt-20 -96.39 143.53 27.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.126 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.55 -171.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -149.46 62.98 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.164 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 1.3 mt-10 -168.95 -68.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.097 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.0 p 52.44 38.92 26.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -146.91 25.96 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.069 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -159.24 161.65 32.21 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -15.88 35.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -80.22 -18.03 50.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.945 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 t -61.49 -27.29 41.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 67.3 m -81.12 -26.1 36.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.932 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -15.96 63.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -99.81 -42.9 6.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.516 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.7 -39.7 81.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.974 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.627 HD11 ' HG ' ' A' ' 178' ' ' LEU . 6.0 tp -56.51 -32.36 64.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.804 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 5.8 tptp -75.87 -38.9 57.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -58.18 -44.43 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.526 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.1 mt -72.67 -15.93 61.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 110' ' ' ARG . 3.8 ttt-85 -84.84 -12.39 53.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.249 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 1.5 mm100 -72.49 -64.81 0.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.658 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -177.73 -169.14 0.2 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.425 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' SER . 0.5 OUTLIER 69.87 -71.95 0.12 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.21 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.526 ' HG3' HD23 ' A' ' 109' ' ' LEU . 8.3 mmm180 -75.67 100.3 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.728 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.466 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -80.31 135.04 54.34 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.126 -179.374 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.73 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 16.4 Cg_exo -68.2 156.74 64.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.819 2.346 . . . . 0.0 112.104 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.8 t -130.44 140.57 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -92.29 98.04 11.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 132' ' ' ASP . . . -125.77 -162.33 11.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.682 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.31 102.14 6.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.699 0.285 . . . . 0.0 110.598 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.487 HD23 HD23 ' A' ' 187' ' ' LEU . 40.8 tp -69.2 128.52 36.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.708 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.567 ' HB2' ' HG2' ' A' ' 129' ' ' ARG . 34.4 m170 -121.73 87.95 2.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.773 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.726 HG23 ' HB2' ' A' ' 82' ' ' SER . 35.8 t -62.8 94.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.148 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.819 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -98.39 144.86 27.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.287 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -60.61 -7.93 8.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.94 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.94 34.54 5.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.727 0.298 . . . . 0.0 110.997 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.652 ' HA2' HG13 ' A' ' 144' ' ' ILE . . . 109.14 143.51 10.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.774 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.78 164.03 27.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.567 ' HG2' ' HB2' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -158.04 114.78 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.534 179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.483 HG23 ' HB ' ' A' ' 140' ' ' VAL . 17.1 t -99.39 103.21 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.517 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.79 109.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.376 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.411 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -48.68 139.61 9.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.093 -179.034 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -98.63 12.98 33.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.864 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -138.57 0.73 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.2 m -148.89 -26.46 0.3 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.438 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm 49.64 35.33 8.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.667 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.31 -5.15 54.71 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.63 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.619 HD21 ' HB3' ' A' ' 141' ' ' ASP . 7.3 tp 66.26 149.52 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 110.898 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.418 ' N ' ' HG ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -138.49 -35.91 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.526 -179.017 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.483 ' HB ' HG23 ' A' ' 130' ' ' VAL . 21.0 t -113.84 95.74 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 111.351 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.619 ' HB3' HD21 ' A' ' 138' ' ' LEU . 3.4 p30 -102.66 25.79 8.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.597 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -76.65 -164.82 0.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.256 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.617 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 9.2 m -141.11 158.39 43.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.921 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.652 HG13 ' HA2' ' A' ' 127' ' ' GLY . 30.4 mt -73.13 -41.69 58.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.844 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.33 -7.14 56.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.568 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.617 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -87.9 -40.58 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.814 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 143' ' ' THR . 0.9 OUTLIER -74.86 152.91 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.803 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -65.29 0.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.722 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 26.5 p90 -174.33 141.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.83 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.4 m -67.25 166.25 14.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.479 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -170.09 124.54 0.66 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.34 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.1 -158.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.676 2.251 . . . . 0.0 112.405 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.726 179.561 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.42 ' HG3' ' HA ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.796 0.331 . . . . 0.0 110.686 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -147.82 124.0 1.82 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.691 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 4.7 m-85 -126.34 165.25 19.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.632 0.253 . . . . 0.0 110.562 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.73 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -163.6 158.83 21.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 -179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.551 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -131.46 148.85 52.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.252 178.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.821 HG23 ' HB2' ' A' ' 174' ' ' CYS . 1.0 OUTLIER -106.58 150.54 9.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.411 . . . . 0.0 111.62 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -146.37 100.02 3.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.45 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.645 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 7.3 ptt180 -72.44 -153.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -178.23 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.093 0.473 . . . . 0.0 111.6 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.0 -3.87 60.63 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.3 t -171.97 -9.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.936 0.398 . . . . 0.0 110.366 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.45 HG21 ' CG ' ' A' ' 173' ' ' MET . 2.0 m -133.86 -6.88 2.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.101 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 59.09 16.91 5.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.168 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.27 179.69 2.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.781 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -85.07 113.53 21.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.45 ' CG ' HG21 ' A' ' 169' ' ' THR . 0.9 OUTLIER -131.49 116.45 17.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.622 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.821 ' HB2' HG23 ' A' ' 163' ' ' ILE . 27.3 t -108.75 129.27 55.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.222 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.551 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 1.8 m-70 -96.95 142.22 29.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.73 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -124.09 157.13 18.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.331 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 22.7 p90 -161.05 172.5 16.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.676 0.274 . . . . 0.0 110.422 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.627 ' HG ' HD11 ' A' ' 106' ' ' LEU . 1.2 mp -138.53 148.9 44.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 0.0 111.106 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.83 121.6 25.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.069 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.74 8.48 9.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.434 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 17.7 mmmt -102.12 -29.14 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.944 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.42 ' HA ' ' HG3' ' A' ' 158' ' ' ARG . 1.7 m-20 56.98 81.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.966 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.4 t -159.89 -33.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.29 37.46 80.49 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.411 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -151.47 -32.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.313 . . . . 0.0 111.136 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.52 ' HB2' HD12 ' A' ' 187' ' ' LEU . 5.7 mmt180 -74.01 -11.9 60.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.065 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.52 HD12 ' HB2' ' A' ' 186' ' ' ARG . 5.5 mp -135.29 -43.93 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 t -57.22 -75.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.509 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -28.59 57.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.252 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.84 84.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.918 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 187' ' ' LEU . 94.1 t -68.74 -36.36 73.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.69 -11.34 35.56 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.32 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.411 ' O ' HG23 ' A' ' 197' ' ' VAL . 56.5 m -107.78 -16.11 14.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 0.0 110.566 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.08 -51.55 66.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.213 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.542 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.9 p90 -62.0 -38.02 87.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.75 -26.61 64.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 193' ' ' CYS . 47.0 t -97.44 -22.21 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.754 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 15.8 t -65.61 -29.92 70.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.975 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.679 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 5.1 p -168.71 145.14 3.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.779 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -60.16 154.95 18.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.024 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 13.9 mmm -129.06 -15.42 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.264 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 9.5 t -84.82 20.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -63.49 159.8 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -91.75 0.76 57.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.783 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 59.26 81.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.132 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -74.36 150.95 87.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.86 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.571 2.181 . . . . 0.0 112.394 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.665 0.269 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -26.62 40.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -47.1 87.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.762 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -83.05 -15.95 48.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.881 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -53.62 -52.45 59.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.28 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.4 t -61.08 -43.62 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.565 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -55.21 -35.21 64.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.337 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 m -77.09 -92.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.531 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 179.54 35.72 0.0 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.393 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.516 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.1 t -173.03 100.81 0.13 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.009 0.433 . . . . 0.0 111.887 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.872 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.0 t -124.29 -149.45 0.42 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.413 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.718 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.4 OUTLIER 53.74 -153.33 0.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.768 0.318 . . . . 0.0 111.805 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -158.99 -168.34 2.34 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.749 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.7 OUTLIER -52.32 143.15 15.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.532 -179.307 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -136.91 -171.87 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.987 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.827 ' HD2' ' HB2' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -142.23 89.94 2.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 91.5 t80 -58.31 107.68 0.52 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.01 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.6 ' HB3' HD22 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -70.06 -60.66 2.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.61 -134.11 3.14 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.469 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -152.41 131.28 12.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 110.898 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.42 164.74 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.783 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -100.87 136.32 40.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.967 0.413 . . . . 0.0 111.012 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.3 m -140.25 140.37 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.96 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.506 ' HA ' ' HE3' ' A' ' 172' ' ' TRP . 50.0 m-85 -102.14 64.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -147.89 -81.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.075 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.03 46.61 22.43 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.92 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.87 70.75 1.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.775 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.25 179.27 20.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.247 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.49 -7.42 24.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -83.62 9.49 11.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -80.13 -19.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.0 p -83.05 -36.88 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.961 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -66.17 -4.96 8.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.105 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -119.59 -53.65 2.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.082 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.97 -53.34 59.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.212 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -55.54 -36.36 66.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.695 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -38.24 90.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.75 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 104' ' ' GLU . 48.7 t -62.6 -45.24 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.727 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.684 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -61.74 -37.61 84.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.586 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -28.94 64.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.93 2.54 53.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.257 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.613 ' HB3' ' HG2' ' A' ' 114' ' ' ARG . 0.1 OUTLIER -109.7 -163.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.916 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -96.56 15.95 20.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.684 ' HG3' HD23 ' A' ' 109' ' ' LEU . 1.5 mmt180 -67.14 101.74 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.01 126.79 90.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.095 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.827 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 88.1 Cg_endo -78.66 153.97 26.74 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.545 2.163 . . . . 0.0 112.314 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -129.49 121.51 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.206 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -77.96 109.41 11.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -139.33 -152.74 5.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.6 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.512 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -128.92 126.27 39.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.834 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.434 ' N ' HD13 ' A' ' 120' ' ' LEU . 19.8 tp -102.25 116.25 32.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.62 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.702 ' HE1' HG23 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -107.09 93.12 4.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.872 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 45.2 t -60.82 95.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.551 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -94.6 129.7 41.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.198 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.06 5.22 1.37 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.217 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 124' ' ' SER . 7.7 p-10 -134.86 27.81 3.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.886 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 126.21 107.07 1.53 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.376 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.0 mt -61.34 150.7 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.949 0.405 . . . . 0.0 111.296 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 129' ' ' ARG . 5.7 ttm-85 -142.66 151.61 41.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.528 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.425 ' CG2' ' HB ' ' A' ' 140' ' ' VAL . 50.8 t -141.04 110.79 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.804 0.335 . . . . 0.0 111.368 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.702 HG23 ' HE1' ' A' ' 122' ' ' HIS . 17.8 t -104.16 126.4 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.835 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 0.3 OUTLIER -54.07 151.94 6.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.569 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -104.91 8.52 34.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.028 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.74 -4.2 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.226 0.536 . . . . 0.0 110.347 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.2 m -141.83 -21.36 0.72 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.898 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.559 ' HA ' HG12 ' A' ' 131' ' ' VAL . 19.5 mmtp 52.09 36.96 20.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.218 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.01 -112.3 1.67 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.377 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 tp -169.78 119.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.698 0.285 . . . . 0.0 110.647 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.73 -49.77 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.319 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.425 ' HB ' ' CG2' ' A' ' 130' ' ' VAL . 8.2 t -114.22 105.42 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 111.311 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -118.53 34.3 5.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -73.29 -166.63 0.34 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.138 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.676 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 27.1 m -144.42 155.03 43.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.887 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.551 HD11 ' O ' ' A' ' 124' ' ' SER . 17.2 mt -64.08 -53.73 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.955 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.11 -9.19 51.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.853 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.614 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 36.9 tttm -85.81 -51.29 6.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.046 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 143' ' ' THR . 4.4 m -69.28 145.35 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.073 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.82 -63.86 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -166.15 142.9 5.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.699 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.469 ' H ' ' H ' ' B' ' 4' ' ' ASN . 1.2 m -71.78 165.12 24.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.3 101.2 0.48 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.41 -90.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.425 2.083 . . . . 0.0 112.366 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.812 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.44 156.75 15.43 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.346 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.64 157.21 43.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.757 0.313 . . . . 0.0 110.952 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.77 138.03 17.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.125 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -114.76 144.44 43.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.736 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -109.99 157.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.991 0.424 . . . . 0.0 111.589 -178.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 14.5 t -161.24 136.05 7.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.571 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -88.73 -151.22 0.2 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.267 -179.264 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 170' ' ' ARG . 6.5 p-10 -65.7 -149.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.435 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 168' ' ' THR . . . 83.35 -8.41 64.59 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 167' ' ' GLY . 0.6 OUTLIER -163.03 -42.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.081 0.467 . . . . 0.0 110.171 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.451 HG22 ' HG3' ' A' ' 171' ' ' ARG . 16.6 m -96.32 -11.4 25.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.946 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.46 ' HA ' ' HB2' ' A' ' 166' ' ' ASP . 1.1 mtp180 63.44 20.06 12.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.934 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.451 ' HG3' HG22 ' A' ' 169' ' ' THR . 1.6 ptp85 -174.31 173.47 3.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.678 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.7 OUTLIER -85.9 105.02 16.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 8.9 mtp -121.41 139.55 53.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.653 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.418 ' HB2' HG23 ' A' ' 163' ' ' ILE . 25.2 t -118.27 141.81 48.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.933 0.396 . . . . 0.0 110.984 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -111.14 151.31 28.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.548 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -128.22 156.2 20.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.64 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -170.78 132.93 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.12 173.62 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.834 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -97.98 133.62 42.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.09 -24.06 61.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.776 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -82.08 -28.0 32.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.913 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.05 84.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.998 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 t -169.24 -38.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.55 26.6 62.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.402 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -132.49 -23.7 2.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 111.203 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.573 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -86.9 -17.99 31.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 186' ' ' ARG . 5.9 mp -124.87 -49.2 1.74 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.249 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.8 -46.55 87.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.241 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.89 1.26 13.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.316 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.505 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -101.15 -46.74 4.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.109 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.693 ' HA ' HG11 ' A' ' 123' ' ' VAL . 8.5 p -71.41 -20.72 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.4 -14.04 66.13 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.722 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.9 m -103.84 1.06 31.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.988 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.61 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -78.51 -42.31 29.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.987 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.517 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.0 m-85 -60.57 -37.77 82.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.626 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.488 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -54.59 -34.6 62.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.439 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.6 -10.67 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.173 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.6 t -84.3 -16.31 43.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.191 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.333 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.816 0.341 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -159.83 144.11 14.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.963 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.469 ' H ' ' H ' ' A' ' 150' ' ' CYS . 22.7 t-20 -62.89 105.18 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.037 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -9.08 53.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -81.05 11.74 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.226 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -56.87 142.47 41.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.33 10.17 13.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 32.4 t0 56.04 78.15 0.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.144 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 26.2 m-85 -61.79 139.0 95.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.028 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 47.0 Cg_exo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.656 2.237 . . . . 0.0 112.386 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.842 0.353 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -86.3 -28.34 23.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -66.89 -47.91 70.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.594 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.673 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -69.72 -26.8 64.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.5 80.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.687 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 194' ' ' ALA . 42.1 t -59.33 -36.83 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.3 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.673 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 2.2 mtm-85 -65.36 -37.09 85.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.117 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -75.66 -5.97 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.435 178.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 70.58 46.89 0.51 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.414 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.836 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -172.57 87.04 0.07 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.47 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.86 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.7 t -119.7 -149.19 0.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.302 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.625 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 57.64 -154.85 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.375 . . . . 0.0 111.573 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.506 ' HB2' HD11 ' A' ' 187' ' ' LEU . 5.5 m-85 -158.32 -170.77 3.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.503 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.6 OUTLIER -53.14 154.35 3.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.79 0.329 . . . . 0.0 111.005 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -148.28 -170.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.073 0.464 . . . . 0.0 111.592 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 5.1 mmtp -141.54 80.15 1.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.467 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 48.4 t80 -56.83 108.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.276 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 178' ' ' LEU . 7.9 mt -70.53 -51.37 29.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.664 ' HA3' ' HD3' ' A' ' 114' ' ' ARG . . . 152.71 -131.48 3.37 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.615 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.517 ' H ' ' HD3' ' A' ' 114' ' ' ARG . 1.4 p -153.3 134.15 13.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.819 0.342 . . . . 0.0 110.854 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.0 m -128.02 146.2 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -71.33 132.94 45.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.168 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.7 m -117.26 -178.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.046 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -139.34 59.61 1.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.037 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -171.54 -63.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.821 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.425 ' HA ' HG21 ' A' ' 163' ' ' ILE . 17.8 m 60.23 31.32 20.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.399 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 7.3 ptt180 -165.39 88.12 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.95 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.19 158.73 9.16 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.753 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -37.77 54.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 110.86 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 2.2 pt20 -67.36 -22.55 65.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.92 -33.13 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.08 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 83.5 m -80.07 -39.33 29.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.997 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.661 ' HG2' ' HA ' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -64.26 -28.63 69.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.047 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 108' ' ' VAL . 68.0 mt-10 -81.31 -50.87 9.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.88 -36.78 75.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.321 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.8 tp -57.87 -38.9 76.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -73.21 -37.99 66.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.1 t -58.66 -38.49 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.721 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.9 mt -72.76 -33.58 66.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -80.91 -3.32 51.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.759 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -117.32 -13.52 10.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.9 p -93.62 -166.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -101.38 27.4 6.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.046 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.721 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -72.79 113.55 9.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.75 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 131.11 91.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 90.8 Cg_endo -85.05 145.59 9.9 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.742 2.295 . . . . 0.0 112.187 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 1.8 t -108.43 155.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -116.49 103.25 10.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.971 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.42 -164.73 12.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.622 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.537 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -112.15 131.41 55.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 111.143 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.7 HD23 HD23 ' A' ' 187' ' ' LEU . 22.0 tp -98.14 120.8 39.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.171 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.836 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 74.7 m-70 -109.16 98.46 7.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.09 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.86 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 16.9 t -67.11 100.3 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.246 0.546 . . . . 0.0 110.503 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -98.9 131.43 44.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.268 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.86 20.94 1.01 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.616 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 124' ' ' SER . 9.3 t70 -150.32 14.69 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.782 0.325 . . . . 0.0 110.759 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.801 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 139.4 107.87 0.76 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.684 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 123' ' ' VAL . 12.8 mt -50.59 150.1 2.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.842 0.353 . . . . 0.0 111.131 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.797 ' HG2' HD11 ' A' ' 138' ' ' LEU . 15.3 ttm180 -145.32 113.43 6.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.427 HG22 ' CD1' ' A' ' 121' ' ' LEU . 2.8 t -111.46 115.17 49.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 111.657 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 2.1 t -97.33 156.92 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.647 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.527 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 0.3 OUTLIER -95.69 165.08 12.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.417 179.123 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.45 -5.82 18.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 135' ' ' THR . 0.0 OUTLIER -107.69 -36.95 6.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.939 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 137' ' ' GLY . 8.8 t -118.99 -12.5 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.527 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 30.5 mmtt 59.25 23.02 11.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.777 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.67 ' H ' HG23 ' A' ' 135' ' ' THR . . . -87.91 -161.77 37.26 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.131 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.797 HD11 ' HG2' ' A' ' 129' ' ' ARG . 3.1 tp -116.17 124.32 50.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.0 -25.62 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.365 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.4 t -132.45 94.67 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.863 0.363 . . . . 0.0 111.131 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.526 ' HB2' HD23 ' A' ' 138' ' ' LEU . 37.6 t70 -96.77 72.0 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.756 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.14 -175.78 3.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.877 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 20.2 m -136.47 151.83 49.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.5 mm -61.33 -40.54 86.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.041 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.86 -6.13 59.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.606 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.877 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 2.6 tttp -87.69 -42.95 12.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.907 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 143' ' ' THR . 0.7 OUTLIER -64.89 128.58 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.2 t -62.87 -35.37 79.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.143 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.577 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -147.78 150.77 34.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.344 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.5 m -129.04 80.52 1.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.299 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 102' ' ' CYS . . . -109.72 128.69 24.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.61 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.77 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 69.8 Cg_endo -75.45 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.535 2.156 . . . . 0.0 112.329 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.661 ' HA ' ' HG2' ' A' ' 103' ' ' GLU . 13.8 p-10 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.51 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.433 ' HG2' ' N ' ' A' ' 183' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 120.799 0.333 . . . . 0.0 110.838 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -107.36 143.03 15.86 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.568 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.77 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -123.97 168.18 13.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.653 0.264 . . . . 0.0 110.892 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.02 166.12 26.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.494 . . . . 0.0 111.288 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.55 141.09 20.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.29 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.577 HD12 ' HB2' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -106.72 147.71 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.976 0.417 . . . . 0.0 111.558 -178.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.14 106.5 4.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.641 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -84.89 132.6 34.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.1 p30 44.64 -161.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.869 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.32 -9.6 60.86 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.477 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.6 t -176.06 -19.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 110.425 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.591 HG22 ' HG3' ' A' ' 171' ' ' ARG . 7.6 m -111.08 -15.45 13.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.762 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 58.91 26.48 14.99 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.901 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.591 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -177.88 177.87 1.03 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.023 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.41 132.65 45.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.019 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.506 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -161.1 132.75 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.665 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.422 ' HB2' HG23 ' A' ' 163' ' ' ILE . 20.3 t -116.13 160.19 20.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.307 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -124.92 138.18 54.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.537 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.534 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -123.37 147.26 16.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.661 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 6.5 p90 -162.78 143.2 9.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 0.0 110.745 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.499 HD12 HD21 ' A' ' 88' ' ' LEU . 1.2 mt -111.76 154.92 24.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.137 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.427 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -83.71 129.51 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.15 6.27 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.57 -26.53 12.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 55.38 83.07 0.09 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.433 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -169.66 -37.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.076 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.2 28.5 73.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.435 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.88 -16.42 5.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 110.954 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -105.91 -9.77 16.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.7 HD23 HD23 ' A' ' 121' ' ' LEU . 4.1 mp -125.55 -46.3 1.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.194 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -61.8 2.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.989 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.76 -8.27 34.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.141 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.14 -41.7 13.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.236 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.458 ' HA ' HG11 ' A' ' 123' ' ' VAL . 7.0 p -77.44 -29.2 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.046 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.87 -3.83 52.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.231 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 92.2 m -115.27 1.53 13.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 110.683 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.703 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -77.69 -44.26 28.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.07 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.453 ' CD2' HD21 ' A' ' 199' ' ' LEU . 4.2 p90 -64.96 -25.22 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.938 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.462 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -61.14 -19.05 61.07 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.21 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.99 -27.29 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.001 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.9 t -74.76 -30.84 61.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.765 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.754 0.312 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 51.4 p -168.61 161.38 11.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.12 159.91 28.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.999 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 10.2 mtm -130.33 -10.94 4.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.995 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -83.59 8.26 14.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.959 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -63.4 151.69 40.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -98.56 12.92 33.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.862 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t70 56.03 75.99 0.31 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 66.5 m-85 -71.01 143.71 89.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.934 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 48.5 Cg_exo . . . . . 0 C--O 1.249 1.068 0 C-N-CA 122.638 2.225 . . . . 0.0 112.25 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.91 0.386 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.46 -27.29 25.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.862 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -87.26 -23.77 24.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.55 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.738 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.0 OUTLIER -90.45 -15.14 31.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -60.93 -49.44 77.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.943 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.0 t -60.52 -41.0 86.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.255 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.738 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 9.8 mtt180 -56.07 -33.91 65.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.452 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 m -80.7 -92.02 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.7 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.624 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -178.71 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.453 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.611 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -172.44 98.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.788 0.328 . . . . 0.0 111.099 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.608 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 15.7 t -129.0 61.06 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.641 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.642 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -161.01 -156.54 0.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.098 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.486 ' HB3' ' HE2' ' A' ' 181' ' ' LYS . 1.9 m-85 -156.12 -170.55 3.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.179 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 1.4 m -51.13 141.76 13.75 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.99 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.9 m -135.86 -175.55 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.42 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 116' ' ' PRO . 4.6 mtpp -133.99 73.92 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.703 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 78.2 t80 -61.37 108.04 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.45 ' HB2' HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -80.22 -36.54 34.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.12 -127.16 3.02 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.606 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.2 p -164.64 130.11 2.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.07 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m -114.21 146.81 18.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -72.43 129.9 39.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.109 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 174' ' ' CYS . 1.5 m -121.67 176.79 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.924 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -141.3 59.73 1.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 2.3 mt-10 -162.08 -63.17 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.093 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.17 34.44 17.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -146.12 141.76 27.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.979 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.79 -139.48 14.48 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.571 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.25 -33.31 0.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 0.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -18.87 65.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.228 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -37.24 48.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.767 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.469 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 85.8 m -69.22 -28.69 66.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.67 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -22.27 61.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.905 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.2 mm-40 -87.31 -52.59 5.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.96 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.587 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.31 -49.16 78.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.136 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 11.1 tp -53.39 -30.81 41.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.975 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -37.03 67.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.8 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 104' ' ' GLU . 6.0 t -60.82 -48.09 90.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.755 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 105' ' ' ALA . 1.4 mp -70.49 -17.18 62.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.698 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 110' ' ' ARG . 2.0 ttm-85 -87.46 -9.67 53.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.569 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -80.56 -63.86 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.744 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -171.91 -175.67 1.55 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.294 179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 112' ' ' SER . 7.1 mpt_? 70.08 -71.55 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.97 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.509 ' H ' ' HG2' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -66.82 110.56 3.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.932 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.57 142.65 24.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 97.8 Cg_endo -79.42 148.67 21.04 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.575 2.184 . . . . 0.0 112.348 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.23 117.45 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -65.17 97.98 0.29 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.989 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -127.44 -161.48 10.83 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.195 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.48 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -129.27 117.68 21.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.334 . . . . 0.0 110.643 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.639 HD23 HD23 ' A' ' 187' ' ' LEU . 26.5 tp -89.87 130.71 36.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.728 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.422 ' CE1' HD12 ' A' ' 120' ' ' LEU . 30.9 m-70 -118.22 93.19 4.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.915 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.642 HG23 ' HB2' ' A' ' 82' ' ' SER . 79.4 t -66.15 94.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -99.46 135.69 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.346 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -58.06 -9.56 5.85 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.104 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -114.88 32.73 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.29 134.97 6.64 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 mt -66.98 171.1 5.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.907 0.384 . . . . 0.0 111.233 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.576 ' HD3' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -167.24 110.67 0.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.665 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.613 HG22 HD13 ' A' ' 121' ' ' LEU . 7.7 t -106.32 114.8 46.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.92 0.39 . . . . 0.0 111.384 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.72 120.35 57.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.874 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 37.6 m-20 -52.22 152.97 3.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.55 2.52 28.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.939 0.4 . . . . 0.0 111.165 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.42 -24.73 6.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.572 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.01 -10.52 5.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.686 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 27.4 mmtm 54.03 26.27 6.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.817 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 132' ' ' ASP . . . -90.67 135.76 13.03 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.443 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.576 HD11 ' HD3' ' A' ' 129' ' ' ARG . 5.1 tp -67.65 108.17 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.663 0.268 . . . . 0.0 110.619 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 3.0 pt -99.36 -25.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.435 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.544 ' HB ' HG23 ' A' ' 130' ' ' VAL . 74.8 t -136.68 106.19 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.214 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.22 27.93 8.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.327 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -70.24 -173.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.23 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 2.8 m -131.46 164.7 25.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.709 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.461 HD11 ' O ' ' A' ' 124' ' ' SER . 16.0 mt -77.61 -33.45 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.62 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -85.87 -10.87 54.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.45 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 7.1 tttm -83.53 -37.83 22.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.762 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 m -77.67 138.35 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.449 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -60.5 -68.58 0.29 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.516 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 148' ' ' SER . 0.1 OUTLIER -141.22 136.44 31.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.054 178.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.539 ' O ' ' HB3' ' B' ' 2' ' ' PHE . 60.6 m -98.35 93.26 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.549 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -105.11 153.17 39.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.464 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.904 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 82.8 Cg_endo -86.6 -118.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.783 2.322 . . . . 0.0 112.149 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.451 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 18.7 p-10 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.596 0.236 . . . . 0.0 111.042 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 120.857 0.361 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -149.9 119.04 0.99 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.429 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.772 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -111.3 -179.42 3.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.01 0.433 . . . . 0.0 111.034 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -166.44 169.85 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.498 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -150.6 145.54 25.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.511 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -117.03 157.12 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.063 0.459 . . . . 0.0 111.567 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.7 -174.97 5.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.677 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.9 OUTLIER -127.65 -149.37 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.799 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.611 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER -63.57 -163.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.903 0.382 . . . . 0.0 111.384 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.91 -16.29 60.46 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.441 ' H ' ' H ' ' A' ' 169' ' ' THR . 10.7 t -163.96 -5.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 110.068 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.441 ' H ' ' H ' ' A' ' 168' ' ' THR . 6.9 m -132.17 -12.37 3.21 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.611 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 34.3 mtt85 60.8 19.39 9.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.059 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.608 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -171.89 172.79 4.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.935 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -81.76 115.33 20.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.625 179.453 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.608 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 3.2 mtp -131.31 145.91 52.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.511 ' HB2' HG23 ' A' ' 163' ' ' ILE . 16.4 t -119.11 142.95 47.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -112.25 156.63 22.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.628 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 88' ' ' LEU . . . -137.93 146.77 18.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.537 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -164.72 161.06 20.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 0.0 110.959 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.458 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 2.0 mp -127.92 168.6 15.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.88 125.32 45.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.071 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.42 -13.94 45.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.692 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.486 ' HE2' ' HB3' ' A' ' 83' ' ' PHE . 5.9 mmtm -80.73 -28.65 36.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 56.33 37.13 28.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.992 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.43 -44.33 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.987 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.24 31.05 43.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.534 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -127.88 -30.12 2.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 110.978 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.421 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -88.57 -8.94 53.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.742 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.639 HD23 HD23 ' A' ' 121' ' ' LEU . 4.9 mp -127.32 -55.99 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.278 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -63.38 1.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.421 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -59.95 -19.18 50.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.258 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.608 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -79.77 -44.57 20.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.238 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 187' ' ' LEU . 70.9 t -63.8 -32.58 57.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.722 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.95 -7.57 30.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.425 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 59.5 m -109.75 -17.4 13.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.778 0.323 . . . . 0.0 110.97 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.516 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -55.7 -44.83 77.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.128 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.449 ' HD2' ' HB3' ' B' ' 6' ' ' SER . 2.4 p90 -74.9 -29.7 61.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.54 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -60.18 -17.13 38.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 89.8 t -106.82 -27.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.088 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.2 t -75.38 -4.39 39.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 196' ' ' ALA . 5.1 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.904 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.692 0.282 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' B' ' 2' ' ' PHE . 91.0 p 177.39 140.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.881 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -73.1 178.46 4.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.55 -17.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.005 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 195' ' ' PHE . 51.9 p -80.15 3.31 20.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -70.91 164.23 25.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -107.63 -1.31 21.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t70 58.86 95.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.225 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -58.08 146.55 68.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.86 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo . . . . . 0 C--O 1.248 1.011 0 C-N-CA 122.493 2.128 . . . . 0.0 112.285 -179.846 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.09 -38.46 24.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.107 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -63.04 -20.3 65.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.644 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 8.9 tt0 -104.53 -12.94 16.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.635 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -54.77 -48.75 72.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.241 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 81' ' ' CYS . 1.2 t -62.03 -35.51 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.388 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -65.9 -29.96 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -90.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -176.58 34.7 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.519 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.634 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -176.8 102.82 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.894 0.378 . . . . 0.0 111.251 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.545 ' HB3' HG23 ' A' ' 76' ' ' VAL . 23.0 t -141.34 65.28 1.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.649 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -163.27 -160.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.35 . . . . 0.0 111.158 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.403 ' CG ' ' HE3' ' A' ' 181' ' ' LYS . 6.1 m-85 -156.05 -171.17 3.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.898 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.27 148.69 2.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.878 0.371 . . . . 0.0 111.305 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 119' ' ' GLY . 18.2 m -135.7 -167.08 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.24 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.84 75.84 1.5 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.765 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' ' 117' ' ' VAL . 83.0 t80 -63.71 91.82 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.016 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.628 ' HB2' HD22 ' A' ' 109' ' ' LEU . 0.7 OUTLIER -61.46 -43.24 99.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA3' ' HD3' ' A' ' 114' ' ' ARG . . . 150.58 -126.75 2.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.332 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.92 132.34 8.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 0.0 111.107 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG21 ' HB ' ' A' ' 108' ' ' VAL . 4.2 m -126.02 149.91 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.993 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.51 137.22 54.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.9 -169.68 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.898 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -122.77 80.4 1.74 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 63.8 109.22 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.804 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.5 p -45.9 -30.16 1.64 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.576 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.32 126.67 19.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.096 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.3 -125.35 2.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.574 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -170.18 -50.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.718 0.294 . . . . 0.0 110.638 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -78.84 11.51 2.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.188 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 163' ' ' ILE . 9.6 t -62.61 -16.27 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.936 0.398 . . . . 0.0 110.599 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 67.2 m -102.31 -35.49 8.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.875 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.87 -19.72 62.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 76.3 mt-10 -104.49 -48.28 3.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.145 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.413 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -56.84 -37.03 70.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.279 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 160' ' ' PHE . 14.8 tp -58.48 -35.93 72.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.66 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -34.97 61.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.2 t -58.7 -33.14 48.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.668 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.665 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -80.01 -25.12 40.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.529 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.1 -14.47 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.711 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -105.99 -3.86 21.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.949 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.66 -173.53 2.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.03 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.5 10.94 16.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.002 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.665 ' HG3' HD23 ' A' ' 109' ' ' LEU . 5.6 mmp_? -62.98 105.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -83.03 134.79 45.74 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.088 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 72.3 Cg_endo -74.86 142.49 28.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.525 2.15 . . . . 0.0 112.182 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 87' ' ' TYR . 2.3 t -107.5 122.35 61.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -69.17 112.93 6.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.447 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -151.53 145.9 14.16 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.576 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.516 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -83.07 110.14 17.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 0.0 111.004 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.754 HD13 HG22 ' A' ' 130' ' ' VAL . 27.3 tp -80.65 137.68 36.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.586 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.516 ' CE1' HD12 ' A' ' 120' ' ' LEU . 3.6 m-70 -124.08 85.83 2.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.704 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.649 ' H ' ' HB2' ' A' ' 82' ' ' SER . 74.7 t -62.39 98.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.108 0.48 . . . . 0.0 111.002 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -98.53 142.34 30.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.205 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.59 16.84 2.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.672 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 124' ' ' SER . 35.7 t0 -146.97 27.99 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.879 0.371 . . . . 0.0 110.433 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.34 113.07 1.77 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -75.79 141.49 42.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.948 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -142.23 131.55 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.754 HG22 HD13 ' A' ' 121' ' ' LEU . 9.1 t -106.88 112.44 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.73 109.92 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.736 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 2.8 m-20 -51.29 147.38 5.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.983 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -97.41 11.45 36.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.927 0.394 . . . . 0.0 110.651 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.05 -30.64 6.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.869 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.662 HG23 ' H ' ' A' ' 137' ' ' GLY . 14.8 t -132.71 -8.69 3.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.005 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 13.3 mmtp 58.34 22.65 9.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.831 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.662 ' H ' HG23 ' A' ' 135' ' ' THR . . . -75.47 -133.49 0.38 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.577 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 tp -151.12 112.85 4.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 0.0 110.66 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.42 ' H ' HG13 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -96.26 -45.38 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.198 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.629 ' HB ' HG23 ' A' ' 130' ' ' VAL . 36.5 t -119.63 97.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.249 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.86 59.38 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.691 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.17 -169.62 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.044 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.712 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 62.1 m -136.31 156.88 48.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.491 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -57.22 -42.27 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.695 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.429 ' H ' HG22 ' A' ' 143' ' ' THR . 7.5 pt-20 -81.39 -14.22 57.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.428 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.624 ' HB3' ' H ' ' A' ' 143' ' ' THR . 0.7 OUTLIER -76.29 -39.55 53.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.587 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 143' ' ' THR . 1.1 m -80.02 150.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -62.44 1.73 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.624 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.81 ' HB2' ' HB3' ' B' ' 3' ' ' SER . 22.1 p90 -173.22 135.8 0.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.73 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.31 136.17 36.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.294 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.421 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . . . -146.4 102.52 4.03 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.641 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 12.4 Cg_endo -54.76 -83.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.626 2.217 . . . . 0.0 112.408 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.955 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.882 0.372 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -145.2 136.92 6.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.293 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.575 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -122.6 -175.29 3.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.95 173.72 11.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.411 . . . . 0.0 111.05 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -158.24 147.18 19.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.514 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -116.39 158.61 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 0.0 111.51 -178.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.5 p -157.52 -176.54 6.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.483 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -130.6 135.63 48.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.3 p30 44.19 -158.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.811 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.05 -12.36 62.21 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.1 t 179.76 -17.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.096 0.474 . . . . 0.0 110.176 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.93 HG21 ' HG3' ' A' ' 173' ' ' MET . 87.6 m -112.77 -14.18 13.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.499 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 58.37 26.46 14.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.357 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.858 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -174.53 -171.44 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 111.561 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.44 135.54 57.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.477 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.93 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -167.17 145.54 4.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.658 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.712 ' HB2' HG23 ' A' ' 163' ' ' ILE . 44.7 t -128.0 145.35 51.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.163 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -115.14 137.25 52.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.593 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.522 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -110.74 152.91 17.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.673 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -167.51 132.89 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.87 0.367 . . . . 0.0 111.047 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.604 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 3.9 mp -106.42 156.8 18.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.11 120.66 25.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.9 t -70.47 -11.87 61.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.958 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.403 ' HE3' ' CG ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -86.81 -26.19 24.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 54.8 71.82 0.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.4 t -155.17 -30.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 64.91 36.91 93.65 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.401 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -139.52 -30.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.737 0.304 . . . . 0.0 111.021 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.464 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.4 OUTLIER -90.58 -2.53 57.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.886 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 191' ' ' VAL . 5.5 mp -135.96 -58.22 0.76 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.27 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.05 -57.67 8.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.342 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -59.84 -20.54 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.074 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.12 -45.45 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.073 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 187' ' ' LEU . 98.6 t -63.82 -30.71 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.91 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.481 ' HA2' ' HE1' ' A' ' 195' ' ' PHE . . . -64.09 -7.38 23.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.427 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.452 ' O ' HG23 ' A' ' 197' ' ' VAL . 1.0 OUTLIER -119.24 -5.12 10.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 0.0 110.743 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -74.5 -52.53 11.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.333 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.481 ' HE1' ' HA2' ' A' ' 192' ' ' GLY . 40.1 p90 -65.94 -31.14 71.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.945 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.603 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -58.22 -24.22 58.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.791 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 193' ' ' CYS . 22.3 t -93.75 -18.97 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.962 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 3.7 t -74.89 -27.07 60.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.957 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.801 0.334 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.81 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER 62.87 118.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.184 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -57.5 157.59 6.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.07 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 3.1 mtp -125.0 0.21 7.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.018 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 32.6 p -92.01 25.08 2.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.496 ' HD2' ' H ' ' B' ' 9' ' ' ASP . 39.4 p90 -72.14 162.0 30.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -114.74 11.7 16.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.489 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ASP . . . . . 0.496 ' H ' ' HD2' ' B' ' 7' ' ' PHE . 35.3 t70 57.45 78.27 0.24 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.211 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 30.2 m-85 -63.08 146.4 95.85 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 15.5 Cg_exo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.725 2.283 . . . . 0.0 112.384 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.906 0.384 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.63 -28.13 45.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.272 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.41 -29.16 69.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.308 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.706 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.6 tm-20 -82.52 -23.2 34.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.688 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.18 -49.97 72.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.903 HG11 ' HA ' ' A' ' 194' ' ' ALA . 55.2 t -63.51 -42.17 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.487 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.706 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -55.31 -37.12 66.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.272 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 2.7 m -71.74 -90.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.218 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.641 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 176.91 38.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.422 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.649 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 1.5 t -174.23 102.34 0.1 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.986 0.422 . . . . 0.0 112.045 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.429 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 9.6 t -142.17 56.81 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.994 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.695 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -151.75 -151.34 0.38 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.168 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -155.41 -172.89 4.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.023 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.508 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.6 OUTLIER -53.92 146.64 13.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.494 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 121' ' ' LEU . 10.5 m -146.56 -176.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.19 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 1.1 mptt -143.0 81.54 1.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.875 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HE1' ' HB3' ' A' ' 175' ' ' HIS . 82.0 t80 -61.32 100.08 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.684 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.474 ' HB2' HD22 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -64.85 -48.33 74.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.61 -131.42 3.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.595 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.96 133.56 22.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.71 0.29 . . . . 0.0 110.991 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.79 157.69 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -83.55 142.96 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -179.01 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.898 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.64 59.66 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.173 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 2.7 tt0 -170.22 -61.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.072 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.5 p 48.71 54.25 10.97 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.965 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 1.7 ptm180 -163.38 114.47 1.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.993 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.77 -137.03 12.5 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.419 ' HB2' ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -147.58 -19.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.867 0.365 . . . . 0.0 110.761 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -79.26 4.72 14.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.071 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -87.38 -15.52 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.767 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.435 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 89.4 m -88.43 -34.37 17.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.813 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.14 -22.51 66.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 108' ' ' VAL . 5.5 mm-40 -93.66 -46.37 7.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.78 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -56.23 -32.68 64.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.973 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.61 -39.9 76.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.702 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -24.49 65.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.738 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 104' ' ' GLU . 59.0 t -75.13 -45.89 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 105' ' ' ALA . 1.3 mt -60.07 -35.7 75.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.957 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -72.09 -39.24 69.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.712 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -77.09 -11.95 59.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.26 -174.98 2.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 113' ' ' ARG . 1.4 mtp85 -87.67 14.37 8.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.485 ' HG3' ' HA ' ' A' ' 109' ' ' LEU . 3.1 mmp_? -61.34 103.26 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -76.2 123.31 87.95 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.133 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 73.5 Cg_endo -75.66 172.82 15.57 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.488 2.125 . . . . 0.0 112.211 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.4 t -130.47 140.23 49.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.21 72.87 8.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 132' ' ' ASP . . . -123.95 149.24 16.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.708 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -80.14 126.79 31.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 110.94 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.675 HD23 HD23 ' A' ' 187' ' ' LEU . 51.8 tp -89.52 136.82 32.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.499 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 89.8 m-70 -126.72 94.76 4.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.1 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.695 ' H ' ' HB2' ' A' ' 82' ' ' SER . 54.3 t -60.8 97.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.016 0.436 . . . . 0.0 110.725 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.641 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 11.9 p -103.53 137.0 42.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.269 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -78.56 39.92 1.98 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.692 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -162.07 13.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.397 . . . . 0.0 110.729 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.776 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 134.57 97.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.468 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.513 ' HG ' HG13 ' A' ' 144' ' ' ILE . 2.4 mt -53.68 138.58 34.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.068 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.827 ' HG2' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -137.31 142.22 41.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.609 HG23 ' HB ' ' A' ' 140' ' ' VAL . 8.7 t -114.93 102.33 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.035 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.85 114.99 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.412 ' HA ' ' CA ' ' A' ' 119' ' ' GLY . 4.6 t0 -50.5 144.72 7.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.077 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.21 5.15 51.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.165 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 -32.74 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.692 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.49 -19.53 13.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.737 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm 50.02 39.63 19.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.41 -124.07 5.23 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.492 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.827 HD11 ' HG2' ' A' ' 129' ' ' ARG . 10.3 tp -154.76 113.81 3.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 110.726 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.427 HD12 HG12 ' A' ' 130' ' ' VAL . 5.5 mt -96.23 -54.01 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.4 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.609 ' HB ' HG23 ' A' ' 130' ' ' VAL . 98.9 t -112.5 111.81 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.904 0.383 . . . . 0.0 111.313 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.32 25.32 10.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.608 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.404 ' H ' HG12 ' A' ' 140' ' ' VAL . 70.7 mm-40 -68.43 -170.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.169 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.776 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 5.6 m -146.03 154.29 41.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.931 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.513 HG13 ' HG ' ' A' ' 128' ' ' LEU . 13.6 mt -70.11 -43.51 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.706 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.24 -1.05 31.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.683 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.412 ' CB ' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -96.89 -43.08 7.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 143' ' ' THR . 0.6 OUTLIER -66.02 145.06 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 110.993 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.411 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -55.39 -64.8 0.73 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.628 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.634 ' HD1' HD13 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -144.51 -178.01 5.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.869 179.122 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' B' ' 3' ' ' SER . 2.2 t -123.18 155.58 36.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.419 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 99' ' ' MET . . . -176.12 126.06 0.34 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.77 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.586 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 96.4 Cg_endo -85.09 -90.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.76 2.307 . . . . 0.0 112.308 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 5.9 p-10 . . . . . 0 C--O 1.232 0.166 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.568 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.858 0.361 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 153' ' ' ASP . . . -105.19 143.82 15.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.355 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.586 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -119.22 169.68 9.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.323 . . . . 0.0 110.87 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.678 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -164.41 176.84 8.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -147.43 145.52 29.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.403 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.645 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -106.85 152.49 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.468 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.13 127.54 12.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.685 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -99.95 113.49 26.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.48 ' HA ' ' N ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER 50.45 -153.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.311 179.25 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.94 -37.31 2.51 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.385 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.26 5.47 0.34 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.1 OUTLIER -128.72 -17.79 3.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.731 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.48 ' N ' ' HA ' ' A' ' 166' ' ' ASP . 0.1 OUTLIER 58.6 25.35 13.09 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.095 -178.378 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 172.19 176.4 0.09 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.552 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.08 124.33 26.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.5 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.767 ' HB2' HG21 ' A' ' 169' ' ' THR . 24.6 mtp -153.63 125.45 7.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.203 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.645 ' HB2' HG23 ' A' ' 163' ' ' ILE . 6.7 t -106.84 141.05 38.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.353 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 7.5 m-70 -103.54 129.87 50.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.001 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.678 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -112.57 154.33 16.94 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.35 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -158.73 136.22 10.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.731 0.3 . . . . 0.0 110.536 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.8 mt -97.07 139.85 32.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.299 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.34 115.69 17.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.779 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 3.0 t -58.91 -23.69 61.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.437 ' H ' ' HG2' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -82.34 -28.52 31.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.045 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 55.08 82.93 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.8 t -161.33 -37.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.925 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.51 18.61 78.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.578 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -134.81 -0.37 2.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 0.0 110.816 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.525 ' HB2' HD12 ' A' ' 187' ' ' LEU . 1.1 mmt180 -98.54 -25.38 14.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.903 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.675 HD23 HD23 ' A' ' 121' ' ' LEU . 4.2 mp -124.39 -51.04 1.75 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.806 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.0 t -58.26 -49.38 77.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.673 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 1.4 t-80 -69.67 -1.92 10.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.547 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.429 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -103.97 -40.75 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.167 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.617 ' HA ' HG11 ' A' ' 123' ' ' VAL . 4.8 p -67.92 -15.29 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.08 97.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.565 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 66.1 m -84.35 -11.58 56.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.988 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.903 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -60.06 -28.46 67.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.274 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -80.89 -37.73 29.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.603 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -55.91 -21.84 22.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.264 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 197' ' ' VAL . 0.8 OUTLIER -75.3 -42.1 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.803 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 85.4 m -78.76 -15.12 58.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.483 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.603 HD12 ' HA ' ' A' ' 196' ' ' ALA . 8.3 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.817 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 3.4 p90 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.634 0.254 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' A' ' 150' ' ' CYS . 2.7 p -145.34 171.34 14.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.937 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -81.18 161.1 24.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.974 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' MET . . . . . 0.459 ' HB2' HD21 ' A' ' 199' ' ' LEU . 16.3 mtp -134.34 -7.49 2.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.026 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 20.6 t -93.12 27.13 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -62.72 158.25 19.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.75 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -85.05 7.3 21.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.857 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 17.7 t70 53.67 68.73 0.8 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.136 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.412 ' HE2' ' HA ' ' A' ' 146' ' ' LYS . 60.7 m-85 -67.86 140.69 94.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 C--O 1.248 1.004 0 C-N-CA 122.534 2.156 . . . . 0.0 112.336 -179.802 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.838 0.351 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.69 -32.58 6.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -60.36 -41.47 93.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.873 0.368 . . . . 0.0 110.777 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.858 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.6 mt-10 -92.88 -5.08 51.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.762 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -66.08 -46.42 77.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.045 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 81' ' ' CYS . 0.9 OUTLIER -64.79 -36.58 77.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.394 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.858 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -59.31 -39.27 82.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.359 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -91.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.555 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.455 ' CA ' ' HB2' ' A' ' 124' ' ' SER . . . -178.36 36.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.488 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.628 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -176.0 101.71 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.668 0.27 . . . . 0.0 111.253 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.466 ' CB ' HG23 ' A' ' 76' ' ' VAL . 16.6 t -128.22 0.06 5.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.791 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.739 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -97.78 -163.38 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.6 0.238 . . . . 0.0 111.042 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.623 ' HB3' ' HD2' ' A' ' 181' ' ' LYS . 8.5 m-85 -154.88 -169.14 3.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.354 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.856 ' HB2' ' HE2' ' A' ' 181' ' ' LYS . 0.3 OUTLIER -41.07 142.31 0.52 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.072 -178.507 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 120' ' ' LEU . 4.1 m -142.26 -165.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.03 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.27 71.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.605 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 89.9 t80 -59.81 99.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -73.62 -40.24 63.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.58 -132.44 3.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.321 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 175' ' ' HIS . 1.2 p -161.69 142.73 11.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.83 0.347 . . . . 0.0 110.927 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.2 m -127.17 153.38 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.067 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.77 142.5 42.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.988 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.94 -178.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.078 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -143.32 59.51 1.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -176.74 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.433 ' OG ' ' HB3' ' A' ' 172' ' ' TRP . 1.0 OUTLIER 62.92 18.52 10.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.61 -178.644 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -119.61 51.92 1.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.29 169.07 37.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.12 -27.39 26.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.937 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.46 -19.02 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.035 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.94 -34.61 49.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.745 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.2 m -82.91 -33.49 26.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -65.63 -20.64 66.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.986 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.7 mm-40 -103.68 -46.44 4.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.048 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.62 -47.03 77.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.694 ' HA ' HD12 ' A' ' 109' ' ' LEU . 15.8 tp -58.33 -32.87 68.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.768 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 1.2 tttm -72.47 -39.77 67.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 104' ' ' GLU . 35.1 t -57.88 -40.95 78.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.766 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.8 mt -65.44 -27.88 68.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.913 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -28.2 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.79 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 14.4 mt-30 -84.69 -23.13 29.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -106.4 169.32 8.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.26 69.47 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.766 ' HG3' HD23 ' A' ' 109' ' ' LEU . 16.1 mmt-85 -72.26 -154.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.924 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.26 85.97 6.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.548 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 91.6 Cg_endo -79.82 128.4 7.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.701 2.267 . . . . 0.0 112.187 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -113.43 164.68 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -112.1 72.52 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -131.39 -167.81 12.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.445 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.557 ' HA ' HG22 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -135.48 141.27 45.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 111.184 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 120' ' ' LEU . 64.3 tp -76.32 147.92 37.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.347 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -127.28 77.45 1.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.724 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 82' ' ' SER . 53.3 t -53.17 98.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 121.108 0.48 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.528 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -106.65 131.78 53.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.146 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.04 -15.08 9.15 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.824 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -112.5 35.72 3.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 113.2 126.19 4.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.448 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.453 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -79.66 139.16 37.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.718 0.294 . . . . 0.0 110.99 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.612 ' HB2' HD11 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.23 141.95 39.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.024 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 140' ' ' VAL . 20.2 t -109.2 114.28 46.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.008 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -104.7 121.31 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.602 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 2.6 t0 -60.94 165.81 3.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.886 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.81 2.15 25.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.55 -45.38 2.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.68 -24.57 19.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.64 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.78 40.58 24.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.795 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.8 -114.92 3.89 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.504 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 129' ' ' ARG . 10.0 tp -168.57 120.27 0.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.771 0.319 . . . . 0.0 110.665 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.597 HD13 HG21 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -101.85 -54.43 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.277 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.579 ' HB ' HG23 ' A' ' 130' ' ' VAL . 80.4 t -103.1 101.78 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.173 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -97.03 21.4 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.61 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -68.54 -177.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.103 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.571 ' O ' HG22 ' A' ' 147' ' ' VAL . 28.4 m -140.75 157.53 45.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.593 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 124' ' ' SER . 21.4 mt -59.86 -45.97 94.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.188 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -76.88 -1.47 28.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 5.3 tttt -99.58 -38.17 8.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.921 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 143' ' ' THR . 1.9 m -75.07 130.44 36.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.043 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.429 ' HB3' ' HD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -65.7 -50.12 66.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.032 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.478 ' HD2' ' HB2' ' B' ' 3' ' ' SER . 61.9 m-85 -131.55 -173.05 3.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 0.0 111.363 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 161' ' ' SER . 8.9 t -161.89 34.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.043 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.23 148.85 95.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.108 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.923 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 61.4 Cg_endo -88.79 -142.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.053 2.502 . . . . 0.0 112.305 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.474 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 23.5 t0 . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.709 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 182' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.87 0.367 . . . . 0.0 110.93 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.72 128.73 3.87 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.537 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -121.46 168.5 11.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.688 0.28 . . . . 0.0 110.702 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 150' ' ' CYS . 1.1 m -157.87 172.28 18.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -145.41 145.21 31.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.593 178.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.777 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.1 OUTLIER -111.62 169.54 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.289 -179.025 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.434 ' H ' HG22 ' A' ' 163' ' ' ILE . 40.9 t -169.98 136.6 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.624 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.75 115.32 30.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 111.148 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 50.09 -159.72 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.401 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.42 -16.0 42.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.775 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.427 ' H ' ' H ' ' A' ' 169' ' ' THR . 1.1 t -170.28 -4.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.063 0.459 . . . . 0.0 110.044 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.61 HG22 ' HG3' ' A' ' 171' ' ' ARG . 11.7 m -133.19 -12.65 2.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.977 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 5.6 mmt180 58.96 23.37 11.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.61 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -174.3 171.77 3.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.221 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.433 ' HB3' ' OG ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -74.98 119.98 19.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.936 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.527 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 0.1 OUTLIER -142.44 146.23 34.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.641 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.777 ' HB2' HG23 ' A' ' 163' ' ' ILE . 16.9 t -131.54 124.71 30.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.95 0.405 . . . . 0.0 111.293 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 9.2 m-70 -91.41 136.58 33.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.228 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -114.35 154.06 17.21 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.221 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 21.3 p90 -161.89 143.42 11.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.666 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.87 138.07 50.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.022 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.41 113.87 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.072 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 3.6 t -64.53 -32.47 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.957 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.856 ' HE2' ' HB2' ' A' ' 84' ' ' SER . 0.1 OUTLIER -65.47 -27.07 68.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.027 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.547 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 65.4 m-20 55.95 90.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.199 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 t -168.23 -43.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.777 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.39 30.51 56.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 32.3 tt0 -136.27 -42.39 0.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.701 0.286 . . . . 0.0 110.986 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.552 ' HB2' ' HD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -75.17 -5.95 47.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.9 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp -131.29 -49.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.995 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -60.94 2.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 0.3 OUTLIER -62.37 -13.1 25.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.396 -179.438 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -88.19 -44.4 10.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.153 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.49 ' HA ' HG11 ' A' ' 123' ' ' VAL . 1.7 p -69.95 -24.38 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.86 -10.22 83.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.458 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.8 m -110.0 14.4 23.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.392 . . . . 0.0 110.557 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.59 -43.4 11.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.172 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' B' ' 4' ' ' ASN . 5.1 p90 -61.34 -33.35 73.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.733 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.63 -27.41 64.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.886 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.94 -5.53 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.756 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 2.0 t -88.97 -5.4 57.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.923 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.021 179.766 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.923 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.406 0.146 . . . . 0.0 110.882 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 149' ' ' PHE . 0.0 OUTLIER 64.51 131.74 0.02 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.976 0.417 . . . . 0.0 111.369 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 7.6 p30 -109.95 -165.6 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.742 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' MET . . . . . 0.418 ' HG2' ' CE2' ' B' ' 7' ' ' PHE . 0.0 OUTLIER -125.94 -137.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.6 p 56.55 18.17 3.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.562 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.487 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 32.1 p90 -85.69 151.88 23.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.687 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -82.78 9.02 10.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ASP . . . . . 0.487 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 8.1 t0 54.46 70.33 0.63 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.777 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.436 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 31.0 m-85 -60.0 139.2 90.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.958 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 32.1 Cg_exo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.705 2.27 . . . . 0.0 112.229 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.831 0.348 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.56 -16.39 10.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.151 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -104.91 -13.93 15.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.3 -14.56 14.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.79 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -66.95 -50.79 61.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.017 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.447 HG23 ' SG ' ' A' ' 81' ' ' CYS . 1.8 t -59.83 -44.88 95.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.799 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -57.97 -39.17 77.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.536 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.1 m -69.2 -93.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.526 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.6 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -177.9 30.98 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.382 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.684 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -171.73 100.13 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.903 0.382 . . . . 0.0 111.789 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 4.1 t -121.7 -147.48 0.39 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.126 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.657 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 52.83 -157.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 111.635 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.491 ' HB3' ' HD2' ' A' ' 181' ' ' LYS . 2.8 m-85 -159.14 -166.21 1.78 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.492 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 0.2 OUTLIER -46.77 151.1 0.63 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.726 0.298 . . . . 0.0 111.309 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -145.7 -169.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.102 0.477 . . . . 0.0 111.706 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -152.4 71.91 0.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.266 178.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 22.4 t80 -56.06 111.22 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.192 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 mt -70.53 -80.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.07 -127.5 1.02 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.561 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 8.3 p -155.84 137.75 14.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.703 0.287 . . . . 0.0 111.04 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.33 157.87 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -75.84 147.08 39.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.211 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.49 -176.05 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.58 ' HA ' ' HE3' ' A' ' 172' ' ' TRP . 1.7 t80 -146.03 64.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.256 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.03 -68.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.442 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.54 19.62 6.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.822 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.38 125.4 12.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.33 -112.67 1.31 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.546 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.533 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -174.36 -34.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 111.05 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -76.65 -9.74 58.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.299 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.6 -22.85 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 24.0 m -87.24 -33.99 19.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 153' ' ' ASP . 2.9 mt-10 -64.03 -15.66 59.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.026 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.4 mt-10 -97.32 -48.73 5.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.039 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.14 -34.22 71.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.133 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.48 HD21 ' HA3' ' A' ' 159' ' ' GLY . 6.8 tp -64.71 -29.84 70.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -45.99 30.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.835 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' GLU . 4.0 t -59.28 -37.73 70.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.173 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.587 HD23 ' HG3' ' A' ' 114' ' ' ARG . 8.5 mt -70.51 -26.75 63.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -9.68 59.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -114.93 1.78 14.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.034 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -118.19 -18.33 9.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.283 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.5 69.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.874 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.587 ' HG3' HD23 ' A' ' 109' ' ' LEU . 18.7 mmt180 -84.77 43.43 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.49 90.94 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.421 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 70.2 Cg_endo -74.03 163.17 37.43 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.605 2.204 . . . . 0.0 112.075 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.3 t -124.44 160.94 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.818 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.476 ' HB2' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -130.75 79.5 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -135.16 -174.17 13.33 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.752 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.499 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -101.97 122.97 45.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.749 0.309 . . . . 0.0 110.968 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.474 ' HB2' HG21 ' A' ' 85' ' ' VAL . 28.9 tp -86.6 124.11 32.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.377 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.684 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 67.6 m-70 -112.72 90.48 3.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.972 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 191' ' ' VAL . 44.1 t -66.3 94.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.052 0.453 . . . . 0.0 110.851 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.6 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -91.8 141.06 29.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.938 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.31 34.39 1.54 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.671 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -166.43 18.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.858 0.361 . . . . 0.0 110.568 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.96 106.64 0.64 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.473 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.05 136.1 51.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 111.106 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.82 137.59 41.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 139' ' ' ILE . 3.8 t -119.47 118.47 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.147 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 136' ' ' LYS . 5.7 t -106.74 117.22 52.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.83 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.432 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 3.1 m-20 -51.4 145.03 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.964 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.87 15.47 25.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.533 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.64 -5.76 2.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.592 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.72 -13.62 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.435 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.44 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.9 OUTLIER 50.66 42.55 27.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.6 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.28 -117.73 4.37 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tp -171.54 128.12 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.683 0.278 . . . . 0.0 110.726 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.553 HG13 ' HB ' ' A' ' 130' ' ' VAL . 1.3 pt -114.69 -39.82 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.321 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.547 ' HB ' HG23 ' A' ' 130' ' ' VAL . 13.0 t -122.84 105.2 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.196 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -111.81 28.62 8.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -70.8 -177.0 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.113 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.74 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 21.7 m -128.41 156.79 42.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.559 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.53 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -67.71 -48.54 75.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.813 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -17.28 61.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.74 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 15.8 tttt -74.0 -53.67 9.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.837 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.11 144.19 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.104 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.8 t -46.56 -58.15 4.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.95 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.761 ' HA ' ' HB3' ' B' ' 4' ' ' ASN . 40.1 p90 -173.1 151.83 2.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.983 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 56.2 m -91.58 113.26 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.533 ' HB1' ' HG2' ' A' ' 99' ' ' MET . . . -120.91 98.56 47.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.074 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 50.1 Cg_exo -54.42 -90.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.454 2.102 . . . . 0.0 112.236 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.496 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 10.7 p-10 . . . . . 0 C--N 1.332 -0.16 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.475 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.79 ' HG2' ' H ' ' A' ' 183' ' ' SER . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.928 0.394 . . . . 0.0 111.082 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.48 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.63 127.57 2.97 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.591 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.503 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -117.08 166.68 11.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.332 . . . . 0.0 110.646 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.584 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 16.4 m -157.96 161.12 38.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.989 0.423 . . . . 0.0 111.288 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.8 145.76 44.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.191 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 174' ' ' CYS . 1.3 mt -112.94 159.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.01 0.433 . . . . 0.0 111.586 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 29.6 p -147.67 153.35 39.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.346 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.29 119.97 36.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 111.406 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.716 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 54.26 -160.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.34 179.034 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.04 -18.19 52.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.428 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.421 ' H ' ' H ' ' A' ' 169' ' ' THR . 8.9 t -168.4 -0.49 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.046 0.45 . . . . 0.0 109.943 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.561 HG21 ' HG3' ' A' ' 173' ' ' MET . 3.9 m -135.35 -20.36 1.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.04 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.716 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 31.6 mtt-85 58.34 42.82 20.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.957 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.441 ' HD3' ' O ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -179.82 -139.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.797 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.58 ' HE3' ' HA ' ' A' ' 94' ' ' PHE . 9.7 m0 -111.18 136.31 50.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.903 0.382 . . . . 0.0 111.377 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.561 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -157.89 130.61 7.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.239 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.438 ' HB2' HG23 ' A' ' 163' ' ' ILE . 34.7 t -117.25 136.72 52.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.426 . . . . 0.0 111.531 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 161' ' ' SER . 10.0 m170 -106.73 151.23 25.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.292 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -129.54 155.16 20.73 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.02 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -159.35 144.16 15.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.738 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 mt -108.91 176.6 5.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.075 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -111.16 128.4 55.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.8 OUTLIER -62.72 -31.76 72.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.916 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.491 ' HD2' ' HB3' ' A' ' 83' ' ' PHE . 4.0 mttm -90.98 -19.91 22.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 183' ' ' SER . 61.3 m-20 57.39 -157.42 0.29 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.837 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.79 ' H ' ' HG2' ' A' ' 158' ' ' ARG . 8.7 t 72.63 -20.88 0.25 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.635 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 182' ' ' ASP . . . 54.16 40.12 66.08 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.91 -10.59 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.79 0.328 . . . . 0.0 110.884 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.488 ' HD3' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -115.64 4.77 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.922 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 121' ' ' LEU . 5.0 mp -142.62 -51.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.308 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.0 t -56.87 -62.22 1.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.549 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.72 -3.82 7.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.608 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -92.4 -47.31 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.248 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.858 ' HA ' HG11 ' A' ' 123' ' ' VAL . 8.2 p -71.07 -20.05 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.267 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.54 -4.55 52.74 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.718 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.458 ' O ' HG23 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -112.33 -6.75 14.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.359 . . . . 0.0 110.794 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.28 -59.69 3.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.987 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -65.62 -26.9 68.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.776 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -66.12 -18.92 65.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 193' ' ' CYS . 86.7 t -105.58 -26.19 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.97 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 19.1 t -76.64 -10.21 59.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.676 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 196' ' ' ALA . 4.6 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.057 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.7 150.29 11.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.02 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.761 ' HB3' ' HA ' ' A' ' 149' ' ' PHE . 3.5 t30 -67.65 146.95 53.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.684 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 14.1 mtp -126.05 -4.19 6.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.081 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -92.83 24.6 3.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.496 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 37.7 p90 -80.62 156.2 26.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.165 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -90.37 9.92 27.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ASP . . . . . 0.496 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 31.0 t0 58.87 71.53 0.58 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.049 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 18.3 m-85 -62.08 141.84 95.67 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 33.0 Cg_exo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.617 2.212 . . . . 0.0 112.312 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.742 0.306 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -45.24 48.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.726 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -65.77 -21.24 66.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.684 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.605 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.5 tt0 -106.58 -2.48 21.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.733 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -64.83 -50.98 64.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.98 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.604 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.8 t -55.09 -37.5 43.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.3 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.605 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 4.8 mtm180 -66.23 -35.91 81.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.184 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 m -81.11 1.47 31.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.601 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 66.77 43.7 2.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.516 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.605 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -172.36 84.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.99 0.424 . . . . 0.0 111.326 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.801 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.8 t -111.48 -151.43 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.352 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.627 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.4 OUTLIER 55.62 -160.04 0.19 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.866 0.365 . . . . 0.0 111.379 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 187' ' ' LEU . 22.0 m-85 -157.37 -167.77 2.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.236 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.435 ' HA ' HD22 ' A' ' 120' ' ' LEU . 71.9 m -49.01 148.64 2.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.82 0.343 . . . . 0.0 111.038 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.432 HG11 HD22 ' A' ' 121' ' ' LEU . 2.7 m -144.52 -173.82 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.043 0.449 . . . . 0.0 111.537 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -137.1 68.85 1.41 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.762 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 36.7 t80 -56.67 110.2 0.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.805 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -83.56 -52.71 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.33 -179.04 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 162.78 -137.56 4.88 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.756 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.549 ' HB3' ' ND1' ' A' ' 175' ' ' HIS . 0.8 OUTLIER -151.35 128.25 11.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.686 0.279 . . . . 0.0 111.087 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.99 162.52 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.03 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -81.45 143.04 32.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.953 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -145.44 127.67 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -92.79 61.01 3.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.94 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.64 -77.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.27 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.577 ' HA ' HG21 ' A' ' 163' ' ' ILE . 0.3 OUTLIER 54.59 32.4 16.95 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.696 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -134.34 132.06 39.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.693 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.38 -164.69 38.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.438 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.83 -11.19 12.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.003 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.9 15.08 0.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.393 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.94 -17.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.41 ' CB ' ' HB2' ' A' ' 161' ' ' SER . 16.9 p -87.74 -34.3 18.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.123 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.424 ' HG3' ' HA ' ' A' ' 153' ' ' ASP . 26.0 mt-10 -66.23 -0.21 2.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.961 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -120.34 -59.64 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.372 . . . . 0.0 111.367 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.517 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -55.5 -38.46 69.21 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.464 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.95 -36.53 62.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -76.66 -37.51 56.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.023 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.15 -44.59 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.615 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -72.19 -17.44 61.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.813 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.09 -11.37 58.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.665 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -80.4 -62.48 1.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.821 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.12 -163.96 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.271 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 72.26 -65.81 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.564 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.615 ' HG3' HD23 ' A' ' 109' ' ' LEU . 31.0 mmt180 -94.56 109.17 21.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.842 0.353 . . . . 0.0 111.001 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -82.1 142.48 47.86 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.982 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HB3' HD23 ' A' ' 88' ' ' LEU . 73.3 Cg_endo -77.33 160.05 32.65 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.589 2.193 . . . . 0.0 112.565 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 87' ' ' TYR . 1.4 t -128.15 152.22 35.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.056 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -96.84 100.09 11.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.751 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -144.51 -169.7 13.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.781 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.511 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.4 OUTLIER -117.78 128.75 55.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.655 0.264 . . . . 0.0 110.623 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.456 HD23 HD23 ' A' ' 187' ' ' LEU . 61.3 tp -92.78 122.44 35.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.177 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 8.0 m-70 -112.88 89.18 3.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.019 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.831 HG11 ' HA ' ' A' ' 191' ' ' VAL . 54.3 t -67.27 90.86 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.056 0.455 . . . . 0.0 110.527 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 p -82.92 156.54 23.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.452 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.47 -7.1 38.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.362 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 143' ' ' THR . 0.5 OUTLIER -124.16 34.61 5.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 110.839 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.654 ' HA2' HG13 ' A' ' 144' ' ' ILE . . . 122.52 -162.45 16.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.574 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.42 HD22 HG22 ' A' ' 123' ' ' VAL . 1.6 mt -122.96 166.86 14.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -159.84 103.87 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.667 HG12 HD12 ' A' ' 139' ' ' ILE . 4.4 t -90.32 98.57 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.21 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 136' ' ' LYS . 0.7 OUTLIER -92.38 114.57 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.913 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.401 ' HB3' HG22 ' A' ' 135' ' ' THR . 0.3 OUTLIER -52.72 146.99 9.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.61 19.28 11.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -131.15 -19.75 2.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.749 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.754 HG23 ' H ' ' A' ' 137' ' ' GLY . 12.2 t -134.87 -21.65 1.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.88 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.596 ' HA ' HG12 ' A' ' 131' ' ' VAL . 9.3 mmtt 56.65 23.95 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.817 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.754 ' H ' HG23 ' A' ' 135' ' ' THR . . . -77.43 -105.43 0.16 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.443 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.3 tp -165.95 102.34 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 110.699 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.667 HD12 HG12 ' A' ' 130' ' ' VAL . 3.2 mt -80.16 -30.06 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.213 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.475 HG12 HG23 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -156.56 148.38 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.267 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -129.29 48.57 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.819 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.47 ' HG3' ' HE2' ' A' ' 162' ' ' TYR . 8.2 mm100 -79.09 -175.58 4.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.052 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 2.6 m -149.0 164.85 33.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.654 HG13 ' HA2' ' A' ' 127' ' ' GLY . 69.2 mt -82.83 -37.93 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -12.2 60.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.626 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -86.43 -48.63 8.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.7 m -64.97 141.45 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.12 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 t -49.87 -65.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.808 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -159.64 123.33 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.805 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 77.0 m -59.87 163.16 4.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.42 125.12 0.74 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.075 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 72.3 Cg_endo -76.1 -94.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.557 2.171 . . . . 0.0 112.438 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.424 ' HA ' ' HG3' ' A' ' 103' ' ' GLU . 5.3 p-10 . . . . . 0 C--O 1.232 0.139 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.434 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.497 HH11 ' HB3' ' A' ' 182' ' ' ASP . 8.8 mtm180 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.803 0.335 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.516 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -122.81 140.37 13.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.419 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -119.49 168.08 11.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 110.833 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 175' ' ' HIS . 13.5 m -154.02 160.52 42.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.859 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.47 ' HE2' ' HG3' ' A' ' 142' ' ' GLN . 4.7 p90 -134.1 151.59 51.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.799 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.577 HG21 ' HA ' ' A' ' 96' ' ' SER . 0.7 OUTLIER -115.77 157.16 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.046 0.451 . . . . 0.0 111.734 -178.531 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.98 135.94 9.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.287 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -118.22 119.99 36.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.895 0.378 . . . . 0.0 111.675 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.86 -164.12 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.713 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.19 -17.61 12.22 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.847 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.442 ' H ' ' H ' ' A' ' 169' ' ' THR . 1.6 t -174.05 -0.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.031 0.443 . . . . 0.0 109.932 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -125.0 -15.73 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.868 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.44 21.31 9.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 177.91 176.48 0.43 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.1 121.32 25.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.663 ' HB2' HG21 ' A' ' 169' ' ' THR . 9.4 mtp -143.02 138.67 30.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.568 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.438 ' HB2' HG23 ' A' ' 163' ' ' ILE . 5.6 t -123.02 136.68 54.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.151 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.549 ' ND1' ' HB3' ' A' ' 90' ' ' CYS . 5.6 m-70 -102.44 157.71 16.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.555 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -133.07 145.26 17.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.865 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 17.8 p90 -153.95 136.44 15.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.768 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.516 HD23 ' HA3' ' A' ' 159' ' ' GLY . 5.7 mt -101.82 166.26 10.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.938 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.16 115.83 29.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -10.75 56.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -84.79 -24.09 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.497 ' HB3' HH11 ' A' ' 158' ' ' ARG . 47.1 m-20 56.98 82.97 0.11 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.6 t -167.02 -58.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.102 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.37 29.11 11.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.299 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -133.88 -54.71 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.416 ' HB2' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -59.93 -15.74 24.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.271 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.456 HD23 HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -115.16 -53.89 2.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -49.89 75.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.404 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -73.99 9.0 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.206 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.62 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -103.53 -55.75 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.81 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.831 ' HA ' HG11 ' A' ' 123' ' ' VAL . 13.2 p -64.03 -25.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -63.69 -19.42 62.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.335 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 91.8 m -103.09 10.22 38.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.828 0.347 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.604 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -90.56 -34.0 15.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.217 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.496 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 1.6 m-85 -62.03 -45.35 93.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.002 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.712 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -58.2 -16.03 12.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.597 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.21 -27.99 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.185 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -27.32 60.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.712 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.249 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.751 0.31 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -168.16 153.91 7.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.722 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -65.39 146.83 54.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.79 -12.26 13.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 83.5 p -91.34 25.6 2.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.84 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -61.57 145.24 52.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.071 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.89 0.24 56.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t0 56.6 78.41 0.22 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -82.44 150.98 64.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.998 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.585 2.19 . . . . 0.0 112.333 179.933 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.844 0.354 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.17 -28.32 65.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.652 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.31 -16.03 61.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.672 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.622 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 5.7 mt-10 -105.31 -16.07 14.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.663 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -54.81 -45.64 74.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.061 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.1 t -64.52 -45.38 95.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.465 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.622 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -54.19 -31.89 54.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.274 178.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -78.93 -91.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.399 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 178.45 34.97 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.373 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.545 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.4 t -174.35 101.21 0.1 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.929 0.395 . . . . 0.0 111.913 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.797 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 2.8 t -122.49 -149.09 0.42 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.461 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.765 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 54.55 -155.68 0.24 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.847 0.356 . . . . 0.0 111.81 178.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -159.39 -169.35 2.58 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.502 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.404 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -51.12 147.04 5.71 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.831 0.348 . . . . 0.0 110.962 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -140.77 -174.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.453 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.09 70.6 1.3 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.596 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 41.1 t80 -52.01 99.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.741 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.589 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 0.7 OUTLIER -71.41 -6.32 39.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.272 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.36 -164.48 12.14 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.619 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 10.1 p -125.72 144.51 50.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.683 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.549 HG12 ' HD2' ' A' ' 114' ' ' ARG . 33.1 m -131.04 161.89 40.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.021 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.03 155.36 20.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.724 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.9 165.87 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.973 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -134.97 59.76 1.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.006 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -155.81 -71.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 54.13 41.09 32.16 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -148.65 108.73 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.999 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.01 -144.32 16.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.765 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.45 -29.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.84 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -73.87 1.65 10.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.13 -28.12 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.031 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.849 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 1.7 m -90.79 -17.55 26.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -7.49 34.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.564 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.6 mm-40 -117.46 -41.34 2.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.019 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.08 82.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.68 -39.27 76.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -70.39 -38.78 74.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 104' ' ' GLU . 22.8 t -56.44 -34.61 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.639 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.782 HD23 ' HG3' ' A' ' 114' ' ' ARG . 2.5 mt -72.21 -28.16 63.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.669 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -12.76 59.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.55 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.84 -18.42 15.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.198 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.7 m -118.7 171.82 7.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.083 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -114.33 66.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.644 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.782 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -63.35 -92.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.2 -179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -150.01 75.72 8.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.337 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 67.2 Cg_endo -73.97 108.72 2.72 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.637 2.225 . . . . 0.0 112.219 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.26 125.98 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.017 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.61 106.49 18.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.908 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -148.45 -171.99 17.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.822 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -100.02 138.89 36.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.04 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.665 HD13 HG22 ' A' ' 130' ' ' VAL . 28.0 tp -108.81 125.42 51.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.181 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 0.1 OUTLIER -117.76 95.61 5.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.292 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.817 HG11 ' HA ' ' A' ' 191' ' ' VAL . 74.9 t -67.1 94.22 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.977 0.418 . . . . 0.0 110.557 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.653 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -92.13 143.0 26.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.627 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -80.1 37.65 2.17 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.648 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -168.89 20.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.729 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 135.39 101.05 0.65 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.221 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 8.6 mt -60.89 132.82 55.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -122.13 146.72 46.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.654 179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.665 HG22 HD13 ' A' ' 121' ' ' LEU . 16.2 t -133.52 98.02 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.26 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.47 ' H ' ' HE1' ' A' ' 122' ' ' HIS . 2.3 t -98.07 124.81 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.889 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.542 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 8.5 t70 -53.67 160.39 1.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.6 OUTLIER -99.49 -1.51 38.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.387 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.03 -43.67 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.937 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.47 -23.2 21.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.43 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 131' ' ' VAL . 6.1 mmtp 50.62 26.55 2.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.19 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.73 -109.05 0.73 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.418 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 141' ' ' ASP . 13.8 tp -160.04 116.72 2.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.93 0.395 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 132' ' ' ASP . 6.5 mm -96.54 -56.39 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.156 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 t -127.68 116.42 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.233 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.432 ' HB3' HD21 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -111.78 39.99 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.581 179.106 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -77.19 -168.44 1.11 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.47 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.613 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 5.1 m -146.05 158.34 43.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.826 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.653 HD11 ' O ' ' A' ' 124' ' ' SER . 4.5 mt -67.65 -35.63 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.041 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -80.62 -11.02 59.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.683 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -90.59 -40.58 11.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 143' ' ' THR . 1.0 OUTLIER -64.86 125.77 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.99 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.6 -73.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.112 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.46 124.49 12.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.29 159.99 22.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.413 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -170.51 108.53 0.43 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.035 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.38 9.95 2.95 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.487 2.125 . . . . 0.0 112.459 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.53 0.193 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.386 -179.41 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.702 ' HG2' ' N ' ' A' ' 183' ' ' SER . 1.3 mpt_? . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.919 0.39 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -105.52 144.68 15.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.729 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 1.7 m-85 -131.34 150.97 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.849 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 0.9 OUTLIER -154.39 151.82 29.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.463 -178.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.543 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -127.05 163.0 24.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.282 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.629 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.8 OUTLIER -122.24 161.49 23.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.975 0.417 . . . . 0.0 111.362 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 2.1 t -155.93 118.93 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.621 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -89.93 119.01 29.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.458 ' HA ' ' N ' ' A' ' 170' ' ' ARG . 0.5 OUTLIER 50.35 -152.14 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.221 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.67 -29.8 2.92 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.775 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.56 -1.15 0.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.031 0.444 . . . . 0.0 109.952 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.775 HG22 ' HG3' ' A' ' 171' ' ' ARG . 1.6 m -128.98 -20.96 3.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.458 ' N ' ' HA ' ' A' ' 166' ' ' ASP . 5.7 mtt-85 66.41 24.14 10.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.316 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.775 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER 178.14 -176.86 0.21 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.051 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.17 132.28 48.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.194 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.537 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -163.21 124.45 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.561 179.201 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.629 ' HB2' HG23 ' A' ' 163' ' ' ILE . 1.9 t -115.84 140.94 48.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.96 0.41 . . . . 0.0 111.251 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.543 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -108.28 145.44 34.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -129.61 152.9 19.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.121 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 42.5 p90 -156.43 154.31 30.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.719 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.444 HD12 HD21 ' A' ' 88' ' ' LEU . 9.1 mt -112.59 158.12 20.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.821 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.435 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -88.38 118.43 28.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.854 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.14 -4.29 16.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.023 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -101.57 -29.64 11.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 58.0 92.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.702 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 28.9 t -167.08 -36.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.009 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.78 19.05 76.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -136.75 -20.87 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.573 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -79.09 -25.6 43.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.037 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 186' ' ' ARG . 6.7 mp -120.89 -43.33 2.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.4 t -58.4 -52.49 65.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -75.57 7.63 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.227 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.79 -56.82 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.091 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.817 ' HA ' HG11 ' A' ' 123' ' ' VAL . 7.6 p -65.76 -22.07 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.204 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.64 -18.95 62.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.508 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.481 ' O ' HG23 ' A' ' 197' ' ' VAL . 1.1 m -105.07 -3.3 23.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 110.712 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.528 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -64.52 -46.26 83.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.152 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.485 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.7 p90 -70.07 -39.1 75.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.991 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.435 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -57.98 -20.03 35.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.514 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 77' ' ' ARG . 35.5 t -105.48 -24.84 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.7 t -73.29 -3.11 24.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.771 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 5.0 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.102 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.734 0.302 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.5 p -173.81 141.94 0.86 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.643 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -60.62 161.46 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.149 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 9.8 ttp -124.17 -2.15 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.959 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p -93.95 17.32 12.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.991 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -65.37 146.02 55.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.974 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -88.45 -1.57 58.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.954 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t0 55.03 77.13 0.22 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 23.5 m-85 -60.03 141.91 89.63 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 32.5 Cg_exo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.583 2.189 . . . . 0.0 112.267 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.89 0.376 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.54 -39.32 53.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.98 -39.69 79.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.694 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -74.56 -15.56 60.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -63.78 -47.84 79.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.472 HG22 HG12 ' A' ' 123' ' ' VAL . 24.3 t -58.8 -40.89 81.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -65.63 -31.88 73.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.396 178.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.66 -0.93 40.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.514 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 69.0 39.94 1.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.594 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.768 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -171.37 88.02 0.1 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.074 0.464 . . . . 0.0 111.439 178.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.928 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.9 t -117.75 -145.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.078 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.662 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.55 -156.67 0.19 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.925 0.393 . . . . 0.0 111.483 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -161.81 -167.94 1.82 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.539 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 5.4 m -50.78 150.26 2.98 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.977 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.47 -171.77 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.021 0.439 . . . . 0.0 111.839 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.02 80.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.289 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.534 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -53.91 166.44 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.296 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 18.4 mt -126.42 -46.97 1.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.628 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.14 -127.0 2.3 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.434 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.8 p -152.6 134.21 14.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.988 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 HD11 ' A' ' 109' ' ' LEU . 6.1 m -135.19 159.84 40.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 2.9 pt-20 -88.72 138.99 30.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.397 . . . . 0.0 110.986 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 m -129.33 127.07 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.94 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.89 65.77 4.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.967 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.618 ' HG3' ' HG3' ' A' ' 97' ' ' ARG . 1.4 tp10 -163.31 -65.57 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.282 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.4 22.89 11.37 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.642 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -151.84 117.04 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.901 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.41 158.65 11.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.454 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.74 -4.89 54.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.805 0.336 . . . . 0.0 111.031 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.75 -20.7 30.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.7 t -61.29 -32.68 53.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.844 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.413 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 58.5 m -85.6 -27.09 25.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.983 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.27 -15.44 63.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.017 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 108' ' ' VAL . 30.5 mt-10 -110.11 -45.63 3.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.85 -31.79 68.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.35 -42.11 90.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.667 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -73.75 -32.53 63.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.788 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 104' ' ' GLU . 52.1 t -55.99 -42.51 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.572 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -68.65 -35.38 77.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.549 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -69.1 -22.85 63.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.501 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -94.81 -14.38 24.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.769 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m -94.21 179.35 5.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.091 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -90.79 12.38 19.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.439 ' CG ' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -57.68 110.87 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.927 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 136.22 94.36 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.279 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -84.83 153.25 11.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.816 2.344 . . . . 0.0 112.565 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.534 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -128.54 97.55 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.774 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -80.73 129.68 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 -179.358 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -167.39 -163.01 20.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.291 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -106.02 118.34 36.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.814 0.34 . . . . 0.0 111.077 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.987 HD13 HG22 ' A' ' 130' ' ' VAL . 13.4 tp -89.3 127.16 35.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.456 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.768 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 35.5 m-70 -112.86 95.99 5.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.014 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.928 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 40.0 t -65.46 95.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.043 0.449 . . . . 0.0 110.441 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.48 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -94.42 126.7 39.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.222 179.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -63.17 -1.29 3.94 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.831 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -131.56 32.79 4.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 110.817 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.69 102.28 1.15 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.452 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mt -68.64 125.63 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 111.319 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.576 ' HB2' HD11 ' A' ' 138' ' ' LEU . 0.9 OUTLIER -121.1 143.34 49.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.435 179.071 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.987 HG22 HD13 ' A' ' 121' ' ' LEU . 18.4 t -122.67 115.1 44.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.904 0.383 . . . . 0.0 111.483 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.8 t -94.68 147.67 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.35 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 137' ' ' GLY . 38.7 m-20 -83.42 161.3 21.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.789 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -112.54 5.25 17.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.625 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.12 -3.06 5.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.968 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.401 ' H ' ' H ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -150.38 -14.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.523 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 23.1 mmtt 53.98 29.71 10.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.085 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 132' ' ' ASP . . . -99.33 148.4 18.69 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.394 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 129' ' ' ARG . 6.2 tp -76.36 120.88 22.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.902 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 9.5 pt -108.5 -16.01 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.228 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 130' ' ' VAL . 84.4 t -129.88 94.75 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 111.148 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.416 ' CG ' HD23 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -96.62 17.21 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.715 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.403 ' HG2' HG13 ' A' ' 140' ' ' VAL . 29.3 mm-40 -72.46 -173.84 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.828 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 24.4 m -142.56 160.58 40.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.619 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 124' ' ' SER . 45.0 mt -59.36 -56.28 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.26 -18.95 64.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.779 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.828 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 1.8 tttp -71.2 -61.38 1.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.973 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 143' ' ' THR . 2.6 m -61.25 140.04 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.093 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -43.89 -67.86 0.24 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.081 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.642 ' HZ ' ' HA ' ' A' ' 97' ' ' ARG . 0.3 OUTLIER -169.76 142.52 2.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.167 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.42 165.06 19.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.587 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -166.37 124.64 1.07 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.352 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.464 ' HB2' ' H ' ' A' ' 153' ' ' ASP . 90.8 Cg_endo -82.86 -136.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.693 2.262 . . . . 0.0 112.104 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.464 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.821 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.465 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.954 0.407 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -148.35 114.75 0.7 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.468 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.4 m-85 -107.92 171.49 7.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.772 0.32 . . . . 0.0 111.203 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.658 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -165.11 154.48 12.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.46 160.38 34.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.52 151.96 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 110.29 6.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -83.36 97.96 9.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.98 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 51.94 -160.01 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.973 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 72.24 -3.3 23.64 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.768 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.426 ' H ' ' H ' ' A' ' 169' ' ' THR . 8.9 t -172.19 -8.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 0.0 110.061 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.694 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -129.41 -16.14 3.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.835 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 58.45 29.84 18.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.773 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -178.71 -167.41 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.712 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.77 99.5 10.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 0.0 110.78 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.694 ' HB2' HG21 ' A' ' 169' ' ' THR . 3.8 mtp -138.81 147.05 42.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.977 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.29 148.48 52.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.118 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -107.11 145.77 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.684 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.658 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -121.33 157.05 16.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.714 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 15.4 p90 -165.85 175.71 8.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.682 0.277 . . . . 0.0 110.504 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.502 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 1.2 mp -139.89 -172.85 3.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.967 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -115.82 130.67 56.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.021 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 84' ' ' SER . 7.3 t -67.35 -27.84 67.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.184 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.404 ' HB2' ' HD3' ' A' ' 186' ' ' ARG . 4.2 mttm -83.47 -42.23 17.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.162 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 57.86 89.94 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.016 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.8 t -156.97 -26.31 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.988 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.567 ' H ' ' CZ ' ' A' ' 186' ' ' ARG . . . 84.61 5.74 86.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.607 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -131.54 12.65 4.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.852 0.358 . . . . 0.0 111.061 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.689 HH11 ' HB2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -115.18 -10.17 12.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 -179.272 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.689 ' HB2' HH11 ' A' ' 186' ' ' ARG . 1.5 mp -148.42 -45.95 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.354 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.0 t -51.17 -63.53 1.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.626 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 5.06 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.638 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.49 -53.14 3.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.225 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.49 ' HA ' HG11 ' A' ' 123' ' ' VAL . 5.2 p -70.07 -18.32 21.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.07 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 195' ' ' PHE . . . -73.74 1.74 44.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.257 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.421 ' O ' HG23 ' A' ' 197' ' ' VAL . 56.7 m -118.09 -5.57 10.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.697 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -66.06 -52.56 47.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.205 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.551 ' HD1' HD11 ' A' ' 199' ' ' LEU . 46.2 p90 -65.4 -24.24 67.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.764 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.901 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -66.81 -8.72 30.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.286 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 193' ' ' CYS . 3.4 t -101.97 -12.95 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.114 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.96 3.71 22.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.691 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.901 HD12 ' HA ' ' A' ' 196' ' ' ALA . 4.9 mt . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.054 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.96 0.41 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 1.4 p -165.41 136.22 3.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -57.8 111.03 1.02 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.025 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.6 6.93 45.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.163 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 73.9 p -96.32 18.54 13.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -67.34 150.23 49.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.04 11.71 33.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 14.5 t70 56.85 80.68 0.15 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.15 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.8 152.14 84.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.486 2.124 . . . . 0.0 112.231 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.962 0.41 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -36.07 68.24 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.46 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.74 -22.79 66.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.361 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.647 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 3.6 mt-10 -96.02 -14.32 23.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.648 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -58.33 -50.78 72.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.807 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 t -63.77 -39.86 86.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.367 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.647 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -58.22 -35.39 71.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.454 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.9 m -78.41 -90.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.556 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 179.28 32.69 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.525 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.78 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -170.26 99.66 0.27 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.92 0.391 . . . . 0.0 111.938 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.752 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.1 t -119.94 -151.53 0.48 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.104 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.744 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 55.26 -155.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.837 0.351 . . . . 0.0 111.46 179.264 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.58 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 1.9 m-85 -164.32 -167.64 1.35 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.63 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.4 150.44 3.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.069 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 m -147.71 -178.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 111.871 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 3.7 mmtt -130.63 85.99 2.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.657 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.622 ' HB3' HG23 ' A' ' 117' ' ' VAL . 29.1 t80 -58.56 94.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 3.9 mt -67.1 -17.47 64.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.055 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 114' ' ' ARG . . . 117.59 -131.03 9.13 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.572 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.511 ' N ' HD21 ' A' ' 109' ' ' LEU . 7.1 p -156.61 141.6 17.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.686 0.279 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 m -131.84 161.85 40.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.205 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -83.32 131.25 35.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.371 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 174' ' ' CYS . 16.3 m -141.65 131.87 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.94 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -103.04 73.4 1.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.941 0.401 . . . . 0.0 111.105 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.569 ' HB3' HG21 ' A' ' 101' ' ' VAL . 1.4 mt-10 -164.78 -71.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.059 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 p 45.15 33.5 1.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -121.86 -40.61 2.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.484 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.52 158.28 15.43 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.901 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -17.89 59.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.866 0.365 . . . . 0.0 110.904 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -72.36 -24.68 61.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 95' ' ' GLU . 6.7 t -59.94 -30.18 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.53 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 96.5 m -79.72 -28.25 40.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.766 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.71 -14.63 61.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.135 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.9 mt-10 -108.72 -44.32 4.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.22 -31.87 69.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.086 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.78 -38.55 91.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -40.87 84.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' GLU . 5.1 t -63.25 -44.51 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.666 HD23 ' HG3' ' A' ' 114' ' ' ARG . 3.0 mt -61.31 -34.95 76.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.269 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 110' ' ' ARG . 11.1 ttt-85 -74.05 -31.48 62.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.738 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -86.63 -14.45 42.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.308 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.12 -6.78 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.311 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 36.68 71.56 0.13 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.652 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.666 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -82.72 68.12 9.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.931 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 58.43 82.87 0.23 Allowed Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.361 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 92.7 Cg_endo -80.52 135.05 10.26 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.623 2.215 . . . . 0.0 112.23 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -129.85 158.94 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.191 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.6 ttp-105 -119.68 98.5 6.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -131.69 169.78 21.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.615 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -92.34 104.2 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.693 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.812 HD13 HG22 ' A' ' 130' ' ' VAL . 15.9 tp -74.92 129.11 37.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.425 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.78 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 52.2 m170 -115.05 94.6 4.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.752 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 71.4 t -69.31 90.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.927 0.394 . . . . 0.0 110.506 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.665 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -90.17 140.79 29.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.195 179.179 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.49 1.95 4.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.774 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -130.64 32.45 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 119.66 122.98 3.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.536 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.406 ' CD2' HG13 ' A' ' 123' ' ' VAL . 2.6 mt -76.05 141.93 41.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.739 0.304 . . . . 0.0 111.041 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -145.47 122.56 11.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.69 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.812 HG22 HD13 ' A' ' 121' ' ' LEU . 2.2 t -102.16 118.51 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.337 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 t -106.2 116.62 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.768 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.55 151.43 2.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.028 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.48 -6.83 54.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.364 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.72 -50.3 2.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.966 0.412 . . . . 0.0 110.695 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.0 m -82.95 -21.75 33.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.636 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp 51.69 28.19 4.64 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.211 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.41 -116.2 1.12 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.435 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tp -171.97 113.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.693 0.282 . . . . 0.0 110.543 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.583 HG13 ' HB ' ' A' ' 130' ' ' VAL . 2.9 pt -94.49 -41.49 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.497 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.668 ' HB ' HG23 ' A' ' 130' ' ' VAL . 39.8 t -122.85 103.78 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.177 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -113.19 48.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.798 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -98.11 -166.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.804 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.555 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 12.1 m -133.96 158.4 43.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.665 HD11 ' O ' ' A' ' 124' ' ' SER . 2.0 mt -65.05 -44.56 95.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.664 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.05 -20.02 56.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.56 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 12.9 tttp -69.82 -45.34 68.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.709 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 164' ' ' CYS . 5.9 m -74.83 150.98 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.747 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.8 -53.89 49.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.446 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.654 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 40.3 p90 -174.62 -174.21 0.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.1 t -110.95 157.92 19.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.726 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.0 115.6 0.55 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.844 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 84.4 Cg_endo -79.96 -119.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 111.996 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.431 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 8.1 p-10 . . . . . 0 C--N 1.332 -0.165 0 CA-C-O 120.742 0.306 . . . . 0.0 110.72 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 121.023 0.439 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.98 133.64 10.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.466 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.844 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 1.7 m-85 -126.92 163.65 23.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.3 . . . . 0.0 110.665 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -164.6 144.57 7.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.009 0.433 . . . . 0.0 111.255 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -126.44 139.59 53.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.481 178.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.4 OUTLIER -101.04 139.99 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.242 -179.489 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.485 ' HB2' HG12 ' A' ' 147' ' ' VAL . 10.7 t -149.02 129.62 14.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.716 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.654 ' H ' ' HE ' ' A' ' 165' ' ' ARG . 0.2 OUTLIER -92.87 122.62 35.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.711 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 50.38 -158.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.432 179.527 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.48 -29.51 8.29 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.457 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.439 ' H ' ' H ' ' A' ' 169' ' ' THR . 9.4 t -164.63 6.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.57 . . . . 0.0 109.532 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.582 HG21 ' HG3' ' A' ' 173' ' ' MET . 24.7 m -136.88 -18.1 1.39 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.65 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.711 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 7.3 mtt180 57.72 32.48 21.94 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.407 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.511 ' HB2' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -163.41 150.11 12.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.711 -178.299 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -75.02 79.11 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.405 178.22 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.582 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.2 OUTLIER -110.57 166.78 10.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.078 -179.055 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.656 ' HB2' HG23 ' A' ' 163' ' ' ILE . 53.2 t -123.6 127.59 48.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.48 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 15.0 m-70 -90.75 124.99 35.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.559 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -108.2 156.28 15.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.612 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -170.66 152.68 3.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.714 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.562 HD11 HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -121.5 165.9 14.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.52 126.24 34.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.971 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 4.5 t -61.99 -21.07 64.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.815 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.58 ' HE3' ' HB3' ' A' ' 83' ' ' PHE . 2.8 mmtp -84.39 -23.02 30.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.672 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 55.08 83.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.1 t -159.74 -64.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 108.44 41.51 1.48 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.385 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.35 -33.48 0.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.752 0.31 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.556 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -72.48 -11.51 60.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.706 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 186' ' ' ARG . 5.2 mp -137.07 -36.89 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.114 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.2 t -57.94 -55.6 32.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.256 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.25 0.43 16.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.054 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -89.17 -54.81 3.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.67 ' HA ' HG11 ' A' ' 123' ' ' VAL . 10.9 p -75.41 -30.48 22.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.68 -9.49 45.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.252 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 57.5 m -110.53 -10.28 14.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 110.707 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.61 -43.35 94.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.244 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.471 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 2.0 p90 -61.74 -32.58 72.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.725 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -61.86 -33.66 74.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.21 5.62 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.641 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -93.62 -43.92 8.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.823 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.866 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.658 0.266 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.654 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.9 p -168.81 148.36 4.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.942 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 149' ' ' PHE . 9.4 m-80 -64.36 156.93 27.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.811 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 20.5 mtm -126.63 -18.18 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -76.52 0.1 21.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.083 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -63.12 148.91 46.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.972 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -97.22 4.61 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.926 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 29.2 t0 56.98 77.3 0.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -70.03 151.61 96.05 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.763 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.487 2.125 . . . . 0.0 112.262 179.696 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.838 0.352 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.39 -32.6 26.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.562 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -71.78 -36.22 70.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.243 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.74 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -69.36 -19.45 63.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.265 178.704 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -61.69 -52.15 65.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.945 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.9 -37.99 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.54 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.74 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 11.5 mtp180 -56.89 -40.34 76.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.461 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -75.61 -91.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.477 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 179.34 38.51 0.0 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.343 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.552 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.7 t -173.2 95.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.991 0.424 . . . . 0.0 111.466 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.612 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 11.6 t -122.68 10.29 9.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.534 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -114.2 -162.84 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.218 -179.44 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.683 ' HB2' HD11 ' A' ' 187' ' ' LEU . 60.3 m-85 -150.07 -168.6 3.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.72 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.623 ' HA ' HD22 ' A' ' 120' ' ' LEU . 1.0 OUTLIER -47.53 151.52 0.79 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.87 0.367 . . . . 0.0 111.366 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.42 -170.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.125 0.488 . . . . 0.0 111.679 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.93 73.09 1.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.311 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 83.6 t80 -55.45 98.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.143 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 178' ' ' LEU . 4.3 mt -61.36 -50.03 74.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.492 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 153.04 -128.13 2.38 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.241 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.423 ' N ' HD21 ' A' ' 109' ' ' LEU . 1.6 p -161.79 126.15 3.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 0.0 110.866 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.3 m -110.18 165.8 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.036 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.77 116.02 28.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.142 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.3 m -108.99 -165.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.865 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.95 65.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 1.2 mm-40 -166.32 -66.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.81 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.54 ' HA ' HG21 ' A' ' 163' ' ' ILE . 2.1 m 59.92 33.23 21.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 15.7 ptt180 -169.57 80.57 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.59 146.62 4.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.246 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.453 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -72.29 -29.89 64.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.775 0.322 . . . . 0.0 111.206 -179.421 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.453 ' N ' ' HG3' ' A' ' 99' ' ' MET . 0.5 OUTLIER -77.39 -21.19 53.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.926 -179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 t -60.73 -35.02 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 55.5 m -73.26 -49.98 24.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.951 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -56.33 -29.68 61.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.295 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.5 mm-40 -76.57 -51.72 11.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.94 -31.63 68.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.048 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.68 -43.33 93.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.845 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -62.86 -43.27 99.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 104' ' ' GLU . 18.8 t -62.62 -39.81 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.047 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.637 HD23 ' HG3' ' A' ' 114' ' ' ARG . 8.1 mt -65.83 -36.15 82.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.827 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -76.13 -14.35 60.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.298 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -95.87 -16.53 21.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.786 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.84 -177.08 3.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.59 ' H ' ' HE ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -116.85 71.77 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.814 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.637 ' HG3' HD23 ' A' ' 109' ' ' LEU . 22.7 mmt180 -85.19 22.52 1.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.071 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 54.29 88.15 0.13 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.817 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 17.2 Cg_exo -66.57 137.29 45.78 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.82 2.347 . . . . 0.0 111.77 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.76 113.39 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.01 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -75.28 107.42 7.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.697 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -142.67 -167.3 11.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.834 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -118.4 122.87 43.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.658 0.266 . . . . 0.0 110.715 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.705 HD13 HG22 ' A' ' 130' ' ' VAL . 32.4 tp -89.5 133.76 34.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.777 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.494 ' CD2' HD12 ' A' ' 120' ' ' LEU . 14.2 m170 -123.03 94.75 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.186 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 53.2 t -62.28 96.15 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.061 0.457 . . . . 0.0 110.338 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.634 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -99.7 130.6 45.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.487 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -64.25 -0.24 4.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.961 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -126.17 29.01 5.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.855 0.36 . . . . 0.0 110.807 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 117.19 113.49 2.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.259 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.585 HD21 HG22 ' A' ' 123' ' ' VAL . 0.5 OUTLIER -57.04 146.33 27.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 -179.426 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -138.41 120.35 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 121' ' ' LEU . 2.2 t -110.29 108.28 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 111.271 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.99 117.69 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.058 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 76.9 m-20 -53.71 156.75 2.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.75 1.39 29.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -116.62 -31.33 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.523 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.25 -6.53 9.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.727 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 4.4 mmtm 50.91 25.59 2.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.11 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.11 167.27 30.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.357 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 138' ' ' LEU . 8.7 tp -99.48 116.32 31.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.61 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.559 HG13 ' HB ' ' A' ' 130' ' ' VAL . 1.2 pt -94.42 -50.23 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.374 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.491 ' HB ' HG23 ' A' ' 130' ' ' VAL . 48.7 t -110.37 95.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.916 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -105.09 67.49 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.656 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -114.8 -171.91 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.152 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 88.6 m -131.16 151.88 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.552 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.634 HD11 ' O ' ' A' ' 124' ' ' SER . 3.4 mt -61.28 -31.89 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.655 ' H ' HG22 ' A' ' 143' ' ' THR . 2.1 mt-10 -90.65 -6.62 54.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.516 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.661 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 5.7 tptm -90.08 -37.75 14.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.028 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -58.42 134.32 23.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.806 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.6 t -70.61 -21.15 62.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.462 ' CB ' HD12 ' A' ' 163' ' ' ILE . 0.2 OUTLIER -170.05 151.96 4.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.125 0.488 . . . . 0.0 111.514 -179.285 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.32 137.22 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.916 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.572 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -168.55 119.81 0.66 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.66 0.267 . . . . 0.0 111.687 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 55.9 Cg_endo -69.43 -94.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.342 2.028 . . . . 0.0 111.625 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.459 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 120.757 0.313 . . . . 0.0 111.476 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.54 129.73 6.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.56 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.591 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 0.5 OUTLIER -127.13 155.42 43.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 110.682 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.573 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -160.84 159.98 30.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 111.273 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.97 143.1 33.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.323 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.54 HG21 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -104.23 148.7 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.948 0.404 . . . . 0.0 111.183 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.8 p -135.37 148.65 49.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.74 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.28 101.37 9.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.01 -152.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.075 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.73 -15.03 22.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.508 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.416 ' H ' ' H ' ' A' ' 169' ' ' THR . 15.1 t -171.25 -0.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 110.008 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.499 HG21 ' HB2' ' A' ' 173' ' ' MET . 3.3 m -127.63 -18.74 4.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.083 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 60.07 30.66 20.11 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.783 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -179.43 -168.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.882 179.53 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -98.78 112.39 24.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.025 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.783 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 25.3 mtp -139.6 149.84 44.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.567 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.516 ' HB2' HG23 ' A' ' 163' ' ' ILE . 20.4 t -117.69 147.37 42.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.154 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -114.78 137.2 52.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.445 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -128.84 156.55 21.17 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.994 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -166.93 155.85 10.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 111.076 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.464 HD12 HD21 ' A' ' 88' ' ' LEU . 1.4 mt -111.93 178.17 4.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.612 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.591 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -113.57 125.66 54.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 0.0 110.959 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.3 OUTLIER -71.13 -5.07 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.787 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.445 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 13.1 mmmt -91.01 -37.54 13.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 58.14 85.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.99 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.2 t -163.86 -39.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.83 17.94 79.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.494 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -132.57 1.11 3.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.868 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.43 ' HB2' HD12 ' A' ' 187' ' ' LEU . 8.6 mmm180 -108.8 -33.6 6.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 83' ' ' PHE . 5.7 mp -114.99 -43.21 3.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.125 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.5 t -58.72 -66.39 0.5 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.451 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.6 -16.22 55.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.157 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.72 -56.28 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.22 -19.72 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.018 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -77.47 -0.14 71.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.334 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 58.0 m -120.29 0.37 10.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.31 -40.94 50.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.104 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 7.1 p90 -67.72 -31.18 70.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.814 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.442 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -61.4 -29.39 69.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.373 . . . . 0.0 110.969 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 4.9 t -99.29 0.48 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.889 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -92.6 -38.31 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.222 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.73 0.3 . . . . 0.0 110.904 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.94 162.25 23.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.003 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -65.81 167.09 9.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 3.6 mtp -134.92 -22.45 1.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 60.3 p -81.2 14.91 2.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -62.55 153.9 30.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.934 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -91.33 -0.27 57.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 t0 56.36 78.59 0.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.197 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.667 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 25.5 m-85 -66.45 -51.61 41.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.134 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 31.8 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.213 1.942 . . . . 0.0 112.255 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.929 0.395 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.48 -33.34 48.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -65.26 -22.02 66.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.575 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.736 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.5 mt-10 -100.61 -13.68 18.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.802 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -59.5 -46.89 87.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.763 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 194' ' ' ALA . 7.1 t -61.49 -42.64 94.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.349 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.736 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 7.5 mtp180 -54.45 -34.8 62.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.143 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 1.4 m -78.12 -90.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.251 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 176.28 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.683 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.576 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -173.7 98.0 0.11 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.866 0.365 . . . . 0.0 111.777 -179.599 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.413 ' H ' ' N ' ' A' ' 123' ' ' VAL . 10.3 t -139.26 63.48 1.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.393 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.738 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -159.44 -155.15 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.802 0.334 . . . . 0.0 111.297 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -154.62 -172.82 4.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.596 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 3.4 t -51.1 152.34 2.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.801 0.334 . . . . 0.0 111.168 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.74 -167.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.286 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.417 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -148.18 65.3 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.823 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 55.0 t80 -62.6 117.02 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.567 ' O ' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -116.45 62.6 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.408 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.549 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 62.77 -168.7 17.73 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.396 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.449 ' C ' HD21 ' A' ' 109' ' ' LEU . 0.7 OUTLIER -138.47 146.37 41.97 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.519 HG13 ' CD2' ' A' ' 109' ' ' LEU . 4.6 m -115.24 163.86 12.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.369 . . . . 0.0 111.188 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.63 145.88 29.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.027 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -139.02 178.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.648 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -145.77 65.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 0.0 111.16 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -169.08 -72.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 p 67.48 0.76 2.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.2 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.501 ' HE ' HH22 ' A' ' 165' ' ' ARG . 0.0 OUTLIER -154.8 114.48 3.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.789 179.308 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 140.07 121.21 1.81 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.159 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 60.48 -88.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.617 0.246 . . . . 0.0 110.551 -178.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.481 ' O ' HD11 ' A' ' 163' ' ' ILE . 0.6 OUTLIER -154.15 -28.25 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.034 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.476 ' HB ' HD13 ' A' ' 163' ' ' ILE . 1.1 t 49.38 23.46 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.371 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 62.6 m -118.64 -24.22 6.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.013 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -9.31 58.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.018 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 108' ' ' VAL . 21.2 mt-10 -104.52 -53.76 2.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.24 -51.12 71.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.222 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.1 tp -57.77 -32.09 67.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -67.36 -43.01 82.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 104' ' ' GLU . 9.4 t -59.21 -49.92 81.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.842 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.3 mt -65.85 -25.03 67.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.591 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -77.64 -25.59 49.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.626 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 23.1 mt-30 -91.36 -19.88 22.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.201 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 m -113.6 179.36 3.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 0.0 111.253 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.66 72.38 0.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.675 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.842 ' HG3' HD23 ' A' ' 109' ' ' LEU . 3.8 mmt180 -82.66 40.44 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.232 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 59.0 77.9 0.37 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.567 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 87.9 Cg_endo -81.09 121.8 4.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.667 2.245 . . . . 0.0 112.256 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.02 140.74 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 118' ' ' ARG . 12.3 ttp180 -99.39 103.6 15.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.623 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -135.58 172.68 22.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.8 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -92.44 127.26 37.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.795 0.331 . . . . 0.0 111.0 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.723 HD13 HG22 ' A' ' 130' ' ' VAL . 39.6 tp -97.06 129.62 44.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.56 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.463 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 89.6 m-70 -116.71 93.02 4.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.852 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 82' ' ' SER . 41.9 t -58.35 103.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.982 0.42 . . . . 0.0 110.849 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.711 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -100.76 134.65 43.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.192 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.61 8.57 4.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.015 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -137.35 28.19 2.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 110.615 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.761 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 124.63 113.22 1.99 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.315 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.489 HD21 HG22 ' A' ' 123' ' ' VAL . 1.3 mt -58.0 144.25 40.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 111.233 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.582 ' HE ' HD11 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -136.5 124.62 23.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.817 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.723 HG22 HD13 ' A' ' 121' ' ' LEU . 2.9 t -110.93 112.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.311 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.9 t -104.9 114.22 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.795 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.47 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 1.4 m-20 -48.86 147.57 2.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.895 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.623 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -103.23 9.04 38.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.616 -179.83 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.63 -1.19 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.403 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.409 ' H ' ' H ' ' A' ' 136' ' ' LYS . 3.2 m -151.52 -11.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.546 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 22.9 mmtp 54.77 25.74 6.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.895 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.65 -166.84 35.83 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.549 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.582 HD11 ' HE ' ' A' ' 129' ' ' ARG . 8.6 tp -119.18 116.92 27.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.913 0.387 . . . . 0.0 110.634 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.428 HD12 HG12 ' A' ' 130' ' ' VAL . 6.3 mt -98.02 -57.29 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.263 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.558 HG13 ' HG2' ' A' ' 142' ' ' GLN . 61.3 t -124.51 116.63 48.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.407 ' HB3' HD21 ' A' ' 138' ' ' LEU . 0.6 OUTLIER -121.45 36.48 4.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.583 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.558 ' HG2' HG13 ' A' ' 140' ' ' VAL . 73.1 mm-40 -81.75 -165.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.111 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.761 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 19.3 m -129.42 153.94 47.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.711 HD11 ' O ' ' A' ' 124' ' ' SER . 3.5 mt -65.89 -44.9 92.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.0 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -78.64 -0.21 29.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.506 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.415 ' CB ' ' HB ' ' A' ' 143' ' ' THR . 28.5 tttt -95.73 -44.84 7.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.667 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -62.29 148.22 10.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.93 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.8 t -83.11 -37.03 24.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.201 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -137.95 -172.68 3.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.908 0.385 . . . . 0.0 111.395 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.8 t -168.35 25.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.456 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.498 ' HB3' ' HB2' ' A' ' 102' ' ' CYS . . . -51.12 138.94 25.23 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.159 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.92 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 72.2 Cg_endo -95.56 12.86 1.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.35 2.7 . . . . 0.0 112.385 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.174 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 183' ' ' SER . 2.6 mtt180 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.866 0.365 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.605 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -133.59 128.89 5.16 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.41 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -104.46 168.43 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.3 . . . . 0.0 110.805 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.45 150.94 14.65 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.005 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -132.17 145.61 51.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.636 179.015 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -107.44 144.5 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.188 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.9 130.51 9.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.611 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 3.3 mtt-85 -74.91 -144.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.48 ' H ' ' HB3' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.17 -166.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.909 0.385 . . . . 0.0 111.136 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.61 -11.45 68.39 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.397 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.3 t -166.55 -8.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 109.926 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.771 HG21 ' HB2' ' A' ' 173' ' ' MET . 18.5 m -129.7 -9.79 4.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.645 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 61.19 17.4 8.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.131 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 171' ' ' ARG . 0.9 OUTLIER -176.44 174.31 1.95 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.94 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -77.53 109.58 11.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.995 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.771 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -138.08 159.64 41.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.638 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.795 ' HB2' HG23 ' A' ' 163' ' ' ILE . 31.1 t -129.39 139.36 51.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.859 0.361 . . . . 0.0 111.236 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -103.53 143.58 32.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.665 179.561 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -126.55 149.86 17.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.859 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -166.5 139.41 3.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.755 0.312 . . . . 0.0 110.715 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.605 HD23 ' HA3' ' A' ' 159' ' ' GLY . 1.5 mt -100.11 -177.81 3.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.943 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -110.48 129.99 55.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.052 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER -76.5 1.28 17.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.172 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -99.85 -23.69 14.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.756 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 55.97 79.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.155 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.407 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 1.5 t -165.9 -59.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.941 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.78 32.2 6.03 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.553 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -141.81 -32.39 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.731 0.3 . . . . 0.0 110.953 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.503 ' HB2' HD12 ' A' ' 187' ' ' LEU . 4.9 mmm180 -73.57 -6.06 44.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.836 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.596 HD23 HD23 ' A' ' 121' ' ' LEU . 5.6 mp -139.24 -50.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.441 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 3.6 t -62.18 -60.87 2.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.336 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 0.1 OUTLIER -52.64 -37.2 58.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.82 -41.78 91.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 187' ' ' LEU . 24.7 t -62.25 -32.3 54.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.76 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -59.3 -20.62 51.29 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.529 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 2.6 m -95.18 -15.42 23.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.729 0.3 . . . . 0.0 111.097 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.703 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -63.07 -30.87 71.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.18 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.467 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 1.3 m-85 -72.86 -40.11 65.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.804 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -54.98 -21.05 10.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.586 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.5 t -105.56 -12.88 9.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -79.36 -27.06 41.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.02 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.839 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.92 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.634 0.254 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 63.84 158.25 0.08 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.449 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -87.82 -173.15 4.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.207 -179.555 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 68.9 mtp -125.98 -30.31 2.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.823 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.463 ' HB3' HD23 ' A' ' 199' ' ' LEU . 89.6 p -88.09 36.91 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.452 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.641 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 3.1 p90 -63.94 -3.34 2.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.849 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 55.69 8.89 0.36 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.665 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' ASP . . . . . 0.641 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 21.5 t70 48.9 76.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.401 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -58.92 135.65 87.32 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.472 2.115 . . . . 0.0 112.24 179.924 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.893 0.378 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -83.51 -19.95 34.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.986 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 34.0 tt0 -63.52 -29.99 71.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.617 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -100.57 -17.26 17.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.978 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -58.07 -52.66 64.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.537 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 194' ' ' ALA . 0.9 OUTLIER -66.36 -35.32 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.729 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.617 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 3.1 mtp180 -55.34 -24.03 27.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.109 0.48 . . . . 0.0 109.808 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.42 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -98.03 -97.11 0.21 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.659 179.032 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.501 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -176.47 48.36 0.01 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.565 0.221 . . . . 0.0 111.457 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.642 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 1.4 t -176.04 86.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.919 0.39 . . . . 0.0 111.112 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.693 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 6.7 t -121.22 4.16 10.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.5 OUTLIER -111.97 -156.97 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.161 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.407 ' CG ' ' HE2' ' A' ' 181' ' ' LYS . 16.5 m-85 -154.84 -171.63 3.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.558 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 0.9 OUTLIER -53.01 150.71 5.33 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.048 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.81 -168.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.528 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -143.24 81.28 1.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.925 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 55.6 t80 -62.28 93.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.668 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 178' ' ' LEU . 1.1 mp -58.21 -41.01 83.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.16 -130.44 3.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.357 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -164.28 141.21 6.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 111.046 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.89 172.7 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.486 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 4.1 pt-20 -95.15 142.43 27.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.889 0.376 . . . . 0.0 111.053 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.71 163.65 36.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -121.24 65.34 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.058 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -175.77 -70.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.036 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.422 ' HA ' HD13 ' A' ' 163' ' ' ILE . 0.7 OUTLIER 58.72 25.89 13.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.863 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.88 61.8 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.64 160.78 24.37 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.722 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.493 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -77.18 -30.8 55.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.782 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.493 ' N ' ' HG3' ' A' ' 99' ' ' MET . 8.2 mp0 -69.01 -23.04 64.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.028 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.5 t -58.56 -33.37 48.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 110.537 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.862 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 58.5 m -80.54 -37.01 32.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.615 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.3 -34.7 78.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.93 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 108' ' ' VAL . 8.4 mt-10 -76.96 -52.84 8.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.908 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.92 66.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.962 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 tp -66.08 -36.68 83.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.951 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.8 tptp -70.22 -46.21 64.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 104' ' ' GLU . 11.0 t -60.75 -38.06 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.867 HD23 ' HG3' ' A' ' 114' ' ' ARG . 18.7 mt -61.55 -31.97 72.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.075 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 110' ' ' ARG . 1.2 tpp85 -78.08 -32.88 50.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -81.89 -15.36 54.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.793 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.7 m -105.13 179.42 4.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.82 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.612 ' H ' HH11 ' A' ' 113' ' ' ARG . 0.0 OUTLIER -115.88 65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.867 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.26 20.32 3.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 55.34 95.04 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.993 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 93.3 Cg_endo -80.5 127.27 6.43 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.79 2.326 . . . . 0.0 112.087 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.33 143.79 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.225 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -102.69 97.83 7.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.65 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -131.64 163.06 23.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.911 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.475 ' HB3' ' HE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -87.18 124.22 33.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.735 0.302 . . . . 0.0 110.977 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.835 HD13 HG22 ' A' ' 130' ' ' VAL . 29.4 tp -96.85 135.34 38.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.763 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.642 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 1.9 m-70 -125.43 105.39 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.094 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 11.4 t -70.46 104.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 0.0 110.838 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -104.81 143.37 33.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.408 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.31 28.96 1.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.848 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 124' ' ' SER . 3.0 t70 -153.51 21.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.594 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 124.73 131.72 3.71 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.523 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.672 HD23 HD11 ' A' ' 121' ' ' LEU . 1.7 mp -67.16 168.77 9.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 14.5 ttm180 -168.75 115.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.903 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.835 HG22 HD13 ' A' ' 121' ' ' LEU . 3.9 t -107.97 109.21 27.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.07 0.462 . . . . 0.0 111.421 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.57 115.38 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.941 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.405 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 88.5 m-20 -50.9 144.58 8.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.24 17.19 21.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.988 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -127.67 -8.69 5.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.606 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.09 -8.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.843 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp 58.1 25.78 12.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.551 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.18 -138.5 0.25 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.444 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' A' ' 141' ' ' ASP . 15.7 tp -159.09 116.06 2.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.663 0.268 . . . . 0.0 110.438 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.632 HG13 ' HB ' ' A' ' 130' ' ' VAL . 3.6 pt -106.73 -28.48 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.562 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.638 ' HB ' HG23 ' A' ' 130' ' ' VAL . 43.1 t -137.35 116.65 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.167 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.588 ' HB2' HD21 ' A' ' 138' ' ' LEU . 17.8 t0 -130.04 29.91 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.345 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -76.55 -167.51 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.206 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 144' ' ' ILE . 1.8 m -123.66 171.0 9.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.658 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.47 HD11 ' O ' ' A' ' 124' ' ' SER . 47.3 mt -88.03 -28.16 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.701 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.77 -8.98 50.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.86 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -92.96 -39.63 11.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 143' ' ' THR . 1.2 m -61.77 126.1 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.013 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.39 -49.9 73.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.414 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 163' ' ' ILE . 12.3 m-85 -130.44 -171.94 2.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.095 0.474 . . . . 0.0 111.526 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.3 t -162.35 35.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.31 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.488 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -68.41 143.58 95.64 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.498 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.914 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 71.6 Cg_endo -87.68 -89.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.722 2.281 . . . . 0.0 112.111 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 110.755 179.616 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 120.782 0.325 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.731 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -127.9 129.33 6.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.671 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -102.91 168.87 8.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.604 0.24 . . . . 0.0 110.448 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.862 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 24.4 m -158.76 155.65 28.35 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.012 0.434 . . . . 0.0 111.375 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -132.29 160.05 37.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.077 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -117.14 153.63 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.401 . . . . 0.0 111.638 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 6.4 t -159.49 118.12 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.447 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.665 HH21 ' HB3' ' B' ' 10' ' ' PHE . 15.2 ptt85 -74.01 -152.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.29 -178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -55.45 -179.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.199 0.523 . . . . 0.0 111.69 -178.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.93 -8.37 29.5 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 15.2 t -170.08 -5.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.244 -0.478 . . . . 0.0 109.934 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.505 HG22 ' HG3' ' A' ' 171' ' ' ARG . 22.4 m -133.43 -12.6 2.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.054 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 170' ' ' ARG . 43.3 mtt180 62.29 22.58 13.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.799 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.505 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -175.71 -179.07 1.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.9 OUTLIER -81.49 124.0 29.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.9 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -142.5 126.33 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 34.8 t -104.11 136.32 43.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 2.5 m-70 -105.82 145.69 30.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.359 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.05 154.73 21.49 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.185 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -161.66 144.67 12.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.715 0.293 . . . . 0.0 110.739 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.731 HD23 ' HA3' ' A' ' 159' ' ' GLY . 1.1 mt -105.29 162.52 13.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.131 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.13 122.5 32.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 84' ' ' SER . 0.5 OUTLIER -71.83 -11.23 60.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.935 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.407 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 8.2 mmmt -89.34 -17.21 29.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.715 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 53.84 80.63 0.11 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.02 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.42 -43.08 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.091 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.94 31.61 55.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.306 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -146.08 -34.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.701 0.286 . . . . 0.0 110.793 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.49 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.7 OUTLIER -59.51 -28.25 66.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.793 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.574 HD23 HD23 ' A' ' 121' ' ' LEU . 4.8 mp -117.04 -39.13 3.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.879 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 191' ' ' VAL . 0.5 OUTLIER -57.13 -63.06 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.32 -179.496 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -16.05 61.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.373 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.0 -53.61 8.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.025 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.475 ' HA ' HG11 ' A' ' 123' ' ' VAL . 9.9 p -63.46 -18.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.08 -1.54 59.99 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.334 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.3 m -120.54 -4.7 9.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.32 . . . . 0.0 110.781 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.586 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -74.82 -45.61 42.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.248 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 38.9 p90 -68.3 -36.18 78.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.072 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -56.65 -31.69 64.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.022 0.439 . . . . 0.0 110.69 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.46 -19.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.812 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' CYS . . . . . 0.634 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -73.37 -6.02 43.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.548 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 196' ' ' ALA . 2.6 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.005 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.914 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.573 0.225 . . . . 0.0 111.17 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.504 ' H ' ' HB3' ' B' ' 2' ' ' PHE . 7.9 t 62.96 157.14 0.06 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.137 0.494 . . . . 0.0 111.246 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -92.51 176.53 6.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.829 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mtp -123.32 -7.31 8.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.7 p -83.62 6.87 19.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -62.56 145.57 54.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -106.85 10.11 30.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 t70 54.42 70.54 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.983 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.665 ' HB3' HH21 ' A' ' 165' ' ' ARG . 44.8 m-85 -61.3 134.92 93.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.967 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.598 2.199 . . . . 0.0 112.445 -179.725 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.763 0.316 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -91.13 -25.53 19.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.966 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.63 -34.3 77.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.721 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.4 mt-10 -92.38 -9.38 41.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 81' ' ' CYS . . . -60.16 -50.59 73.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.2 t -56.51 -40.61 69.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.955 0.407 . . . . 0.0 110.432 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.721 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 5.3 mtm180 -65.03 -32.03 73.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.332 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.2 m -81.12 3.46 23.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.61 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.409 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 65.01 41.92 4.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.42 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -176.17 85.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.56 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 13.1 t -116.35 21.4 13.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.371 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.733 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -117.06 -160.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.33 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.416 ' O ' HG13 ' A' ' 85' ' ' VAL . 3.2 m-85 -158.66 -169.5 2.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.537 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 2.3 t -48.94 142.09 6.93 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.893 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 83' ' ' PHE . 22.3 m -138.0 -171.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.062 0.458 . . . . 0.0 111.761 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -141.65 60.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.416 179.193 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.504 ' O ' HG23 ' A' ' 117' ' ' VAL . 71.4 t80 -53.26 114.84 1.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.03 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -82.66 -56.08 4.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.022 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.0 -124.64 1.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.483 ' HB3' ' ND1' ' A' ' 175' ' ' HIS . 1.2 p -164.76 142.19 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.936 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.453 HG22 HD11 ' A' ' 109' ' ' LEU . 15.5 m -133.51 163.41 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.998 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -91.56 130.14 37.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.7 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.606 HG21 HG11 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -131.54 128.98 61.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.195 -179.402 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -91.26 68.7 5.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 98' ' ' GLY . 0.7 OUTLIER -162.18 -65.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.137 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.722 ' HA ' HG21 ' A' ' 101' ' ' VAL . 50.4 p 52.78 22.66 2.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.991 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 96' ' ' SER . 10.1 mtp180 -149.36 -56.19 0.19 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.912 0.386 . . . . 0.0 111.601 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.6 ' H ' ' HG2' ' A' ' 95' ' ' GLU . . . -61.6 135.96 47.17 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.692 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.1 tpt 53.32 23.28 3.17 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.527 0.331 . . . . 0.0 111.789 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 151' ' ' ALA . 11.3 mp0 61.03 5.15 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.408 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' A' ' 96' ' ' SER . 2.3 t 53.43 30.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.856 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.6 p -118.18 -47.43 2.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.219 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -3.38 13.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.586 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -118.22 -57.57 2.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.65 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -54.58 -53.21 57.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.214 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.646 HD11 ' HG ' ' A' ' 178' ' ' LEU . 4.1 tp -50.34 -34.49 24.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -67.15 -38.52 85.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.803 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 36.7 t -63.57 -46.8 93.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.318 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.704 HD23 ' HG3' ' A' ' 114' ' ' ARG . 3.5 mp -72.46 -18.79 61.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.109 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -94.84 -11.13 29.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.541 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -71.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.581 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.8 t -175.89 88.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.381 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -165.17 -62.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.704 ' HG3' HD23 ' A' ' 109' ' ' LEU . 3.8 mmp_? -101.24 110.35 22.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.381 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -62.44 134.06 94.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.119 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.494 ' HB2' ' HE2' ' A' ' 86' ' ' LYS . 73.3 Cg_endo -78.28 161.1 29.13 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.654 2.236 . . . . 0.0 112.603 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -130.36 153.75 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.79 179.265 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.48 97.57 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -141.46 166.9 26.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.5 113.92 25.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.331 . . . . 0.0 110.878 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.982 HD13 HG22 ' A' ' 130' ' ' VAL . 25.4 tp -83.8 138.48 33.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.758 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.528 ' H ' HD12 ' A' ' 121' ' ' LEU . 11.2 m170 -123.17 84.18 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.733 ' H ' ' HB2' ' A' ' 82' ' ' SER . 48.4 t -58.75 102.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.852 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.565 ' O ' HD11 ' A' ' 144' ' ' ILE . 3.7 p -105.18 144.33 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.548 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.7 19.8 1.93 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.888 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.0 22.64 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.665 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.18 118.5 2.59 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.395 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.416 ' CD2' HG22 ' A' ' 123' ' ' VAL . 2.7 mt -54.1 144.7 18.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 111.171 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 16.4 ttm180 -147.58 112.21 5.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.982 HG22 HD13 ' A' ' 121' ' ' LEU . 1.9 t -100.39 133.32 43.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.093 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.5 t -121.97 109.05 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.458 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -53.03 157.49 1.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.218 -179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -3.64 53.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -116.19 -54.69 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.386 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.6 m -80.74 -31.84 35.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.459 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 4.2 mmtm 52.39 29.95 7.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.9 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.19 -108.7 1.51 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.45 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tp -160.59 113.76 2.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.678 0.275 . . . . 0.0 110.727 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.55 -49.07 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.36 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.754 ' HB ' HG23 ' A' ' 130' ' ' VAL . 93.4 t -122.45 102.52 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.42 25.95 11.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.408 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.443 ' HG2' HG13 ' A' ' 140' ' ' VAL . 56.1 mm-40 -76.23 -156.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.166 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.866 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 59.9 m -135.46 161.75 34.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.966 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.565 HD11 ' O ' ' A' ' 124' ' ' SER . 2.5 mt -77.24 -33.42 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.718 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.671 ' H ' HG22 ' A' ' 143' ' ' THR . 5.6 mt-10 -86.09 -24.3 26.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.389 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.866 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -60.03 -41.04 91.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.772 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.6 m -73.16 144.92 12.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.8 t -49.56 -55.28 14.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.763 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' B' ' 3' ' ' SER . 30.8 p90 -168.97 126.93 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.72 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 116.67 13.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . . . -131.11 104.07 15.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.036 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.519 ' HB3' ' HD1' ' A' ' 160' ' ' PHE . 32.7 Cg_exo -62.3 -88.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.674 2.249 . . . . 0.0 112.248 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.66 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.439 ' HB2' ' NH1' ' A' ' 158' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.8 0.333 . . . . 0.0 110.982 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -106.31 147.46 16.24 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.351 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.519 ' HD1' ' HB3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -124.48 169.16 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 0.0 110.845 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.513 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 3.3 m -168.58 151.0 5.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.082 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.663 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -134.95 148.04 49.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.531 178.812 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.894 HG23 ' HB3' ' A' ' 174' ' ' CYS . 0.2 OUTLIER -103.89 151.38 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.209 -179.056 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.91 106.95 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.85 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 15.7 ptm180 -68.29 -156.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.196 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.08 -162.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.462 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.93 -10.16 53.7 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.405 ' H ' ' H ' ' A' ' 169' ' ' THR . 0.6 OUTLIER -155.45 -19.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.949 0.404 . . . . 0.0 110.302 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 173' ' ' MET . 2.9 m -130.25 -2.41 4.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.721 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.5 9.64 3.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -172.44 -176.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.658 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -78.52 122.08 25.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 110.942 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.539 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -147.74 110.06 4.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.738 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.894 ' HB3' HG23 ' A' ' 163' ' ' ILE . 28.2 p -98.11 159.89 14.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.231 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.663 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 4.6 m-70 -122.96 142.2 51.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.228 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.513 ' HA2' ' OG ' ' A' ' 161' ' ' SER . . . -111.8 150.12 18.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.856 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -170.29 133.35 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.872 0.368 . . . . 0.0 110.756 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 106' ' ' LEU . 4.7 mp -110.16 171.07 7.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.244 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.44 128.47 41.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.5 OUTLIER -78.37 -0.34 28.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.576 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.98 -21.08 18.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 158' ' ' ARG . 11.6 m-20 55.51 83.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.97 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.2 t -168.99 -42.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.19 42.63 42.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.441 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.02 -34.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.743 0.306 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.455 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.3 OUTLIER -75.84 -16.65 60.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.504 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 191' ' ' VAL . 4.5 mp -126.93 -44.17 1.65 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.019 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 t -59.98 -69.19 0.23 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -21.0 58.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.02 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.9 -52.61 19.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 187' ' ' LEU . 96.5 t -61.16 -31.46 50.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.27 -17.43 46.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.283 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 96.1 m -104.12 -11.37 17.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.719 0.295 . . . . 0.0 110.845 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.99 -33.63 67.32 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.536 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 0.0 OUTLIER -77.51 -34.99 53.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.279 178.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.404 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -55.87 -26.03 45.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.874 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.49 -19.46 5.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.686 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' CYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -72.56 -12.08 60.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.604 178.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 196' ' ' ALA . 1.5 mt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.879 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.42 ' HB2' ' H ' ' B' ' 3' ' ' SER . 1.2 p90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.495 0.188 . . . . 0.0 110.547 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 1.4 p -163.91 162.99 23.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.855 0.359 . . . . 0.0 111.192 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' B' ' 7' ' ' PHE . 41.5 p-10 -76.44 175.4 9.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.063 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 36.6 mtp -128.33 -24.14 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.2 t -90.0 23.64 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.466 ' HB3' ' ND2' ' B' ' 4' ' ' ASN . 43.5 p90 -65.08 149.87 49.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -83.82 0.48 47.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 t0 57.41 94.67 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.026 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.585 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 11.1 m-85 -90.4 -51.32 0.33 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.504 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 35.8 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.113 1.875 . . . . 0.0 112.272 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.794 0.33 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.47 -26.08 32.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.81 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -29.52 70.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.703 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.65 -17.35 17.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.791 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -52.63 -51.57 59.46 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.295 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 194' ' ' ALA . 10.4 t -58.29 -43.97 87.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.727 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -55.17 -39.06 69.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.655 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -72.44 -91.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.638 179.618 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.462 ' H ' ' HB2' ' A' ' 78' ' ' SER . . . 179.84 36.4 0.0 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.24 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.575 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -173.77 101.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 111.556 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 8.5 t -134.54 55.46 1.89 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.844 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.499 ' CB ' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -152.59 -163.05 1.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.822 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.48 ' CG ' ' HE3' ' A' ' 181' ' ' LYS . 10.5 m-85 -156.96 -171.33 3.61 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.819 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -49.56 145.96 4.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.919 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.0 m -143.89 173.53 5.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.971 0.415 . . . . 0.0 111.83 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -122.38 61.19 0.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.327 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.538 ' HA ' ' HB3' ' A' ' 177' ' ' PHE . 1.0 OUTLIER -54.06 96.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.94 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -62.86 -31.36 72.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.78 -131.76 5.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.519 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -158.9 130.27 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.404 HG22 HD11 ' A' ' 109' ' ' LEU . 2.3 m -120.64 136.21 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.977 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 112.56 5.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.069 0.461 . . . . 0.0 110.659 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.403 HG21 HG11 ' A' ' 101' ' ' VAL . 17.0 m -103.58 173.64 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -122.2 64.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -149.53 -90.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 p 63.3 9.62 4.15 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.454 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.433 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -166.52 47.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.988 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -125.21 -129.68 3.39 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.27 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.42 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 9.4 ttt -75.38 -73.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.578 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.584 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . 3.9 mt-30 -146.57 -24.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.824 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.403 HG11 HG21 ' A' ' 93' ' ' VAL . 39.0 t 73.18 -30.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.291 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 100' ' ' GLN . 3.7 p -63.17 -27.61 69.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.53 -18.26 38.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.79 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.8 mt-10 -120.02 -44.63 2.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.727 0.299 . . . . 0.0 111.457 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.554 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -55.13 -46.31 75.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.597 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 tp -54.23 -33.73 59.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.181 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.598 ' HE3' ' HE ' ' A' ' 110' ' ' ARG . 11.5 tptm -74.93 -45.54 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.229 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 104' ' ' GLU . 16.1 t -56.54 -30.1 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.396 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.613 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.5 mt -87.66 -23.54 24.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.008 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.598 ' HE ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -82.46 -9.95 59.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.473 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 42.1 mt-30 -75.21 -62.85 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.723 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 2.0 t -177.33 -168.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.544 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 112' ' ' SER . 1.3 mpt_? 70.61 -69.19 0.18 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.297 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.613 ' HG3' HD23 ' A' ' 109' ' ' LEU . 8.3 mmt180 -84.28 91.8 7.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.456 ' H ' ' HG2' ' A' ' 115' ' ' ARG . 6.5 ptp180 -69.08 141.7 92.15 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.707 ' HB3' HD23 ' A' ' 88' ' ' LEU . 72.3 Cg_endo -77.73 133.16 12.51 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.589 2.193 . . . . 0.0 112.69 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.0 143.59 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.969 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -101.72 108.19 19.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -150.68 178.98 27.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.44 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.435 HD12 ' NE2' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -99.67 118.01 35.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.74 0.305 . . . . 0.0 111.033 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.74 HD13 HG22 ' A' ' 130' ' ' VAL . 24.4 tp -92.89 138.46 31.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.642 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.526 ' H ' HD12 ' A' ' 121' ' ' LEU . 11.3 m170 -123.62 103.67 8.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.02 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.499 HG23 ' CB ' ' A' ' 82' ' ' SER . 42.8 t -71.66 102.45 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.4 . . . . 0.0 110.513 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.584 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -106.16 117.95 35.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.359 179.638 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.72 -16.17 3.69 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.713 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -111.59 34.63 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.687 0.279 . . . . 0.0 110.975 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.764 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 114.75 111.31 2.87 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.412 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.17 162.55 5.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.961 0.41 . . . . 0.0 111.299 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.56 119.85 5.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.513 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.74 HG22 HD13 ' A' ' 121' ' ' LEU . 1.9 t -107.15 127.94 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.605 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.52 156.29 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.506 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.99 148.26 23.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.766 0.317 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.438 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.7 OUTLIER -99.09 19.79 14.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -138.94 -9.32 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.965 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 137' ' ' GLY . 13.6 t -154.16 -10.39 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.876 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 13.8 mmtm 60.16 27.26 16.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.552 ' H ' HG23 ' A' ' 135' ' ' THR . . . -73.62 -159.68 5.92 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.408 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' ' 141' ' ' ASP . 11.5 tp -121.97 118.73 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.689 0.28 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.52 HD12 HG12 ' A' ' 130' ' ' VAL . 8.7 mt -96.84 -55.26 6.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.012 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.495 HG11 ' OH ' ' A' ' 162' ' ' TYR . 95.6 t -139.2 118.07 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.497 ' HB2' HD21 ' A' ' 138' ' ' LEU . 4.4 t0 -122.06 74.06 1.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -119.47 -165.01 1.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.187 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.764 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 1.6 m -115.52 177.31 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.908 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.656 HD13 ' HB1' ' A' ' 194' ' ' ALA . 8.1 mt -96.18 -42.3 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.835 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -81.3 -10.21 59.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.664 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.708 ' HE2' HG21 ' A' ' 168' ' ' THR . 1.7 ttpm? -77.03 -43.35 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.811 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.451 HG11 ' CD2' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -70.29 154.2 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.948 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.62 -68.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.921 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' B' ' 3' ' ' SER . 0.0 OUTLIER -155.19 129.15 8.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.999 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -85.58 104.76 15.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.826 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.512 ' HB1' ' HG2' ' A' ' 100' ' ' GLN . . . -118.2 133.18 23.48 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.261 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 56.3 Cg_endo -70.69 -87.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.407 2.072 . . . . 0.0 112.156 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.78 0.324 . . . . 0.0 110.91 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.685 0.279 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.55 134.64 8.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.578 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -131.3 142.82 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.644 0.259 . . . . 0.0 110.772 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 1.2 m -153.51 131.2 11.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.069 0.462 . . . . 0.0 111.402 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.495 ' OH ' HG11 ' A' ' 140' ' ' VAL . 38.1 p90 -109.13 164.99 11.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.519 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.505 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -126.84 163.2 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.448 -179.565 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.75 110.87 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.678 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.739 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 2.5 ptp180 -72.37 -163.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.132 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -175.05 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.71 -2.04 88.4 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.488 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.708 HG21 ' HE2' ' A' ' 146' ' ' LYS . 8.8 t -167.75 -12.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.392 . . . . 0.0 110.471 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.7 OUTLIER -136.14 1.12 2.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.928 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 64.79 1.52 1.43 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.465 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 171' ' ' ARG . 5.1 ptp180 -175.47 -179.68 1.31 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.032 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.739 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -86.0 94.18 9.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.064 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.67 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.9 OUTLIER -107.23 129.93 54.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.765 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.505 ' HB2' HG23 ' A' ' 163' ' ' ILE . 17.9 t -114.14 110.95 20.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.102 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . 3.1 m80 -85.26 126.44 33.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -112.95 154.19 17.08 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.526 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.538 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . 30.6 p90 -166.21 175.93 7.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.827 0.346 . . . . 0.0 111.064 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.1 mp -137.89 175.16 9.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.932 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.489 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -105.06 119.53 39.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.5 OUTLIER -71.11 -13.67 62.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.728 ' HB2' ' HD2' ' A' ' 186' ' ' ARG . 1.5 mmmp? -83.05 -30.95 27.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.954 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 57.09 92.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.331 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.535 ' HB3' ' HD3' ' A' ' 186' ' ' ARG . 1.5 t -169.22 -38.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.517 ' H ' ' CZ ' ' A' ' 186' ' ' ARG . . . 76.65 47.53 9.95 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.635 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -155.96 -36.33 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.828 0.347 . . . . 0.0 110.908 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.728 ' HD2' ' HB2' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -66.09 -29.99 70.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 186' ' ' ARG . 4.7 mp -118.69 -42.19 2.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.371 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 t -57.66 -75.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.443 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -58.85 -24.78 62.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.2 -56.75 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.076 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.63 -34.06 53.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -60.45 -15.35 38.76 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.619 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 73.4 m -102.34 -12.77 17.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.64 0.257 . . . . 0.0 111.093 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.656 ' HB1' HD13 ' A' ' 144' ' ' ILE . . . -58.14 -29.18 65.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.414 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.46 ' CG ' ' HA ' ' B' ' 4' ' ' ASN . 0.1 OUTLIER -81.49 -27.23 34.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.788 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.672 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -62.03 -12.88 21.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.03 -31.64 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -1.89 19.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.819 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' A' ' 196' ' ' ALA . 3.4 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.964 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.463 ' CE1' ' HD3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.696 0.284 . . . . 0.0 110.517 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.699 ' HB2' ' HB3' ' A' ' 149' ' ' PHE . 4.8 p 62.51 154.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.477 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.46 ' HA ' ' CG ' ' A' ' 195' ' ' PHE . 0.6 OUTLIER -70.47 153.69 42.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.13 -21.11 12.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.805 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t -95.41 20.78 8.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.438 ' HB3' ' OD1' ' B' ' 4' ' ' ASN . 26.3 p90 -61.5 149.07 39.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.976 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -103.49 -4.56 23.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.911 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 54.64 83.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.933 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 14.7 m-85 -56.58 145.34 60.8 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 40.0 Cg_exo . . . . . 0 C--O 1.25 1.088 0 C-N-CA 122.55 2.167 . . . . 0.0 112.387 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.809 0.338 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.08 -43.73 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -80.3 -46.4 16.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.887 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 77' ' ' ARG . 12.9 tt0 -65.5 -23.1 66.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.006 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -55.8 -52.8 62.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.132 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 194' ' ' ALA . 3.1 t -62.79 -43.01 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.624 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.477 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 37.2 mtp180 -54.22 -34.93 61.79 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.329 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 11.6 m -78.05 -90.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.369 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.431 ' H ' ' HB2' ' A' ' 78' ' ' SER . . . 177.05 36.22 0.0 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.232 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.527 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -170.41 101.2 0.26 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.889 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 2.9 t -127.94 -147.35 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.285 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.771 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.47 -163.06 0.1 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 111.607 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.554 ' HB3' ' HD3' ' A' ' 181' ' ' LYS . 2.1 m-85 -158.28 -169.09 2.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.333 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 3.5 m -42.58 144.26 0.56 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.762 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.637 HG12 HD21 ' A' ' 187' ' ' LEU . 34.9 m -139.5 -170.55 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.591 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.69 74.81 1.19 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.701 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.584 ' HB3' HG23 ' A' ' 117' ' ' VAL . 42.8 t80 -58.56 97.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.09 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -64.18 -33.63 76.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.81 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.54 -152.05 24.15 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.5 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.41 129.98 32.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.312 . . . . 0.0 110.797 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.68 152.86 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -84.81 144.66 28.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.44 -172.23 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.997 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -150.0 59.81 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.064 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.508 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -170.06 -77.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.98 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.6 m 61.01 24.83 14.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.988 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 3.5 ptt-85 -135.78 37.61 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.774 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -160.15 161.24 32.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.486 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.458 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -83.92 -37.25 22.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 111.065 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -70.4 -9.77 57.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.168 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.84 -36.88 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.85 0.357 . . . . 0.0 110.925 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.562 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 3.5 m -79.17 -24.62 43.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.478 ' HA ' ' OD2' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -71.62 -7.74 49.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.972 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.4 mm-40 -111.77 -49.89 2.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.963 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.2 -41.83 80.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.635 ' HA ' HD12 ' A' ' 109' ' ' LEU . 3.1 tp -58.24 -36.96 73.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.604 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -67.39 -38.07 84.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.607 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.6 t -60.7 -33.33 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.557 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 106' ' ' LEU . 2.5 mt -77.39 -26.94 52.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.661 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.97 -21.02 44.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.614 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -98.48 1.23 46.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.974 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.95 172.05 13.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.954 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.453 ' H ' ' HG2' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -110.74 74.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.717 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.546 ' HG3' HD23 ' A' ' 109' ' ' LEU . 4.2 mmp_? -86.87 36.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.177 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 115' ' ' ARG . 0.1 OUTLIER 56.16 87.13 0.15 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.65 178.578 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 3.5 Cg_exo -76.2 116.39 4.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.969 2.446 . . . . 0.0 111.886 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -85.43 145.42 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.966 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -104.26 102.6 12.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.327 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.741 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -158.78 -137.64 2.3 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.176 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.474 ' HA ' HG22 ' A' ' 85' ' ' VAL . 3.0 pp -155.2 169.56 23.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 111.101 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.706 HD13 HG22 ' A' ' 130' ' ' VAL . 54.4 tp -112.07 140.25 46.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.136 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 4.7 m-70 -121.5 85.65 2.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.112 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.889 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 69.0 t -60.4 93.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.159 0.504 . . . . 0.0 111.228 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.583 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -87.05 142.04 28.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.857 177.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.87 23.47 1.7 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.415 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 124' ' ' SER . 21.6 t0 -155.55 27.61 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.529 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.25 112.24 1.73 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.282 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.46 159.35 8.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.83 0.348 . . . . 0.0 111.026 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -154.5 116.74 4.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.706 HG22 HD13 ' A' ' 121' ' ' LEU . 13.6 t -101.24 106.09 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.086 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.22 129.35 53.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.977 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.741 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -64.4 175.78 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.01 -4.66 13.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -117.04 -45.13 2.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.381 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.6 m -92.22 -24.04 19.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.451 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 54.09 32.89 16.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.627 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -102.87 -178.56 26.72 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.466 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 tp -87.11 135.9 33.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.808 0.337 . . . . 0.0 110.792 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 130' ' ' VAL . 40.8 mt -116.88 -51.77 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.034 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.598 HG13 ' HG2' ' A' ' 142' ' ' GLN . 92.7 t -117.75 103.72 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.863 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -96.36 32.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.598 ' HG2' HG13 ' A' ' 140' ' ' VAL . 20.2 mm100 -77.5 -173.06 2.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 82.8 m -150.09 148.91 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.776 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.583 HD11 ' O ' ' A' ' 124' ' ' SER . 1.0 OUTLIER -63.22 -39.87 86.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.628 179.473 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.564 ' H ' HG22 ' A' ' 143' ' ' THR . 1.7 mt-10 -84.46 13.92 5.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.681 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.643 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 10.0 tttp -115.43 -48.49 2.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.978 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 164' ' ' CYS . 5.8 m -69.58 146.48 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.101 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.6 t -53.54 -63.09 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.414 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 0.3 OUTLIER -170.73 146.23 2.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.776 178.77 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.37 165.59 22.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.96 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.562 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -167.16 100.82 0.63 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.222 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.25 30.94 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.037 2.491 . . . . 0.0 112.433 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 103' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.104 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.736 0.303 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.38 130.31 9.35 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.488 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.583 ' HZ ' ' HA2' ' A' ' 184' ' ' GLY . 3.3 m-85 -128.93 152.56 48.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.338 . . . . 0.0 111.012 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.55 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -161.74 148.51 14.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.09 162.47 24.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.843 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.74 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -120.47 151.43 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.076 0.465 . . . . 0.0 111.418 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.504 ' HB2' HG12 ' A' ' 147' ' ' VAL . 10.0 t -150.95 148.03 27.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.332 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HB2' ' H ' ' A' ' 166' ' ' ASP . 0.1 OUTLIER -100.09 -158.66 0.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 -179.496 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.442 ' H ' ' HB2' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -57.24 -176.85 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.207 0.527 . . . . 0.0 111.658 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 168' ' ' THR . . . 108.72 -12.07 35.34 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 167' ' ' GLY . 0.5 OUTLIER -163.62 -22.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.134 -0.533 . . . . 0.0 109.984 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.406 HG22 ' HG3' ' A' ' 171' ' ' ARG . 33.3 m -113.2 -12.77 13.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.832 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 65.12 17.2 10.95 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.284 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 171' ' ' ARG . 0.9 OUTLIER -173.0 -170.03 0.61 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.051 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.68 112.86 24.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.3 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.59 173.53 8.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.461 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.74 ' HB2' HG23 ' A' ' 163' ' ' ILE . 19.5 t -155.01 129.59 9.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.752 0.31 . . . . 0.0 111.292 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.43 155.17 17.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.504 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -137.48 155.46 23.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.786 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.488 ' HE2' HD23 ' A' ' 187' ' ' LEU . 11.9 p90 -166.62 176.07 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.361 . . . . 0.0 110.811 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.2 mp -146.23 152.05 38.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.795 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.33 113.28 7.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 4.0 t -57.37 -41.52 80.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.554 ' HD3' ' HB3' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -73.36 -21.29 60.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.557 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 62.27 103.68 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.997 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.8 t -163.77 -43.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.583 ' HA2' ' HZ ' ' A' ' 160' ' ' PHE . . . 76.39 17.34 80.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.317 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.73 -25.67 2.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 0.0 111.018 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -80.8 -17.7 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.991 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.637 HD21 HG12 ' A' ' 85' ' ' VAL . 9.5 mp -119.59 -46.6 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.229 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 t -61.86 -56.77 15.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.517 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.92 -5.46 21.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.621 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -96.78 -48.42 5.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.698 0.285 . . . . 0.0 111.544 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.491 ' HA ' HG11 ' A' ' 123' ' ' VAL . 1.7 p -70.7 -22.11 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.211 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.88 67.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.395 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 77.4 m -119.72 4.39 11.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.773 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.651 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -78.11 -51.77 9.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.169 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.549 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 51.0 p90 -63.72 -26.2 68.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.705 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -62.45 -23.14 66.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.11 11.85 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.6 -13.05 10.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.979 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.705 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.141 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.67 0.271 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -167.63 150.13 5.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.843 179.677 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' B' ' 7' ' ' PHE . 0.1 OUTLIER -60.19 146.78 42.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.739 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 12.0 mtm -116.45 -15.63 10.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.127 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 9.1 p -84.74 20.79 1.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.205 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.472 ' HB3' ' OD1' ' B' ' 4' ' ' ASN . 44.0 p90 -64.05 149.8 46.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -90.62 11.94 20.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 39.0 t0 56.0 85.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.804 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.581 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 2.7 m-85 -92.85 -52.24 0.27 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.392 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 26.5 Cg_exo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.117 1.878 . . . . 0.0 112.212 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.883 0.373 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.56 -18.07 18.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.768 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -62.63 -38.91 92.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.568 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.749 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -92.27 -7.5 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.429 179.259 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 81' ' ' CYS . . . -65.85 -49.12 69.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.84 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 ' CB ' ' A' ' 81' ' ' CYS . 1.2 t -61.06 -36.31 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.047 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.749 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -66.53 -34.36 77.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.276 178.627 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.32 6.26 14.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.756 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 66.32 42.43 3.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.589 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.415 ' HB ' ' ND1' ' A' ' 122' ' ' HIS . 1.5 t -177.19 86.95 0.02 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.241 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.536 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 11.5 t -116.69 4.84 13.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.473 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.698 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.4 OUTLIER -103.78 -167.93 1.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.721 0.295 . . . . 0.0 111.251 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -152.74 -171.07 3.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -39.0 141.99 0.25 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.823 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -149.41 -165.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.323 -179.409 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.19 70.61 0.93 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -61.58 119.88 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.82 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.457 ' HB2' HD22 ' A' ' 109' ' ' LEU . 1.2 mp -79.03 -75.39 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.259 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.85 -117.57 0.45 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.349 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.608 ' N ' HD21 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -159.14 128.45 5.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.713 0.292 . . . . 0.0 110.768 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.506 HG13 ' HG ' ' A' ' 109' ' ' LEU . 3.7 m -123.12 158.03 28.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.331 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.1 152.64 30.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.583 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.9 m -141.55 150.09 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.303 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.454 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 1.7 t80 -118.48 59.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.389 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 94' ' ' PHE . 4.7 mt-10 -154.07 -68.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.692 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.62 14.99 1.92 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.211 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -141.13 116.54 10.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.008 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.8 -170.98 15.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.561 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.408 ' O ' ' HG2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -116.06 -26.28 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 110.738 -179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -69.28 -11.71 61.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.321 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.416 ' HB ' HD11 ' A' ' 163' ' ' ILE . 14.1 t -59.6 -27.5 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 110.988 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 73.2 m -79.32 -39.32 33.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.151 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.36 -14.69 63.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.285 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.8 mt-10 -103.98 -47.77 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.039 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.95 74.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.16 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 tp -57.37 -44.4 84.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.72 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.571 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -69.08 -34.34 74.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.606 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.2 t -61.68 -31.0 49.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.333 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.608 HD21 ' N ' ' A' ' 90' ' ' CYS . 1.2 mt -80.29 -30.32 38.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.852 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.571 ' HG2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -80.41 -21.2 42.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.501 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -19.2 20.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.901 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.6 m -100.32 10.97 40.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.057 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER 32.01 78.79 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.301 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -95.07 22.2 6.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.909 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 56.59 104.94 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.861 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.59 149.16 30.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.514 2.143 . . . . 0.0 111.951 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.439 HG12 ' OD1' ' A' ' 132' ' ' ASP . 0.7 OUTLIER -103.88 136.34 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.085 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.13 82.61 8.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.063 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -151.76 -179.6 27.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.132 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.17 158.22 24.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 0.0 111.236 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.669 HD13 HG22 ' A' ' 130' ' ' VAL . 67.7 tp -96.09 146.7 24.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.222 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.415 ' ND1' ' HB ' ' A' ' 80' ' ' THR . 1.7 m170 -123.68 76.85 1.46 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.821 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.698 ' H ' ' HB2' ' A' ' 82' ' ' SER . 40.7 t -53.0 104.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.956 0.408 . . . . 0.0 110.582 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.658 ' O ' HD11 ' A' ' 144' ' ' ILE . 2.0 t -110.48 126.39 54.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.469 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -55.6 -14.29 6.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.607 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -108.29 31.09 5.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 0.0 110.831 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 114.87 125.5 4.03 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.6 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -62.5 163.82 8.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.86 0.362 . . . . 0.0 110.947 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.415 ' HB3' HH11 ' A' ' 129' ' ' ARG . 0.3 OUTLIER -169.76 133.9 1.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.78 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.669 HG22 HD13 ' A' ' 121' ' ' LEU . 2.8 t -110.12 125.91 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.85 0.357 . . . . 0.0 111.261 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.31 132.23 64.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.619 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.592 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -61.87 -173.89 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 0.0 111.018 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.74 -15.47 5.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.774 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.54 -22.04 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.584 HG23 ' H ' ' A' ' 137' ' ' GLY . 9.4 t -133.19 -18.79 2.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.331 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.32 33.5 23.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.737 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.584 ' H ' HG23 ' A' ' 135' ' ' THR . . . -84.11 145.68 22.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.439 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 24.0 tp -75.1 128.86 36.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.787 0.327 . . . . 0.0 110.924 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.5 mt -111.1 -50.37 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.625 ' HB ' HG23 ' A' ' 130' ' ' VAL . 53.8 t -104.25 114.99 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.971 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -117.27 57.44 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.716 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.58 -176.2 2.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.133 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.554 ' O ' HG22 ' A' ' 147' ' ' VAL . 2.4 m -121.16 168.63 11.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.667 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.658 HD11 ' O ' ' A' ' 124' ' ' SER . 5.8 mt -84.33 -33.09 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 110.873 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -83.67 -13.16 54.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.615 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -87.05 -42.35 13.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.981 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 143' ' ' THR . 0.6 OUTLIER -61.73 126.7 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.923 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.85 -37.72 63.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.878 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.849 ' HB2' HD12 ' A' ' 163' ' ' ILE . 9.6 m-85 -151.97 166.37 31.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.084 0.469 . . . . 0.0 111.626 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' B' ' 3' ' ' SER . 0.5 OUTLIER -147.75 63.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.797 177.602 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.452 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -90.06 136.93 28.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.984 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 72.7 Cg_endo -80.16 -91.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.704 2.269 . . . . 0.0 111.603 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.677 0.275 . . . . 0.0 110.655 178.849 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 158' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.63 123.3 4.46 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -115.39 161.94 17.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.645 0.259 . . . . 0.0 110.54 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -158.92 -177.87 6.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.013 0.435 . . . . 0.0 111.448 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -156.38 158.06 36.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.085 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.849 HD12 ' HB2' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -123.71 165.04 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.069 0.461 . . . . 0.0 112.027 -177.288 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.42 ' H ' HG22 ' A' ' 163' ' ' ILE . 5.7 p -165.57 135.6 3.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.394 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -160.43 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 111.263 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -175.17 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.442 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.25 -7.32 69.16 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.445 ' H ' ' H ' ' A' ' 169' ' ' THR . 2.1 t -168.95 -11.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.216 -0.492 . . . . 0.0 110.002 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.673 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -128.08 -7.88 5.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.739 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 64.15 9.72 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.574 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -176.12 -173.72 0.58 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.968 0.413 . . . . 0.0 111.317 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.93 108.07 19.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.593 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.673 ' HB2' HG21 ' A' ' 169' ' ' THR . 24.9 mtp -128.36 133.51 48.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.759 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' CYS . . . . . 0.437 ' HB2' HG23 ' A' ' 163' ' ' ILE . 43.5 t -113.58 132.43 55.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' A' ' 161' ' ' SER . 35.1 m170 -98.8 158.72 15.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.624 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -139.81 149.41 20.78 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.005 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 10.3 p90 -157.08 135.98 11.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.78 0.324 . . . . 0.0 110.815 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.68 160.19 14.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.499 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . . . -96.52 118.02 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -6.56 45.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -26.76 20.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.765 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.16 75.87 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.027 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -165.65 -32.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.786 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 63.82 37.09 94.17 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.514 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -133.29 -31.25 1.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 111.011 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.443 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 4.1 mmt180 -88.16 -5.72 58.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.82 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 191' ' ' VAL . 0.2 OUTLIER -128.07 -58.0 1.22 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.29 -179.274 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -62.51 1.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.344 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.98 -19.64 32.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.29 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.05 -45.65 33.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.03 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 187' ' ' LEU . 40.0 t -66.4 -29.05 45.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.962 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.53 -17.69 48.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.366 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 68.6 m -110.58 -8.73 14.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.761 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.1 94.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.187 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.518 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 3.5 p90 -70.42 -29.59 66.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.763 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.08 -22.7 51.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.066 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 49.4 t -101.43 -21.95 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.528 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.16 -28.23 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.467 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.516 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.724 0.297 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.406 ' HA ' ' SG ' ' A' ' 150' ' ' CYS . 0.2 OUTLIER -156.76 166.43 33.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.148 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -70.12 128.14 35.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 1.2 mtm -95.97 -19.76 19.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.516 ' HB3' HD23 ' A' ' 199' ' ' LEU . 16.0 p -75.04 7.38 3.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.404 ' HD2' ' H ' ' B' ' 9' ' ' ASP . 38.7 p90 -57.19 146.92 26.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -99.44 11.36 39.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.716 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' ASP . . . . . 0.404 ' H ' ' HD2' ' B' ' 7' ' ' PHE . 13.4 t70 54.42 72.74 0.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.953 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.464 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 65.8 m-85 -65.84 139.98 97.07 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 28.1 Cg_exo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.678 2.252 . . . . 0.0 112.31 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.849 0.357 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.54 -29.31 22.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -69.17 -38.41 78.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.688 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.5 tt0 -84.98 -10.61 56.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.641 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -59.87 -54.92 40.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.009 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 194' ' ' ALA . 14.6 t -58.17 -40.32 76.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.542 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 5.8 mtp180 -58.51 -38.29 77.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.456 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 m -75.13 -91.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.414 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 179.65 35.29 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.53 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.634 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -173.16 99.78 0.12 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.895 0.379 . . . . 0.0 111.739 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 4.1 t -120.73 -150.02 0.44 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.23 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.573 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.77 -157.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 111.539 179.202 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.577 ' HB3' ' HE2' ' A' ' 181' ' ' LYS . 6.1 m-85 -159.0 -167.03 1.99 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.416 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.7 m -51.59 153.61 2.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.706 0.289 . . . . 0.0 110.995 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.487 HG21 ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -144.33 -173.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.415 -179.489 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 86' ' ' LYS . 10.1 mmmm -142.3 63.95 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.69 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.487 ' HE1' HG21 ' A' ' 85' ' ' VAL . 31.8 m-85 -57.81 103.12 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.54 HD13 ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -67.69 -33.61 75.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.479 -178.382 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.73 -167.44 28.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.602 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.5 ' HB3' ' NE2' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -114.89 128.44 56.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.074 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.76 144.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.028 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.49 141.96 42.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.06 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.94 154.98 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -120.97 61.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.812 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 22.3 mt-10 -152.42 -76.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.254 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m 62.67 29.76 16.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -151.4 107.3 3.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.659 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.57 146.3 7.56 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.316 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.416 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -78.03 -23.39 48.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.748 0.309 . . . . 0.0 110.953 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -70.31 -20.74 62.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.104 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.8 t -59.73 -39.24 79.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 57.6 m -70.77 -36.89 73.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -9.2 18.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.219 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.493 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.5 mt-10 -99.93 -55.53 2.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.011 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.55 -31.79 66.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.238 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.514 HD21 ' HA3' ' A' ' 159' ' ' GLY . 6.8 tp -59.18 -46.56 88.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -67.01 -32.24 73.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.3 t -58.39 -49.94 80.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.986 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.615 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.3 mt -64.68 -22.31 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.678 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 110' ' ' ARG . 7.0 tpt180 -82.45 -28.14 31.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.709 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -97.67 -2.2 41.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.919 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.434 ' HB3' ' HG2' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -107.1 -177.65 3.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.049 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.79 16.29 5.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.093 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.615 ' HG3' HD23 ' A' ' 109' ' ' LEU . 12.2 mmt180 -67.46 99.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.929 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -73.47 135.71 78.61 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 74.2 Cg_endo -77.12 161.74 32.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.585 2.19 . . . . 0.0 112.552 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -124.25 108.73 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.738 179.339 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 96.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.998 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -139.0 161.9 25.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.533 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.509 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -89.28 129.86 35.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 111.025 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.761 HD13 HG22 ' A' ' 130' ' ' VAL . 28.0 tp -101.48 123.42 45.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.634 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 12.1 m-70 -112.81 89.3 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.911 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 82' ' ' SER . 69.1 t -68.82 89.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.399 . . . . 0.0 110.937 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.692 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 1.2 p -84.32 150.74 25.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.234 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.32 34.4 2.44 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.385 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.99 19.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.809 0.338 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.685 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 134.04 112.59 1.31 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.546 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.432 ' CD2' HG13 ' A' ' 123' ' ' VAL . 1.5 mt -65.42 154.05 39.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 111.184 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.492 ' HD3' HG22 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -151.52 124.79 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.8 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.761 HG22 HD13 ' A' ' 121' ' ' LEU . 2.8 t -112.45 113.75 45.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.441 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.492 HG22 ' HD3' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -107.6 117.25 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.581 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 2.6 t0 -51.96 158.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -108.89 0.95 20.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.061 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.69 -20.46 8.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.191 0.52 . . . . 0.0 110.01 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.1 m -123.4 -24.84 4.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.067 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 54.81 27.34 8.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.793 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.22 -109.6 1.19 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.364 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.649 HD21 ' HB2' ' A' ' 141' ' ' ASP . 27.3 tp -160.02 131.2 5.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.778 0.323 . . . . 0.0 111.1 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.8 mt -113.47 -48.92 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.041 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.5 t -136.93 112.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.649 ' HB2' HD21 ' A' ' 138' ' ' LEU . 3.2 t0 -118.14 65.57 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.798 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -112.61 -171.8 1.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.947 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 38.1 m -125.21 158.72 33.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.433 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -66.31 -48.08 82.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.916 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -75.09 -21.95 58.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.612 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.947 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 2.8 ttmm -63.07 -52.34 63.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.694 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 147' ' ' VAL . 2.3 m -67.95 143.09 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -44.92 -67.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.107 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -165.08 124.93 1.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.961 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.0 t -63.85 159.37 19.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.765 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.519 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -157.25 136.06 7.88 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.421 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 153' ' ' ASP . 89.5 Cg_endo -80.2 -142.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.643 2.228 . . . . 0.0 111.993 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.77 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.625 ' HG2' ' HA ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.769 0.319 . . . . 0.0 110.965 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.514 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -119.45 112.06 2.19 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.652 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 1.5 m-85 -119.55 151.57 38.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.715 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -159.81 170.26 21.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.858 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.581 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -147.51 164.46 33.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.158 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.5 132.6 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.058 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.4 p -111.01 153.64 25.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -119.1 94.01 4.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.008 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.64 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 49.08 29.17 2.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.481 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 168' ' ' THR . . . -65.35 -13.82 58.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.551 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 167' ' ' GLY . 9.0 t 175.75 15.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.736 HG21 ' HG3' ' A' ' 173' ' ' MET . 24.6 m -124.78 -11.52 7.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.887 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 0.0 OUTLIER 60.49 31.15 20.23 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.719 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.428 ' CG ' HG22 ' A' ' 169' ' ' THR . 0.2 OUTLIER -176.35 -168.43 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.589 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.99 126.17 39.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.362 . . . . 0.0 111.196 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.736 ' HG3' HG21 ' A' ' 169' ' ' THR . 1.4 mtp -142.24 161.38 38.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.635 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 33.9 t -140.69 116.07 10.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.077 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.581 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 11.9 m-70 -92.15 134.5 34.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.71 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.715 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -118.0 143.34 17.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.532 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 41.4 p90 -149.96 154.16 37.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 0.0 111.223 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.89 135.49 51.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.643 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -59.74 117.49 5.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -16.12 63.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.741 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.577 ' HE2' ' HB3' ' A' ' 83' ' ' PHE . 3.4 mmtt -88.41 -26.91 21.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.781 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.625 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 4.3 m-20 57.59 87.64 0.06 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.2 t -162.5 -30.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.996 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.94 20.35 76.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.399 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -137.66 2.09 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.689 0.28 . . . . 0.0 111.02 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.472 ' HB2' HD12 ' A' ' 187' ' ' LEU . 7.8 mmt85 -106.25 -14.88 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.738 HD23 HD23 ' A' ' 121' ' ' LEU . 4.4 mp -134.55 -39.94 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -59.27 -60.26 4.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -18.21 64.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.31 -41.55 63.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 187' ' ' LEU . 67.7 t -73.62 -29.53 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.68 -7.64 29.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.248 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.571 ' O ' HG23 ' A' ' 197' ' ' VAL . 68.3 m -108.47 -19.77 13.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.697 0.284 . . . . 0.0 110.751 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.458 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -58.91 -60.8 3.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.159 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -64.69 -32.71 74.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.664 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.641 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -57.44 -16.81 10.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.236 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 193' ' ' CYS . 56.4 t -105.34 -29.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.055 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -9.56 58.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.718 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 196' ' ' ALA . 4.3 mt . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.915 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.036 0 CA-C-O 120.641 0.258 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 93.0 p 51.4 95.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.177 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -52.38 146.26 9.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.396 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 23.2 ttm -113.03 3.86 16.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.914 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.8 p -94.02 19.35 9.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.429 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 28.6 p90 -62.88 152.24 36.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.01 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -85.05 11.55 9.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.739 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' ASP . . . . . 0.429 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 22.5 t0 57.46 80.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.035 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.625 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 24.0 m-85 -90.38 -50.8 0.34 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.248 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 45.0 Cg_exo . . . . . 0 C--O 1.25 1.085 0 C-N-CA 122.197 1.932 . . . . 0.0 112.278 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 120.677 0.275 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.51 -54.52 44.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.94 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.6 m0 -71.92 -24.07 61.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -11.08 60.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.295 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.96 -22.22 9.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.948 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -85.21 -18.95 32.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -44.0 97.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.6 mt-10 -97.62 -5.95 34.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -63.92 -55.98 18.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.501 HG23 ' CB ' ' A' ' 81' ' ' CYS . 1.2 t -61.54 -36.27 72.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.707 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.404 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 22.9 mtp180 -62.0 -28.6 69.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.373 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.6 m -85.66 -92.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.819 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -175.94 34.14 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.454 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.543 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.8 t -174.41 97.22 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.036 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.645 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 10.5 t -122.88 6.01 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.591 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.726 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -113.15 -153.38 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.076 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.434 ' CG ' ' HE2' ' A' ' 181' ' ' LYS . 6.8 m-85 -154.56 -169.39 3.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.684 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.63 137.61 15.32 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.763 0.315 . . . . 0.0 111.012 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.53 179.54 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 0.0 111.675 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -133.0 66.56 1.56 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.814 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -58.3 101.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.73 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -69.84 -37.91 76.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.151 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.98 -132.08 4.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.467 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 136.94 21.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.099 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -130.77 167.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.833 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 5.6 pt-20 -96.39 143.53 27.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.126 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.55 -171.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -149.46 62.98 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.164 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 1.3 mt-10 -168.95 -68.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.097 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.0 p 52.44 38.92 26.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -146.91 25.96 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.069 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -159.24 161.65 32.21 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -15.88 35.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -80.22 -18.03 50.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.945 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 t -61.49 -27.29 41.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 67.3 m -81.12 -26.1 36.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.932 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -15.96 63.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -99.81 -42.9 6.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.516 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.7 -39.7 81.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.974 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.627 HD11 ' HG ' ' A' ' 178' ' ' LEU . 6.0 tp -56.51 -32.36 64.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.804 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 5.8 tptp -75.87 -38.9 57.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -58.18 -44.43 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.526 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.1 mt -72.67 -15.93 61.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 110' ' ' ARG . 3.8 ttt-85 -84.84 -12.39 53.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.249 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 1.5 mm100 -72.49 -64.81 0.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.658 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -177.73 -169.14 0.2 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.425 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' SER . 0.5 OUTLIER 69.87 -71.95 0.12 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.21 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.526 ' HG3' HD23 ' A' ' 109' ' ' LEU . 8.3 mmm180 -75.67 100.3 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.728 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.466 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -80.31 135.04 54.34 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.126 -179.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.73 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 16.4 Cg_exo -68.2 156.74 64.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.819 2.346 . . . . 0.0 112.104 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.8 t -130.44 140.57 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -92.29 98.04 11.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 132' ' ' ASP . . . -125.77 -162.33 11.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.682 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.31 102.14 6.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.699 0.285 . . . . 0.0 110.598 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.487 HD23 HD23 ' A' ' 187' ' ' LEU . 40.8 tp -69.2 128.52 36.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.708 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.567 ' HB2' ' HG2' ' A' ' 129' ' ' ARG . 34.4 m170 -121.73 87.95 2.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.773 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.726 HG23 ' HB2' ' A' ' 82' ' ' SER . 35.8 t -62.8 94.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.148 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.819 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -98.39 144.86 27.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.287 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -60.61 -7.93 8.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.94 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.94 34.54 5.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.727 0.298 . . . . 0.0 110.997 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.652 ' HA2' HG13 ' A' ' 144' ' ' ILE . . . 109.14 143.51 10.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.774 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.78 164.03 27.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.567 ' HG2' ' HB2' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -158.04 114.78 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.534 179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.483 HG23 ' HB ' ' A' ' 140' ' ' VAL . 17.1 t -99.39 103.21 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.517 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.79 109.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.376 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.411 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -48.68 139.61 9.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.093 -179.034 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -98.63 12.98 33.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.864 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -138.57 0.73 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.2 m -148.89 -26.46 0.3 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.438 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm 49.64 35.33 8.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.667 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.31 -5.15 54.71 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.63 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.619 HD21 ' HB3' ' A' ' 141' ' ' ASP . 7.3 tp 66.26 149.52 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 110.898 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.418 ' N ' ' HG ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -138.49 -35.91 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.526 -179.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.483 ' HB ' HG23 ' A' ' 130' ' ' VAL . 21.0 t -113.84 95.74 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 111.351 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.619 ' HB3' HD21 ' A' ' 138' ' ' LEU . 3.4 p30 -102.66 25.79 8.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.597 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -76.65 -164.82 0.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.256 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.617 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 9.2 m -141.11 158.39 43.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.921 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.652 HG13 ' HA2' ' A' ' 127' ' ' GLY . 30.4 mt -73.13 -41.69 58.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.844 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.33 -7.14 56.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.568 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.617 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -87.9 -40.58 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.814 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 143' ' ' THR . 0.9 OUTLIER -74.86 152.91 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.803 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -65.29 0.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.722 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 26.5 p90 -174.33 141.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.83 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.4 m -67.25 166.25 14.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.479 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -170.09 124.54 0.66 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.34 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.498 ' HG3' ' N ' ' B' ' 1' ' ' GLY . 86.9 Cg_endo -82.1 -158.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.676 2.251 . . . . 0.0 112.405 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -130.89 -179.42 5.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.726 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 154' ' ' ARG . 1.7 mmm180 -130.58 21.25 5.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.902 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -88.37 -57.74 2.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.46 14.54 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 57.62 21.39 7.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.277 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.42 ' HG3' ' HA ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -110.41 16.95 21.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.686 179.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -147.82 124.0 1.82 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.691 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 4.7 m-85 -126.34 165.25 19.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.632 0.253 . . . . 0.0 110.562 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.73 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -163.6 158.83 21.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 -179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.551 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -131.46 148.85 52.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.252 178.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.821 HG23 ' HB2' ' A' ' 174' ' ' CYS . 1.0 OUTLIER -106.58 150.54 9.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.411 . . . . 0.0 111.62 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -146.37 100.02 3.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.45 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.645 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 7.3 ptt180 -72.44 -153.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -178.23 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.093 0.473 . . . . 0.0 111.6 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.0 -3.87 60.63 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.3 t -171.97 -9.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.936 0.398 . . . . 0.0 110.366 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.45 HG21 ' CG ' ' A' ' 173' ' ' MET . 2.0 m -133.86 -6.88 2.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.101 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 59.09 16.91 5.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.168 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.27 179.69 2.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.781 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -85.07 113.53 21.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.45 ' CG ' HG21 ' A' ' 169' ' ' THR . 0.9 OUTLIER -131.49 116.45 17.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.622 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.821 ' HB2' HG23 ' A' ' 163' ' ' ILE . 27.3 t -108.75 129.27 55.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.222 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.551 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 1.8 m-70 -96.95 142.22 29.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.73 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -124.09 157.13 18.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.331 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 22.7 p90 -161.05 172.5 16.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.676 0.274 . . . . 0.0 110.422 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.627 ' HG ' HD11 ' A' ' 106' ' ' LEU . 1.2 mp -138.53 148.9 44.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 0.0 111.106 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.83 121.6 25.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.069 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.74 8.48 9.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.434 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 17.7 mmmt -102.12 -29.14 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.944 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.42 ' HA ' ' HG3' ' A' ' 158' ' ' ARG . 1.7 m-20 56.98 81.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.966 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.4 t -159.89 -33.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.29 37.46 80.49 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.411 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -151.47 -32.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.313 . . . . 0.0 111.136 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.52 ' HB2' HD12 ' A' ' 187' ' ' LEU . 5.7 mmt180 -74.01 -11.9 60.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.065 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.52 HD12 ' HB2' ' A' ' 186' ' ' ARG . 5.5 mp -135.29 -43.93 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 t -57.22 -75.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.509 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -28.59 57.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.252 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.84 84.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.918 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 187' ' ' LEU . 94.1 t -68.74 -36.36 73.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.69 -11.34 35.56 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.32 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.411 ' O ' HG23 ' A' ' 197' ' ' VAL . 56.5 m -107.78 -16.11 14.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 0.0 110.566 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.08 -51.55 66.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.213 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.542 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.9 p90 -62.0 -38.02 87.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.75 -26.61 64.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.446 ' HA ' ' HG2' ' A' ' 200' ' ' GLU . 47.0 t -97.44 -22.21 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.754 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 15.8 t -65.61 -29.92 70.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.975 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER -105.8 29.46 6.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 197' ' ' VAL . 4.6 mm-40 -68.08 -29.3 68.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.865 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.498 ' N ' ' HG3' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.113 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.8 178.02 7.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.679 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 5.1 p -168.71 145.14 3.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.779 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -60.16 154.95 18.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.024 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 13.9 mmm -129.06 -15.42 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.264 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 9.5 t -84.82 20.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -63.49 159.8 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -91.75 0.76 57.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.783 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 59.26 81.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.132 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -74.36 150.95 87.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.86 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.571 2.181 . . . . 0.0 112.394 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.825 0.345 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -79.17 -39.15 34.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -73.71 -30.84 63.08 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -67.77 -9.54 44.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.631 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.05 -19.68 11.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.042 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -26.62 40.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -47.1 87.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.762 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -83.05 -15.95 48.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.881 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -53.62 -52.45 59.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.28 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.4 t -61.08 -43.62 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.565 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -55.21 -35.21 64.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.337 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 m -77.09 -92.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.531 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 179.54 35.72 0.0 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.393 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.516 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.1 t -173.03 100.81 0.13 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.009 0.433 . . . . 0.0 111.887 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.872 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.0 t -124.29 -149.45 0.42 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.413 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.718 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.4 OUTLIER 53.74 -153.33 0.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.768 0.318 . . . . 0.0 111.805 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -158.99 -168.34 2.34 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.749 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.7 OUTLIER -52.32 143.15 15.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.532 -179.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -136.91 -171.87 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.987 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.827 ' HD2' ' HB2' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -142.23 89.94 2.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 91.5 t80 -58.31 107.68 0.52 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.01 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.6 ' HB3' HD22 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -70.06 -60.66 2.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.61 -134.11 3.14 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.469 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -152.41 131.28 12.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 110.898 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.42 164.74 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.783 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -100.87 136.32 40.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.967 0.413 . . . . 0.0 111.012 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.3 m -140.25 140.37 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.96 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.506 ' HA ' ' HE3' ' A' ' 172' ' ' TRP . 50.0 m-85 -102.14 64.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -147.89 -81.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.075 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.03 46.61 22.43 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.92 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.87 70.75 1.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.775 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.25 179.27 20.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.247 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.49 -7.42 24.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -83.62 9.49 11.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -80.13 -19.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.0 p -83.05 -36.88 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.961 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -66.17 -4.96 8.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.105 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -119.59 -53.65 2.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.082 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.97 -53.34 59.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.212 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -55.54 -36.36 66.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.695 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -38.24 90.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.75 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 104' ' ' GLU . 48.7 t -62.6 -45.24 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.727 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.684 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -61.74 -37.61 84.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.586 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -28.94 64.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.93 2.54 53.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.257 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.613 ' HB3' ' HG2' ' A' ' 114' ' ' ARG . 0.1 OUTLIER -109.7 -163.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.916 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -96.56 15.95 20.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.684 ' HG3' HD23 ' A' ' 109' ' ' LEU . 1.5 mmt180 -67.14 101.74 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.01 126.79 90.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.095 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.827 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 88.1 Cg_endo -78.66 153.97 26.74 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.545 2.163 . . . . 0.0 112.314 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -129.49 121.51 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.206 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -77.96 109.41 11.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -139.33 -152.74 5.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.6 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.512 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -128.92 126.27 39.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.834 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.434 ' N ' HD13 ' A' ' 120' ' ' LEU . 19.8 tp -102.25 116.25 32.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.62 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.702 ' HE1' HG23 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -107.09 93.12 4.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.872 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 45.2 t -60.82 95.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.551 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -94.6 129.7 41.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.198 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.06 5.22 1.37 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.217 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 124' ' ' SER . 7.7 p-10 -134.86 27.81 3.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.886 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 126.21 107.07 1.53 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.376 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.0 mt -61.34 150.7 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.949 0.405 . . . . 0.0 111.296 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 129' ' ' ARG . 5.7 ttm-85 -142.66 151.61 41.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.528 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.425 ' CG2' ' HB ' ' A' ' 140' ' ' VAL . 50.8 t -141.04 110.79 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.804 0.335 . . . . 0.0 111.368 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.702 HG23 ' HE1' ' A' ' 122' ' ' HIS . 17.8 t -104.16 126.4 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.835 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 0.3 OUTLIER -54.07 151.94 6.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.569 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -104.91 8.52 34.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.028 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.74 -4.2 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.226 0.536 . . . . 0.0 110.347 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.2 m -141.83 -21.36 0.72 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.898 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.559 ' HA ' HG12 ' A' ' 131' ' ' VAL . 19.5 mmtp 52.09 36.96 20.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.218 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.01 -112.3 1.67 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.377 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 tp -169.78 119.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.698 0.285 . . . . 0.0 110.647 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.73 -49.77 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.319 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.425 ' HB ' ' CG2' ' A' ' 130' ' ' VAL . 8.2 t -114.22 105.42 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 111.311 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -118.53 34.3 5.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -73.29 -166.63 0.34 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.138 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.676 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 27.1 m -144.42 155.03 43.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.887 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.551 HD11 ' O ' ' A' ' 124' ' ' SER . 17.2 mt -64.08 -53.73 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.955 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.11 -9.19 51.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.853 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.614 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 36.9 tttm -85.81 -51.29 6.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.046 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 143' ' ' THR . 4.4 m -69.28 145.35 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.073 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.82 -63.86 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -166.15 142.9 5.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.699 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.469 ' H ' ' H ' ' B' ' 4' ' ' ASN . 1.2 m -71.78 165.12 24.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.3 101.2 0.48 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HG2' ' HA2' ' B' ' 1' ' ' GLY . 45.6 Cg_endo -68.41 -90.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.425 2.083 . . . . 0.0 112.366 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -173.49 -164.03 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.812 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 154' ' ' ARG . 10.1 mmm180 -80.73 -83.64 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.67 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -176.0 48.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.12 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -169.27 -17.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.244 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -82.81 -33.24 27.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.225 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 58.99 15.16 3.78 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.958 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.44 156.75 15.43 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.346 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.64 157.21 43.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.757 0.313 . . . . 0.0 110.952 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.77 138.03 17.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.125 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -114.76 144.44 43.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.736 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -109.99 157.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.991 0.424 . . . . 0.0 111.589 -178.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 14.5 t -161.24 136.05 7.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.571 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -88.73 -151.22 0.2 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.267 -179.264 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 170' ' ' ARG . 6.5 p-10 -65.7 -149.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.435 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 168' ' ' THR . . . 83.35 -8.41 64.59 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 167' ' ' GLY . 0.6 OUTLIER -163.03 -42.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.081 0.467 . . . . 0.0 110.171 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.451 HG22 ' HG3' ' A' ' 171' ' ' ARG . 16.6 m -96.32 -11.4 25.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.946 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.46 ' HA ' ' HB2' ' A' ' 166' ' ' ASP . 1.1 mtp180 63.44 20.06 12.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.934 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.451 ' HG3' HG22 ' A' ' 169' ' ' THR . 1.6 ptp85 -174.31 173.47 3.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.678 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.7 OUTLIER -85.9 105.02 16.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 8.9 mtp -121.41 139.55 53.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.653 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.418 ' HB2' HG23 ' A' ' 163' ' ' ILE . 25.2 t -118.27 141.81 48.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.933 0.396 . . . . 0.0 110.984 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -111.14 151.31 28.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.548 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -128.22 156.2 20.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.64 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -170.78 132.93 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.12 173.62 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.834 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -97.98 133.62 42.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.09 -24.06 61.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.776 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -82.08 -28.0 32.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.913 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.05 84.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.998 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 t -169.24 -38.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.55 26.6 62.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.402 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -132.49 -23.7 2.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 111.203 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.573 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -86.9 -17.99 31.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 186' ' ' ARG . 5.9 mp -124.87 -49.2 1.74 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.249 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.8 -46.55 87.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.241 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.89 1.26 13.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.316 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.505 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -101.15 -46.74 4.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.109 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.693 ' HA ' HG11 ' A' ' 123' ' ' VAL . 8.5 p -71.41 -20.72 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.4 -14.04 66.13 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.722 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.9 m -103.84 1.06 31.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.988 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.61 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -78.51 -42.31 29.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.987 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.517 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.0 m-85 -60.57 -37.77 82.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.626 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.488 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -54.59 -34.6 62.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.439 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.6 -10.67 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.173 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.6 t -84.3 -16.31 43.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.191 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER -123.62 44.8 2.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.333 . . . . 0.0 111.241 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.46 -29.88 70.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.641 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.715 179.257 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.125 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.31 176.45 5.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.816 0.341 . . . . 0.0 110.685 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -159.83 144.11 14.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.963 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.469 ' H ' ' H ' ' A' ' 150' ' ' CYS . 22.7 t-20 -62.89 105.18 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.037 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -9.08 53.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -81.05 11.74 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.226 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -56.87 142.47 41.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.33 10.17 13.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 32.4 t0 56.04 78.15 0.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.144 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 26.2 m-85 -61.79 139.0 95.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.028 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 47.0 Cg_exo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.656 2.237 . . . . 0.0 112.386 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.7 t60 . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 120.845 0.355 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.89 -69.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -65.83 -27.69 68.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -10.42 54.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.492 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.76 -23.36 12.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.876 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -86.3 -28.34 23.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -66.89 -47.91 70.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.594 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.673 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -69.72 -26.8 64.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.5 80.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.687 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 194' ' ' ALA . 42.1 t -59.33 -36.83 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.3 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.673 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 2.2 mtm-85 -65.36 -37.09 85.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.117 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -75.66 -5.97 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.435 178.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 70.58 46.89 0.51 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.414 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.836 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -172.57 87.04 0.07 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.47 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.86 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.7 t -119.7 -149.19 0.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.302 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.625 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 57.64 -154.85 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.375 . . . . 0.0 111.573 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.506 ' HB2' HD11 ' A' ' 187' ' ' LEU . 5.5 m-85 -158.32 -170.77 3.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.503 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.6 OUTLIER -53.14 154.35 3.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.79 0.329 . . . . 0.0 111.005 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -148.28 -170.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.073 0.464 . . . . 0.0 111.592 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 5.1 mmtp -141.54 80.15 1.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.467 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 48.4 t80 -56.83 108.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.276 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 178' ' ' LEU . 7.9 mt -70.53 -51.37 29.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.664 ' HA3' ' HD3' ' A' ' 114' ' ' ARG . . . 152.71 -131.48 3.37 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.615 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.517 ' H ' ' HD3' ' A' ' 114' ' ' ARG . 1.4 p -153.3 134.15 13.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.819 0.342 . . . . 0.0 110.854 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.0 m -128.02 146.2 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -71.33 132.94 45.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.168 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.7 m -117.26 -178.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.046 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -139.34 59.61 1.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.037 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -171.54 -63.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.821 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.425 ' HA ' HG21 ' A' ' 163' ' ' ILE . 17.8 m 60.23 31.32 20.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.399 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 7.3 ptt180 -165.39 88.12 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.95 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.19 158.73 9.16 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.753 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -37.77 54.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 110.86 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 2.2 pt20 -67.36 -22.55 65.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.92 -33.13 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.08 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 83.5 m -80.07 -39.33 29.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.997 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.661 ' HG2' ' HA ' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -64.26 -28.63 69.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.047 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 108' ' ' VAL . 68.0 mt-10 -81.31 -50.87 9.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.88 -36.78 75.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.321 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.8 tp -57.87 -38.9 76.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -73.21 -37.99 66.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.1 t -58.66 -38.49 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.721 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.9 mt -72.76 -33.58 66.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -80.91 -3.32 51.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.759 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -117.32 -13.52 10.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.9 p -93.62 -166.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -101.38 27.4 6.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.046 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.721 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -72.79 113.55 9.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.75 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 131.11 91.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 90.8 Cg_endo -85.05 145.59 9.9 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.742 2.295 . . . . 0.0 112.187 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 1.8 t -108.43 155.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -116.49 103.25 10.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.971 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.42 -164.73 12.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.622 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.537 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -112.15 131.41 55.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 111.143 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.7 HD23 HD23 ' A' ' 187' ' ' LEU . 22.0 tp -98.14 120.8 39.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.171 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.836 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 74.7 m-70 -109.16 98.46 7.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.09 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.86 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 16.9 t -67.11 100.3 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.246 0.546 . . . . 0.0 110.503 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -98.9 131.43 44.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.268 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.86 20.94 1.01 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.616 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 124' ' ' SER . 9.3 t70 -150.32 14.69 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.782 0.325 . . . . 0.0 110.759 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.801 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 139.4 107.87 0.76 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.684 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 123' ' ' VAL . 12.8 mt -50.59 150.1 2.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.842 0.353 . . . . 0.0 111.131 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.797 ' HG2' HD11 ' A' ' 138' ' ' LEU . 15.3 ttm180 -145.32 113.43 6.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.427 HG22 ' CD1' ' A' ' 121' ' ' LEU . 2.8 t -111.46 115.17 49.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 111.657 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 2.1 t -97.33 156.92 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.647 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.527 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 0.3 OUTLIER -95.69 165.08 12.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.417 179.123 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.45 -5.82 18.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 135' ' ' THR . 0.0 OUTLIER -107.69 -36.95 6.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.939 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 137' ' ' GLY . 8.8 t -118.99 -12.5 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.527 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 30.5 mmtt 59.25 23.02 11.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.777 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.67 ' H ' HG23 ' A' ' 135' ' ' THR . . . -87.91 -161.77 37.26 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.131 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.797 HD11 ' HG2' ' A' ' 129' ' ' ARG . 3.1 tp -116.17 124.32 50.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.0 -25.62 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.365 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.4 t -132.45 94.67 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.863 0.363 . . . . 0.0 111.131 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.526 ' HB2' HD23 ' A' ' 138' ' ' LEU . 37.6 t70 -96.77 72.0 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.756 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.14 -175.78 3.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.877 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 20.2 m -136.47 151.83 49.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.5 mm -61.33 -40.54 86.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.041 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.86 -6.13 59.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.606 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.877 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 2.6 tttp -87.69 -42.95 12.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.907 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 143' ' ' THR . 0.7 OUTLIER -64.89 128.58 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.2 t -62.87 -35.37 79.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.143 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.577 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -147.78 150.77 34.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.344 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.5 m -129.04 80.52 1.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.299 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 102' ' ' CYS . . . -109.72 128.69 24.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.61 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.77 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 69.8 Cg_endo -75.45 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.535 2.156 . . . . 0.0 112.329 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.661 ' HA ' ' HG2' ' A' ' 103' ' ' GLU . 13.8 p-10 -154.64 -176.81 6.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.51 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.416 ' HG2' ' HG3' ' A' ' 103' ' ' GLU . 0.2 OUTLIER -130.03 -3.37 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.305 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.41 ' HB3' ' H ' ' A' ' 156' ' ' HIS . 14.9 t-20 -100.6 -85.94 0.4 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.599 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.41 ' H ' ' HB3' ' A' ' 155' ' ' ASN . 1.0 OUTLIER 170.39 20.37 0.0 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.114 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.468 ' H ' ' HG2' ' A' ' 157' ' ' GLU . 3.7 pt-20 -74.43 5.36 4.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.376 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.433 ' HG2' ' N ' ' A' ' 183' ' ' SER . 0.1 OUTLIER 54.22 27.06 7.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.799 0.333 . . . . 0.0 110.838 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -107.36 143.03 15.86 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.568 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.77 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -123.97 168.18 13.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.653 0.264 . . . . 0.0 110.892 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.02 166.12 26.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.494 . . . . 0.0 111.288 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.55 141.09 20.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.29 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.577 HD12 ' HB2' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -106.72 147.71 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.976 0.417 . . . . 0.0 111.558 -178.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.14 106.5 4.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.641 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -84.89 132.6 34.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.1 p30 44.64 -161.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.869 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.32 -9.6 60.86 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.477 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.6 t -176.06 -19.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 110.425 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.591 HG22 ' HG3' ' A' ' 171' ' ' ARG . 7.6 m -111.08 -15.45 13.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.762 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 58.91 26.48 14.99 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.901 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.591 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -177.88 177.87 1.03 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.023 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.41 132.65 45.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.019 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.506 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -161.1 132.75 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.665 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.422 ' HB2' HG23 ' A' ' 163' ' ' ILE . 20.3 t -116.13 160.19 20.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.307 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -124.92 138.18 54.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.537 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.534 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -123.37 147.26 16.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.661 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 6.5 p90 -162.78 143.2 9.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 0.0 110.745 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.499 HD12 HD21 ' A' ' 88' ' ' LEU . 1.2 mt -111.76 154.92 24.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.137 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.427 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -83.71 129.51 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.15 6.27 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.57 -26.53 12.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 55.38 83.07 0.09 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.433 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -169.66 -37.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.076 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.2 28.5 73.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.435 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.88 -16.42 5.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 110.954 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -105.91 -9.77 16.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.7 HD23 HD23 ' A' ' 121' ' ' LEU . 4.1 mp -125.55 -46.3 1.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.194 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -61.8 2.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.989 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.76 -8.27 34.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.141 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.14 -41.7 13.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.236 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.458 ' HA ' HG11 ' A' ' 123' ' ' VAL . 7.0 p -77.44 -29.2 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.046 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.87 -3.83 52.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.231 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 92.2 m -115.27 1.53 13.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 110.683 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.703 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -77.69 -44.26 28.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.07 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.453 ' CD2' HD21 ' A' ' 199' ' ' LEU . 4.2 p90 -64.96 -25.22 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.938 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.462 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -61.14 -19.05 61.07 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.21 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.99 -27.29 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.001 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.9 t -74.76 -30.84 61.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.765 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.5 OUTLIER -117.99 39.57 3.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -61.16 -50.09 74.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.976 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.716 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.509 ' HA3' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.44 -164.54 2.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.312 . . . . 0.0 110.795 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 51.4 p -168.61 161.38 11.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.12 159.91 28.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.999 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 10.2 mtm -130.33 -10.94 4.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.995 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -83.59 8.26 14.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.959 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -63.4 151.69 40.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -98.56 12.92 33.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.862 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t70 56.03 75.99 0.31 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 66.5 m-85 -71.01 143.71 89.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.934 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 48.5 Cg_exo . . . . . 0 C--O 1.249 1.068 0 C-N-CA 122.638 2.225 . . . . 0.0 112.25 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.836 0.351 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -152.41 -67.62 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.585 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -22.71 60.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.377 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -68.23 -23.56 64.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.055 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.65 -18.69 20.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.645 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.46 -27.29 25.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.862 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -87.26 -23.77 24.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.55 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.738 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.0 OUTLIER -90.45 -15.14 31.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -60.93 -49.44 77.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.943 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.0 t -60.52 -41.0 86.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.255 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.738 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 9.8 mtt180 -56.07 -33.91 65.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.452 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 m -80.7 -92.02 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.7 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.624 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -178.71 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.453 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.611 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -172.44 98.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.788 0.328 . . . . 0.0 111.099 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.608 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 15.7 t -129.0 61.06 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.641 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.642 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -161.01 -156.54 0.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.098 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.486 ' HB3' ' HE2' ' A' ' 181' ' ' LYS . 1.9 m-85 -156.12 -170.55 3.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.179 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 1.4 m -51.13 141.76 13.75 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.99 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.9 m -135.86 -175.55 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.42 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 116' ' ' PRO . 4.6 mtpp -133.99 73.92 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.703 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 78.2 t80 -61.37 108.04 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.45 ' HB2' HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -80.22 -36.54 34.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.12 -127.16 3.02 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.606 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.2 p -164.64 130.11 2.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.07 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m -114.21 146.81 18.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -72.43 129.9 39.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.109 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 174' ' ' CYS . 1.5 m -121.67 176.79 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.924 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -141.3 59.73 1.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 2.3 mt-10 -162.08 -63.17 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.093 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.17 34.44 17.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -146.12 141.76 27.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.979 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.79 -139.48 14.48 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.571 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.25 -33.31 0.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 0.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -18.87 65.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.228 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -37.24 48.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.767 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.469 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 85.8 m -69.22 -28.69 66.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.67 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -22.27 61.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.905 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.2 mm-40 -87.31 -52.59 5.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.96 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.587 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.31 -49.16 78.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.136 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 11.1 tp -53.39 -30.81 41.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.975 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -37.03 67.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.8 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 104' ' ' GLU . 6.0 t -60.82 -48.09 90.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.755 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 105' ' ' ALA . 1.4 mp -70.49 -17.18 62.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.698 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 110' ' ' ARG . 2.0 ttm-85 -87.46 -9.67 53.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.569 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -80.56 -63.86 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.744 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -171.91 -175.67 1.55 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.294 179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 112' ' ' SER . 7.1 mpt_? 70.08 -71.55 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.97 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.509 ' H ' ' HG2' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -66.82 110.56 3.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.932 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.57 142.65 24.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 97.8 Cg_endo -79.42 148.67 21.04 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.575 2.184 . . . . 0.0 112.348 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.23 117.45 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -65.17 97.98 0.29 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.989 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -127.44 -161.48 10.83 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.195 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.48 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -129.27 117.68 21.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.334 . . . . 0.0 110.643 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.639 HD23 HD23 ' A' ' 187' ' ' LEU . 26.5 tp -89.87 130.71 36.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.728 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.422 ' CE1' HD12 ' A' ' 120' ' ' LEU . 30.9 m-70 -118.22 93.19 4.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.915 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.642 HG23 ' HB2' ' A' ' 82' ' ' SER . 79.4 t -66.15 94.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -99.46 135.69 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.346 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -58.06 -9.56 5.85 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.104 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -114.88 32.73 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.29 134.97 6.64 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 mt -66.98 171.1 5.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.907 0.384 . . . . 0.0 111.233 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.576 ' HD3' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -167.24 110.67 0.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.665 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.613 HG22 HD13 ' A' ' 121' ' ' LEU . 7.7 t -106.32 114.8 46.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.92 0.39 . . . . 0.0 111.384 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.72 120.35 57.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.874 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 37.6 m-20 -52.22 152.97 3.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.55 2.52 28.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.939 0.4 . . . . 0.0 111.165 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.42 -24.73 6.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.572 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.01 -10.52 5.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.686 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 27.4 mmtm 54.03 26.27 6.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.817 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 132' ' ' ASP . . . -90.67 135.76 13.03 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.443 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.576 HD11 ' HD3' ' A' ' 129' ' ' ARG . 5.1 tp -67.65 108.17 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.663 0.268 . . . . 0.0 110.619 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 3.0 pt -99.36 -25.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.435 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.544 ' HB ' HG23 ' A' ' 130' ' ' VAL . 74.8 t -136.68 106.19 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.214 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.22 27.93 8.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.327 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -70.24 -173.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.23 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 2.8 m -131.46 164.7 25.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.709 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.461 HD11 ' O ' ' A' ' 124' ' ' SER . 16.0 mt -77.61 -33.45 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.62 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -85.87 -10.87 54.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.45 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 7.1 tttm -83.53 -37.83 22.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.762 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 m -77.67 138.35 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.449 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -60.5 -68.58 0.29 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.516 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 148' ' ' SER . 0.1 OUTLIER -141.22 136.44 31.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.054 178.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.539 ' O ' ' HB3' ' B' ' 2' ' ' PHE . 60.6 m -98.35 93.26 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.549 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -105.11 153.17 39.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.464 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.904 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 82.8 Cg_endo -86.6 -118.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.783 2.322 . . . . 0.0 112.149 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.451 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 18.7 p-10 -148.68 -3.99 0.45 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.596 0.236 . . . . 0.0 111.042 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 45.42 23.54 0.13 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.995 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -103.8 -55.93 2.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.389 . . . . 0.0 110.657 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.533 ' HB2' ' HG3' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -142.07 2.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.402 178.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 60.61 30.75 19.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.081 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 156' ' ' HIS . 6.6 mtm180 -116.83 7.39 13.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.806 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -149.9 119.04 0.99 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.429 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.772 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -111.3 -179.42 3.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.01 0.433 . . . . 0.0 111.034 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -166.44 169.85 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.498 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -150.6 145.54 25.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.511 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -117.03 157.12 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.063 0.459 . . . . 0.0 111.567 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.7 -174.97 5.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.677 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.9 OUTLIER -127.65 -149.37 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.799 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.611 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER -63.57 -163.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.903 0.382 . . . . 0.0 111.384 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.91 -16.29 60.46 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.441 ' H ' ' H ' ' A' ' 169' ' ' THR . 10.7 t -163.96 -5.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 110.068 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.441 ' H ' ' H ' ' A' ' 168' ' ' THR . 6.9 m -132.17 -12.37 3.21 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.611 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 34.3 mtt85 60.8 19.39 9.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.059 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.608 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -171.89 172.79 4.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.935 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -81.76 115.33 20.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.625 179.453 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.608 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 3.2 mtp -131.31 145.91 52.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.511 ' HB2' HG23 ' A' ' 163' ' ' ILE . 16.4 t -119.11 142.95 47.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -112.25 156.63 22.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.628 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 88' ' ' LEU . . . -137.93 146.77 18.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.537 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -164.72 161.06 20.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 0.0 110.959 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.458 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 2.0 mp -127.92 168.6 15.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.88 125.32 45.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.071 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.42 -13.94 45.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.692 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.486 ' HE2' ' HB3' ' A' ' 83' ' ' PHE . 5.9 mmtm -80.73 -28.65 36.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 56.33 37.13 28.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.992 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.43 -44.33 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.987 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.24 31.05 43.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.534 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -127.88 -30.12 2.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 110.978 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.421 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -88.57 -8.94 53.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.742 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.639 HD23 HD23 ' A' ' 121' ' ' LEU . 4.9 mp -127.32 -55.99 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.278 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -63.38 1.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.421 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -59.95 -19.18 50.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.258 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.608 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -79.77 -44.57 20.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.238 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 187' ' ' LEU . 70.9 t -63.8 -32.58 57.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.722 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.95 -7.57 30.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.425 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 59.5 m -109.75 -17.4 13.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.778 0.323 . . . . 0.0 110.97 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.516 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -55.7 -44.83 77.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.128 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.449 ' HD2' ' HB3' ' B' ' 6' ' ' SER . 2.4 p90 -74.9 -29.7 61.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.54 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -60.18 -17.13 38.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 89.8 t -106.82 -27.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.088 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.2 t -75.38 -4.39 39.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 196' ' ' ALA . 5.1 mt -73.62 -10.19 59.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.16 -46.84 87.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.965 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.904 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER -125.19 150.94 46.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.692 0.282 . . . . 0.0 110.966 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' B' ' 2' ' ' PHE . 91.0 p 177.39 140.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.881 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -73.1 178.46 4.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.55 -17.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.005 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 195' ' ' PHE . 51.9 p -80.15 3.31 20.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -70.91 164.23 25.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -107.63 -1.31 21.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t70 58.86 95.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.225 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -58.08 146.55 68.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.86 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo . . . . . 0 C--O 1.248 1.011 0 C-N-CA 122.493 2.128 . . . . 0.0 112.285 -179.846 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.797 0.332 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.33 -35.53 9.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.897 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.789 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -64.02 -26.77 68.72 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.501 179.069 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -63.92 -18.23 64.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.275 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.81 -7.7 10.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.616 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.789 ' HB2' ' HA ' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -82.09 -38.46 24.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.107 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -63.04 -20.3 65.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.644 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 8.9 tt0 -104.53 -12.94 16.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.635 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -54.77 -48.75 72.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.241 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 81' ' ' CYS . 1.2 t -62.03 -35.51 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.388 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -65.9 -29.96 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -90.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -176.58 34.7 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.519 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.634 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -176.8 102.82 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.894 0.378 . . . . 0.0 111.251 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.545 ' HB3' HG23 ' A' ' 76' ' ' VAL . 23.0 t -141.34 65.28 1.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.649 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -163.27 -160.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.35 . . . . 0.0 111.158 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.403 ' CG ' ' HE3' ' A' ' 181' ' ' LYS . 6.1 m-85 -156.05 -171.17 3.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.898 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.27 148.69 2.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.878 0.371 . . . . 0.0 111.305 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 119' ' ' GLY . 18.2 m -135.7 -167.08 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.24 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.84 75.84 1.5 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.765 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' ' 117' ' ' VAL . 83.0 t80 -63.71 91.82 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.016 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.628 ' HB2' HD22 ' A' ' 109' ' ' LEU . 0.7 OUTLIER -61.46 -43.24 99.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA3' ' HD3' ' A' ' 114' ' ' ARG . . . 150.58 -126.75 2.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.332 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.92 132.34 8.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 0.0 111.107 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG21 ' HB ' ' A' ' 108' ' ' VAL . 4.2 m -126.02 149.91 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.993 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.51 137.22 54.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.9 -169.68 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.898 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -122.77 80.4 1.74 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 63.8 109.22 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.804 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.5 p -45.9 -30.16 1.64 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.576 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.32 126.67 19.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.096 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.3 -125.35 2.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.574 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -170.18 -50.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.718 0.294 . . . . 0.0 110.638 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -78.84 11.51 2.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.188 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 163' ' ' ILE . 9.6 t -62.61 -16.27 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.936 0.398 . . . . 0.0 110.599 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 67.2 m -102.31 -35.49 8.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.875 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.87 -19.72 62.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 76.3 mt-10 -104.49 -48.28 3.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.145 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.413 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -56.84 -37.03 70.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.279 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 160' ' ' PHE . 14.8 tp -58.48 -35.93 72.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.66 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -34.97 61.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.2 t -58.7 -33.14 48.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.668 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.665 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -80.01 -25.12 40.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.529 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.1 -14.47 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.711 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -105.99 -3.86 21.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.949 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.66 -173.53 2.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.03 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.5 10.94 16.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.002 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.665 ' HG3' HD23 ' A' ' 109' ' ' LEU . 5.6 mmp_? -62.98 105.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -83.03 134.79 45.74 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.088 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 72.3 Cg_endo -74.86 142.49 28.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.525 2.15 . . . . 0.0 112.182 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 87' ' ' TYR . 2.3 t -107.5 122.35 61.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -69.17 112.93 6.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.447 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -151.53 145.9 14.16 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.576 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.516 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -83.07 110.14 17.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 0.0 111.004 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.754 HD13 HG22 ' A' ' 130' ' ' VAL . 27.3 tp -80.65 137.68 36.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.586 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.516 ' CE1' HD12 ' A' ' 120' ' ' LEU . 3.6 m-70 -124.08 85.83 2.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.704 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.649 ' H ' ' HB2' ' A' ' 82' ' ' SER . 74.7 t -62.39 98.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.108 0.48 . . . . 0.0 111.002 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -98.53 142.34 30.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.205 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.59 16.84 2.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.672 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 124' ' ' SER . 35.7 t0 -146.97 27.99 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.879 0.371 . . . . 0.0 110.433 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.34 113.07 1.77 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -75.79 141.49 42.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.948 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -142.23 131.55 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.754 HG22 HD13 ' A' ' 121' ' ' LEU . 9.1 t -106.88 112.44 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.73 109.92 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.736 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 2.8 m-20 -51.29 147.38 5.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.983 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -97.41 11.45 36.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.927 0.394 . . . . 0.0 110.651 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.05 -30.64 6.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.869 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.662 HG23 ' H ' ' A' ' 137' ' ' GLY . 14.8 t -132.71 -8.69 3.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.005 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 13.3 mmtp 58.34 22.65 9.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.831 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.662 ' H ' HG23 ' A' ' 135' ' ' THR . . . -75.47 -133.49 0.38 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.577 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 tp -151.12 112.85 4.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 0.0 110.66 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.42 ' H ' HG13 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -96.26 -45.38 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.198 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.629 ' HB ' HG23 ' A' ' 130' ' ' VAL . 36.5 t -119.63 97.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.249 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.86 59.38 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.691 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.17 -169.62 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.044 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.712 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 62.1 m -136.31 156.88 48.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.491 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -57.22 -42.27 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.695 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.429 ' H ' HG22 ' A' ' 143' ' ' THR . 7.5 pt-20 -81.39 -14.22 57.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.428 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.624 ' HB3' ' H ' ' A' ' 143' ' ' THR . 0.7 OUTLIER -76.29 -39.55 53.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.587 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 143' ' ' THR . 1.1 m -80.02 150.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -62.44 1.73 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.624 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.81 ' HB2' ' HB3' ' B' ' 3' ' ' SER . 22.1 p90 -173.22 135.8 0.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.73 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.31 136.17 36.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.294 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.421 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . . . -146.4 102.52 4.03 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.641 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 12.4 Cg_endo -54.76 -83.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.626 2.217 . . . . 0.0 112.408 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -165.99 169.33 14.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.955 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.426 ' H ' ' HG3' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -57.0 -45.43 83.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.976 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -111.6 -63.77 1.37 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.802 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.498 ' NE2' ' HA3' ' A' ' 184' ' ' GLY . 0.5 OUTLIER -178.15 -73.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.831 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 58.43 14.49 2.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.087 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 49.19 32.26 4.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -145.2 136.92 6.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.293 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.575 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -122.6 -175.29 3.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.95 173.72 11.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.411 . . . . 0.0 111.05 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -158.24 147.18 19.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.514 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -116.39 158.61 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 0.0 111.51 -178.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.5 p -157.52 -176.54 6.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.483 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -130.6 135.63 48.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.3 p30 44.19 -158.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.811 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.05 -12.36 62.21 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.1 t 179.76 -17.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.096 0.474 . . . . 0.0 110.176 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.93 HG21 ' HG3' ' A' ' 173' ' ' MET . 87.6 m -112.77 -14.18 13.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.499 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 58.37 26.46 14.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.357 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.858 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -174.53 -171.44 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 111.561 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.44 135.54 57.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.477 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.93 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -167.17 145.54 4.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.658 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.712 ' HB2' HG23 ' A' ' 163' ' ' ILE . 44.7 t -128.0 145.35 51.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.163 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -115.14 137.25 52.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.593 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.522 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -110.74 152.91 17.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.673 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -167.51 132.89 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.87 0.367 . . . . 0.0 111.047 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.604 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 3.9 mp -106.42 156.8 18.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.11 120.66 25.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.9 t -70.47 -11.87 61.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.958 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.403 ' HE3' ' CG ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -86.81 -26.19 24.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 54.8 71.82 0.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.4 t -155.17 -30.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.498 ' HA3' ' NE2' ' A' ' 156' ' ' HIS . . . 64.91 36.91 93.65 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.401 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -139.52 -30.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.737 0.304 . . . . 0.0 111.021 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.464 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.4 OUTLIER -90.58 -2.53 57.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.886 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 191' ' ' VAL . 5.5 mp -135.96 -58.22 0.76 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.27 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.05 -57.67 8.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.342 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -59.84 -20.54 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.074 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.12 -45.45 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.073 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 187' ' ' LEU . 98.6 t -63.82 -30.71 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.91 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.481 ' HA2' ' HE1' ' A' ' 195' ' ' PHE . . . -64.09 -7.38 23.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.427 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.452 ' O ' HG23 ' A' ' 197' ' ' VAL . 1.0 OUTLIER -119.24 -5.12 10.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 0.0 110.743 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -74.5 -52.53 11.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.333 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.481 ' HE1' ' HA2' ' A' ' 192' ' ' GLY . 40.1 p90 -65.94 -31.14 71.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.945 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.603 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -58.22 -24.22 58.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.791 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 193' ' ' CYS . 22.3 t -93.75 -18.97 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.962 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 3.7 t -74.89 -27.07 60.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.957 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.4 OUTLIER -112.56 24.43 12.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -39.97 95.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.755 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.905 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.465 ' HA2' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.357 -0.297 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -119.15 -47.38 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.801 0.334 . . . . 0.0 110.759 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.81 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER 62.87 118.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.184 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -57.5 157.59 6.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.07 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 3.1 mtp -125.0 0.21 7.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.018 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 32.6 p -92.01 25.08 2.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.496 ' HD2' ' H ' ' B' ' 9' ' ' ASP . 39.4 p90 -72.14 162.0 30.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -114.74 11.7 16.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.489 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ASP . . . . . 0.496 ' H ' ' HD2' ' B' ' 7' ' ' PHE . 35.3 t70 57.45 78.27 0.24 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.211 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 30.2 m-85 -63.08 146.4 95.85 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 15.5 Cg_exo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.725 2.283 . . . . 0.0 112.384 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.746 0.308 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.22 -48.5 81.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.589 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.38 -22.36 61.15 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.546 178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -25.68 65.02 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.396 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.35 -23.13 17.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.646 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.63 -28.13 45.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.272 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.41 -29.16 69.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.308 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.706 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.6 tm-20 -82.52 -23.2 34.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.688 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.18 -49.97 72.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.903 HG11 ' HA ' ' A' ' 194' ' ' ALA . 55.2 t -63.51 -42.17 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.487 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.706 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -55.31 -37.12 66.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.272 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 2.7 m -71.74 -90.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.218 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.641 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 176.91 38.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.422 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.649 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 1.5 t -174.23 102.34 0.1 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.986 0.422 . . . . 0.0 112.045 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.429 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 9.6 t -142.17 56.81 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.994 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.695 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -151.75 -151.34 0.38 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.168 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -155.41 -172.89 4.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.023 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.508 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.6 OUTLIER -53.92 146.64 13.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.494 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 121' ' ' LEU . 10.5 m -146.56 -176.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.19 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 1.1 mptt -143.0 81.54 1.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.875 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HE1' ' HB3' ' A' ' 175' ' ' HIS . 82.0 t80 -61.32 100.08 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.684 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.474 ' HB2' HD22 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -64.85 -48.33 74.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.61 -131.42 3.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.595 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.96 133.56 22.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.71 0.29 . . . . 0.0 110.991 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.79 157.69 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -83.55 142.96 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -179.01 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.898 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.64 59.66 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.173 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 2.7 tt0 -170.22 -61.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.072 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.5 p 48.71 54.25 10.97 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.965 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 1.7 ptm180 -163.38 114.47 1.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.993 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.77 -137.03 12.5 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.419 ' HB2' ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -147.58 -19.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.867 0.365 . . . . 0.0 110.761 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -79.26 4.72 14.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.071 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -87.38 -15.52 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.767 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.435 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 89.4 m -88.43 -34.37 17.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.813 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.14 -22.51 66.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 108' ' ' VAL . 5.5 mm-40 -93.66 -46.37 7.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.78 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -56.23 -32.68 64.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.973 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.61 -39.9 76.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.702 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -24.49 65.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.738 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 104' ' ' GLU . 59.0 t -75.13 -45.89 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 105' ' ' ALA . 1.3 mt -60.07 -35.7 75.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.957 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -72.09 -39.24 69.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.712 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -77.09 -11.95 59.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.26 -174.98 2.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 113' ' ' ARG . 1.4 mtp85 -87.67 14.37 8.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.485 ' HG3' ' HA ' ' A' ' 109' ' ' LEU . 3.1 mmp_? -61.34 103.26 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -76.2 123.31 87.95 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.133 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 73.5 Cg_endo -75.66 172.82 15.57 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.488 2.125 . . . . 0.0 112.211 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.4 t -130.47 140.23 49.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.21 72.87 8.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 132' ' ' ASP . . . -123.95 149.24 16.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.708 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -80.14 126.79 31.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 110.94 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.675 HD23 HD23 ' A' ' 187' ' ' LEU . 51.8 tp -89.52 136.82 32.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.499 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 89.8 m-70 -126.72 94.76 4.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.1 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.695 ' H ' ' HB2' ' A' ' 82' ' ' SER . 54.3 t -60.8 97.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.016 0.436 . . . . 0.0 110.725 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.641 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 11.9 p -103.53 137.0 42.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.269 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -78.56 39.92 1.98 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.692 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -162.07 13.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.397 . . . . 0.0 110.729 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.776 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 134.57 97.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.468 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.513 ' HG ' HG13 ' A' ' 144' ' ' ILE . 2.4 mt -53.68 138.58 34.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.068 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.827 ' HG2' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -137.31 142.22 41.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.609 HG23 ' HB ' ' A' ' 140' ' ' VAL . 8.7 t -114.93 102.33 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.035 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.85 114.99 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.412 ' HA ' ' CA ' ' A' ' 119' ' ' GLY . 4.6 t0 -50.5 144.72 7.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.077 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.21 5.15 51.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.165 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 -32.74 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.692 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.49 -19.53 13.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.737 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm 50.02 39.63 19.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.41 -124.07 5.23 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.492 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.827 HD11 ' HG2' ' A' ' 129' ' ' ARG . 10.3 tp -154.76 113.81 3.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 110.726 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.427 HD12 HG12 ' A' ' 130' ' ' VAL . 5.5 mt -96.23 -54.01 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.4 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.609 ' HB ' HG23 ' A' ' 130' ' ' VAL . 98.9 t -112.5 111.81 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.904 0.383 . . . . 0.0 111.313 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.32 25.32 10.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.608 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.404 ' H ' HG12 ' A' ' 140' ' ' VAL . 70.7 mm-40 -68.43 -170.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.169 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.776 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 5.6 m -146.03 154.29 41.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.931 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.513 HG13 ' HG ' ' A' ' 128' ' ' LEU . 13.6 mt -70.11 -43.51 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.706 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.24 -1.05 31.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.683 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.412 ' CB ' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -96.89 -43.08 7.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 143' ' ' THR . 0.6 OUTLIER -66.02 145.06 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 110.993 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.411 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -55.39 -64.8 0.73 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.628 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.634 ' HD1' HD13 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -144.51 -178.01 5.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.869 179.122 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' B' ' 3' ' ' SER . 2.2 t -123.18 155.58 36.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.419 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 99' ' ' MET . . . -176.12 126.06 0.34 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.77 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.586 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 96.4 Cg_endo -85.09 -90.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.76 2.307 . . . . 0.0 112.308 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 5.9 p-10 -174.17 -173.75 0.83 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.568 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.6 mtm-85 -74.66 -85.76 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.636 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.65 47.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.775 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.89 -33.19 0.38 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.178 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -98.0 -26.31 14.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.308 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 59.03 18.25 6.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 110.972 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 153' ' ' ASP . . . -105.19 143.82 15.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.355 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.586 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -119.22 169.68 9.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.323 . . . . 0.0 110.87 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.678 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -164.41 176.84 8.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -147.43 145.52 29.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.403 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.645 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -106.85 152.49 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.468 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.13 127.54 12.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.685 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -99.95 113.49 26.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.48 ' HA ' ' N ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER 50.45 -153.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.311 179.25 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.94 -37.31 2.51 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.385 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.26 5.47 0.34 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.1 OUTLIER -128.72 -17.79 3.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.731 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.48 ' N ' ' HA ' ' A' ' 166' ' ' ASP . 0.1 OUTLIER 58.6 25.35 13.09 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.095 -178.378 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 172.19 176.4 0.09 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.552 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.08 124.33 26.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.5 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.767 ' HB2' HG21 ' A' ' 169' ' ' THR . 24.6 mtp -153.63 125.45 7.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.203 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.645 ' HB2' HG23 ' A' ' 163' ' ' ILE . 6.7 t -106.84 141.05 38.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.353 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 7.5 m-70 -103.54 129.87 50.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.001 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.678 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -112.57 154.33 16.94 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.35 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -158.73 136.22 10.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.731 0.3 . . . . 0.0 110.536 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.8 mt -97.07 139.85 32.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.299 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.34 115.69 17.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.779 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 3.0 t -58.91 -23.69 61.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.437 ' H ' ' HG2' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -82.34 -28.52 31.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.045 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 55.08 82.93 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.8 t -161.33 -37.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.925 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.51 18.61 78.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.578 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -134.81 -0.37 2.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 0.0 110.816 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.525 ' HB2' HD12 ' A' ' 187' ' ' LEU . 1.1 mmt180 -98.54 -25.38 14.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.903 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.675 HD23 HD23 ' A' ' 121' ' ' LEU . 4.2 mp -124.39 -51.04 1.75 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.806 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.0 t -58.26 -49.38 77.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.673 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 1.4 t-80 -69.67 -1.92 10.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.547 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.429 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -103.97 -40.75 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.167 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.617 ' HA ' HG11 ' A' ' 123' ' ' VAL . 4.8 p -67.92 -15.29 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.08 97.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.565 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 66.1 m -84.35 -11.58 56.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.988 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.903 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -60.06 -28.46 67.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.274 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -80.89 -37.73 29.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.603 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -55.91 -21.84 22.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.264 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 197' ' ' VAL . 0.8 OUTLIER -75.3 -42.1 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.803 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 85.4 m -78.76 -15.12 58.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.483 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.603 HD12 ' HA ' ' A' ' 196' ' ' ALA . 8.3 mt -87.19 -26.18 23.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.817 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.62 -18.63 65.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.7 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 201' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.992 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.056 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -163.31 161.12 24.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.634 0.254 . . . . 0.0 111.106 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' A' ' 150' ' ' CYS . 2.7 p -145.34 171.34 14.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.937 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -81.18 161.1 24.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.974 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.459 ' HB2' HD21 ' A' ' 199' ' ' LEU . 16.3 mtp -134.34 -7.49 2.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.026 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 20.6 t -93.12 27.13 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -62.72 158.25 19.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.75 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -85.05 7.3 21.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.857 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 17.7 t70 53.67 68.73 0.8 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.136 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.412 ' HE2' ' HA ' ' A' ' 146' ' ' LYS . 60.7 m-85 -67.86 140.69 94.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 C--O 1.248 1.004 0 C-N-CA 122.534 2.156 . . . . 0.0 112.336 -179.802 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.825 0.345 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' OE1' ' HB3' ' A' ' 186' ' ' ARG . 0.9 OUTLIER -78.64 -52.77 7.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.974 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -62.84 -25.14 68.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.897 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -27.2 60.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.678 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . -108.23 11.25 27.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.884 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.69 -32.58 6.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -60.36 -41.47 93.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.873 0.368 . . . . 0.0 110.777 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.858 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.6 mt-10 -92.88 -5.08 51.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.762 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -66.08 -46.42 77.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.045 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 81' ' ' CYS . 0.9 OUTLIER -64.79 -36.58 77.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.394 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.858 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -59.31 -39.27 82.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.359 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -91.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.555 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.455 ' CA ' ' HB2' ' A' ' 124' ' ' SER . . . -178.36 36.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.488 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.628 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -176.0 101.71 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.668 0.27 . . . . 0.0 111.253 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.466 ' CB ' HG23 ' A' ' 76' ' ' VAL . 16.6 t -128.22 0.06 5.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.791 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.739 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -97.78 -163.38 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.6 0.238 . . . . 0.0 111.042 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.623 ' HB3' ' HD2' ' A' ' 181' ' ' LYS . 8.5 m-85 -154.88 -169.14 3.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.354 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.856 ' HB2' ' HE2' ' A' ' 181' ' ' LYS . 0.3 OUTLIER -41.07 142.31 0.52 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.072 -178.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 120' ' ' LEU . 4.1 m -142.26 -165.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.03 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.27 71.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.605 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 89.9 t80 -59.81 99.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -73.62 -40.24 63.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.58 -132.44 3.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.321 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 175' ' ' HIS . 1.2 p -161.69 142.73 11.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.83 0.347 . . . . 0.0 110.927 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.2 m -127.17 153.38 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.067 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.77 142.5 42.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.988 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.94 -178.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.078 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -143.32 59.51 1.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -176.74 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.433 ' OG ' ' HB3' ' A' ' 172' ' ' TRP . 1.0 OUTLIER 62.92 18.52 10.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.61 -178.644 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -119.61 51.92 1.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.29 169.07 37.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.12 -27.39 26.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.937 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.46 -19.02 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.035 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.94 -34.61 49.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.745 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.2 m -82.91 -33.49 26.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -65.63 -20.64 66.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.986 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.7 mm-40 -103.68 -46.44 4.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.048 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.62 -47.03 77.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.694 ' HA ' HD12 ' A' ' 109' ' ' LEU . 15.8 tp -58.33 -32.87 68.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.768 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 1.2 tttm -72.47 -39.77 67.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 104' ' ' GLU . 35.1 t -57.88 -40.95 78.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.766 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.8 mt -65.44 -27.88 68.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.913 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -28.2 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.79 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 14.4 mt-30 -84.69 -23.13 29.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -106.4 169.32 8.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.26 69.47 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.766 ' HG3' HD23 ' A' ' 109' ' ' LEU . 16.1 mmt-85 -72.26 -154.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.924 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.26 85.97 6.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.548 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 91.6 Cg_endo -79.82 128.4 7.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.701 2.267 . . . . 0.0 112.187 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -113.43 164.68 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -112.1 72.52 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -131.39 -167.81 12.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.445 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.557 ' HA ' HG22 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -135.48 141.27 45.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 111.184 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 120' ' ' LEU . 64.3 tp -76.32 147.92 37.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.347 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -127.28 77.45 1.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.724 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 82' ' ' SER . 53.3 t -53.17 98.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 121.108 0.48 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.528 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -106.65 131.78 53.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.146 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.04 -15.08 9.15 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.824 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -112.5 35.72 3.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 113.2 126.19 4.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.448 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.453 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -79.66 139.16 37.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.718 0.294 . . . . 0.0 110.99 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.612 ' HB2' HD11 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.23 141.95 39.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.024 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 140' ' ' VAL . 20.2 t -109.2 114.28 46.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.008 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -104.7 121.31 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.602 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 2.6 t0 -60.94 165.81 3.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.886 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.81 2.15 25.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.55 -45.38 2.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.68 -24.57 19.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.64 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.78 40.58 24.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.795 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.8 -114.92 3.89 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.504 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 129' ' ' ARG . 10.0 tp -168.57 120.27 0.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.771 0.319 . . . . 0.0 110.665 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.597 HD13 HG21 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -101.85 -54.43 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.277 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.579 ' HB ' HG23 ' A' ' 130' ' ' VAL . 80.4 t -103.1 101.78 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.173 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -97.03 21.4 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.61 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -68.54 -177.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.103 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.571 ' O ' HG22 ' A' ' 147' ' ' VAL . 28.4 m -140.75 157.53 45.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.593 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 124' ' ' SER . 21.4 mt -59.86 -45.97 94.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.188 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -76.88 -1.47 28.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 5.3 tttt -99.58 -38.17 8.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.921 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 143' ' ' THR . 1.9 m -75.07 130.44 36.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.043 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.429 ' HB3' ' HD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -65.7 -50.12 66.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.032 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.478 ' HD2' ' HB2' ' B' ' 3' ' ' SER . 61.9 m-85 -131.55 -173.05 3.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 0.0 111.363 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 161' ' ' SER . 8.9 t -161.89 34.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.043 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.23 148.85 95.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.108 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.923 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 61.4 Cg_endo -88.79 -142.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.053 2.502 . . . . 0.0 112.305 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 157' ' ' GLU . 23.5 t0 -135.79 77.66 1.68 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.709 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 62.44 10.81 4.21 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.121 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.44 36.63 13.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.35 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.66 -0.22 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.162 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 153' ' ' ASP . 1.9 mt-10 -112.31 0.89 15.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.079 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 182' ' ' ASP . 1.0 OUTLIER 53.15 43.94 30.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.93 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.72 128.73 3.87 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.537 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -121.46 168.5 11.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.688 0.28 . . . . 0.0 110.702 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 150' ' ' CYS . 1.1 m -157.87 172.28 18.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -145.41 145.21 31.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.593 178.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.777 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.1 OUTLIER -111.62 169.54 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.289 -179.025 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.434 ' H ' HG22 ' A' ' 163' ' ' ILE . 40.9 t -169.98 136.6 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.624 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.75 115.32 30.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 111.148 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 50.09 -159.72 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.401 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.42 -16.0 42.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.775 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.427 ' H ' ' H ' ' A' ' 169' ' ' THR . 1.1 t -170.28 -4.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.063 0.459 . . . . 0.0 110.044 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.61 HG22 ' HG3' ' A' ' 171' ' ' ARG . 11.7 m -133.19 -12.65 2.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.977 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 5.6 mmt180 58.96 23.37 11.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.61 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -174.3 171.77 3.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.221 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.433 ' HB3' ' OG ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -74.98 119.98 19.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.936 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.527 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 0.1 OUTLIER -142.44 146.23 34.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.641 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.777 ' HB2' HG23 ' A' ' 163' ' ' ILE . 16.9 t -131.54 124.71 30.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.95 0.405 . . . . 0.0 111.293 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 9.2 m-70 -91.41 136.58 33.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.228 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -114.35 154.06 17.21 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.221 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 21.3 p90 -161.89 143.42 11.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.666 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.87 138.07 50.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.022 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.41 113.87 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.072 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 3.6 t -64.53 -32.47 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.957 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.856 ' HE2' ' HB2' ' A' ' 84' ' ' SER . 0.1 OUTLIER -65.47 -27.07 68.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.027 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.547 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 65.4 m-20 55.95 90.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.199 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 t -168.23 -43.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.777 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.39 30.51 56.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 32.3 tt0 -136.27 -42.39 0.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.701 0.286 . . . . 0.0 110.986 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.552 ' HB2' ' HD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -75.17 -5.95 47.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.9 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp -131.29 -49.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.995 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -60.94 2.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 0.3 OUTLIER -62.37 -13.1 25.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.396 -179.438 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -88.19 -44.4 10.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.153 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.49 ' HA ' HG11 ' A' ' 123' ' ' VAL . 1.7 p -69.95 -24.38 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.86 -10.22 83.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.458 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.8 m -110.0 14.4 23.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.392 . . . . 0.0 110.557 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.59 -43.4 11.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.172 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' B' ' 4' ' ' ASN . 5.1 p90 -61.34 -33.35 73.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.733 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.63 -27.41 64.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.886 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.94 -5.53 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.756 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 2.0 t -88.97 -5.4 57.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.923 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.67 -12.4 59.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.021 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -61.73 -32.71 72.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.947 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 201' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.905 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.923 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -145.78 -104.61 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.406 0.146 . . . . 0.0 110.882 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 149' ' ' PHE . 0.0 OUTLIER 64.51 131.74 0.02 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.976 0.417 . . . . 0.0 111.369 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 7.6 p30 -109.95 -165.6 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.742 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.418 ' HG2' ' CE2' ' B' ' 7' ' ' PHE . 0.0 OUTLIER -125.94 -137.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.6 p 56.55 18.17 3.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.562 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.487 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 32.1 p90 -85.69 151.88 23.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.687 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -82.78 9.02 10.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ASP . . . . . 0.487 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 8.1 t0 54.46 70.33 0.63 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.777 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.436 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 31.0 m-85 -60.0 139.2 90.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.958 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 32.1 Cg_exo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.705 2.27 . . . . 0.0 112.229 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.6 t60 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.821 0.343 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.67 -39.59 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.811 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -30.01 70.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.553 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -67.01 -11.13 56.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.568 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.44 6.97 6.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.946 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.56 -16.39 10.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.151 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -104.91 -13.93 15.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.3 -14.56 14.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.79 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -66.95 -50.79 61.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.017 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.447 HG23 ' SG ' ' A' ' 81' ' ' CYS . 1.8 t -59.83 -44.88 95.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.799 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -57.97 -39.17 77.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.536 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.1 m -69.2 -93.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.526 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.6 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -177.9 30.98 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.382 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.684 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -171.73 100.13 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.903 0.382 . . . . 0.0 111.789 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 4.1 t -121.7 -147.48 0.39 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.126 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.657 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 52.83 -157.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 111.635 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.491 ' HB3' ' HD2' ' A' ' 181' ' ' LYS . 2.8 m-85 -159.14 -166.21 1.78 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.492 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 0.2 OUTLIER -46.77 151.1 0.63 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.726 0.298 . . . . 0.0 111.309 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -145.7 -169.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.102 0.477 . . . . 0.0 111.706 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -152.4 71.91 0.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.266 178.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 22.4 t80 -56.06 111.22 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.192 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 mt -70.53 -80.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.07 -127.5 1.02 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.561 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 8.3 p -155.84 137.75 14.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.703 0.287 . . . . 0.0 111.04 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.33 157.87 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -75.84 147.08 39.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.211 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.49 -176.05 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.58 ' HA ' ' HE3' ' A' ' 172' ' ' TRP . 1.7 t80 -146.03 64.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.256 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.03 -68.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.442 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.54 19.62 6.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.822 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.38 125.4 12.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.33 -112.67 1.31 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.546 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.533 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -174.36 -34.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 111.05 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -76.65 -9.74 58.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.299 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.6 -22.85 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 24.0 m -87.24 -33.99 19.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 153' ' ' ASP . 2.9 mt-10 -64.03 -15.66 59.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.026 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.4 mt-10 -97.32 -48.73 5.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.039 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.14 -34.22 71.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.133 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.48 HD21 ' HA3' ' A' ' 159' ' ' GLY . 6.8 tp -64.71 -29.84 70.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -45.99 30.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.835 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' GLU . 4.0 t -59.28 -37.73 70.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.173 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.587 HD23 ' HG3' ' A' ' 114' ' ' ARG . 8.5 mt -70.51 -26.75 63.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -9.68 59.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -114.93 1.78 14.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.034 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -118.19 -18.33 9.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.283 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.5 69.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.874 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.587 ' HG3' HD23 ' A' ' 109' ' ' LEU . 18.7 mmt180 -84.77 43.43 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.49 90.94 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.421 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 70.2 Cg_endo -74.03 163.17 37.43 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.605 2.204 . . . . 0.0 112.075 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.3 t -124.44 160.94 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.818 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.476 ' HB2' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -130.75 79.5 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -135.16 -174.17 13.33 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.752 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.499 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -101.97 122.97 45.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.749 0.309 . . . . 0.0 110.968 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.474 ' HB2' HG21 ' A' ' 85' ' ' VAL . 28.9 tp -86.6 124.11 32.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.377 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.684 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 67.6 m-70 -112.72 90.48 3.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.972 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 191' ' ' VAL . 44.1 t -66.3 94.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.052 0.453 . . . . 0.0 110.851 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.6 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -91.8 141.06 29.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.938 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.31 34.39 1.54 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.671 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -166.43 18.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.858 0.361 . . . . 0.0 110.568 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.96 106.64 0.64 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.473 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.05 136.1 51.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 111.106 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.82 137.59 41.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 139' ' ' ILE . 3.8 t -119.47 118.47 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.147 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 136' ' ' LYS . 5.7 t -106.74 117.22 52.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.83 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.432 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 3.1 m-20 -51.4 145.03 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.964 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.87 15.47 25.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.533 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.64 -5.76 2.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.592 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.72 -13.62 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.435 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.44 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.9 OUTLIER 50.66 42.55 27.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.6 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.28 -117.73 4.37 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tp -171.54 128.12 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.683 0.278 . . . . 0.0 110.726 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.553 HG13 ' HB ' ' A' ' 130' ' ' VAL . 1.3 pt -114.69 -39.82 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.321 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.547 ' HB ' HG23 ' A' ' 130' ' ' VAL . 13.0 t -122.84 105.2 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.196 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -111.81 28.62 8.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -70.8 -177.0 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.113 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.74 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 21.7 m -128.41 156.79 42.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.559 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.53 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -67.71 -48.54 75.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.813 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -17.28 61.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.74 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 15.8 tttt -74.0 -53.67 9.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.837 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.11 144.19 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.104 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.8 t -46.56 -58.15 4.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.95 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.761 ' HA ' ' HB3' ' B' ' 4' ' ' ASN . 40.1 p90 -173.1 151.83 2.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.983 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 56.2 m -91.58 113.26 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.533 ' HB1' ' HG2' ' A' ' 99' ' ' MET . . . -120.91 98.56 47.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.074 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 50.1 Cg_exo -54.42 -90.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.454 2.102 . . . . 0.0 112.236 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.496 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 10.7 p-10 -178.88 -149.52 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.475 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.12 13.81 2.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.756 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.77 47.32 18.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.983 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.05 -38.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.885 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -75.25 -9.91 58.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.79 ' HG2' ' H ' ' A' ' 183' ' ' SER . 0.9 OUTLIER 56.15 47.83 18.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.082 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.48 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.63 127.57 2.97 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.591 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.503 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -117.08 166.68 11.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.332 . . . . 0.0 110.646 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.584 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 16.4 m -157.96 161.12 38.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.989 0.423 . . . . 0.0 111.288 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.8 145.76 44.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.191 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 174' ' ' CYS . 1.3 mt -112.94 159.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.01 0.433 . . . . 0.0 111.586 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 29.6 p -147.67 153.35 39.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.346 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.29 119.97 36.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 111.406 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.716 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 54.26 -160.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.34 179.034 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.04 -18.19 52.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.428 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.421 ' H ' ' H ' ' A' ' 169' ' ' THR . 8.9 t -168.4 -0.49 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.046 0.45 . . . . 0.0 109.943 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.561 HG21 ' HG3' ' A' ' 173' ' ' MET . 3.9 m -135.35 -20.36 1.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.04 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.716 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 31.6 mtt-85 58.34 42.82 20.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.957 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.441 ' HD3' ' O ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -179.82 -139.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.797 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.58 ' HE3' ' HA ' ' A' ' 94' ' ' PHE . 9.7 m0 -111.18 136.31 50.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.903 0.382 . . . . 0.0 111.377 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.561 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -157.89 130.61 7.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.239 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.438 ' HB2' HG23 ' A' ' 163' ' ' ILE . 34.7 t -117.25 136.72 52.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.426 . . . . 0.0 111.531 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 161' ' ' SER . 10.0 m170 -106.73 151.23 25.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.292 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -129.54 155.16 20.73 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.02 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -159.35 144.16 15.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.738 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 mt -108.91 176.6 5.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.075 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -111.16 128.4 55.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.8 OUTLIER -62.72 -31.76 72.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.916 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.491 ' HD2' ' HB3' ' A' ' 83' ' ' PHE . 4.0 mttm -90.98 -19.91 22.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 183' ' ' SER . 61.3 m-20 57.39 -157.42 0.29 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.837 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.79 ' H ' ' HG2' ' A' ' 158' ' ' ARG . 8.7 t 72.63 -20.88 0.25 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.635 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 182' ' ' ASP . . . 54.16 40.12 66.08 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.91 -10.59 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.79 0.328 . . . . 0.0 110.884 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.488 ' HD3' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -115.64 4.77 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.922 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 121' ' ' LEU . 5.0 mp -142.62 -51.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.308 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.0 t -56.87 -62.22 1.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.549 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.72 -3.82 7.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.608 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -92.4 -47.31 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.248 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.858 ' HA ' HG11 ' A' ' 123' ' ' VAL . 8.2 p -71.07 -20.05 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.267 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.54 -4.55 52.74 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.718 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.458 ' O ' HG23 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -112.33 -6.75 14.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.359 . . . . 0.0 110.794 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.28 -59.69 3.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.987 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -65.62 -26.9 68.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.776 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -66.12 -18.92 65.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 193' ' ' CYS . 86.7 t -105.58 -26.19 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.97 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 19.1 t -76.64 -10.21 59.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.676 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 196' ' ' ALA . 4.6 mt -63.08 -42.5 99.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.057 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 201' ' ' ARG . 0.0 OUTLIER -58.83 -29.63 67.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.533 ' N ' ' HG3' ' A' ' 200' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.163 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.487 2.095 0 N-CA-C 112.598 -0.201 . . . . 0.0 112.598 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -160.08 -164.94 1.37 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.7 150.29 11.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.02 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.761 ' HB3' ' HA ' ' A' ' 149' ' ' PHE . 3.5 t30 -67.65 146.95 53.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.684 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 14.1 mtp -126.05 -4.19 6.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.081 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -92.83 24.6 3.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.496 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 37.7 p90 -80.62 156.2 26.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.165 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -90.37 9.92 27.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ASP . . . . . 0.496 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 31.0 t0 58.87 71.53 0.58 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.049 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 18.3 m-85 -62.08 141.84 95.67 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 33.0 Cg_exo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.617 2.212 . . . . 0.0 112.312 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.839 0.352 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -95.93 -34.74 11.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.094 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -65.24 -18.24 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.937 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -70.66 -20.96 62.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.425 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.5 -25.59 13.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.773 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -74.3 -45.24 48.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.726 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -65.77 -21.24 66.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.684 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.605 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.5 tt0 -106.58 -2.48 21.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.733 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -64.83 -50.98 64.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.98 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.604 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.8 t -55.09 -37.5 43.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.3 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.605 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 4.8 mtm180 -66.23 -35.91 81.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.184 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 m -81.11 1.47 31.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.601 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 66.77 43.7 2.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.516 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.605 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -172.36 84.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.99 0.424 . . . . 0.0 111.326 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.801 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.8 t -111.48 -151.43 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.352 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.627 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.4 OUTLIER 55.62 -160.04 0.19 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.866 0.365 . . . . 0.0 111.379 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 187' ' ' LEU . 22.0 m-85 -157.37 -167.77 2.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.236 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.435 ' HA ' HD22 ' A' ' 120' ' ' LEU . 71.9 m -49.01 148.64 2.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.82 0.343 . . . . 0.0 111.038 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.432 HG11 HD22 ' A' ' 121' ' ' LEU . 2.7 m -144.52 -173.82 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.043 0.449 . . . . 0.0 111.537 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -137.1 68.85 1.41 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.762 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 36.7 t80 -56.67 110.2 0.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.805 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -83.56 -52.71 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.33 -179.04 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 162.78 -137.56 4.88 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.756 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.549 ' HB3' ' ND1' ' A' ' 175' ' ' HIS . 0.8 OUTLIER -151.35 128.25 11.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.686 0.279 . . . . 0.0 111.087 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.99 162.52 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.03 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -81.45 143.04 32.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.953 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -145.44 127.67 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -92.79 61.01 3.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.94 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.64 -77.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.27 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.577 ' HA ' HG21 ' A' ' 163' ' ' ILE . 0.3 OUTLIER 54.59 32.4 16.95 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.696 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -134.34 132.06 39.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.693 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.38 -164.69 38.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.438 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.83 -11.19 12.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.003 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.9 15.08 0.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.393 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.94 -17.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.41 ' CB ' ' HB2' ' A' ' 161' ' ' SER . 16.9 p -87.74 -34.3 18.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.123 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.798 ' HG2' ' HD2' ' A' ' 154' ' ' ARG . 26.0 mt-10 -66.23 -0.21 2.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.961 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -120.34 -59.64 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.372 . . . . 0.0 111.367 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.517 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -55.5 -38.46 69.21 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.464 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.95 -36.53 62.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -76.66 -37.51 56.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.023 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.15 -44.59 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.615 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -72.19 -17.44 61.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.813 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.09 -11.37 58.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.665 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -80.4 -62.48 1.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.821 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.12 -163.96 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.271 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 72.26 -65.81 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.564 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.615 ' HG3' HD23 ' A' ' 109' ' ' LEU . 31.0 mmt180 -94.56 109.17 21.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.842 0.353 . . . . 0.0 111.001 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -82.1 142.48 47.86 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.982 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HB3' HD23 ' A' ' 88' ' ' LEU . 73.3 Cg_endo -77.33 160.05 32.65 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.589 2.193 . . . . 0.0 112.565 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 87' ' ' TYR . 1.4 t -128.15 152.22 35.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.056 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -96.84 100.09 11.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.751 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -144.51 -169.7 13.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.781 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.511 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.4 OUTLIER -117.78 128.75 55.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.655 0.264 . . . . 0.0 110.623 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.456 HD23 HD23 ' A' ' 187' ' ' LEU . 61.3 tp -92.78 122.44 35.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.177 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 8.0 m-70 -112.88 89.18 3.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.019 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.831 HG11 ' HA ' ' A' ' 191' ' ' VAL . 54.3 t -67.27 90.86 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.056 0.455 . . . . 0.0 110.527 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 p -82.92 156.54 23.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.452 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.47 -7.1 38.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.362 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 143' ' ' THR . 0.5 OUTLIER -124.16 34.61 5.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 110.839 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.654 ' HA2' HG13 ' A' ' 144' ' ' ILE . . . 122.52 -162.45 16.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.574 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.42 HD22 HG22 ' A' ' 123' ' ' VAL . 1.6 mt -122.96 166.86 14.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -159.84 103.87 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.667 HG12 HD12 ' A' ' 139' ' ' ILE . 4.4 t -90.32 98.57 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.21 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 136' ' ' LYS . 0.7 OUTLIER -92.38 114.57 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.913 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.401 ' HB3' HG22 ' A' ' 135' ' ' THR . 0.3 OUTLIER -52.72 146.99 9.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.61 19.28 11.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -131.15 -19.75 2.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.749 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.754 HG23 ' H ' ' A' ' 137' ' ' GLY . 12.2 t -134.87 -21.65 1.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.88 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.596 ' HA ' HG12 ' A' ' 131' ' ' VAL . 9.3 mmtt 56.65 23.95 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.817 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.754 ' H ' HG23 ' A' ' 135' ' ' THR . . . -77.43 -105.43 0.16 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.443 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.3 tp -165.95 102.34 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 110.699 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.667 HD12 HG12 ' A' ' 130' ' ' VAL . 3.2 mt -80.16 -30.06 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.213 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.475 HG12 HG23 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -156.56 148.38 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.267 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -129.29 48.57 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.819 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.47 ' HG3' ' HE2' ' A' ' 162' ' ' TYR . 8.2 mm100 -79.09 -175.58 4.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.052 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 2.6 m -149.0 164.85 33.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.654 HG13 ' HA2' ' A' ' 127' ' ' GLY . 69.2 mt -82.83 -37.93 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -12.2 60.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.626 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -86.43 -48.63 8.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.7 m -64.97 141.45 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.12 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 t -49.87 -65.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.808 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -159.64 123.33 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.805 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 77.0 m -59.87 163.16 4.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.42 125.12 0.74 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.075 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 72.3 Cg_endo -76.1 -94.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.557 2.171 . . . . 0.0 112.438 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.424 ' HA ' ' HG3' ' A' ' 103' ' ' GLU . 5.3 p-10 -175.64 -158.8 0.07 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.434 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.798 ' HD2' ' HG2' ' A' ' 103' ' ' GLU . 1.0 OUTLIER -67.3 -89.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.463 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -179.41 40.61 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.029 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.6 -17.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.264 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.98 -27.85 49.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.223 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.497 HH11 ' HB3' ' A' ' 182' ' ' ASP . 8.8 mtm180 58.9 19.26 6.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.759 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.516 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -122.81 140.37 13.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.419 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -119.49 168.08 11.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 110.833 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 175' ' ' HIS . 13.5 m -154.02 160.52 42.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.859 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.47 ' HE2' ' HG3' ' A' ' 142' ' ' GLN . 4.7 p90 -134.1 151.59 51.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.799 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.577 HG21 ' HA ' ' A' ' 96' ' ' SER . 0.7 OUTLIER -115.77 157.16 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.046 0.451 . . . . 0.0 111.734 -178.531 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.98 135.94 9.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.287 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -118.22 119.99 36.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.895 0.378 . . . . 0.0 111.675 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.86 -164.12 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.713 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.19 -17.61 12.22 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.847 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.442 ' H ' ' H ' ' A' ' 169' ' ' THR . 1.6 t -174.05 -0.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.031 0.443 . . . . 0.0 109.932 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -125.0 -15.73 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.868 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.44 21.31 9.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 177.91 176.48 0.43 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.1 121.32 25.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.663 ' HB2' HG21 ' A' ' 169' ' ' THR . 9.4 mtp -143.02 138.67 30.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.568 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.438 ' HB2' HG23 ' A' ' 163' ' ' ILE . 5.6 t -123.02 136.68 54.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.151 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.549 ' ND1' ' HB3' ' A' ' 90' ' ' CYS . 5.6 m-70 -102.44 157.71 16.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.555 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -133.07 145.26 17.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.865 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 17.8 p90 -153.95 136.44 15.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.768 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.516 HD23 ' HA3' ' A' ' 159' ' ' GLY . 5.7 mt -101.82 166.26 10.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.938 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.16 115.83 29.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -10.75 56.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -84.79 -24.09 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.497 ' HB3' HH11 ' A' ' 158' ' ' ARG . 47.1 m-20 56.98 82.97 0.11 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.6 t -167.02 -58.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.102 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.37 29.11 11.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.299 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -133.88 -54.71 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.416 ' HB2' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -59.93 -15.74 24.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.271 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.456 HD23 HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -115.16 -53.89 2.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -49.89 75.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.404 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -73.99 9.0 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.206 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.62 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -103.53 -55.75 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.81 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.831 ' HA ' HG11 ' A' ' 123' ' ' VAL . 13.2 p -64.03 -25.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -63.69 -19.42 62.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.335 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 91.8 m -103.09 10.22 38.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.828 0.347 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.604 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -90.56 -34.0 15.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.217 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.496 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 1.6 m-85 -62.03 -45.35 93.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.002 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.712 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -58.2 -16.03 12.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.597 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.21 -27.99 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.185 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -27.32 60.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.712 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.7 OUTLIER -111.13 16.82 20.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.249 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.36 -66.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.858 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -138.03 -174.75 3.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.751 0.31 . . . . 0.0 110.993 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -168.16 153.91 7.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.722 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -65.39 146.83 54.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.79 -12.26 13.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 83.5 p -91.34 25.6 2.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.84 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -61.57 145.24 52.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.071 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.89 0.24 56.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t0 56.6 78.41 0.22 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -82.44 150.98 64.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.998 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.585 2.19 . . . . 0.0 112.333 179.933 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.077 0 CA-C-O 120.801 0.334 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -164.24 -45.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.043 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -27.85 36.63 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -69.48 -11.08 60.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.515 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.4 -27.22 8.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.957 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.17 -28.32 65.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.652 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.31 -16.03 61.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.672 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.622 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 5.7 mt-10 -105.31 -16.07 14.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.663 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -54.81 -45.64 74.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.061 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.1 t -64.52 -45.38 95.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.465 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.622 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -54.19 -31.89 54.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.274 178.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -78.93 -91.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.399 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 178.45 34.97 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.373 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.545 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.4 t -174.35 101.21 0.1 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.929 0.395 . . . . 0.0 111.913 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.797 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 2.8 t -122.49 -149.09 0.42 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.461 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.765 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 54.55 -155.68 0.24 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.847 0.356 . . . . 0.0 111.81 178.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -159.39 -169.35 2.58 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.502 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.404 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -51.12 147.04 5.71 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.831 0.348 . . . . 0.0 110.962 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -140.77 -174.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.453 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.09 70.6 1.3 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.596 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 41.1 t80 -52.01 99.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.741 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.589 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 0.7 OUTLIER -71.41 -6.32 39.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.272 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.36 -164.48 12.14 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.619 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 10.1 p -125.72 144.51 50.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.683 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.549 HG12 ' HD2' ' A' ' 114' ' ' ARG . 33.1 m -131.04 161.89 40.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.021 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.03 155.36 20.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.724 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.9 165.87 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.973 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -134.97 59.76 1.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.006 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -155.81 -71.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 54.13 41.09 32.16 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -148.65 108.73 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.999 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.01 -144.32 16.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.765 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.45 -29.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.84 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -73.87 1.65 10.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.13 -28.12 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.031 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.849 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 1.7 m -90.79 -17.55 26.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -7.49 34.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.564 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.6 mm-40 -117.46 -41.34 2.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.019 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.08 82.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.68 -39.27 76.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -70.39 -38.78 74.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 104' ' ' GLU . 22.8 t -56.44 -34.61 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.639 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.782 HD23 ' HG3' ' A' ' 114' ' ' ARG . 2.5 mt -72.21 -28.16 63.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.669 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -12.76 59.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.55 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.84 -18.42 15.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.198 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.7 m -118.7 171.82 7.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.083 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -114.33 66.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.782 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -63.35 -92.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.2 -179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -150.01 75.72 8.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.337 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 67.2 Cg_endo -73.97 108.72 2.72 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.637 2.225 . . . . 0.0 112.219 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.26 125.98 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.017 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.61 106.49 18.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.908 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -148.45 -171.99 17.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.822 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -100.02 138.89 36.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.04 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.665 HD13 HG22 ' A' ' 130' ' ' VAL . 28.0 tp -108.81 125.42 51.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.181 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 0.1 OUTLIER -117.76 95.61 5.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.292 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.817 HG11 ' HA ' ' A' ' 191' ' ' VAL . 74.9 t -67.1 94.22 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.977 0.418 . . . . 0.0 110.557 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.653 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -92.13 143.0 26.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.627 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -80.1 37.65 2.17 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.648 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -168.89 20.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.729 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 135.39 101.05 0.65 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.221 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 8.6 mt -60.89 132.82 55.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -122.13 146.72 46.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.654 179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.665 HG22 HD13 ' A' ' 121' ' ' LEU . 16.2 t -133.52 98.02 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.26 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.47 ' H ' ' HE1' ' A' ' 122' ' ' HIS . 2.3 t -98.07 124.81 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.889 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.542 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 8.5 t70 -53.67 160.39 1.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.484 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.6 OUTLIER -99.49 -1.51 38.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.387 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.03 -43.67 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.937 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.47 -23.2 21.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.43 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 131' ' ' VAL . 6.1 mmtp 50.62 26.55 2.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.19 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.73 -109.05 0.73 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.418 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 141' ' ' ASP . 13.8 tp -160.04 116.72 2.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.93 0.395 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 132' ' ' ASP . 6.5 mm -96.54 -56.39 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.156 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 t -127.68 116.42 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.233 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.432 ' HB3' HD21 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -111.78 39.99 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.581 179.106 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -77.19 -168.44 1.11 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.47 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.613 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 5.1 m -146.05 158.34 43.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.826 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.653 HD11 ' O ' ' A' ' 124' ' ' SER . 4.5 mt -67.65 -35.63 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.041 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -80.62 -11.02 59.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.683 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -90.59 -40.58 11.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 143' ' ' THR . 1.0 OUTLIER -64.86 125.77 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.99 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.6 -73.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.112 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.46 124.49 12.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.29 159.99 22.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.413 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -170.51 108.53 0.43 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.035 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.656 ' HD2' ' HA3' ' B' ' 1' ' ' GLY . 88.1 Cg_endo -78.38 9.95 2.95 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.487 2.125 . . . . 0.0 112.459 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.64 -149.69 0.43 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.386 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.5 -101.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.423 0.154 . . . . 0.0 110.711 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.424 ' HB3' ' H ' ' A' ' 156' ' ' HIS . 11.7 t-20 49.72 -98.54 0.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.962 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.424 ' H ' ' HB3' ' A' ' 155' ' ' ASN . 0.2 OUTLIER 175.71 1.94 0.0 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.058 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -82.78 2.03 36.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.36 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.702 ' HG2' ' N ' ' A' ' 183' ' ' SER . 1.3 mpt_? 55.84 38.09 29.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.919 0.39 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -105.52 144.68 15.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.729 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 1.7 m-85 -131.34 150.97 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.849 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 0.9 OUTLIER -154.39 151.82 29.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.463 -178.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.543 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -127.05 163.0 24.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.282 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.629 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.8 OUTLIER -122.24 161.49 23.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.975 0.417 . . . . 0.0 111.362 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 2.1 t -155.93 118.93 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.621 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -89.93 119.01 29.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.458 ' HA ' ' N ' ' A' ' 170' ' ' ARG . 0.5 OUTLIER 50.35 -152.14 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.221 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.67 -29.8 2.92 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.775 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.56 -1.15 0.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.031 0.444 . . . . 0.0 109.952 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.775 HG22 ' HG3' ' A' ' 171' ' ' ARG . 1.6 m -128.98 -20.96 3.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.458 ' N ' ' HA ' ' A' ' 166' ' ' ASP . 5.7 mtt-85 66.41 24.14 10.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.316 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.775 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER 178.14 -176.86 0.21 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.051 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.17 132.28 48.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.194 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.537 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -163.21 124.45 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.561 179.201 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.629 ' HB2' HG23 ' A' ' 163' ' ' ILE . 1.9 t -115.84 140.94 48.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.96 0.41 . . . . 0.0 111.251 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.543 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -108.28 145.44 34.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -129.61 152.9 19.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.121 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 42.5 p90 -156.43 154.31 30.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.719 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.444 HD12 HD21 ' A' ' 88' ' ' LEU . 9.1 mt -112.59 158.12 20.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.821 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.435 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -88.38 118.43 28.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.854 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.14 -4.29 16.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.023 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -101.57 -29.64 11.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 58.0 92.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.702 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 28.9 t -167.08 -36.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.009 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.78 19.05 76.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -136.75 -20.87 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.573 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -79.09 -25.6 43.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.037 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 186' ' ' ARG . 6.7 mp -120.89 -43.33 2.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.4 t -58.4 -52.49 65.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -75.57 7.63 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.227 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.79 -56.82 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.091 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.817 ' HA ' HG11 ' A' ' 123' ' ' VAL . 7.6 p -65.76 -22.07 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.204 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.64 -18.95 62.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.508 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.481 ' O ' HG23 ' A' ' 197' ' ' VAL . 1.1 m -105.07 -3.3 23.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 110.712 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.528 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -64.52 -46.26 83.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.152 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.485 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.7 p90 -70.07 -39.1 75.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.991 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.435 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -57.98 -20.03 35.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.514 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 77' ' ' ARG . 35.5 t -105.48 -24.84 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.7 t -73.29 -3.11 24.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.771 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 5.0 mt -89.06 1.05 56.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.102 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.37 -3.59 43.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.041 -179.526 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.656 ' HA3' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.62 -164.58 0.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.734 0.302 . . . . 0.0 110.785 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.5 p -173.81 141.94 0.86 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.643 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -60.62 161.46 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.149 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 9.8 ttp -124.17 -2.15 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.959 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p -93.95 17.32 12.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.991 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -65.37 146.02 55.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.974 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -88.45 -1.57 58.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.954 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t0 55.03 77.13 0.22 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 23.5 m-85 -60.03 141.91 89.63 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 32.5 Cg_exo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.583 2.189 . . . . 0.0 112.267 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.8 t60 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.798 0.332 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -98.68 -47.84 5.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -26.45 68.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.61 -8.49 34.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.678 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.24 -24.75 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.013 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.54 -39.32 53.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.98 -39.69 79.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.694 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -74.56 -15.56 60.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -63.78 -47.84 79.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.472 HG22 HG12 ' A' ' 123' ' ' VAL . 24.3 t -58.8 -40.89 81.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -65.63 -31.88 73.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.396 178.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.66 -0.93 40.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.514 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 69.0 39.94 1.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.594 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.768 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -171.37 88.02 0.1 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.074 0.464 . . . . 0.0 111.439 178.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.928 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.9 t -117.75 -145.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.078 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.662 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.55 -156.67 0.19 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.925 0.393 . . . . 0.0 111.483 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -161.81 -167.94 1.82 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.539 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 5.4 m -50.78 150.26 2.98 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.977 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.47 -171.77 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.021 0.439 . . . . 0.0 111.839 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.02 80.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.289 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.534 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -53.91 166.44 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.296 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 18.4 mt -126.42 -46.97 1.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.628 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.14 -127.0 2.3 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.434 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.8 p -152.6 134.21 14.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.988 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 HD11 ' A' ' 109' ' ' LEU . 6.1 m -135.19 159.84 40.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 2.9 pt-20 -88.72 138.99 30.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.397 . . . . 0.0 110.986 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 m -129.33 127.07 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.94 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.89 65.77 4.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.967 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.618 ' HG3' ' HG3' ' A' ' 97' ' ' ARG . 1.4 tp10 -163.31 -65.57 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.282 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.4 22.89 11.37 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.642 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -151.84 117.04 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.901 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.41 158.65 11.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.454 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.74 -4.89 54.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.805 0.336 . . . . 0.0 111.031 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.75 -20.7 30.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.7 t -61.29 -32.68 53.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.844 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.413 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 58.5 m -85.6 -27.09 25.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.983 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.27 -15.44 63.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.017 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 108' ' ' VAL . 30.5 mt-10 -110.11 -45.63 3.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.85 -31.79 68.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.35 -42.11 90.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.667 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -73.75 -32.53 63.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.788 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 104' ' ' GLU . 52.1 t -55.99 -42.51 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.572 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -68.65 -35.38 77.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.549 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -69.1 -22.85 63.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.501 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -94.81 -14.38 24.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.769 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m -94.21 179.35 5.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.091 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -90.79 12.38 19.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.439 ' CG ' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -57.68 110.87 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.927 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 136.22 94.36 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.279 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -84.83 153.25 11.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.816 2.344 . . . . 0.0 112.565 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.534 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -128.54 97.55 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.774 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -80.73 129.68 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 -179.358 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -167.39 -163.01 20.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.291 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -106.02 118.34 36.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.814 0.34 . . . . 0.0 111.077 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.987 HD13 HG22 ' A' ' 130' ' ' VAL . 13.4 tp -89.3 127.16 35.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.456 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.768 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 35.5 m-70 -112.86 95.99 5.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.014 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.928 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 40.0 t -65.46 95.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.043 0.449 . . . . 0.0 110.441 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.48 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -94.42 126.7 39.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.222 179.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -63.17 -1.29 3.94 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.831 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -131.56 32.79 4.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 110.817 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.69 102.28 1.15 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.452 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mt -68.64 125.63 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 111.319 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.576 ' HB2' HD11 ' A' ' 138' ' ' LEU . 0.9 OUTLIER -121.1 143.34 49.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.435 179.071 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.987 HG22 HD13 ' A' ' 121' ' ' LEU . 18.4 t -122.67 115.1 44.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.904 0.383 . . . . 0.0 111.483 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.8 t -94.68 147.67 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.35 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 137' ' ' GLY . 38.7 m-20 -83.42 161.3 21.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.789 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -112.54 5.25 17.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.625 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.12 -3.06 5.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.968 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.401 ' H ' ' H ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -150.38 -14.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.523 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 23.1 mmtt 53.98 29.71 10.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.085 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 132' ' ' ASP . . . -99.33 148.4 18.69 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.394 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 129' ' ' ARG . 6.2 tp -76.36 120.88 22.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.902 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 9.5 pt -108.5 -16.01 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.228 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 130' ' ' VAL . 84.4 t -129.88 94.75 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 111.148 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.416 ' CG ' HD23 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -96.62 17.21 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.715 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.403 ' HG2' HG13 ' A' ' 140' ' ' VAL . 29.3 mm-40 -72.46 -173.84 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.828 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 24.4 m -142.56 160.58 40.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.619 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 124' ' ' SER . 45.0 mt -59.36 -56.28 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.26 -18.95 64.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.779 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.828 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 1.8 tttp -71.2 -61.38 1.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.973 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 143' ' ' THR . 2.6 m -61.25 140.04 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.093 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -43.89 -67.86 0.24 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.081 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.642 ' HZ ' ' HA ' ' A' ' 97' ' ' ARG . 0.3 OUTLIER -169.76 142.52 2.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.167 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.42 165.06 19.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.587 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -166.37 124.64 1.07 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.352 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.517 ' HG3' ' HA3' ' B' ' 1' ' ' GLY . 90.8 Cg_endo -82.86 -136.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.693 2.262 . . . . 0.0 112.104 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.464 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -130.3 -163.4 1.31 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.821 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 -19.18 1.76 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.115 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -90.67 -59.6 2.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.405 ' HB3' ' HG3' ' A' ' 158' ' ' ARG . 0.1 OUTLIER -151.62 129.74 11.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.54 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -72.44 74.6 1.03 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.399 . . . . 0.0 111.06 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.465 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -133.21 -4.77 3.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -148.35 114.75 0.7 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.468 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.4 m-85 -107.92 171.49 7.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.772 0.32 . . . . 0.0 111.203 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.658 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -165.11 154.48 12.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.46 160.38 34.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.52 151.96 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 110.29 6.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -83.36 97.96 9.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.98 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 51.94 -160.01 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.973 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 72.24 -3.3 23.64 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.768 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.426 ' H ' ' H ' ' A' ' 169' ' ' THR . 8.9 t -172.19 -8.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 0.0 110.061 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.694 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -129.41 -16.14 3.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.835 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 58.45 29.84 18.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.773 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -178.71 -167.41 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.712 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.77 99.5 10.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 0.0 110.78 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.694 ' HB2' HG21 ' A' ' 169' ' ' THR . 3.8 mtp -138.81 147.05 42.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.977 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.29 148.48 52.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.118 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -107.11 145.77 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.684 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.658 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -121.33 157.05 16.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.714 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 15.4 p90 -165.85 175.71 8.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.682 0.277 . . . . 0.0 110.504 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.502 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 1.2 mp -139.89 -172.85 3.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.967 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -115.82 130.67 56.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.021 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 84' ' ' SER . 7.3 t -67.35 -27.84 67.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.184 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.404 ' HB2' ' HD3' ' A' ' 186' ' ' ARG . 4.2 mttm -83.47 -42.23 17.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.162 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 57.86 89.94 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.016 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.8 t -156.97 -26.31 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.988 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.567 ' H ' ' CZ ' ' A' ' 186' ' ' ARG . . . 84.61 5.74 86.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.607 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -131.54 12.65 4.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.852 0.358 . . . . 0.0 111.061 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.689 HH11 ' HB2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -115.18 -10.17 12.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 -179.272 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.689 ' HB2' HH11 ' A' ' 186' ' ' ARG . 1.5 mp -148.42 -45.95 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.354 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.0 t -51.17 -63.53 1.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.626 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 5.06 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.638 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.49 -53.14 3.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.225 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.49 ' HA ' HG11 ' A' ' 123' ' ' VAL . 5.2 p -70.07 -18.32 21.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.07 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 195' ' ' PHE . . . -73.74 1.74 44.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.257 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.421 ' O ' HG23 ' A' ' 197' ' ' VAL . 56.7 m -118.09 -5.57 10.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.697 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -66.06 -52.56 47.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.205 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.551 ' HD1' HD11 ' A' ' 199' ' ' LEU . 46.2 p90 -65.4 -24.24 67.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.764 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.901 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -66.81 -8.72 30.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.286 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 193' ' ' CYS . 3.4 t -101.97 -12.95 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.114 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.96 3.71 22.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.691 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.901 HD12 ' HA ' ' A' ' 196' ' ' ALA . 4.9 mt -88.13 -48.89 7.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.054 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -61.43 -19.34 61.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.948 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 201' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.094 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.517 ' HA3' ' HG3' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.81 166.29 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.96 0.41 . . . . 0.0 111.143 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 1.4 p -165.41 136.22 3.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -57.8 111.03 1.02 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.025 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.6 6.93 45.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.163 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 73.9 p -96.32 18.54 13.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -67.34 150.23 49.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.04 11.71 33.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 14.5 t70 56.85 80.68 0.15 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.15 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.8 152.14 84.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.486 2.124 . . . . 0.0 112.231 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.1 t60 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.817 0.341 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.74 -36.49 16.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.726 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 1.7 m0 -66.27 -27.2 67.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.602 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -62.99 -22.37 66.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.136 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.22 -18.32 13.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.574 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.726 ' HB2' ' HA ' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -72.52 -36.07 68.24 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.46 179.289 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.74 -22.79 66.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.361 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.647 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 3.6 mt-10 -96.02 -14.32 23.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.648 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -58.33 -50.78 72.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.807 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 t -63.77 -39.86 86.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.367 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.647 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -58.22 -35.39 71.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.454 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.9 m -78.41 -90.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.556 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 179.28 32.69 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.525 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.78 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -170.26 99.66 0.27 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.92 0.391 . . . . 0.0 111.938 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.752 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.1 t -119.94 -151.53 0.48 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.104 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.744 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 55.26 -155.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.837 0.351 . . . . 0.0 111.46 179.264 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.58 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 1.9 m-85 -164.32 -167.64 1.35 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.63 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.4 150.44 3.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.069 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 m -147.71 -178.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 111.871 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 3.7 mmtt -130.63 85.99 2.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.657 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.622 ' HB3' HG23 ' A' ' 117' ' ' VAL . 29.1 t80 -58.56 94.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 3.9 mt -67.1 -17.47 64.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.055 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 114' ' ' ARG . . . 117.59 -131.03 9.13 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.572 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.511 ' N ' HD21 ' A' ' 109' ' ' LEU . 7.1 p -156.61 141.6 17.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.686 0.279 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 m -131.84 161.85 40.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.205 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -83.32 131.25 35.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.371 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 174' ' ' CYS . 16.3 m -141.65 131.87 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.94 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -103.04 73.4 1.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.941 0.401 . . . . 0.0 111.105 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.569 ' HB3' HG21 ' A' ' 101' ' ' VAL . 1.4 mt-10 -164.78 -71.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.059 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 p 45.15 33.5 1.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -121.86 -40.61 2.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.484 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.52 158.28 15.43 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.901 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -17.89 59.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.866 0.365 . . . . 0.0 110.904 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -72.36 -24.68 61.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 95' ' ' GLU . 6.7 t -59.94 -30.18 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.53 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 96.5 m -79.72 -28.25 40.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.766 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.71 -14.63 61.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.135 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.9 mt-10 -108.72 -44.32 4.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.22 -31.87 69.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.086 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.78 -38.55 91.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -40.87 84.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' GLU . 5.1 t -63.25 -44.51 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.666 HD23 ' HG3' ' A' ' 114' ' ' ARG . 3.0 mt -61.31 -34.95 76.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.269 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 110' ' ' ARG . 11.1 ttt-85 -74.05 -31.48 62.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.738 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -86.63 -14.45 42.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.308 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.12 -6.78 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.311 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 36.68 71.56 0.13 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.652 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.666 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -82.72 68.12 9.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.931 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 58.43 82.87 0.23 Allowed Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.361 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 92.7 Cg_endo -80.52 135.05 10.26 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.623 2.215 . . . . 0.0 112.23 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -129.85 158.94 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.191 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.6 ttp-105 -119.68 98.5 6.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -131.69 169.78 21.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.615 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -92.34 104.2 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.693 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.812 HD13 HG22 ' A' ' 130' ' ' VAL . 15.9 tp -74.92 129.11 37.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.425 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.78 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 52.2 m170 -115.05 94.6 4.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.752 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 71.4 t -69.31 90.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.927 0.394 . . . . 0.0 110.506 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.665 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -90.17 140.79 29.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.195 179.179 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.49 1.95 4.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.774 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -130.64 32.45 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 119.66 122.98 3.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.536 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.406 ' CD2' HG13 ' A' ' 123' ' ' VAL . 2.6 mt -76.05 141.93 41.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.739 0.304 . . . . 0.0 111.041 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -145.47 122.56 11.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.69 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.812 HG22 HD13 ' A' ' 121' ' ' LEU . 2.2 t -102.16 118.51 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.337 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 t -106.2 116.62 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.768 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.55 151.43 2.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.028 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.48 -6.83 54.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.364 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.72 -50.3 2.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.966 0.412 . . . . 0.0 110.695 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.0 m -82.95 -21.75 33.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.636 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp 51.69 28.19 4.64 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.211 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.41 -116.2 1.12 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.435 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tp -171.97 113.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.693 0.282 . . . . 0.0 110.543 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.583 HG13 ' HB ' ' A' ' 130' ' ' VAL . 2.9 pt -94.49 -41.49 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.497 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.668 ' HB ' HG23 ' A' ' 130' ' ' VAL . 39.8 t -122.85 103.78 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.177 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -113.19 48.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.798 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -98.11 -166.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.804 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.555 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 12.1 m -133.96 158.4 43.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.665 HD11 ' O ' ' A' ' 124' ' ' SER . 2.0 mt -65.05 -44.56 95.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.664 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.05 -20.02 56.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.56 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 12.9 tttp -69.82 -45.34 68.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.709 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 164' ' ' CYS . 5.9 m -74.83 150.98 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.747 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.8 -53.89 49.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.446 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.654 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 40.3 p90 -174.62 -174.21 0.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.1 t -110.95 157.92 19.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.726 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.0 115.6 0.55 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.844 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 84.4 Cg_endo -79.96 -119.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 111.996 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.431 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 8.1 p-10 -160.28 178.81 9.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.742 0.306 . . . . 0.0 110.72 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -120.28 -2.06 10.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.109 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -64.18 -66.43 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.649 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.78 2.97 3.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.434 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 60.18 15.87 5.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.091 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -104.04 1.35 30.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.535 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.98 133.64 10.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.466 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.844 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 1.7 m-85 -126.92 163.65 23.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.3 . . . . 0.0 110.665 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -164.6 144.57 7.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.009 0.433 . . . . 0.0 111.255 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -126.44 139.59 53.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.481 178.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.4 OUTLIER -101.04 139.99 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.242 -179.489 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.485 ' HB2' HG12 ' A' ' 147' ' ' VAL . 10.7 t -149.02 129.62 14.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.716 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.654 ' H ' ' HE ' ' A' ' 165' ' ' ARG . 0.2 OUTLIER -92.87 122.62 35.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.711 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 50.38 -158.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.432 179.527 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.48 -29.51 8.29 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.457 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.439 ' H ' ' H ' ' A' ' 169' ' ' THR . 9.4 t -164.63 6.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.57 . . . . 0.0 109.532 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.582 HG21 ' HG3' ' A' ' 173' ' ' MET . 24.7 m -136.88 -18.1 1.39 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.65 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.711 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 7.3 mtt180 57.72 32.48 21.94 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.407 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.511 ' HB2' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -163.41 150.11 12.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.711 -178.299 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -75.02 79.11 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.405 178.22 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.582 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.2 OUTLIER -110.57 166.78 10.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.078 -179.055 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.656 ' HB2' HG23 ' A' ' 163' ' ' ILE . 53.2 t -123.6 127.59 48.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.48 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 15.0 m-70 -90.75 124.99 35.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.559 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -108.2 156.28 15.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.612 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -170.66 152.68 3.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.714 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.562 HD11 HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -121.5 165.9 14.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.52 126.24 34.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.971 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 4.5 t -61.99 -21.07 64.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.815 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.58 ' HE3' ' HB3' ' A' ' 83' ' ' PHE . 2.8 mmtp -84.39 -23.02 30.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.672 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 55.08 83.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.1 t -159.74 -64.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 108.44 41.51 1.48 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.385 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.35 -33.48 0.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.752 0.31 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.556 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -72.48 -11.51 60.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.706 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 186' ' ' ARG . 5.2 mp -137.07 -36.89 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.114 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.2 t -57.94 -55.6 32.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.256 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.25 0.43 16.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.054 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -89.17 -54.81 3.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.67 ' HA ' HG11 ' A' ' 123' ' ' VAL . 10.9 p -75.41 -30.48 22.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.68 -9.49 45.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.252 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 57.5 m -110.53 -10.28 14.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 110.707 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.61 -43.35 94.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.244 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.471 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 2.0 p90 -61.74 -32.58 72.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.725 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -61.86 -33.66 74.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.21 5.62 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.641 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -93.62 -43.92 8.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.823 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.0 OUTLIER -74.55 -3.02 28.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.866 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 201' ' ' ARG . 0.0 OUTLIER -59.64 -28.95 67.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.643 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.431 ' N ' ' HG3' ' A' ' 200' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.702 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.42 174.81 10.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.0 110.978 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.654 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.9 p -168.81 148.36 4.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.942 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 149' ' ' PHE . 9.4 m-80 -64.36 156.93 27.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.811 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 20.5 mtm -126.63 -18.18 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -76.52 0.1 21.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.083 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -63.12 148.91 46.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.972 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -97.22 4.61 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.926 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 29.2 t0 56.98 77.3 0.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -70.03 151.61 96.05 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.763 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.487 2.125 . . . . 0.0 112.262 179.696 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.676 0.274 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -72.11 -59.17 2.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.478 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.63 -16.49 56.96 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.432 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -68.99 -32.76 72.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.96 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.2 -19.2 23.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.631 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.39 -32.6 26.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.562 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -71.78 -36.22 70.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.243 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.74 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -69.36 -19.45 63.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.265 178.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -61.69 -52.15 65.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.945 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.9 -37.99 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.54 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.74 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 11.5 mtp180 -56.89 -40.34 76.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.461 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -75.61 -91.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.477 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 179.34 38.51 0.0 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.343 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.552 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.7 t -173.2 95.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.991 0.424 . . . . 0.0 111.466 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.612 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 11.6 t -122.68 10.29 9.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.534 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -114.2 -162.84 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.218 -179.44 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.683 ' HB2' HD11 ' A' ' 187' ' ' LEU . 60.3 m-85 -150.07 -168.6 3.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.72 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.623 ' HA ' HD22 ' A' ' 120' ' ' LEU . 1.0 OUTLIER -47.53 151.52 0.79 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.87 0.367 . . . . 0.0 111.366 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.42 -170.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.125 0.488 . . . . 0.0 111.679 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.93 73.09 1.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.311 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 83.6 t80 -55.45 98.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.143 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 178' ' ' LEU . 4.3 mt -61.36 -50.03 74.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.492 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 153.04 -128.13 2.38 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.241 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.423 ' N ' HD21 ' A' ' 109' ' ' LEU . 1.6 p -161.79 126.15 3.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 0.0 110.866 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.3 m -110.18 165.8 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.036 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.77 116.02 28.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.142 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.3 m -108.99 -165.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.865 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.95 65.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 1.2 mm-40 -166.32 -66.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.81 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.54 ' HA ' HG21 ' A' ' 163' ' ' ILE . 2.1 m 59.92 33.23 21.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 15.7 ptt180 -169.57 80.57 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.59 146.62 4.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.246 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.453 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -72.29 -29.89 64.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.775 0.322 . . . . 0.0 111.206 -179.421 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.453 ' N ' ' HG3' ' A' ' 99' ' ' MET . 0.5 OUTLIER -77.39 -21.19 53.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.926 -179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 t -60.73 -35.02 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 55.5 m -73.26 -49.98 24.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.951 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.487 ' HG3' ' HG2' ' A' ' 154' ' ' ARG . 2.9 tm-20 -56.33 -29.68 61.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.295 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.5 mm-40 -76.57 -51.72 11.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.94 -31.63 68.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.048 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.68 -43.33 93.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.845 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -62.86 -43.27 99.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 104' ' ' GLU . 18.8 t -62.62 -39.81 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.047 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.637 HD23 ' HG3' ' A' ' 114' ' ' ARG . 8.1 mt -65.83 -36.15 82.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.827 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -76.13 -14.35 60.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.298 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -95.87 -16.53 21.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.786 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.84 -177.08 3.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.59 ' H ' ' HE ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -116.85 71.77 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.814 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.637 ' HG3' HD23 ' A' ' 109' ' ' LEU . 22.7 mmt180 -85.19 22.52 1.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.071 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 54.29 88.15 0.13 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.817 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 17.2 Cg_exo -66.57 137.29 45.78 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.82 2.347 . . . . 0.0 111.77 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.76 113.39 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.01 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -75.28 107.42 7.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.697 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -142.67 -167.3 11.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.834 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -118.4 122.87 43.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.658 0.266 . . . . 0.0 110.715 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.705 HD13 HG22 ' A' ' 130' ' ' VAL . 32.4 tp -89.5 133.76 34.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.777 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.494 ' CD2' HD12 ' A' ' 120' ' ' LEU . 14.2 m170 -123.03 94.75 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.186 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 53.2 t -62.28 96.15 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.061 0.457 . . . . 0.0 110.338 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.634 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -99.7 130.6 45.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.487 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -64.25 -0.24 4.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.961 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -126.17 29.01 5.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.855 0.36 . . . . 0.0 110.807 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 117.19 113.49 2.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.259 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.585 HD21 HG22 ' A' ' 123' ' ' VAL . 0.5 OUTLIER -57.04 146.33 27.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 -179.426 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -138.41 120.35 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 121' ' ' LEU . 2.2 t -110.29 108.28 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 111.271 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.99 117.69 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.058 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 76.9 m-20 -53.71 156.75 2.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.75 1.39 29.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -116.62 -31.33 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.523 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.25 -6.53 9.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.727 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 4.4 mmtm 50.91 25.59 2.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.11 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.11 167.27 30.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.357 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 138' ' ' LEU . 8.7 tp -99.48 116.32 31.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.61 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.559 HG13 ' HB ' ' A' ' 130' ' ' VAL . 1.2 pt -94.42 -50.23 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.374 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.491 ' HB ' HG23 ' A' ' 130' ' ' VAL . 48.7 t -110.37 95.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.916 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -105.09 67.49 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.656 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -114.8 -171.91 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.152 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 88.6 m -131.16 151.88 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.552 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.634 HD11 ' O ' ' A' ' 124' ' ' SER . 3.4 mt -61.28 -31.89 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.655 ' H ' HG22 ' A' ' 143' ' ' THR . 2.1 mt-10 -90.65 -6.62 54.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.516 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.661 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 5.7 tptm -90.08 -37.75 14.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.028 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -58.42 134.32 23.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.806 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.6 t -70.61 -21.15 62.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.462 ' CB ' HD12 ' A' ' 163' ' ' ILE . 0.2 OUTLIER -170.05 151.96 4.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.125 0.488 . . . . 0.0 111.514 -179.285 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.32 137.22 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.916 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.572 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -168.55 119.81 0.66 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.66 0.267 . . . . 0.0 111.687 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 55.9 Cg_endo -69.43 -94.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.342 2.028 . . . . 0.0 111.625 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.79 -163.13 1.28 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.459 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.487 ' HG2' ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -124.95 14.43 8.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.802 0.334 . . . . 0.0 111.266 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 28.5 t-20 -164.81 -74.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 155' ' ' ASN . 5.8 t60 176.06 36.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.96 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.506 ' C ' ' HG2' ' A' ' 158' ' ' ARG . 14.1 mm-40 -85.97 28.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.296 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.506 ' HG2' ' C ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER 37.95 39.52 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.476 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.54 129.73 6.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.56 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.591 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 0.5 OUTLIER -127.13 155.42 43.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 110.682 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.573 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -160.84 159.98 30.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 111.273 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.97 143.1 33.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.323 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.54 HG21 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -104.23 148.7 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.948 0.404 . . . . 0.0 111.183 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.8 p -135.37 148.65 49.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.74 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.28 101.37 9.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.01 -152.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.075 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.73 -15.03 22.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.508 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.416 ' H ' ' H ' ' A' ' 169' ' ' THR . 15.1 t -171.25 -0.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 110.008 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.499 HG21 ' HB2' ' A' ' 173' ' ' MET . 3.3 m -127.63 -18.74 4.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.083 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 60.07 30.66 20.11 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.783 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -179.43 -168.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.882 179.53 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -98.78 112.39 24.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.025 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.783 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 25.3 mtp -139.6 149.84 44.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.567 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.516 ' HB2' HG23 ' A' ' 163' ' ' ILE . 20.4 t -117.69 147.37 42.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.154 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -114.78 137.2 52.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.445 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -128.84 156.55 21.17 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.994 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -166.93 155.85 10.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 111.076 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.464 HD12 HD21 ' A' ' 88' ' ' LEU . 1.4 mt -111.93 178.17 4.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.612 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.591 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -113.57 125.66 54.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 0.0 110.959 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.3 OUTLIER -71.13 -5.07 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.787 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.445 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 13.1 mmmt -91.01 -37.54 13.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 58.14 85.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.99 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.2 t -163.86 -39.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.83 17.94 79.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.494 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -132.57 1.11 3.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.868 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.43 ' HB2' HD12 ' A' ' 187' ' ' LEU . 8.6 mmm180 -108.8 -33.6 6.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 83' ' ' PHE . 5.7 mp -114.99 -43.21 3.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.125 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.5 t -58.72 -66.39 0.5 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.451 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.6 -16.22 55.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.157 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.72 -56.28 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.22 -19.72 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.018 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -77.47 -0.14 71.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.334 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 58.0 m -120.29 0.37 10.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.31 -40.94 50.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.104 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 7.1 p90 -67.72 -31.18 70.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.814 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.442 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -61.4 -29.39 69.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.373 . . . . 0.0 110.969 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.459 ' HA ' ' HG2' ' A' ' 200' ' ' GLU . 4.9 t -99.29 0.48 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.889 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -92.6 -38.31 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.222 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.2 OUTLIER -87.91 16.98 5.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.73 0.3 . . . . 0.0 110.904 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 197' ' ' VAL . 70.9 mm-40 -63.31 -35.26 79.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.376 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.466 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.604 -0.198 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -161.63 154.44 20.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.94 162.25 23.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.003 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -65.81 167.09 9.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 3.6 mtp -134.92 -22.45 1.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 60.3 p -81.2 14.91 2.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -62.55 153.9 30.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.934 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -91.33 -0.27 57.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 t0 56.36 78.59 0.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.197 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.667 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 25.5 m-85 -66.45 -51.61 41.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.134 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 31.8 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.213 1.942 . . . . 0.0 112.255 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.803 0.335 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -99.69 -46.83 5.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.869 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 1.5 m0 -67.23 -21.0 65.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.785 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.25 -18.78 63.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.511 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -106.62 -21.62 13.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.86 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 69' ' ' TRP . 1.6 m-20 -78.48 -33.34 48.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -65.26 -22.02 66.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.575 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.736 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.5 mt-10 -100.61 -13.68 18.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.802 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -59.5 -46.89 87.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.763 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 194' ' ' ALA . 7.1 t -61.49 -42.64 94.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.349 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.736 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 7.5 mtp180 -54.45 -34.8 62.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.143 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 1.4 m -78.12 -90.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.251 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 176.28 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.683 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.576 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -173.7 98.0 0.11 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.866 0.365 . . . . 0.0 111.777 -179.599 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.413 ' H ' ' N ' ' A' ' 123' ' ' VAL . 10.3 t -139.26 63.48 1.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.393 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.738 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -159.44 -155.15 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.802 0.334 . . . . 0.0 111.297 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -154.62 -172.82 4.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.596 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 3.4 t -51.1 152.34 2.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.801 0.334 . . . . 0.0 111.168 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.74 -167.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.286 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.417 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -148.18 65.3 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.823 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 55.0 t80 -62.6 117.02 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.567 ' O ' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -116.45 62.6 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.408 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.549 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 62.77 -168.7 17.73 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.396 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.449 ' C ' HD21 ' A' ' 109' ' ' LEU . 0.7 OUTLIER -138.47 146.37 41.97 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.519 HG13 ' CD2' ' A' ' 109' ' ' LEU . 4.6 m -115.24 163.86 12.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.369 . . . . 0.0 111.188 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.63 145.88 29.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.027 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -139.02 178.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.648 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -145.77 65.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 0.0 111.16 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -169.08 -72.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 p 67.48 0.76 2.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.2 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.501 ' HE ' HH22 ' A' ' 165' ' ' ARG . 0.0 OUTLIER -154.8 114.48 3.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.789 179.308 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 140.07 121.21 1.81 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.159 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 60.48 -88.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.617 0.246 . . . . 0.0 110.551 -178.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.481 ' O ' HD11 ' A' ' 163' ' ' ILE . 0.6 OUTLIER -154.15 -28.25 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.034 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.476 ' HB ' HD13 ' A' ' 163' ' ' ILE . 1.1 t 49.38 23.46 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.371 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 62.6 m -118.64 -24.22 6.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.013 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -9.31 58.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.018 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 108' ' ' VAL . 21.2 mt-10 -104.52 -53.76 2.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.24 -51.12 71.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.222 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.1 tp -57.77 -32.09 67.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -67.36 -43.01 82.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 104' ' ' GLU . 9.4 t -59.21 -49.92 81.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.842 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.3 mt -65.85 -25.03 67.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.591 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -77.64 -25.59 49.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.626 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 23.1 mt-30 -91.36 -19.88 22.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.201 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 m -113.6 179.36 3.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 0.0 111.253 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.66 72.38 0.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.675 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.842 ' HG3' HD23 ' A' ' 109' ' ' LEU . 3.8 mmt180 -82.66 40.44 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.232 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 59.0 77.9 0.37 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.567 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 87.9 Cg_endo -81.09 121.8 4.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.667 2.245 . . . . 0.0 112.256 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.02 140.74 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 118' ' ' ARG . 12.3 ttp180 -99.39 103.6 15.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.623 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -135.58 172.68 22.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.8 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -92.44 127.26 37.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.795 0.331 . . . . 0.0 111.0 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.723 HD13 HG22 ' A' ' 130' ' ' VAL . 39.6 tp -97.06 129.62 44.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.56 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.463 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 89.6 m-70 -116.71 93.02 4.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.852 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 82' ' ' SER . 41.9 t -58.35 103.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.982 0.42 . . . . 0.0 110.849 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.711 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -100.76 134.65 43.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.192 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.61 8.57 4.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.015 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -137.35 28.19 2.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 110.615 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.761 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 124.63 113.22 1.99 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.315 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.489 HD21 HG22 ' A' ' 123' ' ' VAL . 1.3 mt -58.0 144.25 40.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 111.233 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.582 ' HE ' HD11 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -136.5 124.62 23.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.817 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.723 HG22 HD13 ' A' ' 121' ' ' LEU . 2.9 t -110.93 112.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.311 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.9 t -104.9 114.22 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.795 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.47 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 1.4 m-20 -48.86 147.57 2.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.895 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.623 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -103.23 9.04 38.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.616 -179.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.63 -1.19 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.403 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.409 ' H ' ' H ' ' A' ' 136' ' ' LYS . 3.2 m -151.52 -11.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.546 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 22.9 mmtp 54.77 25.74 6.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.895 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.65 -166.84 35.83 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.549 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.582 HD11 ' HE ' ' A' ' 129' ' ' ARG . 8.6 tp -119.18 116.92 27.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.913 0.387 . . . . 0.0 110.634 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.428 HD12 HG12 ' A' ' 130' ' ' VAL . 6.3 mt -98.02 -57.29 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.263 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.558 HG13 ' HG2' ' A' ' 142' ' ' GLN . 61.3 t -124.51 116.63 48.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.407 ' HB3' HD21 ' A' ' 138' ' ' LEU . 0.6 OUTLIER -121.45 36.48 4.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.583 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.558 ' HG2' HG13 ' A' ' 140' ' ' VAL . 73.1 mm-40 -81.75 -165.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.111 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.761 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 19.3 m -129.42 153.94 47.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.711 HD11 ' O ' ' A' ' 124' ' ' SER . 3.5 mt -65.89 -44.9 92.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.0 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -78.64 -0.21 29.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.506 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.415 ' CB ' ' HB ' ' A' ' 143' ' ' THR . 28.5 tttt -95.73 -44.84 7.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.667 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -62.29 148.22 10.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.93 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.8 t -83.11 -37.03 24.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.201 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -137.95 -172.68 3.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.908 0.385 . . . . 0.0 111.395 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.8 t -168.35 25.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.456 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.498 ' HB3' ' HB2' ' A' ' 102' ' ' CYS . . . -51.12 138.94 25.23 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.159 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.92 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 72.2 Cg_endo -95.56 12.86 1.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.35 2.7 . . . . 0.0 112.385 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER 61.94 65.29 0.92 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.174 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 61.03 8.21 1.84 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.764 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 50.64 30.52 4.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.948 0.404 . . . . 0.0 111.11 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.25 -23.12 4.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.747 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.2 -2.29 58.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.724 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 183' ' ' SER . 2.6 mtt180 56.76 24.2 8.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.898 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.605 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -133.59 128.89 5.16 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.41 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -104.46 168.43 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.3 . . . . 0.0 110.805 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.45 150.94 14.65 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.005 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -132.17 145.61 51.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.636 179.015 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -107.44 144.5 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.188 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.9 130.51 9.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.611 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 3.3 mtt-85 -74.91 -144.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.48 ' H ' ' HB3' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.17 -166.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.909 0.385 . . . . 0.0 111.136 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.61 -11.45 68.39 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.397 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.3 t -166.55 -8.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 109.926 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.771 HG21 ' HB2' ' A' ' 173' ' ' MET . 18.5 m -129.7 -9.79 4.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.645 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 61.19 17.4 8.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.131 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 171' ' ' ARG . 0.9 OUTLIER -176.44 174.31 1.95 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.94 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -77.53 109.58 11.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.995 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.771 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -138.08 159.64 41.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.638 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.795 ' HB2' HG23 ' A' ' 163' ' ' ILE . 31.1 t -129.39 139.36 51.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.859 0.361 . . . . 0.0 111.236 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -103.53 143.58 32.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.665 179.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -126.55 149.86 17.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.859 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -166.5 139.41 3.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.755 0.312 . . . . 0.0 110.715 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.605 HD23 ' HA3' ' A' ' 159' ' ' GLY . 1.5 mt -100.11 -177.81 3.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.943 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -110.48 129.99 55.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.052 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER -76.5 1.28 17.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.172 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -99.85 -23.69 14.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.756 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 55.97 79.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.155 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.407 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 1.5 t -165.9 -59.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.941 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.78 32.2 6.03 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.553 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -141.81 -32.39 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.731 0.3 . . . . 0.0 110.953 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.503 ' HB2' HD12 ' A' ' 187' ' ' LEU . 4.9 mmm180 -73.57 -6.06 44.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.836 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.596 HD23 HD23 ' A' ' 121' ' ' LEU . 5.6 mp -139.24 -50.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.441 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 3.6 t -62.18 -60.87 2.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.336 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 0.1 OUTLIER -52.64 -37.2 58.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.82 -41.78 91.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 187' ' ' LEU . 24.7 t -62.25 -32.3 54.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.76 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -59.3 -20.62 51.29 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.529 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 2.6 m -95.18 -15.42 23.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.729 0.3 . . . . 0.0 111.097 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.703 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -63.07 -30.87 71.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.18 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.467 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 1.3 m-85 -72.86 -40.11 65.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.804 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -54.98 -21.05 10.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.586 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.5 t -105.56 -12.88 9.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -79.36 -27.06 41.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.02 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -101.42 35.79 2.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.839 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.08 -39.99 76.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.653 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 33.6 ttp85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.79 179.426 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.92 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -139.99 -91.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.634 0.254 . . . . 0.0 110.835 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 63.84 158.25 0.08 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.449 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -87.82 -173.15 4.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.207 -179.555 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 68.9 mtp -125.98 -30.31 2.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.823 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.463 ' HB3' HD23 ' A' ' 199' ' ' LEU . 89.6 p -88.09 36.91 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.452 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.641 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 3.1 p90 -63.94 -3.34 2.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.849 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 55.69 8.89 0.36 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.665 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ASP . . . . . 0.641 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 21.5 t70 48.9 76.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.401 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -58.92 135.65 87.32 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.472 2.115 . . . . 0.0 112.24 179.924 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.608 0.242 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 76.25 -56.8 0.57 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.542 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -68.29 -11.0 58.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.701 0.286 . . . . 0.0 110.855 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -77.87 -4.69 47.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.043 0.449 . . . . 0.0 110.094 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.93 -31.55 4.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.108 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -83.51 -19.95 34.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.986 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 34.0 tt0 -63.52 -29.99 71.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.617 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -100.57 -17.26 17.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.978 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -58.07 -52.66 64.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.537 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 194' ' ' ALA . 0.9 OUTLIER -66.36 -35.32 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.729 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.617 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 3.1 mtp180 -55.34 -24.03 27.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.109 0.48 . . . . 0.0 109.808 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.42 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -98.03 -97.11 0.21 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.659 179.032 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.501 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -176.47 48.36 0.01 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.565 0.221 . . . . 0.0 111.457 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.642 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 1.4 t -176.04 86.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.919 0.39 . . . . 0.0 111.112 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.693 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 6.7 t -121.22 4.16 10.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.5 OUTLIER -111.97 -156.97 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.161 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.407 ' CG ' ' HE2' ' A' ' 181' ' ' LYS . 16.5 m-85 -154.84 -171.63 3.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.558 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 0.9 OUTLIER -53.01 150.71 5.33 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.048 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.81 -168.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.528 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -143.24 81.28 1.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.925 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 55.6 t80 -62.28 93.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.668 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 178' ' ' LEU . 1.1 mp -58.21 -41.01 83.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.16 -130.44 3.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.357 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -164.28 141.21 6.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 111.046 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.89 172.7 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.486 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 4.1 pt-20 -95.15 142.43 27.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.889 0.376 . . . . 0.0 111.053 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.71 163.65 36.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -121.24 65.34 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.058 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -175.77 -70.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.036 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.422 ' HA ' HD13 ' A' ' 163' ' ' ILE . 0.7 OUTLIER 58.72 25.89 13.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.863 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.88 61.8 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.64 160.78 24.37 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.722 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.493 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -77.18 -30.8 55.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.782 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.493 ' N ' ' HG3' ' A' ' 99' ' ' MET . 8.2 mp0 -69.01 -23.04 64.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.028 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.5 t -58.56 -33.37 48.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 110.537 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.862 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 58.5 m -80.54 -37.01 32.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.615 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.3 -34.7 78.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.93 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 108' ' ' VAL . 8.4 mt-10 -76.96 -52.84 8.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.908 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.92 66.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.962 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 tp -66.08 -36.68 83.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.951 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.8 tptp -70.22 -46.21 64.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 104' ' ' GLU . 11.0 t -60.75 -38.06 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.867 HD23 ' HG3' ' A' ' 114' ' ' ARG . 18.7 mt -61.55 -31.97 72.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.075 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 110' ' ' ARG . 1.2 tpp85 -78.08 -32.88 50.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -81.89 -15.36 54.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.793 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.7 m -105.13 179.42 4.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.82 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.612 ' H ' HH11 ' A' ' 113' ' ' ARG . 0.0 OUTLIER -115.88 65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.867 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.26 20.32 3.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 55.34 95.04 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.993 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 93.3 Cg_endo -80.5 127.27 6.43 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.79 2.326 . . . . 0.0 112.087 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.33 143.79 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.225 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -102.69 97.83 7.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.65 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -131.64 163.06 23.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.911 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.475 ' HB3' ' HE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -87.18 124.22 33.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.735 0.302 . . . . 0.0 110.977 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.835 HD13 HG22 ' A' ' 130' ' ' VAL . 29.4 tp -96.85 135.34 38.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.763 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.642 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 1.9 m-70 -125.43 105.39 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.094 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 11.4 t -70.46 104.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 0.0 110.838 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -104.81 143.37 33.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.408 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.31 28.96 1.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.848 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 124' ' ' SER . 3.0 t70 -153.51 21.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.594 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 124.73 131.72 3.71 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.523 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.672 HD23 HD11 ' A' ' 121' ' ' LEU . 1.7 mp -67.16 168.77 9.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 14.5 ttm180 -168.75 115.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.903 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.835 HG22 HD13 ' A' ' 121' ' ' LEU . 3.9 t -107.97 109.21 27.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.07 0.462 . . . . 0.0 111.421 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.57 115.38 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.941 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.405 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 88.5 m-20 -50.9 144.58 8.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.24 17.19 21.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.988 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -127.67 -8.69 5.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.606 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.09 -8.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.843 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp 58.1 25.78 12.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.551 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.18 -138.5 0.25 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.444 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' A' ' 141' ' ' ASP . 15.7 tp -159.09 116.06 2.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.663 0.268 . . . . 0.0 110.438 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.632 HG13 ' HB ' ' A' ' 130' ' ' VAL . 3.6 pt -106.73 -28.48 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.562 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.638 ' HB ' HG23 ' A' ' 130' ' ' VAL . 43.1 t -137.35 116.65 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.167 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.588 ' HB2' HD21 ' A' ' 138' ' ' LEU . 17.8 t0 -130.04 29.91 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.345 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -76.55 -167.51 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.206 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 144' ' ' ILE . 1.8 m -123.66 171.0 9.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.658 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.47 HD11 ' O ' ' A' ' 124' ' ' SER . 47.3 mt -88.03 -28.16 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.701 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.77 -8.98 50.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.86 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -92.96 -39.63 11.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 143' ' ' THR . 1.2 m -61.77 126.1 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.013 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.39 -49.9 73.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.414 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 163' ' ' ILE . 12.3 m-85 -130.44 -171.94 2.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.095 0.474 . . . . 0.0 111.526 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.3 t -162.35 35.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.31 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.488 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -68.41 143.58 95.64 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.498 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.914 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 71.6 Cg_endo -87.68 -89.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.722 2.281 . . . . 0.0 112.111 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -167.72 -163.93 0.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 110.755 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.96 28.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.015 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 57.39 45.89 19.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -164.89 -27.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.912 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -75.58 -18.04 59.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 56.53 18.94 3.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.071 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.731 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -127.9 129.33 6.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.671 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -102.91 168.87 8.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.604 0.24 . . . . 0.0 110.448 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.862 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 24.4 m -158.76 155.65 28.35 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.012 0.434 . . . . 0.0 111.375 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -132.29 160.05 37.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.077 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -117.14 153.63 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.401 . . . . 0.0 111.638 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 6.4 t -159.49 118.12 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.447 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.665 HH21 ' HB3' ' B' ' 10' ' ' PHE . 15.2 ptt85 -74.01 -152.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.29 -178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -55.45 -179.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.199 0.523 . . . . 0.0 111.69 -178.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.93 -8.37 29.5 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 15.2 t -170.08 -5.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.244 -0.478 . . . . 0.0 109.934 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.505 HG22 ' HG3' ' A' ' 171' ' ' ARG . 22.4 m -133.43 -12.6 2.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.054 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 170' ' ' ARG . 43.3 mtt180 62.29 22.58 13.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.799 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.505 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -175.71 -179.07 1.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.9 OUTLIER -81.49 124.0 29.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.9 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -142.5 126.33 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 34.8 t -104.11 136.32 43.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 2.5 m-70 -105.82 145.69 30.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.359 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.05 154.73 21.49 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.185 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -161.66 144.67 12.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.715 0.293 . . . . 0.0 110.739 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.731 HD23 ' HA3' ' A' ' 159' ' ' GLY . 1.1 mt -105.29 162.52 13.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.131 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.13 122.5 32.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 84' ' ' SER . 0.5 OUTLIER -71.83 -11.23 60.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.935 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.407 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 8.2 mmmt -89.34 -17.21 29.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.715 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 53.84 80.63 0.11 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.02 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.42 -43.08 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.091 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.94 31.61 55.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.306 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -146.08 -34.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.701 0.286 . . . . 0.0 110.793 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.49 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.7 OUTLIER -59.51 -28.25 66.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.793 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.574 HD23 HD23 ' A' ' 121' ' ' LEU . 4.8 mp -117.04 -39.13 3.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.879 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 191' ' ' VAL . 0.5 OUTLIER -57.13 -63.06 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.32 -179.496 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -16.05 61.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.373 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.0 -53.61 8.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.025 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.475 ' HA ' HG11 ' A' ' 123' ' ' VAL . 9.9 p -63.46 -18.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.08 -1.54 59.99 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.334 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.3 m -120.54 -4.7 9.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.32 . . . . 0.0 110.781 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.586 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -74.82 -45.61 42.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.248 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 38.9 p90 -68.3 -36.18 78.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.072 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -56.65 -31.69 64.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.022 0.439 . . . . 0.0 110.69 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.46 -19.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.812 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.634 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -73.37 -6.02 43.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.548 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 196' ' ' ALA . 2.6 mt -88.74 14.02 11.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -92.11 -34.96 14.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.196 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.271 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.914 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -145.7 -98.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.573 0.225 . . . . 0.0 111.17 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.504 ' H ' ' HB3' ' B' ' 2' ' ' PHE . 7.9 t 62.96 157.14 0.06 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.137 0.494 . . . . 0.0 111.246 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -92.51 176.53 6.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.829 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mtp -123.32 -7.31 8.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.7 p -83.62 6.87 19.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -62.56 145.57 54.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -106.85 10.11 30.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 t70 54.42 70.54 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.983 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.665 ' HB3' HH21 ' A' ' 165' ' ' ARG . 44.8 m-85 -61.3 134.92 93.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.967 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.598 2.199 . . . . 0.0 112.445 -179.725 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.0 t60 . . . . . 0 N--CA 1.461 0.085 0 CA-C-O 120.862 0.363 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -63.9 -48.28 77.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -25.18 68.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.929 0.395 . . . . 0.0 110.757 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -70.12 -7.78 44.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -125.96 -8.89 6.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.969 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -91.13 -25.53 19.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.966 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.63 -34.3 77.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.721 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.4 mt-10 -92.38 -9.38 41.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 81' ' ' CYS . . . -60.16 -50.59 73.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.2 t -56.51 -40.61 69.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.955 0.407 . . . . 0.0 110.432 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.721 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 5.3 mtm180 -65.03 -32.03 73.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.332 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.2 m -81.12 3.46 23.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.61 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.409 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 65.01 41.92 4.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.42 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -176.17 85.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.56 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 13.1 t -116.35 21.4 13.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.371 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.733 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -117.06 -160.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.33 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.416 ' O ' HG13 ' A' ' 85' ' ' VAL . 3.2 m-85 -158.66 -169.5 2.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.537 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 2.3 t -48.94 142.09 6.93 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.893 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 83' ' ' PHE . 22.3 m -138.0 -171.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.062 0.458 . . . . 0.0 111.761 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -141.65 60.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.416 179.193 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.504 ' O ' HG23 ' A' ' 117' ' ' VAL . 71.4 t80 -53.26 114.84 1.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.03 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -82.66 -56.08 4.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.022 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.0 -124.64 1.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.483 ' HB3' ' ND1' ' A' ' 175' ' ' HIS . 1.2 p -164.76 142.19 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.936 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.453 HG22 HD11 ' A' ' 109' ' ' LEU . 15.5 m -133.51 163.41 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.998 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -91.56 130.14 37.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.7 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.606 HG21 HG11 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -131.54 128.98 61.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.195 -179.402 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -91.26 68.7 5.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 98' ' ' GLY . 0.7 OUTLIER -162.18 -65.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.137 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.722 ' HA ' HG21 ' A' ' 101' ' ' VAL . 50.4 p 52.78 22.66 2.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.991 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 96' ' ' SER . 10.1 mtp180 -149.36 -56.19 0.19 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.912 0.386 . . . . 0.0 111.601 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.6 ' H ' ' HG2' ' A' ' 95' ' ' GLU . . . -61.6 135.96 47.17 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.692 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.1 tpt 53.32 23.28 3.17 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.527 0.331 . . . . 0.0 111.789 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 151' ' ' ALA . 11.3 mp0 61.03 5.15 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.408 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' A' ' 96' ' ' SER . 2.3 t 53.43 30.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.856 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.6 p -118.18 -47.43 2.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.219 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -3.38 13.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.586 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -118.22 -57.57 2.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.65 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -54.58 -53.21 57.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.214 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.646 HD11 ' HG ' ' A' ' 178' ' ' LEU . 4.1 tp -50.34 -34.49 24.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -67.15 -38.52 85.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.803 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 36.7 t -63.57 -46.8 93.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.318 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.704 HD23 ' HG3' ' A' ' 114' ' ' ARG . 3.5 mp -72.46 -18.79 61.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.109 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -94.84 -11.13 29.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.541 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -71.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.581 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.8 t -175.89 88.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.381 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -165.17 -62.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.704 ' HG3' HD23 ' A' ' 109' ' ' LEU . 3.8 mmp_? -101.24 110.35 22.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.381 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -62.44 134.06 94.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.119 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.494 ' HB2' ' HE2' ' A' ' 86' ' ' LYS . 73.3 Cg_endo -78.28 161.1 29.13 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.654 2.236 . . . . 0.0 112.603 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -130.36 153.75 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.79 179.265 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.48 97.57 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -141.46 166.9 26.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.5 113.92 25.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.331 . . . . 0.0 110.878 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.982 HD13 HG22 ' A' ' 130' ' ' VAL . 25.4 tp -83.8 138.48 33.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.758 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.528 ' H ' HD12 ' A' ' 121' ' ' LEU . 11.2 m170 -123.17 84.18 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.733 ' H ' ' HB2' ' A' ' 82' ' ' SER . 48.4 t -58.75 102.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.852 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.565 ' O ' HD11 ' A' ' 144' ' ' ILE . 3.7 p -105.18 144.33 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.548 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.7 19.8 1.93 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.888 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.0 22.64 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.665 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.18 118.5 2.59 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.395 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.416 ' CD2' HG22 ' A' ' 123' ' ' VAL . 2.7 mt -54.1 144.7 18.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 111.171 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 16.4 ttm180 -147.58 112.21 5.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.982 HG22 HD13 ' A' ' 121' ' ' LEU . 1.9 t -100.39 133.32 43.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.093 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.5 t -121.97 109.05 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.458 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -53.03 157.49 1.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.218 -179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -3.64 53.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -116.19 -54.69 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.386 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.6 m -80.74 -31.84 35.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.459 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 4.2 mmtm 52.39 29.95 7.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.9 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.19 -108.7 1.51 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.45 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tp -160.59 113.76 2.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.678 0.275 . . . . 0.0 110.727 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.55 -49.07 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.36 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.754 ' HB ' HG23 ' A' ' 130' ' ' VAL . 93.4 t -122.45 102.52 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.42 25.95 11.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.408 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.443 ' HG2' HG13 ' A' ' 140' ' ' VAL . 56.1 mm-40 -76.23 -156.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.166 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.866 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 59.9 m -135.46 161.75 34.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.966 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.565 HD11 ' O ' ' A' ' 124' ' ' SER . 2.5 mt -77.24 -33.42 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.718 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.671 ' H ' HG22 ' A' ' 143' ' ' THR . 5.6 mt-10 -86.09 -24.3 26.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.389 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.866 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -60.03 -41.04 91.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.772 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.6 m -73.16 144.92 12.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.8 t -49.56 -55.28 14.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.763 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' B' ' 3' ' ' SER . 30.8 p90 -168.97 126.93 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.72 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 116.67 13.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . . . -131.11 104.07 15.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.036 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.519 ' HB3' ' HD1' ' A' ' 160' ' ' PHE . 32.7 Cg_exo -62.3 -88.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.674 2.249 . . . . 0.0 112.248 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -166.48 177.95 6.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.66 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -145.6 33.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.072 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.42 ' HB3' ' H ' ' A' ' 156' ' ' HIS . 11.9 t-20 -124.0 -87.24 0.63 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.42 ' H ' ' HB3' ' A' ' 155' ' ' ASN . 1.9 t60 178.36 3.94 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 156' ' ' HIS . 2.8 mm-40 -68.52 -8.31 40.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.334 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.439 ' HB2' ' NH1' ' A' ' 158' ' ' ARG . 0.9 OUTLIER 56.47 23.23 7.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.982 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -106.31 147.46 16.24 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.351 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.519 ' HD1' ' HB3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -124.48 169.16 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 0.0 110.845 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.513 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 3.3 m -168.58 151.0 5.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.082 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.663 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -134.95 148.04 49.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.531 178.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.894 HG23 ' HB3' ' A' ' 174' ' ' CYS . 0.2 OUTLIER -103.89 151.38 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.209 -179.056 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.91 106.95 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.85 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 15.7 ptm180 -68.29 -156.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.196 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.08 -162.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.462 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.93 -10.16 53.7 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.405 ' H ' ' H ' ' A' ' 169' ' ' THR . 0.6 OUTLIER -155.45 -19.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.949 0.404 . . . . 0.0 110.302 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 173' ' ' MET . 2.9 m -130.25 -2.41 4.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.721 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.5 9.64 3.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -172.44 -176.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.658 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -78.52 122.08 25.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 110.942 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.539 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -147.74 110.06 4.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.738 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.894 ' HB3' HG23 ' A' ' 163' ' ' ILE . 28.2 p -98.11 159.89 14.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.231 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.663 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 4.6 m-70 -122.96 142.2 51.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.228 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.513 ' HA2' ' OG ' ' A' ' 161' ' ' SER . . . -111.8 150.12 18.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.856 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -170.29 133.35 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.872 0.368 . . . . 0.0 110.756 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 106' ' ' LEU . 4.7 mp -110.16 171.07 7.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.244 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.44 128.47 41.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.5 OUTLIER -78.37 -0.34 28.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.576 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.98 -21.08 18.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 158' ' ' ARG . 11.6 m-20 55.51 83.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.97 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.2 t -168.99 -42.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.19 42.63 42.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.441 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.02 -34.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.743 0.306 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.455 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.3 OUTLIER -75.84 -16.65 60.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.504 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 191' ' ' VAL . 4.5 mp -126.93 -44.17 1.65 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.019 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 t -59.98 -69.19 0.23 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -21.0 58.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.02 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.9 -52.61 19.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 187' ' ' LEU . 96.5 t -61.16 -31.46 50.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.27 -17.43 46.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.283 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 96.1 m -104.12 -11.37 17.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.719 0.295 . . . . 0.0 110.845 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.99 -33.63 67.32 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.536 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 0.0 OUTLIER -77.51 -34.99 53.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.279 178.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.404 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -55.87 -26.03 45.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.874 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.49 -19.46 5.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.686 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -72.56 -12.08 60.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.604 178.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 196' ' ' ALA . 1.5 mt -81.2 10.64 5.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.879 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -56.36 -20.94 21.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.377 -0.289 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.42 ' HB2' ' H ' ' B' ' 3' ' ' SER . 1.2 p90 -88.12 -148.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.495 0.188 . . . . 0.0 110.547 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 1.4 p -163.91 162.99 23.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.855 0.359 . . . . 0.0 111.192 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' B' ' 7' ' ' PHE . 41.5 p-10 -76.44 175.4 9.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.063 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 36.6 mtp -128.33 -24.14 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.2 t -90.0 23.64 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.466 ' HB3' ' ND2' ' B' ' 4' ' ' ASN . 43.5 p90 -65.08 149.87 49.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -83.82 0.48 47.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 t0 57.41 94.67 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.026 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.585 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 11.1 m-85 -90.4 -51.32 0.33 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.504 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 35.8 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.113 1.875 . . . . 0.0 112.272 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -108.55 -35.51 6.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.295 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -63.57 -23.07 67.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.048 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -70.82 -25.09 62.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.934 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.63 -23.83 16.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.959 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.47 -26.08 32.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.81 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -29.52 70.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.703 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.65 -17.35 17.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.791 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -52.63 -51.57 59.46 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.295 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 194' ' ' ALA . 10.4 t -58.29 -43.97 87.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.727 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -55.17 -39.06 69.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.655 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -72.44 -91.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.638 179.618 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.462 ' H ' ' HB2' ' A' ' 78' ' ' SER . . . 179.84 36.4 0.0 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.24 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.575 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -173.77 101.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 111.556 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 8.5 t -134.54 55.46 1.89 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.844 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.499 ' CB ' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -152.59 -163.05 1.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.822 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.48 ' CG ' ' HE3' ' A' ' 181' ' ' LYS . 10.5 m-85 -156.96 -171.33 3.61 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.819 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -49.56 145.96 4.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.919 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.0 m -143.89 173.53 5.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.971 0.415 . . . . 0.0 111.83 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -122.38 61.19 0.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.327 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.538 ' HA ' ' HB3' ' A' ' 177' ' ' PHE . 1.0 OUTLIER -54.06 96.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.94 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -62.86 -31.36 72.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.78 -131.76 5.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.519 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -158.9 130.27 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.404 HG22 HD11 ' A' ' 109' ' ' LEU . 2.3 m -120.64 136.21 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.977 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 112.56 5.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.069 0.461 . . . . 0.0 110.659 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.403 HG21 HG11 ' A' ' 101' ' ' VAL . 17.0 m -103.58 173.64 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -122.2 64.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -149.53 -90.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 p 63.3 9.62 4.15 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.454 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.433 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -166.52 47.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.988 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -125.21 -129.68 3.39 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.27 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.42 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 9.4 ttt -75.38 -73.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.578 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.584 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . 3.9 mt-30 -146.57 -24.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.824 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.403 HG11 HG21 ' A' ' 93' ' ' VAL . 39.0 t 73.18 -30.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.291 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 100' ' ' GLN . 3.7 p -63.17 -27.61 69.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.714 ' HG3' ' HB3' ' A' ' 154' ' ' ARG . 2.0 tt0 -59.53 -18.26 38.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.79 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.8 mt-10 -120.02 -44.63 2.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.727 0.299 . . . . 0.0 111.457 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.554 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -55.13 -46.31 75.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.597 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 tp -54.23 -33.73 59.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.181 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.598 ' HE3' ' HE ' ' A' ' 110' ' ' ARG . 11.5 tptm -74.93 -45.54 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.229 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 104' ' ' GLU . 16.1 t -56.54 -30.1 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.396 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.613 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.5 mt -87.66 -23.54 24.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.008 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.598 ' HE ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -82.46 -9.95 59.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.473 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 42.1 mt-30 -75.21 -62.85 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.723 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 2.0 t -177.33 -168.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.544 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 112' ' ' SER . 1.3 mpt_? 70.61 -69.19 0.18 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.297 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.613 ' HG3' HD23 ' A' ' 109' ' ' LEU . 8.3 mmt180 -84.28 91.8 7.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.456 ' H ' ' HG2' ' A' ' 115' ' ' ARG . 6.5 ptp180 -69.08 141.7 92.15 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.707 ' HB3' HD23 ' A' ' 88' ' ' LEU . 72.3 Cg_endo -77.73 133.16 12.51 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.589 2.193 . . . . 0.0 112.69 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.0 143.59 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.969 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -101.72 108.19 19.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -150.68 178.98 27.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.44 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.435 HD12 ' NE2' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -99.67 118.01 35.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.74 0.305 . . . . 0.0 111.033 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.74 HD13 HG22 ' A' ' 130' ' ' VAL . 24.4 tp -92.89 138.46 31.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.642 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.526 ' H ' HD12 ' A' ' 121' ' ' LEU . 11.3 m170 -123.62 103.67 8.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.02 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.499 HG23 ' CB ' ' A' ' 82' ' ' SER . 42.8 t -71.66 102.45 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.4 . . . . 0.0 110.513 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.584 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -106.16 117.95 35.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.359 179.638 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.72 -16.17 3.69 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.713 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -111.59 34.63 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.687 0.279 . . . . 0.0 110.975 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.764 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 114.75 111.31 2.87 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.412 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.17 162.55 5.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.961 0.41 . . . . 0.0 111.299 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.56 119.85 5.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.513 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.74 HG22 HD13 ' A' ' 121' ' ' LEU . 1.9 t -107.15 127.94 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.605 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.52 156.29 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.506 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.99 148.26 23.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.766 0.317 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.438 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.7 OUTLIER -99.09 19.79 14.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -138.94 -9.32 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.965 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 137' ' ' GLY . 13.6 t -154.16 -10.39 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.876 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 13.8 mmtm 60.16 27.26 16.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.552 ' H ' HG23 ' A' ' 135' ' ' THR . . . -73.62 -159.68 5.92 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.408 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' ' 141' ' ' ASP . 11.5 tp -121.97 118.73 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.689 0.28 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.52 HD12 HG12 ' A' ' 130' ' ' VAL . 8.7 mt -96.84 -55.26 6.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.012 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.495 HG11 ' OH ' ' A' ' 162' ' ' TYR . 95.6 t -139.2 118.07 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.497 ' HB2' HD21 ' A' ' 138' ' ' LEU . 4.4 t0 -122.06 74.06 1.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -119.47 -165.01 1.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.187 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.764 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 1.6 m -115.52 177.31 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.908 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.656 HD13 ' HB1' ' A' ' 194' ' ' ALA . 8.1 mt -96.18 -42.3 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.835 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -81.3 -10.21 59.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.664 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.708 ' HE2' HG21 ' A' ' 168' ' ' THR . 1.7 ttpm? -77.03 -43.35 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.811 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.451 HG11 ' CD2' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -70.29 154.2 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.948 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.62 -68.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.921 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' B' ' 3' ' ' SER . 0.0 OUTLIER -155.19 129.15 8.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.999 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -85.58 104.76 15.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.826 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.512 ' HB1' ' HG2' ' A' ' 100' ' ' GLN . . . -118.2 133.18 23.48 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.261 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.839 ' HD2' ' HA3' ' B' ' 1' ' ' GLY . 56.3 Cg_endo -70.69 -87.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.407 2.072 . . . . 0.0 112.156 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -145.69 -166.23 2.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.78 0.324 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.714 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -70.69 -13.91 62.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -166.4 -63.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.68 55.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.966 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -86.3 30.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.968 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? 56.17 19.39 3.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.963 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.55 134.64 8.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.578 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -131.3 142.82 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.644 0.259 . . . . 0.0 110.772 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 1.2 m -153.51 131.2 11.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.069 0.462 . . . . 0.0 111.402 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.495 ' OH ' HG11 ' A' ' 140' ' ' VAL . 38.1 p90 -109.13 164.99 11.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.519 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.505 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -126.84 163.2 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.448 -179.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.75 110.87 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.678 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.739 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 2.5 ptp180 -72.37 -163.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.132 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -175.05 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.71 -2.04 88.4 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.488 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.708 HG21 ' HE2' ' A' ' 146' ' ' LYS . 8.8 t -167.75 -12.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.392 . . . . 0.0 110.471 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.7 OUTLIER -136.14 1.12 2.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.928 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 64.79 1.52 1.43 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.465 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 171' ' ' ARG . 5.1 ptp180 -175.47 -179.68 1.31 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.032 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.739 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -86.0 94.18 9.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.064 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.67 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.9 OUTLIER -107.23 129.93 54.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.765 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.505 ' HB2' HG23 ' A' ' 163' ' ' ILE . 17.9 t -114.14 110.95 20.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.102 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . 3.1 m80 -85.26 126.44 33.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -112.95 154.19 17.08 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.526 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.538 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . 30.6 p90 -166.21 175.93 7.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.827 0.346 . . . . 0.0 111.064 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.1 mp -137.89 175.16 9.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.932 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.489 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -105.06 119.53 39.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.5 OUTLIER -71.11 -13.67 62.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.728 ' HB2' ' HD2' ' A' ' 186' ' ' ARG . 1.5 mmmp? -83.05 -30.95 27.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.954 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 57.09 92.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.331 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.535 ' HB3' ' HD3' ' A' ' 186' ' ' ARG . 1.5 t -169.22 -38.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.517 ' H ' ' CZ ' ' A' ' 186' ' ' ARG . . . 76.65 47.53 9.95 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.635 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -155.96 -36.33 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.828 0.347 . . . . 0.0 110.908 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.728 ' HD2' ' HB2' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -66.09 -29.99 70.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 186' ' ' ARG . 4.7 mp -118.69 -42.19 2.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.371 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 t -57.66 -75.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.443 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -58.85 -24.78 62.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.2 -56.75 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.076 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.63 -34.06 53.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -60.45 -15.35 38.76 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.619 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 73.4 m -102.34 -12.77 17.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.64 0.257 . . . . 0.0 111.093 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.656 ' HB1' HD13 ' A' ' 144' ' ' ILE . . . -58.14 -29.18 65.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.414 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.46 ' CG ' ' HA ' ' B' ' 4' ' ' ASN . 0.1 OUTLIER -81.49 -27.23 34.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.788 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.672 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -62.03 -12.88 21.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.03 -31.64 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -1.89 19.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.819 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' A' ' 196' ' ' ALA . 3.4 mt -75.44 -8.67 57.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.964 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.06 -25.39 66.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.038 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.751 179.791 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.839 ' HA3' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.463 ' CE1' ' HD3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -108.21 -49.15 3.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.696 0.284 . . . . 0.0 110.517 179.06 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.699 ' HB2' ' HB3' ' A' ' 149' ' ' PHE . 4.8 p 62.51 154.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.477 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.46 ' HA ' ' CG ' ' A' ' 195' ' ' PHE . 0.6 OUTLIER -70.47 153.69 42.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.13 -21.11 12.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.805 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t -95.41 20.78 8.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.438 ' HB3' ' OD1' ' B' ' 4' ' ' ASN . 26.3 p90 -61.5 149.07 39.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.976 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -103.49 -4.56 23.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.911 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 54.64 83.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.933 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 14.7 m-85 -56.58 145.34 60.8 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 40.0 Cg_exo . . . . . 0 C--O 1.25 1.088 0 C-N-CA 122.55 2.167 . . . . 0.0 112.387 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.943 0.401 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.86 -38.37 19.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.001 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -26.42 61.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.035 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -74.06 -2.84 26.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . -126.78 -11.41 6.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.08 -43.73 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -80.3 -46.4 16.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.887 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 77' ' ' ARG . 12.9 tt0 -65.5 -23.1 66.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.006 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -55.8 -52.8 62.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.132 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 194' ' ' ALA . 3.1 t -62.79 -43.01 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.624 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.477 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 37.2 mtp180 -54.22 -34.93 61.79 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.329 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 11.6 m -78.05 -90.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.369 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.431 ' H ' ' HB2' ' A' ' 78' ' ' SER . . . 177.05 36.22 0.0 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.232 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.527 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -170.41 101.2 0.26 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.889 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 2.9 t -127.94 -147.35 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.285 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.771 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.47 -163.06 0.1 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 111.607 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.554 ' HB3' ' HD3' ' A' ' 181' ' ' LYS . 2.1 m-85 -158.28 -169.09 2.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.333 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 3.5 m -42.58 144.26 0.56 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.762 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.637 HG12 HD21 ' A' ' 187' ' ' LEU . 34.9 m -139.5 -170.55 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.591 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.69 74.81 1.19 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.701 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.584 ' HB3' HG23 ' A' ' 117' ' ' VAL . 42.8 t80 -58.56 97.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.09 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -64.18 -33.63 76.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.81 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.54 -152.05 24.15 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.5 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.41 129.98 32.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.312 . . . . 0.0 110.797 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.68 152.86 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -84.81 144.66 28.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.44 -172.23 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.997 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -150.0 59.81 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.064 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.508 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -170.06 -77.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.98 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.6 m 61.01 24.83 14.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.988 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 3.5 ptt-85 -135.78 37.61 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.774 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -160.15 161.24 32.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.486 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.458 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -83.92 -37.25 22.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 111.065 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -70.4 -9.77 57.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.168 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.84 -36.88 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.85 0.357 . . . . 0.0 110.925 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.562 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 3.5 m -79.17 -24.62 43.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.478 ' HA ' ' OD2' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -71.62 -7.74 49.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.972 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.4 mm-40 -111.77 -49.89 2.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.963 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.2 -41.83 80.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.635 ' HA ' HD12 ' A' ' 109' ' ' LEU . 3.1 tp -58.24 -36.96 73.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.604 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -67.39 -38.07 84.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.607 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.6 t -60.7 -33.33 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.557 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 106' ' ' LEU . 2.5 mt -77.39 -26.94 52.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.661 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.97 -21.02 44.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.614 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -98.48 1.23 46.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.974 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.95 172.05 13.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.954 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.453 ' H ' ' HG2' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -110.74 74.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.717 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.546 ' HG3' HD23 ' A' ' 109' ' ' LEU . 4.2 mmp_? -86.87 36.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.177 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 115' ' ' ARG . 0.1 OUTLIER 56.16 87.13 0.15 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.65 178.578 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 3.5 Cg_exo -76.2 116.39 4.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.969 2.446 . . . . 0.0 111.886 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -85.43 145.42 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.966 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -104.26 102.6 12.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.327 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.741 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -158.78 -137.64 2.3 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.176 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.474 ' HA ' HG22 ' A' ' 85' ' ' VAL . 3.0 pp -155.2 169.56 23.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 111.101 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.706 HD13 HG22 ' A' ' 130' ' ' VAL . 54.4 tp -112.07 140.25 46.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.136 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 4.7 m-70 -121.5 85.65 2.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.112 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.889 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 69.0 t -60.4 93.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.159 0.504 . . . . 0.0 111.228 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.583 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -87.05 142.04 28.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.857 177.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.87 23.47 1.7 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.415 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 124' ' ' SER . 21.6 t0 -155.55 27.61 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.529 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.25 112.24 1.73 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.282 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.46 159.35 8.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.83 0.348 . . . . 0.0 111.026 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -154.5 116.74 4.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.706 HG22 HD13 ' A' ' 121' ' ' LEU . 13.6 t -101.24 106.09 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.086 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.22 129.35 53.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.977 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.741 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -64.4 175.78 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.01 -4.66 13.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -117.04 -45.13 2.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.381 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.6 m -92.22 -24.04 19.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.451 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 54.09 32.89 16.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.627 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -102.87 -178.56 26.72 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.466 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 tp -87.11 135.9 33.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.808 0.337 . . . . 0.0 110.792 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 130' ' ' VAL . 40.8 mt -116.88 -51.77 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.034 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.598 HG13 ' HG2' ' A' ' 142' ' ' GLN . 92.7 t -117.75 103.72 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.863 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -96.36 32.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.598 ' HG2' HG13 ' A' ' 140' ' ' VAL . 20.2 mm100 -77.5 -173.06 2.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 82.8 m -150.09 148.91 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.776 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.583 HD11 ' O ' ' A' ' 124' ' ' SER . 1.0 OUTLIER -63.22 -39.87 86.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.628 179.473 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.564 ' H ' HG22 ' A' ' 143' ' ' THR . 1.7 mt-10 -84.46 13.92 5.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.681 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.643 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 10.0 tttp -115.43 -48.49 2.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.978 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 164' ' ' CYS . 5.8 m -69.58 146.48 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.101 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.6 t -53.54 -63.09 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.414 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 0.3 OUTLIER -170.73 146.23 2.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.776 178.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.37 165.59 22.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.96 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.562 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -167.16 100.82 0.63 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.222 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.854 ' HD2' ' HA3' ' B' ' 1' ' ' GLY . 5.8 Cg_exo -76.25 30.94 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.037 2.491 . . . . 0.0 112.433 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 103' ' ' GLU . 1.0 OUTLIER 60.4 -93.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.104 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -131.79 -4.45 3.63 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.016 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.23 44.08 22.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -139.27 -24.43 0.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.803 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -105.84 11.29 32.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.986 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 57.67 27.29 14.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.162 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.38 130.31 9.35 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.488 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.583 ' HZ ' ' HA2' ' A' ' 184' ' ' GLY . 3.3 m-85 -128.93 152.56 48.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.338 . . . . 0.0 111.012 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.55 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -161.74 148.51 14.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.09 162.47 24.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.843 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.74 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -120.47 151.43 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.076 0.465 . . . . 0.0 111.418 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.504 ' HB2' HG12 ' A' ' 147' ' ' VAL . 10.0 t -150.95 148.03 27.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.332 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HB2' ' H ' ' A' ' 166' ' ' ASP . 0.1 OUTLIER -100.09 -158.66 0.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 -179.496 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.442 ' H ' ' HB2' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -57.24 -176.85 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.207 0.527 . . . . 0.0 111.658 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 168' ' ' THR . . . 108.72 -12.07 35.34 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 167' ' ' GLY . 0.5 OUTLIER -163.62 -22.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.134 -0.533 . . . . 0.0 109.984 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.406 HG22 ' HG3' ' A' ' 171' ' ' ARG . 33.3 m -113.2 -12.77 13.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.832 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 65.12 17.2 10.95 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.284 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 171' ' ' ARG . 0.9 OUTLIER -173.0 -170.03 0.61 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.051 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.68 112.86 24.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.3 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.59 173.53 8.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.461 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.74 ' HB2' HG23 ' A' ' 163' ' ' ILE . 19.5 t -155.01 129.59 9.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.752 0.31 . . . . 0.0 111.292 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.43 155.17 17.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.504 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -137.48 155.46 23.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.786 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.488 ' HE2' HD23 ' A' ' 187' ' ' LEU . 11.9 p90 -166.62 176.07 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.361 . . . . 0.0 110.811 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.2 mp -146.23 152.05 38.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.795 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.33 113.28 7.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 4.0 t -57.37 -41.52 80.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.554 ' HD3' ' HB3' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -73.36 -21.29 60.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.557 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 62.27 103.68 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.997 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.8 t -163.77 -43.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.583 ' HA2' ' HZ ' ' A' ' 160' ' ' PHE . . . 76.39 17.34 80.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.317 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.73 -25.67 2.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 0.0 111.018 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -80.8 -17.7 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.991 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.637 HD21 HG12 ' A' ' 85' ' ' VAL . 9.5 mp -119.59 -46.6 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.229 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 t -61.86 -56.77 15.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.517 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.92 -5.46 21.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.621 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -96.78 -48.42 5.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.698 0.285 . . . . 0.0 111.544 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.491 ' HA ' HG11 ' A' ' 123' ' ' VAL . 1.7 p -70.7 -22.11 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.211 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.88 67.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.395 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 77.4 m -119.72 4.39 11.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.773 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.651 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -78.11 -51.77 9.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.169 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.549 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 51.0 p90 -63.72 -26.2 68.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.705 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -62.45 -23.14 66.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.11 11.85 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.6 -13.05 10.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.979 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.705 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.4 OUTLIER -119.55 -0.45 10.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.141 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -103.5 -47.54 4.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.239 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.058 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.854 ' HA3' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.7 -156.36 0.7 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.67 0.271 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -167.63 150.13 5.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.843 179.677 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' B' ' 7' ' ' PHE . 0.1 OUTLIER -60.19 146.78 42.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.739 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 12.0 mtm -116.45 -15.63 10.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.127 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 9.1 p -84.74 20.79 1.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.205 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.472 ' HB3' ' OD1' ' B' ' 4' ' ' ASN . 44.0 p90 -64.05 149.8 46.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -90.62 11.94 20.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 39.0 t0 56.0 85.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.804 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.581 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 2.7 m-85 -92.85 -52.24 0.27 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.392 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 26.5 Cg_exo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.117 1.878 . . . . 0.0 112.212 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.816 0.341 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.87 -34.06 17.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.67 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -31.31 72.46 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.732 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -67.38 -17.36 64.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.59 -15.75 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.841 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.56 -18.07 18.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.768 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -62.63 -38.91 92.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.568 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.749 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -92.27 -7.5 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.429 179.259 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 81' ' ' CYS . . . -65.85 -49.12 69.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.84 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 ' CB ' ' A' ' 81' ' ' CYS . 1.2 t -61.06 -36.31 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.047 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.749 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -66.53 -34.36 77.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.276 178.627 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.32 6.26 14.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.756 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 66.32 42.43 3.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.589 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.415 ' HB ' ' ND1' ' A' ' 122' ' ' HIS . 1.5 t -177.19 86.95 0.02 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.241 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.536 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 11.5 t -116.69 4.84 13.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.473 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.698 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.4 OUTLIER -103.78 -167.93 1.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.721 0.295 . . . . 0.0 111.251 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -152.74 -171.07 3.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -39.0 141.99 0.25 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.823 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -149.41 -165.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.323 -179.409 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.19 70.61 0.93 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -61.58 119.88 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.82 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.457 ' HB2' HD22 ' A' ' 109' ' ' LEU . 1.2 mp -79.03 -75.39 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.259 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.85 -117.57 0.45 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.349 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.608 ' N ' HD21 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -159.14 128.45 5.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.713 0.292 . . . . 0.0 110.768 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.506 HG13 ' HG ' ' A' ' 109' ' ' LEU . 3.7 m -123.12 158.03 28.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.331 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.1 152.64 30.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.583 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.9 m -141.55 150.09 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.303 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.454 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 1.7 t80 -118.48 59.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.389 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 94' ' ' PHE . 4.7 mt-10 -154.07 -68.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.692 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.62 14.99 1.92 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.211 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -141.13 116.54 10.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.008 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.8 -170.98 15.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.561 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.408 ' O ' ' HG2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -116.06 -26.28 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 110.738 -179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -69.28 -11.71 61.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.321 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.416 ' HB ' HD11 ' A' ' 163' ' ' ILE . 14.1 t -59.6 -27.5 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 110.988 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 73.2 m -79.32 -39.32 33.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.151 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.36 -14.69 63.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.285 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.8 mt-10 -103.98 -47.77 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.039 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.95 74.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.16 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 tp -57.37 -44.4 84.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.72 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.571 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -69.08 -34.34 74.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.606 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.2 t -61.68 -31.0 49.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.333 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.608 HD21 ' N ' ' A' ' 90' ' ' CYS . 1.2 mt -80.29 -30.32 38.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.852 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.571 ' HG2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -80.41 -21.2 42.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.501 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -19.2 20.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.901 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.6 m -100.32 10.97 40.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.057 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER 32.01 78.79 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.301 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -95.07 22.2 6.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.909 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 56.59 104.94 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.861 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.59 149.16 30.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.514 2.143 . . . . 0.0 111.951 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.439 HG12 ' OD1' ' A' ' 132' ' ' ASP . 0.7 OUTLIER -103.88 136.34 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.085 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.13 82.61 8.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.063 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -151.76 -179.6 27.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.132 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.17 158.22 24.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 0.0 111.236 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.669 HD13 HG22 ' A' ' 130' ' ' VAL . 67.7 tp -96.09 146.7 24.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.222 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.415 ' ND1' ' HB ' ' A' ' 80' ' ' THR . 1.7 m170 -123.68 76.85 1.46 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.821 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.698 ' H ' ' HB2' ' A' ' 82' ' ' SER . 40.7 t -53.0 104.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.956 0.408 . . . . 0.0 110.582 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.658 ' O ' HD11 ' A' ' 144' ' ' ILE . 2.0 t -110.48 126.39 54.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.469 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -55.6 -14.29 6.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.607 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -108.29 31.09 5.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 0.0 110.831 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 114.87 125.5 4.03 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.6 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -62.5 163.82 8.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.86 0.362 . . . . 0.0 110.947 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.415 ' HB3' HH11 ' A' ' 129' ' ' ARG . 0.3 OUTLIER -169.76 133.9 1.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.78 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.669 HG22 HD13 ' A' ' 121' ' ' LEU . 2.8 t -110.12 125.91 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.85 0.357 . . . . 0.0 111.261 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.31 132.23 64.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.619 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.592 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -61.87 -173.89 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 0.0 111.018 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.74 -15.47 5.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.774 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.54 -22.04 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.584 HG23 ' H ' ' A' ' 137' ' ' GLY . 9.4 t -133.19 -18.79 2.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.331 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.32 33.5 23.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.737 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.584 ' H ' HG23 ' A' ' 135' ' ' THR . . . -84.11 145.68 22.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.439 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 24.0 tp -75.1 128.86 36.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.787 0.327 . . . . 0.0 110.924 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.5 mt -111.1 -50.37 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.625 ' HB ' HG23 ' A' ' 130' ' ' VAL . 53.8 t -104.25 114.99 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.971 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -117.27 57.44 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.716 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.58 -176.2 2.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.133 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.554 ' O ' HG22 ' A' ' 147' ' ' VAL . 2.4 m -121.16 168.63 11.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.667 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.658 HD11 ' O ' ' A' ' 124' ' ' SER . 5.8 mt -84.33 -33.09 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 110.873 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -83.67 -13.16 54.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.615 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -87.05 -42.35 13.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.981 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 143' ' ' THR . 0.6 OUTLIER -61.73 126.7 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.923 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.85 -37.72 63.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.878 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.849 ' HB2' HD12 ' A' ' 163' ' ' ILE . 9.6 m-85 -151.97 166.37 31.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.084 0.469 . . . . 0.0 111.626 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' B' ' 3' ' ' SER . 0.5 OUTLIER -147.75 63.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.797 177.602 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.452 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -90.06 136.93 28.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.984 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 72.7 Cg_endo -80.16 -91.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.704 2.269 . . . . 0.0 111.603 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -136.23 -166.75 1.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.677 0.275 . . . . 0.0 110.655 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -116.81 9.22 13.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.029 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -168.14 -65.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.851 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.33 39.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.716 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.89 0.36 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.006 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 158' ' ' ARG . 0.0 OUTLIER 58.16 21.7 8.3 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.755 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.63 123.3 4.46 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -115.39 161.94 17.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.645 0.259 . . . . 0.0 110.54 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -158.92 -177.87 6.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.013 0.435 . . . . 0.0 111.448 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -156.38 158.06 36.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.085 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.849 HD12 ' HB2' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -123.71 165.04 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.069 0.461 . . . . 0.0 112.027 -177.288 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.42 ' H ' HG22 ' A' ' 163' ' ' ILE . 5.7 p -165.57 135.6 3.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.394 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -160.43 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 111.263 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -175.17 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.442 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.25 -7.32 69.16 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.445 ' H ' ' H ' ' A' ' 169' ' ' THR . 2.1 t -168.95 -11.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.216 -0.492 . . . . 0.0 110.002 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.673 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -128.08 -7.88 5.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.739 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 64.15 9.72 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.574 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -176.12 -173.72 0.58 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.968 0.413 . . . . 0.0 111.317 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.93 108.07 19.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.593 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.673 ' HB2' HG21 ' A' ' 169' ' ' THR . 24.9 mtp -128.36 133.51 48.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.759 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.437 ' HB2' HG23 ' A' ' 163' ' ' ILE . 43.5 t -113.58 132.43 55.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' A' ' 161' ' ' SER . 35.1 m170 -98.8 158.72 15.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.624 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -139.81 149.41 20.78 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.005 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 10.3 p90 -157.08 135.98 11.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.78 0.324 . . . . 0.0 110.815 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.68 160.19 14.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.499 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . . . -96.52 118.02 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -6.56 45.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -26.76 20.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.765 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.16 75.87 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.027 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -165.65 -32.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.786 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 63.82 37.09 94.17 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.514 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -133.29 -31.25 1.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 111.011 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.443 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 4.1 mmt180 -88.16 -5.72 58.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.82 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 191' ' ' VAL . 0.2 OUTLIER -128.07 -58.0 1.22 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.29 -179.274 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -62.51 1.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.344 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -57.98 -19.64 32.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.29 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.05 -45.65 33.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.03 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 187' ' ' LEU . 40.0 t -66.4 -29.05 45.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.962 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.53 -17.69 48.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.366 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 68.6 m -110.58 -8.73 14.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.761 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.1 94.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.187 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.518 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 3.5 p90 -70.42 -29.59 66.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.763 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.08 -22.7 51.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.066 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 49.4 t -101.43 -21.95 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.528 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.16 -28.23 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.467 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.3 OUTLIER -103.34 47.77 0.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.516 178.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.0 -34.0 71.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.039 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.709 179.715 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.81 174.58 14.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.724 0.297 . . . . 0.0 110.77 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.406 ' HA ' ' SG ' ' A' ' 150' ' ' CYS . 0.2 OUTLIER -156.76 166.43 33.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.148 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -70.12 128.14 35.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 1.2 mtm -95.97 -19.76 19.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.516 ' HB3' HD23 ' A' ' 199' ' ' LEU . 16.0 p -75.04 7.38 3.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.404 ' HD2' ' H ' ' B' ' 9' ' ' ASP . 38.7 p90 -57.19 146.92 26.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -99.44 11.36 39.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.716 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ASP . . . . . 0.404 ' H ' ' HD2' ' B' ' 7' ' ' PHE . 13.4 t70 54.42 72.74 0.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.953 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.464 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 65.8 m-85 -65.84 139.98 97.07 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 28.1 Cg_exo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.678 2.252 . . . . 0.0 112.31 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.78 0.324 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -115.07 -41.98 3.26 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.13 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -27.54 68.74 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.031 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -70.15 -22.2 63.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.16 -17.98 15.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.54 -29.31 22.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -69.17 -38.41 78.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.688 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.5 tt0 -84.98 -10.61 56.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.641 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -59.87 -54.92 40.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.009 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 194' ' ' ALA . 14.6 t -58.17 -40.32 76.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.542 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 5.8 mtp180 -58.51 -38.29 77.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.456 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 m -75.13 -91.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.414 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 179.65 35.29 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.53 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.634 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -173.16 99.78 0.12 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.895 0.379 . . . . 0.0 111.739 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 4.1 t -120.73 -150.02 0.44 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.23 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.573 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.77 -157.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 111.539 179.202 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.577 ' HB3' ' HE2' ' A' ' 181' ' ' LYS . 6.1 m-85 -159.0 -167.03 1.99 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.416 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.7 m -51.59 153.61 2.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.706 0.289 . . . . 0.0 110.995 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.487 HG21 ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -144.33 -173.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.415 -179.489 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 86' ' ' LYS . 10.1 mmmm -142.3 63.95 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.69 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.487 ' HE1' HG21 ' A' ' 85' ' ' VAL . 31.8 m-85 -57.81 103.12 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.54 HD13 ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -67.69 -33.61 75.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.479 -178.382 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.73 -167.44 28.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.602 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.5 ' HB3' ' NE2' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -114.89 128.44 56.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.074 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.76 144.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.028 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.49 141.96 42.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.06 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.94 154.98 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -120.97 61.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.812 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 22.3 mt-10 -152.42 -76.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.254 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m 62.67 29.76 16.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -151.4 107.3 3.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.659 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.57 146.3 7.56 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.316 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.416 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -78.03 -23.39 48.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.748 0.309 . . . . 0.0 110.953 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -70.31 -20.74 62.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.104 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.8 t -59.73 -39.24 79.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 57.6 m -70.77 -36.89 73.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -9.2 18.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.219 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.493 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.5 mt-10 -99.93 -55.53 2.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.011 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.55 -31.79 66.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.238 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.514 HD21 ' HA3' ' A' ' 159' ' ' GLY . 6.8 tp -59.18 -46.56 88.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -67.01 -32.24 73.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.3 t -58.39 -49.94 80.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.986 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.615 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.3 mt -64.68 -22.31 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.678 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 110' ' ' ARG . 7.0 tpt180 -82.45 -28.14 31.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.709 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -97.67 -2.2 41.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.919 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.434 ' HB3' ' HG2' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -107.1 -177.65 3.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.049 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.79 16.29 5.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.093 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.615 ' HG3' HD23 ' A' ' 109' ' ' LEU . 12.2 mmt180 -67.46 99.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.929 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -73.47 135.71 78.61 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 74.2 Cg_endo -77.12 161.74 32.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.585 2.19 . . . . 0.0 112.552 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -124.25 108.73 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.738 179.339 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 96.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.998 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -139.0 161.9 25.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.533 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.509 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -89.28 129.86 35.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 111.025 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.761 HD13 HG22 ' A' ' 130' ' ' VAL . 28.0 tp -101.48 123.42 45.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.634 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 12.1 m-70 -112.81 89.3 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.911 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 82' ' ' SER . 69.1 t -68.82 89.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.399 . . . . 0.0 110.937 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.692 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 1.2 p -84.32 150.74 25.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.234 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.32 34.4 2.44 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.385 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.99 19.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.809 0.338 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.685 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 134.04 112.59 1.31 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.546 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.432 ' CD2' HG13 ' A' ' 123' ' ' VAL . 1.5 mt -65.42 154.05 39.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 111.184 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.492 ' HD3' HG22 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -151.52 124.79 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.8 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.761 HG22 HD13 ' A' ' 121' ' ' LEU . 2.8 t -112.45 113.75 45.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.441 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.492 HG22 ' HD3' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -107.6 117.25 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.581 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 2.6 t0 -51.96 158.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -108.89 0.95 20.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.061 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.69 -20.46 8.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.191 0.52 . . . . 0.0 110.01 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.1 m -123.4 -24.84 4.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.067 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 54.81 27.34 8.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.793 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.22 -109.6 1.19 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.364 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.649 HD21 ' HB2' ' A' ' 141' ' ' ASP . 27.3 tp -160.02 131.2 5.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.778 0.323 . . . . 0.0 111.1 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.8 mt -113.47 -48.92 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.041 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.5 t -136.93 112.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.649 ' HB2' HD21 ' A' ' 138' ' ' LEU . 3.2 t0 -118.14 65.57 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.798 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -112.61 -171.8 1.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.947 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 38.1 m -125.21 158.72 33.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.433 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -66.31 -48.08 82.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.916 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -75.09 -21.95 58.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.612 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.947 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 2.8 ttmm -63.07 -52.34 63.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.694 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 147' ' ' VAL . 2.3 m -67.95 143.09 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -44.92 -67.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.107 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -165.08 124.93 1.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.961 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.0 t -63.85 159.37 19.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.765 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.519 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -157.25 136.06 7.88 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.421 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 153' ' ' ASP . 89.5 Cg_endo -80.2 -142.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.643 2.228 . . . . 0.0 111.993 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 0.8 OUTLIER -111.81 -153.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.77 179.685 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -36.17 65.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.048 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -157.32 -58.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.251 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.437 ' C ' ' H ' ' A' ' 158' ' ' ARG . 0.0 OUTLIER -166.38 37.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.14 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -72.87 10.68 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.706 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.625 ' HG2' ' HA ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER 57.81 25.77 12.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.965 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.514 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -119.45 112.06 2.19 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.652 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 1.5 m-85 -119.55 151.57 38.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.715 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -159.81 170.26 21.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.858 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.581 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -147.51 164.46 33.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.158 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.5 132.6 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.058 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.4 p -111.01 153.64 25.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -119.1 94.01 4.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.008 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.64 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 49.08 29.17 2.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.481 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 168' ' ' THR . . . -65.35 -13.82 58.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.551 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 167' ' ' GLY . 9.0 t 175.75 15.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.736 HG21 ' HG3' ' A' ' 173' ' ' MET . 24.6 m -124.78 -11.52 7.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.887 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 0.0 OUTLIER 60.49 31.15 20.23 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.719 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.428 ' CG ' HG22 ' A' ' 169' ' ' THR . 0.2 OUTLIER -176.35 -168.43 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.589 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.99 126.17 39.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.362 . . . . 0.0 111.196 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.736 ' HG3' HG21 ' A' ' 169' ' ' THR . 1.4 mtp -142.24 161.38 38.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.635 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 33.9 t -140.69 116.07 10.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.077 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.581 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 11.9 m-70 -92.15 134.5 34.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.71 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.715 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -118.0 143.34 17.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.532 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 41.4 p90 -149.96 154.16 37.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 0.0 111.223 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.89 135.49 51.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.643 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -59.74 117.49 5.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -16.12 63.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.741 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.577 ' HE2' ' HB3' ' A' ' 83' ' ' PHE . 3.4 mmtt -88.41 -26.91 21.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.781 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.625 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 4.3 m-20 57.59 87.64 0.06 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.2 t -162.5 -30.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.996 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.94 20.35 76.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.399 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -137.66 2.09 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.689 0.28 . . . . 0.0 111.02 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.472 ' HB2' HD12 ' A' ' 187' ' ' LEU . 7.8 mmt85 -106.25 -14.88 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.738 HD23 HD23 ' A' ' 121' ' ' LEU . 4.4 mp -134.55 -39.94 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -59.27 -60.26 4.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -18.21 64.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.31 -41.55 63.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 187' ' ' LEU . 67.7 t -73.62 -29.53 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.68 -7.64 29.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.248 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.571 ' O ' HG23 ' A' ' 197' ' ' VAL . 68.3 m -108.47 -19.77 13.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.697 0.284 . . . . 0.0 110.751 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.458 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -58.91 -60.8 3.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.159 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -64.69 -32.71 74.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.664 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.641 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -57.44 -16.81 10.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.236 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 193' ' ' CYS . 56.4 t -105.34 -29.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.055 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -9.56 58.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.718 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 196' ' ' ALA . 4.3 mt -81.93 77.67 8.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.915 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -74.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.601 -0.2 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.27 -66.73 0.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.641 0.258 . . . . 0.0 110.996 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 93.0 p 51.4 95.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.177 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -52.38 146.26 9.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.396 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 23.2 ttm -113.03 3.86 16.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.914 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.8 p -94.02 19.35 9.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.429 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 28.6 p90 -62.88 152.24 36.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.01 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -85.05 11.55 9.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.739 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ASP . . . . . 0.429 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 22.5 t0 57.46 80.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.035 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.625 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 24.0 m-85 -90.38 -50.8 0.34 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.248 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 45.0 Cg_exo . . . . . 0 C--O 1.25 1.085 0 C-N-CA 122.197 1.932 . . . . 0.0 112.278 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.855 0.36 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -85.21 -18.95 32.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -44.0 97.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.6 mt-10 -97.62 -5.95 34.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -63.92 -55.98 18.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.501 HG23 ' CB ' ' A' ' 81' ' ' CYS . 1.2 t -61.54 -36.27 72.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.707 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.404 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 22.9 mtp180 -62.0 -28.6 69.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.373 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.6 m -85.66 -92.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.819 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -175.94 34.14 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.454 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.543 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.8 t -174.41 97.22 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.036 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.645 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 10.5 t -122.88 6.01 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.591 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.726 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -113.15 -153.38 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.076 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.434 ' CG ' ' HE2' ' A' ' 181' ' ' LYS . 6.8 m-85 -154.56 -169.39 3.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.684 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.63 137.61 15.32 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.763 0.315 . . . . 0.0 111.012 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.53 179.54 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 0.0 111.675 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -133.0 66.56 1.56 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.814 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -58.3 101.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.73 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -69.84 -37.91 76.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.151 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.98 -132.08 4.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.467 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.74 ' HB3' ' HD2' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -148.23 136.94 21.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.099 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -130.77 167.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.833 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 5.6 pt-20 -96.39 143.53 27.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.126 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.55 -171.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -149.46 62.98 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.164 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 1.3 mt-10 -168.95 -68.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.097 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.0 p 52.44 38.92 26.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -146.91 25.96 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.069 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -159.24 161.65 32.21 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -15.88 35.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -80.22 -18.03 50.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.945 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 t -61.49 -27.29 41.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 67.3 m -81.12 -26.1 36.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.932 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -15.96 63.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -99.81 -42.9 6.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.516 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.7 -39.7 81.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.974 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.627 HD11 ' HG ' ' A' ' 178' ' ' LEU . 6.0 tp -56.51 -32.36 64.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.804 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 5.8 tptp -75.87 -38.9 57.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -58.18 -44.43 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.526 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.1 mt -72.67 -15.93 61.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 110' ' ' ARG . 3.8 ttt-85 -84.84 -12.39 53.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.249 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 1.5 mm100 -72.49 -64.81 0.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.658 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -177.73 -169.14 0.2 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.425 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' SER . 0.5 OUTLIER 69.87 -71.95 0.12 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.21 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.526 ' HG3' HD23 ' A' ' 109' ' ' LEU . 8.3 mmm180 -75.67 100.3 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.728 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.466 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -80.31 135.04 54.34 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.126 -179.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.73 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 16.4 Cg_exo -68.2 156.74 64.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.819 2.346 . . . . 0.0 112.104 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.8 t -130.44 140.57 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -92.29 98.04 11.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 132' ' ' ASP . . . -125.77 -162.33 11.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.682 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.31 102.14 6.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.699 0.285 . . . . 0.0 110.598 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.487 HD23 HD23 ' A' ' 187' ' ' LEU . 40.8 tp -69.2 128.52 36.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.708 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.567 ' HB2' ' HG2' ' A' ' 129' ' ' ARG . 34.4 m170 -121.73 87.95 2.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.773 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.726 HG23 ' HB2' ' A' ' 82' ' ' SER . 35.8 t -62.8 94.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.148 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.819 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -98.39 144.86 27.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.287 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -60.61 -7.93 8.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.94 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.94 34.54 5.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.727 0.298 . . . . 0.0 110.997 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.652 ' HA2' HG13 ' A' ' 144' ' ' ILE . . . 109.14 143.51 10.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.774 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.78 164.03 27.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.567 ' HG2' ' HB2' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -158.04 114.78 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.534 179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.483 HG23 ' HB ' ' A' ' 140' ' ' VAL . 17.1 t -99.39 103.21 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.517 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.79 109.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.376 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.411 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -48.68 139.61 9.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.093 -179.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -98.63 12.98 33.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.864 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -138.57 0.73 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.2 m -148.89 -26.46 0.3 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.438 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm 49.64 35.33 8.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.667 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.31 -5.15 54.71 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.63 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.619 HD21 ' HB3' ' A' ' 141' ' ' ASP . 7.3 tp 66.26 149.52 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 110.898 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.418 ' N ' ' HG ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -138.49 -35.91 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.526 -179.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.483 ' HB ' HG23 ' A' ' 130' ' ' VAL . 21.0 t -113.84 95.74 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 111.351 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.619 ' HB3' HD21 ' A' ' 138' ' ' LEU . 3.4 p30 -102.66 25.79 8.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.597 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -76.65 -164.82 0.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.256 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.617 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 9.2 m -141.11 158.39 43.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.921 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.652 HG13 ' HA2' ' A' ' 127' ' ' GLY . 30.4 mt -73.13 -41.69 58.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.844 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.33 -7.14 56.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.568 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.617 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -87.9 -40.58 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.814 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 143' ' ' THR . 0.9 OUTLIER -74.86 152.91 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.803 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -65.29 0.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.722 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 26.5 p90 -174.33 141.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.83 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.4 m -67.25 166.25 14.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.479 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -170.09 124.54 0.66 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.34 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.1 -158.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.676 2.251 . . . . 0.0 112.405 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.726 179.561 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.42 ' HG3' ' HA ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.796 0.331 . . . . 0.0 110.686 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -147.82 124.0 1.82 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.691 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 4.7 m-85 -126.34 165.25 19.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.632 0.253 . . . . 0.0 110.562 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.73 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -163.6 158.83 21.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 -179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.551 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -131.46 148.85 52.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.252 178.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.821 HG23 ' HB2' ' A' ' 174' ' ' CYS . 1.0 OUTLIER -106.58 150.54 9.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.411 . . . . 0.0 111.62 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -146.37 100.02 3.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.45 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.645 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 7.3 ptt180 -72.44 -153.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -178.23 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.093 0.473 . . . . 0.0 111.6 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.0 -3.87 60.63 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.3 t -171.97 -9.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.936 0.398 . . . . 0.0 110.366 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.45 HG21 ' CG ' ' A' ' 173' ' ' MET . 2.0 m -133.86 -6.88 2.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.101 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 59.09 16.91 5.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.168 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.27 179.69 2.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.781 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -85.07 113.53 21.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.45 ' CG ' HG21 ' A' ' 169' ' ' THR . 0.9 OUTLIER -131.49 116.45 17.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.622 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.821 ' HB2' HG23 ' A' ' 163' ' ' ILE . 27.3 t -108.75 129.27 55.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.222 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.74 ' HD2' ' HB3' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -96.95 142.22 29.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 179.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.73 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -124.09 157.13 18.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.331 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 22.7 p90 -161.05 172.5 16.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.676 0.274 . . . . 0.0 110.422 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.627 ' HG ' HD11 ' A' ' 106' ' ' LEU . 1.2 mp -138.53 148.9 44.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 0.0 111.106 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.83 121.6 25.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.069 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.74 8.48 9.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.434 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 17.7 mmmt -102.12 -29.14 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.944 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.42 ' HA ' ' HG3' ' A' ' 158' ' ' ARG . 1.7 m-20 56.98 81.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.966 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.4 t -159.89 -33.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.29 37.46 80.49 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.411 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -151.47 -32.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.313 . . . . 0.0 111.136 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.52 ' HB2' HD12 ' A' ' 187' ' ' LEU . 5.7 mmt180 -74.01 -11.9 60.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.065 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.52 HD12 ' HB2' ' A' ' 186' ' ' ARG . 5.5 mp -135.29 -43.93 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 t -57.22 -75.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.509 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -28.59 57.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.252 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.84 84.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.918 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 187' ' ' LEU . 94.1 t -68.74 -36.36 73.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.69 -11.34 35.56 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.32 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.411 ' O ' HG23 ' A' ' 197' ' ' VAL . 56.5 m -107.78 -16.11 14.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 0.0 110.566 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.08 -51.55 66.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.213 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.542 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.9 p90 -62.0 -38.02 87.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.75 -26.61 64.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 193' ' ' CYS . 47.0 t -97.44 -22.21 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.754 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 15.8 t -65.61 -29.92 70.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.975 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.679 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 5.1 p -168.71 145.14 3.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.779 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.689 HD21 ' HB3' ' B' ' 7' ' ' PHE . 2.5 p-10 -60.16 154.95 18.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.024 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 13.9 mmm -129.06 -15.42 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.264 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 9.5 t -84.82 20.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.689 ' HB3' HD21 ' B' ' 4' ' ' ASN . 40.1 p90 -63.49 159.8 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -91.75 0.76 57.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.783 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 59.26 81.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.132 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -74.36 150.95 87.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.86 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.571 2.181 . . . . 0.0 112.394 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.665 0.269 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -26.62 40.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -47.1 87.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.762 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -83.05 -15.95 48.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.881 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -53.62 -52.45 59.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.28 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.4 t -61.08 -43.62 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.565 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -55.21 -35.21 64.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.337 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 m -77.09 -92.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.531 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 179.54 35.72 0.0 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.393 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.516 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.1 t -173.03 100.81 0.13 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.009 0.433 . . . . 0.0 111.887 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.872 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.0 t -124.29 -149.45 0.42 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.413 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.718 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.4 OUTLIER 53.74 -153.33 0.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.768 0.318 . . . . 0.0 111.805 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -158.99 -168.34 2.34 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.749 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.7 OUTLIER -52.32 143.15 15.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.532 -179.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -136.91 -171.87 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.987 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.827 ' HD2' ' HB2' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -142.23 89.94 2.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 91.5 t80 -58.31 107.68 0.52 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.01 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.6 ' HB3' HD22 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -70.06 -60.66 2.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.61 -134.11 3.14 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.469 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.406 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 0.9 OUTLIER -152.41 131.28 12.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 110.898 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.42 164.74 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.783 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -100.87 136.32 40.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.967 0.413 . . . . 0.0 111.012 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.3 m -140.25 140.37 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.96 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.506 ' HA ' ' HE3' ' A' ' 172' ' ' TRP . 50.0 m-85 -102.14 64.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -147.89 -81.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.075 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.03 46.61 22.43 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.92 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.87 70.75 1.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.775 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.25 179.27 20.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.247 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.49 -7.42 24.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -83.62 9.49 11.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -80.13 -19.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.0 p -83.05 -36.88 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.961 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -66.17 -4.96 8.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.105 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -119.59 -53.65 2.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.082 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.97 -53.34 59.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.212 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -55.54 -36.36 66.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.695 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -38.24 90.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.75 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 104' ' ' GLU . 48.7 t -62.6 -45.24 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.727 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.684 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -61.74 -37.61 84.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.586 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -28.94 64.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.93 2.54 53.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.257 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.613 ' HB3' ' HG2' ' A' ' 114' ' ' ARG . 0.1 OUTLIER -109.7 -163.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.916 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -96.56 15.95 20.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.684 ' HG3' HD23 ' A' ' 109' ' ' LEU . 1.5 mmt180 -67.14 101.74 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.01 126.79 90.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.095 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.827 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 88.1 Cg_endo -78.66 153.97 26.74 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.545 2.163 . . . . 0.0 112.314 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -129.49 121.51 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.206 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -77.96 109.41 11.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -139.33 -152.74 5.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.6 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.512 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -128.92 126.27 39.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.834 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.434 ' N ' HD13 ' A' ' 120' ' ' LEU . 19.8 tp -102.25 116.25 32.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.62 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.702 ' HE1' HG23 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -107.09 93.12 4.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.872 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 45.2 t -60.82 95.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.551 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -94.6 129.7 41.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.198 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.06 5.22 1.37 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.217 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 124' ' ' SER . 7.7 p-10 -134.86 27.81 3.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.886 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 126.21 107.07 1.53 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.376 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.0 mt -61.34 150.7 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.949 0.405 . . . . 0.0 111.296 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 129' ' ' ARG . 5.7 ttm-85 -142.66 151.61 41.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.528 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.425 ' CG2' ' HB ' ' A' ' 140' ' ' VAL . 50.8 t -141.04 110.79 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.804 0.335 . . . . 0.0 111.368 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.702 HG23 ' HE1' ' A' ' 122' ' ' HIS . 17.8 t -104.16 126.4 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.835 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 0.3 OUTLIER -54.07 151.94 6.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.569 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -104.91 8.52 34.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.028 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.74 -4.2 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.226 0.536 . . . . 0.0 110.347 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.2 m -141.83 -21.36 0.72 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.898 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.559 ' HA ' HG12 ' A' ' 131' ' ' VAL . 19.5 mmtp 52.09 36.96 20.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.218 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.01 -112.3 1.67 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.377 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 tp -169.78 119.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.698 0.285 . . . . 0.0 110.647 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.73 -49.77 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.319 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.425 ' HB ' ' CG2' ' A' ' 130' ' ' VAL . 8.2 t -114.22 105.42 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 111.311 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -118.53 34.3 5.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -73.29 -166.63 0.34 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.138 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.676 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 27.1 m -144.42 155.03 43.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.887 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.551 HD11 ' O ' ' A' ' 124' ' ' SER . 17.2 mt -64.08 -53.73 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.955 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.11 -9.19 51.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.853 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.614 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 36.9 tttm -85.81 -51.29 6.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.046 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 143' ' ' THR . 4.4 m -69.28 145.35 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.073 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.82 -63.86 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -166.15 142.9 5.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.699 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.469 ' H ' ' H ' ' B' ' 4' ' ' ASN . 1.2 m -71.78 165.12 24.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.3 101.2 0.48 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.41 -90.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.425 2.083 . . . . 0.0 112.366 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.812 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.44 156.75 15.43 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.346 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.64 157.21 43.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.757 0.313 . . . . 0.0 110.952 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.77 138.03 17.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.125 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -114.76 144.44 43.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.736 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -109.99 157.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.991 0.424 . . . . 0.0 111.589 -178.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 14.5 t -161.24 136.05 7.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.571 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -88.73 -151.22 0.2 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.267 -179.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 170' ' ' ARG . 6.5 p-10 -65.7 -149.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.435 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 168' ' ' THR . . . 83.35 -8.41 64.59 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 167' ' ' GLY . 0.6 OUTLIER -163.03 -42.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.081 0.467 . . . . 0.0 110.171 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.451 HG22 ' HG3' ' A' ' 171' ' ' ARG . 16.6 m -96.32 -11.4 25.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.946 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.46 ' HA ' ' HB2' ' A' ' 166' ' ' ASP . 1.1 mtp180 63.44 20.06 12.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.934 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.451 ' HG3' HG22 ' A' ' 169' ' ' THR . 1.6 ptp85 -174.31 173.47 3.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.678 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.7 OUTLIER -85.9 105.02 16.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 8.9 mtp -121.41 139.55 53.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.653 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.418 ' HB2' HG23 ' A' ' 163' ' ' ILE . 25.2 t -118.27 141.81 48.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.933 0.396 . . . . 0.0 110.984 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.406 ' CE1' ' HB3' ' A' ' 90' ' ' CYS . 11.9 m170 -111.14 151.31 28.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.548 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -128.22 156.2 20.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.64 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -170.78 132.93 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.12 173.62 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.834 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -97.98 133.62 42.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.09 -24.06 61.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.776 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -82.08 -28.0 32.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.913 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.05 84.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.998 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 t -169.24 -38.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.55 26.6 62.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.402 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -132.49 -23.7 2.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 111.203 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.573 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -86.9 -17.99 31.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 186' ' ' ARG . 5.9 mp -124.87 -49.2 1.74 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.249 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.8 -46.55 87.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.241 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.89 1.26 13.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.316 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.505 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -101.15 -46.74 4.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.109 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.693 ' HA ' HG11 ' A' ' 123' ' ' VAL . 8.5 p -71.41 -20.72 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.4 -14.04 66.13 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.722 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.9 m -103.84 1.06 31.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.988 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.61 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -78.51 -42.31 29.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.987 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.517 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.0 m-85 -60.57 -37.77 82.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.626 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.488 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -54.59 -34.6 62.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.439 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.6 -10.67 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.173 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.6 t -84.3 -16.31 43.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.191 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.333 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.816 0.341 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -159.83 144.11 14.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.963 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.469 ' H ' ' H ' ' A' ' 150' ' ' CYS . 22.7 t-20 -62.89 105.18 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.037 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -9.08 53.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -81.05 11.74 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.226 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -56.87 142.47 41.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.33 10.17 13.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 32.4 t0 56.04 78.15 0.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.144 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 26.2 m-85 -61.79 139.0 95.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.028 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 47.0 Cg_exo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.656 2.237 . . . . 0.0 112.386 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.842 0.353 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -86.3 -28.34 23.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -66.89 -47.91 70.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.594 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.673 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -69.72 -26.8 64.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.5 80.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.687 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 194' ' ' ALA . 42.1 t -59.33 -36.83 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.3 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.673 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 2.2 mtm-85 -65.36 -37.09 85.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.117 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -75.66 -5.97 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.435 178.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 70.58 46.89 0.51 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.414 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.836 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -172.57 87.04 0.07 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.47 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.86 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.7 t -119.7 -149.19 0.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.302 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.625 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 57.64 -154.85 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.375 . . . . 0.0 111.573 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.506 ' HB2' HD11 ' A' ' 187' ' ' LEU . 5.5 m-85 -158.32 -170.77 3.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.503 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.6 OUTLIER -53.14 154.35 3.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.79 0.329 . . . . 0.0 111.005 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -148.28 -170.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.073 0.464 . . . . 0.0 111.592 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 5.1 mmtp -141.54 80.15 1.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.467 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 48.4 t80 -56.83 108.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.276 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 178' ' ' LEU . 7.9 mt -70.53 -51.37 29.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.664 ' HA3' ' HD3' ' A' ' 114' ' ' ARG . . . 152.71 -131.48 3.37 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.615 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.517 ' H ' ' HD3' ' A' ' 114' ' ' ARG . 1.4 p -153.3 134.15 13.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.819 0.342 . . . . 0.0 110.854 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.0 m -128.02 146.2 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -71.33 132.94 45.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.168 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.7 m -117.26 -178.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.046 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -139.34 59.61 1.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.037 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -171.54 -63.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.821 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.425 ' HA ' HG21 ' A' ' 163' ' ' ILE . 17.8 m 60.23 31.32 20.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.399 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 7.3 ptt180 -165.39 88.12 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.95 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.19 158.73 9.16 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.753 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -37.77 54.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 110.86 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 2.2 pt20 -67.36 -22.55 65.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.92 -33.13 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.08 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 83.5 m -80.07 -39.33 29.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.997 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.661 ' HG2' ' HA ' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -64.26 -28.63 69.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.047 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 108' ' ' VAL . 68.0 mt-10 -81.31 -50.87 9.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.88 -36.78 75.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.321 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.8 tp -57.87 -38.9 76.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -73.21 -37.99 66.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.1 t -58.66 -38.49 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.721 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.9 mt -72.76 -33.58 66.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -80.91 -3.32 51.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.759 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -117.32 -13.52 10.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.9 p -93.62 -166.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -101.38 27.4 6.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.046 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.721 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -72.79 113.55 9.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.75 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 131.11 91.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 90.8 Cg_endo -85.05 145.59 9.9 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.742 2.295 . . . . 0.0 112.187 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 1.8 t -108.43 155.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -116.49 103.25 10.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.971 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.42 -164.73 12.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.622 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.537 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -112.15 131.41 55.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 111.143 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.7 HD23 HD23 ' A' ' 187' ' ' LEU . 22.0 tp -98.14 120.8 39.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.171 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.836 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 74.7 m-70 -109.16 98.46 7.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.09 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.86 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 16.9 t -67.11 100.3 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.246 0.546 . . . . 0.0 110.503 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -98.9 131.43 44.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.268 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.86 20.94 1.01 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.616 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 124' ' ' SER . 9.3 t70 -150.32 14.69 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.782 0.325 . . . . 0.0 110.759 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.801 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 139.4 107.87 0.76 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.684 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 123' ' ' VAL . 12.8 mt -50.59 150.1 2.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.842 0.353 . . . . 0.0 111.131 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.797 ' HG2' HD11 ' A' ' 138' ' ' LEU . 15.3 ttm180 -145.32 113.43 6.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.427 HG22 ' CD1' ' A' ' 121' ' ' LEU . 2.8 t -111.46 115.17 49.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 111.657 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 2.1 t -97.33 156.92 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.647 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.527 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 0.3 OUTLIER -95.69 165.08 12.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.417 179.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.45 -5.82 18.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 135' ' ' THR . 0.0 OUTLIER -107.69 -36.95 6.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.939 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 137' ' ' GLY . 8.8 t -118.99 -12.5 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.527 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 30.5 mmtt 59.25 23.02 11.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.777 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.67 ' H ' HG23 ' A' ' 135' ' ' THR . . . -87.91 -161.77 37.26 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.131 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.797 HD11 ' HG2' ' A' ' 129' ' ' ARG . 3.1 tp -116.17 124.32 50.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.0 -25.62 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.365 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.4 t -132.45 94.67 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.863 0.363 . . . . 0.0 111.131 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.526 ' HB2' HD23 ' A' ' 138' ' ' LEU . 37.6 t70 -96.77 72.0 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.756 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.14 -175.78 3.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.877 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 20.2 m -136.47 151.83 49.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.5 mm -61.33 -40.54 86.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.041 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.86 -6.13 59.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.606 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.877 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 2.6 tttp -87.69 -42.95 12.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.907 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 143' ' ' THR . 0.7 OUTLIER -64.89 128.58 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.2 t -62.87 -35.37 79.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.143 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.577 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -147.78 150.77 34.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.344 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.5 m -129.04 80.52 1.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.299 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 102' ' ' CYS . . . -109.72 128.69 24.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.61 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.77 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 69.8 Cg_endo -75.45 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.535 2.156 . . . . 0.0 112.329 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.661 ' HA ' ' HG2' ' A' ' 103' ' ' GLU . 13.8 p-10 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.51 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.433 ' HG2' ' N ' ' A' ' 183' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 120.799 0.333 . . . . 0.0 110.838 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -107.36 143.03 15.86 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.568 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.77 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -123.97 168.18 13.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.653 0.264 . . . . 0.0 110.892 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.02 166.12 26.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.494 . . . . 0.0 111.288 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.55 141.09 20.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.29 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.577 HD12 ' HB2' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -106.72 147.71 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.976 0.417 . . . . 0.0 111.558 -178.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.14 106.5 4.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.641 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -84.89 132.6 34.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.1 p30 44.64 -161.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.869 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.32 -9.6 60.86 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.477 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.6 t -176.06 -19.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 110.425 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.591 HG22 ' HG3' ' A' ' 171' ' ' ARG . 7.6 m -111.08 -15.45 13.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.762 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 58.91 26.48 14.99 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.901 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.591 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -177.88 177.87 1.03 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.023 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.41 132.65 45.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.019 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.506 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -161.1 132.75 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.665 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.422 ' HB2' HG23 ' A' ' 163' ' ' ILE . 20.3 t -116.13 160.19 20.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.307 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -124.92 138.18 54.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.537 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.534 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -123.37 147.26 16.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.661 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 6.5 p90 -162.78 143.2 9.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 0.0 110.745 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.499 HD12 HD21 ' A' ' 88' ' ' LEU . 1.2 mt -111.76 154.92 24.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.137 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.427 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -83.71 129.51 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.15 6.27 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.57 -26.53 12.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 55.38 83.07 0.09 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.433 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -169.66 -37.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.076 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.2 28.5 73.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.435 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.88 -16.42 5.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 110.954 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -105.91 -9.77 16.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.7 HD23 HD23 ' A' ' 121' ' ' LEU . 4.1 mp -125.55 -46.3 1.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.194 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -61.8 2.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.989 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.76 -8.27 34.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.141 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.14 -41.7 13.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.236 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.458 ' HA ' HG11 ' A' ' 123' ' ' VAL . 7.0 p -77.44 -29.2 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.046 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.87 -3.83 52.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.231 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 92.2 m -115.27 1.53 13.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 110.683 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.703 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -77.69 -44.26 28.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.07 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.453 ' CD2' HD21 ' A' ' 199' ' ' LEU . 4.2 p90 -64.96 -25.22 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.938 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.462 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -61.14 -19.05 61.07 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.21 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.99 -27.29 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.001 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.9 t -74.76 -30.84 61.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.765 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.754 0.312 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 51.4 p -168.61 161.38 11.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.571 HD21 ' HB3' ' B' ' 7' ' ' PHE . 0.6 OUTLIER -78.12 159.91 28.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.999 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 10.2 mtm -130.33 -10.94 4.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.995 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -83.59 8.26 14.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.959 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.571 ' HB3' HD21 ' B' ' 4' ' ' ASN . 52.5 p90 -63.4 151.69 40.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -98.56 12.92 33.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.862 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t70 56.03 75.99 0.31 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 66.5 m-85 -71.01 143.71 89.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.934 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 48.5 Cg_exo . . . . . 0 C--O 1.249 1.068 0 C-N-CA 122.638 2.225 . . . . 0.0 112.25 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.91 0.386 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.46 -27.29 25.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.862 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -87.26 -23.77 24.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.55 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.738 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.0 OUTLIER -90.45 -15.14 31.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -60.93 -49.44 77.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.943 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.0 t -60.52 -41.0 86.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.255 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.738 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 9.8 mtt180 -56.07 -33.91 65.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.452 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 m -80.7 -92.02 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.7 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.624 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -178.71 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.453 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.611 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -172.44 98.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.788 0.328 . . . . 0.0 111.099 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.608 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 15.7 t -129.0 61.06 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.641 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.642 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -161.01 -156.54 0.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.098 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.486 ' HB3' ' HE2' ' A' ' 181' ' ' LYS . 1.9 m-85 -156.12 -170.55 3.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.179 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 1.4 m -51.13 141.76 13.75 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.99 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.9 m -135.86 -175.55 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.42 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 116' ' ' PRO . 4.6 mtpp -133.99 73.92 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.703 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 78.2 t80 -61.37 108.04 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.45 ' HB2' HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -80.22 -36.54 34.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.12 -127.16 3.02 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.606 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.2 p -164.64 130.11 2.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.07 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m -114.21 146.81 18.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -72.43 129.9 39.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.109 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 174' ' ' CYS . 1.5 m -121.67 176.79 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.924 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -141.3 59.73 1.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 2.3 mt-10 -162.08 -63.17 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.093 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.17 34.44 17.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -146.12 141.76 27.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.979 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.79 -139.48 14.48 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.571 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.25 -33.31 0.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 0.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -18.87 65.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.228 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -37.24 48.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.767 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.469 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 85.8 m -69.22 -28.69 66.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.67 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -22.27 61.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.905 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.2 mm-40 -87.31 -52.59 5.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.96 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.587 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.31 -49.16 78.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.136 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 11.1 tp -53.39 -30.81 41.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.975 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -37.03 67.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.8 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 104' ' ' GLU . 6.0 t -60.82 -48.09 90.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.755 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 105' ' ' ALA . 1.4 mp -70.49 -17.18 62.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.698 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 110' ' ' ARG . 2.0 ttm-85 -87.46 -9.67 53.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.569 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -80.56 -63.86 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.744 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -171.91 -175.67 1.55 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.294 179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 112' ' ' SER . 7.1 mpt_? 70.08 -71.55 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.97 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.509 ' H ' ' HG2' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -66.82 110.56 3.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.932 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.57 142.65 24.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 97.8 Cg_endo -79.42 148.67 21.04 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.575 2.184 . . . . 0.0 112.348 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.23 117.45 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -65.17 97.98 0.29 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.989 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -127.44 -161.48 10.83 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.195 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.48 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -129.27 117.68 21.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.334 . . . . 0.0 110.643 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.639 HD23 HD23 ' A' ' 187' ' ' LEU . 26.5 tp -89.87 130.71 36.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.728 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.422 ' CE1' HD12 ' A' ' 120' ' ' LEU . 30.9 m-70 -118.22 93.19 4.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.915 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.642 HG23 ' HB2' ' A' ' 82' ' ' SER . 79.4 t -66.15 94.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -99.46 135.69 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.346 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -58.06 -9.56 5.85 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.104 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -114.88 32.73 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.29 134.97 6.64 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 mt -66.98 171.1 5.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.907 0.384 . . . . 0.0 111.233 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.576 ' HD3' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -167.24 110.67 0.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.665 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.613 HG22 HD13 ' A' ' 121' ' ' LEU . 7.7 t -106.32 114.8 46.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.92 0.39 . . . . 0.0 111.384 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.72 120.35 57.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.874 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 37.6 m-20 -52.22 152.97 3.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.55 2.52 28.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.939 0.4 . . . . 0.0 111.165 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.42 -24.73 6.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.572 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.01 -10.52 5.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.686 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 27.4 mmtm 54.03 26.27 6.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.817 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 132' ' ' ASP . . . -90.67 135.76 13.03 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.443 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.576 HD11 ' HD3' ' A' ' 129' ' ' ARG . 5.1 tp -67.65 108.17 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.663 0.268 . . . . 0.0 110.619 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 3.0 pt -99.36 -25.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.435 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.544 ' HB ' HG23 ' A' ' 130' ' ' VAL . 74.8 t -136.68 106.19 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.214 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.22 27.93 8.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.327 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -70.24 -173.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.23 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 2.8 m -131.46 164.7 25.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.709 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.461 HD11 ' O ' ' A' ' 124' ' ' SER . 16.0 mt -77.61 -33.45 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.62 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -85.87 -10.87 54.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.45 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 7.1 tttm -83.53 -37.83 22.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.762 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 m -77.67 138.35 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.449 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -60.5 -68.58 0.29 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.516 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 148' ' ' SER . 0.1 OUTLIER -141.22 136.44 31.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.054 178.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.539 ' O ' ' HB3' ' B' ' 2' ' ' PHE . 60.6 m -98.35 93.26 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.549 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -105.11 153.17 39.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.464 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.904 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 82.8 Cg_endo -86.6 -118.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.783 2.322 . . . . 0.0 112.149 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.451 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 18.7 p-10 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.596 0.236 . . . . 0.0 111.042 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 120.857 0.361 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -149.9 119.04 0.99 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.429 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.772 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -111.3 -179.42 3.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.01 0.433 . . . . 0.0 111.034 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -166.44 169.85 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.498 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -150.6 145.54 25.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.511 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -117.03 157.12 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.063 0.459 . . . . 0.0 111.567 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.7 -174.97 5.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.677 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.9 OUTLIER -127.65 -149.37 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.799 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.611 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER -63.57 -163.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.903 0.382 . . . . 0.0 111.384 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.91 -16.29 60.46 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.441 ' H ' ' H ' ' A' ' 169' ' ' THR . 10.7 t -163.96 -5.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 110.068 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.441 ' H ' ' H ' ' A' ' 168' ' ' THR . 6.9 m -132.17 -12.37 3.21 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.611 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 34.3 mtt85 60.8 19.39 9.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.059 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.608 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -171.89 172.79 4.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.935 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -81.76 115.33 20.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.625 179.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.608 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 3.2 mtp -131.31 145.91 52.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.511 ' HB2' HG23 ' A' ' 163' ' ' ILE . 16.4 t -119.11 142.95 47.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -112.25 156.63 22.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.628 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 88' ' ' LEU . . . -137.93 146.77 18.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.537 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -164.72 161.06 20.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 0.0 110.959 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.458 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 2.0 mp -127.92 168.6 15.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.88 125.32 45.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.071 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.42 -13.94 45.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.692 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.486 ' HE2' ' HB3' ' A' ' 83' ' ' PHE . 5.9 mmtm -80.73 -28.65 36.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 56.33 37.13 28.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.992 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.43 -44.33 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.987 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.24 31.05 43.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.534 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -127.88 -30.12 2.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 110.978 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.421 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -88.57 -8.94 53.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.742 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.639 HD23 HD23 ' A' ' 121' ' ' LEU . 4.9 mp -127.32 -55.99 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.278 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -63.38 1.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.421 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -59.95 -19.18 50.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.258 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.608 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -79.77 -44.57 20.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.238 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 187' ' ' LEU . 70.9 t -63.8 -32.58 57.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.722 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.95 -7.57 30.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.425 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 59.5 m -109.75 -17.4 13.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.778 0.323 . . . . 0.0 110.97 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.516 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -55.7 -44.83 77.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.128 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.449 ' HD2' ' HB3' ' B' ' 6' ' ' SER . 2.4 p90 -74.9 -29.7 61.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.54 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -60.18 -17.13 38.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 89.8 t -106.82 -27.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.088 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.2 t -75.38 -4.39 39.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 196' ' ' ALA . 5.1 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.904 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.692 0.282 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' B' ' 2' ' ' PHE . 91.0 p 177.39 140.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.881 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -73.1 178.46 4.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.55 -17.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.005 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 195' ' ' PHE . 51.9 p -80.15 3.31 20.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -70.91 164.23 25.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -107.63 -1.31 21.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t70 58.86 95.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.225 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -58.08 146.55 68.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.86 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo . . . . . 0 C--O 1.248 1.011 0 C-N-CA 122.493 2.128 . . . . 0.0 112.285 -179.846 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.09 -38.46 24.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.107 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -63.04 -20.3 65.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.644 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 8.9 tt0 -104.53 -12.94 16.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.635 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -54.77 -48.75 72.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.241 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 81' ' ' CYS . 1.2 t -62.03 -35.51 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.388 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -65.9 -29.96 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -90.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -176.58 34.7 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.519 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.634 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -176.8 102.82 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.894 0.378 . . . . 0.0 111.251 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.545 ' HB3' HG23 ' A' ' 76' ' ' VAL . 23.0 t -141.34 65.28 1.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.649 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -163.27 -160.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.35 . . . . 0.0 111.158 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.403 ' CG ' ' HE3' ' A' ' 181' ' ' LYS . 6.1 m-85 -156.05 -171.17 3.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.898 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.27 148.69 2.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.878 0.371 . . . . 0.0 111.305 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 119' ' ' GLY . 18.2 m -135.7 -167.08 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.24 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.84 75.84 1.5 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.765 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' ' 117' ' ' VAL . 83.0 t80 -63.71 91.82 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.016 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.628 ' HB2' HD22 ' A' ' 109' ' ' LEU . 0.7 OUTLIER -61.46 -43.24 99.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA3' ' HD3' ' A' ' 114' ' ' ARG . . . 150.58 -126.75 2.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.332 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.92 132.34 8.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 0.0 111.107 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG21 ' HB ' ' A' ' 108' ' ' VAL . 4.2 m -126.02 149.91 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.993 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.51 137.22 54.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.9 -169.68 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.898 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -122.77 80.4 1.74 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 63.8 109.22 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.804 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.5 p -45.9 -30.16 1.64 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.576 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.32 126.67 19.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.096 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.3 -125.35 2.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.574 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -170.18 -50.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.718 0.294 . . . . 0.0 110.638 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -78.84 11.51 2.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.188 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 163' ' ' ILE . 9.6 t -62.61 -16.27 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.936 0.398 . . . . 0.0 110.599 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 67.2 m -102.31 -35.49 8.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.875 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.87 -19.72 62.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 76.3 mt-10 -104.49 -48.28 3.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.145 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.413 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -56.84 -37.03 70.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.279 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 160' ' ' PHE . 14.8 tp -58.48 -35.93 72.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.66 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -34.97 61.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.2 t -58.7 -33.14 48.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.668 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.665 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -80.01 -25.12 40.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.529 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.1 -14.47 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.711 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -105.99 -3.86 21.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.949 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.66 -173.53 2.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.03 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.5 10.94 16.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.002 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.665 ' HG3' HD23 ' A' ' 109' ' ' LEU . 5.6 mmp_? -62.98 105.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -83.03 134.79 45.74 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.088 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 72.3 Cg_endo -74.86 142.49 28.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.525 2.15 . . . . 0.0 112.182 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 87' ' ' TYR . 2.3 t -107.5 122.35 61.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -69.17 112.93 6.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.447 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -151.53 145.9 14.16 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.576 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.516 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -83.07 110.14 17.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 0.0 111.004 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.754 HD13 HG22 ' A' ' 130' ' ' VAL . 27.3 tp -80.65 137.68 36.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.586 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.516 ' CE1' HD12 ' A' ' 120' ' ' LEU . 3.6 m-70 -124.08 85.83 2.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.704 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.649 ' H ' ' HB2' ' A' ' 82' ' ' SER . 74.7 t -62.39 98.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.108 0.48 . . . . 0.0 111.002 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -98.53 142.34 30.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.205 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.59 16.84 2.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.672 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 124' ' ' SER . 35.7 t0 -146.97 27.99 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.879 0.371 . . . . 0.0 110.433 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.34 113.07 1.77 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -75.79 141.49 42.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.948 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -142.23 131.55 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.754 HG22 HD13 ' A' ' 121' ' ' LEU . 9.1 t -106.88 112.44 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.73 109.92 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.736 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 2.8 m-20 -51.29 147.38 5.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.983 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -97.41 11.45 36.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.927 0.394 . . . . 0.0 110.651 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.05 -30.64 6.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.869 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.662 HG23 ' H ' ' A' ' 137' ' ' GLY . 14.8 t -132.71 -8.69 3.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.005 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 13.3 mmtp 58.34 22.65 9.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.831 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.662 ' H ' HG23 ' A' ' 135' ' ' THR . . . -75.47 -133.49 0.38 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.577 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 tp -151.12 112.85 4.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 0.0 110.66 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.42 ' H ' HG13 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -96.26 -45.38 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.198 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.629 ' HB ' HG23 ' A' ' 130' ' ' VAL . 36.5 t -119.63 97.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.249 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.86 59.38 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.691 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.17 -169.62 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.044 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.712 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 62.1 m -136.31 156.88 48.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.491 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -57.22 -42.27 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.695 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.429 ' H ' HG22 ' A' ' 143' ' ' THR . 7.5 pt-20 -81.39 -14.22 57.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.428 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.624 ' HB3' ' H ' ' A' ' 143' ' ' THR . 0.7 OUTLIER -76.29 -39.55 53.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.587 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 143' ' ' THR . 1.1 m -80.02 150.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -62.44 1.73 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.624 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.81 ' HB2' ' HB3' ' B' ' 3' ' ' SER . 22.1 p90 -173.22 135.8 0.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.73 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.31 136.17 36.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.294 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.421 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . . . -146.4 102.52 4.03 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.641 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 12.4 Cg_endo -54.76 -83.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.626 2.217 . . . . 0.0 112.408 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.955 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.882 0.372 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -145.2 136.92 6.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.293 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.575 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -122.6 -175.29 3.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.95 173.72 11.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.411 . . . . 0.0 111.05 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -158.24 147.18 19.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.514 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -116.39 158.61 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 0.0 111.51 -178.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.5 p -157.52 -176.54 6.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.483 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -130.6 135.63 48.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.3 p30 44.19 -158.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.811 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.05 -12.36 62.21 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.1 t 179.76 -17.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.096 0.474 . . . . 0.0 110.176 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.93 HG21 ' HG3' ' A' ' 173' ' ' MET . 87.6 m -112.77 -14.18 13.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.499 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 58.37 26.46 14.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.357 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.858 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -174.53 -171.44 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 111.561 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.44 135.54 57.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.477 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.93 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -167.17 145.54 4.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.658 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.712 ' HB2' HG23 ' A' ' 163' ' ' ILE . 44.7 t -128.0 145.35 51.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.163 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -115.14 137.25 52.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.593 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.522 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -110.74 152.91 17.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.673 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -167.51 132.89 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.87 0.367 . . . . 0.0 111.047 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.604 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 3.9 mp -106.42 156.8 18.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.11 120.66 25.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.9 t -70.47 -11.87 61.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.958 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.403 ' HE3' ' CG ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -86.81 -26.19 24.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 54.8 71.82 0.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.4 t -155.17 -30.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 64.91 36.91 93.65 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.401 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -139.52 -30.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.737 0.304 . . . . 0.0 111.021 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.464 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.4 OUTLIER -90.58 -2.53 57.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.886 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 191' ' ' VAL . 5.5 mp -135.96 -58.22 0.76 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.27 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.05 -57.67 8.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.342 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -59.84 -20.54 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.074 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.12 -45.45 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.073 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 187' ' ' LEU . 98.6 t -63.82 -30.71 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.91 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.481 ' HA2' ' HE1' ' A' ' 195' ' ' PHE . . . -64.09 -7.38 23.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.427 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.452 ' O ' HG23 ' A' ' 197' ' ' VAL . 1.0 OUTLIER -119.24 -5.12 10.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 0.0 110.743 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -74.5 -52.53 11.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.333 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.481 ' HE1' ' HA2' ' A' ' 192' ' ' GLY . 40.1 p90 -65.94 -31.14 71.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.945 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.603 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -58.22 -24.22 58.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.791 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 193' ' ' CYS . 22.3 t -93.75 -18.97 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.962 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 3.7 t -74.89 -27.07 60.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.957 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.801 0.334 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.81 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER 62.87 118.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.184 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.561 ' ND2' ' HA ' ' A' ' 149' ' ' PHE . 21.0 p30 -57.5 157.59 6.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.07 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 3.1 mtp -125.0 0.21 7.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.018 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 32.6 p -92.01 25.08 2.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.496 ' HD2' ' H ' ' B' ' 9' ' ' ASP . 39.4 p90 -72.14 162.0 30.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -114.74 11.7 16.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.489 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . 0.496 ' H ' ' HD2' ' B' ' 7' ' ' PHE . 35.3 t70 57.45 78.27 0.24 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.211 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 30.2 m-85 -63.08 146.4 95.85 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 15.5 Cg_exo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.725 2.283 . . . . 0.0 112.384 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.906 0.384 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.63 -28.13 45.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.272 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.41 -29.16 69.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.308 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.706 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.6 tm-20 -82.52 -23.2 34.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.688 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.18 -49.97 72.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.903 HG11 ' HA ' ' A' ' 194' ' ' ALA . 55.2 t -63.51 -42.17 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.487 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.706 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -55.31 -37.12 66.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.272 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 2.7 m -71.74 -90.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.218 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.641 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 176.91 38.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.422 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.649 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 1.5 t -174.23 102.34 0.1 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.986 0.422 . . . . 0.0 112.045 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.429 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 9.6 t -142.17 56.81 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.994 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.695 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -151.75 -151.34 0.38 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.168 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -155.41 -172.89 4.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.023 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.508 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.6 OUTLIER -53.92 146.64 13.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.494 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 121' ' ' LEU . 10.5 m -146.56 -176.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.19 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 1.1 mptt -143.0 81.54 1.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.875 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HE1' ' HB3' ' A' ' 175' ' ' HIS . 82.0 t80 -61.32 100.08 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.684 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.474 ' HB2' HD22 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -64.85 -48.33 74.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.61 -131.42 3.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.595 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 175' ' ' HIS . 0.8 OUTLIER -144.96 133.56 22.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.71 0.29 . . . . 0.0 110.991 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.79 157.69 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -83.55 142.96 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -179.01 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.898 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.64 59.66 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.173 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 2.7 tt0 -170.22 -61.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.072 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.5 p 48.71 54.25 10.97 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.965 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 1.7 ptm180 -163.38 114.47 1.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.993 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.77 -137.03 12.5 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.419 ' HB2' ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -147.58 -19.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.867 0.365 . . . . 0.0 110.761 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -79.26 4.72 14.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.071 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -87.38 -15.52 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.767 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.435 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 89.4 m -88.43 -34.37 17.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.813 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.14 -22.51 66.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 108' ' ' VAL . 5.5 mm-40 -93.66 -46.37 7.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.78 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -56.23 -32.68 64.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.973 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.61 -39.9 76.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.702 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -24.49 65.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.738 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 104' ' ' GLU . 59.0 t -75.13 -45.89 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 105' ' ' ALA . 1.3 mt -60.07 -35.7 75.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.957 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -72.09 -39.24 69.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.712 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -77.09 -11.95 59.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.26 -174.98 2.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 113' ' ' ARG . 1.4 mtp85 -87.67 14.37 8.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.485 ' HG3' ' HA ' ' A' ' 109' ' ' LEU . 3.1 mmp_? -61.34 103.26 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -76.2 123.31 87.95 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.133 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 73.5 Cg_endo -75.66 172.82 15.57 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.488 2.125 . . . . 0.0 112.211 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.4 t -130.47 140.23 49.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.21 72.87 8.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 132' ' ' ASP . . . -123.95 149.24 16.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.708 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -80.14 126.79 31.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 110.94 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.675 HD23 HD23 ' A' ' 187' ' ' LEU . 51.8 tp -89.52 136.82 32.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.499 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 89.8 m-70 -126.72 94.76 4.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.1 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.695 ' H ' ' HB2' ' A' ' 82' ' ' SER . 54.3 t -60.8 97.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.016 0.436 . . . . 0.0 110.725 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.641 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 11.9 p -103.53 137.0 42.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.269 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -78.56 39.92 1.98 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.692 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -162.07 13.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.397 . . . . 0.0 110.729 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.776 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 134.57 97.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.468 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.513 ' HG ' HG13 ' A' ' 144' ' ' ILE . 2.4 mt -53.68 138.58 34.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.068 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.827 ' HG2' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -137.31 142.22 41.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.609 HG23 ' HB ' ' A' ' 140' ' ' VAL . 8.7 t -114.93 102.33 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.035 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.85 114.99 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.412 ' HA ' ' CA ' ' A' ' 119' ' ' GLY . 4.6 t0 -50.5 144.72 7.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.077 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.21 5.15 51.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.165 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 -32.74 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.692 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.49 -19.53 13.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.737 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm 50.02 39.63 19.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.41 -124.07 5.23 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.492 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.827 HD11 ' HG2' ' A' ' 129' ' ' ARG . 10.3 tp -154.76 113.81 3.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 110.726 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.427 HD12 HG12 ' A' ' 130' ' ' VAL . 5.5 mt -96.23 -54.01 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.4 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.609 ' HB ' HG23 ' A' ' 130' ' ' VAL . 98.9 t -112.5 111.81 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.904 0.383 . . . . 0.0 111.313 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.32 25.32 10.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.608 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.404 ' H ' HG12 ' A' ' 140' ' ' VAL . 70.7 mm-40 -68.43 -170.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.169 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.776 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 5.6 m -146.03 154.29 41.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.931 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.513 HG13 ' HG ' ' A' ' 128' ' ' LEU . 13.6 mt -70.11 -43.51 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.706 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.24 -1.05 31.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.683 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.412 ' CB ' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -96.89 -43.08 7.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 143' ' ' THR . 0.6 OUTLIER -66.02 145.06 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 110.993 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.411 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -55.39 -64.8 0.73 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.628 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.634 ' HD1' HD13 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -144.51 -178.01 5.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.869 179.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' B' ' 3' ' ' SER . 2.2 t -123.18 155.58 36.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.419 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 99' ' ' MET . . . -176.12 126.06 0.34 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.77 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.586 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 96.4 Cg_endo -85.09 -90.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.76 2.307 . . . . 0.0 112.308 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 5.9 p-10 . . . . . 0 C--O 1.232 0.166 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.568 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.858 0.361 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 153' ' ' ASP . . . -105.19 143.82 15.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.355 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.586 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -119.22 169.68 9.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.323 . . . . 0.0 110.87 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.678 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -164.41 176.84 8.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -147.43 145.52 29.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.403 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.645 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -106.85 152.49 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.468 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.13 127.54 12.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.685 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -99.95 113.49 26.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.48 ' HA ' ' N ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER 50.45 -153.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.311 179.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.94 -37.31 2.51 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.385 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.26 5.47 0.34 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.1 OUTLIER -128.72 -17.79 3.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.731 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.48 ' N ' ' HA ' ' A' ' 166' ' ' ASP . 0.1 OUTLIER 58.6 25.35 13.09 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.095 -178.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 172.19 176.4 0.09 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.552 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.08 124.33 26.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.5 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.767 ' HB2' HG21 ' A' ' 169' ' ' THR . 24.6 mtp -153.63 125.45 7.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.203 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.645 ' HB2' HG23 ' A' ' 163' ' ' ILE . 6.7 t -106.84 141.05 38.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.353 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 8.5 m170 -103.54 129.87 50.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.001 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.678 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -112.57 154.33 16.94 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.35 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -158.73 136.22 10.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.731 0.3 . . . . 0.0 110.536 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.8 mt -97.07 139.85 32.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.299 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.34 115.69 17.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.779 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 3.0 t -58.91 -23.69 61.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.437 ' H ' ' HG2' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -82.34 -28.52 31.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.045 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 55.08 82.93 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.8 t -161.33 -37.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.925 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.51 18.61 78.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.578 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -134.81 -0.37 2.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 0.0 110.816 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.525 ' HB2' HD12 ' A' ' 187' ' ' LEU . 1.1 mmt180 -98.54 -25.38 14.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.903 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.675 HD23 HD23 ' A' ' 121' ' ' LEU . 4.2 mp -124.39 -51.04 1.75 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.806 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.0 t -58.26 -49.38 77.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.673 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 1.4 t-80 -69.67 -1.92 10.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.547 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.429 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -103.97 -40.75 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.167 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.617 ' HA ' HG11 ' A' ' 123' ' ' VAL . 4.8 p -67.92 -15.29 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.08 97.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.565 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 66.1 m -84.35 -11.58 56.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.988 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.903 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -60.06 -28.46 67.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.274 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -80.89 -37.73 29.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.603 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -55.91 -21.84 22.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.264 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 197' ' ' VAL . 0.8 OUTLIER -75.3 -42.1 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.803 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 85.4 m -78.76 -15.12 58.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.483 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.603 HD12 ' HA ' ' A' ' 196' ' ' ALA . 8.3 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.817 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 3.4 p90 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.634 0.254 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' A' ' 150' ' ' CYS . 2.7 p -145.34 171.34 14.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.937 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -81.18 161.1 24.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.974 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . 0.459 ' HB2' HD21 ' A' ' 199' ' ' LEU . 16.3 mtp -134.34 -7.49 2.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.026 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 20.6 t -93.12 27.13 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -62.72 158.25 19.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.75 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -85.05 7.3 21.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.857 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 17.7 t70 53.67 68.73 0.8 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.136 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.412 ' HE2' ' HA ' ' A' ' 146' ' ' LYS . 60.7 m-85 -67.86 140.69 94.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 C--O 1.248 1.004 0 C-N-CA 122.534 2.156 . . . . 0.0 112.336 -179.802 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.838 0.351 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.69 -32.58 6.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -60.36 -41.47 93.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.873 0.368 . . . . 0.0 110.777 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.858 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.6 mt-10 -92.88 -5.08 51.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.762 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -66.08 -46.42 77.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.045 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 81' ' ' CYS . 0.9 OUTLIER -64.79 -36.58 77.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.394 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.858 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -59.31 -39.27 82.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.359 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -91.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.555 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.455 ' CA ' ' HB2' ' A' ' 124' ' ' SER . . . -178.36 36.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.488 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.628 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -176.0 101.71 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.668 0.27 . . . . 0.0 111.253 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.466 ' CB ' HG23 ' A' ' 76' ' ' VAL . 16.6 t -128.22 0.06 5.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.791 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.739 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -97.78 -163.38 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.6 0.238 . . . . 0.0 111.042 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.623 ' HB3' ' HD2' ' A' ' 181' ' ' LYS . 8.5 m-85 -154.88 -169.14 3.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.354 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.856 ' HB2' ' HE2' ' A' ' 181' ' ' LYS . 0.3 OUTLIER -41.07 142.31 0.52 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.072 -178.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 120' ' ' LEU . 4.1 m -142.26 -165.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.03 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.27 71.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.605 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 89.9 t80 -59.81 99.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -73.62 -40.24 63.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.58 -132.44 3.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.321 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 175' ' ' HIS . 1.2 p -161.69 142.73 11.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.83 0.347 . . . . 0.0 110.927 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.2 m -127.17 153.38 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.067 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.77 142.5 42.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.988 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.94 -178.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.078 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -143.32 59.51 1.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -176.74 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.433 ' OG ' ' HB3' ' A' ' 172' ' ' TRP . 1.0 OUTLIER 62.92 18.52 10.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.61 -178.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -119.61 51.92 1.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.29 169.07 37.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.12 -27.39 26.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.937 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.46 -19.02 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.035 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.94 -34.61 49.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.745 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.2 m -82.91 -33.49 26.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -65.63 -20.64 66.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.986 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.7 mm-40 -103.68 -46.44 4.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.048 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.62 -47.03 77.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.694 ' HA ' HD12 ' A' ' 109' ' ' LEU . 15.8 tp -58.33 -32.87 68.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.768 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 1.2 tttm -72.47 -39.77 67.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 104' ' ' GLU . 35.1 t -57.88 -40.95 78.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.766 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.8 mt -65.44 -27.88 68.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.913 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -28.2 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.79 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 14.4 mt-30 -84.69 -23.13 29.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -106.4 169.32 8.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.26 69.47 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.766 ' HG3' HD23 ' A' ' 109' ' ' LEU . 16.1 mmt-85 -72.26 -154.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.924 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.26 85.97 6.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.548 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 91.6 Cg_endo -79.82 128.4 7.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.701 2.267 . . . . 0.0 112.187 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -113.43 164.68 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -112.1 72.52 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -131.39 -167.81 12.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.445 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.557 ' HA ' HG22 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -135.48 141.27 45.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 111.184 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 120' ' ' LEU . 64.3 tp -76.32 147.92 37.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.347 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -127.28 77.45 1.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.724 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 82' ' ' SER . 53.3 t -53.17 98.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 121.108 0.48 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.528 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -106.65 131.78 53.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.146 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.04 -15.08 9.15 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.824 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -112.5 35.72 3.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 113.2 126.19 4.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.448 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.453 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -79.66 139.16 37.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.718 0.294 . . . . 0.0 110.99 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.612 ' HB2' HD11 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.23 141.95 39.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.024 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 140' ' ' VAL . 20.2 t -109.2 114.28 46.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.008 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -104.7 121.31 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.602 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 2.6 t0 -60.94 165.81 3.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.886 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.81 2.15 25.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.55 -45.38 2.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.68 -24.57 19.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.64 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.78 40.58 24.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.795 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.8 -114.92 3.89 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.504 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 129' ' ' ARG . 10.0 tp -168.57 120.27 0.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.771 0.319 . . . . 0.0 110.665 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.597 HD13 HG21 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -101.85 -54.43 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.277 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.579 ' HB ' HG23 ' A' ' 130' ' ' VAL . 80.4 t -103.1 101.78 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.173 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -97.03 21.4 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.61 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -68.54 -177.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.103 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.571 ' O ' HG22 ' A' ' 147' ' ' VAL . 28.4 m -140.75 157.53 45.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.593 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 124' ' ' SER . 21.4 mt -59.86 -45.97 94.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.188 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -76.88 -1.47 28.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 5.3 tttt -99.58 -38.17 8.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.921 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 143' ' ' THR . 1.9 m -75.07 130.44 36.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.043 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.429 ' HB3' ' HD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -65.7 -50.12 66.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.032 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.478 ' HD2' ' HB2' ' B' ' 3' ' ' SER . 61.9 m-85 -131.55 -173.05 3.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 0.0 111.363 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 161' ' ' SER . 8.9 t -161.89 34.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.043 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.23 148.85 95.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.108 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.923 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 61.4 Cg_endo -88.79 -142.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.053 2.502 . . . . 0.0 112.305 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.474 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 23.5 t0 . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.709 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 182' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.87 0.367 . . . . 0.0 110.93 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.72 128.73 3.87 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.537 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -121.46 168.5 11.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.688 0.28 . . . . 0.0 110.702 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 150' ' ' CYS . 1.1 m -157.87 172.28 18.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -145.41 145.21 31.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.593 178.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.777 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.1 OUTLIER -111.62 169.54 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.289 -179.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.434 ' H ' HG22 ' A' ' 163' ' ' ILE . 40.9 t -169.98 136.6 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.624 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.75 115.32 30.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 111.148 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 50.09 -159.72 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.401 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.42 -16.0 42.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.775 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.427 ' H ' ' H ' ' A' ' 169' ' ' THR . 1.1 t -170.28 -4.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.063 0.459 . . . . 0.0 110.044 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.61 HG22 ' HG3' ' A' ' 171' ' ' ARG . 11.7 m -133.19 -12.65 2.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.977 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 5.6 mmt180 58.96 23.37 11.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.61 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -174.3 171.77 3.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.221 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.433 ' HB3' ' OG ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -74.98 119.98 19.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.936 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.527 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 0.1 OUTLIER -142.44 146.23 34.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.641 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.777 ' HB2' HG23 ' A' ' 163' ' ' ILE . 16.9 t -131.54 124.71 30.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.95 0.405 . . . . 0.0 111.293 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 9.2 m-70 -91.41 136.58 33.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.228 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -114.35 154.06 17.21 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.221 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 21.3 p90 -161.89 143.42 11.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.666 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.87 138.07 50.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.022 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.41 113.87 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.072 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 3.6 t -64.53 -32.47 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.957 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.856 ' HE2' ' HB2' ' A' ' 84' ' ' SER . 0.1 OUTLIER -65.47 -27.07 68.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.027 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.547 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 65.4 m-20 55.95 90.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.199 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 t -168.23 -43.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.777 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.39 30.51 56.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 32.3 tt0 -136.27 -42.39 0.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.701 0.286 . . . . 0.0 110.986 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.552 ' HB2' ' HD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -75.17 -5.95 47.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.9 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp -131.29 -49.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.995 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -60.94 2.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 0.3 OUTLIER -62.37 -13.1 25.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.396 -179.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -88.19 -44.4 10.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.153 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.49 ' HA ' HG11 ' A' ' 123' ' ' VAL . 1.7 p -69.95 -24.38 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.86 -10.22 83.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.458 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.8 m -110.0 14.4 23.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.392 . . . . 0.0 110.557 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.59 -43.4 11.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.172 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' B' ' 4' ' ' ASN . 5.1 p90 -61.34 -33.35 73.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.733 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.63 -27.41 64.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.886 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.94 -5.53 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.756 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 2.0 t -88.97 -5.4 57.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.923 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.021 179.766 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.923 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.406 0.146 . . . . 0.0 110.882 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 149' ' ' PHE . 0.0 OUTLIER 64.51 131.74 0.02 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.976 0.417 . . . . 0.0 111.369 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 7.6 p30 -109.95 -165.6 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.742 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . 0.418 ' HG2' ' CE2' ' B' ' 7' ' ' PHE . 0.0 OUTLIER -125.94 -137.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.6 p 56.55 18.17 3.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.562 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.487 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 32.1 p90 -85.69 151.88 23.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.687 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -82.78 9.02 10.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . 0.487 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 8.1 t0 54.46 70.33 0.63 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.777 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.436 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 31.0 m-85 -60.0 139.2 90.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.958 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 32.1 Cg_exo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.705 2.27 . . . . 0.0 112.229 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.831 0.348 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.56 -16.39 10.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.151 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -104.91 -13.93 15.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.3 -14.56 14.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.79 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -66.95 -50.79 61.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.017 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.447 HG23 ' SG ' ' A' ' 81' ' ' CYS . 1.8 t -59.83 -44.88 95.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.799 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -57.97 -39.17 77.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.536 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.1 m -69.2 -93.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.526 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.6 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -177.9 30.98 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.382 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.684 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -171.73 100.13 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.903 0.382 . . . . 0.0 111.789 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 4.1 t -121.7 -147.48 0.39 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.126 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.657 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 52.83 -157.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 111.635 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.491 ' HB3' ' HD2' ' A' ' 181' ' ' LYS . 2.8 m-85 -159.14 -166.21 1.78 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.492 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 0.2 OUTLIER -46.77 151.1 0.63 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.726 0.298 . . . . 0.0 111.309 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -145.7 -169.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.102 0.477 . . . . 0.0 111.706 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -152.4 71.91 0.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.266 178.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 22.4 t80 -56.06 111.22 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.192 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 mt -70.53 -80.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.07 -127.5 1.02 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.561 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 8.3 p -155.84 137.75 14.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.703 0.287 . . . . 0.0 111.04 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.33 157.87 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -75.84 147.08 39.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.211 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.49 -176.05 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.58 ' HA ' ' HE3' ' A' ' 172' ' ' TRP . 1.7 t80 -146.03 64.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.256 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.03 -68.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.442 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.54 19.62 6.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.822 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.38 125.4 12.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.33 -112.67 1.31 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.546 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.533 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -174.36 -34.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 111.05 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -76.65 -9.74 58.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.299 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.6 -22.85 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 24.0 m -87.24 -33.99 19.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 153' ' ' ASP . 2.9 mt-10 -64.03 -15.66 59.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.026 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.4 mt-10 -97.32 -48.73 5.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.039 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.14 -34.22 71.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.133 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.48 HD21 ' HA3' ' A' ' 159' ' ' GLY . 6.8 tp -64.71 -29.84 70.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -45.99 30.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.835 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' GLU . 4.0 t -59.28 -37.73 70.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.173 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.587 HD23 ' HG3' ' A' ' 114' ' ' ARG . 8.5 mt -70.51 -26.75 63.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -9.68 59.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -114.93 1.78 14.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.034 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -118.19 -18.33 9.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.283 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.5 69.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.874 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.587 ' HG3' HD23 ' A' ' 109' ' ' LEU . 18.7 mmt180 -84.77 43.43 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.49 90.94 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.421 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 70.2 Cg_endo -74.03 163.17 37.43 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.605 2.204 . . . . 0.0 112.075 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.3 t -124.44 160.94 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.818 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.476 ' HB2' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -130.75 79.5 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -135.16 -174.17 13.33 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.752 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.499 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -101.97 122.97 45.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.749 0.309 . . . . 0.0 110.968 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.474 ' HB2' HG21 ' A' ' 85' ' ' VAL . 28.9 tp -86.6 124.11 32.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.377 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.684 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 67.6 m-70 -112.72 90.48 3.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.972 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 191' ' ' VAL . 44.1 t -66.3 94.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.052 0.453 . . . . 0.0 110.851 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.6 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -91.8 141.06 29.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.938 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.31 34.39 1.54 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.671 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -166.43 18.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.858 0.361 . . . . 0.0 110.568 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.96 106.64 0.64 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.473 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.05 136.1 51.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 111.106 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.82 137.59 41.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 139' ' ' ILE . 3.8 t -119.47 118.47 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.147 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 136' ' ' LYS . 5.7 t -106.74 117.22 52.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.83 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.432 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 3.1 m-20 -51.4 145.03 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.964 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.87 15.47 25.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.533 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.64 -5.76 2.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.592 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.72 -13.62 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.435 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.44 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.9 OUTLIER 50.66 42.55 27.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.6 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.28 -117.73 4.37 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tp -171.54 128.12 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.683 0.278 . . . . 0.0 110.726 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.553 HG13 ' HB ' ' A' ' 130' ' ' VAL . 1.3 pt -114.69 -39.82 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.321 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.547 ' HB ' HG23 ' A' ' 130' ' ' VAL . 13.0 t -122.84 105.2 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.196 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -111.81 28.62 8.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -70.8 -177.0 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.113 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.74 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 21.7 m -128.41 156.79 42.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.559 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.53 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -67.71 -48.54 75.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.813 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -17.28 61.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.74 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 15.8 tttt -74.0 -53.67 9.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.837 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.11 144.19 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.104 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.8 t -46.56 -58.15 4.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.95 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.761 ' HA ' ' HB3' ' B' ' 4' ' ' ASN . 40.1 p90 -173.1 151.83 2.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.983 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 56.2 m -91.58 113.26 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.533 ' HB1' ' HG2' ' A' ' 99' ' ' MET . . . -120.91 98.56 47.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.074 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 50.1 Cg_exo -54.42 -90.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.454 2.102 . . . . 0.0 112.236 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.496 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 10.7 p-10 . . . . . 0 C--N 1.332 -0.16 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.475 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.79 ' HG2' ' H ' ' A' ' 183' ' ' SER . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.928 0.394 . . . . 0.0 111.082 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.48 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.63 127.57 2.97 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.591 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.503 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -117.08 166.68 11.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.332 . . . . 0.0 110.646 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.584 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 16.4 m -157.96 161.12 38.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.989 0.423 . . . . 0.0 111.288 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.8 145.76 44.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.191 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 174' ' ' CYS . 1.3 mt -112.94 159.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.01 0.433 . . . . 0.0 111.586 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 29.6 p -147.67 153.35 39.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.346 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.29 119.97 36.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 111.406 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.716 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 54.26 -160.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.34 179.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.04 -18.19 52.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.428 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.421 ' H ' ' H ' ' A' ' 169' ' ' THR . 8.9 t -168.4 -0.49 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.046 0.45 . . . . 0.0 109.943 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.561 HG21 ' HG3' ' A' ' 173' ' ' MET . 3.9 m -135.35 -20.36 1.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.04 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.716 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 31.6 mtt-85 58.34 42.82 20.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.957 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.441 ' HD3' ' O ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -179.82 -139.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.797 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.58 ' HE3' ' HA ' ' A' ' 94' ' ' PHE . 9.7 m0 -111.18 136.31 50.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.903 0.382 . . . . 0.0 111.377 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.561 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -157.89 130.61 7.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.239 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.438 ' HB2' HG23 ' A' ' 163' ' ' ILE . 34.7 t -117.25 136.72 52.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.426 . . . . 0.0 111.531 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 161' ' ' SER . 10.0 m170 -106.73 151.23 25.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.292 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -129.54 155.16 20.73 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.02 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -159.35 144.16 15.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.738 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 mt -108.91 176.6 5.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.075 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -111.16 128.4 55.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.8 OUTLIER -62.72 -31.76 72.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.916 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.491 ' HD2' ' HB3' ' A' ' 83' ' ' PHE . 4.0 mttm -90.98 -19.91 22.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 183' ' ' SER . 61.3 m-20 57.39 -157.42 0.29 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.837 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.79 ' H ' ' HG2' ' A' ' 158' ' ' ARG . 8.7 t 72.63 -20.88 0.25 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.635 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 182' ' ' ASP . . . 54.16 40.12 66.08 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.91 -10.59 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.79 0.328 . . . . 0.0 110.884 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.488 ' HD3' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -115.64 4.77 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.922 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 121' ' ' LEU . 5.0 mp -142.62 -51.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.308 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.0 t -56.87 -62.22 1.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.549 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.72 -3.82 7.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.608 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -92.4 -47.31 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.248 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.858 ' HA ' HG11 ' A' ' 123' ' ' VAL . 8.2 p -71.07 -20.05 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.267 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.54 -4.55 52.74 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.718 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.458 ' O ' HG23 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -112.33 -6.75 14.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.359 . . . . 0.0 110.794 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.28 -59.69 3.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.987 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -65.62 -26.9 68.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.776 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -66.12 -18.92 65.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 193' ' ' CYS . 86.7 t -105.58 -26.19 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.97 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 19.1 t -76.64 -10.21 59.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.676 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 196' ' ' ALA . 4.6 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.057 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.7 150.29 11.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.02 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.761 ' HB3' ' HA ' ' A' ' 149' ' ' PHE . 3.5 t30 -67.65 146.95 53.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.684 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 14.1 mtp -126.05 -4.19 6.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.081 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -92.83 24.6 3.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.496 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 37.7 p90 -80.62 156.2 26.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.165 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -90.37 9.92 27.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . 0.496 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 31.0 t0 58.87 71.53 0.58 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.049 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 18.3 m-85 -62.08 141.84 95.67 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 33.0 Cg_exo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.617 2.212 . . . . 0.0 112.312 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.742 0.306 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -45.24 48.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.726 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -65.77 -21.24 66.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.684 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.605 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.5 tt0 -106.58 -2.48 21.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.733 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -64.83 -50.98 64.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.98 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.604 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.8 t -55.09 -37.5 43.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.3 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.605 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 4.8 mtm180 -66.23 -35.91 81.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.184 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 m -81.11 1.47 31.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.601 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 66.77 43.7 2.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.516 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.605 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -172.36 84.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.99 0.424 . . . . 0.0 111.326 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.801 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.8 t -111.48 -151.43 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.352 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.627 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.4 OUTLIER 55.62 -160.04 0.19 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.866 0.365 . . . . 0.0 111.379 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 187' ' ' LEU . 22.0 m-85 -157.37 -167.77 2.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.236 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.435 ' HA ' HD22 ' A' ' 120' ' ' LEU . 71.9 m -49.01 148.64 2.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.82 0.343 . . . . 0.0 111.038 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.432 HG11 HD22 ' A' ' 121' ' ' LEU . 2.7 m -144.52 -173.82 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.043 0.449 . . . . 0.0 111.537 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -137.1 68.85 1.41 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.762 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 36.7 t80 -56.67 110.2 0.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.805 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -83.56 -52.71 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.33 -179.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 162.78 -137.56 4.88 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.756 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.549 ' HB3' ' ND1' ' A' ' 175' ' ' HIS . 0.8 OUTLIER -151.35 128.25 11.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.686 0.279 . . . . 0.0 111.087 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.99 162.52 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.03 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -81.45 143.04 32.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.953 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -145.44 127.67 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -92.79 61.01 3.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.94 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.64 -77.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.27 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.577 ' HA ' HG21 ' A' ' 163' ' ' ILE . 0.3 OUTLIER 54.59 32.4 16.95 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.696 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -134.34 132.06 39.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.693 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.38 -164.69 38.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.438 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.83 -11.19 12.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.003 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -77.9 15.08 0.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.393 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.94 -17.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.41 ' CB ' ' HB2' ' A' ' 161' ' ' SER . 16.9 p -87.74 -34.3 18.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.123 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.424 ' HG3' ' HA ' ' A' ' 153' ' ' ASP . 26.0 mt-10 -66.23 -0.21 2.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.961 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -120.34 -59.64 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.372 . . . . 0.0 111.367 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.517 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -55.5 -38.46 69.21 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.464 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.95 -36.53 62.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -76.66 -37.51 56.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.023 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.15 -44.59 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.615 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -72.19 -17.44 61.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.813 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.09 -11.37 58.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.665 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -80.4 -62.48 1.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.821 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.12 -163.96 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.271 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 72.26 -65.81 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.564 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.615 ' HG3' HD23 ' A' ' 109' ' ' LEU . 31.0 mmt180 -94.56 109.17 21.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.842 0.353 . . . . 0.0 111.001 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -82.1 142.48 47.86 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.982 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HB3' HD23 ' A' ' 88' ' ' LEU . 73.3 Cg_endo -77.33 160.05 32.65 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.589 2.193 . . . . 0.0 112.565 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 87' ' ' TYR . 1.4 t -128.15 152.22 35.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.056 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -96.84 100.09 11.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.751 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -144.51 -169.7 13.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.781 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.511 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.4 OUTLIER -117.78 128.75 55.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.655 0.264 . . . . 0.0 110.623 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.456 HD23 HD23 ' A' ' 187' ' ' LEU . 61.3 tp -92.78 122.44 35.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.177 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 8.0 m-70 -112.88 89.18 3.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.019 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.831 HG11 ' HA ' ' A' ' 191' ' ' VAL . 54.3 t -67.27 90.86 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.056 0.455 . . . . 0.0 110.527 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 p -82.92 156.54 23.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.452 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.47 -7.1 38.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.362 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 143' ' ' THR . 0.5 OUTLIER -124.16 34.61 5.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 110.839 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.654 ' HA2' HG13 ' A' ' 144' ' ' ILE . . . 122.52 -162.45 16.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.574 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.42 HD22 HG22 ' A' ' 123' ' ' VAL . 1.6 mt -122.96 166.86 14.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -159.84 103.87 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.667 HG12 HD12 ' A' ' 139' ' ' ILE . 4.4 t -90.32 98.57 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.21 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 136' ' ' LYS . 0.7 OUTLIER -92.38 114.57 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.913 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.401 ' HB3' HG22 ' A' ' 135' ' ' THR . 0.3 OUTLIER -52.72 146.99 9.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.61 19.28 11.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -131.15 -19.75 2.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.749 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.754 HG23 ' H ' ' A' ' 137' ' ' GLY . 12.2 t -134.87 -21.65 1.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.88 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.596 ' HA ' HG12 ' A' ' 131' ' ' VAL . 9.3 mmtt 56.65 23.95 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.817 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.754 ' H ' HG23 ' A' ' 135' ' ' THR . . . -77.43 -105.43 0.16 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.443 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.3 tp -165.95 102.34 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 110.699 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.667 HD12 HG12 ' A' ' 130' ' ' VAL . 3.2 mt -80.16 -30.06 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.213 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.475 HG12 HG23 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -156.56 148.38 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.267 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -129.29 48.57 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.819 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.47 ' HG3' ' HE2' ' A' ' 162' ' ' TYR . 1.5 mm-40 -79.09 -175.58 4.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.052 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 2.6 m -149.0 164.85 33.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.654 HG13 ' HA2' ' A' ' 127' ' ' GLY . 69.2 mt -82.83 -37.93 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -12.2 60.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.626 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -86.43 -48.63 8.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.7 m -64.97 141.45 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.12 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 t -49.87 -65.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.808 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -159.64 123.33 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.805 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 77.0 m -59.87 163.16 4.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.42 125.12 0.74 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.075 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 72.3 Cg_endo -76.1 -94.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.557 2.171 . . . . 0.0 112.438 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.424 ' HA ' ' HG3' ' A' ' 103' ' ' GLU . 5.3 p-10 . . . . . 0 C--O 1.232 0.139 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.434 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.497 HH11 ' HB3' ' A' ' 182' ' ' ASP . 8.8 mtm180 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.803 0.335 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.516 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -122.81 140.37 13.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.419 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -119.49 168.08 11.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 110.833 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 175' ' ' HIS . 13.5 m -154.02 160.52 42.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.859 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.47 ' HE2' ' HG3' ' A' ' 142' ' ' GLN . 4.7 p90 -134.1 151.59 51.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.799 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.577 HG21 ' HA ' ' A' ' 96' ' ' SER . 0.7 OUTLIER -115.77 157.16 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.046 0.451 . . . . 0.0 111.734 -178.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.98 135.94 9.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.287 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -118.22 119.99 36.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.895 0.378 . . . . 0.0 111.675 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.86 -164.12 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.713 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.19 -17.61 12.22 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.847 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.442 ' H ' ' H ' ' A' ' 169' ' ' THR . 1.6 t -174.05 -0.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.031 0.443 . . . . 0.0 109.932 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -125.0 -15.73 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.868 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.44 21.31 9.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 177.91 176.48 0.43 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.1 121.32 25.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.663 ' HB2' HG21 ' A' ' 169' ' ' THR . 9.4 mtp -143.02 138.67 30.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.568 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.438 ' HB2' HG23 ' A' ' 163' ' ' ILE . 5.6 t -123.02 136.68 54.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.151 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.549 ' ND1' ' HB3' ' A' ' 90' ' ' CYS . 5.6 m-70 -102.44 157.71 16.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.555 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -133.07 145.26 17.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.865 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 17.8 p90 -153.95 136.44 15.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.768 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.516 HD23 ' HA3' ' A' ' 159' ' ' GLY . 5.7 mt -101.82 166.26 10.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.938 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.16 115.83 29.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -10.75 56.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -84.79 -24.09 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.497 ' HB3' HH11 ' A' ' 158' ' ' ARG . 47.1 m-20 56.98 82.97 0.11 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.6 t -167.02 -58.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.102 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.37 29.11 11.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.299 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -133.88 -54.71 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.416 ' HB2' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -59.93 -15.74 24.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.271 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.456 HD23 HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -115.16 -53.89 2.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -49.89 75.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.404 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -73.99 9.0 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.206 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.62 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -103.53 -55.75 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.81 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.831 ' HA ' HG11 ' A' ' 123' ' ' VAL . 13.2 p -64.03 -25.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -63.69 -19.42 62.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.335 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 91.8 m -103.09 10.22 38.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.828 0.347 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.604 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -90.56 -34.0 15.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.217 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.496 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 1.6 m-85 -62.03 -45.35 93.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.002 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.712 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -58.2 -16.03 12.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.597 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.21 -27.99 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.185 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -27.32 60.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.712 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.249 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.751 0.31 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -168.16 153.91 7.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.722 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -65.39 146.83 54.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.79 -12.26 13.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 83.5 p -91.34 25.6 2.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.84 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -61.57 145.24 52.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.071 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.89 0.24 56.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t0 56.6 78.41 0.22 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -82.44 150.98 64.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.998 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.585 2.19 . . . . 0.0 112.333 179.933 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.844 0.354 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.17 -28.32 65.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.652 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.31 -16.03 61.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.672 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.622 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 5.7 mt-10 -105.31 -16.07 14.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.663 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -54.81 -45.64 74.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.061 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.1 t -64.52 -45.38 95.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.465 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.622 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -54.19 -31.89 54.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.274 178.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -78.93 -91.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.399 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 178.45 34.97 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.373 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.545 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.4 t -174.35 101.21 0.1 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.929 0.395 . . . . 0.0 111.913 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.797 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 2.8 t -122.49 -149.09 0.42 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.461 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.765 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 54.55 -155.68 0.24 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.847 0.356 . . . . 0.0 111.81 178.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -159.39 -169.35 2.58 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.502 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.404 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -51.12 147.04 5.71 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.831 0.348 . . . . 0.0 110.962 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -140.77 -174.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.453 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.09 70.6 1.3 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.596 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 41.1 t80 -52.01 99.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.741 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.589 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 0.7 OUTLIER -71.41 -6.32 39.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.272 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.36 -164.48 12.14 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.619 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 10.1 p -125.72 144.51 50.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.683 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.549 HG12 ' HD2' ' A' ' 114' ' ' ARG . 33.1 m -131.04 161.89 40.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.021 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.03 155.36 20.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.724 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.9 165.87 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.973 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -134.97 59.76 1.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.006 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -155.81 -71.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 54.13 41.09 32.16 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -148.65 108.73 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.999 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.01 -144.32 16.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.765 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.45 -29.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.84 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -73.87 1.65 10.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.13 -28.12 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.031 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.849 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 1.7 m -90.79 -17.55 26.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -7.49 34.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.564 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.6 mm-40 -117.46 -41.34 2.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.019 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.08 82.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.68 -39.27 76.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -70.39 -38.78 74.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 104' ' ' GLU . 22.8 t -56.44 -34.61 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.639 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.782 HD23 ' HG3' ' A' ' 114' ' ' ARG . 2.5 mt -72.21 -28.16 63.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.669 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -12.76 59.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.55 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.84 -18.42 15.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.198 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.7 m -118.7 171.82 7.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.083 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -114.33 66.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.782 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -63.35 -92.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.2 -179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -150.01 75.72 8.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.337 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 67.2 Cg_endo -73.97 108.72 2.72 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.637 2.225 . . . . 0.0 112.219 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.26 125.98 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.017 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.61 106.49 18.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.908 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -148.45 -171.99 17.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.822 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -100.02 138.89 36.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.04 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.665 HD13 HG22 ' A' ' 130' ' ' VAL . 28.0 tp -108.81 125.42 51.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.181 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 0.1 OUTLIER -117.76 95.61 5.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.292 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.817 HG11 ' HA ' ' A' ' 191' ' ' VAL . 74.9 t -67.1 94.22 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.977 0.418 . . . . 0.0 110.557 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.653 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -92.13 143.0 26.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.627 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -80.1 37.65 2.17 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.648 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -168.89 20.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.729 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 135.39 101.05 0.65 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.221 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 8.6 mt -60.89 132.82 55.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -122.13 146.72 46.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.654 179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.665 HG22 HD13 ' A' ' 121' ' ' LEU . 16.2 t -133.52 98.02 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.26 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.47 ' H ' ' HE1' ' A' ' 122' ' ' HIS . 2.3 t -98.07 124.81 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.889 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.542 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 8.5 t70 -53.67 160.39 1.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.6 OUTLIER -99.49 -1.51 38.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.387 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.03 -43.67 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.937 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.47 -23.2 21.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.43 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 131' ' ' VAL . 6.1 mmtp 50.62 26.55 2.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.19 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.73 -109.05 0.73 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.418 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 141' ' ' ASP . 13.8 tp -160.04 116.72 2.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.93 0.395 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 132' ' ' ASP . 6.5 mm -96.54 -56.39 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.156 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 t -127.68 116.42 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.233 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.432 ' HB3' HD21 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -111.78 39.99 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.581 179.106 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -77.19 -168.44 1.11 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.47 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.613 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 5.1 m -146.05 158.34 43.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.826 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.653 HD11 ' O ' ' A' ' 124' ' ' SER . 4.5 mt -67.65 -35.63 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.041 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -80.62 -11.02 59.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.683 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -90.59 -40.58 11.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 143' ' ' THR . 1.0 OUTLIER -64.86 125.77 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.99 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.6 -73.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.112 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.46 124.49 12.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.29 159.99 22.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.413 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -170.51 108.53 0.43 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.035 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.38 9.95 2.95 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.487 2.125 . . . . 0.0 112.459 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.53 0.193 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.386 -179.41 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.702 ' HG2' ' N ' ' A' ' 183' ' ' SER . 1.3 mpt_? . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.919 0.39 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -105.52 144.68 15.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.729 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 1.7 m-85 -131.34 150.97 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.849 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 0.9 OUTLIER -154.39 151.82 29.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.463 -178.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.543 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -127.05 163.0 24.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.282 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.629 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.8 OUTLIER -122.24 161.49 23.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.975 0.417 . . . . 0.0 111.362 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 2.1 t -155.93 118.93 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.621 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -89.93 119.01 29.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.458 ' HA ' ' N ' ' A' ' 170' ' ' ARG . 0.5 OUTLIER 50.35 -152.14 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.221 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.67 -29.8 2.92 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.775 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.56 -1.15 0.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.031 0.444 . . . . 0.0 109.952 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.775 HG22 ' HG3' ' A' ' 171' ' ' ARG . 1.6 m -128.98 -20.96 3.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.458 ' N ' ' HA ' ' A' ' 166' ' ' ASP . 5.7 mtt-85 66.41 24.14 10.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.316 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.775 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER 178.14 -176.86 0.21 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.051 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.17 132.28 48.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.194 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.537 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -163.21 124.45 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.561 179.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.629 ' HB2' HG23 ' A' ' 163' ' ' ILE . 1.9 t -115.84 140.94 48.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.96 0.41 . . . . 0.0 111.251 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.543 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -108.28 145.44 34.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -129.61 152.9 19.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.121 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 42.5 p90 -156.43 154.31 30.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.719 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.444 HD12 HD21 ' A' ' 88' ' ' LEU . 9.1 mt -112.59 158.12 20.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.821 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.435 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -88.38 118.43 28.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.854 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.14 -4.29 16.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.023 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -101.57 -29.64 11.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 58.0 92.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.702 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 28.9 t -167.08 -36.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.009 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.78 19.05 76.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -136.75 -20.87 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.573 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -79.09 -25.6 43.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.037 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 186' ' ' ARG . 6.7 mp -120.89 -43.33 2.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.4 t -58.4 -52.49 65.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -75.57 7.63 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.227 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.79 -56.82 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.091 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.817 ' HA ' HG11 ' A' ' 123' ' ' VAL . 7.6 p -65.76 -22.07 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.204 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.64 -18.95 62.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.508 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.481 ' O ' HG23 ' A' ' 197' ' ' VAL . 1.1 m -105.07 -3.3 23.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 110.712 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.528 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -64.52 -46.26 83.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.152 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.485 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.7 p90 -70.07 -39.1 75.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.991 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.435 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -57.98 -20.03 35.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.514 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 77' ' ' ARG . 35.5 t -105.48 -24.84 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.7 t -73.29 -3.11 24.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.771 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 5.0 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.102 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.734 0.302 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.5 p -173.81 141.94 0.86 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.643 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -60.62 161.46 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.149 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 9.8 ttp -124.17 -2.15 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.959 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p -93.95 17.32 12.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.991 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -65.37 146.02 55.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.974 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -88.45 -1.57 58.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.954 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t0 55.03 77.13 0.22 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 23.5 m-85 -60.03 141.91 89.63 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 32.5 Cg_exo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.583 2.189 . . . . 0.0 112.267 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.89 0.376 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.54 -39.32 53.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.98 -39.69 79.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.694 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -74.56 -15.56 60.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -63.78 -47.84 79.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.472 HG22 HG12 ' A' ' 123' ' ' VAL . 24.3 t -58.8 -40.89 81.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -65.63 -31.88 73.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.396 178.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.66 -0.93 40.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.514 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 69.0 39.94 1.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.594 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.768 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -171.37 88.02 0.1 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.074 0.464 . . . . 0.0 111.439 178.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.928 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.9 t -117.75 -145.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.078 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.662 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.55 -156.67 0.19 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.925 0.393 . . . . 0.0 111.483 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -161.81 -167.94 1.82 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.539 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 5.4 m -50.78 150.26 2.98 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.977 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.47 -171.77 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.021 0.439 . . . . 0.0 111.839 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.02 80.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.289 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.534 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -53.91 166.44 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.296 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 18.4 mt -126.42 -46.97 1.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.628 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.14 -127.0 2.3 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.434 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.8 p -152.6 134.21 14.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.988 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 HD11 ' A' ' 109' ' ' LEU . 6.1 m -135.19 159.84 40.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 2.9 pt-20 -88.72 138.99 30.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.397 . . . . 0.0 110.986 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 m -129.33 127.07 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.94 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.89 65.77 4.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.967 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.618 ' HG3' ' HG3' ' A' ' 97' ' ' ARG . 1.4 tp10 -163.31 -65.57 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.282 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.4 22.89 11.37 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.642 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -151.84 117.04 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.901 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.41 158.65 11.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.454 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.74 -4.89 54.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.805 0.336 . . . . 0.0 111.031 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.75 -20.7 30.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.7 t -61.29 -32.68 53.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.844 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.413 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 58.5 m -85.6 -27.09 25.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.983 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.27 -15.44 63.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.017 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 108' ' ' VAL . 30.5 mt-10 -110.11 -45.63 3.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.85 -31.79 68.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.35 -42.11 90.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.667 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -73.75 -32.53 63.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.788 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 104' ' ' GLU . 52.1 t -55.99 -42.51 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.572 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -68.65 -35.38 77.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.549 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -69.1 -22.85 63.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.501 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -94.81 -14.38 24.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.769 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m -94.21 179.35 5.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.091 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -90.79 12.38 19.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.439 ' CG ' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -57.68 110.87 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.927 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 136.22 94.36 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.279 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -84.83 153.25 11.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.816 2.344 . . . . 0.0 112.565 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.534 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -128.54 97.55 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.774 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -80.73 129.68 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 -179.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -167.39 -163.01 20.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.291 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -106.02 118.34 36.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.814 0.34 . . . . 0.0 111.077 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.987 HD13 HG22 ' A' ' 130' ' ' VAL . 13.4 tp -89.3 127.16 35.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.456 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.768 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 35.5 m-70 -112.86 95.99 5.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.014 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.928 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 40.0 t -65.46 95.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.043 0.449 . . . . 0.0 110.441 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.48 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -94.42 126.7 39.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.222 179.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -63.17 -1.29 3.94 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.831 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -131.56 32.79 4.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 110.817 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.69 102.28 1.15 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.452 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mt -68.64 125.63 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 111.319 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.576 ' HB2' HD11 ' A' ' 138' ' ' LEU . 0.9 OUTLIER -121.1 143.34 49.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.435 179.071 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.987 HG22 HD13 ' A' ' 121' ' ' LEU . 18.4 t -122.67 115.1 44.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.904 0.383 . . . . 0.0 111.483 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.8 t -94.68 147.67 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.35 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 137' ' ' GLY . 38.7 m-20 -83.42 161.3 21.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.789 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -112.54 5.25 17.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.625 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.12 -3.06 5.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.968 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.401 ' H ' ' H ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -150.38 -14.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.523 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 23.1 mmtt 53.98 29.71 10.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.085 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 132' ' ' ASP . . . -99.33 148.4 18.69 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.394 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 129' ' ' ARG . 6.2 tp -76.36 120.88 22.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.902 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 9.5 pt -108.5 -16.01 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.228 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 130' ' ' VAL . 84.4 t -129.88 94.75 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 111.148 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.416 ' CG ' HD23 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -96.62 17.21 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.715 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.403 ' HG2' HG13 ' A' ' 140' ' ' VAL . 7.6 mm100 -72.46 -173.84 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.828 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 24.4 m -142.56 160.58 40.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.619 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 124' ' ' SER . 45.0 mt -59.36 -56.28 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.26 -18.95 64.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.779 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.828 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 1.8 tttp -71.2 -61.38 1.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.973 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 143' ' ' THR . 2.6 m -61.25 140.04 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.093 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -43.89 -67.86 0.24 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.081 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.642 ' HZ ' ' HA ' ' A' ' 97' ' ' ARG . 0.3 OUTLIER -169.76 142.52 2.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.167 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.42 165.06 19.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.587 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -166.37 124.64 1.07 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.352 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.464 ' HB2' ' H ' ' A' ' 153' ' ' ASP . 90.8 Cg_endo -82.86 -136.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.693 2.262 . . . . 0.0 112.104 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.464 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.821 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.465 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.954 0.407 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -148.35 114.75 0.7 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.468 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.4 m-85 -107.92 171.49 7.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.772 0.32 . . . . 0.0 111.203 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.658 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -165.11 154.48 12.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.46 160.38 34.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.52 151.96 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 110.29 6.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -83.36 97.96 9.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.98 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 51.94 -160.01 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.973 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 72.24 -3.3 23.64 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.768 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.426 ' H ' ' H ' ' A' ' 169' ' ' THR . 8.9 t -172.19 -8.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 0.0 110.061 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.694 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -129.41 -16.14 3.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.835 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 58.45 29.84 18.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.773 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -178.71 -167.41 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.712 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.77 99.5 10.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 0.0 110.78 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.694 ' HB2' HG21 ' A' ' 169' ' ' THR . 3.8 mtp -138.81 147.05 42.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.977 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.29 148.48 52.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.118 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -107.11 145.77 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.684 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.658 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -121.33 157.05 16.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.714 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 15.4 p90 -165.85 175.71 8.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.682 0.277 . . . . 0.0 110.504 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.502 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 1.2 mp -139.89 -172.85 3.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.967 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -115.82 130.67 56.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.021 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 84' ' ' SER . 7.3 t -67.35 -27.84 67.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.184 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.404 ' HB2' ' HD3' ' A' ' 186' ' ' ARG . 4.2 mttm -83.47 -42.23 17.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.162 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 57.86 89.94 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.016 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.8 t -156.97 -26.31 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.988 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.567 ' H ' ' CZ ' ' A' ' 186' ' ' ARG . . . 84.61 5.74 86.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.607 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -131.54 12.65 4.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.852 0.358 . . . . 0.0 111.061 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.689 HH11 ' HB2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -115.18 -10.17 12.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 -179.272 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.689 ' HB2' HH11 ' A' ' 186' ' ' ARG . 1.5 mp -148.42 -45.95 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.354 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.0 t -51.17 -63.53 1.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.626 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 5.06 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.638 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.49 -53.14 3.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.225 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.49 ' HA ' HG11 ' A' ' 123' ' ' VAL . 5.2 p -70.07 -18.32 21.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.07 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 195' ' ' PHE . . . -73.74 1.74 44.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.257 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.421 ' O ' HG23 ' A' ' 197' ' ' VAL . 56.7 m -118.09 -5.57 10.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.697 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -66.06 -52.56 47.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.205 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.551 ' HD1' HD11 ' A' ' 199' ' ' LEU . 46.2 p90 -65.4 -24.24 67.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.764 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.901 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -66.81 -8.72 30.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.286 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 193' ' ' CYS . 3.4 t -101.97 -12.95 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.114 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.96 3.71 22.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.691 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.901 HD12 ' HA ' ' A' ' 196' ' ' ALA . 4.9 mt . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.054 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.96 0.41 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 1.4 p -165.41 136.22 3.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.413 ' H ' ' ND2' ' B' ' 4' ' ' ASN . 0.8 OUTLIER -57.8 111.03 1.02 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.025 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.6 6.93 45.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.163 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 73.9 p -96.32 18.54 13.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -67.34 150.23 49.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.04 11.71 33.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 14.5 t70 56.85 80.68 0.15 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.15 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.8 152.14 84.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.486 2.124 . . . . 0.0 112.231 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.962 0.41 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -36.07 68.24 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.46 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.74 -22.79 66.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.361 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.647 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 3.6 mt-10 -96.02 -14.32 23.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.648 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -58.33 -50.78 72.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.807 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 t -63.77 -39.86 86.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.367 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.647 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -58.22 -35.39 71.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.454 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.9 m -78.41 -90.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.556 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 179.28 32.69 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.525 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.78 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -170.26 99.66 0.27 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.92 0.391 . . . . 0.0 111.938 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.752 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.1 t -119.94 -151.53 0.48 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.104 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.744 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 55.26 -155.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.837 0.351 . . . . 0.0 111.46 179.264 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.58 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 1.9 m-85 -164.32 -167.64 1.35 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.63 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.4 150.44 3.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.069 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 m -147.71 -178.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 111.871 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 3.7 mmtt -130.63 85.99 2.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.657 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.622 ' HB3' HG23 ' A' ' 117' ' ' VAL . 29.1 t80 -58.56 94.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 3.9 mt -67.1 -17.47 64.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.055 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 114' ' ' ARG . . . 117.59 -131.03 9.13 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.572 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.511 ' N ' HD21 ' A' ' 109' ' ' LEU . 7.1 p -156.61 141.6 17.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.686 0.279 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 m -131.84 161.85 40.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.205 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -83.32 131.25 35.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.371 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 174' ' ' CYS . 16.3 m -141.65 131.87 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.94 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -103.04 73.4 1.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.941 0.401 . . . . 0.0 111.105 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.569 ' HB3' HG21 ' A' ' 101' ' ' VAL . 1.4 mt-10 -164.78 -71.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.059 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 p 45.15 33.5 1.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -121.86 -40.61 2.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.484 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.52 158.28 15.43 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.901 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -17.89 59.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.866 0.365 . . . . 0.0 110.904 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -72.36 -24.68 61.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 95' ' ' GLU . 6.7 t -59.94 -30.18 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.53 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 96.5 m -79.72 -28.25 40.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.766 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.71 -14.63 61.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.135 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.9 mt-10 -108.72 -44.32 4.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.22 -31.87 69.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.086 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.78 -38.55 91.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -40.87 84.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' GLU . 5.1 t -63.25 -44.51 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.666 HD23 ' HG3' ' A' ' 114' ' ' ARG . 3.0 mt -61.31 -34.95 76.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.269 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 110' ' ' ARG . 11.1 ttt-85 -74.05 -31.48 62.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.738 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -86.63 -14.45 42.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.308 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.12 -6.78 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.311 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 36.68 71.56 0.13 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.652 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.666 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -82.72 68.12 9.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.931 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 58.43 82.87 0.23 Allowed Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.361 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 92.7 Cg_endo -80.52 135.05 10.26 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.623 2.215 . . . . 0.0 112.23 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -129.85 158.94 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.191 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.6 ttp-105 -119.68 98.5 6.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -131.69 169.78 21.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.615 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -92.34 104.2 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.693 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.812 HD13 HG22 ' A' ' 130' ' ' VAL . 15.9 tp -74.92 129.11 37.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.425 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.78 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 52.2 m170 -115.05 94.6 4.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.752 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 71.4 t -69.31 90.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.927 0.394 . . . . 0.0 110.506 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.665 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -90.17 140.79 29.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.195 179.179 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.49 1.95 4.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.774 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -130.64 32.45 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 119.66 122.98 3.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.536 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.406 ' CD2' HG13 ' A' ' 123' ' ' VAL . 2.6 mt -76.05 141.93 41.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.739 0.304 . . . . 0.0 111.041 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -145.47 122.56 11.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.69 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.812 HG22 HD13 ' A' ' 121' ' ' LEU . 2.2 t -102.16 118.51 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.337 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 t -106.2 116.62 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.768 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.55 151.43 2.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.028 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.48 -6.83 54.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.364 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.72 -50.3 2.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.966 0.412 . . . . 0.0 110.695 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.0 m -82.95 -21.75 33.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.636 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp 51.69 28.19 4.64 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.211 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.41 -116.2 1.12 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.435 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tp -171.97 113.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.693 0.282 . . . . 0.0 110.543 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.583 HG13 ' HB ' ' A' ' 130' ' ' VAL . 2.9 pt -94.49 -41.49 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.497 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.668 ' HB ' HG23 ' A' ' 130' ' ' VAL . 39.8 t -122.85 103.78 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.177 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -113.19 48.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.798 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -98.11 -166.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.804 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.555 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 12.1 m -133.96 158.4 43.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.665 HD11 ' O ' ' A' ' 124' ' ' SER . 2.0 mt -65.05 -44.56 95.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.664 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.05 -20.02 56.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.56 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 12.9 tttp -69.82 -45.34 68.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.709 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 164' ' ' CYS . 5.9 m -74.83 150.98 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.747 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.8 -53.89 49.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.446 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.654 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 40.3 p90 -174.62 -174.21 0.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.1 t -110.95 157.92 19.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.726 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.0 115.6 0.55 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.844 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 84.4 Cg_endo -79.96 -119.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 111.996 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.431 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 8.1 p-10 . . . . . 0 C--N 1.332 -0.165 0 CA-C-O 120.742 0.306 . . . . 0.0 110.72 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 121.023 0.439 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.98 133.64 10.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.466 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.844 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 1.7 m-85 -126.92 163.65 23.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.3 . . . . 0.0 110.665 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -164.6 144.57 7.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.009 0.433 . . . . 0.0 111.255 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -126.44 139.59 53.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.481 178.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.4 OUTLIER -101.04 139.99 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.242 -179.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.485 ' HB2' HG12 ' A' ' 147' ' ' VAL . 10.7 t -149.02 129.62 14.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.716 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.654 ' H ' ' HE ' ' A' ' 165' ' ' ARG . 0.2 OUTLIER -92.87 122.62 35.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.711 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 50.38 -158.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.432 179.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.48 -29.51 8.29 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.457 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.439 ' H ' ' H ' ' A' ' 169' ' ' THR . 9.4 t -164.63 6.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.57 . . . . 0.0 109.532 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.582 HG21 ' HG3' ' A' ' 173' ' ' MET . 24.7 m -136.88 -18.1 1.39 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.65 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.711 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 7.3 mtt180 57.72 32.48 21.94 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.407 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.511 ' HB2' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -163.41 150.11 12.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.711 -178.299 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -75.02 79.11 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.405 178.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.582 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.2 OUTLIER -110.57 166.78 10.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.078 -179.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.656 ' HB2' HG23 ' A' ' 163' ' ' ILE . 53.2 t -123.6 127.59 48.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.48 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 10.8 m170 -90.75 124.99 35.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.559 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -108.2 156.28 15.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.612 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -170.66 152.68 3.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.714 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.562 HD11 HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -121.5 165.9 14.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.52 126.24 34.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.971 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 4.5 t -61.99 -21.07 64.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.815 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.58 ' HE3' ' HB3' ' A' ' 83' ' ' PHE . 2.8 mmtp -84.39 -23.02 30.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.672 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 55.08 83.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.1 t -159.74 -64.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 108.44 41.51 1.48 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.385 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.35 -33.48 0.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.752 0.31 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.556 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -72.48 -11.51 60.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.706 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 186' ' ' ARG . 5.2 mp -137.07 -36.89 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.114 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.2 t -57.94 -55.6 32.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.256 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.25 0.43 16.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.054 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -89.17 -54.81 3.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.67 ' HA ' HG11 ' A' ' 123' ' ' VAL . 10.9 p -75.41 -30.48 22.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.68 -9.49 45.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.252 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 57.5 m -110.53 -10.28 14.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 110.707 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.61 -43.35 94.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.244 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.471 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 2.0 p90 -61.74 -32.58 72.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.725 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -61.86 -33.66 74.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.21 5.62 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.641 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -93.62 -43.92 8.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.823 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.866 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.658 0.266 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.654 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.9 p -168.81 148.36 4.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.942 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 149' ' ' PHE . 9.4 m-80 -64.36 156.93 27.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.811 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 20.5 mtm -126.63 -18.18 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -76.52 0.1 21.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.083 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -63.12 148.91 46.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.972 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -97.22 4.61 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.926 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 29.2 t0 56.98 77.3 0.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -70.03 151.61 96.05 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.763 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.487 2.125 . . . . 0.0 112.262 179.696 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.838 0.352 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.39 -32.6 26.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.562 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -71.78 -36.22 70.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.243 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.74 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -69.36 -19.45 63.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.265 178.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -61.69 -52.15 65.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.945 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.9 -37.99 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.54 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.74 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 11.5 mtp180 -56.89 -40.34 76.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.461 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -75.61 -91.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.477 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 179.34 38.51 0.0 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.343 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.552 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.7 t -173.2 95.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.991 0.424 . . . . 0.0 111.466 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.612 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 11.6 t -122.68 10.29 9.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.534 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -114.2 -162.84 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.218 -179.44 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.683 ' HB2' HD11 ' A' ' 187' ' ' LEU . 60.3 m-85 -150.07 -168.6 3.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.72 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.623 ' HA ' HD22 ' A' ' 120' ' ' LEU . 1.0 OUTLIER -47.53 151.52 0.79 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.87 0.367 . . . . 0.0 111.366 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.42 -170.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.125 0.488 . . . . 0.0 111.679 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.93 73.09 1.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.311 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 83.6 t80 -55.45 98.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.143 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 178' ' ' LEU . 4.3 mt -61.36 -50.03 74.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.492 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 153.04 -128.13 2.38 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.241 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.423 ' N ' HD21 ' A' ' 109' ' ' LEU . 1.6 p -161.79 126.15 3.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 0.0 110.866 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.3 m -110.18 165.8 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.036 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.77 116.02 28.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.142 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.3 m -108.99 -165.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.865 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.95 65.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 1.2 mm-40 -166.32 -66.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.81 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.54 ' HA ' HG21 ' A' ' 163' ' ' ILE . 2.1 m 59.92 33.23 21.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 15.7 ptt180 -169.57 80.57 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.59 146.62 4.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.246 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.453 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -72.29 -29.89 64.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.775 0.322 . . . . 0.0 111.206 -179.421 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.453 ' N ' ' HG3' ' A' ' 99' ' ' MET . 0.5 OUTLIER -77.39 -21.19 53.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.926 -179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 t -60.73 -35.02 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 55.5 m -73.26 -49.98 24.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.951 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -56.33 -29.68 61.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.295 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.5 mm-40 -76.57 -51.72 11.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.94 -31.63 68.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.048 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.68 -43.33 93.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.845 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -62.86 -43.27 99.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 104' ' ' GLU . 18.8 t -62.62 -39.81 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.047 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.637 HD23 ' HG3' ' A' ' 114' ' ' ARG . 8.1 mt -65.83 -36.15 82.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.827 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -76.13 -14.35 60.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.298 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -95.87 -16.53 21.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.786 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.84 -177.08 3.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.59 ' H ' ' HE ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -116.85 71.77 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.814 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.637 ' HG3' HD23 ' A' ' 109' ' ' LEU . 22.7 mmt180 -85.19 22.52 1.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.071 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 54.29 88.15 0.13 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.817 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 17.2 Cg_exo -66.57 137.29 45.78 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.82 2.347 . . . . 0.0 111.77 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.76 113.39 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.01 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -75.28 107.42 7.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.697 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -142.67 -167.3 11.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.834 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -118.4 122.87 43.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.658 0.266 . . . . 0.0 110.715 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.705 HD13 HG22 ' A' ' 130' ' ' VAL . 32.4 tp -89.5 133.76 34.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.777 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.494 ' CD2' HD12 ' A' ' 120' ' ' LEU . 14.2 m170 -123.03 94.75 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.186 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 53.2 t -62.28 96.15 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.061 0.457 . . . . 0.0 110.338 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.634 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -99.7 130.6 45.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.487 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -64.25 -0.24 4.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.961 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -126.17 29.01 5.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.855 0.36 . . . . 0.0 110.807 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 117.19 113.49 2.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.259 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.585 HD21 HG22 ' A' ' 123' ' ' VAL . 0.5 OUTLIER -57.04 146.33 27.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 -179.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -138.41 120.35 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 121' ' ' LEU . 2.2 t -110.29 108.28 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 111.271 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.99 117.69 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.058 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 76.9 m-20 -53.71 156.75 2.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.75 1.39 29.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -116.62 -31.33 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.523 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.25 -6.53 9.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.727 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 4.4 mmtm 50.91 25.59 2.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.11 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.11 167.27 30.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.357 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 138' ' ' LEU . 8.7 tp -99.48 116.32 31.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.61 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.559 HG13 ' HB ' ' A' ' 130' ' ' VAL . 1.2 pt -94.42 -50.23 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.374 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.491 ' HB ' HG23 ' A' ' 130' ' ' VAL . 48.7 t -110.37 95.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.916 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -105.09 67.49 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.656 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -114.8 -171.91 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.152 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 88.6 m -131.16 151.88 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.552 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.634 HD11 ' O ' ' A' ' 124' ' ' SER . 3.4 mt -61.28 -31.89 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.655 ' H ' HG22 ' A' ' 143' ' ' THR . 2.1 mt-10 -90.65 -6.62 54.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.516 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.661 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 5.7 tptm -90.08 -37.75 14.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.028 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -58.42 134.32 23.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.806 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.6 t -70.61 -21.15 62.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.462 ' CB ' HD12 ' A' ' 163' ' ' ILE . 0.2 OUTLIER -170.05 151.96 4.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.125 0.488 . . . . 0.0 111.514 -179.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.32 137.22 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.916 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.572 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -168.55 119.81 0.66 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.66 0.267 . . . . 0.0 111.687 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 55.9 Cg_endo -69.43 -94.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.342 2.028 . . . . 0.0 111.625 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.459 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 120.757 0.313 . . . . 0.0 111.476 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.54 129.73 6.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.56 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.591 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 0.5 OUTLIER -127.13 155.42 43.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 110.682 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.573 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -160.84 159.98 30.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 111.273 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.97 143.1 33.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.323 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.54 HG21 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -104.23 148.7 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.948 0.404 . . . . 0.0 111.183 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.8 p -135.37 148.65 49.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.74 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.28 101.37 9.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.01 -152.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.075 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.73 -15.03 22.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.508 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.416 ' H ' ' H ' ' A' ' 169' ' ' THR . 15.1 t -171.25 -0.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 110.008 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.499 HG21 ' HB2' ' A' ' 173' ' ' MET . 3.3 m -127.63 -18.74 4.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.083 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 60.07 30.66 20.11 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.783 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -179.43 -168.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.882 179.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -98.78 112.39 24.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.025 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.783 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 25.3 mtp -139.6 149.84 44.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.567 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.516 ' HB2' HG23 ' A' ' 163' ' ' ILE . 20.4 t -117.69 147.37 42.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.154 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -114.78 137.2 52.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.445 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -128.84 156.55 21.17 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.994 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -166.93 155.85 10.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 111.076 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.464 HD12 HD21 ' A' ' 88' ' ' LEU . 1.4 mt -111.93 178.17 4.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.612 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.591 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -113.57 125.66 54.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 0.0 110.959 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.3 OUTLIER -71.13 -5.07 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.787 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.445 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 13.1 mmmt -91.01 -37.54 13.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 58.14 85.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.99 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.2 t -163.86 -39.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.83 17.94 79.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.494 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -132.57 1.11 3.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.868 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.43 ' HB2' HD12 ' A' ' 187' ' ' LEU . 8.6 mmm180 -108.8 -33.6 6.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 83' ' ' PHE . 5.7 mp -114.99 -43.21 3.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.125 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.5 t -58.72 -66.39 0.5 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.451 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.6 -16.22 55.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.157 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.72 -56.28 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.22 -19.72 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.018 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -77.47 -0.14 71.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.334 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 58.0 m -120.29 0.37 10.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.31 -40.94 50.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.104 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 7.1 p90 -67.72 -31.18 70.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.814 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.442 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -61.4 -29.39 69.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.373 . . . . 0.0 110.969 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 4.9 t -99.29 0.48 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.889 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -92.6 -38.31 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.222 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.73 0.3 . . . . 0.0 110.904 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.94 162.25 23.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.003 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -65.81 167.09 9.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 3.6 mtp -134.92 -22.45 1.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 60.3 p -81.2 14.91 2.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -62.55 153.9 30.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.934 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -91.33 -0.27 57.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 t0 56.36 78.59 0.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.197 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.667 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 25.5 m-85 -66.45 -51.61 41.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.134 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 31.8 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.213 1.942 . . . . 0.0 112.255 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.929 0.395 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.48 -33.34 48.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -65.26 -22.02 66.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.575 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.736 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.5 mt-10 -100.61 -13.68 18.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.802 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -59.5 -46.89 87.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.763 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 194' ' ' ALA . 7.1 t -61.49 -42.64 94.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.349 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.736 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 7.5 mtp180 -54.45 -34.8 62.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.143 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 1.4 m -78.12 -90.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.251 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 176.28 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.683 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.576 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -173.7 98.0 0.11 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.866 0.365 . . . . 0.0 111.777 -179.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.413 ' H ' ' N ' ' A' ' 123' ' ' VAL . 10.3 t -139.26 63.48 1.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.393 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.738 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -159.44 -155.15 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.802 0.334 . . . . 0.0 111.297 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -154.62 -172.82 4.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.596 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 3.4 t -51.1 152.34 2.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.801 0.334 . . . . 0.0 111.168 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.74 -167.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.286 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.417 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -148.18 65.3 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.823 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 55.0 t80 -62.6 117.02 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.567 ' O ' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -116.45 62.6 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.408 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.549 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 62.77 -168.7 17.73 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.396 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.449 ' C ' HD21 ' A' ' 109' ' ' LEU . 0.7 OUTLIER -138.47 146.37 41.97 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.519 HG13 ' CD2' ' A' ' 109' ' ' LEU . 4.6 m -115.24 163.86 12.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.369 . . . . 0.0 111.188 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.63 145.88 29.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.027 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -139.02 178.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.648 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -145.77 65.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 0.0 111.16 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -169.08 -72.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 p 67.48 0.76 2.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.2 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.501 ' HE ' HH22 ' A' ' 165' ' ' ARG . 0.0 OUTLIER -154.8 114.48 3.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.789 179.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 140.07 121.21 1.81 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.159 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 60.48 -88.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.617 0.246 . . . . 0.0 110.551 -178.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.481 ' O ' HD11 ' A' ' 163' ' ' ILE . 0.6 OUTLIER -154.15 -28.25 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.034 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.476 ' HB ' HD13 ' A' ' 163' ' ' ILE . 1.1 t 49.38 23.46 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.371 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 62.6 m -118.64 -24.22 6.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.013 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -9.31 58.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.018 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 108' ' ' VAL . 21.2 mt-10 -104.52 -53.76 2.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.24 -51.12 71.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.222 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.1 tp -57.77 -32.09 67.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -67.36 -43.01 82.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 104' ' ' GLU . 9.4 t -59.21 -49.92 81.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.842 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.3 mt -65.85 -25.03 67.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.591 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -77.64 -25.59 49.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.626 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 23.1 mt-30 -91.36 -19.88 22.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.201 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 m -113.6 179.36 3.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 0.0 111.253 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.66 72.38 0.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.675 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.842 ' HG3' HD23 ' A' ' 109' ' ' LEU . 3.8 mmt180 -82.66 40.44 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.232 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 59.0 77.9 0.37 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.567 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 87.9 Cg_endo -81.09 121.8 4.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.667 2.245 . . . . 0.0 112.256 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.02 140.74 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 118' ' ' ARG . 12.3 ttp180 -99.39 103.6 15.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.623 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -135.58 172.68 22.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.8 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -92.44 127.26 37.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.795 0.331 . . . . 0.0 111.0 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.723 HD13 HG22 ' A' ' 130' ' ' VAL . 39.6 tp -97.06 129.62 44.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.56 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.463 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 89.6 m-70 -116.71 93.02 4.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.852 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 82' ' ' SER . 41.9 t -58.35 103.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.982 0.42 . . . . 0.0 110.849 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.711 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -100.76 134.65 43.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.192 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.61 8.57 4.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.015 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -137.35 28.19 2.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 110.615 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.761 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 124.63 113.22 1.99 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.315 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.489 HD21 HG22 ' A' ' 123' ' ' VAL . 1.3 mt -58.0 144.25 40.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 111.233 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.582 ' HE ' HD11 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -136.5 124.62 23.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.817 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.723 HG22 HD13 ' A' ' 121' ' ' LEU . 2.9 t -110.93 112.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.311 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.9 t -104.9 114.22 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.795 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.47 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 1.4 m-20 -48.86 147.57 2.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.895 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.623 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -103.23 9.04 38.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.616 -179.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.63 -1.19 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.403 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.409 ' H ' ' H ' ' A' ' 136' ' ' LYS . 3.2 m -151.52 -11.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.546 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 22.9 mmtp 54.77 25.74 6.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.895 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.65 -166.84 35.83 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.549 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.582 HD11 ' HE ' ' A' ' 129' ' ' ARG . 8.6 tp -119.18 116.92 27.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.913 0.387 . . . . 0.0 110.634 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.428 HD12 HG12 ' A' ' 130' ' ' VAL . 6.3 mt -98.02 -57.29 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.263 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.558 HG13 ' HG2' ' A' ' 142' ' ' GLN . 61.3 t -124.51 116.63 48.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.407 ' HB3' HD21 ' A' ' 138' ' ' LEU . 0.6 OUTLIER -121.45 36.48 4.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.583 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.558 ' HG2' HG13 ' A' ' 140' ' ' VAL . 73.1 mm-40 -81.75 -165.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.111 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.761 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 19.3 m -129.42 153.94 47.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.711 HD11 ' O ' ' A' ' 124' ' ' SER . 3.5 mt -65.89 -44.9 92.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.0 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -78.64 -0.21 29.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.506 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.415 ' CB ' ' HB ' ' A' ' 143' ' ' THR . 28.5 tttt -95.73 -44.84 7.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.667 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -62.29 148.22 10.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.93 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.8 t -83.11 -37.03 24.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.201 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -137.95 -172.68 3.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.908 0.385 . . . . 0.0 111.395 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.8 t -168.35 25.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.456 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.498 ' HB3' ' HB2' ' A' ' 102' ' ' CYS . . . -51.12 138.94 25.23 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.159 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.92 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 72.2 Cg_endo -95.56 12.86 1.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.35 2.7 . . . . 0.0 112.385 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.174 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 183' ' ' SER . 2.6 mtt180 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.866 0.365 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.605 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -133.59 128.89 5.16 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.41 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -104.46 168.43 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.3 . . . . 0.0 110.805 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.45 150.94 14.65 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.005 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -132.17 145.61 51.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.636 179.015 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -107.44 144.5 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.188 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.9 130.51 9.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.611 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 3.3 mtt-85 -74.91 -144.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.48 ' H ' ' HB3' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.17 -166.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.909 0.385 . . . . 0.0 111.136 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.61 -11.45 68.39 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.397 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.3 t -166.55 -8.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 109.926 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.771 HG21 ' HB2' ' A' ' 173' ' ' MET . 18.5 m -129.7 -9.79 4.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.645 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 61.19 17.4 8.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.131 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 171' ' ' ARG . 0.9 OUTLIER -176.44 174.31 1.95 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.94 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -77.53 109.58 11.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.995 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.771 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -138.08 159.64 41.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.638 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.795 ' HB2' HG23 ' A' ' 163' ' ' ILE . 31.1 t -129.39 139.36 51.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.859 0.361 . . . . 0.0 111.236 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -103.53 143.58 32.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.665 179.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -126.55 149.86 17.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.859 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -166.5 139.41 3.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.755 0.312 . . . . 0.0 110.715 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.605 HD23 ' HA3' ' A' ' 159' ' ' GLY . 1.5 mt -100.11 -177.81 3.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.943 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -110.48 129.99 55.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.052 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER -76.5 1.28 17.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.172 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -99.85 -23.69 14.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.756 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 55.97 79.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.155 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.407 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 1.5 t -165.9 -59.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.941 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.78 32.2 6.03 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.553 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -141.81 -32.39 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.731 0.3 . . . . 0.0 110.953 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.503 ' HB2' HD12 ' A' ' 187' ' ' LEU . 4.9 mmm180 -73.57 -6.06 44.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.836 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.596 HD23 HD23 ' A' ' 121' ' ' LEU . 5.6 mp -139.24 -50.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.441 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 3.6 t -62.18 -60.87 2.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.336 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 0.1 OUTLIER -52.64 -37.2 58.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.82 -41.78 91.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 187' ' ' LEU . 24.7 t -62.25 -32.3 54.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.76 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -59.3 -20.62 51.29 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.529 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 2.6 m -95.18 -15.42 23.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.729 0.3 . . . . 0.0 111.097 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.703 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -63.07 -30.87 71.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.18 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.467 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 1.3 m-85 -72.86 -40.11 65.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.804 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -54.98 -21.05 10.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.586 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.5 t -105.56 -12.88 9.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -79.36 -27.06 41.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.02 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.839 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.92 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.634 0.254 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 63.84 158.25 0.08 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.449 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -87.82 -173.15 4.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.207 -179.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 68.9 mtp -125.98 -30.31 2.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.823 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.463 ' HB3' HD23 ' A' ' 199' ' ' LEU . 89.6 p -88.09 36.91 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.452 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.641 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 3.1 p90 -63.94 -3.34 2.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.849 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 55.69 8.89 0.36 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.665 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . 0.641 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 21.5 t70 48.9 76.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.401 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -58.92 135.65 87.32 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.472 2.115 . . . . 0.0 112.24 179.924 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.893 0.378 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -83.51 -19.95 34.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.986 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 34.0 tt0 -63.52 -29.99 71.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.617 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -100.57 -17.26 17.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.978 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -58.07 -52.66 64.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.537 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 194' ' ' ALA . 0.9 OUTLIER -66.36 -35.32 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.729 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.617 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 3.1 mtp180 -55.34 -24.03 27.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.109 0.48 . . . . 0.0 109.808 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.42 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -98.03 -97.11 0.21 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.659 179.032 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.501 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -176.47 48.36 0.01 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.565 0.221 . . . . 0.0 111.457 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.642 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 1.4 t -176.04 86.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.919 0.39 . . . . 0.0 111.112 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.693 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 6.7 t -121.22 4.16 10.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.5 OUTLIER -111.97 -156.97 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.161 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.407 ' CG ' ' HE2' ' A' ' 181' ' ' LYS . 16.5 m-85 -154.84 -171.63 3.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.558 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 0.9 OUTLIER -53.01 150.71 5.33 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.048 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.81 -168.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.528 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -143.24 81.28 1.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.925 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 55.6 t80 -62.28 93.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.668 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 178' ' ' LEU . 1.1 mp -58.21 -41.01 83.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.16 -130.44 3.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.357 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -164.28 141.21 6.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 111.046 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.89 172.7 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.486 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 4.1 pt-20 -95.15 142.43 27.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.889 0.376 . . . . 0.0 111.053 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.71 163.65 36.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -121.24 65.34 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.058 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -175.77 -70.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.036 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.422 ' HA ' HD13 ' A' ' 163' ' ' ILE . 0.7 OUTLIER 58.72 25.89 13.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.863 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.88 61.8 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.64 160.78 24.37 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.722 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.493 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -77.18 -30.8 55.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.782 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.626 ' H ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER -69.01 -23.04 64.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.028 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.5 t -58.56 -33.37 48.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 110.537 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.862 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 58.5 m -80.54 -37.01 32.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.615 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.3 -34.7 78.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.93 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 108' ' ' VAL . 8.4 mt-10 -76.96 -52.84 8.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.908 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.92 66.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.962 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 tp -66.08 -36.68 83.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.951 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.8 tptp -70.22 -46.21 64.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 104' ' ' GLU . 11.0 t -60.75 -38.06 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.867 HD23 ' HG3' ' A' ' 114' ' ' ARG . 18.7 mt -61.55 -31.97 72.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.075 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 110' ' ' ARG . 1.2 tpp85 -78.08 -32.88 50.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.5 ' NE2' ' HA ' ' A' ' 108' ' ' VAL . 4.3 mt-30 -81.89 -15.36 54.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.793 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.7 m -105.13 179.42 4.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.82 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.612 ' H ' HH11 ' A' ' 113' ' ' ARG . 0.0 OUTLIER -115.88 65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.867 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.26 20.32 3.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 55.34 95.04 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.993 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 93.3 Cg_endo -80.5 127.27 6.43 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.79 2.326 . . . . 0.0 112.087 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.33 143.79 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.225 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -102.69 97.83 7.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.65 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -131.64 163.06 23.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.911 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.475 ' HB3' ' HE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -87.18 124.22 33.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.735 0.302 . . . . 0.0 110.977 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.835 HD13 HG22 ' A' ' 130' ' ' VAL . 29.4 tp -96.85 135.34 38.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.763 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.642 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 1.9 m-70 -125.43 105.39 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.094 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 11.4 t -70.46 104.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 0.0 110.838 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -104.81 143.37 33.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.408 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.31 28.96 1.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.848 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 124' ' ' SER . 3.0 t70 -153.51 21.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.594 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 124.73 131.72 3.71 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.523 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.672 HD23 HD11 ' A' ' 121' ' ' LEU . 1.7 mp -67.16 168.77 9.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 14.5 ttm180 -168.75 115.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.903 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.835 HG22 HD13 ' A' ' 121' ' ' LEU . 3.9 t -107.97 109.21 27.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.07 0.462 . . . . 0.0 111.421 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.57 115.38 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.941 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.405 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 88.5 m-20 -50.9 144.58 8.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.24 17.19 21.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.988 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -127.67 -8.69 5.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.606 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.09 -8.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.843 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp 58.1 25.78 12.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.551 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.18 -138.5 0.25 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.444 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' A' ' 141' ' ' ASP . 15.7 tp -159.09 116.06 2.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.663 0.268 . . . . 0.0 110.438 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.632 HG13 ' HB ' ' A' ' 130' ' ' VAL . 3.6 pt -106.73 -28.48 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.562 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.638 ' HB ' HG23 ' A' ' 130' ' ' VAL . 43.1 t -137.35 116.65 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.167 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.588 ' HB2' HD21 ' A' ' 138' ' ' LEU . 17.8 t0 -130.04 29.91 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.345 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -76.55 -167.51 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.206 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 144' ' ' ILE . 1.8 m -123.66 171.0 9.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.658 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.47 HD11 ' O ' ' A' ' 124' ' ' SER . 47.3 mt -88.03 -28.16 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.701 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.77 -8.98 50.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.86 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -92.96 -39.63 11.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 143' ' ' THR . 1.2 m -61.77 126.1 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.013 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.39 -49.9 73.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.414 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 163' ' ' ILE . 12.3 m-85 -130.44 -171.94 2.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.095 0.474 . . . . 0.0 111.526 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.3 t -162.35 35.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.31 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.488 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -68.41 143.58 95.64 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.498 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.914 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 71.6 Cg_endo -87.68 -89.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.722 2.281 . . . . 0.0 112.111 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 110.755 179.616 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 120.782 0.325 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.731 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -127.9 129.33 6.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.671 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -102.91 168.87 8.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.604 0.24 . . . . 0.0 110.448 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.862 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 24.4 m -158.76 155.65 28.35 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.012 0.434 . . . . 0.0 111.375 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -132.29 160.05 37.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.077 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -117.14 153.63 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.401 . . . . 0.0 111.638 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 6.4 t -159.49 118.12 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.447 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.665 HH21 ' HB3' ' B' ' 10' ' ' PHE . 15.2 ptt85 -74.01 -152.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.29 -178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -55.45 -179.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.199 0.523 . . . . 0.0 111.69 -178.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.93 -8.37 29.5 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 15.2 t -170.08 -5.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.244 -0.478 . . . . 0.0 109.934 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.505 HG22 ' HG3' ' A' ' 171' ' ' ARG . 22.4 m -133.43 -12.6 2.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.054 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 170' ' ' ARG . 43.3 mtt180 62.29 22.58 13.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.799 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.505 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -175.71 -179.07 1.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.9 OUTLIER -81.49 124.0 29.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.9 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -142.5 126.33 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 34.8 t -104.11 136.32 43.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 1.3 m80 -105.82 145.69 30.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.359 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.05 154.73 21.49 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.185 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -161.66 144.67 12.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.715 0.293 . . . . 0.0 110.739 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.731 HD23 ' HA3' ' A' ' 159' ' ' GLY . 1.1 mt -105.29 162.52 13.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.131 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.13 122.5 32.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 84' ' ' SER . 0.5 OUTLIER -71.83 -11.23 60.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.935 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.407 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 8.2 mmmt -89.34 -17.21 29.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.715 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 53.84 80.63 0.11 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.02 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.42 -43.08 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.091 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.94 31.61 55.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.306 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -146.08 -34.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.701 0.286 . . . . 0.0 110.793 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.49 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.7 OUTLIER -59.51 -28.25 66.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.793 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.574 HD23 HD23 ' A' ' 121' ' ' LEU . 4.8 mp -117.04 -39.13 3.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.879 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 191' ' ' VAL . 0.5 OUTLIER -57.13 -63.06 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.32 -179.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -16.05 61.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.373 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.0 -53.61 8.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.025 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.475 ' HA ' HG11 ' A' ' 123' ' ' VAL . 9.9 p -63.46 -18.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.08 -1.54 59.99 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.334 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.3 m -120.54 -4.7 9.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.32 . . . . 0.0 110.781 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.586 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -74.82 -45.61 42.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.248 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 38.9 p90 -68.3 -36.18 78.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.072 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -56.65 -31.69 64.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.022 0.439 . . . . 0.0 110.69 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.46 -19.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.812 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . 0.634 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -73.37 -6.02 43.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.548 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 196' ' ' ALA . 2.6 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.005 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.914 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.573 0.225 . . . . 0.0 111.17 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.504 ' H ' ' HB3' ' B' ' 2' ' ' PHE . 7.9 t 62.96 157.14 0.06 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.137 0.494 . . . . 0.0 111.246 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -92.51 176.53 6.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.829 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mtp -123.32 -7.31 8.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.7 p -83.62 6.87 19.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -62.56 145.57 54.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -106.85 10.11 30.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 t70 54.42 70.54 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.983 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.665 ' HB3' HH21 ' A' ' 165' ' ' ARG . 44.8 m-85 -61.3 134.92 93.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.967 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.598 2.199 . . . . 0.0 112.445 -179.725 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.763 0.316 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -91.13 -25.53 19.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.966 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.63 -34.3 77.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.721 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.4 mt-10 -92.38 -9.38 41.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 81' ' ' CYS . . . -60.16 -50.59 73.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.2 t -56.51 -40.61 69.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.955 0.407 . . . . 0.0 110.432 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.721 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 5.3 mtm180 -65.03 -32.03 73.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.332 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.2 m -81.12 3.46 23.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.61 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.409 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 65.01 41.92 4.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.42 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -176.17 85.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.56 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 13.1 t -116.35 21.4 13.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.371 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.733 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -117.06 -160.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.33 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.416 ' O ' HG13 ' A' ' 85' ' ' VAL . 3.2 m-85 -158.66 -169.5 2.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.537 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 2.3 t -48.94 142.09 6.93 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.893 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 83' ' ' PHE . 22.3 m -138.0 -171.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.062 0.458 . . . . 0.0 111.761 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -141.65 60.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.416 179.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.504 ' O ' HG23 ' A' ' 117' ' ' VAL . 71.4 t80 -53.26 114.84 1.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.03 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -82.66 -56.08 4.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.022 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.0 -124.64 1.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.483 ' HB3' ' ND1' ' A' ' 175' ' ' HIS . 1.2 p -164.76 142.19 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.936 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.453 HG22 HD11 ' A' ' 109' ' ' LEU . 15.5 m -133.51 163.41 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.998 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -91.56 130.14 37.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.7 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.606 HG21 HG11 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -131.54 128.98 61.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.195 -179.402 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -91.26 68.7 5.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 98' ' ' GLY . 0.7 OUTLIER -162.18 -65.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.137 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.722 ' HA ' HG21 ' A' ' 101' ' ' VAL . 50.4 p 52.78 22.66 2.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.991 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 96' ' ' SER . 10.1 mtp180 -149.36 -56.19 0.19 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.912 0.386 . . . . 0.0 111.601 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.6 ' H ' ' HG2' ' A' ' 95' ' ' GLU . . . -61.6 135.96 47.17 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.692 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.1 tpt 53.32 23.28 3.17 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.527 0.331 . . . . 0.0 111.789 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 151' ' ' ALA . 11.3 mp0 61.03 5.15 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.408 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' A' ' 96' ' ' SER . 2.3 t 53.43 30.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.856 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.6 p -118.18 -47.43 2.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.219 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -3.38 13.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.586 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -118.22 -57.57 2.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.65 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -54.58 -53.21 57.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.214 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.646 HD11 ' HG ' ' A' ' 178' ' ' LEU . 4.1 tp -50.34 -34.49 24.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -67.15 -38.52 85.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.803 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 36.7 t -63.57 -46.8 93.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.318 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.704 HD23 ' HG3' ' A' ' 114' ' ' ARG . 3.5 mp -72.46 -18.79 61.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.109 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -94.84 -11.13 29.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.541 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -71.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.581 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.8 t -175.89 88.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.381 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -165.17 -62.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.704 ' HG3' HD23 ' A' ' 109' ' ' LEU . 3.8 mmp_? -101.24 110.35 22.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.381 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -62.44 134.06 94.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.119 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.494 ' HB2' ' HE2' ' A' ' 86' ' ' LYS . 73.3 Cg_endo -78.28 161.1 29.13 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.654 2.236 . . . . 0.0 112.603 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -130.36 153.75 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.79 179.265 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.48 97.57 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -141.46 166.9 26.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.5 113.92 25.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.331 . . . . 0.0 110.878 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.982 HD13 HG22 ' A' ' 130' ' ' VAL . 25.4 tp -83.8 138.48 33.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.758 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.528 ' H ' HD12 ' A' ' 121' ' ' LEU . 11.2 m170 -123.17 84.18 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.733 ' H ' ' HB2' ' A' ' 82' ' ' SER . 48.4 t -58.75 102.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.852 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.565 ' O ' HD11 ' A' ' 144' ' ' ILE . 3.7 p -105.18 144.33 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.548 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.7 19.8 1.93 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.888 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.0 22.64 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.665 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.18 118.5 2.59 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.395 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.416 ' CD2' HG22 ' A' ' 123' ' ' VAL . 2.7 mt -54.1 144.7 18.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 111.171 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 16.4 ttm180 -147.58 112.21 5.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.982 HG22 HD13 ' A' ' 121' ' ' LEU . 1.9 t -100.39 133.32 43.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.093 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.5 t -121.97 109.05 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.458 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -53.03 157.49 1.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.218 -179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -3.64 53.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -116.19 -54.69 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.386 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.6 m -80.74 -31.84 35.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.459 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 4.2 mmtm 52.39 29.95 7.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.9 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.19 -108.7 1.51 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.45 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tp -160.59 113.76 2.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.678 0.275 . . . . 0.0 110.727 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.55 -49.07 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.36 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.754 ' HB ' HG23 ' A' ' 130' ' ' VAL . 93.4 t -122.45 102.52 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.42 25.95 11.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.408 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.443 ' HG2' HG13 ' A' ' 140' ' ' VAL . 56.1 mm-40 -76.23 -156.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.166 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.866 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 59.9 m -135.46 161.75 34.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.966 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.565 HD11 ' O ' ' A' ' 124' ' ' SER . 2.5 mt -77.24 -33.42 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.718 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.671 ' H ' HG22 ' A' ' 143' ' ' THR . 5.6 mt-10 -86.09 -24.3 26.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.389 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.866 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -60.03 -41.04 91.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.772 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.6 m -73.16 144.92 12.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.8 t -49.56 -55.28 14.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.763 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' B' ' 3' ' ' SER . 30.8 p90 -168.97 126.93 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.72 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 116.67 13.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . . . -131.11 104.07 15.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.036 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.519 ' HB3' ' HD1' ' A' ' 160' ' ' PHE . 32.7 Cg_exo -62.3 -88.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.674 2.249 . . . . 0.0 112.248 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.66 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.439 ' HB2' ' NH1' ' A' ' 158' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.8 0.333 . . . . 0.0 110.982 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -106.31 147.46 16.24 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.351 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.519 ' HD1' ' HB3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -124.48 169.16 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 0.0 110.845 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.513 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 3.3 m -168.58 151.0 5.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.082 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.663 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -134.95 148.04 49.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.531 178.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.894 HG23 ' HB3' ' A' ' 174' ' ' CYS . 0.2 OUTLIER -103.89 151.38 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.209 -179.056 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.91 106.95 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.85 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 15.7 ptm180 -68.29 -156.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.196 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.08 -162.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.462 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.93 -10.16 53.7 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.405 ' H ' ' H ' ' A' ' 169' ' ' THR . 0.6 OUTLIER -155.45 -19.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.949 0.404 . . . . 0.0 110.302 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 173' ' ' MET . 2.9 m -130.25 -2.41 4.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.721 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.5 9.64 3.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -172.44 -176.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.658 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -78.52 122.08 25.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 110.942 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.539 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -147.74 110.06 4.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.738 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.894 ' HB3' HG23 ' A' ' 163' ' ' ILE . 28.2 p -98.11 159.89 14.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.231 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.663 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 4.6 m-70 -122.96 142.2 51.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.228 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.513 ' HA2' ' OG ' ' A' ' 161' ' ' SER . . . -111.8 150.12 18.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.856 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -170.29 133.35 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.872 0.368 . . . . 0.0 110.756 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 106' ' ' LEU . 4.7 mp -110.16 171.07 7.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.244 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.44 128.47 41.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.5 OUTLIER -78.37 -0.34 28.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.576 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.98 -21.08 18.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 158' ' ' ARG . 11.6 m-20 55.51 83.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.97 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.2 t -168.99 -42.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.19 42.63 42.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.441 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.02 -34.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.743 0.306 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.455 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.3 OUTLIER -75.84 -16.65 60.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.504 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 191' ' ' VAL . 4.5 mp -126.93 -44.17 1.65 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.019 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 t -59.98 -69.19 0.23 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -21.0 58.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.02 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.9 -52.61 19.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 187' ' ' LEU . 96.5 t -61.16 -31.46 50.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.27 -17.43 46.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.283 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 96.1 m -104.12 -11.37 17.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.719 0.295 . . . . 0.0 110.845 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.99 -33.63 67.32 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.536 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 0.0 OUTLIER -77.51 -34.99 53.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.279 178.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.404 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -55.87 -26.03 45.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.874 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.49 -19.46 5.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.686 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -72.56 -12.08 60.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.604 178.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 196' ' ' ALA . 1.5 mt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.879 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.42 ' HB2' ' H ' ' B' ' 3' ' ' SER . 1.2 p90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.495 0.188 . . . . 0.0 110.547 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 1.4 p -163.91 162.99 23.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.855 0.359 . . . . 0.0 111.192 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' B' ' 7' ' ' PHE . 41.5 p-10 -76.44 175.4 9.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.063 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 36.6 mtp -128.33 -24.14 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.2 t -90.0 23.64 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.466 ' HB3' ' ND2' ' B' ' 4' ' ' ASN . 43.5 p90 -65.08 149.87 49.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -83.82 0.48 47.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 t0 57.41 94.67 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.026 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.585 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 11.1 m-85 -90.4 -51.32 0.33 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.504 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 35.8 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.113 1.875 . . . . 0.0 112.272 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.794 0.33 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.47 -26.08 32.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.81 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -29.52 70.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.703 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.65 -17.35 17.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.791 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -52.63 -51.57 59.46 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.295 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 194' ' ' ALA . 10.4 t -58.29 -43.97 87.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.727 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -55.17 -39.06 69.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.655 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -72.44 -91.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.638 179.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.462 ' H ' ' HB2' ' A' ' 78' ' ' SER . . . 179.84 36.4 0.0 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.24 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.575 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -173.77 101.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 111.556 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 8.5 t -134.54 55.46 1.89 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.844 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.499 ' CB ' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -152.59 -163.05 1.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.822 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.48 ' CG ' ' HE3' ' A' ' 181' ' ' LYS . 10.5 m-85 -156.96 -171.33 3.61 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.819 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -49.56 145.96 4.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.919 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.0 m -143.89 173.53 5.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.971 0.415 . . . . 0.0 111.83 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -122.38 61.19 0.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.327 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.538 ' HA ' ' HB3' ' A' ' 177' ' ' PHE . 1.0 OUTLIER -54.06 96.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.94 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -62.86 -31.36 72.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.78 -131.76 5.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.519 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -158.9 130.27 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.404 HG22 HD11 ' A' ' 109' ' ' LEU . 2.3 m -120.64 136.21 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.977 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 112.56 5.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.069 0.461 . . . . 0.0 110.659 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.403 HG21 HG11 ' A' ' 101' ' ' VAL . 17.0 m -103.58 173.64 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -122.2 64.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -149.53 -90.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 p 63.3 9.62 4.15 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.454 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.433 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -166.52 47.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.988 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -125.21 -129.68 3.39 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.27 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.42 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 9.4 ttt -75.38 -73.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.578 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.584 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . 4.9 mt-30 -146.57 -24.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.824 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.403 HG11 HG21 ' A' ' 93' ' ' VAL . 39.0 t 73.18 -30.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.291 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 100' ' ' GLN . 3.7 p -63.17 -27.61 69.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.53 -18.26 38.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.79 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.8 mt-10 -120.02 -44.63 2.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.727 0.299 . . . . 0.0 111.457 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.554 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -55.13 -46.31 75.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.597 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 tp -54.23 -33.73 59.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.181 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.598 ' HE3' ' HE ' ' A' ' 110' ' ' ARG . 11.5 tptm -74.93 -45.54 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.229 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 104' ' ' GLU . 16.1 t -56.54 -30.1 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.396 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.613 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.5 mt -87.66 -23.54 24.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.008 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.598 ' HE ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -82.46 -9.95 59.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.473 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 42.1 mt-30 -75.21 -62.85 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.723 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 2.0 t -177.33 -168.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.544 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 112' ' ' SER . 1.3 mpt_? 70.61 -69.19 0.18 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.297 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.613 ' HG3' HD23 ' A' ' 109' ' ' LEU . 8.3 mmt180 -84.28 91.8 7.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.456 ' H ' ' HG2' ' A' ' 115' ' ' ARG . 6.5 ptp180 -69.08 141.7 92.15 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.707 ' HB3' HD23 ' A' ' 88' ' ' LEU . 72.3 Cg_endo -77.73 133.16 12.51 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.589 2.193 . . . . 0.0 112.69 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.0 143.59 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.969 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -101.72 108.19 19.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -150.68 178.98 27.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.44 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.435 HD12 ' NE2' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -99.67 118.01 35.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.74 0.305 . . . . 0.0 111.033 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.74 HD13 HG22 ' A' ' 130' ' ' VAL . 24.4 tp -92.89 138.46 31.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.642 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.526 ' H ' HD12 ' A' ' 121' ' ' LEU . 11.3 m170 -123.62 103.67 8.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.02 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.499 HG23 ' CB ' ' A' ' 82' ' ' SER . 42.8 t -71.66 102.45 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.4 . . . . 0.0 110.513 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.584 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -106.16 117.95 35.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.359 179.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.72 -16.17 3.69 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.713 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -111.59 34.63 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.687 0.279 . . . . 0.0 110.975 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.764 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 114.75 111.31 2.87 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.412 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.17 162.55 5.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.961 0.41 . . . . 0.0 111.299 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.56 119.85 5.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.513 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.74 HG22 HD13 ' A' ' 121' ' ' LEU . 1.9 t -107.15 127.94 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.605 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.52 156.29 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.506 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.99 148.26 23.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.766 0.317 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.438 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.7 OUTLIER -99.09 19.79 14.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -138.94 -9.32 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.965 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 137' ' ' GLY . 13.6 t -154.16 -10.39 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.876 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 13.8 mmtm 60.16 27.26 16.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.552 ' H ' HG23 ' A' ' 135' ' ' THR . . . -73.62 -159.68 5.92 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.408 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' ' 141' ' ' ASP . 11.5 tp -121.97 118.73 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.689 0.28 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.52 HD12 HG12 ' A' ' 130' ' ' VAL . 8.7 mt -96.84 -55.26 6.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.012 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.495 HG11 ' OH ' ' A' ' 162' ' ' TYR . 95.6 t -139.2 118.07 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.497 ' HB2' HD21 ' A' ' 138' ' ' LEU . 4.4 t0 -122.06 74.06 1.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -119.47 -165.01 1.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.187 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.764 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 1.6 m -115.52 177.31 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.908 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.656 HD13 ' HB1' ' A' ' 194' ' ' ALA . 8.1 mt -96.18 -42.3 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.835 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -81.3 -10.21 59.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.664 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.708 ' HE2' HG21 ' A' ' 168' ' ' THR . 1.7 ttpm? -77.03 -43.35 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.811 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.451 HG11 ' CD2' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -70.29 154.2 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.948 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.62 -68.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.921 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' B' ' 3' ' ' SER . 0.0 OUTLIER -155.19 129.15 8.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.999 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -85.58 104.76 15.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.826 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.512 ' HB1' ' HG2' ' A' ' 100' ' ' GLN . . . -118.2 133.18 23.48 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.261 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.539 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 56.3 Cg_endo -70.69 -87.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.407 2.072 . . . . 0.0 112.156 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.78 0.324 . . . . 0.0 110.91 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.685 0.279 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.55 134.64 8.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.578 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -131.3 142.82 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.644 0.259 . . . . 0.0 110.772 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 1.2 m -153.51 131.2 11.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.069 0.462 . . . . 0.0 111.402 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.495 ' OH ' HG11 ' A' ' 140' ' ' VAL . 38.1 p90 -109.13 164.99 11.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.519 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.505 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -126.84 163.2 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.448 -179.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.75 110.87 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.678 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.739 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 2.5 ptp180 -72.37 -163.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.132 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -175.05 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.71 -2.04 88.4 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.488 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.708 HG21 ' HE2' ' A' ' 146' ' ' LYS . 8.8 t -167.75 -12.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.392 . . . . 0.0 110.471 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.7 OUTLIER -136.14 1.12 2.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.928 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 64.79 1.52 1.43 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.465 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 171' ' ' ARG . 5.1 ptp180 -175.47 -179.68 1.31 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.032 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.739 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -86.0 94.18 9.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.064 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.67 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.9 OUTLIER -107.23 129.93 54.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.505 ' HB2' HG23 ' A' ' 163' ' ' ILE . 17.9 t -114.14 110.95 20.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.102 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . 3.1 m80 -85.26 126.44 33.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -112.95 154.19 17.08 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.526 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.538 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . 30.6 p90 -166.21 175.93 7.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.827 0.346 . . . . 0.0 111.064 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.1 mp -137.89 175.16 9.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.932 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.489 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -105.06 119.53 39.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.5 OUTLIER -71.11 -13.67 62.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.728 ' HB2' ' HD2' ' A' ' 186' ' ' ARG . 1.5 mmmp? -83.05 -30.95 27.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.954 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 57.09 92.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.331 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.535 ' HB3' ' HD3' ' A' ' 186' ' ' ARG . 1.5 t -169.22 -38.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.517 ' H ' ' CZ ' ' A' ' 186' ' ' ARG . . . 76.65 47.53 9.95 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.635 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -155.96 -36.33 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.828 0.347 . . . . 0.0 110.908 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.728 ' HD2' ' HB2' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -66.09 -29.99 70.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 186' ' ' ARG . 4.7 mp -118.69 -42.19 2.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.371 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 t -57.66 -75.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.443 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -58.85 -24.78 62.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.2 -56.75 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.076 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.63 -34.06 53.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -60.45 -15.35 38.76 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.619 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 73.4 m -102.34 -12.77 17.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.64 0.257 . . . . 0.0 111.093 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.656 ' HB1' HD13 ' A' ' 144' ' ' ILE . . . -58.14 -29.18 65.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.414 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.46 ' CG ' ' HA ' ' B' ' 4' ' ' ASN . 0.1 OUTLIER -81.49 -27.23 34.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.788 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.672 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -62.03 -12.88 21.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.03 -31.64 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -1.89 19.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.819 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' A' ' 196' ' ' ALA . 3.4 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.964 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.463 ' CE1' ' HD3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.696 0.284 . . . . 0.0 110.517 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.699 ' HB2' ' HB3' ' A' ' 149' ' ' PHE . 4.8 p 62.51 154.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.477 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.46 ' HA ' ' CG ' ' A' ' 195' ' ' PHE . 0.6 OUTLIER -70.47 153.69 42.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.13 -21.11 12.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.805 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t -95.41 20.78 8.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.438 ' HB3' ' OD1' ' B' ' 4' ' ' ASN . 26.3 p90 -61.5 149.07 39.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.976 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -103.49 -4.56 23.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.911 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 54.64 83.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.933 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 14.7 m-85 -56.58 145.34 60.8 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 40.0 Cg_exo . . . . . 0 C--O 1.25 1.088 0 C-N-CA 122.55 2.167 . . . . 0.0 112.387 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.809 0.338 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.08 -43.73 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -80.3 -46.4 16.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.887 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 77' ' ' ARG . 12.9 tt0 -65.5 -23.1 66.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.006 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -55.8 -52.8 62.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.132 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 194' ' ' ALA . 3.1 t -62.79 -43.01 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.624 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.477 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 37.2 mtp180 -54.22 -34.93 61.79 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.329 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 11.6 m -78.05 -90.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.369 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.431 ' H ' ' HB2' ' A' ' 78' ' ' SER . . . 177.05 36.22 0.0 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.232 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.527 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -170.41 101.2 0.26 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.889 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 2.9 t -127.94 -147.35 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.285 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.771 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.47 -163.06 0.1 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 111.607 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.554 ' HB3' ' HD3' ' A' ' 181' ' ' LYS . 2.1 m-85 -158.28 -169.09 2.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.333 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 3.5 m -42.58 144.26 0.56 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.762 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.637 HG12 HD21 ' A' ' 187' ' ' LEU . 34.9 m -139.5 -170.55 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.591 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.69 74.81 1.19 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.701 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.584 ' HB3' HG23 ' A' ' 117' ' ' VAL . 42.8 t80 -58.56 97.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.09 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -64.18 -33.63 76.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.81 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.54 -152.05 24.15 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.5 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.41 129.98 32.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.312 . . . . 0.0 110.797 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.68 152.86 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -84.81 144.66 28.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.44 -172.23 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.997 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -150.0 59.81 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.064 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.508 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -170.06 -77.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.98 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.6 m 61.01 24.83 14.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.988 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 3.5 ptt-85 -135.78 37.61 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.774 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -160.15 161.24 32.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.486 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.458 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -83.92 -37.25 22.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 111.065 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -70.4 -9.77 57.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.168 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.84 -36.88 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.85 0.357 . . . . 0.0 110.925 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.562 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 3.5 m -79.17 -24.62 43.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.478 ' HA ' ' OD2' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -71.62 -7.74 49.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.972 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.4 mm-40 -111.77 -49.89 2.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.963 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.2 -41.83 80.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.635 ' HA ' HD12 ' A' ' 109' ' ' LEU . 3.1 tp -58.24 -36.96 73.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.604 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -67.39 -38.07 84.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.607 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.6 t -60.7 -33.33 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.557 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 106' ' ' LEU . 2.5 mt -77.39 -26.94 52.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.661 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.97 -21.02 44.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.614 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -98.48 1.23 46.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.974 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.95 172.05 13.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.954 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.453 ' H ' ' HG2' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -110.74 74.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.717 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.546 ' HG3' HD23 ' A' ' 109' ' ' LEU . 4.2 mmp_? -86.87 36.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.177 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 115' ' ' ARG . 0.1 OUTLIER 56.16 87.13 0.15 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.65 178.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 3.5 Cg_exo -76.2 116.39 4.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.969 2.446 . . . . 0.0 111.886 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -85.43 145.42 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.966 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -104.26 102.6 12.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.327 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.741 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -158.78 -137.64 2.3 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.176 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.474 ' HA ' HG22 ' A' ' 85' ' ' VAL . 3.0 pp -155.2 169.56 23.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 111.101 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.706 HD13 HG22 ' A' ' 130' ' ' VAL . 54.4 tp -112.07 140.25 46.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.136 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 4.7 m-70 -121.5 85.65 2.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.112 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.889 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 69.0 t -60.4 93.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.159 0.504 . . . . 0.0 111.228 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.583 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -87.05 142.04 28.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.857 177.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.87 23.47 1.7 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.415 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 124' ' ' SER . 21.6 t0 -155.55 27.61 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.529 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.25 112.24 1.73 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.282 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.46 159.35 8.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.83 0.348 . . . . 0.0 111.026 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -154.5 116.74 4.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.706 HG22 HD13 ' A' ' 121' ' ' LEU . 13.6 t -101.24 106.09 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.086 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.22 129.35 53.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.977 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.741 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -64.4 175.78 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.01 -4.66 13.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -117.04 -45.13 2.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.381 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.6 m -92.22 -24.04 19.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.451 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 54.09 32.89 16.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.627 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -102.87 -178.56 26.72 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.466 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 tp -87.11 135.9 33.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.808 0.337 . . . . 0.0 110.792 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 130' ' ' VAL . 40.8 mt -116.88 -51.77 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.034 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.598 HG13 ' HG2' ' A' ' 142' ' ' GLN . 92.7 t -117.75 103.72 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.863 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -96.36 32.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.598 ' HG2' HG13 ' A' ' 140' ' ' VAL . 20.2 mm100 -77.5 -173.06 2.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 82.8 m -150.09 148.91 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.776 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.583 HD11 ' O ' ' A' ' 124' ' ' SER . 1.0 OUTLIER -63.22 -39.87 86.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.628 179.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.564 ' H ' HG22 ' A' ' 143' ' ' THR . 1.7 mt-10 -84.46 13.92 5.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.681 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.643 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 10.0 tttp -115.43 -48.49 2.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.978 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 164' ' ' CYS . 5.8 m -69.58 146.48 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.101 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.6 t -53.54 -63.09 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.414 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 0.3 OUTLIER -170.73 146.23 2.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.776 178.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.37 165.59 22.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.96 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.562 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -167.16 100.82 0.63 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.222 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.25 30.94 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.037 2.491 . . . . 0.0 112.433 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 103' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.104 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.736 0.303 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.38 130.31 9.35 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.488 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.583 ' HZ ' ' HA2' ' A' ' 184' ' ' GLY . 3.3 m-85 -128.93 152.56 48.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.338 . . . . 0.0 111.012 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.55 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -161.74 148.51 14.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.09 162.47 24.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.843 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.74 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -120.47 151.43 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.076 0.465 . . . . 0.0 111.418 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.504 ' HB2' HG12 ' A' ' 147' ' ' VAL . 10.0 t -150.95 148.03 27.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.332 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HB2' ' H ' ' A' ' 166' ' ' ASP . 0.1 OUTLIER -100.09 -158.66 0.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 -179.496 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.442 ' H ' ' HB2' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -57.24 -176.85 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.207 0.527 . . . . 0.0 111.658 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 168' ' ' THR . . . 108.72 -12.07 35.34 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 167' ' ' GLY . 0.5 OUTLIER -163.62 -22.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.134 -0.533 . . . . 0.0 109.984 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.406 HG22 ' HG3' ' A' ' 171' ' ' ARG . 33.3 m -113.2 -12.77 13.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.832 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 65.12 17.2 10.95 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.284 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 171' ' ' ARG . 0.9 OUTLIER -173.0 -170.03 0.61 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.051 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.68 112.86 24.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.3 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.59 173.53 8.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.461 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.74 ' HB2' HG23 ' A' ' 163' ' ' ILE . 19.5 t -155.01 129.59 9.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.752 0.31 . . . . 0.0 111.292 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.43 155.17 17.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.504 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -137.48 155.46 23.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.786 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.488 ' HE2' HD23 ' A' ' 187' ' ' LEU . 11.9 p90 -166.62 176.07 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.361 . . . . 0.0 110.811 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.2 mp -146.23 152.05 38.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.795 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.33 113.28 7.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 4.0 t -57.37 -41.52 80.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.554 ' HD3' ' HB3' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -73.36 -21.29 60.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.557 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 62.27 103.68 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.997 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.8 t -163.77 -43.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.583 ' HA2' ' HZ ' ' A' ' 160' ' ' PHE . . . 76.39 17.34 80.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.317 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.73 -25.67 2.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 0.0 111.018 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -80.8 -17.7 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.991 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.637 HD21 HG12 ' A' ' 85' ' ' VAL . 9.5 mp -119.59 -46.6 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.229 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 t -61.86 -56.77 15.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.517 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.92 -5.46 21.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.621 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -96.78 -48.42 5.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.698 0.285 . . . . 0.0 111.544 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.491 ' HA ' HG11 ' A' ' 123' ' ' VAL . 1.7 p -70.7 -22.11 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.211 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.88 67.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.395 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 77.4 m -119.72 4.39 11.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.773 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.651 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -78.11 -51.77 9.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.169 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.549 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 51.0 p90 -63.72 -26.2 68.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.705 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -62.45 -23.14 66.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.11 11.85 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.6 -13.05 10.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.979 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.705 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.141 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.67 0.271 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -167.63 150.13 5.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.843 179.677 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' B' ' 7' ' ' PHE . 0.1 OUTLIER -60.19 146.78 42.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.739 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 12.0 mtm -116.45 -15.63 10.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.127 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 9.1 p -84.74 20.79 1.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.205 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.472 ' HB3' ' OD1' ' B' ' 4' ' ' ASN . 44.0 p90 -64.05 149.8 46.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -90.62 11.94 20.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 39.0 t0 56.0 85.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.804 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.581 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 2.7 m-85 -92.85 -52.24 0.27 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.392 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 26.5 Cg_exo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.117 1.878 . . . . 0.0 112.212 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.883 0.373 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.56 -18.07 18.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.768 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -62.63 -38.91 92.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.568 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.749 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -92.27 -7.5 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.429 179.259 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 81' ' ' CYS . . . -65.85 -49.12 69.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.84 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 ' CB ' ' A' ' 81' ' ' CYS . 1.2 t -61.06 -36.31 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.047 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.749 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -66.53 -34.36 77.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.276 178.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.32 6.26 14.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.756 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 66.32 42.43 3.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.589 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.415 ' HB ' ' ND1' ' A' ' 122' ' ' HIS . 1.5 t -177.19 86.95 0.02 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.241 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.536 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 11.5 t -116.69 4.84 13.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.473 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.698 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.4 OUTLIER -103.78 -167.93 1.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.721 0.295 . . . . 0.0 111.251 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -152.74 -171.07 3.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -39.0 141.99 0.25 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.823 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -149.41 -165.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.323 -179.409 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.19 70.61 0.93 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -61.58 119.88 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.82 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.457 ' HB2' HD22 ' A' ' 109' ' ' LEU . 1.2 mp -79.03 -75.39 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.259 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.85 -117.57 0.45 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.349 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.608 ' N ' HD21 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -159.14 128.45 5.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.713 0.292 . . . . 0.0 110.768 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.506 HG13 ' HG ' ' A' ' 109' ' ' LEU . 3.7 m -123.12 158.03 28.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.331 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.1 152.64 30.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.583 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.9 m -141.55 150.09 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.303 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.454 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 1.7 t80 -118.48 59.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.389 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 94' ' ' PHE . 4.7 mt-10 -154.07 -68.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.692 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.62 14.99 1.92 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.211 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -141.13 116.54 10.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.008 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.8 -170.98 15.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.561 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.408 ' O ' ' HG2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -116.06 -26.28 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 110.738 -179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -69.28 -11.71 61.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.321 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.416 ' HB ' HD11 ' A' ' 163' ' ' ILE . 14.1 t -59.6 -27.5 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 110.988 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 73.2 m -79.32 -39.32 33.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.151 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.36 -14.69 63.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.285 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.8 mt-10 -103.98 -47.77 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.039 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.95 74.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.16 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 tp -57.37 -44.4 84.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.72 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.571 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -69.08 -34.34 74.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.606 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.2 t -61.68 -31.0 49.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.333 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.608 HD21 ' N ' ' A' ' 90' ' ' CYS . 1.2 mt -80.29 -30.32 38.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.852 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.571 ' HG2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -80.41 -21.2 42.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.501 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -19.2 20.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.901 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.6 m -100.32 10.97 40.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.057 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER 32.01 78.79 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.301 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -95.07 22.2 6.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.909 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 56.59 104.94 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.861 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.59 149.16 30.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.514 2.143 . . . . 0.0 111.951 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.439 HG12 ' OD1' ' A' ' 132' ' ' ASP . 0.7 OUTLIER -103.88 136.34 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.085 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.13 82.61 8.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.063 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -151.76 -179.6 27.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.132 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.17 158.22 24.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 0.0 111.236 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.669 HD13 HG22 ' A' ' 130' ' ' VAL . 67.7 tp -96.09 146.7 24.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.222 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.415 ' ND1' ' HB ' ' A' ' 80' ' ' THR . 1.7 m170 -123.68 76.85 1.46 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.821 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.698 ' H ' ' HB2' ' A' ' 82' ' ' SER . 40.7 t -53.0 104.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.956 0.408 . . . . 0.0 110.582 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.658 ' O ' HD11 ' A' ' 144' ' ' ILE . 2.0 t -110.48 126.39 54.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.469 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -55.6 -14.29 6.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.607 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -108.29 31.09 5.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 0.0 110.831 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 114.87 125.5 4.03 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.6 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -62.5 163.82 8.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.86 0.362 . . . . 0.0 110.947 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.415 ' HB3' HH11 ' A' ' 129' ' ' ARG . 0.3 OUTLIER -169.76 133.9 1.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.78 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.669 HG22 HD13 ' A' ' 121' ' ' LEU . 2.8 t -110.12 125.91 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.85 0.357 . . . . 0.0 111.261 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.31 132.23 64.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.619 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.592 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -61.87 -173.89 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 0.0 111.018 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.74 -15.47 5.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.774 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.54 -22.04 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.584 HG23 ' H ' ' A' ' 137' ' ' GLY . 9.4 t -133.19 -18.79 2.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.331 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.32 33.5 23.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.737 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.584 ' H ' HG23 ' A' ' 135' ' ' THR . . . -84.11 145.68 22.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.439 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 24.0 tp -75.1 128.86 36.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.787 0.327 . . . . 0.0 110.924 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.5 mt -111.1 -50.37 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.625 ' HB ' HG23 ' A' ' 130' ' ' VAL . 53.8 t -104.25 114.99 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.971 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -117.27 57.44 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.716 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.58 -176.2 2.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.133 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.554 ' O ' HG22 ' A' ' 147' ' ' VAL . 2.4 m -121.16 168.63 11.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.667 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.658 HD11 ' O ' ' A' ' 124' ' ' SER . 5.8 mt -84.33 -33.09 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 110.873 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -83.67 -13.16 54.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.615 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -87.05 -42.35 13.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.981 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 143' ' ' THR . 0.6 OUTLIER -61.73 126.7 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.923 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.85 -37.72 63.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.878 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.849 ' HB2' HD12 ' A' ' 163' ' ' ILE . 9.6 m-85 -151.97 166.37 31.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.084 0.469 . . . . 0.0 111.626 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' B' ' 3' ' ' SER . 0.5 OUTLIER -147.75 63.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.797 177.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.452 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -90.06 136.93 28.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.984 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 72.7 Cg_endo -80.16 -91.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.704 2.269 . . . . 0.0 111.603 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.677 0.275 . . . . 0.0 110.655 178.849 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 158' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.63 123.3 4.46 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -115.39 161.94 17.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.645 0.259 . . . . 0.0 110.54 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -158.92 -177.87 6.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.013 0.435 . . . . 0.0 111.448 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -156.38 158.06 36.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.085 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.849 HD12 ' HB2' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -123.71 165.04 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.069 0.461 . . . . 0.0 112.027 -177.288 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.42 ' H ' HG22 ' A' ' 163' ' ' ILE . 5.7 p -165.57 135.6 3.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.394 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -160.43 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 111.263 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -175.17 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.442 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.25 -7.32 69.16 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.445 ' H ' ' H ' ' A' ' 169' ' ' THR . 2.1 t -168.95 -11.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.216 -0.492 . . . . 0.0 110.002 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.673 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -128.08 -7.88 5.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.739 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 64.15 9.72 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.574 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -176.12 -173.72 0.58 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.968 0.413 . . . . 0.0 111.317 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.93 108.07 19.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.593 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.673 ' HB2' HG21 ' A' ' 169' ' ' THR . 24.9 mtp -128.36 133.51 48.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.759 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . 0.437 ' HB2' HG23 ' A' ' 163' ' ' ILE . 43.5 t -113.58 132.43 55.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' A' ' 161' ' ' SER . 35.1 m170 -98.8 158.72 15.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.624 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -139.81 149.41 20.78 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.005 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 10.3 p90 -157.08 135.98 11.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.78 0.324 . . . . 0.0 110.815 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.68 160.19 14.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.499 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . . . -96.52 118.02 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -6.56 45.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -26.76 20.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.765 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.16 75.87 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.027 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -165.65 -32.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.786 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 63.82 37.09 94.17 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.514 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -133.29 -31.25 1.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 111.011 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.443 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 4.1 mmt180 -88.16 -5.72 58.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.82 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 191' ' ' VAL . 0.2 OUTLIER -128.07 -58.0 1.22 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.29 -179.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -62.51 1.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.344 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.98 -19.64 32.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.29 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.05 -45.65 33.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.03 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 187' ' ' LEU . 40.0 t -66.4 -29.05 45.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.962 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.53 -17.69 48.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.366 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 68.6 m -110.58 -8.73 14.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.761 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.1 94.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.187 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.518 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 3.5 p90 -70.42 -29.59 66.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.763 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.08 -22.7 51.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.066 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 49.4 t -101.43 -21.95 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.528 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.16 -28.23 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.467 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.516 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.724 0.297 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.406 ' HA ' ' SG ' ' A' ' 150' ' ' CYS . 0.2 OUTLIER -156.76 166.43 33.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.148 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.559 HD22 ' HB3' ' B' ' 7' ' ' PHE . 1.1 p-10 -70.12 128.14 35.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.994 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 1.2 mtm -95.97 -19.76 19.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.516 ' HB3' HD23 ' A' ' 199' ' ' LEU . 16.0 p -75.04 7.38 3.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.559 ' HB3' HD22 ' B' ' 4' ' ' ASN . 38.7 p90 -57.19 146.92 26.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -99.44 11.36 39.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.716 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . 0.404 ' H ' ' HD2' ' B' ' 7' ' ' PHE . 13.4 t70 54.42 72.74 0.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.953 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.464 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 65.8 m-85 -65.84 139.98 97.07 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 28.1 Cg_exo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.678 2.252 . . . . 0.0 112.31 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.849 0.357 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.54 -29.31 22.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -69.17 -38.41 78.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.688 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.5 tt0 -84.98 -10.61 56.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.641 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -59.87 -54.92 40.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.009 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 194' ' ' ALA . 14.6 t -58.17 -40.32 76.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.542 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 5.8 mtp180 -58.51 -38.29 77.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.456 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 m -75.13 -91.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.414 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 179.65 35.29 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.53 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.634 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -173.16 99.78 0.12 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.895 0.379 . . . . 0.0 111.739 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 4.1 t -120.73 -150.02 0.44 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.23 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.573 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.77 -157.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 111.539 179.202 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.577 ' HB3' ' HE2' ' A' ' 181' ' ' LYS . 6.1 m-85 -159.0 -167.03 1.99 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.416 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.7 m -51.59 153.61 2.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.706 0.289 . . . . 0.0 110.995 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.487 HG21 ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -144.33 -173.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.415 -179.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 86' ' ' LYS . 10.1 mmmm -142.3 63.95 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.69 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.487 ' HE1' HG21 ' A' ' 85' ' ' VAL . 31.8 m-85 -57.81 103.12 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.54 HD13 ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -67.69 -33.61 75.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.479 -178.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.73 -167.44 28.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.602 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.5 ' HB3' ' NE2' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -114.89 128.44 56.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.074 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.76 144.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.028 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.49 141.96 42.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.06 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.94 154.98 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -120.97 61.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.812 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 22.3 mt-10 -152.42 -76.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.254 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m 62.67 29.76 16.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -151.4 107.3 3.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.659 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.57 146.3 7.56 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.316 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.416 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -78.03 -23.39 48.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.748 0.309 . . . . 0.0 110.953 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -70.31 -20.74 62.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.104 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.8 t -59.73 -39.24 79.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 57.6 m -70.77 -36.89 73.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -9.2 18.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.219 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.493 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.5 mt-10 -99.93 -55.53 2.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.011 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.55 -31.79 66.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.238 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.514 HD21 ' HA3' ' A' ' 159' ' ' GLY . 6.8 tp -59.18 -46.56 88.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -67.01 -32.24 73.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.3 t -58.39 -49.94 80.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.986 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.615 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.3 mt -64.68 -22.31 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.678 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 110' ' ' ARG . 7.0 tpt180 -82.45 -28.14 31.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.709 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -97.67 -2.2 41.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.919 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.434 ' HB3' ' HG2' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -107.1 -177.65 3.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.049 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.79 16.29 5.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.093 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.615 ' HG3' HD23 ' A' ' 109' ' ' LEU . 12.2 mmt180 -67.46 99.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.929 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -73.47 135.71 78.61 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 74.2 Cg_endo -77.12 161.74 32.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.585 2.19 . . . . 0.0 112.552 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -124.25 108.73 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.738 179.339 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 96.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.998 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -139.0 161.9 25.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.533 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.509 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -89.28 129.86 35.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 111.025 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.761 HD13 HG22 ' A' ' 130' ' ' VAL . 28.0 tp -101.48 123.42 45.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.634 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 12.1 m-70 -112.81 89.3 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.911 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 82' ' ' SER . 69.1 t -68.82 89.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.399 . . . . 0.0 110.937 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.692 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 1.2 p -84.32 150.74 25.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.234 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.32 34.4 2.44 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.385 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.99 19.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.809 0.338 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.685 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 134.04 112.59 1.31 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.546 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.432 ' CD2' HG13 ' A' ' 123' ' ' VAL . 1.5 mt -65.42 154.05 39.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 111.184 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.492 ' HD3' HG22 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -151.52 124.79 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.8 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.761 HG22 HD13 ' A' ' 121' ' ' LEU . 2.8 t -112.45 113.75 45.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.441 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.492 HG22 ' HD3' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -107.6 117.25 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.581 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 2.6 t0 -51.96 158.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -108.89 0.95 20.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.061 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.69 -20.46 8.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.191 0.52 . . . . 0.0 110.01 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.1 m -123.4 -24.84 4.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.067 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 54.81 27.34 8.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.793 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.22 -109.6 1.19 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.364 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.649 HD21 ' HB2' ' A' ' 141' ' ' ASP . 27.3 tp -160.02 131.2 5.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.778 0.323 . . . . 0.0 111.1 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.8 mt -113.47 -48.92 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.041 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.5 t -136.93 112.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.649 ' HB2' HD21 ' A' ' 138' ' ' LEU . 3.2 t0 -118.14 65.57 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.798 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -112.61 -171.8 1.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.947 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 38.1 m -125.21 158.72 33.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.433 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -66.31 -48.08 82.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.916 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -75.09 -21.95 58.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.612 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.947 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 2.8 ttmm -63.07 -52.34 63.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.694 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 147' ' ' VAL . 2.3 m -67.95 143.09 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -44.92 -67.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.107 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.509 ' HA ' ' ND2' ' B' ' 4' ' ' ASN . 0.1 OUTLIER -165.08 124.93 1.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.961 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.0 t -63.85 159.37 19.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.765 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.519 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -157.25 136.06 7.88 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.421 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 153' ' ' ASP . 89.5 Cg_endo -80.2 -142.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.643 2.228 . . . . 0.0 111.993 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.77 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.625 ' HG2' ' HA ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.769 0.319 . . . . 0.0 110.965 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.514 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -119.45 112.06 2.19 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.652 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 1.5 m-85 -119.55 151.57 38.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.715 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -159.81 170.26 21.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.858 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.581 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -147.51 164.46 33.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.158 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.5 132.6 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.058 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.4 p -111.01 153.64 25.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -119.1 94.01 4.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.008 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.64 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 49.08 29.17 2.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.481 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 168' ' ' THR . . . -65.35 -13.82 58.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.551 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 167' ' ' GLY . 9.0 t 175.75 15.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.736 HG21 ' HG3' ' A' ' 173' ' ' MET . 24.6 m -124.78 -11.52 7.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.887 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 0.0 OUTLIER 60.49 31.15 20.23 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.719 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.428 ' CG ' HG22 ' A' ' 169' ' ' THR . 0.2 OUTLIER -176.35 -168.43 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.589 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.99 126.17 39.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.362 . . . . 0.0 111.196 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.736 ' HG3' HG21 ' A' ' 169' ' ' THR . 1.4 mtp -142.24 161.38 38.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.635 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 33.9 t -140.69 116.07 10.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.077 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.581 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 11.9 m-70 -92.15 134.5 34.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.71 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.715 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -118.0 143.34 17.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.532 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 41.4 p90 -149.96 154.16 37.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 0.0 111.223 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.89 135.49 51.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.643 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -59.74 117.49 5.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -16.12 63.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.741 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.577 ' HE2' ' HB3' ' A' ' 83' ' ' PHE . 3.4 mmtt -88.41 -26.91 21.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.781 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.625 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 4.3 m-20 57.59 87.64 0.06 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.2 t -162.5 -30.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.996 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.94 20.35 76.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.399 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -137.66 2.09 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.689 0.28 . . . . 0.0 111.02 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.472 ' HB2' HD12 ' A' ' 187' ' ' LEU . 7.8 mmt85 -106.25 -14.88 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.738 HD23 HD23 ' A' ' 121' ' ' LEU . 4.4 mp -134.55 -39.94 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -59.27 -60.26 4.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -18.21 64.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.31 -41.55 63.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 187' ' ' LEU . 67.7 t -73.62 -29.53 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.68 -7.64 29.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.248 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.571 ' O ' HG23 ' A' ' 197' ' ' VAL . 68.3 m -108.47 -19.77 13.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.697 0.284 . . . . 0.0 110.751 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.458 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -58.91 -60.8 3.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.159 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -64.69 -32.71 74.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.664 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.641 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -57.44 -16.81 10.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.236 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 193' ' ' CYS . 56.4 t -105.34 -29.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.055 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -9.56 58.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.718 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 196' ' ' ALA . 4.3 mt . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.915 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.036 0 CA-C-O 120.641 0.258 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 93.0 p 51.4 95.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.177 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 149' ' ' PHE . 3.9 p30 -52.38 146.26 9.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.396 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 23.2 ttm -113.03 3.86 16.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.914 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.8 p -94.02 19.35 9.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.429 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 28.6 p90 -62.88 152.24 36.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.01 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -85.05 11.55 9.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.739 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' ASP . . . . . 0.429 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 22.5 t0 57.46 80.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.035 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.625 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 24.0 m-85 -90.38 -50.8 0.34 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.248 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 45.0 Cg_exo . . . . . 0 C--O 1.25 1.085 0 C-N-CA 122.197 1.932 . . . . 0.0 112.278 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 120.677 0.275 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.51 -54.52 44.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.94 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.6 m0 -71.92 -24.07 61.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -11.08 60.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.295 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.96 -22.22 9.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.948 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -85.21 -18.95 32.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -44.0 97.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.6 mt-10 -97.62 -5.95 34.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -63.92 -55.98 18.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.501 HG23 ' CB ' ' A' ' 81' ' ' CYS . 1.2 t -61.54 -36.27 72.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.707 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.404 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 22.9 mtp180 -62.0 -28.6 69.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.373 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.6 m -85.66 -92.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.819 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -175.94 34.14 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.454 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.543 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.8 t -174.41 97.22 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.036 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.645 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 10.5 t -122.88 6.01 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.591 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.726 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -113.15 -153.38 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.076 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.434 ' CG ' ' HE2' ' A' ' 181' ' ' LYS . 6.8 m-85 -154.56 -169.39 3.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.684 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.63 137.61 15.32 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.763 0.315 . . . . 0.0 111.012 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.53 179.54 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.011 0.434 . . . . 0.0 111.675 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -133.0 66.56 1.56 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.814 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -58.3 101.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.73 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -69.84 -37.91 76.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.151 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.98 -132.08 4.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.467 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.74 ' HB3' ' HD2' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -148.23 136.94 21.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.099 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -130.77 167.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.833 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 5.6 pt-20 -96.39 143.53 27.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.126 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.55 -171.72 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -149.46 62.98 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.164 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 1.3 mt-10 -168.95 -68.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.097 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.0 p 52.44 38.92 26.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -146.91 25.96 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.069 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -159.24 161.65 32.21 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -15.88 35.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -80.22 -18.03 50.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.945 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 t -61.49 -27.29 41.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 67.3 m -81.12 -26.1 36.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.932 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -15.96 63.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -99.81 -42.9 6.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.516 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.7 -39.7 81.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.974 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.627 HD11 ' HG ' ' A' ' 178' ' ' LEU . 6.0 tp -56.51 -32.36 64.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.804 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 111' ' ' GLN . 5.8 tptp -75.87 -38.9 57.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -58.18 -44.43 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.526 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.1 mt -72.67 -15.93 61.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 110' ' ' ARG . 3.8 ttt-85 -84.84 -12.39 53.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.249 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 1.5 mm100 -72.49 -64.81 0.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.658 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -177.73 -169.14 0.2 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.425 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' SER . 0.5 OUTLIER 69.87 -71.95 0.12 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.21 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.526 ' HG3' HD23 ' A' ' 109' ' ' LEU . 8.3 mmm180 -75.67 100.3 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.728 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.466 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -80.31 135.04 54.34 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.126 -179.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.73 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 16.4 Cg_exo -68.2 156.74 64.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.819 2.346 . . . . 0.0 112.104 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.8 t -130.44 140.57 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -92.29 98.04 11.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 132' ' ' ASP . . . -125.77 -162.33 11.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.682 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.31 102.14 6.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.699 0.285 . . . . 0.0 110.598 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.487 HD23 HD23 ' A' ' 187' ' ' LEU . 40.8 tp -69.2 128.52 36.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.708 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.567 ' HB2' ' HG2' ' A' ' 129' ' ' ARG . 34.4 m170 -121.73 87.95 2.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.773 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.726 HG23 ' HB2' ' A' ' 82' ' ' SER . 35.8 t -62.8 94.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.148 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.819 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -98.39 144.86 27.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.287 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -60.61 -7.93 8.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.94 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.94 34.54 5.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.727 0.298 . . . . 0.0 110.997 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.652 ' HA2' HG13 ' A' ' 144' ' ' ILE . . . 109.14 143.51 10.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.774 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.78 164.03 27.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.567 ' HG2' ' HB2' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -158.04 114.78 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.534 179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.483 HG23 ' HB ' ' A' ' 140' ' ' VAL . 17.1 t -99.39 103.21 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.517 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.79 109.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.376 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.411 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -48.68 139.61 9.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.093 -179.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -98.63 12.98 33.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.864 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -138.57 0.73 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.2 m -148.89 -26.46 0.3 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.438 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm 49.64 35.33 8.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.667 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.31 -5.15 54.71 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.63 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.619 HD21 ' HB3' ' A' ' 141' ' ' ASP . 7.3 tp 66.26 149.52 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 110.898 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.418 ' N ' ' HG ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -138.49 -35.91 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.526 -179.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.483 ' HB ' HG23 ' A' ' 130' ' ' VAL . 21.0 t -113.84 95.74 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 111.351 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.619 ' HB3' HD21 ' A' ' 138' ' ' LEU . 3.4 p30 -102.66 25.79 8.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.597 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -76.65 -164.82 0.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.256 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.617 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 9.2 m -141.11 158.39 43.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.921 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.652 HG13 ' HA2' ' A' ' 127' ' ' GLY . 30.4 mt -73.13 -41.69 58.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.844 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.33 -7.14 56.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.568 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.617 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -87.9 -40.58 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.814 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 143' ' ' THR . 0.9 OUTLIER -74.86 152.91 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.803 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -65.29 0.58 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.722 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 26.5 p90 -174.33 141.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.83 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.4 m -67.25 166.25 14.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.479 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -170.09 124.54 0.66 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.34 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.498 ' HG3' ' N ' ' B' ' 1' ' ' GLY . 86.9 Cg_endo -82.1 -158.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.676 2.251 . . . . 0.0 112.405 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -130.89 -179.42 5.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.726 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 154' ' ' ARG . 1.7 mmm180 -130.58 21.25 5.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.902 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.37 -57.74 2.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.485 ' HD2' ' H ' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -154.46 14.54 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 57.62 21.39 7.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.277 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.485 ' H ' ' HD2' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -110.41 16.95 21.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.686 179.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -147.82 124.0 1.82 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.691 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 4.7 m-85 -126.34 165.25 19.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.632 0.253 . . . . 0.0 110.562 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.73 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -163.6 158.83 21.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.992 0.425 . . . . 0.0 111.379 -179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.551 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -131.46 148.85 52.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.252 178.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.821 HG23 ' HB2' ' A' ' 174' ' ' CYS . 1.0 OUTLIER -106.58 150.54 9.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.411 . . . . 0.0 111.62 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -146.37 100.02 3.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.45 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.645 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 7.3 ptt180 -72.44 -153.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -178.23 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.093 0.473 . . . . 0.0 111.6 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.0 -3.87 60.63 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.3 t -171.97 -9.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.936 0.398 . . . . 0.0 110.366 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.45 HG21 ' CG ' ' A' ' 173' ' ' MET . 2.0 m -133.86 -6.88 2.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.101 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 59.09 16.91 5.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.168 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.27 179.69 2.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.781 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -85.07 113.53 21.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.45 ' CG ' HG21 ' A' ' 169' ' ' THR . 0.9 OUTLIER -131.49 116.45 17.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.622 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.821 ' HB2' HG23 ' A' ' 163' ' ' ILE . 27.3 t -108.75 129.27 55.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.222 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.74 ' HD2' ' HB3' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -96.95 142.22 29.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 179.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.73 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -124.09 157.13 18.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.331 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 22.7 p90 -161.05 172.5 16.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.676 0.274 . . . . 0.0 110.422 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.627 ' HG ' HD11 ' A' ' 106' ' ' LEU . 1.2 mp -138.53 148.9 44.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 0.0 111.106 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.83 121.6 25.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.069 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -81.74 8.48 9.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.434 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 17.7 mmmt -102.12 -29.14 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.944 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.42 ' HA ' ' HG3' ' A' ' 158' ' ' ARG . 1.7 m-20 56.98 81.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.966 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.4 t -159.89 -33.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.29 37.46 80.49 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.411 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -151.47 -32.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.313 . . . . 0.0 111.136 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.52 ' HB2' HD12 ' A' ' 187' ' ' LEU . 5.7 mmt180 -74.01 -11.9 60.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.065 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.52 HD12 ' HB2' ' A' ' 186' ' ' ARG . 5.5 mp -135.29 -43.93 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 t -57.22 -75.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.509 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -28.59 57.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.252 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.84 84.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.918 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 187' ' ' LEU . 94.1 t -68.74 -36.36 73.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.69 -11.34 35.56 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.32 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.411 ' O ' HG23 ' A' ' 197' ' ' VAL . 56.5 m -107.78 -16.11 14.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 0.0 110.566 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.08 -51.55 66.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.213 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.542 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.9 p90 -62.0 -38.02 87.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.75 -26.61 64.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.446 ' HA ' ' HG2' ' A' ' 200' ' ' GLU . 47.0 t -97.44 -22.21 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.754 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 15.8 t -65.61 -29.92 70.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.975 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER -105.8 29.46 6.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 197' ' ' VAL . 4.6 mm-40 -68.08 -29.3 68.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.865 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.498 ' N ' ' HG3' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.113 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.8 178.02 7.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.679 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 5.1 p -168.71 145.14 3.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.779 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.689 HD21 ' HB3' ' B' ' 7' ' ' PHE . 2.5 p-10 -60.16 154.95 18.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.024 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 13.9 mmm -129.06 -15.42 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.264 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 9.5 t -84.82 20.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.689 ' HB3' HD21 ' B' ' 4' ' ' ASN . 40.1 p90 -63.49 159.8 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -91.75 0.76 57.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.783 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 59.26 81.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.132 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -74.36 150.95 87.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.86 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.571 2.181 . . . . 0.0 112.394 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.825 0.345 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -79.17 -39.15 34.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -73.71 -30.84 63.08 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -67.77 -9.54 44.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.631 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.05 -19.68 11.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.042 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -26.62 40.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -47.1 87.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.762 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -83.05 -15.95 48.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.881 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -53.62 -52.45 59.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.28 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.4 t -61.08 -43.62 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.565 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -55.21 -35.21 64.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.337 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 m -77.09 -92.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.531 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 179.54 35.72 0.0 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.393 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.516 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.1 t -173.03 100.81 0.13 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.009 0.433 . . . . 0.0 111.887 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.872 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.0 t -124.29 -149.45 0.42 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.413 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.718 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.4 OUTLIER 53.74 -153.33 0.28 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.768 0.318 . . . . 0.0 111.805 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -158.99 -168.34 2.34 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.749 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.7 OUTLIER -52.32 143.15 15.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.532 -179.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -136.91 -171.87 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.987 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.827 ' HD2' ' HB2' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -142.23 89.94 2.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 91.5 t80 -58.31 107.68 0.52 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.01 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.6 ' HB3' HD22 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -70.06 -60.66 2.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.61 -134.11 3.14 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.469 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.406 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 0.9 OUTLIER -152.41 131.28 12.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 110.898 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.42 164.74 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.783 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -100.87 136.32 40.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.967 0.413 . . . . 0.0 111.012 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.3 m -140.25 140.37 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.96 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.506 ' HA ' ' HE3' ' A' ' 172' ' ' TRP . 50.0 m-85 -102.14 64.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -147.89 -81.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.075 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.03 46.61 22.43 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.92 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.87 70.75 1.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.775 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.25 179.27 20.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.247 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.49 -7.42 24.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -83.62 9.49 11.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -80.13 -19.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.0 p -83.05 -36.88 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.961 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -66.17 -4.96 8.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.105 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -119.59 -53.65 2.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.082 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.97 -53.34 59.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.212 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -55.54 -36.36 66.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.695 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -38.24 90.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.75 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 104' ' ' GLU . 48.7 t -62.6 -45.24 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.727 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.684 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -61.74 -37.61 84.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.586 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -28.94 64.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.93 2.54 53.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.257 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.613 ' HB3' ' HG2' ' A' ' 114' ' ' ARG . 0.1 OUTLIER -109.7 -163.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.916 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -96.56 15.95 20.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.684 ' HG3' HD23 ' A' ' 109' ' ' LEU . 1.5 mmt180 -67.14 101.74 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.01 126.79 90.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.095 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.827 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 88.1 Cg_endo -78.66 153.97 26.74 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.545 2.163 . . . . 0.0 112.314 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -129.49 121.51 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.206 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 29.0 ttm-85 -77.96 109.41 11.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.917 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -139.33 -152.74 5.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.6 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.512 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -128.92 126.27 39.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.834 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.434 ' N ' HD13 ' A' ' 120' ' ' LEU . 19.8 tp -102.25 116.25 32.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.62 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.702 ' HE1' HG23 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -107.09 93.12 4.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.872 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 45.2 t -60.82 95.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.551 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -94.6 129.7 41.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.198 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.06 5.22 1.37 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.217 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 124' ' ' SER . 7.7 p-10 -134.86 27.81 3.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.886 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 126.21 107.07 1.53 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.376 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.0 mt -61.34 150.7 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.949 0.405 . . . . 0.0 111.296 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 129' ' ' ARG . 5.7 ttm-85 -142.66 151.61 41.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.528 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.425 ' CG2' ' HB ' ' A' ' 140' ' ' VAL . 50.8 t -141.04 110.79 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.804 0.335 . . . . 0.0 111.368 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.702 HG23 ' HE1' ' A' ' 122' ' ' HIS . 17.8 t -104.16 126.4 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.835 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 0.3 OUTLIER -54.07 151.94 6.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.86 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.569 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -104.91 8.52 34.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.028 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.74 -4.2 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.226 0.536 . . . . 0.0 110.347 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.2 m -141.83 -21.36 0.72 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.898 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.559 ' HA ' HG12 ' A' ' 131' ' ' VAL . 19.5 mmtp 52.09 36.96 20.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.218 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.01 -112.3 1.67 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.377 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 tp -169.78 119.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.698 0.285 . . . . 0.0 110.647 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.73 -49.77 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.319 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.425 ' HB ' ' CG2' ' A' ' 130' ' ' VAL . 8.2 t -114.22 105.42 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 111.311 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -118.53 34.3 5.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.682 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -73.29 -166.63 0.34 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.138 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.676 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 27.1 m -144.42 155.03 43.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.887 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.551 HD11 ' O ' ' A' ' 124' ' ' SER . 17.2 mt -64.08 -53.73 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.955 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.11 -9.19 51.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.853 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.614 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 36.9 tttm -85.81 -51.29 6.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.046 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 143' ' ' THR . 4.4 m -69.28 145.35 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.073 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.82 -63.86 1.01 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -166.15 142.9 5.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.699 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.469 ' H ' ' H ' ' B' ' 4' ' ' ASN . 1.2 m -71.78 165.12 24.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.3 101.2 0.48 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HG2' ' HA2' ' B' ' 1' ' ' GLY . 45.6 Cg_endo -68.41 -90.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.425 2.083 . . . . 0.0 112.366 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -173.49 -164.03 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.812 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 154' ' ' ARG . 10.1 mmm180 -80.73 -83.64 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.67 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -176.0 48.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.12 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -169.27 -17.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.244 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -82.81 -33.24 27.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.225 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 58.99 15.16 3.78 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.958 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.44 156.75 15.43 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.346 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.64 157.21 43.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.757 0.313 . . . . 0.0 110.952 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.77 138.03 17.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.125 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -114.76 144.44 43.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.736 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 149' ' ' PHE . 0.5 OUTLIER -109.99 157.91 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.991 0.424 . . . . 0.0 111.589 -178.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 14.5 t -161.24 136.05 7.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.571 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -88.73 -151.22 0.2 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.267 -179.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 170' ' ' ARG . 6.5 p-10 -65.7 -149.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.435 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 168' ' ' THR . . . 83.35 -8.41 64.59 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 167' ' ' GLY . 0.6 OUTLIER -163.03 -42.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.081 0.467 . . . . 0.0 110.171 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.451 HG22 ' HG3' ' A' ' 171' ' ' ARG . 16.6 m -96.32 -11.4 25.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.946 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.46 ' HA ' ' HB2' ' A' ' 166' ' ' ASP . 1.1 mtp180 63.44 20.06 12.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.934 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.451 ' HG3' HG22 ' A' ' 169' ' ' THR . 1.6 ptp85 -174.31 173.47 3.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.678 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.7 OUTLIER -85.9 105.02 16.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 8.9 mtp -121.41 139.55 53.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.653 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.418 ' HB2' HG23 ' A' ' 163' ' ' ILE . 25.2 t -118.27 141.81 48.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.933 0.396 . . . . 0.0 110.984 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.406 ' CE1' ' HB3' ' A' ' 90' ' ' CYS . 11.9 m170 -111.14 151.31 28.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.548 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -128.22 156.2 20.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.64 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -170.78 132.93 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.12 173.62 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.834 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -97.98 133.62 42.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.09 -24.06 61.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.776 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -82.08 -28.0 32.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.913 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.05 84.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.998 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 t -169.24 -38.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.55 26.6 62.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.402 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -132.49 -23.7 2.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 111.203 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.573 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -86.9 -17.99 31.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.148 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 186' ' ' ARG . 5.9 mp -124.87 -49.2 1.74 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.249 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.8 -46.55 87.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.241 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.89 1.26 13.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.316 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.505 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -101.15 -46.74 4.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.109 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.693 ' HA ' HG11 ' A' ' 123' ' ' VAL . 8.5 p -71.41 -20.72 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.4 -14.04 66.13 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.722 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 16.9 m -103.84 1.06 31.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.795 0.331 . . . . 0.0 110.988 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.61 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -78.51 -42.31 29.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.987 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.517 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.0 m-85 -60.57 -37.77 82.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.626 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.488 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -54.59 -34.6 62.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.439 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.6 t -91.6 -10.67 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.173 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.6 t -84.3 -16.31 43.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.191 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER -123.62 44.8 2.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.333 . . . . 0.0 111.241 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.46 -29.88 70.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.641 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.715 179.257 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.125 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.31 176.45 5.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.816 0.341 . . . . 0.0 110.685 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -159.83 144.11 14.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.963 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.469 ' H ' ' H ' ' A' ' 150' ' ' CYS . 22.7 t-20 -62.89 105.18 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.037 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -9.08 53.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -81.05 11.74 3.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.226 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -56.87 142.47 41.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.33 10.17 13.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 32.4 t0 56.04 78.15 0.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.144 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 26.2 m-85 -61.79 139.0 95.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.028 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 47.0 Cg_exo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.656 2.237 . . . . 0.0 112.386 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.7 t60 . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 120.845 0.355 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.89 -69.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -65.83 -27.69 68.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.8 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -10.42 54.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.492 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.76 -23.36 12.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.876 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -86.3 -28.34 23.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.89 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -66.89 -47.91 70.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.594 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.673 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -69.72 -26.8 64.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.5 80.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.687 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 194' ' ' ALA . 42.1 t -59.33 -36.83 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.3 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.673 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 2.2 mtm-85 -65.36 -37.09 85.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.117 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -75.66 -5.97 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.435 178.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 70.58 46.89 0.51 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.414 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.836 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -172.57 87.04 0.07 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.47 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.86 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.7 t -119.7 -149.19 0.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.302 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.625 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 57.64 -154.85 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.375 . . . . 0.0 111.573 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.506 ' HB2' HD11 ' A' ' 187' ' ' LEU . 5.5 m-85 -158.32 -170.77 3.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.503 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 120' ' ' LEU . 0.6 OUTLIER -53.14 154.35 3.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.79 0.329 . . . . 0.0 111.005 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -148.28 -170.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.073 0.464 . . . . 0.0 111.592 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 5.1 mmtp -141.54 80.15 1.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.467 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 48.4 t80 -56.83 108.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.276 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 178' ' ' LEU . 7.9 mt -70.53 -51.37 29.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.895 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.664 ' HA3' ' HD3' ' A' ' 114' ' ' ARG . . . 152.71 -131.48 3.37 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.615 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.517 ' H ' ' HD3' ' A' ' 114' ' ' ARG . 1.4 p -153.3 134.15 13.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.819 0.342 . . . . 0.0 110.854 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.0 m -128.02 146.2 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -71.33 132.94 45.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.168 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.7 m -117.26 -178.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.046 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -139.34 59.61 1.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.037 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -171.54 -63.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.821 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.425 ' HA ' HG21 ' A' ' 163' ' ' ILE . 17.8 m 60.23 31.32 20.44 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.399 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 7.3 ptt180 -165.39 88.12 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.95 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.19 158.73 9.16 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.753 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -37.77 54.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 110.86 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 2.2 pt20 -67.36 -22.55 65.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.92 -33.13 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.08 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 83.5 m -80.07 -39.33 29.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.997 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.661 ' HG2' ' HA ' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -64.26 -28.63 69.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.047 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 108' ' ' VAL . 68.0 mt-10 -81.31 -50.87 9.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.88 -36.78 75.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.321 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.8 tp -57.87 -38.9 76.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -73.21 -37.99 66.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.1 t -58.66 -38.49 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.721 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.9 mt -72.76 -33.58 66.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -80.91 -3.32 51.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.759 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -117.32 -13.52 10.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.9 p -93.62 -166.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -101.38 27.4 6.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.046 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.721 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -72.79 113.55 9.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.75 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 131.11 91.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 90.8 Cg_endo -85.05 145.59 9.9 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.742 2.295 . . . . 0.0 112.187 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 1.8 t -108.43 155.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -116.49 103.25 10.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.971 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.42 -164.73 12.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.622 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.537 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -112.15 131.41 55.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 111.143 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.7 HD23 HD23 ' A' ' 187' ' ' LEU . 22.0 tp -98.14 120.8 39.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.171 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.836 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 74.7 m-70 -109.16 98.46 7.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.09 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.86 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 16.9 t -67.11 100.3 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.246 0.546 . . . . 0.0 110.503 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -98.9 131.43 44.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.268 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.86 20.94 1.01 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.616 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 124' ' ' SER . 9.3 t70 -150.32 14.69 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.782 0.325 . . . . 0.0 110.759 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.801 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 139.4 107.87 0.76 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.684 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 123' ' ' VAL . 12.8 mt -50.59 150.1 2.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.842 0.353 . . . . 0.0 111.131 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.797 ' HG2' HD11 ' A' ' 138' ' ' LEU . 15.3 ttm180 -145.32 113.43 6.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.427 HG22 ' CD1' ' A' ' 121' ' ' LEU . 2.8 t -111.46 115.17 49.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 111.657 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 137' ' ' GLY . 2.1 t -97.33 156.92 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.647 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.527 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 0.3 OUTLIER -95.69 165.08 12.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.417 179.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.45 -5.82 18.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 135' ' ' THR . 0.0 OUTLIER -107.69 -36.95 6.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.939 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 137' ' ' GLY . 8.8 t -118.99 -12.5 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.527 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 30.5 mmtt 59.25 23.02 11.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.777 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.67 ' H ' HG23 ' A' ' 135' ' ' THR . . . -87.91 -161.77 37.26 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.131 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.797 HD11 ' HG2' ' A' ' 129' ' ' ARG . 3.1 tp -116.17 124.32 50.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.0 -25.62 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.365 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.4 t -132.45 94.67 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.863 0.363 . . . . 0.0 111.131 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.526 ' HB2' HD23 ' A' ' 138' ' ' LEU . 37.6 t70 -96.77 72.0 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.756 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.14 -175.78 3.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.877 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 20.2 m -136.47 151.83 49.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.5 mm -61.33 -40.54 86.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.041 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.86 -6.13 59.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.606 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.877 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 2.6 tttp -87.69 -42.95 12.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.907 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 143' ' ' THR . 0.7 OUTLIER -64.89 128.58 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.2 t -62.87 -35.37 79.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.143 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.577 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -147.78 150.77 34.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.344 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.5 m -129.04 80.52 1.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.299 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 102' ' ' CYS . . . -109.72 128.69 24.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.61 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.77 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 69.8 Cg_endo -75.45 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.535 2.156 . . . . 0.0 112.329 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.661 ' HA ' ' HG2' ' A' ' 103' ' ' GLU . 13.8 p-10 -154.64 -176.81 6.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.51 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.416 ' HG2' ' HG3' ' A' ' 103' ' ' GLU . 0.2 OUTLIER -130.03 -3.37 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.305 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.41 ' HB3' ' H ' ' A' ' 156' ' ' HIS . 1.2 t30 -100.6 -85.94 0.4 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.599 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.41 ' H ' ' HB3' ' A' ' 155' ' ' ASN . 1.0 OUTLIER 170.39 20.37 0.0 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.114 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.468 ' H ' ' HG2' ' A' ' 157' ' ' GLU . 3.7 pt-20 -74.43 5.36 4.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.376 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.433 ' HG2' ' N ' ' A' ' 183' ' ' SER . 0.1 OUTLIER 54.22 27.06 7.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.799 0.333 . . . . 0.0 110.838 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -107.36 143.03 15.86 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.568 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.77 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -123.97 168.18 13.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.653 0.264 . . . . 0.0 110.892 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.02 166.12 26.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.494 . . . . 0.0 111.288 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.55 141.09 20.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.29 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.577 HD12 ' HB2' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -106.72 147.71 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.976 0.417 . . . . 0.0 111.558 -178.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.14 106.5 4.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.641 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -84.89 132.6 34.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.1 p30 44.64 -161.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.869 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.32 -9.6 60.86 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.477 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.6 t -176.06 -19.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 110.425 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.591 HG22 ' HG3' ' A' ' 171' ' ' ARG . 7.6 m -111.08 -15.45 13.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.762 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 58.91 26.48 14.99 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.901 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.591 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -177.88 177.87 1.03 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.023 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.41 132.65 45.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.019 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.506 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -161.1 132.75 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.665 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.422 ' HB2' HG23 ' A' ' 163' ' ' ILE . 20.3 t -116.13 160.19 20.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.307 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -124.92 138.18 54.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.537 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.534 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -123.37 147.26 16.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.661 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 6.5 p90 -162.78 143.2 9.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 0.0 110.745 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.499 HD12 HD21 ' A' ' 88' ' ' LEU . 1.2 mt -111.76 154.92 24.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.137 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.427 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -83.71 129.51 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.15 6.27 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.57 -26.53 12.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 55.38 83.07 0.09 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.433 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -169.66 -37.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.076 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.2 28.5 73.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.435 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.88 -16.42 5.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.835 0.35 . . . . 0.0 110.954 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -105.91 -9.77 16.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.7 HD23 HD23 ' A' ' 121' ' ' LEU . 4.1 mp -125.55 -46.3 1.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.194 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -61.8 2.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.989 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.76 -8.27 34.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.141 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.14 -41.7 13.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.236 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.458 ' HA ' HG11 ' A' ' 123' ' ' VAL . 7.0 p -77.44 -29.2 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.046 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.87 -3.83 52.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.231 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 92.2 m -115.27 1.53 13.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 110.683 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.703 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -77.69 -44.26 28.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.07 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.453 ' CD2' HD21 ' A' ' 199' ' ' LEU . 4.2 p90 -64.96 -25.22 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.938 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.462 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -61.14 -19.05 61.07 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.21 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.99 -27.29 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.001 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.9 t -74.76 -30.84 61.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.765 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.5 OUTLIER -117.99 39.57 3.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -61.16 -50.09 74.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.976 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.716 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.509 ' HA3' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.44 -164.54 2.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.312 . . . . 0.0 110.795 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 51.4 p -168.61 161.38 11.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.571 HD21 ' HB3' ' B' ' 7' ' ' PHE . 0.6 OUTLIER -78.12 159.91 28.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.999 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 10.2 mtm -130.33 -10.94 4.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.995 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -83.59 8.26 14.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.959 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.571 ' HB3' HD21 ' B' ' 4' ' ' ASN . 52.5 p90 -63.4 151.69 40.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -98.56 12.92 33.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.862 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t70 56.03 75.99 0.31 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 66.5 m-85 -71.01 143.71 89.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.934 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 48.5 Cg_exo . . . . . 0 C--O 1.249 1.068 0 C-N-CA 122.638 2.225 . . . . 0.0 112.25 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.836 0.351 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -152.41 -67.62 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.585 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -22.71 60.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.377 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -68.23 -23.56 64.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.055 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.65 -18.69 20.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.645 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.46 -27.29 25.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.862 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -87.26 -23.77 24.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.55 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.738 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.0 OUTLIER -90.45 -15.14 31.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -60.93 -49.44 77.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.943 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.0 t -60.52 -41.0 86.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.255 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.738 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 9.8 mtt180 -56.07 -33.91 65.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.452 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 m -80.7 -92.02 0.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.7 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.624 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -178.71 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.453 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.611 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -172.44 98.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.788 0.328 . . . . 0.0 111.099 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.608 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 15.7 t -129.0 61.06 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.641 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.642 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -161.01 -156.54 0.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.098 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.486 ' HB3' ' HE2' ' A' ' 181' ' ' LYS . 1.9 m-85 -156.12 -170.55 3.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.179 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 1.4 m -51.13 141.76 13.75 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.99 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.9 m -135.86 -175.55 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.42 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 116' ' ' PRO . 4.6 mtpp -133.99 73.92 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.703 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 78.2 t80 -61.37 108.04 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.45 ' HB2' HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -80.22 -36.54 34.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.12 -127.16 3.02 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.606 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 3.2 p -164.64 130.11 2.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.07 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m -114.21 146.81 18.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -72.43 129.9 39.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.109 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 174' ' ' CYS . 1.5 m -121.67 176.79 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.924 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -141.3 59.73 1.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 2.3 mt-10 -162.08 -63.17 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.093 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.17 34.44 17.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -146.12 141.76 27.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.979 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.79 -139.48 14.48 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.571 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.25 -33.31 0.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 0.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -18.87 65.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.228 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -37.24 48.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.767 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.469 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 85.8 m -69.22 -28.69 66.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.67 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -22.27 61.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.905 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.2 mm-40 -87.31 -52.59 5.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.96 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.587 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -58.31 -49.16 78.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.136 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 11.1 tp -53.39 -30.81 41.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.975 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -37.03 67.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.8 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 104' ' ' GLU . 6.0 t -60.82 -48.09 90.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.755 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 105' ' ' ALA . 1.4 mp -70.49 -17.18 62.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.698 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 110' ' ' ARG . 2.0 ttm-85 -87.46 -9.67 53.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.569 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -80.56 -63.86 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.744 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -171.91 -175.67 1.55 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.294 179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 112' ' ' SER . 7.1 mpt_? 70.08 -71.55 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.97 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.509 ' H ' ' HG2' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -66.82 110.56 3.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.932 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.57 142.65 24.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 97.8 Cg_endo -79.42 148.67 21.04 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.575 2.184 . . . . 0.0 112.348 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.23 117.45 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -65.17 97.98 0.29 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.989 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -127.44 -161.48 10.83 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.195 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.48 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -129.27 117.68 21.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.334 . . . . 0.0 110.643 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.639 HD23 HD23 ' A' ' 187' ' ' LEU . 26.5 tp -89.87 130.71 36.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.728 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.422 ' CE1' HD12 ' A' ' 120' ' ' LEU . 30.9 m-70 -118.22 93.19 4.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.915 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.642 HG23 ' HB2' ' A' ' 82' ' ' SER . 79.4 t -66.15 94.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -99.46 135.69 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.346 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -58.06 -9.56 5.85 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.104 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -114.88 32.73 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.29 134.97 6.64 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 mt -66.98 171.1 5.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.907 0.384 . . . . 0.0 111.233 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.576 ' HD3' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -167.24 110.67 0.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.665 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.613 HG22 HD13 ' A' ' 121' ' ' LEU . 7.7 t -106.32 114.8 46.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.92 0.39 . . . . 0.0 111.384 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.72 120.35 57.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.874 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 37.6 m-20 -52.22 152.97 3.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.55 2.52 28.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.939 0.4 . . . . 0.0 111.165 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.42 -24.73 6.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.572 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.01 -10.52 5.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.686 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 27.4 mmtm 54.03 26.27 6.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.817 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 132' ' ' ASP . . . -90.67 135.76 13.03 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.443 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.576 HD11 ' HD3' ' A' ' 129' ' ' ARG . 5.1 tp -67.65 108.17 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.663 0.268 . . . . 0.0 110.619 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 3.0 pt -99.36 -25.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.435 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.544 ' HB ' HG23 ' A' ' 130' ' ' VAL . 74.8 t -136.68 106.19 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.214 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.22 27.93 8.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.327 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -70.24 -173.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.23 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 2.8 m -131.46 164.7 25.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.709 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.461 HD11 ' O ' ' A' ' 124' ' ' SER . 16.0 mt -77.61 -33.45 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.62 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -85.87 -10.87 54.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.45 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 7.1 tttm -83.53 -37.83 22.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.762 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 m -77.67 138.35 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.449 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -60.5 -68.58 0.29 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.516 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 148' ' ' SER . 0.1 OUTLIER -141.22 136.44 31.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.054 178.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.539 ' O ' ' HB3' ' B' ' 2' ' ' PHE . 60.6 m -98.35 93.26 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.549 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -105.11 153.17 39.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.464 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.904 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 82.8 Cg_endo -86.6 -118.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.783 2.322 . . . . 0.0 112.149 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.451 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 18.7 p-10 -148.68 -3.99 0.45 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.596 0.236 . . . . 0.0 111.042 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 45.42 23.54 0.13 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.995 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -103.8 -55.93 2.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.389 . . . . 0.0 110.657 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.533 ' HB2' ' HG3' ' A' ' 158' ' ' ARG . 0.2 OUTLIER -142.07 2.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.402 178.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 60.61 30.75 19.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.081 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 156' ' ' HIS . 6.6 mtm180 -116.83 7.39 13.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.806 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -149.9 119.04 0.99 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.429 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.772 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -111.3 -179.42 3.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.01 0.433 . . . . 0.0 111.034 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -166.44 169.85 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.498 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -150.6 145.54 25.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.511 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -117.03 157.12 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.063 0.459 . . . . 0.0 111.567 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.7 -174.97 5.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.677 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 0.9 OUTLIER -127.65 -149.37 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.799 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.611 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER -63.57 -163.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.903 0.382 . . . . 0.0 111.384 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.91 -16.29 60.46 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.441 ' H ' ' H ' ' A' ' 169' ' ' THR . 10.7 t -163.96 -5.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 110.068 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.441 ' H ' ' H ' ' A' ' 168' ' ' THR . 6.9 m -132.17 -12.37 3.21 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.611 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 34.3 mtt85 60.8 19.39 9.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.059 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.608 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -171.89 172.79 4.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.935 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -81.76 115.33 20.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.625 179.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.608 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 3.2 mtp -131.31 145.91 52.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.511 ' HB2' HG23 ' A' ' 163' ' ' ILE . 16.4 t -119.11 142.95 47.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -112.25 156.63 22.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.628 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 88' ' ' LEU . . . -137.93 146.77 18.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.537 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -164.72 161.06 20.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 0.0 110.959 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.458 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 2.0 mp -127.92 168.6 15.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.88 125.32 45.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.071 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.42 -13.94 45.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.692 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.486 ' HE2' ' HB3' ' A' ' 83' ' ' PHE . 5.9 mmtm -80.73 -28.65 36.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 56.33 37.13 28.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.992 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.43 -44.33 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.987 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.24 31.05 43.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.534 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -127.88 -30.12 2.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 110.978 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.421 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -88.57 -8.94 53.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.742 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.639 HD23 HD23 ' A' ' 121' ' ' LEU . 4.9 mp -127.32 -55.99 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.278 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -63.38 1.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.421 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -59.95 -19.18 50.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.258 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.608 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -79.77 -44.57 20.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.238 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 187' ' ' LEU . 70.9 t -63.8 -32.58 57.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.722 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.95 -7.57 30.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.425 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 59.5 m -109.75 -17.4 13.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.778 0.323 . . . . 0.0 110.97 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.516 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -55.7 -44.83 77.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.128 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.449 ' HD2' ' HB3' ' B' ' 6' ' ' SER . 2.4 p90 -74.9 -29.7 61.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.54 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -60.18 -17.13 38.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.138 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 89.8 t -106.82 -27.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.088 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.2 t -75.38 -4.39 39.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 196' ' ' ALA . 5.1 mt -73.62 -10.19 59.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -59.16 -46.84 87.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.965 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.904 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER -125.19 150.94 46.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.692 0.282 . . . . 0.0 110.966 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' B' ' 2' ' ' PHE . 91.0 p 177.39 140.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.881 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -73.1 178.46 4.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.55 -17.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.005 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 195' ' ' PHE . 51.9 p -80.15 3.31 20.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -70.91 164.23 25.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -107.63 -1.31 21.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t70 58.86 95.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.225 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -58.08 146.55 68.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.86 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo . . . . . 0 C--O 1.248 1.011 0 C-N-CA 122.493 2.128 . . . . 0.0 112.285 -179.846 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.797 0.332 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.33 -35.53 9.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.897 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.789 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -64.02 -26.77 68.72 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.501 179.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -63.92 -18.23 64.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.275 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -117.81 -7.7 10.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.616 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.789 ' HB2' ' HA ' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -82.09 -38.46 24.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.107 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -63.04 -20.3 65.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.644 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 8.9 tt0 -104.53 -12.94 16.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.635 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -54.77 -48.75 72.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.241 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 81' ' ' CYS . 1.2 t -62.03 -35.51 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.388 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -65.9 -29.96 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -90.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -176.58 34.7 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.519 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.634 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -176.8 102.82 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.894 0.378 . . . . 0.0 111.251 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.545 ' HB3' HG23 ' A' ' 76' ' ' VAL . 23.0 t -141.34 65.28 1.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.649 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -163.27 -160.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.35 . . . . 0.0 111.158 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.403 ' CG ' ' HE3' ' A' ' 181' ' ' LYS . 6.1 m-85 -156.05 -171.17 3.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.898 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.27 148.69 2.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.878 0.371 . . . . 0.0 111.305 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 119' ' ' GLY . 18.2 m -135.7 -167.08 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.24 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.84 75.84 1.5 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.765 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' ' 117' ' ' VAL . 83.0 t80 -63.71 91.82 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.016 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.628 ' HB2' HD22 ' A' ' 109' ' ' LEU . 0.7 OUTLIER -61.46 -43.24 99.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA3' ' HD3' ' A' ' 114' ' ' ARG . . . 150.58 -126.75 2.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.332 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.92 132.34 8.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 0.0 111.107 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG21 ' HB ' ' A' ' 108' ' ' VAL . 4.2 m -126.02 149.91 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.993 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.51 137.22 54.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.9 -169.68 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.898 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -122.77 80.4 1.74 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 63.8 109.22 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.804 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.5 p -45.9 -30.16 1.64 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.576 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.32 126.67 19.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.096 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.3 -125.35 2.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.574 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -170.18 -50.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.718 0.294 . . . . 0.0 110.638 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -78.84 11.51 2.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.188 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 163' ' ' ILE . 9.6 t -62.61 -16.27 16.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.936 0.398 . . . . 0.0 110.599 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 67.2 m -102.31 -35.49 8.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.875 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.87 -19.72 62.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 76.3 mt-10 -104.49 -48.28 3.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.145 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.413 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -56.84 -37.03 70.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.279 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 160' ' ' PHE . 14.8 tp -58.48 -35.93 72.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.66 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -34.97 61.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.2 t -58.7 -33.14 48.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.668 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.665 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -80.01 -25.12 40.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.529 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.1 -14.47 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.711 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -105.99 -3.86 21.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.949 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.66 -173.53 2.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.03 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.5 10.94 16.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.002 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.665 ' HG3' HD23 ' A' ' 109' ' ' LEU . 5.6 mmp_? -62.98 105.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -83.03 134.79 45.74 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.088 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 72.3 Cg_endo -74.86 142.49 28.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.525 2.15 . . . . 0.0 112.182 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 87' ' ' TYR . 2.3 t -107.5 122.35 61.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.132 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -69.17 112.93 6.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.447 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -151.53 145.9 14.16 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.576 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.516 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -83.07 110.14 17.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 0.0 111.004 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.754 HD13 HG22 ' A' ' 130' ' ' VAL . 27.3 tp -80.65 137.68 36.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.586 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.516 ' CE1' HD12 ' A' ' 120' ' ' LEU . 3.6 m-70 -124.08 85.83 2.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.704 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.649 ' H ' ' HB2' ' A' ' 82' ' ' SER . 74.7 t -62.39 98.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.108 0.48 . . . . 0.0 111.002 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -98.53 142.34 30.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.205 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.59 16.84 2.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.672 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 124' ' ' SER . 35.7 t0 -146.97 27.99 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.879 0.371 . . . . 0.0 110.433 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.34 113.07 1.77 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -75.79 141.49 42.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.948 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -142.23 131.55 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.754 HG22 HD13 ' A' ' 121' ' ' LEU . 9.1 t -106.88 112.44 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.73 109.92 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.736 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 2.8 m-20 -51.29 147.38 5.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.983 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -97.41 11.45 36.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.927 0.394 . . . . 0.0 110.651 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.05 -30.64 6.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.869 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.662 HG23 ' H ' ' A' ' 137' ' ' GLY . 14.8 t -132.71 -8.69 3.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.005 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 13.3 mmtp 58.34 22.65 9.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.831 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.662 ' H ' HG23 ' A' ' 135' ' ' THR . . . -75.47 -133.49 0.38 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.577 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 tp -151.12 112.85 4.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 0.0 110.66 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.42 ' H ' HG13 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -96.26 -45.38 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.198 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.629 ' HB ' HG23 ' A' ' 130' ' ' VAL . 36.5 t -119.63 97.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.249 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.86 59.38 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.691 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.17 -169.62 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.044 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.712 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 62.1 m -136.31 156.88 48.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.491 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -57.22 -42.27 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.695 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.429 ' H ' HG22 ' A' ' 143' ' ' THR . 7.5 pt-20 -81.39 -14.22 57.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.428 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.624 ' HB3' ' H ' ' A' ' 143' ' ' THR . 0.7 OUTLIER -76.29 -39.55 53.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.587 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 143' ' ' THR . 1.1 m -80.02 150.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -62.44 1.73 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.624 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.81 ' HB2' ' HB3' ' B' ' 3' ' ' SER . 22.1 p90 -173.22 135.8 0.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.73 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.31 136.17 36.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.294 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.421 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . . . -146.4 102.52 4.03 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.641 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 12.4 Cg_endo -54.76 -83.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.626 2.217 . . . . 0.0 112.408 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -165.99 169.33 14.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.955 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.426 ' H ' ' HG3' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -57.0 -45.43 83.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.976 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.6 -63.77 1.37 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.802 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.498 ' NE2' ' HA3' ' A' ' 184' ' ' GLY . 0.5 OUTLIER -178.15 -73.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.831 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 58.43 14.49 2.99 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.087 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 49.19 32.26 4.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -145.2 136.92 6.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.293 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.575 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -122.6 -175.29 3.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.95 173.72 11.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.411 . . . . 0.0 111.05 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -158.24 147.18 19.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.514 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -116.39 158.61 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 0.0 111.51 -178.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.5 p -157.52 -176.54 6.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.483 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -130.6 135.63 48.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.15 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.3 p30 44.19 -158.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.811 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.05 -12.36 62.21 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.1 t 179.76 -17.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.096 0.474 . . . . 0.0 110.176 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.93 HG21 ' HG3' ' A' ' 173' ' ' MET . 87.6 m -112.77 -14.18 13.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.499 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 58.37 26.46 14.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.357 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.858 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -174.53 -171.44 0.58 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 111.561 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.44 135.54 57.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.477 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.93 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -167.17 145.54 4.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.658 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.712 ' HB2' HG23 ' A' ' 163' ' ' ILE . 44.7 t -128.0 145.35 51.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.163 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -115.14 137.25 52.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.593 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.522 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -110.74 152.91 17.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.673 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -167.51 132.89 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.87 0.367 . . . . 0.0 111.047 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.604 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 3.9 mp -106.42 156.8 18.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.11 120.66 25.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.9 t -70.47 -11.87 61.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.958 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.403 ' HE3' ' CG ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -86.81 -26.19 24.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 54.8 71.82 0.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.061 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.4 t -155.17 -30.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.498 ' HA3' ' NE2' ' A' ' 156' ' ' HIS . . . 64.91 36.91 93.65 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.401 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -139.52 -30.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.737 0.304 . . . . 0.0 111.021 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.464 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.4 OUTLIER -90.58 -2.53 57.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.886 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 191' ' ' VAL . 5.5 mp -135.96 -58.22 0.76 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.27 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.05 -57.67 8.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.342 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -59.84 -20.54 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.074 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.12 -45.45 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.073 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 187' ' ' LEU . 98.6 t -63.82 -30.71 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.91 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.481 ' HA2' ' HE1' ' A' ' 195' ' ' PHE . . . -64.09 -7.38 23.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.427 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.452 ' O ' HG23 ' A' ' 197' ' ' VAL . 1.0 OUTLIER -119.24 -5.12 10.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 0.0 110.743 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -74.5 -52.53 11.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.333 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.481 ' HE1' ' HA2' ' A' ' 192' ' ' GLY . 40.1 p90 -65.94 -31.14 71.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.945 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.603 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -58.22 -24.22 58.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.791 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 193' ' ' CYS . 22.3 t -93.75 -18.97 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.962 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 3.7 t -74.89 -27.07 60.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.957 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.4 OUTLIER -112.56 24.43 12.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -39.97 95.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.755 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.905 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.465 ' HA2' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.357 -0.297 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -119.15 -47.38 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.801 0.334 . . . . 0.0 110.759 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.81 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER 62.87 118.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.184 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.561 ' ND2' ' HA ' ' A' ' 149' ' ' PHE . 21.0 p30 -57.5 157.59 6.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.07 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 3.1 mtp -125.0 0.21 7.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.018 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 32.6 p -92.01 25.08 2.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.496 ' HD2' ' H ' ' B' ' 9' ' ' ASP . 39.4 p90 -72.14 162.0 30.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -114.74 11.7 16.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.489 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . 0.496 ' H ' ' HD2' ' B' ' 7' ' ' PHE . 35.3 t70 57.45 78.27 0.24 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.211 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 30.2 m-85 -63.08 146.4 95.85 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 15.5 Cg_exo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.725 2.283 . . . . 0.0 112.384 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.746 0.308 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.22 -48.5 81.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.589 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.38 -22.36 61.15 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.546 178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -25.68 65.02 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.396 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.35 -23.13 17.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.646 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.63 -28.13 45.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.272 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.41 -29.16 69.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.308 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.706 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.6 tm-20 -82.52 -23.2 34.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.688 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.18 -49.97 72.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.903 HG11 ' HA ' ' A' ' 194' ' ' ALA . 55.2 t -63.51 -42.17 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.487 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.706 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -55.31 -37.12 66.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.272 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 2.7 m -71.74 -90.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.218 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.641 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 176.91 38.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.422 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.649 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 1.5 t -174.23 102.34 0.1 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.986 0.422 . . . . 0.0 112.045 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.429 ' SG ' ' HB1' ' A' ' 190' ' ' ALA . 9.6 t -142.17 56.81 1.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.994 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.695 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -151.75 -151.34 0.38 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.168 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -155.41 -172.89 4.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.023 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.508 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.6 OUTLIER -53.92 146.64 13.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.494 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 121' ' ' LEU . 10.5 m -146.56 -176.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.19 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 1.1 mptt -143.0 81.54 1.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.875 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HE1' ' HB3' ' A' ' 175' ' ' HIS . 82.0 t80 -61.32 100.08 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.684 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.474 ' HB2' HD22 ' A' ' 109' ' ' LEU . 1.0 OUTLIER -64.85 -48.33 74.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.61 -131.42 3.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.595 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 175' ' ' HIS . 0.8 OUTLIER -144.96 133.56 22.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.71 0.29 . . . . 0.0 110.991 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.79 157.69 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -83.55 142.96 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -179.01 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.898 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.64 59.66 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.173 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 2.7 tt0 -170.22 -61.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.072 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.5 p 48.71 54.25 10.97 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.965 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 1.7 ptm180 -163.38 114.47 1.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.993 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.77 -137.03 12.5 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.419 ' HB2' ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -147.58 -19.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.867 0.365 . . . . 0.0 110.761 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -79.26 4.72 14.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.071 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -87.38 -15.52 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.767 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.435 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 89.4 m -88.43 -34.37 17.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.813 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.14 -22.51 66.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 108' ' ' VAL . 5.5 mm-40 -93.66 -46.37 7.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.78 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -56.23 -32.68 64.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.973 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.61 -39.9 76.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.702 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -24.49 65.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.738 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 104' ' ' GLU . 59.0 t -75.13 -45.89 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 105' ' ' ALA . 1.3 mt -60.07 -35.7 75.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.957 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -72.09 -39.24 69.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.712 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -77.09 -11.95 59.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.26 -174.98 2.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 113' ' ' ARG . 1.4 mtp85 -87.67 14.37 8.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.485 ' HG3' ' HA ' ' A' ' 109' ' ' LEU . 3.1 mmp_? -61.34 103.26 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -76.2 123.31 87.95 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.133 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 73.5 Cg_endo -75.66 172.82 15.57 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.488 2.125 . . . . 0.0 112.211 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.4 t -130.47 140.23 49.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.21 72.87 8.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 132' ' ' ASP . . . -123.95 149.24 16.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.708 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -80.14 126.79 31.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.328 . . . . 0.0 110.94 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.675 HD23 HD23 ' A' ' 187' ' ' LEU . 51.8 tp -89.52 136.82 32.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.499 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 89.8 m-70 -126.72 94.76 4.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.1 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.695 ' H ' ' HB2' ' A' ' 82' ' ' SER . 54.3 t -60.8 97.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.016 0.436 . . . . 0.0 110.725 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.641 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 11.9 p -103.53 137.0 42.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.269 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -78.56 39.92 1.98 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.692 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -162.07 13.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.397 . . . . 0.0 110.729 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.776 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 134.57 97.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.468 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.513 ' HG ' HG13 ' A' ' 144' ' ' ILE . 2.4 mt -53.68 138.58 34.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.068 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.827 ' HG2' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -137.31 142.22 41.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.609 HG23 ' HB ' ' A' ' 140' ' ' VAL . 8.7 t -114.93 102.33 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.035 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.85 114.99 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.412 ' HA ' ' CA ' ' A' ' 119' ' ' GLY . 4.6 t0 -50.5 144.72 7.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.077 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.21 5.15 51.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.165 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 -32.74 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.692 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.49 -19.53 13.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.737 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm 50.02 39.63 19.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.41 -124.07 5.23 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.492 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.827 HD11 ' HG2' ' A' ' 129' ' ' ARG . 10.3 tp -154.76 113.81 3.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 110.726 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.427 HD12 HG12 ' A' ' 130' ' ' VAL . 5.5 mt -96.23 -54.01 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.4 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.609 ' HB ' HG23 ' A' ' 130' ' ' VAL . 98.9 t -112.5 111.81 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.904 0.383 . . . . 0.0 111.313 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.32 25.32 10.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.608 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.404 ' H ' HG12 ' A' ' 140' ' ' VAL . 70.7 mm-40 -68.43 -170.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.169 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.776 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 5.6 m -146.03 154.29 41.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.931 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.513 HG13 ' HG ' ' A' ' 128' ' ' LEU . 13.6 mt -70.11 -43.51 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.706 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.24 -1.05 31.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.683 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.412 ' CB ' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -96.89 -43.08 7.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 143' ' ' THR . 0.6 OUTLIER -66.02 145.06 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 110.993 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.411 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -55.39 -64.8 0.73 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.628 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.634 ' HD1' HD13 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -144.51 -178.01 5.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.869 179.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' B' ' 3' ' ' SER . 2.2 t -123.18 155.58 36.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.419 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 99' ' ' MET . . . -176.12 126.06 0.34 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.77 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.586 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 96.4 Cg_endo -85.09 -90.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.76 2.307 . . . . 0.0 112.308 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 5.9 p-10 -174.17 -173.75 0.83 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.568 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.6 mtm-85 -74.66 -85.76 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.636 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.65 47.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.775 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.89 -33.19 0.38 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.178 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -98.0 -26.31 14.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.308 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 59.03 18.25 6.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 110.972 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 153' ' ' ASP . . . -105.19 143.82 15.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.355 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.586 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -119.22 169.68 9.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.323 . . . . 0.0 110.87 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.678 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -164.41 176.84 8.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -147.43 145.52 29.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.403 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.645 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -106.85 152.49 8.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.468 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.13 127.54 12.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.685 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -99.95 113.49 26.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.48 ' HA ' ' N ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER 50.45 -153.69 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.311 179.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.94 -37.31 2.51 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.385 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.26 5.47 0.34 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.1 OUTLIER -128.72 -17.79 3.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.731 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.48 ' N ' ' HA ' ' A' ' 166' ' ' ASP . 0.1 OUTLIER 58.6 25.35 13.09 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.095 -178.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 172.19 176.4 0.09 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.552 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.08 124.33 26.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.5 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.767 ' HB2' HG21 ' A' ' 169' ' ' THR . 24.6 mtp -153.63 125.45 7.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.203 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.645 ' HB2' HG23 ' A' ' 163' ' ' ILE . 6.7 t -106.84 141.05 38.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.353 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 8.5 m170 -103.54 129.87 50.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.001 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.678 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -112.57 154.33 16.94 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.35 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -158.73 136.22 10.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.731 0.3 . . . . 0.0 110.536 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.8 mt -97.07 139.85 32.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.299 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.34 115.69 17.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.779 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 3.0 t -58.91 -23.69 61.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.034 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.437 ' H ' ' HG2' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -82.34 -28.52 31.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.045 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 55.08 82.93 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.8 t -161.33 -37.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.925 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.51 18.61 78.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.578 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -134.81 -0.37 2.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 0.0 110.816 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.525 ' HB2' HD12 ' A' ' 187' ' ' LEU . 1.1 mmt180 -98.54 -25.38 14.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.903 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.675 HD23 HD23 ' A' ' 121' ' ' LEU . 4.2 mp -124.39 -51.04 1.75 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.806 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.0 t -58.26 -49.38 77.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.673 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 1.4 t-80 -69.67 -1.92 10.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.547 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.429 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -103.97 -40.75 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.167 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.617 ' HA ' HG11 ' A' ' 123' ' ' VAL . 4.8 p -67.92 -15.29 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.066 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.06 -39.08 97.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.565 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 66.1 m -84.35 -11.58 56.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.988 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.903 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -60.06 -28.46 67.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.274 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -80.89 -37.73 29.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.603 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -55.91 -21.84 22.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.264 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 197' ' ' VAL . 0.8 OUTLIER -75.3 -42.1 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.803 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 85.4 m -78.76 -15.12 58.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.483 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.603 HD12 ' HA ' ' A' ' 196' ' ' ALA . 8.3 mt -87.19 -26.18 23.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.817 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.62 -18.63 65.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.7 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 201' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.992 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.056 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -163.31 161.12 24.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.634 0.254 . . . . 0.0 111.106 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' A' ' 150' ' ' CYS . 2.7 p -145.34 171.34 14.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.937 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -81.18 161.1 24.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.974 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.459 ' HB2' HD21 ' A' ' 199' ' ' LEU . 16.3 mtp -134.34 -7.49 2.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.026 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 20.6 t -93.12 27.13 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -62.72 158.25 19.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.75 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -85.05 7.3 21.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.857 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 17.7 t70 53.67 68.73 0.8 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.136 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.412 ' HE2' ' HA ' ' A' ' 146' ' ' LYS . 60.7 m-85 -67.86 140.69 94.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 C--O 1.248 1.004 0 C-N-CA 122.534 2.156 . . . . 0.0 112.336 -179.802 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.825 0.345 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' OE1' ' HB3' ' A' ' 186' ' ' ARG . 0.9 OUTLIER -78.64 -52.77 7.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.974 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -62.84 -25.14 68.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.897 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -27.2 60.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.678 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . -108.23 11.25 27.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.884 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.69 -32.58 6.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -60.36 -41.47 93.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.873 0.368 . . . . 0.0 110.777 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.858 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.6 mt-10 -92.88 -5.08 51.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.762 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -66.08 -46.42 77.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.045 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 81' ' ' CYS . 0.9 OUTLIER -64.79 -36.58 77.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.394 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.858 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -59.31 -39.27 82.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.359 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -91.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.555 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.455 ' CA ' ' HB2' ' A' ' 124' ' ' SER . . . -178.36 36.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.488 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.628 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -176.0 101.71 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.668 0.27 . . . . 0.0 111.253 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.466 ' CB ' HG23 ' A' ' 76' ' ' VAL . 16.6 t -128.22 0.06 5.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.791 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.739 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -97.78 -163.38 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.6 0.238 . . . . 0.0 111.042 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.623 ' HB3' ' HD2' ' A' ' 181' ' ' LYS . 8.5 m-85 -154.88 -169.14 3.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.354 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.856 ' HB2' ' HE2' ' A' ' 181' ' ' LYS . 0.3 OUTLIER -41.07 142.31 0.52 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.072 -178.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 120' ' ' LEU . 4.1 m -142.26 -165.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.03 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.27 71.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.605 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 89.9 t80 -59.81 99.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.857 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -73.62 -40.24 63.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.58 -132.44 3.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.321 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 175' ' ' HIS . 1.2 p -161.69 142.73 11.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.83 0.347 . . . . 0.0 110.927 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.2 m -127.17 153.38 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.067 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.77 142.5 42.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.988 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.94 -178.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.078 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -143.32 59.51 1.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -176.74 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.433 ' OG ' ' HB3' ' A' ' 172' ' ' TRP . 1.0 OUTLIER 62.92 18.52 10.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.61 -178.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -119.61 51.92 1.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.29 169.07 37.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.12 -27.39 26.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.937 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.46 -19.02 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.035 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.94 -34.61 49.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.745 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.2 m -82.91 -33.49 26.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -65.63 -20.64 66.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.986 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 108' ' ' VAL . 11.7 mm-40 -103.68 -46.44 4.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.048 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.62 -47.03 77.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.694 ' HA ' HD12 ' A' ' 109' ' ' LEU . 15.8 tp -58.33 -32.87 68.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.768 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 1.2 tttm -72.47 -39.77 67.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 104' ' ' GLU . 35.1 t -57.88 -40.95 78.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.847 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.766 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.8 mt -65.44 -27.88 68.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.913 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -28.2 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.79 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 14.4 mt-30 -84.69 -23.13 29.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -106.4 169.32 8.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.26 69.47 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.766 ' HG3' HD23 ' A' ' 109' ' ' LEU . 16.1 mmt-85 -72.26 -154.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.924 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.26 85.97 6.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.548 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 91.6 Cg_endo -79.82 128.4 7.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.701 2.267 . . . . 0.0 112.187 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -113.43 164.68 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -112.1 72.52 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -131.39 -167.81 12.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.445 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.557 ' HA ' HG22 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -135.48 141.27 45.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 111.184 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 120' ' ' LEU . 64.3 tp -76.32 147.92 37.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.347 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -127.28 77.45 1.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.724 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 82' ' ' SER . 53.3 t -53.17 98.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 121.108 0.48 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.528 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -106.65 131.78 53.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.146 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -56.04 -15.08 9.15 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.824 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -112.5 35.72 3.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 113.2 126.19 4.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.448 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.453 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -79.66 139.16 37.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.718 0.294 . . . . 0.0 110.99 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.612 ' HB2' HD11 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.23 141.95 39.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.024 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 140' ' ' VAL . 20.2 t -109.2 114.28 46.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.008 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -104.7 121.31 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.602 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 2.6 t0 -60.94 165.81 3.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.886 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.81 2.15 25.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.55 -45.38 2.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.68 -24.57 19.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.64 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.78 40.58 24.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.795 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.8 -114.92 3.89 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.504 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 129' ' ' ARG . 10.0 tp -168.57 120.27 0.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.771 0.319 . . . . 0.0 110.665 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.597 HD13 HG21 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -101.85 -54.43 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.277 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.579 ' HB ' HG23 ' A' ' 130' ' ' VAL . 80.4 t -103.1 101.78 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.173 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -97.03 21.4 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.61 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -68.54 -177.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.103 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.571 ' O ' HG22 ' A' ' 147' ' ' VAL . 28.4 m -140.75 157.53 45.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.593 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 124' ' ' SER . 21.4 mt -59.86 -45.97 94.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.188 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -76.88 -1.47 28.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 5.3 tttt -99.58 -38.17 8.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.921 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 143' ' ' THR . 1.9 m -75.07 130.44 36.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.043 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.429 ' HB3' ' HD1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -65.7 -50.12 66.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.032 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.478 ' HD2' ' HB2' ' B' ' 3' ' ' SER . 61.9 m-85 -131.55 -173.05 3.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 0.0 111.363 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 161' ' ' SER . 8.9 t -161.89 34.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.043 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.23 148.85 95.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.108 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.923 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 61.4 Cg_endo -88.79 -142.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.053 2.502 . . . . 0.0 112.305 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 157' ' ' GLU . 23.5 t0 -135.79 77.66 1.68 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.709 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 62.44 10.81 4.21 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.121 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.44 36.63 13.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.35 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.66 -0.22 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.162 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 153' ' ' ASP . 1.9 mt-10 -112.31 0.89 15.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.079 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 182' ' ' ASP . 1.0 OUTLIER 53.15 43.94 30.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.93 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.72 128.73 3.87 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.537 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -121.46 168.5 11.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.688 0.28 . . . . 0.0 110.702 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 150' ' ' CYS . 1.1 m -157.87 172.28 18.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -145.41 145.21 31.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.593 178.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.777 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.1 OUTLIER -111.62 169.54 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.289 -179.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.434 ' H ' HG22 ' A' ' 163' ' ' ILE . 40.9 t -169.98 136.6 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.624 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.75 115.32 30.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 111.148 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 50.09 -159.72 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.401 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.42 -16.0 42.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.775 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.427 ' H ' ' H ' ' A' ' 169' ' ' THR . 1.1 t -170.28 -4.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.063 0.459 . . . . 0.0 110.044 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.61 HG22 ' HG3' ' A' ' 171' ' ' ARG . 11.7 m -133.19 -12.65 2.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.977 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 5.6 mmt180 58.96 23.37 11.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.61 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -174.3 171.77 3.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.221 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.433 ' HB3' ' OG ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -74.98 119.98 19.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.936 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.527 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 0.1 OUTLIER -142.44 146.23 34.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.641 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.777 ' HB2' HG23 ' A' ' 163' ' ' ILE . 16.9 t -131.54 124.71 30.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.95 0.405 . . . . 0.0 111.293 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 9.2 m-70 -91.41 136.58 33.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.228 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -114.35 154.06 17.21 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.221 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 21.3 p90 -161.89 143.42 11.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.666 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.87 138.07 50.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.022 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.41 113.87 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.072 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 3.6 t -64.53 -32.47 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.957 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.856 ' HE2' ' HB2' ' A' ' 84' ' ' SER . 0.1 OUTLIER -65.47 -27.07 68.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.027 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.547 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 65.4 m-20 55.95 90.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.199 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 t -168.23 -43.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.777 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.39 30.51 56.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 32.3 tt0 -136.27 -42.39 0.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.701 0.286 . . . . 0.0 110.986 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.552 ' HB2' ' HD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -75.17 -5.95 47.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.9 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 mp -131.29 -49.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.995 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -60.94 2.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 0.3 OUTLIER -62.37 -13.1 25.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.396 -179.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -88.19 -44.4 10.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.153 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.49 ' HA ' HG11 ' A' ' 123' ' ' VAL . 1.7 p -69.95 -24.38 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.86 -10.22 83.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.458 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 64.8 m -110.0 14.4 23.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.392 . . . . 0.0 110.557 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.59 -43.4 11.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.172 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' B' ' 4' ' ' ASN . 5.1 p90 -61.34 -33.35 73.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.733 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.63 -27.41 64.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.886 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.94 -5.53 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.756 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 2.0 t -88.97 -5.4 57.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.923 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.67 -12.4 59.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.021 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -61.73 -32.71 72.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.947 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 201' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.905 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.923 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -145.78 -104.61 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.406 0.146 . . . . 0.0 110.882 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 149' ' ' PHE . 0.0 OUTLIER 64.51 131.74 0.02 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.976 0.417 . . . . 0.0 111.369 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 7.6 p30 -109.95 -165.6 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.742 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.418 ' HG2' ' CE2' ' B' ' 7' ' ' PHE . 0.0 OUTLIER -125.94 -137.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.6 p 56.55 18.17 3.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.562 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.487 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 32.1 p90 -85.69 151.88 23.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.687 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -82.78 9.02 10.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . 0.487 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 8.1 t0 54.46 70.33 0.63 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.777 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.436 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 31.0 m-85 -60.0 139.2 90.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.958 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 32.1 Cg_exo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.705 2.27 . . . . 0.0 112.229 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.6 t60 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.821 0.343 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -39.59 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.811 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -30.01 70.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.553 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -67.01 -11.13 56.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.568 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.44 6.97 6.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.946 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.56 -16.39 10.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.151 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -104.91 -13.93 15.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.3 -14.56 14.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.79 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -66.95 -50.79 61.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.017 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.447 HG23 ' SG ' ' A' ' 81' ' ' CYS . 1.8 t -59.83 -44.88 95.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.799 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -57.97 -39.17 77.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.536 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.1 m -69.2 -93.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.526 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.6 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -177.9 30.98 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.382 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.684 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -171.73 100.13 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.903 0.382 . . . . 0.0 111.789 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 4.1 t -121.7 -147.48 0.39 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.126 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.657 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 52.83 -157.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 111.635 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.491 ' HB3' ' HD2' ' A' ' 181' ' ' LYS . 2.8 m-85 -159.14 -166.21 1.78 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.492 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 0.2 OUTLIER -46.77 151.1 0.63 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.726 0.298 . . . . 0.0 111.309 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.474 HG21 ' HB2' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -145.7 -169.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.102 0.477 . . . . 0.0 111.706 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -152.4 71.91 0.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.266 178.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 22.4 t80 -56.06 111.22 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.192 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 mt -70.53 -80.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.07 -127.5 1.02 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.561 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 8.3 p -155.84 137.75 14.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.703 0.287 . . . . 0.0 111.04 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.33 157.87 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -75.84 147.08 39.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.211 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.49 -176.05 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.58 ' HA ' ' HE3' ' A' ' 172' ' ' TRP . 1.7 t80 -146.03 64.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.256 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.03 -68.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.442 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.54 19.62 6.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.822 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.38 125.4 12.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.33 -112.67 1.31 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.546 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.533 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -174.36 -34.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 111.05 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -76.65 -9.74 58.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.299 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.6 -22.85 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 24.0 m -87.24 -33.99 19.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 153' ' ' ASP . 2.9 mt-10 -64.03 -15.66 59.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.026 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 3.4 mt-10 -97.32 -48.73 5.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.039 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.14 -34.22 71.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.133 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.48 HD21 ' HA3' ' A' ' 159' ' ' GLY . 6.8 tp -64.71 -29.84 70.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -45.99 30.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.835 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' GLU . 4.0 t -59.28 -37.73 70.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.173 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.587 HD23 ' HG3' ' A' ' 114' ' ' ARG . 8.5 mt -70.51 -26.75 63.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -9.68 59.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -114.93 1.78 14.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.034 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -118.19 -18.33 9.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.283 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.5 69.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.874 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.587 ' HG3' HD23 ' A' ' 109' ' ' LEU . 18.7 mmt180 -84.77 43.43 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.49 90.94 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.421 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 70.2 Cg_endo -74.03 163.17 37.43 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.605 2.204 . . . . 0.0 112.075 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 2.3 t -124.44 160.94 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.818 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.476 ' HB2' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -130.75 79.5 1.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -135.16 -174.17 13.33 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.752 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.499 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -101.97 122.97 45.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.749 0.309 . . . . 0.0 110.968 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.474 ' HB2' HG21 ' A' ' 85' ' ' VAL . 28.9 tp -86.6 124.11 32.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.377 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.684 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 67.6 m-70 -112.72 90.48 3.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.972 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 191' ' ' VAL . 44.1 t -66.3 94.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.052 0.453 . . . . 0.0 110.851 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.6 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -91.8 141.06 29.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.938 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.31 34.39 1.54 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.671 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -166.43 18.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.858 0.361 . . . . 0.0 110.568 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.96 106.64 0.64 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.473 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.05 136.1 51.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 111.106 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.82 137.59 41.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 139' ' ' ILE . 3.8 t -119.47 118.47 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.147 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 136' ' ' LYS . 5.7 t -106.74 117.22 52.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.83 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.432 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 3.1 m-20 -51.4 145.03 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.964 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.87 15.47 25.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.533 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.64 -5.76 2.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.592 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.72 -13.62 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.435 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.44 ' HA ' HG12 ' A' ' 131' ' ' VAL . 0.9 OUTLIER 50.66 42.55 27.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.6 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.28 -117.73 4.37 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tp -171.54 128.12 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.683 0.278 . . . . 0.0 110.726 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.553 HG13 ' HB ' ' A' ' 130' ' ' VAL . 1.3 pt -114.69 -39.82 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.321 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.547 ' HB ' HG23 ' A' ' 130' ' ' VAL . 13.0 t -122.84 105.2 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.196 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -111.81 28.62 8.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -70.8 -177.0 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.113 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.74 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 21.7 m -128.41 156.79 42.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.559 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.53 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -67.71 -48.54 75.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.813 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -17.28 61.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.74 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 15.8 tttt -74.0 -53.67 9.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.837 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.11 144.19 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.104 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.8 t -46.56 -58.15 4.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.95 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.761 ' HA ' ' HB3' ' B' ' 4' ' ' ASN . 40.1 p90 -173.1 151.83 2.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.983 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 56.2 m -91.58 113.26 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.533 ' HB1' ' HG2' ' A' ' 99' ' ' MET . . . -120.91 98.56 47.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.074 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 50.1 Cg_exo -54.42 -90.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.454 2.102 . . . . 0.0 112.236 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.496 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 10.7 p-10 -178.88 -149.52 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.475 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.12 13.81 2.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.756 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.77 47.32 18.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.983 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.05 -38.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.885 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -75.25 -9.91 58.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.79 ' HG2' ' H ' ' A' ' 183' ' ' SER . 0.9 OUTLIER 56.15 47.83 18.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.082 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.48 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.63 127.57 2.97 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.591 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.503 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -117.08 166.68 11.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.332 . . . . 0.0 110.646 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.584 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 16.4 m -157.96 161.12 38.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.989 0.423 . . . . 0.0 111.288 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.8 145.76 44.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.191 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 174' ' ' CYS . 1.3 mt -112.94 159.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.01 0.433 . . . . 0.0 111.586 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 29.6 p -147.67 153.35 39.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.346 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.29 119.97 36.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 111.406 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.716 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 54.26 -160.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.34 179.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.04 -18.19 52.31 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.428 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.421 ' H ' ' H ' ' A' ' 169' ' ' THR . 8.9 t -168.4 -0.49 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.046 0.45 . . . . 0.0 109.943 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.561 HG21 ' HG3' ' A' ' 173' ' ' MET . 3.9 m -135.35 -20.36 1.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.04 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.716 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 31.6 mtt-85 58.34 42.82 20.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.957 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.441 ' HD3' ' O ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -179.82 -139.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.797 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.58 ' HE3' ' HA ' ' A' ' 94' ' ' PHE . 9.7 m0 -111.18 136.31 50.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.903 0.382 . . . . 0.0 111.377 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.561 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -157.89 130.61 7.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.239 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.438 ' HB2' HG23 ' A' ' 163' ' ' ILE . 34.7 t -117.25 136.72 52.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.426 . . . . 0.0 111.531 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 161' ' ' SER . 10.0 m170 -106.73 151.23 25.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.292 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -129.54 155.16 20.73 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.02 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -159.35 144.16 15.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.738 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 mt -108.91 176.6 5.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.075 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -111.16 128.4 55.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.8 OUTLIER -62.72 -31.76 72.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.916 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.491 ' HD2' ' HB3' ' A' ' 83' ' ' PHE . 4.0 mttm -90.98 -19.91 22.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 183' ' ' SER . 61.3 m-20 57.39 -157.42 0.29 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.837 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.79 ' H ' ' HG2' ' A' ' 158' ' ' ARG . 8.7 t 72.63 -20.88 0.25 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.635 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 182' ' ' ASP . . . 54.16 40.12 66.08 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.91 -10.59 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.79 0.328 . . . . 0.0 110.884 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.488 ' HD3' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -115.64 4.77 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.922 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 121' ' ' LEU . 5.0 mp -142.62 -51.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.308 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.0 t -56.87 -62.22 1.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.549 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.72 -3.82 7.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.608 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -92.4 -47.31 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.248 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.858 ' HA ' HG11 ' A' ' 123' ' ' VAL . 8.2 p -71.07 -20.05 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.267 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.54 -4.55 52.74 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.718 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.458 ' O ' HG23 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -112.33 -6.75 14.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.359 . . . . 0.0 110.794 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.28 -59.69 3.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.987 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -65.62 -26.9 68.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.776 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -66.12 -18.92 65.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 193' ' ' CYS . 86.7 t -105.58 -26.19 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.97 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 19.1 t -76.64 -10.21 59.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.676 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 196' ' ' ALA . 4.6 mt -63.08 -42.5 99.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.057 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 201' ' ' ARG . 0.0 OUTLIER -58.83 -29.63 67.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.533 ' N ' ' HG3' ' A' ' 200' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.163 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.487 2.095 0 N-CA-C 112.598 -0.201 . . . . 0.0 112.598 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -160.08 -164.94 1.37 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.7 150.29 11.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.02 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.761 ' HB3' ' HA ' ' A' ' 149' ' ' PHE . 3.5 t30 -67.65 146.95 53.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.684 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 14.1 mtp -126.05 -4.19 6.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.081 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -92.83 24.6 3.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.496 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 37.7 p90 -80.62 156.2 26.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.165 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -90.37 9.92 27.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.709 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . 0.496 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 31.0 t0 58.87 71.53 0.58 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.049 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 18.3 m-85 -62.08 141.84 95.67 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 33.0 Cg_exo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.617 2.212 . . . . 0.0 112.312 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.839 0.352 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -95.93 -34.74 11.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.094 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -65.24 -18.24 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.937 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -70.66 -20.96 62.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.425 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.5 -25.59 13.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.773 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -74.3 -45.24 48.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.726 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -65.77 -21.24 66.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.684 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.605 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.5 tt0 -106.58 -2.48 21.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.733 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -64.83 -50.98 64.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.98 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.604 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.8 t -55.09 -37.5 43.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.3 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.605 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 4.8 mtm180 -66.23 -35.91 81.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.184 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 m -81.11 1.47 31.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.601 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 66.77 43.7 2.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.516 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.605 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -172.36 84.91 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.99 0.424 . . . . 0.0 111.326 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.801 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.8 t -111.48 -151.43 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.352 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.627 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.4 OUTLIER 55.62 -160.04 0.19 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.866 0.365 . . . . 0.0 111.379 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 187' ' ' LEU . 22.0 m-85 -157.37 -167.77 2.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.236 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.435 ' HA ' HD22 ' A' ' 120' ' ' LEU . 71.9 m -49.01 148.64 2.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.82 0.343 . . . . 0.0 111.038 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.432 HG11 HD22 ' A' ' 121' ' ' LEU . 2.7 m -144.52 -173.82 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.043 0.449 . . . . 0.0 111.537 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -137.1 68.85 1.41 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.762 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 36.7 t80 -56.67 110.2 0.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.805 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -83.56 -52.71 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.33 -179.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 162.78 -137.56 4.88 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.756 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.549 ' HB3' ' ND1' ' A' ' 175' ' ' HIS . 0.8 OUTLIER -151.35 128.25 11.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.686 0.279 . . . . 0.0 111.087 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.99 162.52 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.03 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -81.45 143.04 32.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.953 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -145.44 127.67 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.085 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -92.79 61.01 3.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.94 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.64 -77.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.27 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.577 ' HA ' HG21 ' A' ' 163' ' ' ILE . 0.3 OUTLIER 54.59 32.4 16.95 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.696 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -134.34 132.06 39.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.693 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.38 -164.69 38.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.438 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.83 -11.19 12.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.003 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -77.9 15.08 0.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.393 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.94 -17.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.41 ' CB ' ' HB2' ' A' ' 161' ' ' SER . 16.9 p -87.74 -34.3 18.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.123 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.798 ' HG2' ' HD2' ' A' ' 154' ' ' ARG . 26.0 mt-10 -66.23 -0.21 2.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.961 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -120.34 -59.64 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.372 . . . . 0.0 111.367 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.517 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -55.5 -38.46 69.21 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.464 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.95 -36.53 62.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -76.66 -37.51 56.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.023 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.15 -44.59 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.615 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.2 mt -72.19 -17.44 61.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.813 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.09 -11.37 58.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.665 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -80.4 -62.48 1.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.821 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.12 -163.96 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.271 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 72.26 -65.81 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.564 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.615 ' HG3' HD23 ' A' ' 109' ' ' LEU . 31.0 mmt180 -94.56 109.17 21.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.842 0.353 . . . . 0.0 111.001 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -82.1 142.48 47.86 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.982 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HB3' HD23 ' A' ' 88' ' ' LEU . 73.3 Cg_endo -77.33 160.05 32.65 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.589 2.193 . . . . 0.0 112.565 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 87' ' ' TYR . 1.4 t -128.15 152.22 35.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.056 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -96.84 100.09 11.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.751 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -144.51 -169.7 13.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.781 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.511 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.4 OUTLIER -117.78 128.75 55.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.655 0.264 . . . . 0.0 110.623 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.456 HD23 HD23 ' A' ' 187' ' ' LEU . 61.3 tp -92.78 122.44 35.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.177 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 8.0 m-70 -112.88 89.18 3.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.019 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.831 HG11 ' HA ' ' A' ' 191' ' ' VAL . 54.3 t -67.27 90.86 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.056 0.455 . . . . 0.0 110.527 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 p -82.92 156.54 23.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.452 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.47 -7.1 38.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.362 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 143' ' ' THR . 0.5 OUTLIER -124.16 34.61 5.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 110.839 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.654 ' HA2' HG13 ' A' ' 144' ' ' ILE . . . 122.52 -162.45 16.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.574 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.42 HD22 HG22 ' A' ' 123' ' ' VAL . 1.6 mt -122.96 166.86 14.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -159.84 103.87 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.667 HG12 HD12 ' A' ' 139' ' ' ILE . 4.4 t -90.32 98.57 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.21 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 136' ' ' LYS . 0.7 OUTLIER -92.38 114.57 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.913 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.401 ' HB3' HG22 ' A' ' 135' ' ' THR . 0.3 OUTLIER -52.72 146.99 9.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.61 19.28 11.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -131.15 -19.75 2.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.749 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.754 HG23 ' H ' ' A' ' 137' ' ' GLY . 12.2 t -134.87 -21.65 1.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.88 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.596 ' HA ' HG12 ' A' ' 131' ' ' VAL . 9.3 mmtt 56.65 23.95 8.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.817 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.754 ' H ' HG23 ' A' ' 135' ' ' THR . . . -77.43 -105.43 0.16 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.443 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.3 tp -165.95 102.34 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 110.699 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.667 HD12 HG12 ' A' ' 130' ' ' VAL . 3.2 mt -80.16 -30.06 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.213 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.475 HG12 HG23 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -156.56 148.38 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.267 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -129.29 48.57 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.819 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.47 ' HG3' ' HE2' ' A' ' 162' ' ' TYR . 1.5 mm-40 -79.09 -175.58 4.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.052 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 2.6 m -149.0 164.85 33.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.879 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.654 HG13 ' HA2' ' A' ' 127' ' ' GLY . 69.2 mt -82.83 -37.93 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -12.2 60.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.626 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -86.43 -48.63 8.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.7 m -64.97 141.45 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.12 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 t -49.87 -65.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.808 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -159.64 123.33 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.805 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 77.0 m -59.87 163.16 4.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.42 125.12 0.74 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.075 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 72.3 Cg_endo -76.1 -94.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.557 2.171 . . . . 0.0 112.438 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.424 ' HA ' ' HG3' ' A' ' 103' ' ' GLU . 5.3 p-10 -175.64 -158.8 0.07 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.434 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.798 ' HD2' ' HG2' ' A' ' 103' ' ' GLU . 1.0 OUTLIER -67.3 -89.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.463 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.41 40.61 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.029 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.6 -17.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.264 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.98 -27.85 49.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.223 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.497 HH11 ' HB3' ' A' ' 182' ' ' ASP . 8.8 mtm180 58.9 19.26 6.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.759 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.516 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -122.81 140.37 13.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.419 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.7 OUTLIER -119.49 168.08 11.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 110.833 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 175' ' ' HIS . 13.5 m -154.02 160.52 42.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.859 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.47 ' HE2' ' HG3' ' A' ' 142' ' ' GLN . 4.7 p90 -134.1 151.59 51.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.799 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.577 HG21 ' HA ' ' A' ' 96' ' ' SER . 0.7 OUTLIER -115.77 157.16 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.046 0.451 . . . . 0.0 111.734 -178.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.98 135.94 9.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.287 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -118.22 119.99 36.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.895 0.378 . . . . 0.0 111.675 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.86 -164.12 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.713 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.19 -17.61 12.22 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.847 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.442 ' H ' ' H ' ' A' ' 169' ' ' THR . 1.6 t -174.05 -0.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.031 0.443 . . . . 0.0 109.932 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -125.0 -15.73 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.868 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.44 21.31 9.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 177.91 176.48 0.43 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.1 121.32 25.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.663 ' HB2' HG21 ' A' ' 169' ' ' THR . 9.4 mtp -143.02 138.67 30.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.568 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.438 ' HB2' HG23 ' A' ' 163' ' ' ILE . 5.6 t -123.02 136.68 54.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.151 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.549 ' ND1' ' HB3' ' A' ' 90' ' ' CYS . 5.6 m-70 -102.44 157.71 16.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.555 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -133.07 145.26 17.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.865 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 17.8 p90 -153.95 136.44 15.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.768 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.516 HD23 ' HA3' ' A' ' 159' ' ' GLY . 5.7 mt -101.82 166.26 10.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.938 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.16 115.83 29.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -10.75 56.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -84.79 -24.09 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.497 ' HB3' HH11 ' A' ' 158' ' ' ARG . 47.1 m-20 56.98 82.97 0.11 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.6 t -167.02 -58.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.102 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.37 29.11 11.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.299 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -133.88 -54.71 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.416 ' HB2' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -59.93 -15.74 24.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.271 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.456 HD23 HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -115.16 -53.89 2.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -49.89 75.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.404 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -73.99 9.0 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.206 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.62 ' HB1' ' SG ' ' A' ' 81' ' ' CYS . . . -103.53 -55.75 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.81 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.831 ' HA ' HG11 ' A' ' 123' ' ' VAL . 13.2 p -64.03 -25.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -63.69 -19.42 62.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.335 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 91.8 m -103.09 10.22 38.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.828 0.347 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.604 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -90.56 -34.0 15.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.217 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.496 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 1.6 m-85 -62.03 -45.35 93.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.002 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.712 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -58.2 -16.03 12.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.597 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.21 -27.99 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.185 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -27.32 60.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.712 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.7 OUTLIER -111.13 16.82 20.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.249 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.36 -66.9 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.858 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -138.03 -174.75 3.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.751 0.31 . . . . 0.0 110.993 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -168.16 153.91 7.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.722 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -65.39 146.83 54.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.79 -12.26 13.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 83.5 p -91.34 25.6 2.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.84 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -61.57 145.24 52.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.071 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.89 0.24 56.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t0 56.6 78.41 0.22 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -82.44 150.98 64.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.998 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.585 2.19 . . . . 0.0 112.333 179.933 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.077 0 CA-C-O 120.801 0.334 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -164.24 -45.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.043 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -27.85 36.63 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -69.48 -11.08 60.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.515 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.4 -27.22 8.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.957 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.17 -28.32 65.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.652 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.31 -16.03 61.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.672 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.622 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 5.7 mt-10 -105.31 -16.07 14.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.663 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -54.81 -45.64 74.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.061 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 194' ' ' ALA . 2.1 t -64.52 -45.38 95.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.465 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.622 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -54.19 -31.89 54.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.274 178.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -78.93 -91.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.399 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 178.45 34.97 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.373 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.545 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.4 t -174.35 101.21 0.1 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.929 0.395 . . . . 0.0 111.913 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.797 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 2.8 t -122.49 -149.09 0.42 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.461 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.765 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 54.55 -155.68 0.24 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.847 0.356 . . . . 0.0 111.81 178.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -159.39 -169.35 2.58 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.502 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.404 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -51.12 147.04 5.71 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.831 0.348 . . . . 0.0 110.962 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -140.77 -174.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.453 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.09 70.6 1.3 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.596 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 41.1 t80 -52.01 99.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.741 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.589 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 0.7 OUTLIER -71.41 -6.32 39.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.272 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.36 -164.48 12.14 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.619 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 10.1 p -125.72 144.51 50.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.683 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.549 HG12 ' HD2' ' A' ' 114' ' ' ARG . 33.1 m -131.04 161.89 40.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.021 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.03 155.36 20.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.724 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.9 165.87 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.973 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -134.97 59.76 1.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.006 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -155.81 -71.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 54.13 41.09 32.16 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -148.65 108.73 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.999 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.01 -144.32 16.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.765 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.45 -29.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.84 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -73.87 1.65 10.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.13 -28.12 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.031 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.849 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 1.7 m -90.79 -17.55 26.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -7.49 34.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.564 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.6 mm-40 -117.46 -41.34 2.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.019 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.08 82.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.68 -39.27 76.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -70.39 -38.78 74.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 104' ' ' GLU . 22.8 t -56.44 -34.61 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.639 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.782 HD23 ' HG3' ' A' ' 114' ' ' ARG . 2.5 mt -72.21 -28.16 63.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.669 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -12.76 59.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.55 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.84 -18.42 15.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.198 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.7 m -118.7 171.82 7.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.083 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -114.33 66.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.782 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -63.35 -92.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.2 -179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -150.01 75.72 8.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.337 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 67.2 Cg_endo -73.97 108.72 2.72 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.637 2.225 . . . . 0.0 112.219 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.26 125.98 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.017 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.61 106.49 18.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.908 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -148.45 -171.99 17.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.822 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -100.02 138.89 36.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.04 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.665 HD13 HG22 ' A' ' 130' ' ' VAL . 28.0 tp -108.81 125.42 51.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.181 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 0.1 OUTLIER -117.76 95.61 5.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.292 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.817 HG11 ' HA ' ' A' ' 191' ' ' VAL . 74.9 t -67.1 94.22 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.977 0.418 . . . . 0.0 110.557 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.653 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -92.13 143.0 26.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.627 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -80.1 37.65 2.17 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.648 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -168.89 20.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.729 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 135.39 101.05 0.65 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.221 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 8.6 mt -60.89 132.82 55.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.199 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -122.13 146.72 46.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.654 179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.665 HG22 HD13 ' A' ' 121' ' ' LEU . 16.2 t -133.52 98.02 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.26 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.47 ' H ' ' HE1' ' A' ' 122' ' ' HIS . 2.3 t -98.07 124.81 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.889 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.542 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 8.5 t70 -53.67 160.39 1.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.484 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.6 OUTLIER -99.49 -1.51 38.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.387 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.03 -43.67 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.937 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.47 -23.2 21.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.43 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 131' ' ' VAL . 6.1 mmtp 50.62 26.55 2.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.19 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.73 -109.05 0.73 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.418 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 141' ' ' ASP . 13.8 tp -160.04 116.72 2.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.93 0.395 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 132' ' ' ASP . 6.5 mm -96.54 -56.39 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.156 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 t -127.68 116.42 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.233 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.432 ' HB3' HD21 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -111.78 39.99 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.581 179.106 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -77.19 -168.44 1.11 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.47 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.613 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 5.1 m -146.05 158.34 43.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.826 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.653 HD11 ' O ' ' A' ' 124' ' ' SER . 4.5 mt -67.65 -35.63 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.041 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -80.62 -11.02 59.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.683 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -90.59 -40.58 11.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 143' ' ' THR . 1.0 OUTLIER -64.86 125.77 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.99 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.6 -73.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.112 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -146.46 124.49 12.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.29 159.99 22.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.413 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -170.51 108.53 0.43 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.035 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.656 ' HD2' ' HA3' ' B' ' 1' ' ' GLY . 88.1 Cg_endo -78.38 9.95 2.95 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.487 2.125 . . . . 0.0 112.459 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.64 -149.69 0.43 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.386 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.5 -101.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.423 0.154 . . . . 0.0 110.711 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.424 ' HB3' ' H ' ' A' ' 156' ' ' HIS . 0.1 OUTLIER 49.72 -98.54 0.06 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.962 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.424 ' H ' ' HB3' ' A' ' 155' ' ' ASN . 0.2 OUTLIER 175.71 1.94 0.0 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.058 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -82.78 2.03 36.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.36 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.702 ' HG2' ' N ' ' A' ' 183' ' ' SER . 1.3 mpt_? 55.84 38.09 29.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.919 0.39 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -105.52 144.68 15.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.729 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 1.7 m-85 -131.34 150.97 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.849 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 0.9 OUTLIER -154.39 151.82 29.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.463 -178.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.543 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -127.05 163.0 24.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.282 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.629 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.8 OUTLIER -122.24 161.49 23.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.975 0.417 . . . . 0.0 111.362 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 2.1 t -155.93 118.93 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.621 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -89.93 119.01 29.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.458 ' HA ' ' N ' ' A' ' 170' ' ' ARG . 0.5 OUTLIER 50.35 -152.14 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.221 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.67 -29.8 2.92 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.775 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.56 -1.15 0.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.031 0.444 . . . . 0.0 109.952 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.775 HG22 ' HG3' ' A' ' 171' ' ' ARG . 1.6 m -128.98 -20.96 3.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.458 ' N ' ' HA ' ' A' ' 166' ' ' ASP . 5.7 mtt-85 66.41 24.14 10.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.316 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.775 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER 178.14 -176.86 0.21 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.051 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.17 132.28 48.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.194 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.537 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -163.21 124.45 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.561 179.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.629 ' HB2' HG23 ' A' ' 163' ' ' ILE . 1.9 t -115.84 140.94 48.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.96 0.41 . . . . 0.0 111.251 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.543 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -108.28 145.44 34.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -129.61 152.9 19.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.121 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 42.5 p90 -156.43 154.31 30.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.719 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.444 HD12 HD21 ' A' ' 88' ' ' LEU . 9.1 mt -112.59 158.12 20.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.821 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.435 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -88.38 118.43 28.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.854 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.14 -4.29 16.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.023 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -101.57 -29.64 11.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 58.0 92.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.702 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 28.9 t -167.08 -36.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.009 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.78 19.05 76.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.519 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -136.75 -20.87 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.573 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -79.09 -25.6 43.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.037 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 186' ' ' ARG . 6.7 mp -120.89 -43.33 2.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.4 t -58.4 -52.49 65.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -75.57 7.63 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.227 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.79 -56.82 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.091 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.817 ' HA ' HG11 ' A' ' 123' ' ' VAL . 7.6 p -65.76 -22.07 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.204 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.64 -18.95 62.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.508 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.481 ' O ' HG23 ' A' ' 197' ' ' VAL . 1.1 m -105.07 -3.3 23.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 110.712 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.528 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -64.52 -46.26 83.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.152 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.485 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 2.7 p90 -70.07 -39.1 75.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.991 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.435 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -57.98 -20.03 35.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.514 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 77' ' ' ARG . 35.5 t -105.48 -24.84 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.7 t -73.29 -3.11 24.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.771 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 5.0 mt -89.06 1.05 56.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.102 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.37 -3.59 43.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.041 -179.526 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.656 ' HA3' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.62 -164.58 0.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.734 0.302 . . . . 0.0 110.785 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.5 p -173.81 141.94 0.86 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.643 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -60.62 161.46 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.149 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 9.8 ttp -124.17 -2.15 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.959 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p -93.95 17.32 12.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.991 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -65.37 146.02 55.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.974 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -88.45 -1.57 58.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.954 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t0 55.03 77.13 0.22 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 23.5 m-85 -60.03 141.91 89.63 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 32.5 Cg_exo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.583 2.189 . . . . 0.0 112.267 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.8 t60 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.798 0.332 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -98.68 -47.84 5.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -26.45 68.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.61 -8.49 34.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.678 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.24 -24.75 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.013 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.54 -39.32 53.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.98 -39.69 79.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.694 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -74.56 -15.56 60.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . . . -63.78 -47.84 79.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.472 HG22 HG12 ' A' ' 123' ' ' VAL . 24.3 t -58.8 -40.89 81.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -65.63 -31.88 73.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.396 178.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.66 -0.93 40.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.514 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 69.0 39.94 1.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.594 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.768 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -171.37 88.02 0.1 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.074 0.464 . . . . 0.0 111.439 178.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.928 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.9 t -117.75 -145.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.078 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.662 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.55 -156.67 0.19 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.925 0.393 . . . . 0.0 111.483 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -161.81 -167.94 1.82 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.539 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 5.4 m -50.78 150.26 2.98 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.977 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.47 -171.77 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.021 0.439 . . . . 0.0 111.839 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.02 80.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.289 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.534 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -53.91 166.44 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.296 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 18.4 mt -126.42 -46.97 1.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.628 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.14 -127.0 2.3 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.434 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.8 p -152.6 134.21 14.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.988 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 HD11 ' A' ' 109' ' ' LEU . 6.1 m -135.19 159.84 40.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 2.9 pt-20 -88.72 138.99 30.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.397 . . . . 0.0 110.986 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 m -129.33 127.07 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.94 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.89 65.77 4.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.967 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.618 ' HG3' ' HG3' ' A' ' 97' ' ' ARG . 1.4 tp10 -163.31 -65.57 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.282 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.4 22.89 11.37 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.642 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -151.84 117.04 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.901 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.41 158.65 11.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.454 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.74 -4.89 54.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.805 0.336 . . . . 0.0 111.031 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.75 -20.7 30.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.7 t -61.29 -32.68 53.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.844 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.413 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 58.5 m -85.6 -27.09 25.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.983 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.27 -15.44 63.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.017 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 108' ' ' VAL . 30.5 mt-10 -110.11 -45.63 3.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.85 -31.79 68.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.35 -42.11 90.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.667 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -73.75 -32.53 63.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.788 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 104' ' ' GLU . 52.1 t -55.99 -42.51 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.572 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -68.65 -35.38 77.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.549 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -69.1 -22.85 63.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.501 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -94.81 -14.38 24.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.769 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m -94.21 179.35 5.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.091 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -90.79 12.38 19.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.439 ' CG ' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -57.68 110.87 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.927 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 136.22 94.36 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.279 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -84.83 153.25 11.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.816 2.344 . . . . 0.0 112.565 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.534 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -128.54 97.55 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.774 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -80.73 129.68 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 -179.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -167.39 -163.01 20.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.291 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -106.02 118.34 36.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.814 0.34 . . . . 0.0 111.077 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.987 HD13 HG22 ' A' ' 130' ' ' VAL . 13.4 tp -89.3 127.16 35.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.456 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.768 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 35.5 m-70 -112.86 95.99 5.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.014 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.928 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 40.0 t -65.46 95.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.043 0.449 . . . . 0.0 110.441 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.48 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -94.42 126.7 39.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.222 179.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -63.17 -1.29 3.94 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.831 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -131.56 32.79 4.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 0.0 110.817 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.69 102.28 1.15 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.452 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mt -68.64 125.63 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 111.319 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.576 ' HB2' HD11 ' A' ' 138' ' ' LEU . 0.9 OUTLIER -121.1 143.34 49.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.435 179.071 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.987 HG22 HD13 ' A' ' 121' ' ' LEU . 18.4 t -122.67 115.1 44.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.904 0.383 . . . . 0.0 111.483 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.8 t -94.68 147.67 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.35 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 137' ' ' GLY . 38.7 m-20 -83.42 161.3 21.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.789 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -112.54 5.25 17.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.625 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.12 -3.06 5.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.968 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.401 ' H ' ' H ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -150.38 -14.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.523 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 23.1 mmtt 53.98 29.71 10.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.085 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 132' ' ' ASP . . . -99.33 148.4 18.69 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.394 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 129' ' ' ARG . 6.2 tp -76.36 120.88 22.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.902 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 9.5 pt -108.5 -16.01 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.228 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 130' ' ' VAL . 84.4 t -129.88 94.75 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 111.148 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.416 ' CG ' HD23 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -96.62 17.21 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.715 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.403 ' HG2' HG13 ' A' ' 140' ' ' VAL . 7.6 mm100 -72.46 -173.84 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.828 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 24.4 m -142.56 160.58 40.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.619 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 124' ' ' SER . 45.0 mt -59.36 -56.28 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.26 -18.95 64.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.779 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.828 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 1.8 tttp -71.2 -61.38 1.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.973 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 143' ' ' THR . 2.6 m -61.25 140.04 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.093 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -43.89 -67.86 0.24 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.081 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.642 ' HZ ' ' HA ' ' A' ' 97' ' ' ARG . 0.3 OUTLIER -169.76 142.52 2.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.167 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.42 165.06 19.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.587 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -166.37 124.64 1.07 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.352 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.517 ' HG3' ' HA3' ' B' ' 1' ' ' GLY . 90.8 Cg_endo -82.86 -136.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.693 2.262 . . . . 0.0 112.104 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.464 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -130.3 -163.4 1.31 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.821 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 -19.18 1.76 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.115 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 156' ' ' HIS . 3.4 t30 -90.67 -59.6 2.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.493 ' HB2' ' ND2' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -151.62 129.74 11.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.54 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -72.44 74.6 1.03 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.399 . . . . 0.0 111.06 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.465 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -133.21 -4.77 3.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 178' ' ' LEU . . . -148.35 114.75 0.7 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.468 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.4 m-85 -107.92 171.49 7.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.772 0.32 . . . . 0.0 111.203 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.658 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -165.11 154.48 12.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.46 160.38 34.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.52 151.96 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.48 110.29 6.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -83.36 97.96 9.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.98 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 51.94 -160.01 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.973 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 72.24 -3.3 23.64 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.768 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.426 ' H ' ' H ' ' A' ' 169' ' ' THR . 8.9 t -172.19 -8.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 0.0 110.061 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.694 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -129.41 -16.14 3.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.835 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 58.45 29.84 18.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.773 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -178.71 -167.41 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.712 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.77 99.5 10.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 0.0 110.78 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.694 ' HB2' HG21 ' A' ' 169' ' ' THR . 3.8 mtp -138.81 147.05 42.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.977 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.29 148.48 52.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.118 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -107.11 145.77 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.684 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.658 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -121.33 157.05 16.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.714 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 15.4 p90 -165.85 175.71 8.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.682 0.277 . . . . 0.0 110.504 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.502 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 1.2 mp -139.89 -172.85 3.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.967 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -115.82 130.67 56.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.021 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 84' ' ' SER . 7.3 t -67.35 -27.84 67.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.184 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.404 ' HB2' ' HD3' ' A' ' 186' ' ' ARG . 4.2 mttm -83.47 -42.23 17.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.162 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 57.86 89.94 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.016 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.8 t -156.97 -26.31 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.988 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.567 ' H ' ' CZ ' ' A' ' 186' ' ' ARG . . . 84.61 5.74 86.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.607 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -131.54 12.65 4.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.852 0.358 . . . . 0.0 111.061 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.689 HH11 ' HB2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -115.18 -10.17 12.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 -179.272 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.689 ' HB2' HH11 ' A' ' 186' ' ' ARG . 1.5 mp -148.42 -45.95 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.354 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.0 t -51.17 -63.53 1.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.626 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 5.06 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.638 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.49 -53.14 3.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.225 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.49 ' HA ' HG11 ' A' ' 123' ' ' VAL . 5.2 p -70.07 -18.32 21.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.07 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 195' ' ' PHE . . . -73.74 1.74 44.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.257 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.421 ' O ' HG23 ' A' ' 197' ' ' VAL . 56.7 m -118.09 -5.57 10.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.697 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -66.06 -52.56 47.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.205 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.551 ' HD1' HD11 ' A' ' 199' ' ' LEU . 46.2 p90 -65.4 -24.24 67.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.764 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.901 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -66.81 -8.72 30.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.286 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 193' ' ' CYS . 3.4 t -101.97 -12.95 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.114 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.96 3.71 22.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.691 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.901 HD12 ' HA ' ' A' ' 196' ' ' ALA . 4.9 mt -88.13 -48.89 7.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.054 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -61.43 -19.34 61.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.948 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 201' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.094 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.517 ' HA3' ' HG3' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.81 166.29 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.96 0.41 . . . . 0.0 111.143 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 1.4 p -165.41 136.22 3.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.413 ' H ' ' ND2' ' B' ' 4' ' ' ASN . 0.8 OUTLIER -57.8 111.03 1.02 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.025 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.6 6.93 45.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.163 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 73.9 p -96.32 18.54 13.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -67.34 150.23 49.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.04 11.71 33.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 14.5 t70 56.85 80.68 0.15 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.15 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -75.8 152.14 84.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.486 2.124 . . . . 0.0 112.231 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.1 t60 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.817 0.341 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.74 -36.49 16.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.97 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.726 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 1.7 m0 -66.27 -27.2 67.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.602 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.99 -22.37 66.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.136 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.22 -18.32 13.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.574 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.726 ' HB2' ' HA ' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -72.52 -36.07 68.24 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.46 179.289 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.74 -22.79 66.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.361 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.647 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 3.6 mt-10 -96.02 -14.32 23.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.648 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -58.33 -50.78 72.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.807 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 t -63.77 -39.86 86.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.367 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.647 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -58.22 -35.39 71.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.454 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.9 m -78.41 -90.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.556 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 179.28 32.69 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.525 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.78 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -170.26 99.66 0.27 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.92 0.391 . . . . 0.0 111.938 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.752 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 3.1 t -119.94 -151.53 0.48 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.104 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.744 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER 55.26 -155.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.837 0.351 . . . . 0.0 111.46 179.264 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.58 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 1.9 m-85 -164.32 -167.64 1.35 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.63 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.4 150.44 3.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.069 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 m -147.71 -178.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.092 0.472 . . . . 0.0 111.871 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 3.7 mmtt -130.63 85.99 2.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.657 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.622 ' HB3' HG23 ' A' ' 117' ' ' VAL . 29.1 t80 -58.56 94.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 3.9 mt -67.1 -17.47 64.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.055 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 114' ' ' ARG . . . 117.59 -131.03 9.13 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.572 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.511 ' N ' HD21 ' A' ' 109' ' ' LEU . 7.1 p -156.61 141.6 17.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.686 0.279 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 m -131.84 161.85 40.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.205 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -83.32 131.25 35.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.371 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 174' ' ' CYS . 16.3 m -141.65 131.87 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.94 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -103.04 73.4 1.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.941 0.401 . . . . 0.0 111.105 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.569 ' HB3' HG21 ' A' ' 101' ' ' VAL . 1.4 mt-10 -164.78 -71.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.059 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 p 45.15 33.5 1.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -121.86 -40.61 2.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.484 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.52 158.28 15.43 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.901 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -17.89 59.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.866 0.365 . . . . 0.0 110.904 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -72.36 -24.68 61.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 95' ' ' GLU . 6.7 t -59.94 -30.18 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.53 ' HB3' ' OG ' ' A' ' 161' ' ' SER . 96.5 m -79.72 -28.25 40.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.766 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.71 -14.63 61.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.135 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.9 mt-10 -108.72 -44.32 4.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.22 -31.87 69.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.086 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.78 -38.55 91.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -40.87 84.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' GLU . 5.1 t -63.25 -44.51 99.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.666 HD23 ' HG3' ' A' ' 114' ' ' ARG . 3.0 mt -61.31 -34.95 76.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.269 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 110' ' ' ARG . 11.1 ttt-85 -74.05 -31.48 62.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.738 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -86.63 -14.45 42.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.308 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.12 -6.78 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.311 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 36.68 71.56 0.13 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.652 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.666 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -82.72 68.12 9.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.931 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 58.43 82.87 0.23 Allowed Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.361 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 92.7 Cg_endo -80.52 135.05 10.26 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.623 2.215 . . . . 0.0 112.23 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -129.85 158.94 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.191 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.6 ttp-105 -119.68 98.5 6.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.829 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -131.69 169.78 21.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.615 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -92.34 104.2 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.693 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.812 HD13 HG22 ' A' ' 130' ' ' VAL . 15.9 tp -74.92 129.11 37.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.425 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.78 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 52.2 m170 -115.05 94.6 4.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.752 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 71.4 t -69.31 90.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.927 0.394 . . . . 0.0 110.506 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.665 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -90.17 140.79 29.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.195 179.179 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.49 1.95 4.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.774 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -130.64 32.45 4.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 119.66 122.98 3.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.536 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.406 ' CD2' HG13 ' A' ' 123' ' ' VAL . 2.6 mt -76.05 141.93 41.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.739 0.304 . . . . 0.0 111.041 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -145.47 122.56 11.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.69 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.812 HG22 HD13 ' A' ' 121' ' ' LEU . 2.2 t -102.16 118.51 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.337 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 t -106.2 116.62 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.768 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.55 151.43 2.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.028 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.48 -6.83 54.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.364 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.72 -50.3 2.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.966 0.412 . . . . 0.0 110.695 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.0 m -82.95 -21.75 33.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.636 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp 51.69 28.19 4.64 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.211 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.41 -116.2 1.12 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.435 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tp -171.97 113.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.693 0.282 . . . . 0.0 110.543 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.583 HG13 ' HB ' ' A' ' 130' ' ' VAL . 2.9 pt -94.49 -41.49 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.497 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.668 ' HB ' HG23 ' A' ' 130' ' ' VAL . 39.8 t -122.85 103.78 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.177 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -113.19 48.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.798 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -98.11 -166.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.804 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.555 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 12.1 m -133.96 158.4 43.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.665 HD11 ' O ' ' A' ' 124' ' ' SER . 2.0 mt -65.05 -44.56 95.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.664 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -77.05 -20.02 56.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.56 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 12.9 tttp -69.82 -45.34 68.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.709 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 164' ' ' CYS . 5.9 m -74.83 150.98 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.747 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.8 -53.89 49.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.446 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.654 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 40.3 p90 -174.62 -174.21 0.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.1 t -110.95 157.92 19.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.726 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -169.0 115.6 0.55 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.844 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 84.4 Cg_endo -79.96 -119.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.537 2.158 . . . . 0.0 111.996 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.431 ' H ' ' HB2' ' A' ' 152' ' ' PRO . 8.1 p-10 -160.28 178.81 9.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.742 0.306 . . . . 0.0 110.72 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -120.28 -2.06 10.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.109 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -64.18 -66.43 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.649 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.78 2.97 3.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.434 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 60.18 15.87 5.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.091 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -104.04 1.35 30.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.535 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.98 133.64 10.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.466 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.844 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 1.7 m-85 -126.92 163.65 23.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.3 . . . . 0.0 110.665 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -164.6 144.57 7.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.009 0.433 . . . . 0.0 111.255 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -126.44 139.59 53.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.481 178.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.4 OUTLIER -101.04 139.99 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.242 -179.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.485 ' HB2' HG12 ' A' ' 147' ' ' VAL . 10.7 t -149.02 129.62 14.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.716 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.654 ' H ' ' HE ' ' A' ' 165' ' ' ARG . 0.2 OUTLIER -92.87 122.62 35.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.711 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 50.38 -158.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.432 179.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.48 -29.51 8.29 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.457 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.439 ' H ' ' H ' ' A' ' 169' ' ' THR . 9.4 t -164.63 6.06 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.57 . . . . 0.0 109.532 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.582 HG21 ' HG3' ' A' ' 173' ' ' MET . 24.7 m -136.88 -18.1 1.39 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.65 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.711 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 7.3 mtt180 57.72 32.48 21.94 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.407 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.511 ' HB2' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -163.41 150.11 12.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.711 -178.299 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -75.02 79.11 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.405 178.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.582 ' HG3' HG21 ' A' ' 169' ' ' THR . 0.2 OUTLIER -110.57 166.78 10.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.078 -179.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.656 ' HB2' HG23 ' A' ' 163' ' ' ILE . 53.2 t -123.6 127.59 48.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.48 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 10.8 m170 -90.75 124.99 35.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.559 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -108.2 156.28 15.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.612 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -170.66 152.68 3.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.714 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.562 HD11 HD21 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -121.5 165.9 14.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.52 126.24 34.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.971 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 4.5 t -61.99 -21.07 64.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.815 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.58 ' HE3' ' HB3' ' A' ' 83' ' ' PHE . 2.8 mmtp -84.39 -23.02 30.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.672 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 55.08 83.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.1 t -159.74 -64.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 108.44 41.51 1.48 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.385 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.35 -33.48 0.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.752 0.31 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.556 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -72.48 -11.51 60.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.706 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 186' ' ' ARG . 5.2 mp -137.07 -36.89 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.114 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.2 t -57.94 -55.6 32.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.256 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.25 0.43 16.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.054 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -89.17 -54.81 3.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.67 ' HA ' HG11 ' A' ' 123' ' ' VAL . 10.9 p -75.41 -30.48 22.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.68 -9.49 45.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.252 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 57.5 m -110.53 -10.28 14.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.927 0.394 . . . . 0.0 110.707 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.61 -43.35 94.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.244 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.471 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 2.0 p90 -61.74 -32.58 72.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.725 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -61.86 -33.66 74.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.21 5.62 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.641 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -93.62 -43.92 8.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.823 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.0 OUTLIER -74.55 -3.02 28.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.866 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 201' ' ' ARG . 0.0 OUTLIER -59.64 -28.95 67.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.643 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.431 ' N ' ' HG3' ' A' ' 200' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.702 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.42 174.81 10.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.0 110.978 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.654 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.9 p -168.81 148.36 4.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.942 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 149' ' ' PHE . 9.4 m-80 -64.36 156.93 27.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.811 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 20.5 mtm -126.63 -18.18 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -76.52 0.1 21.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.083 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -63.12 148.91 46.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.972 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -97.22 4.61 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.926 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 29.2 t0 56.98 77.3 0.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -70.03 151.61 96.05 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.763 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.487 2.125 . . . . 0.0 112.262 179.696 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.676 0.274 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -72.11 -59.17 2.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.478 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.63 -16.49 56.96 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.432 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -68.99 -32.76 72.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.96 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.2 -19.2 23.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.631 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.39 -32.6 26.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.562 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -71.78 -36.22 70.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.243 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.74 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -69.36 -19.45 63.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.265 178.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -61.69 -52.15 65.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.945 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.9 -37.99 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.54 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.74 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 11.5 mtp180 -56.89 -40.34 76.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.461 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -75.61 -91.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.477 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 179.34 38.51 0.0 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.343 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.552 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 1.7 t -173.2 95.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.991 0.424 . . . . 0.0 111.466 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.612 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 11.6 t -122.68 10.29 9.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.534 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -114.2 -162.84 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.218 -179.44 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.683 ' HB2' HD11 ' A' ' 187' ' ' LEU . 60.3 m-85 -150.07 -168.6 3.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.72 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.623 ' HA ' HD22 ' A' ' 120' ' ' LEU . 1.0 OUTLIER -47.53 151.52 0.79 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.87 0.367 . . . . 0.0 111.366 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.42 -170.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.125 0.488 . . . . 0.0 111.679 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.93 73.09 1.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.311 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 83.6 t80 -55.45 98.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.143 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 178' ' ' LEU . 4.3 mt -61.36 -50.03 74.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.492 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 153.04 -128.13 2.38 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.241 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.423 ' N ' HD21 ' A' ' 109' ' ' LEU . 1.6 p -161.79 126.15 3.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 0.0 110.866 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.3 m -110.18 165.8 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.036 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.77 116.02 28.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.142 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.3 m -108.99 -165.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.865 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.95 65.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.907 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 1.2 mm-40 -166.32 -66.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.81 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.54 ' HA ' HG21 ' A' ' 163' ' ' ILE . 2.1 m 59.92 33.23 21.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 15.7 ptt180 -169.57 80.57 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.59 146.62 4.98 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.246 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.453 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -72.29 -29.89 64.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.775 0.322 . . . . 0.0 111.206 -179.421 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.453 ' N ' ' HG3' ' A' ' 99' ' ' MET . 0.5 OUTLIER -77.39 -21.19 53.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.926 -179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 t -60.73 -35.02 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 55.5 m -73.26 -49.98 24.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.951 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.487 ' HG3' ' HG2' ' A' ' 154' ' ' ARG . 2.9 tm-20 -56.33 -29.68 61.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.295 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.5 mm-40 -76.57 -51.72 11.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.94 -31.63 68.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.048 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.68 -43.33 93.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.845 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -62.86 -43.27 99.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 104' ' ' GLU . 18.8 t -62.62 -39.81 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.047 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.637 HD23 ' HG3' ' A' ' 114' ' ' ARG . 8.1 mt -65.83 -36.15 82.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.827 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -76.13 -14.35 60.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.298 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -95.87 -16.53 21.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.786 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.84 -177.08 3.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.59 ' H ' ' HE ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -116.85 71.77 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.814 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.637 ' HG3' HD23 ' A' ' 109' ' ' LEU . 22.7 mmt180 -85.19 22.52 1.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.071 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 54.29 88.15 0.13 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.817 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 17.2 Cg_exo -66.57 137.29 45.78 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.82 2.347 . . . . 0.0 111.77 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.76 113.39 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.01 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -75.28 107.42 7.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.697 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -142.67 -167.3 11.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.834 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -118.4 122.87 43.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.658 0.266 . . . . 0.0 110.715 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.705 HD13 HG22 ' A' ' 130' ' ' VAL . 32.4 tp -89.5 133.76 34.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.777 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.494 ' CD2' HD12 ' A' ' 120' ' ' LEU . 14.2 m170 -123.03 94.75 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.186 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 53.2 t -62.28 96.15 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.061 0.457 . . . . 0.0 110.338 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.634 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -99.7 130.6 45.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.487 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -64.25 -0.24 4.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.961 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -126.17 29.01 5.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.855 0.36 . . . . 0.0 110.807 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 117.19 113.49 2.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.259 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.585 HD21 HG22 ' A' ' 123' ' ' VAL . 0.5 OUTLIER -57.04 146.33 27.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 -179.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -138.41 120.35 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 121' ' ' LEU . 2.2 t -110.29 108.28 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 111.271 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.0 t -105.99 117.69 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.058 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 76.9 m-20 -53.71 156.75 2.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.75 1.39 29.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -116.62 -31.33 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.523 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.25 -6.53 9.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.727 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 4.4 mmtm 50.91 25.59 2.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.11 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.11 167.27 30.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.357 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 138' ' ' LEU . 8.7 tp -99.48 116.32 31.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.61 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.559 HG13 ' HB ' ' A' ' 130' ' ' VAL . 1.2 pt -94.42 -50.23 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.374 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.491 ' HB ' HG23 ' A' ' 130' ' ' VAL . 48.7 t -110.37 95.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.916 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -105.09 67.49 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.656 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -114.8 -171.91 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.152 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 88.6 m -131.16 151.88 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.552 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.634 HD11 ' O ' ' A' ' 124' ' ' SER . 3.4 mt -61.28 -31.89 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.655 ' H ' HG22 ' A' ' 143' ' ' THR . 2.1 mt-10 -90.65 -6.62 54.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.516 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.661 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 5.7 tptm -90.08 -37.75 14.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.028 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -58.42 134.32 23.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.806 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.6 t -70.61 -21.15 62.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.462 ' CB ' HD12 ' A' ' 163' ' ' ILE . 0.2 OUTLIER -170.05 151.96 4.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.125 0.488 . . . . 0.0 111.514 -179.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.32 137.22 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.916 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.572 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -168.55 119.81 0.66 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.66 0.267 . . . . 0.0 111.687 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 55.9 Cg_endo -69.43 -94.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.342 2.028 . . . . 0.0 111.625 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.79 -163.13 1.28 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.459 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.487 ' HG2' ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -124.95 14.43 8.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.802 0.334 . . . . 0.0 111.266 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 9.1 t30 -164.81 -74.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 155' ' ' ASN . 5.8 t60 176.06 36.81 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.96 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.506 ' C ' ' HG2' ' A' ' 158' ' ' ARG . 14.1 mm-40 -85.97 28.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.296 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.506 ' HG2' ' C ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER 37.95 39.52 0.24 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.476 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.54 129.73 6.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.56 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.591 ' HE2' ' HB2' ' A' ' 179' ' ' ALA . 0.5 OUTLIER -127.13 155.42 43.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 110.682 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.573 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -160.84 159.98 30.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 111.273 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.97 143.1 33.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.323 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.54 HG21 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -104.23 148.7 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.948 0.404 . . . . 0.0 111.183 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.8 p -135.37 148.65 49.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.74 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.28 101.37 9.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.01 -152.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.075 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.73 -15.03 22.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.508 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.416 ' H ' ' H ' ' A' ' 169' ' ' THR . 15.1 t -171.25 -0.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 110.008 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.499 HG21 ' HB2' ' A' ' 173' ' ' MET . 3.3 m -127.63 -18.74 4.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.083 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 60.07 30.66 20.11 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.783 ' HD2' ' HG3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -179.43 -168.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.882 179.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -98.78 112.39 24.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.025 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.783 ' HG3' ' HD2' ' A' ' 171' ' ' ARG . 25.3 mtp -139.6 149.84 44.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.567 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.516 ' HB2' HG23 ' A' ' 163' ' ' ILE . 20.4 t -117.69 147.37 42.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.154 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -114.78 137.2 52.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.445 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -128.84 156.55 21.17 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.994 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -166.93 155.85 10.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.82 0.343 . . . . 0.0 111.076 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.464 HD12 HD21 ' A' ' 88' ' ' LEU . 1.4 mt -111.93 178.17 4.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.612 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.591 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -113.57 125.66 54.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 0.0 110.959 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.3 OUTLIER -71.13 -5.07 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.787 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.445 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 13.1 mmmt -91.01 -37.54 13.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 58.14 85.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.99 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.2 t -163.86 -39.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.83 17.94 79.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.494 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -132.57 1.11 3.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.868 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.43 ' HB2' HD12 ' A' ' 187' ' ' LEU . 8.6 mmm180 -108.8 -33.6 6.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 83' ' ' PHE . 5.7 mp -114.99 -43.21 3.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.125 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.5 t -58.72 -66.39 0.5 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.451 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.6 -16.22 55.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.157 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.72 -56.28 5.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.22 -19.72 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.018 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -77.47 -0.14 71.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.334 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 58.0 m -120.29 0.37 10.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.31 -40.94 50.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.104 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 7.1 p90 -67.72 -31.18 70.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.814 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.442 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -61.4 -29.39 69.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.373 . . . . 0.0 110.969 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.459 ' HA ' ' HG2' ' A' ' 200' ' ' GLU . 4.9 t -99.29 0.48 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.889 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -92.6 -38.31 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.222 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.2 OUTLIER -87.91 16.98 5.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.73 0.3 . . . . 0.0 110.904 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 197' ' ' VAL . 70.9 mm-40 -63.31 -35.26 79.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.376 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.466 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.604 -0.198 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -161.63 154.44 20.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.94 162.25 23.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.003 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -65.81 167.09 9.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 3.6 mtp -134.92 -22.45 1.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 60.3 p -81.2 14.91 2.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -62.55 153.9 30.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.934 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -91.33 -0.27 57.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 t0 56.36 78.59 0.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.197 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.667 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 25.5 m-85 -66.45 -51.61 41.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.134 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 31.8 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.213 1.942 . . . . 0.0 112.255 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.803 0.335 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -99.69 -46.83 5.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.869 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 1.5 m0 -67.23 -21.0 65.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.785 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.25 -18.78 63.15 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.511 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -106.62 -21.62 13.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.86 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 69' ' ' TRP . 1.6 m-20 -78.48 -33.34 48.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -65.26 -22.02 66.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.575 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.736 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.5 mt-10 -100.61 -13.68 18.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.802 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -59.5 -46.89 87.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.763 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 194' ' ' ALA . 7.1 t -61.49 -42.64 94.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.349 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.736 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 7.5 mtp180 -54.45 -34.8 62.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.143 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 1.4 m -78.12 -90.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.251 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 176.28 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.683 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.576 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -173.7 98.0 0.11 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.866 0.365 . . . . 0.0 111.777 -179.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.413 ' H ' ' N ' ' A' ' 123' ' ' VAL . 10.3 t -139.26 63.48 1.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.393 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.738 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -159.44 -155.15 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.802 0.334 . . . . 0.0 111.297 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -154.62 -172.82 4.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.596 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 3.4 t -51.1 152.34 2.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.801 0.334 . . . . 0.0 111.168 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.74 -167.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.286 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.417 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -148.18 65.3 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.823 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 55.0 t80 -62.6 117.02 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.567 ' O ' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -116.45 62.6 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.408 -178.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.549 ' HA3' ' HB3' ' A' ' 114' ' ' ARG . . . 62.77 -168.7 17.73 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.396 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.449 ' C ' HD21 ' A' ' 109' ' ' LEU . 0.7 OUTLIER -138.47 146.37 41.97 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.519 HG13 ' CD2' ' A' ' 109' ' ' LEU . 4.6 m -115.24 163.86 12.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.369 . . . . 0.0 111.188 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.63 145.88 29.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.027 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -139.02 178.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.648 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -145.77 65.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 0.0 111.16 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -169.08 -72.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 p 67.48 0.76 2.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.2 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.501 ' HE ' HH22 ' A' ' 165' ' ' ARG . 0.0 OUTLIER -154.8 114.48 3.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.789 179.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 140.07 121.21 1.81 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.159 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 60.48 -88.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.617 0.246 . . . . 0.0 110.551 -178.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.481 ' O ' HD11 ' A' ' 163' ' ' ILE . 0.6 OUTLIER -154.15 -28.25 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.034 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.476 ' HB ' HD13 ' A' ' 163' ' ' ILE . 1.1 t 49.38 23.46 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.371 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 62.6 m -118.64 -24.22 6.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.013 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -9.31 58.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.018 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 108' ' ' VAL . 21.2 mt-10 -104.52 -53.76 2.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.24 -51.12 71.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.222 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.1 tp -57.77 -32.09 67.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -67.36 -43.01 82.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 104' ' ' GLU . 9.4 t -59.21 -49.92 81.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.842 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.3 mt -65.85 -25.03 67.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.591 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -77.64 -25.59 49.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.626 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 23.1 mt-30 -91.36 -19.88 22.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.201 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 m -113.6 179.36 3.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.001 0.429 . . . . 0.0 111.253 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.66 72.38 0.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.675 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.842 ' HG3' HD23 ' A' ' 109' ' ' LEU . 3.8 mmt180 -82.66 40.44 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.232 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 59.0 77.9 0.37 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.567 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 87.9 Cg_endo -81.09 121.8 4.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.667 2.245 . . . . 0.0 112.256 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.02 140.74 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 118' ' ' ARG . 12.3 ttp180 -99.39 103.6 15.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.623 ' HA2' ' HB2' ' A' ' 133' ' ' ASP . . . -135.58 172.68 22.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.8 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -92.44 127.26 37.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.795 0.331 . . . . 0.0 111.0 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.723 HD13 HG22 ' A' ' 130' ' ' VAL . 39.6 tp -97.06 129.62 44.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.56 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.463 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 89.6 m-70 -116.71 93.02 4.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.852 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 82' ' ' SER . 41.9 t -58.35 103.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.982 0.42 . . . . 0.0 110.849 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.711 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -100.76 134.65 43.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.192 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -70.61 8.57 4.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.015 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -137.35 28.19 2.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 110.615 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.761 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 124.63 113.22 1.99 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.315 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.489 HD21 HG22 ' A' ' 123' ' ' VAL . 1.3 mt -58.0 144.25 40.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 111.233 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.582 ' HE ' HD11 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -136.5 124.62 23.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.817 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.723 HG22 HD13 ' A' ' 121' ' ' LEU . 2.9 t -110.93 112.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.311 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.9 t -104.9 114.22 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.795 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.47 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 1.4 m-20 -48.86 147.57 2.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.895 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.623 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -103.23 9.04 38.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.616 -179.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.63 -1.19 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.403 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.409 ' H ' ' H ' ' A' ' 136' ' ' LYS . 3.2 m -151.52 -11.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.546 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 132' ' ' ASP . 22.9 mmtp 54.77 25.74 6.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.895 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.65 -166.84 35.83 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.549 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.582 HD11 ' HE ' ' A' ' 129' ' ' ARG . 8.6 tp -119.18 116.92 27.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.913 0.387 . . . . 0.0 110.634 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.428 HD12 HG12 ' A' ' 130' ' ' VAL . 6.3 mt -98.02 -57.29 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.263 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.558 HG13 ' HG2' ' A' ' 142' ' ' GLN . 61.3 t -124.51 116.63 48.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.407 ' HB3' HD21 ' A' ' 138' ' ' LEU . 0.6 OUTLIER -121.45 36.48 4.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.583 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.558 ' HG2' HG13 ' A' ' 140' ' ' VAL . 73.1 mm-40 -81.75 -165.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.111 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.761 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 19.3 m -129.42 153.94 47.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.711 HD11 ' O ' ' A' ' 124' ' ' SER . 3.5 mt -65.89 -44.9 92.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.0 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -78.64 -0.21 29.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.506 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.415 ' CB ' ' HB ' ' A' ' 143' ' ' THR . 28.5 tttt -95.73 -44.84 7.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.667 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -62.29 148.22 10.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.93 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.8 t -83.11 -37.03 24.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.201 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -137.95 -172.68 3.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.908 0.385 . . . . 0.0 111.395 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.8 t -168.35 25.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.456 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.498 ' HB3' ' HB2' ' A' ' 102' ' ' CYS . . . -51.12 138.94 25.23 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.159 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.92 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 72.2 Cg_endo -95.56 12.86 1.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.35 2.7 . . . . 0.0 112.385 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER 61.94 65.29 0.92 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.174 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 61.03 8.21 1.84 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.764 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.64 30.52 4.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.948 0.404 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.25 -23.12 4.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.747 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.2 -2.29 58.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.724 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 183' ' ' SER . 2.6 mtt180 56.76 24.2 8.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.898 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.605 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -133.59 128.89 5.16 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.41 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -104.46 168.43 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.3 . . . . 0.0 110.805 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.45 150.94 14.65 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.005 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -132.17 145.61 51.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.636 179.015 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -107.44 144.5 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.188 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.9 130.51 9.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.611 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 3.3 mtt-85 -74.91 -144.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.48 ' H ' ' HB3' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.17 -166.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.909 0.385 . . . . 0.0 111.136 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.61 -11.45 68.39 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.397 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 1.3 t -166.55 -8.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 109.926 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.771 HG21 ' HB2' ' A' ' 173' ' ' MET . 18.5 m -129.7 -9.79 4.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.645 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 61.19 17.4 8.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.131 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 171' ' ' ARG . 0.9 OUTLIER -176.44 174.31 1.95 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.94 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -77.53 109.58 11.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.995 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.771 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -138.08 159.64 41.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.638 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.795 ' HB2' HG23 ' A' ' 163' ' ' ILE . 31.1 t -129.39 139.36 51.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.859 0.361 . . . . 0.0 111.236 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -103.53 143.58 32.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.665 179.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -126.55 149.86 17.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.859 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -166.5 139.41 3.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.755 0.312 . . . . 0.0 110.715 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.605 HD23 ' HA3' ' A' ' 159' ' ' GLY . 1.5 mt -100.11 -177.81 3.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.943 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -110.48 129.99 55.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.052 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER -76.5 1.28 17.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.172 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -99.85 -23.69 14.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.756 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 55.97 79.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.155 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.407 ' N ' ' HG2' ' A' ' 158' ' ' ARG . 1.5 t -165.9 -59.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.941 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.78 32.2 6.03 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.553 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -141.81 -32.39 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.731 0.3 . . . . 0.0 110.953 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.503 ' HB2' HD12 ' A' ' 187' ' ' LEU . 4.9 mmm180 -73.57 -6.06 44.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.836 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.596 HD23 HD23 ' A' ' 121' ' ' LEU . 5.6 mp -139.24 -50.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.441 ' HB2' ' CE1' ' A' ' 160' ' ' PHE . 3.6 t -62.18 -60.87 2.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.336 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 185' ' ' GLU . 0.1 OUTLIER -52.64 -37.2 58.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.82 -41.78 91.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 187' ' ' LEU . 24.7 t -62.25 -32.3 54.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.76 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -59.3 -20.62 51.29 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.529 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 2.6 m -95.18 -15.42 23.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.729 0.3 . . . . 0.0 111.097 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.703 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -63.07 -30.87 71.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.18 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.467 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 1.3 m-85 -72.86 -40.11 65.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.804 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -54.98 -21.05 10.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.586 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 3.5 t -105.56 -12.88 9.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -79.36 -27.06 41.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.02 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -101.42 35.79 2.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.839 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.08 -39.99 76.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.653 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 33.6 ttp85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.79 179.426 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.92 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -139.99 -91.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.634 0.254 . . . . 0.0 110.835 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 63.84 158.25 0.08 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.449 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -87.82 -173.15 4.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.207 -179.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 68.9 mtp -125.98 -30.31 2.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.823 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.463 ' HB3' HD23 ' A' ' 199' ' ' LEU . 89.6 p -88.09 36.91 0.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.452 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.641 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 3.1 p90 -63.94 -3.34 2.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.849 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 55.69 8.89 0.36 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.665 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . 0.641 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 21.5 t70 48.9 76.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.401 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -58.92 135.65 87.32 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.472 2.115 . . . . 0.0 112.24 179.924 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.608 0.242 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 76.25 -56.8 0.57 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.542 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -68.29 -11.0 58.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.701 0.286 . . . . 0.0 110.855 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -77.87 -4.69 47.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.043 0.449 . . . . 0.0 110.094 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.93 -31.55 4.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.108 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -83.51 -19.95 34.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.986 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 34.0 tt0 -63.52 -29.99 71.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.617 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -100.57 -17.26 17.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.978 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -58.07 -52.66 64.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.537 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 194' ' ' ALA . 0.9 OUTLIER -66.36 -35.32 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.729 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.617 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 3.1 mtp180 -55.34 -24.03 27.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.109 0.48 . . . . 0.0 109.808 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.42 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -98.03 -97.11 0.21 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.659 179.032 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.501 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . -176.47 48.36 0.01 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.565 0.221 . . . . 0.0 111.457 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.642 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 1.4 t -176.04 86.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.919 0.39 . . . . 0.0 111.112 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.693 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 6.7 t -121.22 4.16 10.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.5 OUTLIER -111.97 -156.97 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.161 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.407 ' CG ' ' HE2' ' A' ' 181' ' ' LYS . 16.5 m-85 -154.84 -171.63 3.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.558 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 0.9 OUTLIER -53.01 150.71 5.33 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.048 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.81 -168.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.528 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -143.24 81.28 1.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.925 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 55.6 t80 -62.28 93.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.668 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 178' ' ' LEU . 1.1 mp -58.21 -41.01 83.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.16 -130.44 3.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.357 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -164.28 141.21 6.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 111.046 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.89 172.7 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.486 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 4.1 pt-20 -95.15 142.43 27.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.889 0.376 . . . . 0.0 111.053 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.71 163.65 36.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -121.24 65.34 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.058 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -175.77 -70.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.036 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.422 ' HA ' HD13 ' A' ' 163' ' ' ILE . 0.7 OUTLIER 58.72 25.89 13.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.863 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.88 61.8 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.64 160.78 24.37 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.722 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.493 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -77.18 -30.8 55.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.782 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.626 ' H ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER -69.01 -23.04 64.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.028 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.5 t -58.56 -33.37 48.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 110.537 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.862 ' HB3' ' HB2' ' A' ' 161' ' ' SER . 58.5 m -80.54 -37.01 32.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.615 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.3 -34.7 78.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.93 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 108' ' ' VAL . 8.4 mt-10 -76.96 -52.84 8.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.908 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.92 66.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.962 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 tp -66.08 -36.68 83.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.951 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.8 tptp -70.22 -46.21 64.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 104' ' ' GLU . 11.0 t -60.75 -38.06 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.867 HD23 ' HG3' ' A' ' 114' ' ' ARG . 18.7 mt -61.55 -31.97 72.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.075 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 110' ' ' ARG . 1.2 tpp85 -78.08 -32.88 50.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.5 ' NE2' ' HA ' ' A' ' 108' ' ' VAL . 4.3 mt-30 -81.89 -15.36 54.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.793 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.7 m -105.13 179.42 4.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.82 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.612 ' H ' HH11 ' A' ' 113' ' ' ARG . 0.0 OUTLIER -115.88 65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.867 ' HG3' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -88.26 20.32 3.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 55.34 95.04 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.993 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 93.3 Cg_endo -80.5 127.27 6.43 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.79 2.326 . . . . 0.0 112.087 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.33 143.79 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.225 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -102.69 97.83 7.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.65 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -131.64 163.06 23.79 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.911 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.475 ' HB3' ' HE1' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -87.18 124.22 33.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.735 0.302 . . . . 0.0 110.977 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.835 HD13 HG22 ' A' ' 130' ' ' VAL . 29.4 tp -96.85 135.34 38.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.763 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.642 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 1.9 m-70 -125.43 105.39 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.094 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 11.4 t -70.46 104.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 0.0 110.838 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -104.81 143.37 33.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.408 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.31 28.96 1.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.848 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 124' ' ' SER . 3.0 t70 -153.51 21.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.594 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 124.73 131.72 3.71 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.523 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.672 HD23 HD11 ' A' ' 121' ' ' LEU . 1.7 mp -67.16 168.77 9.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 14.5 ttm180 -168.75 115.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.903 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.835 HG22 HD13 ' A' ' 121' ' ' LEU . 3.9 t -107.97 109.21 27.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.07 0.462 . . . . 0.0 111.421 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.57 115.38 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.941 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.405 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 88.5 m-20 -50.9 144.58 8.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.24 17.19 21.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.988 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -127.67 -8.69 5.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.606 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.09 -8.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.843 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp 58.1 25.78 12.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.551 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.18 -138.5 0.25 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.444 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' A' ' 141' ' ' ASP . 15.7 tp -159.09 116.06 2.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.663 0.268 . . . . 0.0 110.438 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.632 HG13 ' HB ' ' A' ' 130' ' ' VAL . 3.6 pt -106.73 -28.48 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.562 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.638 ' HB ' HG23 ' A' ' 130' ' ' VAL . 43.1 t -137.35 116.65 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.167 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.588 ' HB2' HD21 ' A' ' 138' ' ' LEU . 17.8 t0 -130.04 29.91 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.345 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -76.55 -167.51 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.206 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 144' ' ' ILE . 1.8 m -123.66 171.0 9.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.658 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.47 HD11 ' O ' ' A' ' 124' ' ' SER . 47.3 mt -88.03 -28.16 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.701 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.77 -8.98 50.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.86 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -92.96 -39.63 11.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 143' ' ' THR . 1.2 m -61.77 126.1 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.013 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.39 -49.9 73.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.414 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 163' ' ' ILE . 12.3 m-85 -130.44 -171.94 2.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.095 0.474 . . . . 0.0 111.526 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.3 t -162.35 35.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.31 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.488 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -68.41 143.58 95.64 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.498 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.914 ' HD3' ' HB2' ' B' ' 2' ' ' PHE . 71.6 Cg_endo -87.68 -89.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.722 2.281 . . . . 0.0 112.111 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -167.72 -163.93 0.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 110.755 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.96 28.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.015 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.39 45.89 19.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -164.89 -27.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.912 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -75.58 -18.04 59.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 56.53 18.94 3.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.071 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.731 ' HA3' HD23 ' A' ' 178' ' ' LEU . . . -127.9 129.33 6.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.671 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -102.91 168.87 8.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.604 0.24 . . . . 0.0 110.448 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.862 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 24.4 m -158.76 155.65 28.35 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.012 0.434 . . . . 0.0 111.375 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -132.29 160.05 37.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.077 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -117.14 153.63 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.401 . . . . 0.0 111.638 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 6.4 t -159.49 118.12 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.447 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.665 HH21 ' HB3' ' B' ' 10' ' ' PHE . 15.2 ptt85 -74.01 -152.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.29 -178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -55.45 -179.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.199 0.523 . . . . 0.0 111.69 -178.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.93 -8.37 29.5 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 15.2 t -170.08 -5.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.244 -0.478 . . . . 0.0 109.934 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.505 HG22 ' HG3' ' A' ' 171' ' ' ARG . 22.4 m -133.43 -12.6 2.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.054 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 170' ' ' ARG . 43.3 mtt180 62.29 22.58 13.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.799 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.505 ' HG3' HG22 ' A' ' 169' ' ' THR . 0.0 OUTLIER -175.71 -179.07 1.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.9 OUTLIER -81.49 124.0 29.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.9 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -142.5 126.33 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 34.8 t -104.11 136.32 43.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.198 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 162' ' ' TYR . 1.3 m80 -105.82 145.69 30.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.359 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.05 154.73 21.49 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.185 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -161.66 144.67 12.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.715 0.293 . . . . 0.0 110.739 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.731 HD23 ' HA3' ' A' ' 159' ' ' GLY . 1.1 mt -105.29 162.52 13.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.131 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.13 122.5 32.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 84' ' ' SER . 0.5 OUTLIER -71.83 -11.23 60.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.935 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.407 ' HE2' ' CG ' ' A' ' 83' ' ' PHE . 8.2 mmmt -89.34 -17.21 29.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.715 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 53.84 80.63 0.11 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.02 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.42 -43.08 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.091 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.94 31.61 55.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.306 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -146.08 -34.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.701 0.286 . . . . 0.0 110.793 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.49 ' HB2' HD12 ' A' ' 187' ' ' LEU . 0.7 OUTLIER -59.51 -28.25 66.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.793 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.574 HD23 HD23 ' A' ' 121' ' ' LEU . 4.8 mp -117.04 -39.13 3.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.879 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 191' ' ' VAL . 0.5 OUTLIER -57.13 -63.06 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.32 -179.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -16.05 61.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.373 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.0 -53.61 8.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.025 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.475 ' HA ' HG11 ' A' ' 123' ' ' VAL . 9.9 p -63.46 -18.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -74.08 -1.54 59.99 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.334 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 18.3 m -120.54 -4.7 9.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.32 . . . . 0.0 110.781 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.586 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -74.82 -45.61 42.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.248 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 38.9 p90 -68.3 -36.18 78.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.072 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -56.65 -31.69 64.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.022 0.439 . . . . 0.0 110.69 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.46 -19.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.812 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.634 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.8 OUTLIER -73.37 -6.02 43.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.548 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 196' ' ' ALA . 2.6 mt -88.74 14.02 11.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -92.11 -34.96 14.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.196 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.271 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.914 ' HB2' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -145.7 -98.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.573 0.225 . . . . 0.0 111.17 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.504 ' H ' ' HB3' ' B' ' 2' ' ' PHE . 7.9 t 62.96 157.14 0.06 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.137 0.494 . . . . 0.0 111.246 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -92.51 176.53 6.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.829 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 2.2 mtp -123.32 -7.31 8.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.7 p -83.62 6.87 19.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -62.56 145.57 54.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -106.85 10.11 30.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 t70 54.42 70.54 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.983 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.665 ' HB3' HH21 ' A' ' 165' ' ' ARG . 44.8 m-85 -61.3 134.92 93.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.967 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.598 2.199 . . . . 0.0 112.445 -179.725 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.0 t60 . . . . . 0 N--CA 1.461 0.085 0 CA-C-O 120.862 0.363 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.6 ' H ' HE21 ' A' ' 68' ' ' GLN . 0.1 OUTLIER -63.9 -48.28 77.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -25.18 68.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.929 0.395 . . . . 0.0 110.757 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -70.12 -7.78 44.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -125.96 -8.89 6.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.969 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -91.13 -25.53 19.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.966 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.63 -34.3 77.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.721 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 2.4 mt-10 -92.38 -9.38 41.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 81' ' ' CYS . . . -60.16 -50.59 73.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.2 t -56.51 -40.61 69.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.955 0.407 . . . . 0.0 110.432 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.721 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 5.3 mtm180 -65.03 -32.03 73.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.332 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.2 m -81.12 3.46 23.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.61 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.409 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 65.01 41.92 4.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.42 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -176.17 85.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.56 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 13.1 t -116.35 21.4 13.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.371 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.733 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.1 OUTLIER -117.06 -160.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.33 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.416 ' O ' HG13 ' A' ' 85' ' ' VAL . 3.2 m-85 -158.66 -169.5 2.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.537 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 2.3 t -48.94 142.09 6.93 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.893 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 83' ' ' PHE . 22.3 m -138.0 -171.47 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.062 0.458 . . . . 0.0 111.761 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -141.65 60.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.416 179.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.504 ' O ' HG23 ' A' ' 117' ' ' VAL . 71.4 t80 -53.26 114.84 1.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.03 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -82.66 -56.08 4.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.022 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.0 -124.64 1.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.483 ' HB3' ' ND1' ' A' ' 175' ' ' HIS . 1.2 p -164.76 142.19 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.936 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.453 HG22 HD11 ' A' ' 109' ' ' LEU . 15.5 m -133.51 163.41 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.998 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -91.56 130.14 37.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.7 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.606 HG21 HG11 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -131.54 128.98 61.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.195 -179.402 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -91.26 68.7 5.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 98' ' ' GLY . 0.7 OUTLIER -162.18 -65.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.137 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.722 ' HA ' HG21 ' A' ' 101' ' ' VAL . 50.4 p 52.78 22.66 2.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.991 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 96' ' ' SER . 10.1 mtp180 -149.36 -56.19 0.19 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.912 0.386 . . . . 0.0 111.601 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.6 ' H ' ' HG2' ' A' ' 95' ' ' GLU . . . -61.6 135.96 47.17 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.692 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.1 tpt 53.32 23.28 3.17 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.527 0.331 . . . . 0.0 111.789 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 151' ' ' ALA . 11.3 mp0 61.03 5.15 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.408 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' A' ' 96' ' ' SER . 2.3 t 53.43 30.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.856 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.6 p -118.18 -47.43 2.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.219 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -3.38 13.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.586 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -118.22 -57.57 2.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.65 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -54.58 -53.21 57.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.214 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.646 HD11 ' HG ' ' A' ' 178' ' ' LEU . 4.1 tp -50.34 -34.49 24.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -67.15 -38.52 85.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.803 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 36.7 t -63.57 -46.8 93.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.318 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.704 HD23 ' HG3' ' A' ' 114' ' ' ARG . 3.5 mp -72.46 -18.79 61.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.109 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -94.84 -11.13 29.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.541 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -71.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.581 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.8 t -175.89 88.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.381 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -165.17 -62.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.704 ' HG3' HD23 ' A' ' 109' ' ' LEU . 3.8 mmp_? -101.24 110.35 22.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.381 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -62.44 134.06 94.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.119 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.494 ' HB2' ' HE2' ' A' ' 86' ' ' LYS . 73.3 Cg_endo -78.28 161.1 29.13 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.654 2.236 . . . . 0.0 112.603 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -130.36 153.75 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.79 179.265 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.48 97.57 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -141.46 166.9 26.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.5 113.92 25.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.331 . . . . 0.0 110.878 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.982 HD13 HG22 ' A' ' 130' ' ' VAL . 25.4 tp -83.8 138.48 33.22 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.758 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.528 ' H ' HD12 ' A' ' 121' ' ' LEU . 11.2 m170 -123.17 84.18 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.733 ' H ' ' HB2' ' A' ' 82' ' ' SER . 48.4 t -58.75 102.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.852 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.565 ' O ' HD11 ' A' ' 144' ' ' ILE . 3.7 p -105.18 144.33 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.548 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.7 19.8 1.93 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.888 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.0 22.64 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.665 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.18 118.5 2.59 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.395 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.416 ' CD2' HG22 ' A' ' 123' ' ' VAL . 2.7 mt -54.1 144.7 18.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 111.171 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 16.4 ttm180 -147.58 112.21 5.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.982 HG22 HD13 ' A' ' 121' ' ' LEU . 1.9 t -100.39 133.32 43.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.093 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.5 t -121.97 109.05 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.458 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -53.03 157.49 1.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.218 -179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -3.64 53.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.986 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -116.19 -54.69 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.386 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.6 m -80.74 -31.84 35.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.459 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 4.2 mmtm 52.39 29.95 7.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.9 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.19 -108.7 1.51 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.45 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tp -160.59 113.76 2.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.678 0.275 . . . . 0.0 110.727 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 mt -94.55 -49.07 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.36 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.754 ' HB ' HG23 ' A' ' 130' ' ' VAL . 93.4 t -122.45 102.52 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.433 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.42 25.95 11.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.408 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.443 ' HG2' HG13 ' A' ' 140' ' ' VAL . 56.1 mm-40 -76.23 -156.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.166 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.866 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 59.9 m -135.46 161.75 34.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.966 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.565 HD11 ' O ' ' A' ' 124' ' ' SER . 2.5 mt -77.24 -33.42 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.718 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.671 ' H ' HG22 ' A' ' 143' ' ' THR . 5.6 mt-10 -86.09 -24.3 26.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.389 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.866 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 0.1 OUTLIER -60.03 -41.04 91.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.772 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.6 m -73.16 144.92 12.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.8 t -49.56 -55.28 14.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.763 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' B' ' 3' ' ' SER . 30.8 p90 -168.97 126.93 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.72 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 116.67 13.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . . . -131.11 104.07 15.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.036 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.519 ' HB3' ' HD1' ' A' ' 160' ' ' PHE . 32.7 Cg_exo -62.3 -88.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.674 2.249 . . . . 0.0 112.248 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -166.48 177.95 6.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.66 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -145.6 33.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.072 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.42 ' HB3' ' H ' ' A' ' 156' ' ' HIS . 0.7 OUTLIER -124.0 -87.24 0.63 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 179.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.42 ' H ' ' HB3' ' A' ' 155' ' ' ASN . 1.9 t60 178.36 3.94 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 156' ' ' HIS . 2.8 mm-40 -68.52 -8.31 40.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.334 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.439 ' HB2' ' NH1' ' A' ' 158' ' ' ARG . 0.9 OUTLIER 56.47 23.23 7.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.982 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -106.31 147.46 16.24 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.351 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.519 ' HD1' ' HB3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -124.48 169.16 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.634 0.254 . . . . 0.0 110.845 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.513 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 3.3 m -168.58 151.0 5.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.082 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.663 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -134.95 148.04 49.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.531 178.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.894 HG23 ' HB3' ' A' ' 174' ' ' CYS . 0.2 OUTLIER -103.89 151.38 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.209 -179.056 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.91 106.95 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.85 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 15.7 ptm180 -68.29 -156.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.196 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.08 -162.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.462 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.93 -10.16 53.7 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.405 ' H ' ' H ' ' A' ' 169' ' ' THR . 0.6 OUTLIER -155.45 -19.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.949 0.404 . . . . 0.0 110.302 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 173' ' ' MET . 2.9 m -130.25 -2.41 4.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.721 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.5 9.64 3.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -172.44 -176.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.658 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -78.52 122.08 25.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.4 . . . . 0.0 110.942 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.539 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.0 OUTLIER -147.74 110.06 4.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.738 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.894 ' HB3' HG23 ' A' ' 163' ' ' ILE . 28.2 p -98.11 159.89 14.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.231 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.663 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 4.6 m-70 -122.96 142.2 51.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.228 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.513 ' HA2' ' OG ' ' A' ' 161' ' ' SER . . . -111.8 150.12 18.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.856 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -170.29 133.35 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.872 0.368 . . . . 0.0 110.756 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 106' ' ' LEU . 4.7 mp -110.16 171.07 7.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.244 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.44 128.47 41.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.165 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.5 OUTLIER -78.37 -0.34 28.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.576 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.98 -21.08 18.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 158' ' ' ARG . 11.6 m-20 55.51 83.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.97 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.2 t -168.99 -42.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.19 42.63 42.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.441 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.02 -34.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.743 0.306 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.455 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 0.3 OUTLIER -75.84 -16.65 60.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.504 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 191' ' ' VAL . 4.5 mp -126.93 -44.17 1.65 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.019 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 t -59.98 -69.19 0.23 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -21.0 58.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.02 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.9 -52.61 19.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 187' ' ' LEU . 96.5 t -61.16 -31.46 50.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.673 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.27 -17.43 46.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.283 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 96.1 m -104.12 -11.37 17.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.719 0.295 . . . . 0.0 110.845 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.99 -33.63 67.32 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.041 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.536 ' HA ' ' HB2' ' A' ' 198' ' ' CYS . 0.0 OUTLIER -77.51 -34.99 53.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.279 178.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.404 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -55.87 -26.03 45.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.874 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.49 -19.46 5.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.686 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -72.56 -12.08 60.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.604 178.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 196' ' ' ALA . 1.5 mt -81.2 10.64 5.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.879 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -56.36 -20.94 21.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.377 -0.289 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.42 ' HB2' ' H ' ' B' ' 3' ' ' SER . 1.2 p90 -88.12 -148.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.495 0.188 . . . . 0.0 110.547 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 1.4 p -163.91 162.99 23.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.855 0.359 . . . . 0.0 111.192 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' B' ' 7' ' ' PHE . 41.5 p-10 -76.44 175.4 9.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.063 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 36.6 mtp -128.33 -24.14 3.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.2 t -90.0 23.64 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.466 ' HB3' ' ND2' ' B' ' 4' ' ' ASN . 43.5 p90 -65.08 149.87 49.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -83.82 0.48 47.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 t0 57.41 94.67 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.026 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.585 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 11.1 m-85 -90.4 -51.32 0.33 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.504 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 35.8 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.113 1.875 . . . . 0.0 112.272 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -108.55 -35.51 6.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.295 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -63.57 -23.07 67.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.048 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -70.82 -25.09 62.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.934 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.63 -23.83 16.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.959 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.47 -26.08 32.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.81 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -29.52 70.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.703 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.65 -17.35 17.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.791 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -52.63 -51.57 59.46 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.295 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 194' ' ' ALA . 10.4 t -58.29 -43.97 87.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.727 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -55.17 -39.06 69.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.655 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -72.44 -91.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.638 179.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.462 ' H ' ' HB2' ' A' ' 78' ' ' SER . . . 179.84 36.4 0.0 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.24 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.575 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -173.77 101.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 111.556 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 75' ' ' ALA . 8.5 t -134.54 55.46 1.89 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.844 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.499 ' CB ' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -152.59 -163.05 1.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.822 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.48 ' CG ' ' HE3' ' A' ' 181' ' ' LYS . 10.5 m-85 -156.96 -171.33 3.61 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.819 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -49.56 145.96 4.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.919 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.0 m -143.89 173.53 5.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.971 0.415 . . . . 0.0 111.83 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -122.38 61.19 0.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.327 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.538 ' HA ' ' HB3' ' A' ' 177' ' ' PHE . 1.0 OUTLIER -54.06 96.28 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.94 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -62.86 -31.36 72.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.78 -131.76 5.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.519 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -158.9 130.27 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.404 HG22 HD11 ' A' ' 109' ' ' LEU . 2.3 m -120.64 136.21 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.977 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 112.56 5.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.069 0.461 . . . . 0.0 110.659 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.403 HG21 HG11 ' A' ' 101' ' ' VAL . 17.0 m -103.58 173.64 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -122.2 64.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -149.53 -90.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 p 63.3 9.62 4.15 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.454 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.433 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -166.52 47.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.988 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -125.21 -129.68 3.39 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.27 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.42 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 9.4 ttt -75.38 -73.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.578 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.584 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . 4.9 mt-30 -146.57 -24.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.824 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.403 HG11 HG21 ' A' ' 93' ' ' VAL . 39.0 t 73.18 -30.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.291 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 100' ' ' GLN . 3.7 p -63.17 -27.61 69.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.714 ' HG3' ' HB3' ' A' ' 154' ' ' ARG . 2.0 tt0 -59.53 -18.26 38.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.79 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.8 mt-10 -120.02 -44.63 2.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.727 0.299 . . . . 0.0 111.457 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.554 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -55.13 -46.31 75.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.597 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 tp -54.23 -33.73 59.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.181 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.598 ' HE3' ' HE ' ' A' ' 110' ' ' ARG . 11.5 tptm -74.93 -45.54 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.229 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 104' ' ' GLU . 16.1 t -56.54 -30.1 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.396 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.613 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.5 mt -87.66 -23.54 24.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.008 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.598 ' HE ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -82.46 -9.95 59.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.473 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 107' ' ' LYS . 42.1 mt-30 -75.21 -62.85 1.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.723 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 113' ' ' ARG . 2.0 t -177.33 -168.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.544 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 112' ' ' SER . 1.3 mpt_? 70.61 -69.19 0.18 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.297 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.613 ' HG3' HD23 ' A' ' 109' ' ' LEU . 8.3 mmt180 -84.28 91.8 7.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.456 ' H ' ' HG2' ' A' ' 115' ' ' ARG . 6.5 ptp180 -69.08 141.7 92.15 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.707 ' HB3' HD23 ' A' ' 88' ' ' LEU . 72.3 Cg_endo -77.73 133.16 12.51 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.589 2.193 . . . . 0.0 112.69 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.0 143.59 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.969 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -101.72 108.19 19.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -150.68 178.98 27.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.44 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.435 HD12 ' NE2' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -99.67 118.01 35.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.74 0.305 . . . . 0.0 111.033 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.74 HD13 HG22 ' A' ' 130' ' ' VAL . 24.4 tp -92.89 138.46 31.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.642 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.526 ' H ' HD12 ' A' ' 121' ' ' LEU . 11.3 m170 -123.62 103.67 8.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.02 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.499 HG23 ' CB ' ' A' ' 82' ' ' SER . 42.8 t -71.66 102.45 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.4 . . . . 0.0 110.513 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.584 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.2 OUTLIER -106.16 117.95 35.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.359 179.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.72 -16.17 3.69 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.713 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -111.59 34.63 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.687 0.279 . . . . 0.0 110.975 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.764 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 114.75 111.31 2.87 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.412 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.17 162.55 5.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.961 0.41 . . . . 0.0 111.299 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.56 119.85 5.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.513 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.74 HG22 HD13 ' A' ' 121' ' ' LEU . 1.9 t -107.15 127.94 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.605 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.52 156.29 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.506 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.99 148.26 23.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.766 0.317 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.438 ' HB2' ' HA2' ' A' ' 119' ' ' GLY . 0.7 OUTLIER -99.09 19.79 14.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -138.94 -9.32 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.965 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 137' ' ' GLY . 13.6 t -154.16 -10.39 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.876 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 13.8 mmtm 60.16 27.26 16.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.552 ' H ' HG23 ' A' ' 135' ' ' THR . . . -73.62 -159.68 5.92 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.408 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' ' 141' ' ' ASP . 11.5 tp -121.97 118.73 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.689 0.28 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.52 HD12 HG12 ' A' ' 130' ' ' VAL . 8.7 mt -96.84 -55.26 6.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.012 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.495 HG11 ' OH ' ' A' ' 162' ' ' TYR . 95.6 t -139.2 118.07 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.497 ' HB2' HD21 ' A' ' 138' ' ' LEU . 4.4 t0 -122.06 74.06 1.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -119.47 -165.01 1.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.187 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.764 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 1.6 m -115.52 177.31 4.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.908 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.656 HD13 ' HB1' ' A' ' 194' ' ' ALA . 8.1 mt -96.18 -42.3 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.835 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -81.3 -10.21 59.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.664 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.708 ' HE2' HG21 ' A' ' 168' ' ' THR . 1.7 ttpm? -77.03 -43.35 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.811 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.451 HG11 ' CD2' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -70.29 154.2 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.948 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.62 -68.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.921 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' B' ' 3' ' ' SER . 0.0 OUTLIER -155.19 129.15 8.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.999 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 m -85.58 104.76 15.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.826 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.512 ' HB1' ' HG2' ' A' ' 100' ' ' GLN . . . -118.2 133.18 23.48 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.261 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.839 ' HD2' ' HA3' ' B' ' 1' ' ' GLY . 56.3 Cg_endo -70.69 -87.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.407 2.072 . . . . 0.0 112.156 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -145.69 -166.23 2.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.78 0.324 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.714 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -70.69 -13.91 62.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -166.4 -63.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.68 55.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.966 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -86.3 30.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.968 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? 56.17 19.39 3.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.963 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -125.55 134.64 8.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.578 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -131.3 142.82 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.644 0.259 . . . . 0.0 110.772 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 102' ' ' CYS . 1.2 m -153.51 131.2 11.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.069 0.462 . . . . 0.0 111.402 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.495 ' OH ' HG11 ' A' ' 140' ' ' VAL . 38.1 p90 -109.13 164.99 11.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.519 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.505 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.3 OUTLIER -126.84 163.2 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.448 -179.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.75 110.87 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.678 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.739 ' HA ' ' HA ' ' A' ' 172' ' ' TRP . 2.5 ptp180 -72.37 -163.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.132 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -175.05 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.71 -2.04 88.4 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.488 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.708 HG21 ' HE2' ' A' ' 146' ' ' LYS . 8.8 t -167.75 -12.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.392 . . . . 0.0 110.471 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.7 OUTLIER -136.14 1.12 2.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.928 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 64.79 1.52 1.43 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.465 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 171' ' ' ARG . 5.1 ptp180 -175.47 -179.68 1.31 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.032 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.739 ' HA ' ' HA ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -86.0 94.18 9.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.064 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.67 ' HB2' HG21 ' A' ' 169' ' ' THR . 0.9 OUTLIER -107.23 129.93 54.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.505 ' HB2' HG23 ' A' ' 163' ' ' ILE . 17.9 t -114.14 110.95 20.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.102 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . 3.1 m80 -85.26 126.44 33.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.012 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -112.95 154.19 17.08 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.526 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.538 ' HB3' ' HA ' ' A' ' 87' ' ' TYR . 30.6 p90 -166.21 175.93 7.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.827 0.346 . . . . 0.0 111.064 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.1 mp -137.89 175.16 9.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.932 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.489 ' HB2' ' HE2' ' A' ' 160' ' ' PHE . . . -105.06 119.53 39.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 0.5 OUTLIER -71.11 -13.67 62.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.728 ' HB2' ' HD2' ' A' ' 186' ' ' ARG . 1.5 mmmp? -83.05 -30.95 27.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.954 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 57.09 92.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.331 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.535 ' HB3' ' HD3' ' A' ' 186' ' ' ARG . 1.5 t -169.22 -38.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.517 ' H ' ' CZ ' ' A' ' 186' ' ' ARG . . . 76.65 47.53 9.95 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.635 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -155.96 -36.33 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.828 0.347 . . . . 0.0 110.908 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.728 ' HD2' ' HB2' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -66.09 -29.99 70.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 186' ' ' ARG . 4.7 mp -118.69 -42.19 2.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.371 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 t -57.66 -75.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.443 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -58.85 -24.78 62.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.2 -56.75 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.076 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.63 -34.06 53.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 195' ' ' PHE . . . -60.45 -15.35 38.76 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.619 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 73.4 m -102.34 -12.77 17.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.64 0.257 . . . . 0.0 111.093 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.656 ' HB1' HD13 ' A' ' 144' ' ' ILE . . . -58.14 -29.18 65.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.414 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.46 ' CG ' ' HA ' ' B' ' 4' ' ' ASN . 0.1 OUTLIER -81.49 -27.23 34.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.788 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.672 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -62.03 -12.88 21.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.03 -31.64 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -1.89 19.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.819 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' A' ' 196' ' ' ALA . 3.4 mt -75.44 -8.67 57.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.964 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.06 -25.39 66.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.038 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.751 179.791 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.839 ' HA3' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.463 ' CE1' ' HD3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -108.21 -49.15 3.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.696 0.284 . . . . 0.0 110.517 179.06 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.699 ' HB2' ' HB3' ' A' ' 149' ' ' PHE . 4.8 p 62.51 154.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.477 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.46 ' HA ' ' CG ' ' A' ' 195' ' ' PHE . 0.6 OUTLIER -70.47 153.69 42.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.13 -21.11 12.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.805 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t -95.41 20.78 8.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.438 ' HB3' ' OD1' ' B' ' 4' ' ' ASN . 26.3 p90 -61.5 149.07 39.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.976 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -103.49 -4.56 23.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.911 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 54.64 83.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.933 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 14.7 m-85 -56.58 145.34 60.8 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 40.0 Cg_exo . . . . . 0 C--O 1.25 1.088 0 C-N-CA 122.55 2.167 . . . . 0.0 112.387 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.943 0.401 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.86 -38.37 19.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.001 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -26.42 61.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.035 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -74.06 -2.84 26.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . -126.78 -11.41 6.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.08 -43.73 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -80.3 -46.4 16.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.887 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 77' ' ' ARG . 12.9 tt0 -65.5 -23.1 66.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.006 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -55.8 -52.8 62.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.132 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 194' ' ' ALA . 3.1 t -62.79 -43.01 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.624 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.477 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 37.2 mtp180 -54.22 -34.93 61.79 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.329 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 79' ' ' ALA . 11.6 m -78.05 -90.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.369 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.431 ' H ' ' HB2' ' A' ' 78' ' ' SER . . . 177.05 36.22 0.0 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.232 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.527 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -170.41 101.2 0.26 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.889 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 2.9 t -127.94 -147.35 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.285 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.771 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.47 -163.06 0.1 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 111.607 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.554 ' HB3' ' HD3' ' A' ' 181' ' ' LYS . 2.1 m-85 -158.28 -169.09 2.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.333 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 180' ' ' CYS . 3.5 m -42.58 144.26 0.56 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.762 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.637 HG12 HD21 ' A' ' 187' ' ' LEU . 34.9 m -139.5 -170.55 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.591 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.69 74.81 1.19 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.701 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.584 ' HB3' HG23 ' A' ' 117' ' ' VAL . 42.8 t80 -58.56 97.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.09 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -64.18 -33.63 76.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.81 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.54 -152.05 24.15 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.5 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.41 129.98 32.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.312 . . . . 0.0 110.797 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.68 152.86 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -84.81 144.66 28.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.44 -172.23 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.997 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -150.0 59.81 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.064 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.508 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -170.06 -77.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.98 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.6 m 61.01 24.83 14.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.988 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 3.5 ptt-85 -135.78 37.61 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.774 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -160.15 161.24 32.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.486 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.458 ' HG2' ' HB1' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -83.92 -37.25 22.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 111.065 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -70.4 -9.77 57.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.168 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.84 -36.88 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.85 0.357 . . . . 0.0 110.925 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.562 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 3.5 m -79.17 -24.62 43.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.478 ' HA ' ' OD2' ' A' ' 153' ' ' ASP . 0.4 OUTLIER -71.62 -7.74 49.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.972 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.4 mm-40 -111.77 -49.89 2.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.963 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.2 -41.83 80.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.635 ' HA ' HD12 ' A' ' 109' ' ' LEU . 3.1 tp -58.24 -36.96 73.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.604 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -67.39 -38.07 84.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.607 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 104' ' ' GLU . 3.6 t -60.7 -33.33 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.557 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 106' ' ' LEU . 2.5 mt -77.39 -26.94 52.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.661 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.97 -21.02 44.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.614 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -98.48 1.23 46.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.974 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.95 172.05 13.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.954 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.453 ' H ' ' HG2' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -110.74 74.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.717 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.546 ' HG3' HD23 ' A' ' 109' ' ' LEU . 4.2 mmp_? -86.87 36.63 0.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.177 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 115' ' ' ARG . 0.1 OUTLIER 56.16 87.13 0.15 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.65 178.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 3.5 Cg_exo -76.2 116.39 4.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.969 2.446 . . . . 0.0 111.886 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -85.43 145.42 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.966 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -104.26 102.6 12.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.327 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.741 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -158.78 -137.64 2.3 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.176 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.474 ' HA ' HG22 ' A' ' 85' ' ' VAL . 3.0 pp -155.2 169.56 23.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 111.101 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.706 HD13 HG22 ' A' ' 130' ' ' VAL . 54.4 tp -112.07 140.25 46.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.136 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 4.7 m-70 -121.5 85.65 2.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.112 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.889 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 69.0 t -60.4 93.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.159 0.504 . . . . 0.0 111.228 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.583 ' O ' HD11 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -87.05 142.04 28.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.857 177.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.87 23.47 1.7 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.415 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 124' ' ' SER . 21.6 t0 -155.55 27.61 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.529 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 127.25 112.24 1.73 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.282 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.46 159.35 8.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.83 0.348 . . . . 0.0 111.026 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -154.5 116.74 4.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.706 HG22 HD13 ' A' ' 121' ' ' LEU . 13.6 t -101.24 106.09 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.086 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.22 129.35 53.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.977 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.741 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -64.4 175.78 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.01 -4.66 13.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -117.04 -45.13 2.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.381 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.6 m -92.22 -24.04 19.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.451 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 54.09 32.89 16.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.627 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -102.87 -178.56 26.72 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.466 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 tp -87.11 135.9 33.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.808 0.337 . . . . 0.0 110.792 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 130' ' ' VAL . 40.8 mt -116.88 -51.77 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.034 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.598 HG13 ' HG2' ' A' ' 142' ' ' GLN . 92.7 t -117.75 103.72 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.863 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -96.36 32.94 1.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.598 ' HG2' HG13 ' A' ' 140' ' ' VAL . 20.2 mm100 -77.5 -173.06 2.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.849 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 82.8 m -150.09 148.91 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.776 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.583 HD11 ' O ' ' A' ' 124' ' ' SER . 1.0 OUTLIER -63.22 -39.87 86.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.628 179.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.564 ' H ' HG22 ' A' ' 143' ' ' THR . 1.7 mt-10 -84.46 13.92 5.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.681 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.643 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 10.0 tttp -115.43 -48.49 2.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.978 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 164' ' ' CYS . 5.8 m -69.58 146.48 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.101 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.6 t -53.54 -63.09 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.414 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' B' ' 3' ' ' SER . 0.3 OUTLIER -170.73 146.23 2.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.776 178.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.37 165.59 22.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.96 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.562 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -167.16 100.82 0.63 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.222 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.854 ' HD2' ' HA3' ' B' ' 1' ' ' GLY . 5.8 Cg_exo -76.25 30.94 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.037 2.491 . . . . 0.0 112.433 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 103' ' ' GLU . 1.0 OUTLIER 60.4 -93.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.104 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -131.79 -4.45 3.63 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.016 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.23 44.08 22.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -139.27 -24.43 0.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.803 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -105.84 11.29 32.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.986 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 57.67 27.29 14.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.162 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.38 130.31 9.35 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.488 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.583 ' HZ ' ' HA2' ' A' ' 184' ' ' GLY . 3.3 m-85 -128.93 152.56 48.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.338 . . . . 0.0 111.012 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.55 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -161.74 148.51 14.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.09 162.47 24.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.843 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.74 HG23 ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -120.47 151.43 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.076 0.465 . . . . 0.0 111.418 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.504 ' HB2' HG12 ' A' ' 147' ' ' VAL . 10.0 t -150.95 148.03 27.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.332 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HB2' ' H ' ' A' ' 166' ' ' ASP . 0.1 OUTLIER -100.09 -158.66 0.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 -179.496 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.442 ' H ' ' HB2' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -57.24 -176.85 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.207 0.527 . . . . 0.0 111.658 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 168' ' ' THR . . . 108.72 -12.07 35.34 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 167' ' ' GLY . 0.5 OUTLIER -163.62 -22.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.134 -0.533 . . . . 0.0 109.984 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.406 HG22 ' HG3' ' A' ' 171' ' ' ARG . 33.3 m -113.2 -12.77 13.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.832 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 65.12 17.2 10.95 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.284 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 171' ' ' ARG . 0.9 OUTLIER -173.0 -170.03 0.61 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.051 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.68 112.86 24.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.3 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.59 173.53 8.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.461 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.74 ' HB2' HG23 ' A' ' 163' ' ' ILE . 19.5 t -155.01 129.59 9.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.752 0.31 . . . . 0.0 111.292 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.43 155.17 17.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.504 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -137.48 155.46 23.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.786 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.488 ' HE2' HD23 ' A' ' 187' ' ' LEU . 11.9 p90 -166.62 176.07 7.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.361 . . . . 0.0 110.811 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.2 mp -146.23 152.05 38.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.795 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.33 113.28 7.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 4.0 t -57.37 -41.52 80.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.554 ' HD3' ' HB3' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -73.36 -21.29 60.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.557 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 62.27 103.68 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.997 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.8 t -163.77 -43.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.583 ' HA2' ' HZ ' ' A' ' 160' ' ' PHE . . . 76.39 17.34 80.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.317 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.73 -25.67 2.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 0.0 111.018 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -80.8 -17.7 49.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.991 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.637 HD21 HG12 ' A' ' 85' ' ' VAL . 9.5 mp -119.59 -46.6 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.229 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 t -61.86 -56.77 15.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.517 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.92 -5.46 21.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.621 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -96.78 -48.42 5.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.698 0.285 . . . . 0.0 111.544 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.491 ' HA ' HG11 ' A' ' 123' ' ' VAL . 1.7 p -70.7 -22.11 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.211 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.88 67.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.395 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 77.4 m -119.72 4.39 11.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.773 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.651 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -78.11 -51.77 9.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.169 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.549 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 51.0 p90 -63.72 -26.2 68.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.705 ' HA ' HD11 ' A' ' 199' ' ' LEU . . . -62.45 -23.14 66.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.11 11.85 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.6 -13.05 10.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.979 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.705 HD11 ' HA ' ' A' ' 196' ' ' ALA . 0.4 OUTLIER -119.55 -0.45 10.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.141 179.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -103.5 -47.54 4.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.239 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.058 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.854 ' HA3' ' HD2' ' A' ' 152' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.7 -156.36 0.7 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.67 0.271 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -167.63 150.13 5.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.843 179.677 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' B' ' 7' ' ' PHE . 0.1 OUTLIER -60.19 146.78 42.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.739 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 12.0 mtm -116.45 -15.63 10.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.127 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 9.1 p -84.74 20.79 1.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.205 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.472 ' HB3' ' OD1' ' B' ' 4' ' ' ASN . 44.0 p90 -64.05 149.8 46.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -90.62 11.94 20.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . . . . . . . . . 39.0 t0 56.0 85.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.804 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.581 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 2.7 m-85 -92.85 -52.24 0.27 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.392 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 26.5 Cg_exo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.117 1.878 . . . . 0.0 112.212 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.816 0.341 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.87 -34.06 17.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.67 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -31.31 72.46 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.732 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -67.38 -17.36 64.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.59 -15.75 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.841 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.56 -18.07 18.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.768 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -62.63 -38.91 92.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.568 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.749 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -92.27 -7.5 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.429 179.259 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 81' ' ' CYS . . . -65.85 -49.12 69.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.84 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 ' CB ' ' A' ' 81' ' ' CYS . 1.2 t -61.06 -36.31 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.047 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.749 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -66.53 -34.36 77.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.276 178.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.32 6.26 14.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.756 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 124' ' ' SER . . . 66.32 42.43 3.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.589 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.415 ' HB ' ' ND1' ' A' ' 122' ' ' HIS . 1.5 t -177.19 86.95 0.02 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.241 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.536 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 11.5 t -116.69 4.84 13.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.473 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.698 ' HB2' ' H ' ' A' ' 123' ' ' VAL . 0.4 OUTLIER -103.78 -167.93 1.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.721 0.295 . . . . 0.0 111.251 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -152.74 -171.07 3.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -39.0 141.99 0.25 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.823 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -149.41 -165.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.323 -179.409 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.19 70.61 0.93 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -61.58 119.88 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.82 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.457 ' HB2' HD22 ' A' ' 109' ' ' LEU . 1.2 mp -79.03 -75.39 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.259 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.85 -117.57 0.45 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.349 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.608 ' N ' HD21 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -159.14 128.45 5.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.713 0.292 . . . . 0.0 110.768 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.506 HG13 ' HG ' ' A' ' 109' ' ' LEU . 3.7 m -123.12 158.03 28.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.331 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.1 152.64 30.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.583 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.9 m -141.55 150.09 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.303 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.454 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 1.7 t80 -118.48 59.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.389 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 94' ' ' PHE . 4.7 mt-10 -154.07 -68.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.692 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.62 14.99 1.92 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.211 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -141.13 116.54 10.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.008 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.8 -170.98 15.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.561 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.408 ' O ' ' HG2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -116.06 -26.28 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 110.738 -179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -69.28 -11.71 61.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.321 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.416 ' HB ' HD11 ' A' ' 163' ' ' ILE . 14.1 t -59.6 -27.5 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.887 0.375 . . . . 0.0 110.988 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 73.2 m -79.32 -39.32 33.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.151 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.36 -14.69 63.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.285 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.8 mt-10 -103.98 -47.77 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.039 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.95 74.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.16 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 tp -57.37 -44.4 84.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.72 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.571 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -69.08 -34.34 74.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.606 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.2 t -61.68 -31.0 49.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.333 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.608 HD21 ' N ' ' A' ' 90' ' ' CYS . 1.2 mt -80.29 -30.32 38.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.852 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.571 ' HG2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -80.41 -21.2 42.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.501 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -19.2 20.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.901 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.6 m -100.32 10.97 40.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.057 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER 32.01 78.79 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.301 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -95.07 22.2 6.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.909 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 56.59 104.94 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.861 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.59 149.16 30.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.514 2.143 . . . . 0.0 111.951 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.439 HG12 ' OD1' ' A' ' 132' ' ' ASP . 0.7 OUTLIER -103.88 136.34 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.085 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.13 82.61 8.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.063 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 132' ' ' ASP . . . -151.76 -179.6 27.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.132 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.17 158.22 24.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 0.0 111.236 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.669 HD13 HG22 ' A' ' 130' ' ' VAL . 67.7 tp -96.09 146.7 24.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.222 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.415 ' ND1' ' HB ' ' A' ' 80' ' ' THR . 1.7 m170 -123.68 76.85 1.46 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.821 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.698 ' H ' ' HB2' ' A' ' 82' ' ' SER . 40.7 t -53.0 104.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.956 0.408 . . . . 0.0 110.582 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.658 ' O ' HD11 ' A' ' 144' ' ' ILE . 2.0 t -110.48 126.39 54.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.469 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -55.6 -14.29 6.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.607 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -108.29 31.09 5.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 0.0 110.831 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 114.87 125.5 4.03 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.6 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -62.5 163.82 8.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.86 0.362 . . . . 0.0 110.947 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.415 ' HB3' HH11 ' A' ' 129' ' ' ARG . 0.3 OUTLIER -169.76 133.9 1.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.78 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.669 HG22 HD13 ' A' ' 121' ' ' LEU . 2.8 t -110.12 125.91 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.85 0.357 . . . . 0.0 111.261 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.31 132.23 64.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.619 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.592 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -61.87 -173.89 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 0.0 111.018 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.74 -15.47 5.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.774 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.54 -22.04 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.584 HG23 ' H ' ' A' ' 137' ' ' GLY . 9.4 t -133.19 -18.79 2.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.331 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.32 33.5 23.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.737 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.584 ' H ' HG23 ' A' ' 135' ' ' THR . . . -84.11 145.68 22.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.439 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 24.0 tp -75.1 128.86 36.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.787 0.327 . . . . 0.0 110.924 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.5 mt -111.1 -50.37 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.625 ' HB ' HG23 ' A' ' 130' ' ' VAL . 53.8 t -104.25 114.99 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.971 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -117.27 57.44 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.716 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.58 -176.2 2.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.133 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.554 ' O ' HG22 ' A' ' 147' ' ' VAL . 2.4 m -121.16 168.63 11.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.667 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.658 HD11 ' O ' ' A' ' 124' ' ' SER . 5.8 mt -84.33 -33.09 8.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 110.873 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -83.67 -13.16 54.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.615 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -87.05 -42.35 13.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.981 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 143' ' ' THR . 0.6 OUTLIER -61.73 126.7 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.923 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.85 -37.72 63.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.878 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.849 ' HB2' HD12 ' A' ' 163' ' ' ILE . 9.6 m-85 -151.97 166.37 31.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.084 0.469 . . . . 0.0 111.626 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' B' ' 3' ' ' SER . 0.5 OUTLIER -147.75 63.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.797 177.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.452 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -90.06 136.93 28.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.984 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 160' ' ' PHE . 72.7 Cg_endo -80.16 -91.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.704 2.269 . . . . 0.0 111.603 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -136.23 -166.75 1.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.677 0.275 . . . . 0.0 110.655 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -116.81 9.22 13.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.029 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -168.14 -65.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.851 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.33 39.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.716 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.89 0.36 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.006 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 158' ' ' ARG . 0.0 OUTLIER 58.16 21.7 8.3 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.755 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.63 123.3 4.46 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -115.39 161.94 17.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.645 0.259 . . . . 0.0 110.54 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -158.92 -177.87 6.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.013 0.435 . . . . 0.0 111.448 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -156.38 158.06 36.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.085 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.849 HD12 ' HB2' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -123.71 165.04 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.069 0.461 . . . . 0.0 112.027 -177.288 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.42 ' H ' HG22 ' A' ' 163' ' ' ILE . 5.7 p -165.57 135.6 3.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.394 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -160.43 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 111.263 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -175.17 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.442 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.25 -7.32 69.16 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.445 ' H ' ' H ' ' A' ' 169' ' ' THR . 2.1 t -168.95 -11.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.216 -0.492 . . . . 0.0 110.002 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.673 HG21 ' HB2' ' A' ' 173' ' ' MET . 0.2 OUTLIER -128.08 -7.88 5.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.739 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 64.15 9.72 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.574 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -176.12 -173.72 0.58 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.968 0.413 . . . . 0.0 111.317 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.93 108.07 19.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.593 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.673 ' HB2' HG21 ' A' ' 169' ' ' THR . 24.9 mtp -128.36 133.51 48.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.759 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.437 ' HB2' HG23 ' A' ' 163' ' ' ILE . 43.5 t -113.58 132.43 55.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' A' ' 161' ' ' SER . 35.1 m170 -98.8 158.72 15.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.624 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -139.81 149.41 20.78 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.005 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 10.3 p90 -157.08 135.98 11.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.78 0.324 . . . . 0.0 110.815 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.68 160.19 14.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.499 ' HB2' ' CE2' ' A' ' 160' ' ' PHE . . . -96.52 118.02 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -6.56 45.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -26.76 20.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.765 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.16 75.87 0.26 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.027 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -165.65 -32.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.786 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 63.82 37.09 94.17 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.514 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -133.29 -31.25 1.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 111.011 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.443 ' H ' ' HG2' ' A' ' 186' ' ' ARG . 4.1 mmt180 -88.16 -5.72 58.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.82 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 191' ' ' VAL . 0.2 OUTLIER -128.07 -58.0 1.22 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.29 -179.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -62.51 1.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.344 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.98 -19.64 32.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.29 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.05 -45.65 33.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.03 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 187' ' ' LEU . 40.0 t -66.4 -29.05 45.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.962 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.53 -17.69 48.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.366 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 68.6 m -110.58 -8.73 14.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 110.761 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.1 94.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.187 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.518 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 3.5 p90 -70.42 -29.59 66.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.763 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.08 -22.7 51.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.066 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 49.4 t -101.43 -21.95 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.528 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.16 -28.23 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.467 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 195' ' ' PHE . 0.3 OUTLIER -103.34 47.77 0.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.516 178.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.0 -34.0 71.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.039 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.709 179.715 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.81 174.58 14.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.724 0.297 . . . . 0.0 110.77 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.406 ' HA ' ' SG ' ' A' ' 150' ' ' CYS . 0.2 OUTLIER -156.76 166.43 33.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.148 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.559 HD22 ' HB3' ' B' ' 7' ' ' PHE . 1.1 p-10 -70.12 128.14 35.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.994 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 1.2 mtm -95.97 -19.76 19.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.516 ' HB3' HD23 ' A' ' 199' ' ' LEU . 16.0 p -75.04 7.38 3.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.559 ' HB3' HD22 ' B' ' 4' ' ' ASN . 38.7 p90 -57.19 146.92 26.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -99.44 11.36 39.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.716 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . 0.404 ' H ' ' HD2' ' B' ' 7' ' ' PHE . 13.4 t70 54.42 72.74 0.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.953 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.464 ' HA ' ' HD3' ' B' ' 11' ' ' PRO . 65.8 m-85 -65.84 139.98 97.07 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 10' ' ' PHE . 28.1 Cg_exo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.678 2.252 . . . . 0.0 112.31 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.78 0.324 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -115.07 -41.98 3.26 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.13 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -27.54 68.74 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.031 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -70.15 -22.2 63.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.16 -17.98 15.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.54 -29.31 22.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -69.17 -38.41 78.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.688 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HA ' ' HG3' ' A' ' 77' ' ' ARG . 1.5 tt0 -84.98 -10.61 56.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.641 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 80' ' ' THR . . . -59.87 -54.92 40.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.009 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 194' ' ' ALA . 14.6 t -58.17 -40.32 76.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.542 ' HG3' ' HA ' ' A' ' 74' ' ' GLU . 5.8 mtp180 -58.51 -38.29 77.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.456 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 m -75.13 -91.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.414 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 124' ' ' SER . . . 179.65 35.29 0.0 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.53 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.634 ' HA ' ' HB3' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -173.16 99.78 0.12 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.895 0.379 . . . . 0.0 111.739 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' HIS . 4.1 t -120.73 -150.02 0.44 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.23 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.573 ' HB2' HG23 ' A' ' 123' ' ' VAL . 0.3 OUTLIER 53.77 -157.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 111.539 179.202 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.577 ' HB3' ' HE2' ' A' ' 181' ' ' LYS . 6.1 m-85 -159.0 -167.03 1.99 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.416 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.7 m -51.59 153.61 2.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.706 0.289 . . . . 0.0 110.995 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.487 HG21 ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -144.33 -173.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.415 -179.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 86' ' ' LYS . 10.1 mmmm -142.3 63.95 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.69 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.487 ' HE1' HG21 ' A' ' 85' ' ' VAL . 31.8 m-85 -57.81 103.12 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.54 HD13 ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -67.69 -33.61 75.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.479 -178.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.73 -167.44 28.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.602 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.5 ' HB3' ' NE2' ' A' ' 175' ' ' HIS . 0.0 OUTLIER -114.89 128.44 56.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.074 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.76 144.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.028 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.49 141.96 42.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.06 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.94 154.98 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -120.97 61.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.812 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 22.3 mt-10 -152.42 -76.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.254 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m 62.67 29.76 16.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -151.4 107.3 3.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.659 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.57 146.3 7.56 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.316 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.416 ' HG3' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -78.03 -23.39 48.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.748 0.309 . . . . 0.0 110.953 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 99' ' ' MET . 0.4 OUTLIER -70.31 -20.74 62.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.104 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.8 t -59.73 -39.24 79.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 151' ' ' ALA . 57.6 m -70.77 -36.89 73.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -9.2 18.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.219 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.493 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.5 mt-10 -99.93 -55.53 2.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.011 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.55 -31.79 66.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.238 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.514 HD21 ' HA3' ' A' ' 159' ' ' GLY . 6.8 tp -59.18 -46.56 88.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -67.01 -32.24 73.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.829 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.3 t -58.39 -49.94 80.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.986 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.615 HD23 ' HG3' ' A' ' 114' ' ' ARG . 1.3 mt -64.68 -22.31 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.678 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 110' ' ' ARG . 7.0 tpt180 -82.45 -28.14 31.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.709 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -97.67 -2.2 41.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.919 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.434 ' HB3' ' HG2' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -107.1 -177.65 3.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.049 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.79 16.29 5.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.093 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.615 ' HG3' HD23 ' A' ' 109' ' ' LEU . 12.2 mmt180 -67.46 99.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.929 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -73.47 135.71 78.61 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 74.2 Cg_endo -77.12 161.74 32.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.585 2.19 . . . . 0.0 112.552 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -124.25 108.73 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.738 179.339 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 96.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.998 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -139.0 161.9 25.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.533 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.509 HD12 ' CE1' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -89.28 129.86 35.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 111.025 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.761 HD13 HG22 ' A' ' 130' ' ' VAL . 28.0 tp -101.48 123.42 45.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.634 ' HB3' ' HA ' ' A' ' 80' ' ' THR . 12.1 m-70 -112.81 89.3 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.911 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 82' ' ' SER . 69.1 t -68.82 89.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.399 . . . . 0.0 110.937 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.692 ' HB2' ' HA ' ' A' ' 79' ' ' ALA . 1.2 p -84.32 150.74 25.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.234 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.32 34.4 2.44 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.385 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.99 19.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.809 0.338 . . . . 0.0 110.754 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.685 ' HA2' ' HA ' ' A' ' 143' ' ' THR . . . 134.04 112.59 1.31 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.546 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.432 ' CD2' HG13 ' A' ' 123' ' ' VAL . 1.5 mt -65.42 154.05 39.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 111.184 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.492 ' HD3' HG22 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -151.52 124.79 8.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.8 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.761 HG22 HD13 ' A' ' 121' ' ' LEU . 2.8 t -112.45 113.75 45.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.441 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.492 HG22 ' HD3' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -107.6 117.25 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.581 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 2.6 t0 -51.96 158.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.699 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -108.89 0.95 20.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.061 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.69 -20.46 8.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.191 0.52 . . . . 0.0 110.01 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.1 m -123.4 -24.84 4.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.067 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 54.81 27.34 8.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.793 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.22 -109.6 1.19 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.364 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.649 HD21 ' HB2' ' A' ' 141' ' ' ASP . 27.3 tp -160.02 131.2 5.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.778 0.323 . . . . 0.0 111.1 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.8 mt -113.47 -48.92 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.041 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.5 t -136.93 112.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.649 ' HB2' HD21 ' A' ' 138' ' ' LEU . 3.2 t0 -118.14 65.57 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.798 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -112.61 -171.8 1.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.947 ' HB ' ' HB2' ' A' ' 146' ' ' LYS . 38.1 m -125.21 158.72 33.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.765 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.433 ' H ' HG13 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -66.31 -48.08 82.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.916 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -75.09 -21.95 58.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.612 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.947 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 2.8 ttmm -63.07 -52.34 63.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.694 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 147' ' ' VAL . 2.3 m -67.95 143.09 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -44.92 -67.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.107 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.509 ' HA ' ' ND2' ' B' ' 4' ' ' ASN . 0.1 OUTLIER -165.08 124.93 1.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.961 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.0 t -63.85 159.37 19.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.765 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.519 ' HB3' ' SG ' ' A' ' 102' ' ' CYS . . . -157.25 136.06 7.88 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.421 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 153' ' ' ASP . 89.5 Cg_endo -80.2 -142.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.643 2.228 . . . . 0.0 111.993 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 0.8 OUTLIER -111.81 -153.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.77 179.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -36.17 65.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.048 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.471 HD22 ' CG ' ' A' ' 156' ' ' HIS . 0.4 OUTLIER -157.32 -58.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.251 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.471 ' CG ' HD22 ' A' ' 155' ' ' ASN . 0.6 OUTLIER -166.38 37.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.14 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -72.87 10.68 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.706 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.625 ' HG2' ' HA ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER 57.81 25.77 12.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.965 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.514 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -119.45 112.06 2.19 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.652 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 1.5 m-85 -119.55 151.57 38.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.715 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -159.81 170.26 21.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.858 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.581 ' HE1' ' HB2' ' A' ' 175' ' ' HIS . 0.1 OUTLIER -147.51 164.46 33.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.158 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.5 132.6 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.058 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 26.4 p -111.01 153.64 25.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -119.1 94.01 4.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.008 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.64 ' HB3' ' HA ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 49.08 29.17 2.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.481 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 168' ' ' THR . . . -65.35 -13.82 58.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.551 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 167' ' ' GLY . 9.0 t 175.75 15.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.736 HG21 ' HG3' ' A' ' 173' ' ' MET . 24.6 m -124.78 -11.52 7.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.887 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 166' ' ' ASP . 0.0 OUTLIER 60.49 31.15 20.23 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.719 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.428 ' CG ' HG22 ' A' ' 169' ' ' THR . 0.2 OUTLIER -176.35 -168.43 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.589 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.99 126.17 39.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.362 . . . . 0.0 111.196 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.736 ' HG3' HG21 ' A' ' 169' ' ' THR . 1.4 mtp -142.24 161.38 38.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.635 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 33.9 t -140.69 116.07 10.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.077 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.581 ' HB2' ' HE1' ' A' ' 162' ' ' TYR . 11.9 m-70 -92.15 134.5 34.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.71 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.715 ' HA2' ' HB3' ' A' ' 161' ' ' SER . . . -118.0 143.34 17.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.532 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 160' ' ' PHE . 41.4 p90 -149.96 154.16 37.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 0.0 111.223 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.89 135.49 51.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.643 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -59.74 117.49 5.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -16.12 63.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.741 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.577 ' HE2' ' HB3' ' A' ' 83' ' ' PHE . 3.4 mmtt -88.41 -26.91 21.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.781 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.625 ' HA ' ' HG2' ' A' ' 158' ' ' ARG . 4.3 m-20 57.59 87.64 0.06 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 10.2 t -162.5 -30.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.996 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.94 20.35 76.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.399 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -137.66 2.09 2.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.689 0.28 . . . . 0.0 111.02 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.472 ' HB2' HD12 ' A' ' 187' ' ' LEU . 7.8 mmt85 -106.25 -14.88 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.738 HD23 HD23 ' A' ' 121' ' ' LEU . 4.4 mp -134.55 -39.94 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -59.27 -60.26 4.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -18.21 64.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.31 -41.55 63.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 187' ' ' LEU . 67.7 t -73.62 -29.53 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.68 -7.64 29.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.248 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.571 ' O ' HG23 ' A' ' 197' ' ' VAL . 68.3 m -108.47 -19.77 13.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.697 0.284 . . . . 0.0 110.751 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.458 ' HA ' HG11 ' A' ' 76' ' ' VAL . . . -58.91 -60.8 3.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.159 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -64.69 -32.71 74.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.664 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.641 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -57.44 -16.81 10.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.236 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 193' ' ' CYS . 56.4 t -105.34 -29.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.055 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -9.56 58.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.718 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 196' ' ' ALA . 4.3 mt -81.93 77.67 8.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.915 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -74.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.601 -0.2 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.27 -66.73 0.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.641 0.258 . . . . 0.0 110.996 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 93.0 p 51.4 95.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.177 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 149' ' ' PHE . 3.9 p30 -52.38 146.26 9.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.396 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 23.2 ttm -113.03 3.86 16.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.914 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.8 p -94.02 19.35 9.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.429 ' HD1' ' H ' ' B' ' 9' ' ' ASP . 28.6 p90 -62.88 152.24 36.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.01 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -85.05 11.55 9.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.739 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ASP . . . . . 0.429 ' H ' ' HD1' ' B' ' 7' ' ' PHE . 22.5 t0 57.46 80.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.035 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.625 ' HB2' ' HD3' ' B' ' 11' ' ' PRO . 24.0 m-85 -90.38 -50.8 0.34 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.248 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' B' ' 10' ' ' PHE . 45.0 Cg_exo . . . . . 0 C--O 1.25 1.085 0 C-N-CA 122.197 1.932 . . . . 0.0 112.278 -179.766 . . . . . . . . 1 1 . 1 stop_ save_